Citrus Sinensis ID: 007397
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.993 | 0.767 | 0.501 | 1e-173 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.985 | 0.731 | 0.482 | 1e-166 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.996 | 0.709 | 0.443 | 1e-159 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.996 | 0.703 | 0.425 | 1e-157 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.991 | 0.710 | 0.441 | 1e-154 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.995 | 0.710 | 0.427 | 1e-150 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.991 | 0.720 | 0.421 | 1e-144 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.985 | 0.707 | 0.417 | 1e-143 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.985 | 0.698 | 0.437 | 1e-143 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.973 | 0.718 | 0.415 | 1e-135 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 610 bits (1572), Expect = e-173, Method: Compositional matrix adjust.
Identities = 314/626 (50%), Positives = 418/626 (66%), Gaps = 25/626 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVS----------FRLDNSTAKHARSGPWNGQT 50
MK G N TG R+LT WR+ DDP+ G+ + F L ++ R+GPWNG
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G+P +K + +++ E+EVYY +K N +V TR+QL NG R+ W + W+
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPS-D 167
S D CD Y CG+ +C ++E+P+C CL GF++K+ + W + D S CVR+ D
Sbjct: 282 FYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLD 341
Query: 168 CPGGE-GFLKLPKMKLPENY--WSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLM 224
C GE GFLK+ K+KLP+ W +++M L EC+ C +NC+C AY+ + GG GC++
Sbjct: 342 CGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCIL 401
Query: 225 WFGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRR----VDQENQDQIEDLELPLFELAT 280
WFGDLIDI+E +E GQD ++R+ +S++ +R V Q++ EDLELP +L T
Sbjct: 402 WFGDLIDIREYNEN---GQDLYVRLASSEIETLQRESSRVSSRKQEE-EDLELPFLDLDT 457
Query: 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
++ AT FS NKLG+GGFG VYKGTL GQE+AVKRLS+ S QG+ E KNE+ L +KLQ
Sbjct: 458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQ 517
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
HRNLVK+LG C+ EE++LIYE+ PNKSLD FIFD+ +R LDW KR II G ARG+LY
Sbjct: 518 HRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLY 577
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH+DSRLRIIHRDLK SNVLLD DMN KISDFGLART GGDE E +T +V+GTYGYM+PE
Sbjct: 578 LHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPE 637
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
Y DG FS+KSDVFSFG+LVLEIVSG+RNRG N ++K N++ HAW + + +++ID
Sbjct: 638 YQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDE 697
Query: 521 CYQESC-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKS 579
ESC + EV+R IHI LLCVQ P+DRP+M V+LML S+ +L P+QPG +R
Sbjct: 698 AVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNL 757
Query: 580 TGPDSSSSKPESSSTNASTFTEVEGR 605
D+ S E S N T + ++ R
Sbjct: 758 LFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 584 bits (1505), Expect = e-166, Method: Compositional matrix adjust.
Identities = 320/663 (48%), Positives = 415/663 (62%), Gaps = 67/663 (10%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDN------------STAKHARSGPWNG 48
MKLG N KT E L+ W++ DP+PGD + LD ++ R G WNG
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221
Query: 49 QTFEGIPWM--KDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTS 106
+F G P M ++S+F EV Y + P + +RL L N G HRF+ +
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP-RHRIVSRLVLNNTGKLHRFI-QSKQN 279
Query: 107 KWHKLYSWPFDHCDNYAECGANSNCRVSE--TPSCECLTGFISKSQEDWD-SPDSRSCVR 163
+W + P D CD Y+ CGA + C ++ TPSC CL GF KS W+ S + CV
Sbjct: 280 QWILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVH 339
Query: 164 K-PSDCPGGEGFLKLPKMKLPENYWS----NQSMSLRECEAECTKNCSCRAYANSQVVGG 218
+ P++C + F+K P +KLP+ WS M+L +C+ +C+ NCSC AYAN+ + G
Sbjct: 340 EIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREG 399
Query: 219 GNGCLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDLGYR--------------------- 257
G GCL+WFGDL+D++E S +GQD +IR+ + + ++
Sbjct: 400 GKGCLLWFGDLVDMREYSS---FGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVV 456
Query: 258 ----------RRVDQEN---QDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYK 304
+R EN + EDL+LP+F+ TI+ ATD+FS N LG GGFG VYK
Sbjct: 457 VFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYK 516
Query: 305 GTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364
G L DGQEIAVKRLS S QG+ E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+M
Sbjct: 517 GKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYM 576
Query: 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD 424
PNKSLD+FIFD+ + LDW KR +II G ARG+LYLHQDSRLRIIHRDLK NVLLD+D
Sbjct: 577 PNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDND 636
Query: 425 MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIV 484
MNPKISDFGLA++FGGD+ E STN+V+GTYGYM PEYA DG FSVKSDVFSFG+LVLEI+
Sbjct: 637 MNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEII 696
Query: 485 SGKRNRGLYNSDNKFNVIRHAWNLW--NKGMPWQLIDACYQESCNPDEVIRCIHISLLCV 542
+GK NRG ++D+ N++ H W +W ++ + + + S P EV+RCIH++LLCV
Sbjct: 697 TGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIP-EVLRCIHVALLCV 755
Query: 543 QHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEV 602
Q PEDRP+M SV+LM GSDS L P QPG +R PD SSS S N + T +
Sbjct: 756 QQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNV--PDISSSL-SLRSQNEVSITML 812
Query: 603 EGR 605
+GR
Sbjct: 813 QGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 563 bits (1451), Expect = e-159, Method: Compositional matrix adjust.
Identities = 304/686 (44%), Positives = 410/686 (59%), Gaps = 83/686 (12%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLD----------NSTAKHARSGPWNGQT 50
MKLGW+ KTGF R++ W+S DDP+ GD SF+L+ N ++ RSGPWNG
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIR 226
Query: 51 FEGIPWMKDSVFKLI-VEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G+P M+ + + ++EV Y F+ V +RL + ++G RF W ET W+
Sbjct: 227 FSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN 286
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPS-D 167
+ + P D CD Y ECG C + +P C C+ GF ++ + W D S CVRK
Sbjct: 287 QFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLS 346
Query: 168 CPGGEGFLKLPKMKLPENYWS--NQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
C GG+GF++L KMKLP+ + ++ + ++ECE +C ++C+C A+AN+ + G G+GC+ W
Sbjct: 347 CGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTW 406
Query: 226 FGDLIDIKECSEK-----------------------------------------YVWGQ- 243
G+L DI+ ++ ++W +
Sbjct: 407 TGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRK 466
Query: 244 ---DFFIRVPTSD--------------LGYRRRVDQENQDQIEDLELPLFELATIANATD 286
I P D + RR + +EN +DLELPL E +A AT+
Sbjct: 467 QKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENN--TDDLELPLMEFEEVAMATN 524
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
NFS NKLG+GGFG VYKG L+DGQE+AVKRLSK S QG +E KNEV L ++LQH NLV+
Sbjct: 525 NFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVR 584
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
LL CC+ EK+LIYE++ N SLD +FD+++ L+W RF II G ARGLLYLHQDSR
Sbjct: 585 LLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSR 644
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
RIIHRDLK SN+LLD M PKISDFG+AR FG DE E +T KV+GTYGYM+PEYA DG+
Sbjct: 645 FRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGI 704
Query: 467 FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526
FS+KSDVFSFG+L+LEI+S KRN+G YNSD N++ W W +G ++ID +S
Sbjct: 705 FSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSS 764
Query: 527 NP---DEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS-VLAQPKQPGCLVDRKSTGP 582
+ E++RCI I LLCVQ EDRP+M VILMLGS+S + QPK PG ++R
Sbjct: 765 STFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDT 824
Query: 583 DSSSSKP---ESSSTNASTFTEVEGR 605
DSSSSK ES + N T + ++ R
Sbjct: 825 DSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 554 bits (1427), Expect = e-157, Method: Compositional matrix adjust.
Identities = 294/691 (42%), Positives = 414/691 (59%), Gaps = 88/691 (12%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKH----------ARSGPWNGQT 50
MKLG+NLKTG R+LT WRS+DDP+ G+ S++L+ + RSGPWNG
Sbjct: 169 MKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIR 228
Query: 51 FEGIPWMKDSVFKLIVEH---KEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSK 107
F GIP +D +V + +EV Y F+ N++ +RL L + G + R W +
Sbjct: 229 FSGIP--EDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRI 286
Query: 108 WHKLYSWPFD-HCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKP 165
W++ +S P D CD Y CG + C V+ +P C C+ GF ++ + WD + C+R+
Sbjct: 287 WNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRT 346
Query: 166 SDCPGGEGFLKLPKMKLPENYWS--NQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCL 223
G+GF ++ KMKLPE + ++S+ ++EC+ C +C+C A+AN+ + GG+GC+
Sbjct: 347 QLSCSGDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCV 406
Query: 224 MWFGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRVD---------------------- 261
+W L DI+ + + GQD ++R+ +D+ +R
Sbjct: 407 IWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLW 466
Query: 262 -----------------QENQD------------------QIEDLELPLFELATIANATD 286
Q NQ+ + E+LELPL E+ T+ AT+
Sbjct: 467 KRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATE 526
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
NFS NKLG+GGFG VYKG L+DG+EIAVKRLSK S QG +E NEV L ++LQH NLV+
Sbjct: 527 NFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQ 586
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
+LGCCI+G+EK+LIYE++ N SLD ++F +T+R L+W++RF I G ARGLLYLHQDSR
Sbjct: 587 VLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSR 646
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
RIIHRDLK SN+LLD +M PKISDFG+AR F DE E +T KV+GTYGYM+PEYA G+
Sbjct: 647 FRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGI 706
Query: 467 FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526
FS KSDVFSFG++VLEIVSGK+NRG YN D + +++ + W+ W +G +++D +S
Sbjct: 707 FSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSL 766
Query: 527 N-------PDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQPGCLVDRK 578
+ P EV++CI I LLCVQ E RP+M SV+ M GS++ + QPK PG V R
Sbjct: 767 SSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRS 826
Query: 579 STGPDSSSS----KPESSSTNASTFTEVEGR 605
D SSS + ES + N T + ++ R
Sbjct: 827 PYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 306/693 (44%), Positives = 410/693 (59%), Gaps = 93/693 (13%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKHA----------RSGPWNGQT 50
MK G+ ++G +R +T WRS DP G++++R++ R+G W GQ
Sbjct: 158 MKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217
Query: 51 FEGIPWMKDS-VFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
+ G+P M + +F + + DEV + ++ +VTTR+ L GT RF W+ KW
Sbjct: 218 WSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQRFRWNGRDKKWI 277
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPS--CECLTGFISKSQEDW---DSPDSRSCVRK 164
+S P D CD Y CG N C + T C CL G+ K+ DW D+ D + ++
Sbjct: 278 GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTRIKA 337
Query: 165 PSDCPGGEGFLKLPKMKLPENYWSNQSM--SLRECEAECTKNCSCRAYANS--QVVGGGN 220
S C G EGF KL ++K+P N M +L+ECE C KNCSC AYA++ + G
Sbjct: 338 DSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGAK 397
Query: 221 GCLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDLG------------------------- 255
GCL W G+++D + GQDF++RV S+L
Sbjct: 398 GCLTWHGNMLDTRTYLSS---GQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVM 454
Query: 256 --------YRRRVDQENQ------------------------DQIED----LELPLFELA 279
Y R+ Q Q +++ED ELPLFEL+
Sbjct: 455 LLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELS 514
Query: 280 TIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL 339
TIA AT+NF+ NKLG GGFG VYKG L +G EIAVKRLSK S QG+ E KNEV L SKL
Sbjct: 515 TIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKL 574
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
QHRNLV++LGCC++ EEK+L+YE++PNKSLDYFIF + +R LDW KR II G RG+L
Sbjct: 575 QHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGIL 634
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
YLHQDSRLRIIHRDLK SNVLLD++M PKI+DFGLAR FGG++IEGSTN+V+GTYGYM+P
Sbjct: 635 YLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSP 694
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
EYA DG FS+KSDV+SFG+L+LEI++GKRN Y + N+++H W+ W G ++ID
Sbjct: 695 EYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWENGEAIEIID 752
Query: 520 ACY-QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQPGCLVDR 577
+E+ + EV++C+HI LLCVQ + DRP M SV+ MLG +++ L PK P R
Sbjct: 753 KLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGR 812
Query: 578 K---STGPDSSS--SKPESSSTNASTFTEVEGR 605
+ TG S + S SS+ N T T+V+GR
Sbjct: 813 RRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 531 bits (1369), Expect = e-150, Method: Compositional matrix adjust.
Identities = 293/686 (42%), Positives = 398/686 (58%), Gaps = 84/686 (12%)
Query: 1 MKLGWNLKTG-FERYLTPWRSADDPTPGDVS----------FRLDNSTAKHARSGPWNGQ 49
MK+GW+ K+G F R L W++ DDP+ GD S F + N + RSGPW G
Sbjct: 165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224
Query: 50 TFEGIPWMK--DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSK 107
F +P MK D + E+ + +V Y ++ + + L L + G R W E
Sbjct: 225 RFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQS 283
Query: 108 WHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPDSRSCVRKPS- 166
W +L+ P D CDNY ECG C + +P C C+ GF +++ DS CVRK
Sbjct: 284 WKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKL 343
Query: 167 DCPGGEGFLKLPKMKLPENYWS--NQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLM 224
C G +GF++L KM+LP+ + ++ + L+ECE C K C+C A+AN+ + GG+GC++
Sbjct: 344 SCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVI 403
Query: 225 WFGDLIDI---------------------KECSEKYVWG--------------------- 242
W G L DI K K + G
Sbjct: 404 WSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKR 463
Query: 243 ---QDFFIRVPTSDL-------------GYRRRVDQENQDQIEDLELPLFELATIANATD 286
+ I+ P DL R +EN+ + LELPL E +A AT+
Sbjct: 464 KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENK--TDYLELPLMEWKALAMATN 521
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
NFS +NKLG+GGFG VYKG L+DG+EIAVKRLSK+S QG +E NEV L +KLQH NLV+
Sbjct: 522 NFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVR 581
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
LLGCC+ EK+LIYE++ N SLD +FDQT+ L+W KRF II G ARGLLYLHQDSR
Sbjct: 582 LLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSR 641
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
RIIHRDLK SNVLLD +M PKISDFG+AR FG +E E +T +V+GTYGYM+PEYA DG+
Sbjct: 642 CRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGI 701
Query: 467 FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526
FS+KSDVFSFG+L+LEI+SGKRN+G YNS+ N++ W W +G +++D ++
Sbjct: 702 FSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDAL 761
Query: 527 NPD----EVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD-SVLAQPKQPGCLVDR--KS 579
+ + E++RCI I LLCVQ EDRP M SV++MLGS+ + + QPK+PG V R
Sbjct: 762 SSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLE 821
Query: 580 TGPDSSSSKPESSSTNASTFTEVEGR 605
SS+ + + + N T + ++ R
Sbjct: 822 VDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 288/684 (42%), Positives = 391/684 (57%), Gaps = 84/684 (12%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKHA----------RSGPWNGQT 50
M+LG+ K G +R LT W+S DP GD+ R++ R G W G
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
+ G+P M +F + EDEV + + + +V TR + GT HRF W +W+
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274
Query: 110 KLYSWPFDHCDNYAECGANSNCR--VSETPSCECLTGFISKSQEDWDSPDSR-SCVRK-- 164
+S P + CDNYA CG N C S+T C CL GF K W DS C +K
Sbjct: 275 DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKR 334
Query: 165 PSDCPGGEGFLKLPKMKLPENYWSNQSM--SLRECEAECTKNCSCRAYANS--QVVGGGN 220
S C +GF+KL +MK+P+ ++ M +L+EC+ C KNCSC AYA++ + G
Sbjct: 335 ASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGAI 394
Query: 221 GCLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDLGY------------------------ 256
GCL W G ++D + GQDF+IRV +L
Sbjct: 395 GCLKWHGGMLDARTYLNS---GQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVM 451
Query: 257 ------------RRRVDQENQDQIEDLELPL-------FE-------------LATIANA 284
RR+ ++ +P FE L TI A
Sbjct: 452 LLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVAA 511
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
T+NFS NKLG GGFG VYKG L + EIAVKRLS+ S QG+ E KNEV L SKLQHRNL
Sbjct: 512 TNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNL 571
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V++LGCC++ EEK+L+YE++PNKSLDYFIF + +R LDW KR I+ G ARG+LYLHQD
Sbjct: 572 VRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQD 631
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
SRLRIIHRDLK SN+LLD +M PKISDFG+AR FGG+++EG T++V+GT+GYMAPEYA +
Sbjct: 632 SRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAME 691
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY-Q 523
G FS+KSDV+SFG+L+LEI++GK+N + + N++ H W+LW G ++ID Q
Sbjct: 692 GQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS--NLVGHIWDLWENGEATEIIDNLMDQ 749
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQPGCLVDRKSTGP 582
E+ + EV++CI I LLCVQ + DR M SV++MLG ++ L PK P R+ G
Sbjct: 750 ETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGE 809
Query: 583 DSSSSKPESS-STNASTFTEVEGR 605
+ + K ++ S N TF++++GR
Sbjct: 810 NGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-143, Method: Compositional matrix adjust.
Identities = 285/683 (41%), Positives = 391/683 (57%), Gaps = 87/683 (12%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKHA----------RSGPWNGQT 50
M LG + +TG LT W S DDP+ G+ + + T RSGPWNGQ
Sbjct: 169 MTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIWKNNVPTWRSGPWNGQV 228
Query: 51 FEGIPWMKDSVFKL--IVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKW 108
F G+P M DS+ L + +++ ND+ L+ G ++ W + W
Sbjct: 229 FIGLPNM-DSLLFLDGFNLNSDNQGTISMSYANDSFMYHFNLDPEGIIYQKDWSTSMRTW 287
Query: 109 HKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRK-PS 166
+P+ CD Y CG +C E P C+C+ GF+ K+ +W+ + S C+RK P
Sbjct: 288 RIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPKNNTEWNGGNWSNGCMRKAPL 347
Query: 167 DCP------------GGEGFLKLPKMKLPENYWSNQSMSLRECEAECTKNCSCRAYANSQ 214
C +GFLKL KMK+P + +++ S + C C NCSC AYA +
Sbjct: 348 QCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSEA-SEQVCPKVCLDNCSCTAYAYDR 406
Query: 215 VVGGGNGCLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDLG------------------- 255
G GC++W GDL+D++ G D FIRV S+L
Sbjct: 407 ----GIGCMLWSGDLVDMQSFLGS---GIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLI 459
Query: 256 -----------YRRRV---------------------DQENQDQIEDLELPLFELATIAN 283
Y++R ++ +QI+ ELPLFE +A
Sbjct: 460 AAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQVLAT 519
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
+TD+FS+ NKLG+GGFG VYKG L +GQEIAVKRLS+ S QGL EL NEV++ SKLQHRN
Sbjct: 520 STDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRN 579
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
LVKLLGCCI+GEE++L+YE+MP KSLD ++FD K+++LDW RF+I+ G RGLLYLH+
Sbjct: 580 LVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHR 639
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
DSRL+IIHRDLK SN+LLD ++NPKISDFGLAR F +E E +T +V+GTYGYM+PEYA
Sbjct: 640 DSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAM 699
Query: 464 DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
+G FS KSDVFS G++ LEI+SG+RN + +N N++ +AW LWN G L D
Sbjct: 700 EGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVF 759
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQPGCLVDRKSTGP 582
+ C E+ +C+HI LLCVQ DRP++ +VI ML ++++ LA PKQP +V R ++
Sbjct: 760 DKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEA 819
Query: 583 DSSSSKPESSSTNASTFTEVEGR 605
+SS + S N + T V GR
Sbjct: 820 ESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 299/683 (43%), Positives = 397/683 (58%), Gaps = 87/683 (12%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDN----------STAKHARSGPWNGQT 50
MKLG + K G R++T W+S+ DP+ G F+L+ S + RSGPW+G
Sbjct: 168 MKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFLEVYRSGPWDGLR 227
Query: 51 FEGIPWMK--DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKW 108
F GI M+ D + E++E EV Y F+ + +RL + G F+W+ T +W
Sbjct: 228 FSGILEMQQWDDIIYNFTENRE-EVAYTFRVTDHNSYSRLTINTVGRLEGFMWEPTQQEW 286
Query: 109 HKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPSD 167
+ + P D CD Y CG + C +S +P+C C+ GF S +DW S D + C RK
Sbjct: 287 NMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQPLSPQDWASGDVTGRCRRKTQL 346
Query: 168 CPGGEGFLKLPKMKLPENYWS--NQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
G + F +L MK+P + ++ + L+ECE +C +C+C AYANS + GG+GC++W
Sbjct: 347 TCGEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIW 406
Query: 226 FGDLIDIKECSEKYVWGQDFFI-------------------------------------- 247
G+ DI+ + GQD F+
Sbjct: 407 IGEFRDIRNYAAD---GQDLFVRLAAAEFGERRTIRGKIIGLIIGISLMLVLSFIIYCFW 463
Query: 248 -------RVPTSDLGYRRRVDQ-------------ENQDQIEDLELPLFELATIANATDN 287
R + +GYR R+ + + EDLELPL E T+ AT+N
Sbjct: 464 KKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATEN 523
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
FS +N LG GGFG VYKG L+DGQEIAVKRLS++S QG NE KNEV L ++LQH NLV+L
Sbjct: 524 FSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRL 583
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-LLDWSKRFHIICGTARGLLYLHQDSR 406
L CCI +EK+LIYE++ N SLD +F+ T+ L+W RF II G ARGLLYLHQDSR
Sbjct: 584 LSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSR 643
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
+IIHRDLK SNVLLD +M PKISDFG+AR F DE E +T KV+GTYGYM+PEYA +G+
Sbjct: 644 FKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGI 703
Query: 467 FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526
FSVKSDVFSFG+LVLEIVSGKRNRG +NS N++ + W W +G +++D+ +S
Sbjct: 704 FSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSS 763
Query: 527 ------NPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD-SVLAQPKQPGCLVDRKS 579
P EV+RCI I LLCVQ EDRP M SV+LMLGS+ + QPK+PG V R S
Sbjct: 764 SSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSS 823
Query: 580 --TGPDSSSSKPESSSTNASTFT 600
T SSS+K +S S + T
Sbjct: 824 LDTADSSSSTKRDSESLTVNQIT 846
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 281/676 (41%), Positives = 378/676 (55%), Gaps = 87/676 (12%)
Query: 1 MKLGWNLKTGFERY-LTPWRSADDPTPGDVSFRLDNSTAKHA-------------RSGPW 46
M +G N + G +T W+S DP+PG + L + RSGPW
Sbjct: 161 MLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPW 220
Query: 47 NGQTFEGIPWMKDSVF--KLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDET 104
NGQ F G+P + VF + IV + + ND+ ++ G+ R W ET
Sbjct: 221 NGQMFNGLPDVYAGVFLYRFIV-NDDTNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSET 279
Query: 105 TSKWHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR 163
W P CDNY CG + C + P C C+ GF ++ +W++ + S C R
Sbjct: 280 RRNWTVGLQVPATECDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTR 339
Query: 164 K-PSDCP------GGEGFLKLPKMKLPENYWSNQSMSLRECEAECTKNCSCRAYANSQVV 216
+ P C +GFL+L +MKLP+ + S EC C + CSC A A+
Sbjct: 340 RVPLQCERQNNNGSADGFLRLRRMKLPD-FARRSEASEPECLRTCLQTCSCIAAAH---- 394
Query: 217 GGGNGCLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDLG--------------------- 255
G G GC++W G L+D +E S G D +IR+ S++
Sbjct: 395 GLGYGCMIWNGSLVDSQELSAS---GLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVA 451
Query: 256 ----------YRRRVDQENQD------QIEDL---------ELPLFELATIANATDNFSI 290
++R ++ +D ++E L ELPLFE +A AT+NFS+
Sbjct: 452 ACVLLARRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSL 511
Query: 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGC 350
NKLG+GGFG VYKG L +GQEIAVKRLS+ S QGL EL NEV++ SKLQHRNLVKLLGC
Sbjct: 512 RNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGC 571
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410
CI GEE++L+YEFMP KSLDY++FD + +LLDW RF+II G RGLLYLH+DSRLRII
Sbjct: 572 CIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRII 631
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470
HRDLK SN+LLD ++ PKISDFGLAR F G+E E +T +V+GTYGYMAPEYA GLFS K
Sbjct: 632 HRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEK 691
Query: 471 SDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDE 530
SDVFS G+++LEI+SG+RN + ++ + W++WN+G L+D + E
Sbjct: 692 SDVFSLGVILLEIISGRRN-------SNSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKE 744
Query: 531 VIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQPGCLVDRKSTGPDSSSSKP 589
+ +CIHI LLCVQ DRPS+ +V ML S+ + +PKQP + +SS +
Sbjct: 745 IHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISRNNVPEAESSENSD 804
Query: 590 ESSSTNASTFTEVEGR 605
S N T T+V GR
Sbjct: 805 LKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | ||||||
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.995 | 0.765 | 0.583 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.948 | 0.731 | 0.588 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.993 | 0.747 | 0.553 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.991 | 0.737 | 0.518 | 0.0 | |
| 224122814 | 776 | predicted protein [Populus trichocarpa] | 0.991 | 0.773 | 0.541 | 0.0 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.991 | 0.473 | 0.515 | 0.0 | |
| 302143165 | 657 | unnamed protein product [Vitis vinifera] | 0.995 | 0.916 | 0.528 | 0.0 | |
| 224122822 | 776 | predicted protein [Populus trichocarpa] | 0.991 | 0.773 | 0.535 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.991 | 0.761 | 0.539 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.995 | 0.735 | 0.520 | 0.0 |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/622 (58%), Positives = 452/622 (72%), Gaps = 20/622 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSF--RLDNS--------TAKHARSGPWNGQT 50
MKLGW+L+TG ER L+ WRS+DDP+PGD+++ +L N+ + ++ RSGPW G
Sbjct: 168 MKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIA 227
Query: 51 FEGIP-WMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHR-FVWDETTSKW 108
F G P +++ VFKL EDEVY + N + +R+ + Y + W+E T W
Sbjct: 228 FTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTW 287
Query: 109 HKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR-KPS 166
S P D CDNYA CGAN NC +++ P C CL F KS E W+ D S CVR KP
Sbjct: 288 VLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPL 347
Query: 167 DCPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLM 224
+C G+GF+K +K P+ + W N+SM+L EC A+C +NCSC AY+NS V GGG+GC++
Sbjct: 348 NCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCII 407
Query: 225 WFGDLIDIKECSEKYVWGQDFFIRV-PTSDLGYRRRVDQENQDQIEDLELPLFELATIAN 283
W+GDLIDI++ GQ+ +IR+ P+ ++ DQ + EDLELP FE A I N
Sbjct: 408 WYGDLIDIRQFPAG---GQELYIRMNPSESAEMDQQNDQITDGENEDLELPQFEFAKIVN 464
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
AT+NFSI NKLG+GGFG VYKGTL DGQEIAVKRLS S QG E KNEVIL +KLQHRN
Sbjct: 465 ATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRN 524
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
LVKLLGC IQ EE+LL+YE+MPNKSLD F+FDQTK +LLDWSKRF+IICG ARGLLYLHQ
Sbjct: 525 LVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQ 584
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
DSRLRIIHRDLK+SNVLLD DMNPKISDFGLARTFGGD+ EG+T++V+GTYGYMAPEYAT
Sbjct: 585 DSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYAT 644
Query: 464 DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
DGLFSVKSDVFSFGI++LEIV+GK++RG Y+ DN ++I +AW LW +G P +L+D +
Sbjct: 645 DGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAE 704
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPD 583
ES N EV++CIHISLLCVQ +PEDRPSM SV+LMLG + L +PK+PG DR
Sbjct: 705 ESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEPGFFKDRGPVEAY 764
Query: 584 SSSSKPESSSTNASTFTEVEGR 605
SSSSK ESSSTN + + +E R
Sbjct: 765 SSSSKVESSSTNEISTSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/593 (58%), Positives = 435/593 (73%), Gaps = 19/593 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSF--RLDNS--------TAKHARSGPWNGQT 50
MKLGW+L+TG ER L+ WRS+DDP+PGD+++ +L N+ + ++ RSGPW G
Sbjct: 168 MKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIA 227
Query: 51 FEGIP-WMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHR-FVWDETTSKW 108
F G P +++ VFKL EDEVY + N + +R+ + Y + W+E T W
Sbjct: 228 FTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYTWNEATQTW 287
Query: 109 HKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR-KPS 166
S P D CDNYA CGAN NC +++ P C CL F KS E W+ D S CVR KP
Sbjct: 288 VLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPL 347
Query: 167 DCPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLM 224
+C G+GF+K +K P+ + W N+SM+L EC A+C +NCSC AY+NS V GGG+GC++
Sbjct: 348 NCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCII 407
Query: 225 WFGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRVDQENQDQIEDLELPLFELATIANA 284
W+G LIDI++ GQ+ +IR+ S+ ++ DQ + EDLELP FE A I NA
Sbjct: 408 WYGGLIDIRQFPAG---GQELYIRMNPSESEMDQQNDQITDGENEDLELPQFEFAKIVNA 464
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
T+NFSI NKLG+GGFG VYKGTL DGQEIAVKRLS S QG E KNEVIL +KLQHRNL
Sbjct: 465 TNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNL 524
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
VKLLGC IQ EE+LL+YE+MPNKSLD F+FDQTK +LLDWSKRF+IICG ARGLLYLHQD
Sbjct: 525 VKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQD 584
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
SRLRIIHRDLK+SNVLLD DMNPKISDFGLARTFGGD+ EG+T++V+GTYGYMAPEYATD
Sbjct: 585 SRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATD 644
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
GLFSVKSDVFSFGI++LEIV+GK++RG Y+ DN ++I +AW LW +G P +L+D +E
Sbjct: 645 GLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEE 704
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDR 577
S N EV++CIHISLLCVQ +PEDRPSM SV+LMLG + L +PK+PG DR
Sbjct: 705 SWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEPGFFKDR 757
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/620 (55%), Positives = 430/620 (69%), Gaps = 19/620 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKHA----------RSGPWNGQT 50
MK G N TG +RYL+ W+S DDP+ GD ++ LD S RSGPWNG
Sbjct: 189 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 248
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G P ++ + VF E E+Y+ +K +N +V +RL L NG R +W T W+
Sbjct: 249 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 308
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPS-D 167
+ D CD+YA CGA S C + +P C C+ GF+ K WD+ D S CVRK S D
Sbjct: 309 VYSTAYKDDCDSYALCGAYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLD 368
Query: 168 CPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
C G+GF+K +KLP+ N W N+SM+L+EC + C +NCSC AY NS + GGG+GCL+W
Sbjct: 369 CQKGDGFVKCSGVKLPDTRNSWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLW 428
Query: 226 FGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRVDQENQDQIEDLELPLFELATIANAT 285
FGDLID+KE +E GQDF+IR+ S+L + N+ Q EDLELPLF+L TI NAT
Sbjct: 429 FGDLIDVKEFTEN---GQDFYIRMAASELELNNEGAETNERQ-EDLELPLFDLDTILNAT 484
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
NFS NNKLGEGGFG VYKG L DG+EIAVKRLSK S QGL+E KNEVI SKLQHRNLV
Sbjct: 485 HNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLV 544
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
KLLGCCI GEEK+LIYE+MPNKSL++FIFD + +LDW KRF II G ARGLLYLHQDS
Sbjct: 545 KLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDS 604
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
RLRIIHRDLK NVLLD++MNP+ISDFG+AR+FGG+E + T +V+GTYGYM+PEYA DG
Sbjct: 605 RLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGYMSPEYAIDG 664
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
++SVKSDVFSFG+L+LEI+SGKRNRG + D+ N++ HAW L+ + P +LIDA ++
Sbjct: 665 VYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLELIDASVGDT 724
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSS 585
N EV+R +++ LLCVQ HP+DRP+M SV+LML S+ L QPK+PG +R DS
Sbjct: 725 YNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGALRQPKEPGFFTERNMLEADSL 784
Query: 586 SSKPESSSTNASTFTEVEGR 605
K S N T T +EGR
Sbjct: 785 QCKHAVFSGNEHTITILEGR 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/660 (51%), Positives = 441/660 (66%), Gaps = 60/660 (9%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNST----------AKHARSGPWNGQT 50
MKLGW+ K G +R L+ W+++DDP+PG ++ + N++ +++ RSGPWNG
Sbjct: 160 MKLGWDFKNGIQRRLSAWKTSDDPSPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQ 219
Query: 51 FEGIPWMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHR---FVWDETTSK 107
F P + + + E+ Y ++ IN ++ R+ L N T R +W E
Sbjct: 220 FSAKPTSALPILVYSYVNNKSELSYSYELINSSLIGRMVL--NQTILRREALLWSEPEKN 277
Query: 108 WHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR-KP 165
W + P D+CD Y+ CGA +C + + P+C+CL GF QE W+ D + CVR KP
Sbjct: 278 WKPYAAMPRDYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKP 337
Query: 166 SDCPGGEGFLKLPKMKLPEN--YWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCL 223
+C GF KLP +KLP+ W N+SMSL EC +C +NCSC A+AN+ + G G+GC
Sbjct: 338 LNCSDKTGFAKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCA 397
Query: 224 MWFGDLIDIKECSEKYVWGQDFFIRVPTSDL----------------------------- 254
+WFG+L+DIK GQD ++R+ S+L
Sbjct: 398 IWFGELVDIKVVRRG---GQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGF 454
Query: 255 ----GYRRRVD-----QENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKG 305
RR+++ ++ + Q +DLELPLF LATI+NATDNFS NKLGEGGFG V++G
Sbjct: 455 YVIRSKRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRG 514
Query: 306 TLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365
L DG+EIAVKRLS S QG +E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MP
Sbjct: 515 RLTDGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMP 574
Query: 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425
NKSLD FIFD +++LLDWSKRF+IICG ARG+LYLHQDSRLRIIHRDLK SNVLLD D+
Sbjct: 575 NKSLDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDL 634
Query: 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
NPKISDFG+ARTFGGD+ EG+T +V+GTYGYMAPEYA DG FS+KSDVFSFGIL+LEI+S
Sbjct: 635 NPKISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIIS 694
Query: 486 GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHH 545
G++NRG + ++ N+I HAW LWN+G P +LIDA ES EV+RCIH+SLLC+Q
Sbjct: 695 GEKNRGFFRPNHALNLIGHAWKLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQL 754
Query: 546 PEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVEGR 605
PEDRP+M +V+LML S+ LAQPKQPG ++R S S S K ESS TN T T +E R
Sbjct: 755 PEDRPTMSNVVLMLSSEGSLAQPKQPGFYMERDSLEVFSVSGKNESSITNELTITLLEAR 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122814|ref|XP_002330370.1| predicted protein [Populus trichocarpa] gi|222871755|gb|EEF08886.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/624 (54%), Positives = 438/624 (70%), Gaps = 24/624 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNS----------TAKHARSGPWNGQT 50
MKLG N T +RY++ W+SADDP+ G+ +FRLD + + + RSGPWNG
Sbjct: 158 MKLGRNKVTSLDRYISSWKSADDPSRGNYTFRLDPAAYSELIMIEDSNEKFRSGPWNGMR 217
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G P +K + ++ + DE YY +K +N + +R+ + NG RF W + T W
Sbjct: 218 FSGTPQLKPNPIYTYRFFYDGDEEYYTYKLVNSSFLSRMVINQNGAIQRFTWIDRTQSWE 277
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRK-PSD 167
S D+CD YA CGA + C ++ +P C CL GF +DWD+ D + CVRK P +
Sbjct: 278 LYLSVQTDNCDRYALCGAYATCSINNSPVCSCLVGFSPNVSKDWDTMDWTSGCVRKTPLN 337
Query: 168 CPGGEGFLKLPKMKLPENY--WSNQSMSLRECEAECTKNCSCRAYANSQV-VGGGNGCLM 224
C +GF K +KLPE W N++MSL EC + C KNCSC AY N + + GG+GCL+
Sbjct: 338 C-SEDGFRKFSGVKLPETRKSWFNRTMSLDECRSTCLKNCSCTAYTNLDISINGGSGCLL 396
Query: 225 WFGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRV---DQENQDQIEDLELPLFELATI 281
W GDL+D+++ +E GQD +IR+ S+LG ++ + Q NQ + EDL+LPLF+L+T+
Sbjct: 397 WLGDLVDMRQINEN---GQDIYIRMAASELGKKKDILEPSQNNQGEEEDLKLPLFDLSTM 453
Query: 282 ANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
+ AT++FS+ N LGEGGFG VY+G L DGQEIAVKRLSK S+QGL+E KNEV+ KLQH
Sbjct: 454 SRATNDFSLANILGEGGFGTVYQGKLNDGQEIAVKRLSKTSKQGLDEFKNEVLHIVKLQH 513
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
RNLVKLLGCCI+G+E +LIYE MPNKSLD+FIFD+T+ ++LDW +RFHII G ARGLLYL
Sbjct: 514 RNLVKLLGCCIEGDETMLIYEMMPNKSLDFFIFDKTRDKVLDWPQRFHIINGIARGLLYL 573
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
HQDSRLRIIHRDLK SN+LLDH+MNPKISDFGLAR+ GG+E E +TNKV+GTYGY+APEY
Sbjct: 574 HQDSRLRIIHRDLKASNILLDHEMNPKISDFGLARSVGGNETEANTNKVVGTYGYIAPEY 633
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
A DGL+SVKSDVFSFG++VLEIVSGKRN+G + D+K N++ HAW L+ +G +LI
Sbjct: 634 AIDGLYSVKSDVFSFGVMVLEIVSGKRNKGFCHPDHKQNLLGHAWRLFIEGRSSELIVES 693
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTG 581
ESCN EV+R IHI LLCVQ P DRPSM +V++MLGS+S L QPK+PG R G
Sbjct: 694 IVESCNFYEVLRSIHIGLLCVQRSPRDRPSMSTVVMMLGSESELPQPKEPGFFTTR-DVG 752
Query: 582 PDSSSSKPESSSTNASTFTEVEGR 605
+SSS S N T T++E R
Sbjct: 753 KATSSSTQSKVSVNEITMTQLEAR 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/660 (51%), Positives = 442/660 (66%), Gaps = 60/660 (9%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNST----------AKHARSGPWNGQT 50
MKLGW+ K G +R L+ W+++DDP+PG ++ + N++ +++ RSGPWNG
Sbjct: 160 MKLGWDFKNGIQRRLSAWKTSDDPSPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQ 219
Query: 51 FEGIPWMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHR---FVWDETTSK 107
+ P + + + E+ Y ++ IN ++ R+ L N T R +W E
Sbjct: 220 YSAKPTSALPILVYSYVNNKSELSYSYELINSSLIGRMVL--NQTILRREALLWSEPEKN 277
Query: 108 WHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR-KP 165
W + P D+CD Y+ CGA +C + + P+C+CL GF QE W+ D + CVR KP
Sbjct: 278 WKPYAAMPRDYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKP 337
Query: 166 SDCPGGEGFLKLPKMKLPEN--YWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCL 223
+C GF KLP +KLP+ W N+SMSL EC +C +NCSC A+AN+ + G G+GC
Sbjct: 338 LNCSDKTGFAKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCA 397
Query: 224 MWFGDLIDIKECSEKYVWGQDFFIRVPTSDL----------------------------- 254
+WFG+L+DIK GQD ++R+ S+L
Sbjct: 398 IWFGELVDIKVVRRG---GQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGF 454
Query: 255 ----GYRRRVD-----QENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKG 305
RR+++ ++ + Q +DLELPLF LATI+NATDNFS NKLGEGGFG V++G
Sbjct: 455 YVIRSKRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRG 514
Query: 306 TLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365
L DG+EIAVKRLS S QG +E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MP
Sbjct: 515 RLTDGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMP 574
Query: 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425
NKSLD FIFD +++LLDWSKRF+IICG ARG+LYLHQDSRLRIIHRDLK SNVLLD D+
Sbjct: 575 NKSLDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDL 634
Query: 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
NPKISDFG+ARTFGGD+ EG+T +V+GTYGYMAPEYA DG FS+KSDVFSFGIL+LEI+S
Sbjct: 635 NPKISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIIS 694
Query: 486 GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHH 545
G++NRG + ++ N+I HAW LWN+G P +LIDA ES EV+RCIH+SLLC+Q
Sbjct: 695 GEKNRGFFRPNHALNLIGHAWKLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQL 754
Query: 546 PEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVEGR 605
PEDRP+M +V+LML S+ LAQPKQPG ++R S S S K ESS+TN T T +E +
Sbjct: 755 PEDRPTMSNVVLMLSSEGSLAQPKQPGFYMERDSLEVFSVSGKNESSTTNELTITLLEAK 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143165|emb|CBI20460.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/660 (52%), Positives = 434/660 (65%), Gaps = 58/660 (8%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLD----------NSTAKHARSGPWNGQT 50
MK G N TG +RYL+ W++ DDP+ G+ ++RLD N + RSGPWNG
Sbjct: 1 MKFGRNRVTGLDRYLSSWKTTDDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLR 60
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G P ++ +SV+ + E YY F+ +N +V TRL L G RF W + TS W
Sbjct: 61 FSGFPQLRPNSVYSYAFIFNDKETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWI 120
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRK-PSD 167
S D CD+YA CG C ++ +P CEC+ GF K Q +WD D S CVR P
Sbjct: 121 LYSSAQTDDCDSYALCGVYGICEINRSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMV 180
Query: 168 CPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
C GFLK +KLP+ N W N+SM+L+EC + C NCSC AY NS + GGG+GCL+W
Sbjct: 181 CQKSNGFLKYSGVKLPDTRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLW 240
Query: 226 FGDLIDIKECSEKYVWGQDFFIRVPTSDL-----------GYRRR--------------- 259
FGDLIDI+E +E GQDF+IR+ S+L G +R+
Sbjct: 241 FGDLIDIREYTEN---GQDFYIRMAKSELDAFAMTNSGSKGAKRKWVIVSTVSIVGIILL 297
Query: 260 --------------VDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKG 305
+E ++ EDLELPLF+L TI NATDNFS +NKLGEGGFG VYKG
Sbjct: 298 SLVLTLYVLRKKRLRRKEINEREEDLELPLFDLDTILNATDNFSNDNKLGEGGFGPVYKG 357
Query: 306 TLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365
L DG+EIAVKRLSK S QGL+E KNEV SKLQHRNLVKLLGCCI GEEK+LIYE+MP
Sbjct: 358 MLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCCIHGEEKMLIYEYMP 417
Query: 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425
NKSLD+FIFD + +LDW KRF II G ARGLLYLHQDSRLRIIHRDLK NVLLD++M
Sbjct: 418 NKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEM 477
Query: 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
NP+ISDFG+AR+F G+E E T +V+GTYGYM+PEYA DG++S+KSDVFSFG+LVLEIV+
Sbjct: 478 NPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKSDVFSFGVLVLEIVT 537
Query: 486 GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHH 545
GKRNRG + D+ N++ HAW L+ +G P +LIDA +SCN EV+R +++ LLCVQ
Sbjct: 538 GKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEVLRALNVGLLCVQRS 597
Query: 546 PEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVEGR 605
P+DRPSM SV+LML S+S L QPK+PG +R SS+SK S N T T +EGR
Sbjct: 598 PDDRPSMSSVVLMLSSESALHQPKEPGFFTERNMLEGSSSASKHAIFSGNEHTITLIEGR 657
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122822|ref|XP_002330372.1| predicted protein [Populus trichocarpa] gi|222871757|gb|EEF08888.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/620 (53%), Positives = 436/620 (70%), Gaps = 20/620 (3%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLD-----------NSTAKHARSGPWNGQ 49
MK+G +L TGF+RYL+ W+S DDP+ G+ +FR D NS ++ RSGPWNG
Sbjct: 162 MKMGRDLITGFDRYLSSWKSPDDPSRGNFTFRNDPSGHPEQILTENSIVRY-RSGPWNGL 220
Query: 50 TFEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKW 108
F G+P ++ ++++K E E+YY+++ +N+++ +RL L NG + RF W + T W
Sbjct: 221 RFSGVPQLRPNTLYKFEFVFNEKEIYYRYQLLNNSILSRLVLTQNGNFQRFTWTDQTDVW 280
Query: 109 HKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPSD 167
+ D+C YA CGA C ++ +P C CL GF+ K + WD D S C R+ +
Sbjct: 281 AFYLALFDDYCSRYALCGAYGTCDITSSPVCGCLKGFLPKVPKVWDMMDWSDGCARRTAL 340
Query: 168 CPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
G+GF K +KLP+ W N++M+L EC++ C KNCSC AYAN + GG+GCL+W
Sbjct: 341 NCSGDGFQKYSGVKLPDIRKSWLNKNMNLEECKSMCMKNCSCTAYANLDIREGGSGCLLW 400
Query: 226 FGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRVDQENQDQIEDLELPLFELATIANAT 285
F +LID+++ +E GQD +IR+ S+LG +R ++ + E EL LF+ TI+ +T
Sbjct: 401 FSELIDMRQLNEN---GQDIYIRMAASELGILKR-SADDSCKKEYPELQLFDFGTISCST 456
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+NFS NKLG+GGFG VYKG L DGQEIAVKRLSK S QGL+E KNEVI +KLQHRNLV
Sbjct: 457 NNFSHTNKLGQGGFGPVYKGLLKDGQEIAVKRLSKSSRQGLDEFKNEVIHIAKLQHRNLV 516
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
KLLGCCIQ +E++L+YEFMP KSLD+ IFD+T+ LLDW KR+HII G ARGLLYLHQDS
Sbjct: 517 KLLGCCIQADERMLVYEFMPKKSLDFLIFDRTQSTLLDWPKRYHIINGIARGLLYLHQDS 576
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
RLRIIHRDLK SN+LLD++MNPKISDFGLAR+FG ++ E +TN+V+GTYGYM+PEYA DG
Sbjct: 577 RLRIIHRDLKASNILLDNNMNPKISDFGLARSFGENQTEDNTNRVVGTYGYMSPEYAIDG 636
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
L+S+KSDVFSFG+LV+EIVSG RNRG Y+ D+ N++ HAW L+ +G +LI +ES
Sbjct: 637 LYSIKSDVFSFGVLVIEIVSGSRNRGFYHPDHNLNLLGHAWGLFTEGRSCELITEPIEES 696
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSS 585
CN EV+R IH+ LLCVQ HP DRPSM SV+LML ++ L QPKQPG DR +SS
Sbjct: 697 CNLPEVLRSIHVGLLCVQCHPNDRPSMLSVVLMLCGEAKLPQPKQPGFFTDRALVEANSS 756
Query: 586 SSKPESSSTNASTFTEVEGR 605
S K S S N ST T +E R
Sbjct: 757 SRKNTSCSVNDSTITLLEAR 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/627 (53%), Positives = 441/627 (70%), Gaps = 27/627 (4%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSF--RLDN--------STAKHARSGPWNGQT 50
MK GW+L+TG R L W+S DDP+P D SF L+N K RSGPWNG
Sbjct: 167 MKFGWDLRTGLNRKLIAWKSPDDPSPSDFSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLH 226
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTY--HRFVWDETTSK 107
G P +K + ++ +DE+YY + N ++ +RL L N +Y R+VW E+ +
Sbjct: 227 SSGSPQVKANPIYDFKFVSNKDELYYTYSLKNSSMISRLVL-NATSYVRKRYVWIESKQR 285
Query: 108 WHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVR-KP 165
W S P D CD+Y+ CGAN+NC +S++P C+CL GF K E W S D S C+R K
Sbjct: 286 WEVYTSVPLDLCDSYSLCGANANCVISDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKE 345
Query: 166 SDC--PGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNG 221
C +GF KL +K P+ + W +Q++ L EC+A+C NCSC AYANS + G G+G
Sbjct: 346 LSCENKNKDGFNKLTLLKTPDTTHSWLDQTIGLEECKAKCLDNCSCMAYANSDISGQGSG 405
Query: 222 CLMWFGDLIDIKECSEKYVWGQDFFIRVPTSDL---GYRRRVDQENQDQIEDLELPLFEL 278
C MWFGDLIDI++ + GQD ++R+ S+L + + +Q + Q++D++LP+F+L
Sbjct: 406 CAMWFGDLIDIRQFAAG---GQDVYVRIDASELERSDFSIKSNQNSGMQVDDMDLPVFDL 462
Query: 279 ATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK 338
+TIA AT NF++ NK+GEGGFG VY+G+L DGQEIAVKRLS S QGL E KNEV L +K
Sbjct: 463 STIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTEFKNEVKLIAK 522
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
LQHRNLVKLLGCC++GEEK+L+YE+M N SLD FIFD+ + LDWSKRF+IICG A+GL
Sbjct: 523 LQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDWSKRFNIICGIAKGL 582
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
LYLHQDSRLRIIHRDLK SNVLLD ++NPKISDFG+AR FG D+ EG+T +++GTYGYMA
Sbjct: 583 LYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIFGVDQQEGNTKRIVGTYGYMA 642
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518
PEYATDGLFSVKSDVFSFG+L+LEI+SGKR+RG YN ++ N+I HAW LW +G P +LI
Sbjct: 643 PEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHSQNLIGHAWKLWKEGRPLELI 702
Query: 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRK 578
D ++S + +++ CIH+SLLCVQ +PEDRP M SV+LML S+ L +PKQPG +
Sbjct: 703 DKSIEDSSSLSQMLHCIHVSLLCVQQNPEDRPGMSSVLLMLVSELELPEPKQPG-FFGKY 761
Query: 579 STGPDSSSSKPESSSTNASTFTEVEGR 605
S DSS+SK + SSTN T T +E R
Sbjct: 762 SGEADSSTSKQQLSSTNEITITLLEAR 788
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/663 (52%), Positives = 428/663 (64%), Gaps = 61/663 (9%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNSTAKHA----------RSGPWNGQT 50
MK G N TG +RYL+ W+S DDP+ GD ++ LD S RSGPWNG
Sbjct: 159 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 218
Query: 51 FEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G P ++ + VF E E+Y+ +K +N +V +RL L NG R +W T W+
Sbjct: 219 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 278
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPS-D 167
+ D CD+YA CGA S C + +P C C+ GF+ K WD+ D S CVRK S D
Sbjct: 279 VYSTAYKDDCDSYALCGAYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLD 338
Query: 168 CPGGEGFLKLPKMKLPE--NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
C G+GF K +KLP+ N W N+SM+L+EC + C +NCSC AY NS + GGG+GCL+W
Sbjct: 339 CQKGDGFAKYSGVKLPDTRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLW 398
Query: 226 FGDLIDIKECSEKYVWGQDFFIRVPTSDLGYRRRVDQ----------------------- 262
FGDLIDIKE +E GQDF+IR+ S+L +V +
Sbjct: 399 FGDLIDIKEFTEN---GQDFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTL 455
Query: 263 --------------------ENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRV 302
E ++ EDLELPLF L TI NAT NFS NNKLGEGGFG V
Sbjct: 456 YLLKKRLKRKGTTELNNEGAETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPV 515
Query: 303 YKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362
YKG L DG+EIAVKRLSK S QGL+E KNEVI SKLQHRNLVKLLGCCI GEEK+LIYE
Sbjct: 516 YKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYE 575
Query: 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422
+MPNKSL++FIFD + +LDW KRF II G ARGLLYLHQDSRLRIIHRDLK NVLLD
Sbjct: 576 YMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLD 635
Query: 423 HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLE 482
++MNP+ISDFG+AR+FGG+E T +V+GTYGYM+PEYA DG++SVKSDVFSFG+L LE
Sbjct: 636 NEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLE 695
Query: 483 IVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCV 542
I+SGKRNRG + D+ N++ HAW L+ +G P +LIDA + N EV+R +++ LLCV
Sbjct: 696 IISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGLLCV 755
Query: 543 QHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEV 602
Q HP+DRP+M SV+LML S+ L QPK+PG +R DS K S N T T +
Sbjct: 756 QRHPDDRPNMSSVVLMLSSEGALPQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITIL 815
Query: 603 EGR 605
EGR
Sbjct: 816 EGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.947 | 0.731 | 0.516 | 9e-164 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.527 | 0.375 | 0.593 | 2.4e-155 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.510 | 0.379 | 0.651 | 3.6e-150 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.538 | 0.386 | 0.586 | 4.6e-148 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.517 | 0.369 | 0.591 | 5.3e-147 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.494 | 0.352 | 0.631 | 3.9e-138 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.561 | 0.409 | 0.559 | 2.6e-132 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.581 | 0.415 | 0.536 | 1.4e-131 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.492 | 0.370 | 0.606 | 2.4e-125 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.510 | 0.390 | 0.579 | 1.3e-122 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1594 (566.2 bits), Expect = 9.0e-164, P = 9.0e-164
Identities = 309/598 (51%), Positives = 410/598 (68%)
Query: 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLD-NSTA-----KHA----RSGPWNGQT 50
MK G N TG R+LT WR+ DDP+ G+ + ++D N K++ R+GPWNG
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 51 FEGIPWMKDS-VFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWH 109
F G+P +K + +++ E+EVYY +K N +V TR+QL NG R+ W + W+
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281
Query: 110 KLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKSQEDWDSPD-SRSCVRKPS-D 167
S D CD Y CG+ +C ++E+P+C CL GF++K+ + W + D S CVR+ D
Sbjct: 282 FYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLD 341
Query: 168 CPGGE-GFLKLPKMKLPENY--WSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLM 224
C GE GFLK+ K+KLP+ W +++M L EC+ C +NC+C AY+ + GG GC++
Sbjct: 342 CGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCIL 401
Query: 225 WFGDLIDIKECSEKYVWGQDFFIRVPTSDLG-YRR---RVDQENQDQIEDLELPLFELAT 280
WFGDLIDI+E +E GQD ++R+ +S++ +R RV Q++ EDLELP +L T
Sbjct: 402 WFGDLIDIREYNEN---GQDLYVRLASSEIETLQRESSRVSSRKQEE-EDLELPFLDLDT 457
Query: 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
++ AT FS NKLG+GGFG VYKGTL GQE+AVKRLS+ S QG+ E KNE+ L +KLQ
Sbjct: 458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQ 517
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
HRNLVK+LG C+ EE++LIYE+ PNKSLD FIFD+ +R LDW KR II G ARG+LY
Sbjct: 518 HRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLY 577
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH+DSRLRIIHRDLK SNVLLD DMN KISDFGLART GGDE E +T +V+GTYGYM+PE
Sbjct: 578 LHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPE 637
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
Y DG FS+KSDVFSFG+LVLEIVSG+RNRG N ++K N++ HAW + + +++ID
Sbjct: 638 YQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDE 697
Query: 521 CYQESCNP-DEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDR 577
ESC EV+R IHI LLCVQ P+DRP+M V+LML S+ +L P+QPG +R
Sbjct: 698 AVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNER 755
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 2.4e-155, Sum P(2) = 2.4e-155
Identities = 193/325 (59%), Positives = 239/325 (73%)
Query: 257 RRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVK 316
RR + +EN +DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DGQE+AVK
Sbjct: 497 RRHISRENNT--DDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVK 554
Query: 317 RLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ 376
RLSK S QG +E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLD +FD+
Sbjct: 555 RLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDK 614
Query: 377 TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436
++ L+W RF II G ARGLLYLHQDSR RIIHRDLK SN+LLD M PKISDFG+AR
Sbjct: 615 SRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMAR 674
Query: 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD 496
FG DE E +T KV+GTYGYM+PEYA DG+FS+KSDVFSFG+L+LEI+S KRN+G YNSD
Sbjct: 675 IFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSD 734
Query: 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNP---DEVIRCIHISLLCVQHHPEDRPSMP 553
N++ W W +G ++ID +S + E++RCI I LLCVQ EDRP+M
Sbjct: 735 RDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMS 794
Query: 554 SVILMLGSDSV-LAQPKQPGCLVDR 577
VILMLGS+S + QPK PG ++R
Sbjct: 795 LVILMLGSESTTIPQPKAPGYCLER 819
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 3.6e-150, Sum P(2) = 3.6e-150
Identities = 202/310 (65%), Positives = 244/310 (78%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNE 328
EDL+LP+F+ TI+ ATD+FS N LG GGFG VYKG L DGQEIAVKRLS S QG+ E
Sbjct: 481 EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEE 540
Query: 329 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF 388
KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD+FIFD+ + LDW KR
Sbjct: 541 FKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRM 600
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448
+II G ARG+LYLHQDSRLRIIHRDLK NVLLD+DMNPKISDFGLA++FGGD+ E STN
Sbjct: 601 NIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTN 660
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508
+V+GTYGYM PEYA DG FSVKSDVFSFG+LVLEI++GK NRG ++D+ N++ H W +
Sbjct: 661 RVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKM 720
Query: 509 WNKGMPWQLIDACYQESCNP-DEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQ 567
W + ++ + + E + EV+RCIH++LLCVQ PEDRP+M SV+LM GSDS L
Sbjct: 721 WVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPH 780
Query: 568 PKQPGCLVDR 577
P QPG +R
Sbjct: 781 PTQPGFFTNR 790
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 4.6e-148, Sum P(2) = 4.6e-148
Identities = 194/331 (58%), Positives = 246/331 (74%)
Query: 252 SDLGYRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQ 311
+D+ RR + + E LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+
Sbjct: 483 NDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGK 542
Query: 312 EIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDY 371
EIAVKRLSK+S QG +E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLD
Sbjct: 543 EIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDS 602
Query: 372 FIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431
+FDQT+ L+W KRF II G ARGLLYLHQDSR RIIHRDLK SNVLLD +M PKISD
Sbjct: 603 HLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISD 662
Query: 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRG 491
FG+AR FG +E E +T +V+GTYGYM+PEYA DG+FS+KSDVFSFG+L+LEI+SGKRN+G
Sbjct: 663 FGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKG 722
Query: 492 LYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN---PD-EVIRCIHISLLCVQHHPE 547
YNS+ N++ W W +G +++D +S + P E++RCI I LLCVQ E
Sbjct: 723 FYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAE 782
Query: 548 DRPSMPSVILMLGSDSV-LAQPKQPGCLVDR 577
DRP M SV++MLGS++ + QPK+PG + R
Sbjct: 783 DRPVMSSVMVMLGSETTAIPQPKRPGFCIGR 813
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 5.3e-147, Sum P(2) = 5.3e-147
Identities = 188/318 (59%), Positives = 241/318 (75%)
Query: 265 QDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ 324
+++ + LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+EIAVKRLSK+S Q
Sbjct: 500 ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQ 559
Query: 325 GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDW 384
G +E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLD +FDQT+ L+W
Sbjct: 560 GTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNW 619
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
KRF II G ARGLLYLHQDSR RIIHRDLK SNVLLD +M PKISDFG+AR FG +E E
Sbjct: 620 QKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETE 679
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
+T +V+GTYGYM+PEYA DG+FS+KSDVFSFG+L+LEI+SGKRN+G YNS+ N++
Sbjct: 680 ANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGF 739
Query: 505 AWNLWNKGMPWQLIDACYQESCNPD----EVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560
W W +G +++D ++ + + E++RCI I LLCVQ EDRP M SV++MLG
Sbjct: 740 VWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLG 799
Query: 561 SDSV-LAQPKQPGCLVDR 577
S++ + QPK+PG V R
Sbjct: 800 SETTAIPQPKRPGFCVGR 817
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 3.9e-138, Sum P(3) = 3.9e-138
Identities = 190/301 (63%), Positives = 243/301 (80%)
Query: 272 ELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKN 331
ELP+F L IA AT++F N+LG GGFG VYKG L DG+EIAVKRLS S QG++E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 332 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHII 391
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSLD+F+FD+TK+ L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+AR FGG++ E +T +V+
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511
GTYGYM+PEYA +GLFSVKSDV+SFG+L+LEIVSGKRN L +S++ ++I +AW L+
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTH 751
Query: 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV-LAQPKQ 570
G +L+D + +C+ E +RCIH+++LCVQ +RP+M SV+LML SD+ LA P+Q
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 571 P 571
P
Sbjct: 812 P 812
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 2.6e-132, Sum P(2) = 2.6e-132
Identities = 192/343 (55%), Positives = 240/343 (69%)
Query: 264 NQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE 323
NQ +++ ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G +IAVKRLS+ S
Sbjct: 490 NQYKLK--ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSG 547
Query: 324 QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD 383
QG+ E NEV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD ++FD K+ LLD
Sbjct: 548 QGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLD 607
Query: 384 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443
W RF+II G RGL+YLH+DSRL+IIHRDLK SN+LLD ++NPKISDFGLAR F G+E
Sbjct: 608 WKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNED 667
Query: 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
E ST +V+GTYGYMAPEYA GLFS KSDVFS G+++LEIVSG+RN YN N+
Sbjct: 668 EVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSA 727
Query: 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD- 562
+AW LWN G L+D E C +E+ RC+H+ LLCVQ H DRPS+ +VI ML S+
Sbjct: 728 YAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSEN 787
Query: 563 SVLAQPKQPGCLVDRKXXXXXXXXXXXXXXXXXXXXFTEVEGR 605
S L +PKQP + R T++ GR
Sbjct: 788 SNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 1.4e-131, Sum P(2) = 1.4e-131
Identities = 190/354 (53%), Positives = 250/354 (70%)
Query: 253 DLGYRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQE 312
D+ R D + +D + EL ++ L I AT NFS +NKLGEGGFG VY GTL G+E
Sbjct: 496 DISQSIRFDDDVEDG-KSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEE 554
Query: 313 IAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF 372
+AVKRL + S QGL E KNEVIL +KLQHRNLV+LLGCCI EEK+L+YE+MPNKSLD F
Sbjct: 555 VAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAF 614
Query: 373 IFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432
+F+ K+ LLDW KRF II G ARGLLYLH+DSRLR++HRDLK SN+LLD DM PKISDF
Sbjct: 615 LFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDF 674
Query: 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492
G+AR FGGD+ + +TN+V+GT+GYM+PEYA +G+FSVKSDV+ FG+L+LEI++GKR
Sbjct: 675 GMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSF 734
Query: 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+ ++ N+ +AW WN+ +LID + SC+ +V+RCIHI+LLCVQ H ++RP +
Sbjct: 735 HCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDI 794
Query: 553 PSVILMLGSDSV-LAQPKQPGCLVDRKXXXXXXXXXXXXXXXXXXXXFTEVEGR 605
P+VILML +DS L P+ P ++ + T++ GR
Sbjct: 795 PTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 2.4e-125, Sum P(2) = 2.4e-125
Identities = 182/300 (60%), Positives = 225/300 (75%)
Query: 273 LPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNE 332
L F++ TI NAT+NFS++NKLG+GGFG VYKG L DG+EIAVKRLS S QG E NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 333 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC 392
++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSLD F+FD KR +DW KRF II
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G ARGLLYLH DSRLR+IHRDLK SN+LLD MNPKISDFGLAR + G E + +T +V+G
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNK 511
T GYM+PEYA G+FS KSD++SFG+L+LEI+SG++ +R Y + K +I +AW W++
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGK-TLIAYAWESWSE 714
Query: 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQP 571
L+D +SC+P EV RCI I LLCVQH P DRP+ ++ ML + S L PKQP
Sbjct: 715 YRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQP 774
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
Identities = 182/314 (57%), Positives = 227/314 (72%)
Query: 259 RVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRL 318
R D ++QD + LE FE+ TI AT NFS++NKLG GGFG VYKG L DG+EIAVKRL
Sbjct: 452 RNDLQSQD-VPGLEF--FEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRL 508
Query: 319 SKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK 378
S SEQG E NE++L SKLQHRNLV++LGCC++G+EKLLIYEFM NKSLD F+F K
Sbjct: 509 SSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRK 568
Query: 379 RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
R LDW KRF II G RGLLYLH+DSRLR+IHRDLK SN+LLD MNPKISDFGLAR F
Sbjct: 569 RLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLF 628
Query: 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDN 497
G + + T +V+GT GYM+PEYA G+FS KSD++SFG+L+LEI+SG++ +R Y +
Sbjct: 629 QGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEG 688
Query: 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
K ++ + W W + L+D +S +P EV RC+ I LLCVQH P DRP+ ++
Sbjct: 689 KA-LLAYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLS 747
Query: 558 MLGSDSVLAQPKQP 571
ML + S L PKQP
Sbjct: 748 MLTTTSDLPLPKQP 761
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5015 | 0.9933 | 0.7675 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 605 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-55 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-28 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 4e-57
Identities = 93/278 (33%), Positives = 133/278 (47%), Gaps = 29/278 (10%)
Query: 289 SINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHR 342
++ KLGEG FG VYKG L E+AVK L + SEQ + E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+VKLLG C + E ++ E+M L ++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
IHRDL N L+ ++ KISDFGL+R D+ + +MAPE
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESL 175
Query: 463 TDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+G F+ KSDV+SFG+L+ EI + G++ Y + V+ + L N Q
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEY---LKNGYRLPQ----- 224
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+C P E+ + L C PEDRP+ ++ +L
Sbjct: 225 -PPNC-PPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 6e-55
Identities = 91/271 (33%), Positives = 131/271 (48%), Gaps = 28/271 (10%)
Query: 289 SINNKLGEGGFGRVYKGTLVDG-----QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHR 342
++ KLGEG FG VYKGTL E+AVK L + SEQ + E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+VKLLG C + E +++ E+MP L ++ + + L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
IHRDL N L+ ++ KISDFGL+R D+ + +MAPE
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESL 176
Query: 463 TDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+G F+ KSDV+SFG+L+ EI + G+ Y + V+ + L +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEY---LKKGYRLPK----- 225
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+C P E+ + + L C PEDRP+
Sbjct: 226 -PPNC-PPELYK---LMLQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 5e-54
Identities = 93/286 (32%), Positives = 133/286 (46%), Gaps = 43/286 (15%)
Query: 292 NKLGEGGFGRVYKGTLVDGQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVK 346
KLGEG FG VYKG L E+AVK L + SE+ + E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFI------FDQTKRELLDWSKRFHIICGTARGLLY 400
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGDEIEGSTNKVIGTYGYMAP 459
L + +HRDL N L+ D+ KISDFGL+R + D T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
E DG+F+ KSDV+SFG+L+ EI + GL N + V+ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLEY------------- 219
Query: 518 IDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ Y+ E C PDE+ + L C Q PEDRP+ ++ L
Sbjct: 220 LRKGYRLPKPEYC-PDELYE---LMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 93/291 (31%), Positives = 132/291 (45%), Gaps = 52/291 (17%)
Query: 288 FSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQH 341
+ KLGEG FG VYKGTL ++AVK L + SE+ E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+V+LLG C QGE ++ E+MP L F+ + E L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
+HRDL N L+ ++ KISDFGL+R D+ +MAPE
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ----- 516
DG F+ KSDV+SFG+L+ EI + G P+
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT----LG--------------------EQPYPGMSNE 211
Query: 517 ----LIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
L++ Y+ E+C PDE+ + L C + PEDRP+ ++ L
Sbjct: 212 EVLELLEDGYRLPRPENC-PDEL---YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 5e-50
Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG-LNELKNEVILFSKLQHRNLVKLLGCC 351
LGEGGFG VY G+++A+K + K L EL E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 352 IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIH 411
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 412 RDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-YATDGLFSV 469
RDLK N+LLD D K++DFGL++ D+ ++GT YMAPE G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 470 KSDVFSFGILVLEI 483
KSD++S G+++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 77/274 (28%), Positives = 113/274 (41%), Gaps = 31/274 (11%)
Query: 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNL 344
+ + KLG G FG VYK G+ +AVK L K + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V+L+ + L+ E+ L ++ L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH-- 115
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYGYMAPE-YA 462
IIHRDLK N+LLD + KI+DFGLA+ S+ GT YMAPE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMAPEVLL 171
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGK---RNRGLYNSDNKFNVIRHA-----WNLWNKGMP 514
+ K DV+S G+++ E+++GK + + I W+ G
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 515 W--QLIDACYQESCNPDEVIRCIHISLLCVQHHP 546
LI C N D R + + HP
Sbjct: 232 EAKDLIKKC----LNKDPSKR---PTAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-47
Identities = 74/266 (27%), Positives = 116/266 (43%), Gaps = 24/266 (9%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLV 345
+ I KLGEG FG+VY G+ +A+K + K + E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L ++ L+ E+ L + + + L + RF + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
I+HRDLK N+LLD D + K++DFGLAR E +GT YMAPE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
+ D++S G+++ E+++GK + D++ + P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKPKPPFPPPEWDI----- 223
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPS 551
E I LL PE R +
Sbjct: 224 --SPEAKDLIR-KLLVK--DPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-47
Identities = 72/216 (33%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRN 343
++ LG G FG VY D G+ +AVK LS SE+ L L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 344 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDYFIFDQTKRELLDWSKRF-----HIICGTAR 396
+V+ G E+ L I+ E++ SL + K+F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 397 ----GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
GL YLH I+HRD+K +N+L+D D K++DFG A+ G E T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
T +MAPE + +D++S G V+E+ +GK
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
F I K+G+GGFG VYK G+E+A+K + S++ ++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD-WSKRF---HI--IC-GTARGLL 399
G ++ +E ++ EF SL ++LL ++ I +C +GL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
YLH IIHRD+K +N+LL D K+ DFGL+ + N ++GT +MAP
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGK 487
E + K+D++S GI +E+ GK
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 66/223 (29%), Positives = 114/223 (51%), Gaps = 15/223 (6%)
Query: 268 IEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGL 326
E+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNK 59
Query: 327 NELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK 386
+ NE+++ +H N+V + G+E ++ E+M SL I Q +
Sbjct: 60 ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRM----N 114
Query: 387 RFHI--ICG-TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443
I +C +GL YLH +IHRD+K+ N+LL D + K++DFG A +
Sbjct: 115 EPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KE 169
Query: 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
+ N V+GT +MAPE + K D++S GI+ +E+ G
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 87/265 (32%), Positives = 130/265 (49%), Gaps = 23/265 (8%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
F++ KLG G FG V++G + +A+K L + + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
C GE +I E M SL F+ + +L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
IHRDL N+L+ D+ K++DFGLAR +++ S++K I Y + APE A+ G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKI-PYKWTAPEAASHGTF 181
Query: 468 SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN 527
S KSDV+SFGIL+ E+ + + Y N V I A Y+ C
Sbjct: 182 STKSDVWSFGILLYEMFT--YGQVPYPGMNNHEVY-------------DQITAGYRMPC- 225
Query: 528 PDEVIRCIH-ISLLCVQHHPEDRPS 551
P + + I+ I L C PEDRPS
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 31/214 (14%)
Query: 287 NFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRN 343
N+ + + +G G FG VYKG L G +A+K++S KI E+ L + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 344 LVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFH------IICGTA- 395
+VK +G I+ + L I E+ N SL R+++ K+F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQ 107
Query: 396 --RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
+GL YLH+ +IHRD+K +N+L D K++DFG+A V+GT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGT 162
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+MAPE S SD++S G V+E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-34
Identities = 81/325 (24%), Positives = 128/325 (39%), Gaps = 23/325 (7%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH-R 342
++ I KLGEG FG VY D + +A+K L+K + + E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+VKL L+ E++ SL+ + ++ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMN-PKISDFGLARTFGGD----EIEGSTNKVIGTYGYM 457
IIHRD+K N+LLD D K+ DFGLA+ I + +GT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 458 APEYATDGLF---SVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNKGM 513
APE S SD++S GI + E+++G G NS ++ L +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGC 573
S + + P++R S S + + +
Sbjct: 236 ASP-----LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
Query: 574 LVDRKSTGPDSSSSKPESSSTNAST 598
L+ + P S P + +S
Sbjct: 291 LLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRN 343
+ I ++G+G FG+VY DG+ +K LS +SE+ + NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR-------ELLDWSKRFHIICGTAR 396
++K + + ++ E+ L I Q K ++LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
L YLH SR +I+HRD+K N+ L + K+ DFG+++ T V+GT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
++PE + ++ KSD++S G ++ E+ + K
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 83/272 (30%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
+ KLG G FG V+ GT ++AVK L K E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR-----ELLDWSKRFHIICGTARGLLYLH 402
C + E ++ E+M SL F+ + +L+D + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA------AQIAEGMAYLE 120
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI---EGSTNKVIGTYGYMAP 459
IHRDL N+L+ ++ KI+DFGLAR DE EG+ + T AP
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----AP 173
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
E A G F++KSDV+SFGIL+ EIV+ R Y V+ ++
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVT--YGRVPYPGMTNREVLEQ-------------VE 218
Query: 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
Y+ P+ + L C PE+RP+
Sbjct: 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 33/286 (11%)
Query: 292 NKLGEGGFGRVYKGT---LVDGQ--EIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLV 345
+LGEG FG+V L D ++AVK L+ EQ ++ + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 346 KLLGCC--IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
K G C G LI E++P+ SL ++ Q R+ ++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR--TFGGDEIEGSTNKVIGTYGYMAPEY 461
R IHRDL N+L++ + KISDFGLA+ D + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 462 ATDGLFSVKSDVFSFGILVLEIVS-GKRNRG-------LYNSDNKFNVIRHAWNLWNKGM 513
FS SDV+SFG+ + E+ + G ++ + ++ L +G
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+C PDEV + LC + P+DRPS +IL++
Sbjct: 244 RLPRPPSC------PDEV---YDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 48/286 (16%)
Query: 294 LGEGGFGRVYKGT---LVDGQE---IAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLVK 346
LGEG FG+V+ G L + +AVK L + + + + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFI------------FDQTKRELLDWSKRFHIICGT 394
G C +G+ ++++E+M + L+ F+ D EL S+ I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL-SQLLQIAVQI 131
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGD--EIEGSTNKVI 451
A G++YL + +HRDL T N L+ +D+ KI DFG++R + D + G T I
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLW 509
+M PE F+ +SDV+SFG+++ EI + GK+ GL N + VI
Sbjct: 189 ---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIECITQGR 241
Query: 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
P +C P EV I L C + P+ R ++ +
Sbjct: 242 LLQRP---------RTC-PSEV---YDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKL-Q 340
D+F +GEG F V +E A+K L K I E+ + +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
H ++KL Q EE L + E+ PN L +I K LD L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-------- 451
YLH IIHRDLK N+LLD DM+ KI+DFG A+ + S
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 452 ----------GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT Y++PE + SD+++ G ++ ++++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 294 LGEGGFGRVYKGTLV----DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVK 346
LG+G FG+V LV G+ A+K L K I + + E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 347 LLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
L Q EEKL L+ E+ P L + + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
L II+RDLK N+LLD D + K++DFGLA+ + TN GT Y+APE
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGK 168
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+ D +S G+L+ E+++GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 73/293 (24%), Positives = 116/293 (39%), Gaps = 71/293 (24%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRL-----SKISEQGLNELKNEVILFSKL 339
+ LG+G G VYK G+ A+K++ + +Q L ELK L S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK---TLRSC- 56
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK----------RELLDWSKRFH 389
+ +VK G + E ++ E+M SL + K R++L
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILK------ 110
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS--- 446
GL YLH IIHRD+K SN+L++ KI+DFG+++ +E +
Sbjct: 111 -------GLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKV-----LENTLDQ 156
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506
N +GT YM+PE +S +D++S G+ +LE GK +
Sbjct: 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK----------------FPF 200
Query: 507 NLWNKGMPWQLIDA-CYQESCNPDEVIRCIHIS-------LLCVQHHPEDRPS 551
+ ++L+ A C + S C+Q P+ RPS
Sbjct: 201 LPPGQPSFFELMQAICDGPPPSLPA----EEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 294 LGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGL-NELKNEVILFSKLQHRNLVK 346
LGEG FG+VYKG L +A+K L + +E + E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIF-------------DQTKRELLDWSKRFHIICG 393
LLG C + + +++E++ + L F+ D+T + LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGDEIEGSTNKVIG 452
A G+ YL S +HRDL N L+ + KISDFGL+R + D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+M PE G F+ +SD++SFG+++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 73/209 (34%), Positives = 103/209 (49%), Gaps = 37/209 (17%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRL---SKISEQGLNELKNEVILFSKLQHRNLVKLLGC 350
+G+G FG V G GQ++AVK L S ++ L E + + L+H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS----VMTTLRHPNLVQLLGV 68
Query: 351 CIQGEEKLLIYEFMPNKSL-DYF-------IFDQTKRELLDWSKRFHIICGTARGLLYLH 402
+QG ++ E+M SL DY I T + L ++ + G+ YL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFA--LDV----CEGMEYLE 119
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY--GYMAPE 460
+ +HRDL NVL+ D+ K+SDFGLA+ E S + G + APE
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPE 169
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRN 489
+ FS KSDV+SFGIL+ EI S R
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 31/211 (14%)
Query: 294 LGEGGFGRVYKGT-LVDGQ----EIAVKRL-SKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G FG VYKG + +G+ +A+K L + S + E+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR----ELLDWSKRFHIICGTARGLLYLHQ 403
LG C+ + LI + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG-----YMA 458
R++HRDL NVL+ + KI+DFGLA+ DE + G +MA
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMA 179
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVS-GKR 488
E +++ KSDV+S+G+ V E+++ G +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 82/267 (30%), Positives = 125/267 (46%), Gaps = 35/267 (13%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRNLVKLLGC 350
K+G+G FG VYKG L E+AVK R + + L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410
C+Q + ++ E +P SL F+ + K+ L K + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470
HRDL N L+ + KISDFG++R G S + APE G ++ +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 471 SDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ----E 524
SDV+S+GIL+ E S G+ N + + I++ Y+ +
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPAPQ 218
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPS 551
C P+E+ R + L C + PE+RPS
Sbjct: 219 LC-PEEIYR---LMLQCWAYDPENRPS 241
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 80/231 (34%), Positives = 110/231 (47%), Gaps = 28/231 (12%)
Query: 294 LGEGGFGRVYKGTLVD-------GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRN 343
LG G FG VY+GT D +AVK L K E+ E E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE----LLDWSKRFHIICGTARGLL 399
+VKLLG C+ E + +I E M L ++ D LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 400 YLHQDSRLRIIHRDLKTSNVLL-----DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
YL Q + IHRDL N L+ D D KI DFGLAR + + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504
+MAPE DG F+ +SDV+SFG+L+ EI++ G++ Y + N V++H
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQH 225
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 85/272 (31%), Positives = 127/272 (46%), Gaps = 34/272 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + KLG G FG V+ G ++A+K L K E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+L Q E +I E+M N SL D+ + + L +K + A G+ ++
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE-- 119
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI---EGSTNKVIGTYGYMAPEY 461
R IHRDL+ +N+L+ + KI+DFGLAR +E EG+ + T APE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKR--NRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
G F++KSDV+SFGIL+ EIV+ R G+ N + VI++ + P D
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQNLERGYRMPRP----D 226
Query: 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
C +E + LC + PE+RP+
Sbjct: 227 NCPEELYE---------LMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 18/223 (8%)
Query: 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRN 343
+F I NK+G+G FG V+K D + A+K+ LSK++ + E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD---WSKRFHIICGTARGLLY 400
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH +I+HRD+K+ N+ LD N KI D G+A+ + +T ++GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
D ++ KSDV++ G+++ E +GK ++++N+ +I
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 48/287 (16%)
Query: 292 NKLGEGGFGRVYKGTLV--DGQEI--AVKRLSKISEQGL-NELKNEVILFSKLQHRNLVK 346
+LG G FG V KG + G+E+ AVK L + E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ---TKRELLDWSKRFHIICGTARGLLYLHQ 403
L+G C +GE +L+ E P L ++ + +L + + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA---HQV---AMGMAYLES 113
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG-----YMA 458
+HRDL NVLL + KISDFG++R G GS T G + A
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA----GSDYYRATTAGRWPLKWYA 166
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
PE G FS KSDV+S+G+ + E S K + ++ VI
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----VI-------------A 209
Query: 517 LIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPSMPSVILMLGSD 562
++++ + P+E + I+ I L C ++ PEDRP+ + D
Sbjct: 210 MLESGERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 84/269 (31%), Positives = 121/269 (44%), Gaps = 41/269 (15%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI 352
KLG G FG V++G + +AVK L K + E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 353 QGEEKLLIYEFMPNKSLDYFIFDQTKR-----ELLDWSKRFHIICGTARGLLYLHQDSRL 407
E ++ E M SL ++ R +L+D + + A G+ YL +
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ------VASGMAYLEAQN-- 123
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT---YGYMAPEYATD 464
IHRDL NVL+ + K++DFGLAR D E G + APE A
Sbjct: 124 -YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALY 178
Query: 465 GLFSVKSDVFSFGILVLEIVSGKR--NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
FS+KSDV+SFGIL+ EIV+ R G+ N++ V+ Q +D Y
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VL-------------QQVDQGY 221
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+ C P I L C + P+DRP+
Sbjct: 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
F I KLGEG +G VYK GQ +A+K + E+ L E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 347 LLGCCIQGEEKLLIYEFMPNKS-LDYFIFDQTKRELLDWSKRFHIIC-GTARGLLYLHQD 404
G + + ++ E+ S D I T + L + + I T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTE--EEIAAILYQTLKGLEYLHS- 117
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+ IHRD+K N+LL+ + K++DFG++ N VIGT +MAPE +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 465 GLFSVKSDVFSFGILVLEIVSGK 487
++ K+D++S GI +E+ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 42/111 (37%), Positives = 61/111 (54%), Gaps = 5/111 (4%)
Query: 42 RSGPWNGQTFEGIPWMKDS---VFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHR 98
RSGPWNG F GIP M+ V+ +EVYY ++ N+++ +RL L + G+ R
Sbjct: 2 RSGPWNGIRFSGIPEMQKLSYYVYNFTEN--NEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 99 FVWDETTSKWHKLYSWPFDHCDNYAECGANSNCRVSETPSCECLTGFISKS 149
F W + W+ +S P D CD Y CG C V+ +P C C+ GF+ K+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 75/216 (34%), Positives = 115/216 (53%), Gaps = 36/216 (16%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGL--NELKNEVILFSKLQHR 342
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 343 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKREL-LDWSKR--FHIICGTARGL 398
N+VKLL I E KL L++E+ + L ++ D+ L + K + ++ G L
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRG----L 111
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
Y H RI+HRDLK N+L++ D K++DFGLAR FG T++V+ T Y A
Sbjct: 112 AYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRA 166
Query: 459 PE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
PE Y+T +V D++S G + E+++GK
Sbjct: 167 PEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 288 FSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISE------QGLNELKNEVILFSKLQ 340
+ ++GEG +G+VYK G+ +A+K++ +E + E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 341 HRNLVKLLGCCIQGEEK--LLIYEFMPN-------KSLDYFIFDQTKRELLDWSKRFHII 391
H N+V+L + +++E+M + F Q K +
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK----------CYM 106
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
GL YLH + I+HRD+K SN+L+++D K++DFGLAR + TN+VI
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 452 GTYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSGK 487
T Y PE AT + + D++S G ++ E+ GK
Sbjct: 164 -TLWYRPPELLLGATR--YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRL-SKISEQGLNELKNEVILFSKLQ 340
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H N+++L G + ++I E+M N SLD F+ + + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L S + +HRDL N+L++ ++ K+SDFGL+R E +T + APE
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 461 YATDGLFSVKSDVFSFGILVLEIVS-GKR 488
F+ SDV+SFGI++ E++S G+R
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 91/276 (32%), Positives = 133/276 (48%), Gaps = 41/276 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG G FG V+ G + ++AVK L K + E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKR----ELLDWSKRFHIICGTARGLLY 400
+L + E +I E+M SL D+ D+ + +L+D+S + A G+ Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAY 118
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI---EGSTNKVIGTYGYM 457
+ R IHRDL+ +NVL+ + KI+DFGLAR +E EG+ + +
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI----KWT 171
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVS-GK-RNRGLYNSDNKFNVIRHAWNLWNKGMPW 515
APE G F++KSDV+SFGIL+ EIV+ GK G+ NSD + R MP
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR------GYRMP- 224
Query: 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
E+C PDE+ I C + E+RP+
Sbjct: 225 ------RMENC-PDEL---YDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQHR 342
+F + +G+G FG+V D +++ A+K ++K + + + + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 343 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
LV L Q EE + L+ + + L Y + K + + +F IC L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYL 116
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H IIHRD+K N+LLD + I+DF +A D + T GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEV 170
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKR 488
+SV D +S G+ E + GKR
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 38/212 (17%)
Query: 294 LGEGGFGRVYKG-TLVDGQEIAVKRLS-----KISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G FG VY+G L DG AVK +S + ++ + +L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 348 LGCCIQGEEKLLIY-EFMPNKSL-----DYFIFDQT-----KRELLDWSKRFHIICGTAR 396
LG + E+ L I+ E +P SL Y F + R++L
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
GL YLH +HRD+K +N+L+D + K++DFG+A+ G+ +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYW 167
Query: 457 MAPEY-ATDGLFSVKSDVFSFGILVLEIVSGK 487
MAPE A G + + +D++S G VLE+ +GK
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 294 LGEGGFGRVYKGT---LVDGQE---IAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVK 346
+G+G FGRV++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL-------------------LDWSKR 387
LLG C G+ L++E+M L+ F+ ++ R L +++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEIEGS 446
I A G+ YL S + +HRDL T N L+ +M KI+DFGL+R + D + S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL--YNSDNKFNVIRH 504
N I +M PE ++ +SDV+++G+++ EI S G+ Y VI +
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS----YGMQPYYGMAHEEVIYY 244
Query: 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
+ P D C E N + LC P DRPS S+
Sbjct: 245 VRDGNVLSCP----DNCPLELYN---------LMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 38/274 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG G FG V+ T ++AVK + K + E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKR----ELLDWSKRFHIICGTARGLLY 400
KL + E +I EFM SL D+ D+ + +L+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI---EGSTNKVIGTYGYM 457
+ Q + IHRDL+ +N+L+ + KI+DFGLAR +E EG+ + +
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI----KWT 170
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
APE G F++KSDV+SFGIL++EIV+ R Y + VIR +G
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRAL----ERGYRMPR 224
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+ C +E N I + C ++ PE+RP+
Sbjct: 225 PENCPEELYN---------IMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRL-----SKISEQGLNELKNEVILFSKLQHRNLV 345
+LG G G V K G+ +AVK + I +Q L EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYF---IFDQTKRELLDWSKRFHIICGTARGLLYLH 402
G + + E+M SLD + + +L K I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYLH 117
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFG--------LARTFGGDEIEGSTNKVIGTY 454
+ +IIHRD+K SN+L++ K+ DFG LA+TF +GT
Sbjct: 118 --EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------------VGTS 163
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
YMAPE +SVKSD++S G+ ++E+ +G+
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 33/281 (11%)
Query: 294 LGEGGFGRVY----KGTLVDGQE--IAVKRLSKISEQG-LNELKNEVILFSKLQHRNLVK 346
LG G FG V+ KG +G E + VK L K ++ +E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFI------FDQTKRELLDWSKRFHIICGTARGLLY 400
LLG C + E +I E+ L F+ ++ K L ++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L S R +HRDL N L+ K+S L++ E N +I ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 461 YATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
+ FS KSDV+SFG+L+ E+ + G+ + + N ++ + + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ------AGKLELPVPE 242
Query: 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560
C P + + + C +P+DRPS ++ LG
Sbjct: 243 GC------PSRLYK---LMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 293 KLGEGGFGRVYKG---TLVDGQE---IAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
+LGEG FG+V+ L+ Q+ +AVK L + SE + + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYF---------IFDQTKREL---LDWSKRFHIICGT 394
G C +G L+++E+M + L+ F I + L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
A G++YL + L +HRDL T N L+ + KI DFG++R + + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR 488
+M PE F+ +SD++SFG+++ EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 30/213 (14%)
Query: 294 LGEGGFGRVYKG-TLVDGQEIAVKR--LSKISEQG-------LNELKNEVILFSKLQHRN 343
+G G FG VY G G+ +AVK+ L +S L+ L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSL-----DYFIFDQTKRELLDWSKRFHIICGTARGL 398
+V+ LG + + + E++P S+ +Y F++T + F + +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEET------LVRNF--VRQILKGL 119
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK----VIGTY 454
YLH IIHRD+K +N+L+D+ KISDFG+++ + + TN + G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+MAPE ++ K+D++S G LV+E+++GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-24
Identities = 34/67 (50%), Positives = 47/67 (70%), Gaps = 3/67 (4%)
Query: 168 CPGGEGFLKLPKMKLPEN--YWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMW 225
C GG+GFL+LP MKLP+ ++S+ L+ECE C NCSC AYA + + GG GCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGS-GCLIW 59
Query: 226 FGDLIDI 232
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 10/208 (4%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-IAVKR--LSKISEQGLNELKNEVILFSKLQHR 342
D++ + +G G VY + E +A+KR L K ++EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+VK + G+E L+ ++ SL + R LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF--GGDEIEGSTNKVIGTYGYMAPE 460
+ + IHRD+K N+LL D + KI+DFG++ + GGD +GT +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 461 YATDGL-FSVKSDVFSFGILVLEIVSGK 487
+ K+D++SFGI +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 71/207 (34%), Positives = 111/207 (53%), Gaps = 25/207 (12%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKR-----LSKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG+G FGRVY VD G+E+AVK+ S +++ +N L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 348 LGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKR-----ELLDWSKRFHIICGTARGLLYL 401
GC ++ +E L I+ E+MP S + DQ K E + I+ G+ YL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQIL----EGVEYL 120
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK-VIGTYGYMAPE 460
H + I+HRD+K +N+L D N K+ DFG ++ G+ K V GT +M+PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGK 487
+ + K+DV+S G V+E+++ K
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 293 KLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGL-NELKNEVILFSKLQHRNLV 345
+LGE FG+VYKG L Q +A+K L +E L E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIF-------------DQTKRELLDWSKRFHIIC 392
LLG + + +I+ + + L F+ D+T + L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGDEIEGSTNKVI 451
A G+ +L S ++H+DL T NVL+ +N KISD GL R + D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+M+PE G FS+ SD++S+G+++ E+ S
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 86/278 (30%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 294 LGEGGFGRVYK---GTLVD--GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLL 348
LG+G FG V L D G+ +AVK+L + + L + + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 349 GCCIQ-GEEKL-LIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
G C G L L+ E++P SL DY Q RE LD K +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG---TYGYMAPEYA 462
R +HRDL T N+L++ + KI DFGL + D+ E + G + Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESL 183
Query: 463 TDGLFSVKSDVFSFGILVLEIVS-GKRN--------RGLYNSDNKFNVIRHAWNLWNKGM 513
T+ FSV SDV+SFG+++ E+ + ++ R + N ++ H L
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
C P E+ I C + P RPS
Sbjct: 244 RLPAPPGC------PAEIYA---IMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 32/287 (11%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLV----DGQE--IAVKRLSKI-SEQGLNELKNEVILF 336
D+ ++ LG G FG VY+G D E +AVK L + SEQ ++ E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE----LLDWSKRFHIIC 392
SK H+N+V+L+G + + ++ E M L F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGLARTFGGDEIEGSTNK 449
A+G YL ++ IHRD+ N LL KI+DFG+AR +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509
+ +M PE DG+F+ K+DV+SFG+L+ EI S G + N +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMPYPGRTN--QEVMEFV 234
Query: 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
G + C P V R I C QH PEDRP+ +++
Sbjct: 235 TGGGRLD-----PPKGC-PGPVYR---IMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 82/263 (31%), Positives = 121/263 (46%), Gaps = 32/263 (12%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGCCI 352
LG+G FG V+KGTL D +AVK + Q L + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 353 QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHR 412
Q + ++ E +P D+ F + K++ L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 413 DLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSD 472
DL N L+ + KISDFG++R S K I + APE G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176
Query: 473 VFSFGILVLEIVSGK--RNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN--- 527
V+S+GIL+ E S G+ N + V KG Y+ SC
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQV--------EKG---------YRMSCPQKC 219
Query: 528 PDEVIRCIHISLLCVQHHPEDRP 550
PD+V + + C + PE+RP
Sbjct: 220 PDDVYK---VMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 293 KLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKN--EVILFSKLQHRNLVKLLG 349
K+GEG +G VYK + G+ +A+K++ E E+ L +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
+ L++EFM D + + ++ L S + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-YATDGLFS 468
+HRDLK N+L++ + K++DFGLAR+FG + T Y APE D +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 469 VKSDVFSFGILVLEIVSGK 487
D++S G + E++S +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 288 FSINNKLGEGGFGRVYKGTLV--DG--QEIAVK--RLSKISEQGLNELKNEVILFSKLQH 341
+ LGEG FG V +G L DG ++AVK +L + + E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 342 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDYFIFD---QTKRELLDWSKRFHIIC 392
N++KL+G C + ++I FM + L F+ E L +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEI-EGSTNKV 450
A G+ YL S IHRDL N +L DM ++DFGL++ + GD +G K+
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNRGLYN 494
++A E D +++ KSDV++FG+ + EI + G N +Y+
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRN 343
++ ++G G FG V+ G ++ +++A+K R +SE+ + E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
LV+L G C + L++EFM + L ++ + +R + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
+ +IHRDL N L+ + K+SDFG+ R D+ ST + +PE +
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFS 174
Query: 464 DGLFSVKSDVFSFGILVLEIVS 485
+S KSDV+SFG+L+ E+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRL-SKISEQGLNELKNEVILFSK 338
D ++ LGEG FG+V K V +AVK L +E+ L++L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT--- 394
+ +H+N++ LLG C Q ++ E+ + +L F+ + T
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 395 ----------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG-DEI 443
ARG+ +L + IHRDL NVL+ D KI+DFGLAR D
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+TN + +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 189 RKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 72/300 (24%), Positives = 134/300 (44%), Gaps = 56/300 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKG---TLVDGQ---EIAVKRLSK---ISEQGLNELKNEVILF 336
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWS--------KR 387
+ ++V+LLG G+ L++ E M L Y +++R + + ++
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL---RSRRPEAENNPGLGPPTLQK 120
Query: 388 FHIICG-TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
F + A G+ YL + +HRDL N ++ D+ KI DFG+ R +
Sbjct: 121 FIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNRGLYNSDNKF 499
K + +MAPE DG+F+ KSDV+SFG+++ E+ + G N +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237
Query: 500 NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ E+C PD + + + +C Q++P+ RP+ ++ L
Sbjct: 238 GHLD------------------LPENC-PD---KLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 76/270 (28%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 289 SINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
++ +KLG G +G VY+G +AVK L K + E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 348 LGCCIQGEEKLLIYEFMPNKS-LDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
LG C + +I EFM + LDY + R+ ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
IHRDL N L+ + K++DFGL+R GD + APE
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNK 181
Query: 467 FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV-IRHAWNLWNKGMPWQLIDACYQES 525
FS+KSDV++FG+L+ EI + Y + + + L KG + + C
Sbjct: 182 FSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKGYRMERPEGC---- 230
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
P +V + C Q +P DRPS +
Sbjct: 231 --PPKVYELMR---ACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKL-Q 340
+ T F + +GEG +G+VYK GQ +A+K + I ++ E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 341 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF------ 388
H N+ G I+ +++L L+ E S + D K L KR
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG-LRKKGKRLKEEWIA 116
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448
+I+ T RGL YLH++ ++IHRD+K N+LL + K+ DFG++ D G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
Query: 449 KVIGTYGYMAPE-----YATDGLFSVKSDVFSFGILVLEIVSGK 487
IGT +MAPE D + +SDV+S GI +E+ GK
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 81/268 (30%), Positives = 123/268 (45%), Gaps = 22/268 (8%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
++ + KLG G FG V+ GT ++AVK L K E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
LV+L + E ++ E+M SL F+ D R L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
R+ IHRDL+++N+L+ + KI+DFGLAR +E + APE A
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 464 DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
G F++KSDV+SFGIL+ E+V+ + R Y N V+ ++ Y+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQ-------------VERGYR 221
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
C D I + L C + PE+RP+
Sbjct: 222 MPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 81/268 (30%), Positives = 114/268 (42%), Gaps = 44/268 (16%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNE--LKNEVILFSKLQHRNLVKLLGCC 351
LG G FG V+ G ++A+K I E ++E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 352 IQGEEKLLIYEFMPNKSLDYFIFDQTKRE----LLDWSKRFHIICGTARGLLYLHQDSRL 407
+ ++ E+M N L ++ ++ + LLD +C + YL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD---VC---EAMEYLESNG-- 120
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT---YGYMAPEYATD 464
IHRDL N L+ D K+SDFGLAR D+ S GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDY 175
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN--VIRHAWNLWNKGMPWQLIDACY 522
FS KSDV+SFG+L+ E+ S G + N V+ ++L Y
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE----GKMPYERFSNSEVVESV------SAGYRL----Y 221
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRP 550
+ P EV I C PEDRP
Sbjct: 222 RPKLAPTEVYT---IMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 287 NFSINNKLGEGGFGRVYK-GTLVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRN 343
+F + KLG+G +G VYK L D Q A+K L +S++ + NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD-QTKRELLDWSKRFHIICGTARGLLYLH 402
++ + G + ++ E+ P L I + KR+L+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
+ +I+HRDLK++N+LL + KI D G+++ IGT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVW 173
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGK 487
+S KSD++S G L+ E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 73/212 (34%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT---LVDGQ---EIAVKRLSKISEQGLNE-LKNEVILFSK 338
+N S LG G FG+V + T L ++AVK L + E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-LLDWSKRFHIICGTAR 396
L H N+V LLG C G L+I E+ L F+ + KRE L A+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAK 152
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE---IEGSTNKVIGT 453
G+ +L + IHRDL NVLL H KI DFGLAR D ++G+ +
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK- 208
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+MAPE + +++ +SDV+S+GIL+ EI S
Sbjct: 209 --WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 294 LGEGGFGRVYKGTLVDGQ-EIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI 352
LG+G +G VY + Q IA+K + + + + L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 353 QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA--RGLLYLHQDSRLRII 410
+ + E +P SL + ++K L +++ I GL YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 411 HRDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL--F 467
HRD+K NVL++ + KISDFG ++ G I T GT YMAPE G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 468 SVKSDVFSFGILVLEIVSGK 487
+D++S G ++E+ +GK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 27/268 (10%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRNLVKLL 348
NK+G G FG+VY L G+ +AVK R+ + + E+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
G + E+ + E+ +L+ + + + + + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTL--QLLEGLAYLHSH---G 119
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTF--GGDEIEGSTNKVIGTYGYMAPEYATDGL 466
I+HRD+K +N+ LDH+ K+ DFG A + + GT YMAPE T G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 467 FSVK---SDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
+D++S G +VLE+ +GKR DN+F ++ H G + D+ Q
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP--WSELDNEFQIMFHV----GAGHKPPIPDSL-Q 232
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
S E + C++ P+ RP+
Sbjct: 233 LS---PEGKDFLD---RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 35/274 (12%)
Query: 294 LGEGGFG------RVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG+G FG R +LV +E+ + RLS E+ + NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
+ L+ E+ +L Y + K +L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
I+HRD+KT N+ L K+ DFG+++ G + T V+GT YM+PE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 468 SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP--WQLIDACYQES 525
+ KSD+++ G ++ E+++ KR +++ N N++ K + + + + Y
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT---FDATNPLNLV-------VKIVQGNYTPVVSVYSS- 227
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
E+I +H +Q PE RP+ V+
Sbjct: 228 ----ELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 292 NKLGEGGFGRVYKGTLV----DGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRNLV 345
+G+G FG V K V DG+ + K + ++E+ +L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 346 KLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLH 402
+ I + L + E+ L I K R+ ++ + I+ L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 403 --QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
D ++HRDLK +N+ LD + N K+ DFGLA+ G D T +GT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGK 487
+ KSD++S G L+ E+ +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 50/295 (16%)
Query: 287 NFSINNKLGEGGFGRVYKGT------LVDGQEIAVKRLSKISEQG-LNELKNEVILFSKL 339
N + LGEG FG+V K T +AVK L + + L +L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE--------LLDWSKRFH-- 389
H +++KL G C Q LLI E+ SL F+ + K + S +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 390 -----------IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
+RG+ YL + ++++HRDL NVL+ KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 439 GGDE--IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD 496
++ ++ S ++ +MA E D +++ +SDV+SFG+L+ EIV+ L +
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNP 229
Query: 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+NL G + + C +E N + L C + P+ RP+
Sbjct: 230 YPGIAPERLFNLLKTGYRMERPENCSEEMYN---------LMLTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-22
Identities = 61/220 (27%), Positives = 118/220 (53%), Gaps = 10/220 (4%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLN 327
E++ L + +I + ++ K+G+G G V+ V GQE+A+K+++ +
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE 61
Query: 328 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR 387
+ NE+++ +L++ N+V L + G+E ++ E++ SL D +D ++
Sbjct: 62 LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQI 117
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+ + L +LH + ++IHRD+K+ NVLL D + K++DFG ++ + ST
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
++GT +MAPE T + K D++S GI+ +E+V G+
Sbjct: 175 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 69/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQDS 405
+ ++ L L+ M L Y I++ + + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF-GGDEIEGSTNKVIGTYGYMAPEYATD 464
RI++RDLK NVLLD N +ISD GLA GG +I+G GT GYMAPE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQG 168
Query: 465 GLFSVKSDVFSFGILVLEIVSGK 487
++ D F+ G + E+++G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 36/216 (16%)
Query: 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLS------KISEQGLNELKNEVILFSKLQHRNLV 345
LG+G +G VY G GQ IAVK++ +E+ +L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 346 KLLGCCIQGEEKLLIYEFMPNKS----LDYF------IFDQTKRELLDWSKRFHIICGTA 395
+ LG C+ + EF+P S L+ F +F + +++LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI---- 451
G+ YLH + ++HRD+K +NV+L + K+ DFG AR + G+ + ++
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT +MAPE + + KSD++S G V E+ +GK
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRL---SKISEQG-------LNELKNEVILFSKLQHR 342
+G+G +GRVY V G+ +AVK++ + I+ + + L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 343 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+V+ LG EE L I+ E++P S+ + + + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS--TNKVIGTYGYMAP 459
H I+HRDLK N+L+D D KISDFG+++ D+I + + G+ +MAP
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVFWMAP 179
Query: 460 EY-ATDGL-FSVKSDVFSFGILVLEIVSGKR 488
E + +S K D++S G +VLE+ +G+R
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 23/223 (10%)
Query: 294 LGEGGFGRVYKGTLVD--GQEI--AVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLL 348
+G+G FG VY GTL+D GQ+I AVK L++I++ + + + E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 349 GCCIQGE-EKLLIYEFMPNKSLDYFIFDQTK----RELLDWSKRFHIICGTARGLLYLHQ 403
G C+ E L++ +M + L FI +T ++L+ + + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKGMEYLAS 116
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY--GYMAPEY 461
+ +HRDL N +LD K++DFGLAR E N +MA E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
F+ KSDV+SFG+L+ E+++ R Y + F++ +
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY 214
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 63/221 (28%), Positives = 119/221 (53%), Gaps = 12/221 (5%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLN 327
E++ L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKK 60
Query: 328 ELK-NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK 386
EL NE+++ + +H N+V L + G+E ++ E++ SL D +D +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 116
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++ + S
Sbjct: 117 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T ++GT +MAPE T + K D++S GI+ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI 352
KLG+G FG V+ GT +A+K L K E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 353 QGEEKLLIYEFMPNKSLDYFIFDQTKR-----ELLDWSKRFHIICGTARGLLYLHQDSRL 407
E ++ E+M SL F+ + + +L+D + + A G+ Y+ R+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMAYVE---RM 121
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
+HRDL+ +N+L+ ++ K++DFGLAR +E + APE A G F
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRF 180
Query: 468 SVKSDVFSFGILVLEIVSGKR--NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
++KSDV+SFGIL+ E+ + R G+ N R + +G Y+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG---------YRMP 223
Query: 526 CNPDEVIRCIH-ISLLCVQHHPEDRPS 551
C P E +H + C + PE+RP+
Sbjct: 224 C-PPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISE----QGLNELKNEVILFSKL 339
NF I K+G+G F VYK L+DG+ +A+K++ +I E + + E+ L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQL 59
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI--FDQTKR---ELLDWSKRFHIICGT 394
H N++K L I+ E ++ E L I F + KR E W K F +C
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQLC-- 116
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
L ++H RI+HRD+K +NV + K+ D GL R F + ++GT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEI 483
YM+PE + ++ KSD++S G L+ E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 293 KLGEGGFGRVYKGTLV-----DGQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVK 346
+LGE FG++YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIF--------------DQTKRELLDWSKRFHIIC 392
LLG Q + +++E++ L F+ D T + LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
A G+ YL S +H+DL N+L+ ++ KISD GL+R + K +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+M PE G FS SD++SFG+++ EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 71/280 (25%), Positives = 104/280 (37%), Gaps = 55/280 (19%)
Query: 293 KLGEGGFGRVYKGTLVDGQ----EIAVKRLSKISEQG-LNELKNEVILFSKLQHRNLVKL 347
KLG+G FG V +G +AVK L +++ E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG----TARGLLYLHQ 403
G + + + E P SL + L +C A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF--GGDEIEGSTNKVIGTYGYMAPEY 461
R IHRDL N+LL D KI DFGL R D + + + + APE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW------ 515
FS SDV+ FG+ + E+ + PW
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGE------------------------EPWAGLSGS 207
Query: 516 ---QLIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPS 551
+ ID + P+ + I+ + L C H+P DRP+
Sbjct: 208 QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 35/214 (16%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQGLNELKNEVILFSKLQHRNLV 345
F++ +G+G FG VYK Q +A+K + + +E + +++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 346 KLLGCCIQGEEKLLIYEFMPNKS----LDYFIFDQTK-----RELLDWSKRFHIICGTAR 396
K G ++G + +I E+ S L D+T RE+L
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-------------L 109
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK---VIGT 453
GL YLH++ IHRD+K +N+LL + + K++DFG++ ++ + +K +GT
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+MAPE + K+D++S GI +E+ G+
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 72/207 (34%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 294 LGEGGFGRV----YKGTLVD-GQEIAVKRL-SKISEQGLNELKNEVILFSKLQHRNLVKL 347
LGEG FG+V Y G+ +AVK L + +Q + K E+ + L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 348 LGCCIQGEEK--LLIYEFMPNKSL-DYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQ 403
GCC + K LI E++P SL DY + +LL ++++ IC G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAYLHS 125
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI-----EGSTNKVIGTYGYMA 458
IHRDL NVLLD+D KI DFGLA+ E + V + A
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYA 178
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVS 485
E + FS SDV+SFG+ + E+++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 294 LGEGGFGRVYKGTLVDGQE-----IAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKL 347
LG G FG VYKG V E +A+K L++ + N E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQT----KRELLDWSKRFHIICGTARGLLYLHQ 403
LG C+ +L + + MP+ L ++ + + LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
R++HRDL NVL+ + KI+DFGLAR GDE E + + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 464 DGLFSVKSDVFSFGILVLEIVS 485
F+ +SDV+S+G+ + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 287 NFSINNKLGEGGFGRVYKG---TLVDGQE---IAVKRLSKISEQGLNELKNEVILFSKLQ 340
N + +LGEG FG+V+ L Q+ +AVK L S+ + E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL----------LDWSKRFHI 390
H ++VK G C++G+ ++++E+M + L+ F+ + L S+ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
A G++YL + +HRDL T N L+ ++ KI DFG++R +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ +M PE F+ +SDV+S G+++ EI +
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS-KISEQGLNELKNEVILFSKLQHRNLVK 346
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDS 405
LLG I ++ E M +L F+ +T+ R L+ + A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+++HRDL N+L+ D K+SDFGLAR G N + + APE
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPV-KWTAPEALKHK 172
Query: 466 LFSVKSDVFSFGILVLEIVSGKR 488
FS KSDV+S+G+L+ E+ S R
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 42/274 (15%)
Query: 294 LGEGGFGRVYK------GTLVDGQEIAVKRLSKISEQG--LNELKNEVILFSKLQHRNLV 345
LG G F Y+ GTL+ +++ R + SEQ + L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
++LG + L E+M S+ + + + + RGL YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN- 122
Query: 406 RLRIIHRDLKTSNVLLD---HDMNPKISDFGLARTF-----GGDEIEGSTNKVIGTYGYM 457
+IIHRD+K +N+L+D + +I+DFG A G E +G +++GT +M
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAFM 175
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI-RHAWNLWNKGMPWQ 516
APE + DV+S G +++E+ + K N +I + A +P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP-- 233
Query: 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP 550
E +P +R ++L C++ PEDRP
Sbjct: 234 -------EHLSPG--LR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-21
Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 165 PSDCPGGE---GFLKLPKMKLPENYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNG 221
P +C G GFLKLP +KLP+N + ++SL EC C NCSC AYA + G G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN---GSGG 58
Query: 222 CLMWFGDLIDIKECSEKYVWGQDFFIRVP 250
CL+W G L +++ S G ++R+
Sbjct: 59 CLLWNGLLNNLRSLSS---GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 290 INNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
+ +LGEG FG+V+ D +AVK L + + + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD--------------QTKRELLDWSKRFH 389
+VK G C G+ ++++E+M + L+ F+ Q K E L S+ H
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLH 127
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
I A G++YL + +HRDL T N L+ ++ KI DFG++R +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR 488
+ +M PE F+ +SDV+SFG+++ EI + GK+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 293 KLGEGGFGRVYKG-TLVDGQEIAVKRLSKISE-QGLNELK-NEVILFSKLQHRNLVKLLG 349
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 350 CCIQGEEKLLIYEFMP---NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
+Q LI+EF+ K LD Q L S + I+ +G+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG- 465
R++HRDLK N+L+D+ K++DFGLAR F G + T++V+ T Y APE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+S D++S G + E+ + K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 65/224 (29%), Positives = 113/224 (50%), Gaps = 40/224 (17%)
Query: 293 KLGEGGFGRVY-------------KGTLVDGQE--IAVKRL-SKISEQGLNELKNEVILF 336
KLGEG FG V+ DGQ +AVK L + +++ N+ E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL------------LDW 384
S+L++ N+++LLG C+ + +I E+M N L+ F+ ++RE+ +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGD-- 441
+ ++ A G+ YL + L +HRDL T N L+ + KI+DFG++R + GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
I+G + + +MA E G F+ SDV++FG+ + E+ +
Sbjct: 186 RIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 12/221 (5%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN 327
E++ L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q
Sbjct: 2 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKK 60
Query: 328 ELK-NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK 386
EL NE+++ + ++ N+V L + G+E ++ E++ SL D +D +
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 116
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++ + S
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T ++GT +MAPE T + K D++S GI+ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 294 LGEGGFGRVY--KGTLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRNLVKLLG 349
+G G FG V+ + D + + +K++ ++++ +NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
++ + +++ E+ P +L +I + LLD H L ++H I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---I 122
Query: 410 IHRDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFS 468
+HRDLKT N+LLD H M KI DFG+++ + V+GT Y++PE ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYN 179
Query: 469 VKSDVFSFGILVLEIVSGKR 488
KSD+++ G ++ E+ S KR
Sbjct: 180 QKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
DNF K+GEG G V T G+++AVK++ +Q L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIIC-GTARGLLYLH 402
V++ + G+E ++ EF+ +L D I T+ ++ +C + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTRMN----EEQIATVCLAVLKALSFLH 132
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
+IHRD+K+ ++LL D K+SDFG E+ ++GT +MAPE
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPEVI 187
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGK 487
+ + + D++S GI+V+E+V G+
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 38/278 (13%)
Query: 294 LGEGGFGRVYKGTL-VDGQE---IAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLL 348
+G G FG V++G L + G++ +A+K L +E+ + +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQ----TKRELLDWSKRFHIICGTARGLLYLHQD 404
G + + ++I E+M N +LD ++ D + +L+ ++ G A G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG--YMAPEYA 462
S + +HRDL N+L++ ++ K+SDFGL+R D+ EG+ G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 463 TDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
F+ SDV+SFGI++ E++S G+R ++ I + L P A
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMDCPSAV 239
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
YQ + L C Q RP ++ +L
Sbjct: 240 YQ-------------LMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRL------SKISEQGLNELKNEVILFSKL 339
+ ++LGEG G V K L + I + + +Q L EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 340 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKRELLDWSKRF------HII 391
+ +VK G + + E+ SLD +++ R I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIA 111
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
+GL YLH +IIHRD+K SN+LL K+ DFG++ G+ +
Sbjct: 112 ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFT 164
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT YMAPE +S+ SDV+S G+ +LE+ +
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 297 GGFGRVY----KGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
G +GRV+ K T G A+K + K I + ++++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 350 CCIQGEEKL-LIYEFMPN---KSL--DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
QG++ L L+ E++P SL + D+ D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA------RTFGGDEIEGSTNKVIGTYGYM 457
IIHRDLK N+L+D + + K++DFGL+ R ++ E +++GT Y+
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSG 486
APE S D +S G ++ E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 283 NATDNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
N D + I +LG+G FG+VYK G A K + SE+ L + E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 342 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFHIIC-GTARGLL 399
N+V L E KL I EF +LD I + +R L + R+ +C L
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY--VCRQMLEALN 117
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
+LH ++IHRDLK N+LL D + K++DFG++ ++ + IGT +MAP
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQ-KRDTFIGTPYWMAP 172
Query: 460 EYA-----TDGLFSVKSDVFSFGILVLEI 483
E D + K+D++S GI ++E+
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 284 ATDNFSINNKLGEGGFGRVY----KGTLVDGQE--IAVKRLSK-ISEQGLNELKNEVILF 336
A + +++ +LG+G FG VY KG + D E +A+K +++ S + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-------LLDWSKRFH 389
+ ++V+LLG QG+ L+I E M L ++ K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
+ A G+ YL+ + + +HRDL N ++ D KI DFG+ R + K
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEI--VSGKRNRGLYNSDNKFNVIRHAWN 507
+ +M+PE DG+F+ SDV+SFG+++ EI ++ + +G+ N V+R
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFV-- 234
Query: 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
M L+D ++C PD + + +C Q++P+ RPS +I
Sbjct: 235 -----MEGGLLDK--PDNC-PDMLFELMR---MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 293 KLGEGGFGRVYKG-TLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRNLVKLLG 349
K+GEG +G VYK + G+ +A+K RL E + E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 350 CCIQGEEKLLIYEFMP---NKSLDYFIFDQTKRELLDWSKRF-HIICGTARGLLYLHQDS 405
+ L++EF+ K +D L+ K + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
R++HRDLK N+L+D + K++DFGLAR F G + T++V+ T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGS 174
Query: 466 -LFSVKSDVFSFGILVLEIVSGK 487
+S D++S G + E+V+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 75/229 (32%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 287 NFSINNKLGEGGFGRVYKG-TLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRN 343
NF K+GEG +G VYK + G+ +A+K RL +E + E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 344 LVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKREL---LDWSKRFHIICGTARGLL 399
+VKLL I E KL L++EF+ ++ L F+ + L S F ++ +GL
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLA 114
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
+ H R++HRDLK N+L++ + K++DFGLAR F G + T++V+ T Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 169
Query: 460 EYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK----FNVIR 503
E +S D++S G + E+V+ R L+ D++ F + R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 29/206 (14%)
Query: 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQG-LNELKNEVILFSKLQH---RNLVKLL 348
+G G +G VY+G V G+ +A+K ++ + +++++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK---RFHIICGTARGLL----YL 401
G ++G +I E+ S+ R L+ ++ I R +L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H+ +IHRD+K +N+L+ + N K+ DFG+A + + ST +GT +MAPE
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEV 172
Query: 462 ATDG-LFSVKSDVFSFGILVLEIVSG 486
T+G + K+D++S GI + E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 292 NKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN-----EVILFSKLQHRNLV 345
KLGEG + VYK G+ +A+K++ + + N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 346 KLLGCCIQGEEKLLIYEFMP--------NKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
LL L++EFM +KS+ T ++ + T RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL-----TPADIKSYMLM------TLRG 114
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L YLH I+HRDLK +N+L+ D K++DFGLAR+FG + T++V+ T Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYR 169
Query: 458 APEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
APE LF + D++S G + E++
Sbjct: 170 APEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ ++ KLG+G FG V+ GT ++A+K L K E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
L + E ++ EFM SL F+ + + L + + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE--- 119
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
R+ IHRDL+ +N+L+ ++ KI+DFGLAR +E + APE A G
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 178
Query: 466 LFSVKSDVFSFGILVLEIVSGKR 488
F++KSDV+SFGIL+ E+V+ R
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 287 NFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELK-NEVILFSKLQHRNL 344
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 345 VKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
V+L I E KL L++E+M +K L ++ R LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST--NKVIGTYGYMAPEY 461
+ R++HRDLK N+L++ K++DFGLAR FG I +T N+V+ T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDV 171
Query: 462 ATDG-LFSVKSDVFSFGILVLEIVSGK 487
+S D++S G ++ E+++G+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 75/223 (33%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 286 DNFSINNKLGEGGFGRVYK----GTLVDGQE----IAVKRLS-KISEQGLNELKNEVILF 336
D + LGEG FG+V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI-----------FDQTK--RELL 382
+ +H+N++ LLG C Q +I E+ +L F+ FD TK E L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
+ ARG+ YL +SR R IHRDL NVL+ D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
T+ +MAPE D +++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 33/210 (15%)
Query: 292 NKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQG--LNELKNEVILFSKLQ---HRNL 344
++GEG +G VYK L G+ +A+K++ +SE+G L+ L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 345 VKLLGCC--IQGEEKL---LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
V+LL C + + +L L++E + ++ L ++ K L + + ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVD 121
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
+LH RI+HRDLK N+L+ D KI+DFGLAR + E + V+ T Y AP
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAP 175
Query: 460 E------YATDGLFSVKSDVFSFGILVLEI 483
E YAT V D++S G + E+
Sbjct: 176 EVLLQSSYAT----PV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
DNF K+GEG G V T+ G+ +AVK++ +Q L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC-GTARGLLYLHQ 403
V++ + G+E ++ EF+ +L + E ++ +C + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHA 134
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
+IHRD+K+ ++LL HD K+SDFG E+ ++GT +MAPE +
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELIS 189
Query: 464 DGLFSVKSDVFSFGILVLEIVSGK 487
+ + D++S GI+V+E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 58/221 (26%), Positives = 118/221 (53%), Gaps = 12/221 (5%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLN 327
E++ L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK 61
Query: 328 ELK-NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK 386
EL NE+++ + ++ N+V L + G+E ++ E++ SL D +D +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 117
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++ + S
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
++GT +MAPE T + K D++S GI+ +E++ G+
Sbjct: 175 --TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 32/188 (17%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRN 343
+ I ++GEG G V+K G+ +A+K+ L ++ N+ E+ QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD--------QTK---RELLDWSKRFHIIC 392
+VKLL G +L+ E+MP+ L + D Q K R LL
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK--------- 110
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G+ Y+H I+HRDLK +N+L+ D KI+DFGLAR F +E +++V
Sbjct: 111 ----GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-A 162
Query: 453 TYGYMAPE 460
T Y APE
Sbjct: 163 TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 64/197 (32%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353
+G+G FG V G G ++AVK + ++ E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 354 GEEKLLIY-EFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIH 411
+ L I E+M SL DY R +L + YL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 412 RDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKS 471
RDL NVL+ D K+SDFGL + E + + + APE + FS KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 472 DVFSFGILVLEIVSGKR 488
DV+SFGIL+ EI S R
Sbjct: 181 DVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNL 344
+++ + ++G G +G VYK + E+ ++ K+ ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 345 VKLLGCCIQGEEKLLI-YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
V G +KL I E+ SL I+ T+ L + + ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE 119
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK---VIGTYGYMAPE 460
IHRD+K +N+LL D + K++DFG++ ++ + K IGT +MAPE
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSA-----QLTATIAKRKSFIGTPYWMAPE 171
Query: 461 YA---TDGLFSVKSDVFSFGILVLEIVSGK 487
A G + K D+++ GI +E+ +
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS---KISEQGLNELKNEVILFSKLQHR 342
NF I K+G G F VY+ T L+D + +A+K++ + + + E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI--FDQTKR---ELLDWSKRFHIICGTARG 397
N++K L I+ E ++ E L I F + KR E W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
H SR R++HRD+K +NV + K+ D GL R F + + ++GT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVS 485
+PE + ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 293 KLGEGGFGRV-YKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCC 351
K+GEG G V G+++AVK + +Q L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 352 IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA-RGLLYLHQDSRLRII 410
+ GEE ++ EF+ +L I QT+ ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470
HRD+K+ ++LL D K+SDFG D + ++GT +MAPE + + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTE 197
Query: 471 SDVFSFGILVLEIVSGK 487
D++S GI+V+E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 281 IANATDNFSINNKLGEGGFGRVYKGTLVDG-----QEIAVKRLSK-ISEQGLNELKNEVI 334
IA + D ++++ L EG FGR++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 335 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDYF-----IFDQTKRELLDWSKRF 388
L L H+N++ +L CI+ E ++Y +M +L F + + + L +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGDE--IEG 445
H+ A G+ YLH + +IH+D+ N ++D ++ KI+D L+R F D +
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ N+ + +MA E + +S SDV+SFG+L+ E+++
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 294 LGEGGFGRVYKGTLV-DGQEI----AVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKL 347
LG G FG VYKG + +G+++ A+K L + + N E+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 348 LGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTK---RELLDWSKRFHIICGTARGLLYLHQ 403
LG C+ +L I + MP L DY + + LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
R++HRDL NVL+ + KI+DFGLA+ G DE E +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 464 DGLFSVKSDVFSFGILVLEIVS 485
+++ +SDV+S+G+ V E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 294 LGEGGFGRVYK------GTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G G V K GT++ + + + S + +Q L EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 348 LGCCIQGEEKLLIYEFMPNKSLD--YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
G + + EFM SLD Y E+L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
RI+HRD+K SN+L++ K+ DFG++ G+ I + +GT YM+PE G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGG 177
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
++VKSDV+S GI ++E+ GK
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLV 345
F+ ++G+G FG VYKG +E+ ++ + +E + +++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+ G ++G + +I E++ S D K L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
R IHRD+K +NVLL + K++DFG+A +I+ N +GT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQS 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+ K+D++S GI +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 75/297 (25%), Positives = 134/297 (45%), Gaps = 40/297 (13%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGT---LVDGQ---EIAVKRLSK-ISEQGLNELKNEVILF 336
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIF-------DQTKRELLDWSKRFH 389
++V+LLG +G+ L++ E M + L ++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
+ A G+ YL+ + +HRDL N ++ HD KI DFG+ R + K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDN-KFNVIRHAW 506
+ +MAPE DG+F+ SD++SFG+++ EI S +GL N KF
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------- 233
Query: 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPSMPSVILMLGSD 562
++D Y + PD + + +C Q +P+ RP+ ++ +L D
Sbjct: 234 ----------VMDGGYLD--QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 277 ELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILF 336
+L+ + + F + +G G +G+VYKG V ++A ++ ++E E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 337 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDYFIFDQTKRELL--DWSKR 387
K HRN+ G I ++ L+ EF S+ + TK L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIA- 124
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+I RGL +LH ++IHRD+K NVLL + K+ DFG++ D G
Sbjct: 125 -YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 178
Query: 448 NKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSG 486
N IGT +MAPE D + +SD++S GI +E+ G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 43/224 (19%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRL-----SKISEQGLNELKNEVILFSKLQ 340
N+ + LG+G FGRVY D G+E+AVK++ S + + +N L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 341 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTK--------------RELLDW 384
H +V+ GC E+ L E MP S I DQ K R++L+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILE- 117
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ +
Sbjct: 118 ------------GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162
Query: 445 GSTNK-VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
G+ K V GT +M+PE + + K+D++S G V+E+++ K
Sbjct: 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVK 346
F + +G G +G+VYKG V ++A ++ ++ E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 347 LLGCCIQ------GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
G I+ ++ L+ EF S+ I TK L +I RGL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSH 126
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LHQ ++IHRD+K NVLL + K+ DFG++ D G N IGT +MAPE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 181
Query: 461 YAT-----DGLFSVKSDVFSFGILVLEIVSG 486
D + KSD++S GI +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 79/274 (28%), Positives = 120/274 (43%), Gaps = 50/274 (18%)
Query: 293 KLGEGGFGRVYKGTLVDGQEI-AVKRLS---KISEQGLNELKNEVILFSKLQHRNLVKLL 348
++G G FG VY V E+ A+K++S K S + ++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC-GTARGLLYLHQDSRL 407
GC ++ L+ E+ + D I + K+ L + IC G +GL YLH R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE--VEIAAICHGALQGLAYLHSHER- 136
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE--YATD- 464
IHRD+K N+LL K++DFG A + N +GT +MAPE A D
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
G + K DV+S GI +E+ +R L+N + + A Y
Sbjct: 189 GQYDGKVDVWSLGITCIEL--AERKPPLFNMN--------------------AMSALYHI 226
Query: 525 SCNPDEVIRCIHISL-------LCVQHHPEDRPS 551
+ N + S C+Q P+DRPS
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 49/233 (21%)
Query: 293 KLGEGGFGRVYKGTLVDGQE-----------------IAVKRL-SKISEQGLNELKNEVI 334
KLGEG FG V+ +V+ Q+ +AVK L ++ N+ EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD----------- 383
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 384 --------WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435
+S H+ A G+ YL S L +HRDL T N L+ ++ KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 436 RT-FGGD--EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
R + GD I+G + + +MA E G F+ SDV++FG+ + EI+
Sbjct: 186 RNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 25/222 (11%)
Query: 294 LGEGGFGRV----YKGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKL-QHRNLV 345
LG+G FG+V KGT + AVK L K + + + E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 346 KLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+L C Q +++L + E++ L + I Q + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR--TFGGDEIEGSTNKVIGTYGYMAPEYA 462
II+RDLK NVLLD + + KI+DFG+ + GG +T+ GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEIL 168
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
+ + D ++ G+L+ E+++G+ + D F I
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLV--DGQE------IAVKRL-SKISEQGLNELKNEVI 334
D + LGEG FG+V + D ++ +AVK L S +E+ L++L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 335 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIF-------------DQTKRE 380
+ + +H+N++ LLG C Q +I E+ +L ++ Q E
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440
L + ARG+ YL + + IHRDL NVL+ D KI+DFGLAR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 441 -DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
D + +TN + +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 193 IDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRL-----SKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG+G FGRVY VD G+E+A K++ S + + ++ L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 348 LGCCI-QGEEKLLIY-EFMPNKSLDYFIFDQTKRE-LLDWSKRFHIICGTARGLLYLHQD 404
GC + E+ L I+ E+MP S+ DQ K L S G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS-TNKVIGTYGYMAPEYAT 463
I+HRD+K +N+L D N K+ DFG ++ + G+ V GT +M+PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 464 DGLFSVKSDVFSFGILVLEIVSGK 487
+ K+DV+S G V+E+++ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 42/275 (15%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGC 350
+LG G FG V G ++A+K + + +SE +E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKR----ELLDWSKRFHIICGTARGLLYLHQDSR 406
C + ++ E+M N L ++ + KR +LL+ K +C G+ YL
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD---VC---EGMAYLESK-- 119
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT---YGYMAPEYAT 463
+ IHRDL N L+D K+SDFGL+R DE S +G+ + PE
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLL 174
Query: 464 DGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
FS KSDV++FG+L+ E+ S GK +N+ + L+ P + Y
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY 231
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
I C E+RP+ ++
Sbjct: 232 A-------------IMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 293 KLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCC 351
K+GEG G V T G+++AVK++ +Q L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 352 IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC-GTARGLLYLHQDSRLRII 410
+ G+E ++ EF+ +L + E ++ +C R L YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQG---VI 140
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470
HRD+K+ ++LL D K+SDFG + + ++GT +MAPE + + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTE 198
Query: 471 SDVFSFGILVLEIVSGK 487
D++S GI+V+E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 55/225 (24%)
Query: 286 DNFSINNKLGEGGFGRV----YKGTLVDGQEIAVKRLSK--ISEQGLNE-LKNEVILFSK 338
D+F LG G FGRV +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRFHIICGT 394
++H LV L G F + +L Y + + EL S RF
Sbjct: 58 IRHPFLVNLYGS------------FQDDSNL-YLVMEYVPGGELFSHLRKSGRFPE--PV 102
Query: 395 AR--------GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
AR L YLH L I++RDLK N+LLD D KI+DFG A+ ++G
Sbjct: 103 ARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGR 154
Query: 447 TNKVIGTYGYMAPEYATDGLFSVK-----SDVFSFGILVLEIVSG 486
T + GT Y+APE + K D ++ GIL+ E+++G
Sbjct: 155 TYTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS---KISEQGLNELKNEVILFSKLQHR 342
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI--FDQTKR---ELLDWSKRFHIICGTARG 397
N++K I+ E ++ E L I F + KR E W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
H SR R++HRD+K +NV + K+ D GL R F + + ++GT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVS 485
+PE + ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 54/288 (18%)
Query: 289 SINNKLGEGGFGRVYKGTLVDGQEI---AVK--RLSKISEQGLNELKNEVILFSKLQHRN 343
++ LGEG FG V +G L I AVK +++ + + + +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 344 LVKLLGCCIQGEEK------LLIYEFMPNKSLDYFIF-----DQTKRELLDWSKRFHIIC 392
+++L+G C+Q E ++I FM + L F+ D + L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMT 119
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEI-EGSTNKV 450
A G+ YL S IHRDL N +L+ +MN ++DFGL++ + GD +G K+
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNRGLYNSDNKFNVIR 503
++A E D +++ KSDV+SFG+ + EI + G N +Y+ + N ++
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234
Query: 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
P +D Y + C +P+DRPS
Sbjct: 235 Q---------PPDCLDGLYS-------------LMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 8e-18
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRL-----SKISEQGLNELKNEVILFSKLQ 340
N+ + LG G FG VY D G+E+AVK++ S+ + + +N L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 341 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKR--ELLDWSKRFHIICGTAR 396
H +V+ GC EEK L E+MP S I DQ K L + R + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTR-QILQ 117
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK-VIGTYG 455
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + G+ K V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+M+PE + + K+DV+S V+E+++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLS-KISEQGLNELKNEVILF 336
D ++ LGEG FG+V + + +AVK L +E+ L++L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI-----------FDQTK--RELL 382
+ +H+N++ LLG C Q +I E+ +L ++ +D + E +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG-D 441
+ ARG+ YL + + IHRDL NVL+ + KI+DFGLAR D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ +TN + +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 293 KLGEGGFGRVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLNELKNEVI 334
KLGEG FG V+ Q+ AVK L S+ + EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD----------- 383
+ S+L N+ +LLG C +I E+M N L+ F+ K
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNSKSLS 128
Query: 384 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGD- 441
+S ++ A G+ YL L +HRDL T N L+ + KI+DFG++R + D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 442 -EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
++G I +MA E G F+ KSDV++FG+ + EI++
Sbjct: 186 YRVQGRAPLPI---RWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 288 FSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
F++ LG+G FG V + L Q++AVK L S + E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 342 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDYFI---------FDQTKRELLDWSK 386
N++KL+G ++ K ++I FM + L F+ F + L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEI-E 444
RF I A G+ YL S IHRDL N +L+ +M ++DFGL++ + GD +
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNRGLYN 494
G +K+ ++A E D +++ SDV++FG+ + EI++ G N +YN
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLV 345
F+ K+G+G FG V+KG Q++ ++ + +E + +++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
K G ++ + +I E++ S D + LD ++ I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ IHRD+K +NVLL K++DFG+A +I+ N +GT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQS 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 294 LGEGGFGRVYKGTLV-DGQEI----AVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G FG VYKG + DG+ + A+K L + S + E+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 348 LGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTK---RELLDWSKRFHIICGTARGLLYLHQ 403
LG C+ +L + + MP L DY ++ + ++LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
+R++HRDL NVL+ + KI+DFGLAR DE E + +MA E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 464 DGLFSVKSDVFSFGILVLEIVS 485
F+ +SDV+S+G+ V E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 48/278 (17%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLS---KISEQGLNELKNEVILFSKLQHRN 343
FS ++G G FG VY V E+ A+K++S K S + ++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
++ GC ++ L+ E+ + D + + ++ + H G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY-- 461
+ +IHRD+K N+LL K+ DFG A I N +GT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 462 -ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
+G + K DV+S GI +E+ +R L+N + + A
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMN--------------------AMSA 222
Query: 521 CYQESCNPDEVIRCIHISLL-------CVQHHPEDRPS 551
Y + N ++ H S C+Q P+DRP+
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
+ + + I +LG+G FG+VYK + G A K + SE+ L + E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA-RGLLY 400
+VKLLG + ++ EF P ++D + + R L + + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML-ELDRGLTE--PQIQVICRQMLEALQY 125
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH ++IIHRDLK NVLL D + K++DFG++ + + IGT +MAPE
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPE 180
Query: 461 YA-----TDGLFSVKSDVFSFGILVLEI 483
D + K+D++S GI ++E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 290 INNKLGEGGFGRVYKGTL-VDGQE---IAVKRL-SKISEQGLNELKNEVILFSKLQHRNL 344
I +G G FG V +G L + G+ +A+K L S +E+ + +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ L G + ++I EFM N +LD F+ + + ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG---TYGYMAPEY 461
S + +HRDL N+L++ ++ K+SDFGL+R D + + +G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 462 ATDGLFSVKSDVFSFGILVLEIVS-GKR 488
F+ SDV+S+GI++ E++S G+R
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQHRNLVKLLG 349
LG GGFGRV + + A+K + K I E G E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLD-WSKRFHIICGTARGLLYLHQDSRL 407
+ ++ + ++ E+ L + D R L D ++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVV-LAFEYLH---NR 112
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
II+RDLK N+LLD + K+ DFG A+ + T GT Y+APE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 468 SVKSDVFSFGILVLEIVSGK 487
D +S GIL+ E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNE--LKNEVILFSKLQHRNLVKLLGC 350
+LG G FG V+ G ++A+K I+E ++E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK---AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410
C Q + ++ EFM N L ++ + ++ L + G+ YL ++S I
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470
HRDL N L+ K+SDFG+ R DE S+ + PE +S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSK 181
Query: 471 SDVFSFGILVLEIVS 485
SDV+SFG+L+ E+ +
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLS-KISEQGLNELKNEVILFSKLQHRNLV 345
F+ ++G+G FG V+KG Q++ A+K + + +E + +++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 346 KLLGCCIQGEEKLLIYEFMPNKS---------LDYFIFDQTKRELLDWSKRFHIICGTAR 396
K G ++G + +I E++ S D F +E+L +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------------K 112
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
GL YLH + + IHRD+K +NVLL + K++DFG+A +I+ +T +GT +
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFW 167
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
MAPE + K+D++S GI +E+ G+
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELK-NEVI-------LFSKL 339
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-------LLDWSKRFHIIC 392
H +VK ++ + +I E+ + LD + + + +W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FI 113
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G+ Y+HQ RI+HRDLK N+ L +++ KI DFG++R G +T G
Sbjct: 114 QLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTG 167
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEI 483
T YM+PE + KSD++S G ++ E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNE---LKNEVILFSKLQHRN 343
F I ++G+GG+G+V+ D EI A+KR+ K LNE + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 344 LVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI---ICGTARGLL 399
LVKLL Q +E L L E++P D+ L + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
LH L IHRDLK N L+D + K++DFGL++ I N V+G+ YMAP
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAP 167
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSG 486
E + D +S G ++ E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 294 LGEGGFGRVY------KGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG+GGFG V G L +++ KRL K +G E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 348 LGCCIQGEEKL-LIYEFMPNKSLDYFIF--DQTKRELLDWSKRFH---IICGTARGLLYL 401
Q + L L+ M L Y I+ D+ + F+ II G L +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
HQ RII+RDLK NVLLD+D N +ISD GLA + + T GT G+MAPE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPEL 168
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGK---RNRG 491
+ D F+ G+ + E+++ + R RG
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 294 LGEGGFGRVYKGTL-VDG--QEIAVKRLSKISEQGLN-ELKNEVILFSKL-QHRNLVKLL 348
+GEG FG+V K + DG + A+KR+ + + + + + E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 349 GCCIQGEEKLLIYEFMPNKSL-DY------------FIFDQTKRELLDWSKRFHIICGTA 395
G C L E+ P+ +L D+ F + L + H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
RG+ YL Q + IHRDL N+L+ + KI+DFGL+R G E+ K +G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEV--YVKKTMGRLP 186
Query: 456 --YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+MA E +++ SDV+S+G+L+ EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVDGQEIAV-KRLSKISEQGLNELKNEVILFSKLQH 341
N + + I +LG+G FG+VYK + +A K + SE+ L + E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG-TARGLLY 400
N+VKLL ++ EF ++D + + +R L + + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTE--PQIRVVCKQTLEALNY 118
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA----RTFGGDEIEGSTNKVIGTYGY 456
LH++ +IIHRDLK N+L D + K++DFG++ RT + IGT +
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYW 169
Query: 457 MAPEY-----ATDGLFSVKSDVFSFGILVLEI 483
MAPE + D + K+DV+S GI ++E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 278 LATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV-IL 335
L ++ + TD + I +G+G +G+VYK T DG AVK L IS+ E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 336 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDWSKRFH 389
S H N+VK G + G + L+ E S+ + + LD + +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG++ + +T+
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 450 VIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSG 486
+GT +MAPE D + + DV+S GI +E+ G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 46/207 (22%)
Query: 284 ATDNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQ------GLNELKNEVILF 336
++ I KLGEG FG VYK + G+ +A+K++ +E+ L E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 337 SKLQHRNLVKLLGCCI-----QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF--- 388
KL+H N+V L+ + ++ +Y P Y D + LL+ +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP-----YMDHDLSG--LLE-NPSVKLT 113
Query: 389 --HIICGTAR---GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF----- 438
I C + G+ YLH++ I+HRD+K +N+L+D+ KI+DFGLAR +
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 439 -----GGDEIEGSTNKVIGTYGYMAPE 460
GG TN V+ T Y PE
Sbjct: 171 NPKGGGGGGTRKYTNLVV-TRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 24/213 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHR 342
D + K+GEG +G VYK V + IA+K RL + E + E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 343 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIF-DQTKRELLDWSKRFHII----CGTAR 396
N+V+L + E++L L++E++ LD D + D++K +I R
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILR 113
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEGSTNKVIGTYG 455
G+ Y H R++HRDLK N+L+D N K++DFGLAR F G + T++V+ T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLW 168
Query: 456 YMAPEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
Y APE +S D++S G + E+V+ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 53/205 (25%)
Query: 288 FSINNKLGEGGFGRVYKG---TLVDGQEIAVKRL--SKISEQGLNELK-NEVILFSKLQH 341
+ I +G G +GRVYK DG+E A+K+ K G+++ E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDW------SKRFHIICGTA 395
N+V L+ ++ +K + Y +FD + +L +KR I
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 396 R--------GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTF----- 438
+ G+ YLH + ++HRDLK +N+L+ + KI D GLAR F
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 439 ---GGDEIEGSTNKVIGTYGYMAPE 460
D V+ T Y APE
Sbjct: 168 PLADLD-------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 293 KLGEGGFGRVYKGTLVDGQEI-AVKR----LSKISEQGLNELKNEVILFSKLQ-HRNLVK 346
+LG+G FG VY + E+ A+K+ E L+ EV KL H N+VK
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--CMNLR-EVKSLRKLNEHPNIVK 62
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSR 406
L + +E ++E+M +L + D+ + S II +GL ++H +
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH---K 117
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS---TNKVIGTYGYMAPE-YA 462
HRDLK N+L+ KI+DFGLAR EI T+ V T Y APE
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYV-STRWYRAPEILL 171
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGK 487
+S D+++ G ++ E+ + +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 293 KLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGC 350
++G G FG V+ G L D +AVK + L + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410
C Q + ++ E + + D+ F +T+ L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT----YGYMAPEYATDGL 466
HRDL N L+ KISDFG++R +E +G G + APE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 467 FSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
+S +SDV+SFGIL+ E S L N + + +G+ + C
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------EQGVRLPCPELC--- 221
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
PD V R + C ++ P RPS +V
Sbjct: 222 ---PDAVYR---LMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQE--------IAVKRLSK-ISEQGLNELKNEVILFSK 338
++ LGEG FG+V + + +AVK L +++ L++L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI-----------FDQTK--RELLDW 384
+ +H+N++ LLG C Q ++ E+ +L ++ FD K E L +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG-DEI 443
ARG+ YL + + IHRDL NVL+ D KI+DFGLAR D
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ +TN + +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 191 KKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 294 LGEGGFGRV------YKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
L+ M L Y I++ +R L + + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
I++RD+K NVLLD N ++SD GLA + + + GT GYMAPE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY 171
Query: 468 SVKSDVFSFGILVLEIVSGK 487
S D F+ G + E+V+G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 291 NNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLG 349
N + G G YKG ++ +G + VK ++ ++ +E+ + KLQH N+VKL+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIG 750
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
C + LI+E++ K+L + + L W +R I G A+ L +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSV 469
+ +L +++D P + L D K + Y+APE +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITE 857
Query: 470 KSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV-------IRHAWNLWNKGMPWQLIDAC- 521
KSD++ FG++++E+++GK +D +F V R+ ++ + M W ID
Sbjct: 858 KSDIYGFGLILIELLTGKS-----PADAEFGVHGSIVEWARYCYSDCHLDM-W--IDPSI 909
Query: 522 -YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563
S N +E++ ++++L C P RP V+ L S S
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 286 DNFSINNKLGEGGFGRVY------------KGTLVDGQE-----IAVKRL-SKISEQGLN 327
+ KLGEG FG V+ K +D +AVK L ++ N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 328 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR 387
+ E+ + S+L+ N+++LL CI + +I E+M N L+ F+ +E + +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 388 FHIICGT--------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-F 438
I T A G+ YL S L +HRDL T N L+ + KI+DFG++R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 439 GGD--EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
GD I+G + + +M+ E G F+ SDV++FG+ + EI++
Sbjct: 182 SGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 294 LGEGGFGRVYKGTLV-DGQEI----AVKRL-SKISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G FG V+KG + +G I A+K + + Q E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
LG C G L+ + P SL + + R+ LD + + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
R++HR+L N+LL D +I+DFG+A D+ + ++ +MA E G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 468 SVKSDVFSFGILVLEIVS 485
+ +SDV+S+G+ V E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 287 NFSINNKLGEGGFGRVYKGTL-VDGQE---IAVKRL-SKISEQGLNELKNEVILFSKLQH 341
I +G G FG V G L + G+ +A+K L + +E+ + +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC------GTA 395
N++ L G + + +++ E+M N SLD F L +F +I G A
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAF--------LRKHDGQFTVIQLVGMLRGIA 116
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
G+ YL S + +HRDL N+L++ ++ K+SDFGL+R +E T G
Sbjct: 117 SGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRG 168
Query: 456 ------YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR 488
+ APE F+ SDV+S+GI++ E++S G+R
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 32/211 (15%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKIS-----EQGLNELKNEVILFSKLQHRNLVKL 347
+G G FG V K G +AVKR+ ++ L +L +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL--DVVMRSS-DCPYIVKF 68
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYF---IFDQTKRELLDWSKRF--HIICGTARGLLYLH 402
G + + + E M + SLD F +++ K + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV--IGTYGYMAPE 460
++ L+IIHRD+K SN+LLD + N K+ DFG++ ++ S K G YMAPE
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 177
Query: 461 ----YATDGLFSVKSDVFSFGILVLEIVSGK 487
A DG + V+SDV+S GI + E+ +GK
Sbjct: 178 RIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEI--AVKRLSKI-SEQGLNELKNEVILFSKL-Q 340
++ + +GEG FG+V + + DG ++ A+K L + SE + E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA----- 395
H N++ LLG C + E+ P +L F+ K +L+ F GTA
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 396 RGLLYLHQD--------SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+ LL D S + IHRDL NVL+ ++ KI+DFGL+R G+E+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV--YV 173
Query: 448 NKVIGTYG--YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
K +G +MA E +++ KSDV+SFG+L+ EIVS
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 292 NKLGEGGFGRVYKGTLVDGQEI-AVKRLS---KISEQGLNELKNEVILFSKLQHRNLVKL 347
+++G G FG VY T E+ AVK++S K + + ++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
GC ++ L+ E+ + D + ++ L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY---ATD 464
+IHRD+K N+LL K++DFG A N +GT +MAPE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDE 194
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494
G + K DV+S GI +E+ +R L+N
Sbjct: 195 GQYDGKVDVWSLGITCIEL--AERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 288 FSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLS---KISEQGLNELKNEVILFSKLQHRN 343
F+ ++G G FG VY V E+ A+K++S K S + ++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
++ GC ++ L+ E+ + D + ++ L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY-- 461
+ +IHRD+K N+LL K++DFG A I N +GT +MAPE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 462 -ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494
+G + K DV+S GI +E+ +R L+N
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 294 LGEGGFGRVY------KGTLVDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVK 346
LGEG FG+V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 347 LLGCCIQGEEK--LLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
G C + LI EF+P+ SL +Y ++ K L K IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK--VIGTYGYMAPEY 461
SR + +HRDL NVL++ + KI DFGL + D+ E T K + + APE
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDLDSPVFWYAPEC 183
Query: 462 ATDGLFSVKSDVFSFGILVLEIVS 485
F + SDV+SFG+ + E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 46/277 (16%)
Query: 294 LGEGGFGRVYKGTLV----DGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRNLVKL 347
+G+G +G V +LV DG++ +K+L+ S + + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 348 LGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+GE+ LL + F L Y + K +LL ++ A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
I+HRDLKT NV L K+ D G+AR ST +IGT YM+PE ++
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNK 177
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN-KGMPWQLIDA---C 521
++ KSDV++ G V E+ + ++HA+N + + +++I+
Sbjct: 178 PYNYKSDVWALGCCVYEMAT----------------LKHAFNAKDMNSLVYRIIEGKLPP 221
Query: 522 YQESCNPD--EVIRCIHISLLCVQHHPEDRPSMPSVI 556
+ +P+ E+I ++L + PE RPS+ S++
Sbjct: 222 MPKDYSPELGELIA----TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 51/227 (22%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN---EVILFSKLQHRN 343
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLD----YFIFD----------QTKRELLDWSKRFH 389
++ LL I P D Y + + ++ + L D ++
Sbjct: 61 IIGLL----------DI--LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY- 107
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS--T 447
+ RGL YLH +IHRDLK SN+L++ + + KI DFGLAR DE E T
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 448 NKVIGTYGYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
V+ T Y APE Y ++ D++S G + E+++ K
Sbjct: 165 EYVV-TRWYRAPELLLSSSRYTK----AI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 294 LGEGGFGRVYKGTLV-DGQEI--AVKRLSK-ISEQGLNELKNEVILFSKL-QHRNLVKLL 348
+GEG FG+V K + DG + A+KR+ + S+ + E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA-----RGLLYLHQ 403
G C L E+ P+ +L F+ K +L+ F I TA + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 404 D--------SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
D S+ + IHRDL N+L+ + KI+DFGL+R G E+ K +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV--YVKKTMGRLP 174
Query: 456 --YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+MA E +++ SDV+S+G+L+ EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 293 KLGEGGFGRVYKGT--LVDGQ-EIAVKRLSKISEQGL-NELKNEVILFSKLQHRNLVKLL 348
+LG G FG V KG + Q ++A+K L +E+ + +E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
G C + E +L+ E L+ F+ K++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY--GYMAPEYATDGL 466
+HRDL NVLL + KISDFGL++ G D+ + G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 467 FSVKSDVFSFGILVLEIVS 485
FS +SDV+S+GI + E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 36/234 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQ------GLNELKNEVILFSK 338
D F I ++GEG +G+VYK D G+ +A+K++ +E+ + E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELL--------DWSKRFHI 390
L HRN+V L ++ L +F +K Y +F+ +L+ +S+
Sbjct: 63 LNHRNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 117
Query: 391 ICGTAR----GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
I + GL Y H+ + L HRD+K SN+LL++ K++DFGLAR + +E
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 447 TNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF 499
TNKVI T Y PE + + DV+S G ++ E+ + + ++ ++ +
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT---KKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNE--LKNEVILFSKLQHRNLVKLL 348
LG+G FG+V L G+ AVK L K I + E + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 349 GCCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
CC Q ++L + EF+ L + I Q R + RF+ T+ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI-EG-STNKVIGTYGYMAPEYATDG 465
II+RDLK NVLLDH+ + K++DFG+ + + I G +T+ GT Y+APE +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502
L+ D ++ G+L+ E++ G N D+ F I
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 66/291 (22%), Positives = 133/291 (45%), Gaps = 40/291 (13%)
Query: 287 NFSINNKLGEGGFGRVYK-------GTLVDGQEIAVKRLS-----KISEQGLNELKNEV- 333
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 334 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIIC 392
I+ +L+H N+V+ ++ + ++ + + L ++F + K++ + ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
L YLH++ R I+HRDL +N++L D I+DFGLA+ + S V+G
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---VVG 175
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512
T Y PE + + K+DV++FG ++ ++ + ++ N+ +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------LQPPFYSTNMLSLA 222
Query: 513 MPWQLIDACYQ---ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560
++++A Y+ E ++V I C+ E RP + V M+
Sbjct: 223 T--KIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 293 KLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGC 350
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 351 CIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
I +E L ++E+M Y I Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST-NKVIGTYGYMAPEY---ATDG 465
+HRDLK N+L+ + K++DFGLAR I T + + T Y P+ ATD
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA---KSIPSQTYSSEVVTLWYRPPDVLLGATD- 180
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+S D++ G + +E++ G+
Sbjct: 181 -YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 24/212 (11%)
Query: 287 NFSINNKLGEGGFGRVY--KGTLVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHR 342
+ I K+GEG FG++Y K D + +K L+K+ + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 343 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDYFIFDQ-----TKRELLDWSKRFHIICGTAR 396
N+V Q +L I E+ L I Q ++ ++L W +
Sbjct: 60 NIVTFFAS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
GL ++H +I+HRD+K+ N+ L + M K+ DFG+AR D +E + +GT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYT-CVGTPY 167
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y++PE + ++ K+D++S G ++ E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 292 NKLGEGGFGRVYK----GTLVDGQEIAVKRLSKISEQGL-NELKNEVILFSKLQHRNLVK 346
N++G G G VYK T G+ A+K + E + ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLD-YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
E ++ EFM SL+ I D+ + L D +++ I+ G A YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA----YLH--- 185
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA--- 462
R I+HRD+K SN+L++ N KI+DFG++R + N +GT YM+PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTD 243
Query: 463 -TDGLFS-VKSDVFSFGILVLEIVSGK 487
G + D++S G+ +LE G+
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 33/273 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQ----EIAVKRLSKISEQGLNEL-KNEVILFSKLQ 340
++ ++ +GEG FG VY+G + + +AVK + + E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H ++VKL+G + ++ E P L ++ Q + LD + + L Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI-EGSTNKVIGTYGYMAP 459
L R +HRD+ NVL+ K+ DFGL+R + + S K+ +MAP
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAP 177
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
E F+ SDV+ FG+ + EI+ G + +G+ N+D VI N MP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VIGRIENGERLPMP--- 230
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRP 550
+C P + C + P RP
Sbjct: 231 ------PNCPP----TLYSLMTKCWAYDPSKRP 253
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 45/277 (16%)
Query: 293 KLGEGGFGRVYKGTLV----DGQEIAVKRL--SKISEQGLNELKNEVILFSKLQHRNLVK 346
K+GEG FG K LV DG++ +K + SK+S + E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-----TKRELLDWSKRFHIICGTARGLLYL 401
+ ++ ++ L I Q + ++LDW F IC L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHV 117
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H +I+HRD+K+ N+ L D K+ DFG+AR T IGT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN-KGMPWQLIDA 520
+ ++ KSD+++ G ++ E+ + ++HA+ N K + ++I
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT----------------LKHAFEAGNMKNLVLKIIRG 216
Query: 521 CYQE-SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
Y S + +R + L + +P DRPS+ S++
Sbjct: 217 SYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 46/223 (20%)
Query: 287 NFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQG---LNELKNEVILFSKLQHR 342
F N++GEG +G VY+ G+ +A+K++ +E+ ++ L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIF------DQTKRELLDWSKR-FH------ 389
N+V+L E + K LD IF +Q LLD F
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
++ RGL YLH++ IIHRDLK SN+LL KI+DFGLART+ G + T K
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPK 168
Query: 450 VIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
V+ T Y APE L + D+++ G ++ E+++ K
Sbjct: 169 VV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 34/276 (12%)
Query: 293 KLGEGGFGRVYKG---TLVDGQEIAVKRLSKISEQGL--NELKNEVILFSKLQHRNLVKL 347
+LG G FG V KG + +AVK L + +EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
+G C + E +L+ E L+ F+ Q + + + ++ + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE-KNITELVHQVSMGMKYLEETN-- 115
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY--GYMAPEYATDG 465
+HRDL NVLL KISDFGL++ G DE K G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-NYYKAKTHGKWPVKWYAPECMNYY 173
Query: 466 LFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
FS KSDV+SFG+L+ E S K +G+ ++ V Q+I++ +
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VT-------------QMIESGER 216
Query: 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
C + LC + ++RP V L L
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG+GGFG V + G+ A KRL K +G + NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQDSR 406
+ L+ M L + I++ + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLA-RTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
++RDLK N+LLD + +ISD GLA + G+ I G +GT GYMAPE +
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQ 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
+++ D + G L+ E++ G+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK----ISEQGLNELKNEVILFSKLQHRNLVKLL 348
LG+G FG+V L E A+K L K + + +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 349 GCCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQD 404
C Q +E L + E++ L + I Q+ + RF+ IICG L +LH+
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI--EGSTNKVIGTYGYMAPEYA 462
II+RDLK NVLLD D + KI+DFG+ + + EG + GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE----NMNGEGKASTFCGTPDYIAPEIL 168
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
++ D +SFG+L+ E++ G+ + D F+ I +
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 48/225 (21%)
Query: 288 FSINNKLGEGGFGRVYKGTLVD---GQEIAVKRLSKISEQGLNELKN---------EVIL 335
+ I KLG+G +G V+K +D + +A+K KI + +N E++
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KI----FDAFRNATDAQRTFREIMF 59
Query: 336 FSKL-QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELL-DWSKRFHI 390
+L H N+VKLL I+ E IY E+M L I + +L D KR+ I
Sbjct: 60 LQELGDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-I 112
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ + L Y+H S +IHRDLK SN+LL+ D K++DFGLAR+ E +
Sbjct: 113 MYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 451 ---IGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
+ T Y APE L D++S G ++ E++ GK
Sbjct: 170 TDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 292 NKLGEGGFGRVYKG---TLVDGQEIAVKRL---SKISEQGLNELKNEVILFSKLQHRNLV 345
+++G G FG+V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF--HIICGTARGLLYLHQ 403
+ LG CI+ LL+ EF P L ++ K + C A GLL+LHQ
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEIEGSTNKVIGTYGYMAPEYA 462
IH DL N L D++ KI D+GLA + D + ++APE
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 463 T---DGLFSVK----SDVFSFGILVLEI 483
L S+++S G+ + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQDSR 406
+ L+ M L + I+ + + F+ I CG L LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLA-RTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
RI++RDLK N+LLD + +ISD GLA G I+G +GT GYMAPE +
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNE 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
++ D ++ G L+ E+++G+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRL-SKISEQGLNELKNEV-ILFSKLQHR 342
D+ + +LG G +G V K V G +AVKR+ + ++ Q L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYF---IFDQTKRELLDWSKRFHIICGTARGLL 399
V G + + + E M + SLD F ++D+ D + I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI--GTYGYM 457
YLH S+L +IHRD+K SNVL++ + K+ DFG++ G ++ S K I G YM
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVD-SVAKTIDAGCKPYM 170
Query: 458 APEYATDGL----FSVKSDVFSFGILVLEIVSGK 487
APE L + VKSDV+S GI ++E+ +G+
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 44/270 (16%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLS-----KISEQGLNELKNEVILFSKLQHRNLVKL 347
LG G G VYK + + I AVK + ++ +Q ++EL+ IL+ K ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE---ILY-KCDSPYIIGF 64
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
G + EFM SLD ++ + +L I +GL YL L
Sbjct: 65 YGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
+I+HRD+K SN+L++ K+ DFG++ + +GT YMAPE + +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 468 SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG--MPWQLIDACYQES 525
+ SDV+S GI +E+ G R Y K N+G MP QL+ E
Sbjct: 171 GIHSDVWSLGISFMELALG---RFPYPQIQK-----------NQGSLMPLQLLQCIVDED 216
Query: 526 CN--PDEVI--RCIHISLLCVQHHPEDRPS 551
P + +H C++ P++RP+
Sbjct: 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 50/226 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQG----LNELKNEVILFSKLQ 340
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 341 HRNLVKL----LGCCIQGEEKLLIYEFMPN--KSL-----DYFIFDQTK---RELLDWSK 386
H N+V + +G + ++ ++ E++ + KSL F+ + K +LL
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---- 116
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
G+ +LH + I+HRDLKTSN+LL++ KI DFGLAR + G ++
Sbjct: 117 ---------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPY 163
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
T V+ T Y APE L K D++S G + E+++ K
Sbjct: 164 TQLVV-TLWYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 294 LGEGGFGRVY---KGTLVD-GQEIAVKRLSKISEQGLNEL--KNEVILFSKLQHRNLVKL 347
LG+G FG+V+ K T D GQ A+K L K + + + + K E + +++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 348 LGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELL--DWSKRFHIICGTARGLLYLHQD 404
Q E KL LI +F+ L F + +E++ + +F++ A L +LH
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYL-AELALALDHLH-- 115
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
L II+RDLK N+LLD + + K++DFGL++ + E GT YMAPE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 465 GLFSVKSDVFSFGILVLEIVSG 486
+ +D +SFG+L+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 38/283 (13%)
Query: 293 KLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKN----EVILFSKLQHRNLVKL 347
+GEG +G V K + GQ +A+K+ + + +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL-LDWSKRFHIICGTARGLLYLHQDSR 406
+ + + L++EF+ + LD D K LD S+ + RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-DG 465
IIHRD+K N+L+ K+ DFG ART E T+ V T Y APE D
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYV-ATRWYRAPELLVGDT 176
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF-----------NVIRHAWNLWNKGMP 514
+ D+++ G LV E+++G+ L+ D+ N+I ++ K
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEP---LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 515 WQ---LIDACYQESCN---PDEVIRCIHISLLCVQHHPEDRPS 551
+ L + E P + ++ C++ P+DRPS
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 14/225 (6%)
Query: 261 DQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK 320
E+ D +D +P + A A+ +++ L G GRV+ T GQ V + K
Sbjct: 41 ASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLK 97
Query: 321 ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE 380
I ++G + E +L + H +++++ + G ++ +P+ S D + + +
Sbjct: 98 IGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSR 152
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440
L + I GL YLH RIIHRD+KT N+ ++ I D G A+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--- 206
Query: 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ + + GT APE ++ K+D++S GI++ E+++
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS---KISEQGLNELKNEVILFSKLQH 341
D+ +G G FGRV+ + A+K ++ I + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 342 RNLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTAR 396
+++L + +++ L + E++P L F + + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCA--- 113
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
L YLH I++RDLK N+LLD + + K++DFG A+ ++ T + GT Y
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+APE + D ++ GIL+ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE-QGLNELKNEVILFSKLQH 341
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+V G ++ ++ + EF SL I+ T L S+ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK---VIGTYGYMA 458
H + +HRD+K +N+LL + + K++DFG++ +I + K IGT +MA
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSA-----QITATIAKRKSFIGTPYWMA 174
Query: 459 PEYAT---DGLFSVKSDVFSFGILVLEI 483
PE A G ++ D+++ GI +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 51/231 (22%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQ-----GLNELKNEVILF 336
+ + + +GEG +G V T G ++A+K++S Q L E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 337 SKLQHRNLVKLLGCCIQG-----EEKLLIYEFMP-------------NKSLDYFIFDQTK 378
+ +H N++ +L + ++ E M N + YF++
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ--- 114
Query: 379 RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 115 ---------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156
Query: 439 GGDEIEGST-NKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGK 487
+ + + T Y APE ++ D++S G ++ E++S +
Sbjct: 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 53/235 (22%)
Query: 290 INNKLGEGGFGRVYKG-TLVDGQEIAVKRL-------------SKISEQGLN-ELKNEVI 334
LGEG +G+V K + G+ +A+K++ + G++ E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HII 391
+ ++++H N++ L+ ++G+ L+ + M ++++D R +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVK 122
Query: 392 C---GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS-- 446
C GL LH+ +HRDL +N+ ++ KI+DFGLAR +G +
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 447 -----------TNKVIGTYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSGK 487
T+KV+ T Y APE A F+V D++S G + E+++GK
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 42/213 (19%)
Query: 294 LGEGGFGRV----YKGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILF---SKLQHRN 343
LG G FG+V YK T G+ A+K L K I+ + L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 344 LVKLLGCCIQGEEKL-LIYEFMPNKSLDYFI----FDQTKRELLDWSKRFHIICGTARGL 398
LV L C Q E+ + + E+ L I F + + F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-------AVFYAAC-VVLGL 114
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG-----STNKVIGT 453
YLH++ +I++RDLK N+LLD + KI+DFGL + EG T+ GT
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFGDRTSTFCGT 164
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
++APE T+ ++ D + G+L+ E++ G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 42/200 (21%)
Query: 307 LVDGQEIAVKRLSKISEQGLNELKN---EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363
V GQ +A+K+LS+ Q + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSR-PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------F 84
Query: 364 MPNKSLDYFIFDQTKRELLDWS-----------KR-----FHIICGTARGLLYLHQDSRL 407
P KSL+ F EL+D + +R + ++CG + +LH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCG----IKHLHSAG-- 138
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
IIHRDLK SN+++ D KI DFGLART G + T V+ Y Y APE +
Sbjct: 139 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY-YRAPEVILGMGY 194
Query: 468 SVKSDVFSFGILVLEIVSGK 487
D++S G ++ E++ G
Sbjct: 195 KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 293 KLGEGGFGRVYKGTLVD--GQEIAVKRLS-KISEQG--LNELKNEVIL--FSKLQHRNLV 345
++GEG +G+V+K + G+ +A+KR+ + E+G L+ ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 346 KLLGCCIQG----EEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
+L C E KL L++E + Y D+ + ++ RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH R++HRDLK N+L+ K++DFGLAR + + + V+ T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLY--NSD 496
++ D++S G + E+ R + L+ +SD
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 33/92 (35%), Positives = 57/92 (61%), Gaps = 6/92 (6%)
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
RGL YL + + +I+HRD+K SN+L++ K+ DFG++ G I+ N +GT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 163
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
YM+PE ++V+SD++S G+ ++E+ G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 297 GGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKN----EVILFSKLQHRNLVKLLGCC 351
G FG VY G A+K L K N++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 352 IQGEEKLLIYEFMPNKSLDYFIFDQTKREL-LDWSKRFHIICGTARGLLYLHQDSRLRII 410
+ L+ E++ I +T L DW+K++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK-VIGTYGYMAPEYATDGLFSV 469
HRD+K N+L+D + K++DFGL+R G NK +GT Y+APE
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFVGTPDYLAPETILGVGDDK 172
Query: 470 KSDVFSFGILVLEIVSGKR 488
SD +S G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 30/236 (12%)
Query: 278 LATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELK 330
T+ T+ + +G G FG V + GQ +A+K++ K ++++ ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 331 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF- 388
L L+H N++ L I E + + E + D ++ K+F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP----LEKQFI 110
Query: 389 -HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+ + RGL Y+H ++HRDLK SN+L++ + + KI DFGLAR +
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162
Query: 448 NKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502
+ T Y APE T + V+ D++S G + E++ GK + N+F++I
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG--LNELKNEVILFSKLQ 340
N ++ + ++G G +G VYK + E+A ++ K+ E G + ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIIC-GTARGL 398
H N+V G + E+ + E+ SL D + EL + +C T +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-----QIAYVCRETLQGL 119
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK---VIGTYG 455
YLH ++ HRD+K +N+LL + + K++DFG+A +I + K IGT
Sbjct: 120 AYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPY 171
Query: 456 YMAPEYAT---DGLFSVKSDVFSFGILVLEI 483
+MAPE A +G ++ D+++ GI +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQDSR 406
+ L+ M L + I++ + F+ I CG L LH R
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLH---R 120
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLA-RTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
RI++RDLK N+LLD + +ISD GLA G+ I G +GT GYMAPE +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNE 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
++ D + G L+ E++ GK
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 293 KLGEGGFGRVYKGTLVDGQEI-AVKRLSKISE-QGL--NELKNEVILFSKLQHRNLVKLL 348
K+GEG +G V+K + EI A+KR+ + +G+ + L+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLY 65
Query: 349 GCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
+ ++KL L++E+ ++ L + FD ++ D + +GL + H
Sbjct: 66 DV-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY---ATD 464
++HRDLK N+L++ + K++DFGLAR FG S V T Y P+ A
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK- 175
Query: 465 GLFSVKSDVFSFGILVLEIVSGKR 488
L+S D++S G + E+ + R
Sbjct: 176 -LYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSK----ISEQGLNELKNEVILFSKLQHRNLVKLL 348
LG+G FG+V L G+ AVK L K I + + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 349 GCCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQD 404
C Q +E L + EF+ L + I D+ + +L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR--TFGGDEIEGSTNKVIGTYGYMAPEYA 462
II+RDLK NV+LD D + KI+DFG+ + FG + + GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEIL 168
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
++ D +SFG+L+ E++ G+ + D F IR
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKN----EVILFSKLQ 340
+ + + +GEG +G V K G+ +A+K+ K SE ++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H N+V L + L++E++ L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H IIHRD+K N+L+ K+ DFG AR T+ V T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 461 -YATDGLFSVKSDVFSFGILVLEIVSG 486
D + DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 286 DNFSINNKLGEGGFGRVYK------GTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL 339
D + ++LG+G +G VYK G + +EI RL + E N++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
+V G + E+M SLD E + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV-IGTYGYMA 458
+L ++ IIHRD+K +NVL++ + K+ DFG++ + S K IG YMA
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMA 169
Query: 459 PEYATDG------LFSVKSDVFSFGILVLEIVSGK 487
PE G ++V+SDV+S G+ +LE+ G+
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 35/209 (16%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV----ILFSKLQHRNLVKLL 348
+G+G FG+V DG+ AVK L K + E K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFD-----------QTKRELLDWSKRFHIICGTARG 397
Q +KL YF+ D Q +R + RF+ A
Sbjct: 62 HYSFQTADKL------------YFVLDYVNGGELFFHLQRERSFPEPRARFYA-AEIASA 108
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L YLH L II+RDLK N+LLD + ++DFGL + G E +T+ GT Y+
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYL 163
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSG 486
APE + D + G ++ E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRN 343
D+F ++LG G G V K I ++L +I N++ E+ + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR---ELLDWSKRFHIICGTARGLLY 400
+V G E + E M SLD + + KR E+L + RGL Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILG-----KVSIAVLRGLAY 118
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L + + +I+HRD+K SN+L++ K+ DFG++ G I+ N +GT YM+PE
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE 172
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGK 487
+SV+SD++S G+ ++E+ G+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 286 DNFSIN--NKLGEGGFGRVYKG--TLVDGQE--IAVKRL-SKISEQGLNELKNEVILFSK 338
DN SI LG G FG + +G L +E +A+ L + S++ E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-LLDWSKRFHIICGTARG 397
H N+V+L G +G +++ E+M N +LD F+ K E L + ++ G A G
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASG 119
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG--STNKVIGTYG 455
+ YL S + +H+ L VL++ D+ KIS F + D+ E +T
Sbjct: 120 MKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVL 173
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR 488
+ APE FS SDV+SFGI++ E++S G+R
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 33/189 (17%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQ------GLNELKNEVILFSKLQHRNL 344
K+G+G FG V+K Q +A+K++ +E+ L E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL----------LDWSKRFHIICGT 394
V L+ C + + K Y +F+ + +L S+ ++
Sbjct: 74 VNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS---TNKVI 451
GL Y+H R +I+HRD+K +N+L+ D K++DFGLAR F + TN+V+
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 452 GTYGYMAPE 460
T Y PE
Sbjct: 186 -TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLN-ELKNEVILFSKLQHRNLVKLL 348
LG+G FG+V L E+ A+K L K + + ++ + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 349 GCCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
CC Q +++L + E++ L + I Q R+ + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTL-ALMFLHRHG-- 116
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-----GTYGYMAPEYA 462
+I+RDLK N+LLD + + K++DFG+ + EG N V GT Y+APE
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
+ + D ++ G+L+ E+++G+ N D+ F I H
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYLHQDSR 406
+ L+ M L + I++ + F+ + CG L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTF-GGDEIEGSTNKVIGTYGYMAPEYATDG 465
RI++RDLK N+LLD + +ISD GLA G+ + G +GT GYMAPE +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNE 176
Query: 466 LFSVKSDVFSFGILVLEIVSGK 487
++ D + G L+ E++ G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRN--LVKL 347
+G GGFG VY D G+ A+K L K +QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 348 LGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ---TKRELLDWSKRFH---IICGTARGLLY 400
+ +KL I + M L Y + ++ E+ RF+ II G
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE----- 111
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H +R +++RDLK +N+LLD + +ISD GLA F + S +GT+GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 461 YATDGL-FSVKSDVFSFGILVLEIVSG 486
G+ + +D FS G ++ +++ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 287 NFSINNKLGEGGFGRVY----KGTLVDGQEIAVKRLSKIS----EQGLNELKNEVILFSK 338
NF + LG G +G+V+ G G+ A+K L K + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
++ + L Q + KL LI +++ L ++ +RE S+ I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLA 117
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L +LHQ L II+RD+K N+LLD + + ++DFGL++ F +E E GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 458 APEY--ATDGLFSVKSDVFSFGILVLEIVSG 486
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 293 KLGEGGFGRVYKGTLVDG---QEIAVKRL-SKISEQGLNELKNEVILFSKLQHRNLVKLL 348
++G G FG+V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELL--DWSKRFHIICGTARGLLYLHQDSR 406
G C + LL+ EF P L ++ K EL+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLA 435
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQ-HRNLVKL 347
K+GEG F V K + G+ A+K + K S + +N L E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 348 LGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYLHQ 403
+ + L++E M D +++ K + L + + + L ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-YA 462
+ I HRD+K N+L+ D K++DFG R + + I T Y APE
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLL 171
Query: 463 TDGLFSVKSDVFSFGILVLEIVS 485
TDG + K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 31/185 (16%)
Query: 382 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441
LD A+G+ +L + IHRD+ NVLL KI DFGLAR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----- 260
Query: 442 EIEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNS 495
+I +N V+ +MAPE D +++V+SDV+S+GIL+ EI S GK
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
Query: 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPSMPS 554
++KF ++++ YQ S PD I+ I +C P +RP+
Sbjct: 321 NSKF---------------YKMVKRGYQMSR-PDFAPPEIYSIMKMCWNLEPTERPTFSQ 364
Query: 555 VILML 559
+ ++
Sbjct: 365 ISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQ--EIAVKRLSK---ISEQGLNELKNEVILFSKLQ 340
++F+ LG G FGRV T + +A+KR K I ++ ++ + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG---TARG 397
H V L G L+ EF+ ++F F L +KRF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQI 140
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+L L I++RDLK N+LLD D K++DFG A+ ++ T + GT Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSG 486
APE + +D ++ GI + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 389 HIICGT---ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445
+I + ARG+ +L SR + IHRDL N+LL + KI DFGLAR D
Sbjct: 174 DLISYSFQVARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKF-NVI 502
+MAPE D +++ +SDV+SFG+L+ EI S G+ D +F +
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDEEFCRRL 289
Query: 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560
+ + P Y I L C ++PEDRP+ ++ +LG
Sbjct: 290 KEGTRM---RAPEYATPEIYS-------------IMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 294 LGEGGFGRVY----KGTLVDGQEIAVKRLSK----ISEQGLNELKNEVILFSKLQHRNLV 345
LG+G FG+V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 346 KLLGCCIQGEEKLL-IYEFMPNKSLDYFI-----FDQTKRELLDWSKRFHIICGTARGLL 399
L C Q +E L + E++ L + I FD + IICG L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQ 110
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR-TFGGDEIEGSTNKVIGTYGYMA 458
+LH I++RDLK N+LLD D + KI+DFG+ + GD T GT Y+A
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIA 164
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
PE ++ D +SFG+L+ E++ G+ ++ + F IR
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN-----EVILFSKLQHR--NLV 345
+G G G+VYK G +AVK++ + + E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HIICGTARGLLYLH 402
K G I + + E M D+ + + + + L YL
Sbjct: 78 KCYGYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN-KVIGTYGYMAPEY 461
+ +IHRD+K SN+LLD N K+ DFG++ G ++ + G YMAPE
Sbjct: 132 EKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAYMAPER 185
Query: 462 AT----DGLFSVKSDVFSFGILVLEIVSGK 487
+ + +++DV+S GI ++E+ +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 283 NATDNFSINNKLGEGGFGRVYK-GTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ- 340
+ +D + I +G+G +G+V+K +G + AVK L I + E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 341 HRNLVKLLGC-----CIQGEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDWSKRFHIICGT 394
H N+VK G G++ L+ E S+ + KR E ++ +I+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
GL +LH + + IHRD+K +N+LL + K+ DFG++ + +T+ +GT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTP 188
Query: 455 GYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSG 486
+MAPE D + + DV+S GI +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 280 TIANATDNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLNELKN--EVILF 336
TI + + + +G G +G V G +AVK+LS+ + ++ + E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF--IFDQTK------------RELL 382
++H N++ LL F P +SL+ F ++ T ++L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
D +F +I RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR DE
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 173
Query: 443 IEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
+ G + T Y APE + + ++ D++S G ++ E+++G+
Sbjct: 174 MTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 294 LGEGGFGRVYKGTLVDGQE----IAVKRLSKI----SEQGLNELKNEVILFSKLQHRNLV 345
LG+GG+G+V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE--LLDWSKRFHIICGTARGLLYLHQ 403
L+ G + LI E++ L F +RE ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS--TNKVIGTYGYMAPEY 461
II+RDLK N+LLD + K++DFGL + + I T+ GT YMAPE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSG 486
D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 51/160 (31%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
ARG+ +L + +HRDL NVLL KI DFGLAR D S
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKG 512
+MAPE D L++ SDV+S+GIL+ EI S G G+ +N I+ + +
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM---- 359
Query: 513 MPWQLIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPS 551
PD + ++ I + C PE RPS
Sbjct: 360 -------------AKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLG 349
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
I E+ L L++E++ +K L ++ D + K F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST--NKVIGTYGYMAPEY---AT 463
++HRDLK N+L++ K++DFGLAR I T N+V+ T Y P+ +T
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 464 DGLFSVKSDVFSFGILVLEIVSGK 487
D +S + D++ G + E+ +G+
Sbjct: 181 D--YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRN 343
D+F ++LG G G V+K + I ++L +I N++ E+ + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYL 401
+V G E + E M SLD + + ++L + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
+ + +I+HRD+K SN+L++ K+ DFG++ G I+ N +GT YM+PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGK 487
+SV+SD++S G+ ++E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 32/158 (20%)
Query: 293 KLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGC 350
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 351 CIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKR-----------FHIICGTARGL 398
I ++ L L++E++ D ++ +D F ++ RGL
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436
Y HQ R++HRDLK N+L+ K++DFGLAR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRN--LVKL 347
+G GGFG VY D G+ A+K L K +QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 348 LGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ---TKRELLDWSKRFH---IICGTARGLLY 400
+ +KL I + M L Y + +++E+ RF+ II G
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE----- 111
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H +R +++RDLK +N+LLD + +ISD GLA F + S +GT+GYMAPE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 461 YATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
G + +D FS G ++ +++ G + + +K + R
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 294 LGEGGFGRVYKGTLV----DGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRNLVKL 347
+GEG FGR LV Q+ A+K RL K S + + + E +L +K++H N+V
Sbjct: 8 VGEGSFGR---ALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 348 LGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ-----TKRELLDWSKRFHIICGTARGLLYL 401
+ + L ++ E+ L I Q + +L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H+ R++HRD+K+ N+ L + K+ DFG AR T +GT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI 171
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGK 487
+ ++ KSD++S G ++ E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 287 NFSINNKLGEGGFGRV----YKGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKL 339
+F + LG G FGRV +KGT G+ A+K L K + + + + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
H +V ++ C Q E ++ + EF+ L + + R D +K +H A +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYH-----AELV 128
Query: 399 L---YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
L YLH II+RDLK N+LLD+ + K++DFG A+ ++ T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
Y+APE D ++ G+L+ E ++G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 293 KLGEGGFGRVYKGTLVD-GQEIAVKRLS-KISEQGLN-ELKNEVILFSKLQ---HRNLVK 346
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 347 LLGCCIQG----EEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
L+ C E K+ L++E + Y D+ L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H + I+HRDLK N+L+ K++DFGLAR + + + V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGK 487
++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKIS-----EQGLNELKNEVILFSKLQHRNLVKL 347
+G+G FG+V DG AVK L K + EQ + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQN-HIMAERNVLLKNLKHPFLVGL 61
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDY------FIFDQTKRELLDWSKRFHIICGTARGLLYL 401
Q EKL LDY F Q +R L+ RF+ A + YL
Sbjct: 62 -HYSFQTAEKLYFV-------LDYVNGGELFFHLQRERCFLEPRARFYA-AEVASAIGYL 112
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H L II+RDLK N+LLD + ++DFGL + G E E +T+ GT Y+APE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEV 167
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSG 486
+ D + G ++ E++ G
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 293 KLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELK---NEVILFSKLQHRNLVKLL 348
K+GEG +G V+K + GQ +A+K+ + SE K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
+ + L++E+ + L+ ++ R + + + II T + + + H+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HN 120
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-DGLF 467
IHRD+K N+L+ K+ DFG AR G + T+ V T Y APE D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYV-ATRWYRAPELLVGDTQY 178
Query: 468 SVKSDVFSFGILVLEIVSG 486
DV++ G + E+++G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 58/223 (26%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKN--EVILFSKLQHRNLVKLLGC 350
+G G +G V + +++A+K+++ + ++ + E+ L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 351 CI-----QGEEKLLIYEFM---------PNKSL-----DYFIFDQTKRELLDWSKRFHII 391
+ ++YE M +++L YF++ +LL
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY-----QLL--------- 118
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLART E + +
Sbjct: 119 ----RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYV 169
Query: 452 GTYGYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
T Y APE Y T DV+S G + E++ K
Sbjct: 170 VTRWYRAPELLLNCSEYTT------AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLG 349
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
+ L++E++ +K L ++ D + K F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-DGLFS 468
+HRDLK N+L++ K++DFGLAR + +N+V+ T Y P+ +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 469 VKSDVFSFGILVLEIVSGK 487
+ D++ G + E+ SG+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
RGL YLH I+HRD+K N+L++ + KI DFGLAR DE + T +V+ Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 456 YMAPEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
Y APE ++ D++S G + E++ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKN--EVILFSKLQHRNLVKLLGC 350
+G G +G V Q++AVK+LS+ + ++ + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 351 CIQGEEKLLIYEFMPNKSLDYF--IFDQTK------------RELLDWSKRFHIICGTAR 396
F P S++ F ++ T ++L D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
GL Y+H IIHRDLK SNV ++ D +I DFGLAR DE+ G + T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWY 181
Query: 457 MAPEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
APE + + ++ D++S G ++ E++ GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR--TFGGDEIEGSTNKVIG 452
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG +T G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T Y+APE + D ++FG+L+ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRN 343
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 344 LVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELL-DWSKRFHIICGTARGLLYL 401
+V LL I +E L L++E++ Y D+ L + K F + RGL Y+
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLF--LFQLLRGLSYI 119
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST--NKVIGTYGYMAP 459
HQ I+HRDLK N+L+ K++DFGLAR + T N+V+ T Y P
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV-TLWYRPP 172
Query: 460 EYATDGL-FSVKSDVFSFGILVLEIVSG 486
+ +S D++ G + +E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 40/197 (20%)
Query: 308 VDGQEIAVKRLSKISEQGLNELK--NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365
V G +AVK+LS+ + + + E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 366 NKSLD-----YFIFDQTKREL-------LDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 413
KSL+ Y + + L LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 414 LKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY----GYMAPEYATDGLFSV 469
LK SN+++ D KI DFGLART TN ++ Y Y APE +
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART-------ACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 470 KSDVFSFGILVLEIVSG 486
D++S G ++ E+V G
Sbjct: 202 NVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 57/242 (23%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSK----ISEQGLNELKNEVILFS 337
D+F + +G G FG V+ LV GQ A+K L K Q + ++ E + +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILA 56
Query: 338 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DYFIFDQTKRELLDWSKRFHII 391
+VKL Q EE L L+ E+MP L +F + + + RF+I
Sbjct: 57 DADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETA-RFYI- 107
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG-GDEIEGSTNK- 449
A +L L +L IHRD+K N+L+D D + K++DFGL + + E N
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 450 -------------------------VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIV 484
+GT Y+APE + ++ D +S G+++ E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 485 SG 486
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKIS----EQGLNELKNEVILFSKLQHRNLVKLLG 349
+G G + +V L +I ++ K ++ ++ ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLLYLHQDSR 406
C Q +L L+ E++ L + + Q +R+L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466
II+RDLK NVLLD D + K++D+G+ + G +T+ GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 467 FSVKSDVFSFGILVLEIVSGK 487
+ D ++ G+L+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKR-LSKISEQGL--NELKNEVILFSKLQH 341
D + K+GEG +G+VYK G+ +A+K+ ++ E+G+ L+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59
Query: 342 RN-LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA----- 395
+V+LL EEK K Y +F+ +L + G
Sbjct: 60 SIYIVRLL-DVEHVEEK-------NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT 111
Query: 396 ---------RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEG 445
+G+ + H + ++HRDLK N+L+D KI+D GL R F ++
Sbjct: 112 IKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKS 167
Query: 446 STNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504
T++++ T Y APE +S D++S G + E+ R + L+ D++ + H
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS---RKQPLFPGDSELQQLLH 223
Query: 505 AWNL 508
+ L
Sbjct: 224 IFKL 227
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLG- 349
+G G +G V G+++A+K+LS+ SE E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 350 --CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWS--KRFHIICGTARGLLYLHQDS 405
+ G+E Y MP Y D K S K +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMP-----YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
IIHRDLK N+ ++ D KI DFGLAR + T V+ T Y APE +
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVV-TRWYRAPEVILNW 189
Query: 466 LFSVKS-DVFSFGILVLEIVSGK 487
+ ++ D++S G ++ E+++GK
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 311 QEIAVKRLSKISEQGLNELK--NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 368
+ +A+K+LS+ + + + E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 369 LDYF--------IFD----QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKT 416
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 417 SNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSF 476
SN+++ D KI DFGLART G + T V+ Y Y APE + D++S
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSV 211
Query: 477 GILVLEIVSGK 487
G ++ E++ G
Sbjct: 212 GCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 279 ATIANATDNFSINNKLGEGGFGRV-YKGTLVDGQEIAVK--RLSKISEQGLNELKNEVI- 334
AT + I+ LG G G V + DG+ AVK + +SE N + EV
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 335 -----LFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF 388
FS ++ H + K + E +L+ + LDY ++E+ +K
Sbjct: 85 LLNCDFFSIVKCHEDFAKKDP---RNPENVLMIALV----LDYANAGDLRQEIKSRAKTN 137
Query: 389 HIICGTARGLLYL-------HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441
GLL++ H S+ +IHRD+K++N+LL + K+ DFG ++ +
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196
Query: 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
+ GT Y+APE +S K+D+FS G+L+ E+++ KR
Sbjct: 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
+G G + +V L + I A+K + K ++ ++ ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLLYLHQDSR 406
C Q E +L + EF+ L + + Q +R+L + RF+ I L +LH+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEIS---LALNFLHERG- 116
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY--ATD 464
II+RDLK NVLLD + + K++D+G+ + G +T+ GT Y+APE D
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 465 GLFSVKSDVFSFGILVLEIVSGK 487
FSV D ++ G+L+ E+++G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 59/240 (24%)
Query: 288 FSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSK-ISEQGLNELKN----EVILFSKLQH 341
+ I +G+GG G VY V + +A+K++ + +SE L LK E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL--LKKRFLREAKIAADLIH 61
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD--WSKR------------ 387
+V + C G+ +Y MP +I T + LL W K
Sbjct: 62 PGIVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 388 ------FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441
FH IC T Y+H S+ ++HRDLK N+LL I D+G A +
Sbjct: 113 GAFLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 442 E---------IEGST-------NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
E K++GT YMAPE S +D+++ G+++ ++++
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQE----IAVKRLSKIS----EQGLNELKNEVILFSK 338
NF + LG G +G+V+ V G + A+K L K + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
++ + L Q + KL LI +++ L + ++RE +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L +LH +L II+RD+K N+LLD + + ++DFGL++ F DE+E + + GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173
Query: 458 APEYAT--DGLFSVKSDVFSFGILVLEIVSG 486
AP+ DG D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 287 NFSINNKLGEGGFGRV----YKGTLVDGQEIAVKRLSKI------SEQGLNELKNEVILF 336
+ + +LG+G +G V T + + +A+K+++ + +++ L ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 337 SKLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--- 390
H+N+ L I +L +YE + L I ++ + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF--GGDEIEGSTN 448
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 449 KVIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
+ + T Y APE + S +S DV+S G ++ E++ K
Sbjct: 168 EYVATRWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 72/276 (26%), Positives = 110/276 (39%), Gaps = 82/276 (29%)
Query: 286 DNFSINNKLGEGGFGRVYKGT------LVDGQEIAVKRLSKISEQG-----LNELKNEVI 334
D + LG G FG+V + + +AVK L + + ++ELK I
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 63
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIY------------------EFMPNKSLDY----- 371
L H N+V LLG C + L++ EF+P K+ D
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQG 123
Query: 372 ----------------------------FIFDQT-------KRELLDWSKRF----HIIC 392
F+ +++ + E D K+ +IC
Sbjct: 124 KSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183
Query: 393 GT---ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
+ A+G+ +L SR + IHRDL N+LL + KI DFGLAR D
Sbjct: 184 YSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+MAPE D +++++SDV+SFG+L+ EI S
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 311 QEIAVKRLSKISEQGLNELK--NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 368
+ +A+K+LS+ + + + E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 369 LDYF--------IFD----QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKT 416
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 417 SNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSF 476
SN+++ D KI DFGLART G + T V+ Y Y APE + D++S
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSV 204
Query: 477 GILVLEIVSGK 487
G ++ E+V K
Sbjct: 205 GCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKIS----EQGLNELKNEVILFSKLQHRNLVKLLG 349
+G G + +V L + I ++ K ++ ++ ++ E +F + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 350 CCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
C Q E +L + E++ L + + Q +R+L + RF+ + L YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYS-AEISLALNYLHERG--- 116
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFS 468
II+RDLK NVLLD + + K++D+G+ + G +T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 469 VKSDVFSFGILVLEIVSGK 487
D ++ G+L+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 66/237 (27%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD---GQEIAVKRLSKISE------QGLNELKNEVILF 336
+ +G G +G V +D G+++A+K++ + + L ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 337 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD---YFIFDQTKRELLDWSKRFHIICG 393
+H N++ + P + Y + D + +L HII
Sbjct: 59 RHFKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDL------HHIIHS 100
Query: 394 TA---------------RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
RGL Y+H + +IHRDLK SN+L++ D +I DFG+AR
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 439 GGDEIEGST--NKVIGTYGYMAPEYATDGLFSV-----KSDVFSFGILVLEIVSGKR 488
E + + T Y APE L S+ D++S G + E++ G+R
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
ARG+ +L SR + IHRDL N+LL + KI DFGLAR D
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+MAPE D +++ +SDV+SFG+L+ EI S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 51/218 (23%)
Query: 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLN------ELKNEVILFSKLQHRNLVK 346
+G G +G+V G+++A+K+LS+ + ++ EL+ L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKHMDHENVIG 78
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYF----------------IFDQTKRELLDWSKRFHI 390
LL F P SL+ F I K L D +F +
Sbjct: 79 LLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-L 123
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR DE+ G
Sbjct: 124 VYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----Y 175
Query: 451 IGTYGYMAPEYATDGLFSVKS-DVFSFGILVLEIVSGK 487
+ T Y APE + + ++ D++S G ++ E+++GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIA---VKRL-SKISEQGLNELKNEVILFSKLQHRNLVKLL 348
++G G FG+V + +A VK L + S + NE + + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 349 GCCIQGEEKLLIYEFMPNKSLD-YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
G C++ LL++E+ L Y +Q R + C A G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLART-FGGDEIEGSTNKVIGTYGYMAPEYAT--- 463
+H DL N L D+ K+ D+G+ + + D IE + + ++APE
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE-TEDDKCVPLRWLAPELVGEFH 177
Query: 464 DGLFSVK----SDVFSFGILVLEI 483
GL + + S+V++ G+ + E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQE----IAVKRLSKIS----EQGLNELKNEVILFSK 338
NF + LG G +G+V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-------DYFIFDQTKRELLDWSKRFHI 390
++ + L Q E KL LI +++ + D F D+ RF+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV---------RFY- 110
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ +L L +L I++RD+K N+LLD + + ++DFGL++ F +E E T
Sbjct: 111 ---SGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSF 166
Query: 451 IGTYGYMAPEYATDGLFSVKS-DVFSFGILVLEIVSG 486
GT YMAPE K+ D +S GIL+ E+++G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 294 LGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEV----ILFSKLQHRNLVKLL 348
+G+G FG+V +DG+ AVK L K E K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 349 GCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
Q EKL + +F+ L F Q +R + RF+ A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
I++RDLK N+LLD + ++DFGL + G +T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 468 SVKSDVFSFGILVLEIVSG 486
D + G ++ E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 294 LGEGGFGRV-YKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGC 350
+G G +G V G ++A+K+L + SE E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 351 CIQGEEKLLIYEFMPNKSLDYFI-------FDQT------KRELLDWSKRFHIICGTARG 397
F P+ SLD F F T K E L + ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L Y+H IIHRDLK N+ ++ D KI DFGLAR + + + T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYR 182
Query: 458 APEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
APE + + ++ D++S G ++ E+++GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 38/201 (18%)
Query: 310 GQEIAVKRLSKISEQGLNE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 365
G E+A+K L + + ++ + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 366 NKSLDYFIFDQ-------TKR---ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 415
++L + T R ++LD + C +G I+HRDLK
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD-----ALACAHNQG-----------IVHRDLK 106
Query: 416 TSNVLL---DHDMNPKISDFGLARTFGG----DEIEGS-TNKVIGTYGYMAPEYATDGLF 467
N+++ + K+ DFG+ G D + T +V+GT Y APE
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 468 SVKSDVFSFGILVLEIVSGKR 488
+ SD++++G++ LE ++G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 34/81 (41%), Positives = 47/81 (58%), Gaps = 10/81 (12%)
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG-----YMAPEYATD 464
IHRDL N+LL H KI DFGLAR +I +N V+ +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 465 GLFSVKSDVFSFGILVLEIVS 485
+++ +SDV+S+GIL+ EI S
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI 352
+G+G FG+VY+ D + I A+K LSK K EV + RN+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAKKEVA--HTIGERNI---LVRTL 51
Query: 353 QGEEKLLI---YEFMPNKSLDYFIFDQTKRELLDW-----------SKRFHIICGTARGL 398
E ++ + F + L Y + D L W +F+I A +
Sbjct: 52 LDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYI----AELV 106
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
L L + I++RDLK N+LLD + + DFGL++ D +TN GT Y+A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLA 164
Query: 459 PEYATDGL-FSVKSDVFSFGILVLEIVSG 486
PE D ++ D +S G+LV E+ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQ 340
NF + LG+G FG+V E+ A+K L K I + + E + +
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
+ L C Q ++L + E++ L Y I Q + + F+ + GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYA-AEISVGLF 115
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYGYMA 458
+LH+ II+RDLK NV+LD + + KI+DFG+ + ++G T + GT Y+A
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYIA 169
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGK 487
PE + D +++G+L+ E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 292 NKLGEGGFGRVYKG-TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLG 349
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
I E L L++E++ + Y L+ + RGL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-F 467
I+HRDLK N+L++ K++DFGLAR + +N+V+ T Y P+ +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 468 SVKSDVFSFGILVLEIVSGK 487
S D++ G ++ E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 68/246 (27%), Positives = 109/246 (44%), Gaps = 25/246 (10%)
Query: 287 NFSINNKLGEGGFGRVY----KGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKL 339
+F+ LG+G FG+V KGT + A+K L K I + + E + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR-- 396
+ L C Q ++L + E++ L Y I Q R K H + A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGR-----FKEPHAVFYAAEIA 111
Query: 397 -GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
GL +LH II+RDLK NV+LD + + KI+DFG+ + D + +T GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPD 166
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515
Y+APE + D ++FG+L+ E+++G+ + D F I + K M
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 226
Query: 516 QLIDAC 521
+ + C
Sbjct: 227 EAVAIC 232
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 34/212 (16%)
Query: 294 LGEGGFGRVYK----GTLVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRNLVKL 347
+ + K TLV AVK+ L S++ L L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFI---FDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ I E ++ M S + + F + EL F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA---IAF-ILKDVLNALDYIHS- 119
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG--------Y 456
IHR +K S++LL D +S + + + G +V+ + +
Sbjct: 120 --KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM--IK-HGKRQRVVHDFPKSSVKNLPW 174
Query: 457 MAPEYATDGL--FSVKSDVFSFGILVLEIVSG 486
++PE L ++ KSD++S GI E+ +G
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 44/205 (21%)
Query: 305 GTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364
GTLV + + L +E+ L L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 365 PNKSLDYFI---FDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421
S + + F + E L + I+ G RGL YLHQ+ IHR++K S++L
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHIL- 133
Query: 422 DHDMNPKISDFGLARTFGGDEI-----EGSTNKVIGTYGYMAPEYATDGL---------- 466
IS GL G + G KV+ Y P+++T L
Sbjct: 134 -------ISGDGLVSLSGLSHLYSLVRNGQKAKVV----YDFPQFSTSVLPWLSPELLRQ 182
Query: 467 ----FSVKSDVFSFGILVLEIVSGK 487
++VKSD++S GI E+ +G+
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 294 LGEGGFGRVYKGT---LVDGQ-----EIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
LG+G F +++KG + D E+ +K L K + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
G C+ G+E +++ E++ SLD ++ + + L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 406 RLRIIHRDLKTSNVLL-----DHDMNP---KISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+ H ++ NVLL NP K+SD G++ T EI ++ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPWV 171
Query: 458 APEYATDGL-FSVKSDVFSFGILVLEIVSG 486
PE + S+ +D +SFG + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 294 LGEGGFGRVYKGTLVD---------GQEIAVKRLSKISEQGLN---ELKNEVILFSKLQH 341
LG+G F +YKG L GQE++V K+ L S+L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL--KVLGSDHRDSLAFFETASLMSQLSH 60
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++LVKL G C++ +E +++ E++ LD F+ + L W + + A L YL
Sbjct: 61 KHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 402 HQDSRLRIIHRDLKTSNVLL-DHDMNP------KISDFGLARTFGGDEIEGSTNKVIGTY 454
+++H ++ N+L+ + +N K+SD G+ T E
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----- 169
Query: 455 GYMAPEYATDGLFSVKS--DVFSFGILVLEIVSG 486
++APE +G S+ D +SFG +LEI S
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
+G+G FG+V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 350 CCIQGEEKL-LIYEFMPNKSLDYFI-----FDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
Q EKL L+ F+ L + + FD ++ RF+ TA L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR-------ARFY----TAELLCALEN 108
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
+ +I+RDLK N+LLD+ + + DFGL + D + TN GT Y+APE
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLL 166
Query: 464 DGLFSVKSDVFSFGILVLEIVSG 486
++ D ++ G+L+ E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYG 455
L YLH + +++RDLK N++LD D + KI+DFGL + D G+T K GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMKTFCGTPE 161
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
Y+APE D + D + G+++ E++ G+ YN D++
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV----ILFSKLQHRNLVKLL 348
+G+G FG+V + + AVK L K + E K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 349 GCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
Q +KL + +++ L Y + Q +R L+ RF+ A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYA-AEIASALGYLHS---L 115
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
I++RDLK N+LLD + ++DFGL + E G+T+ GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 468 SVKSDVFSFGILVLEIVSG 486
D + G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 32/76 (42%), Positives = 41/76 (53%)
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSV 469
+HRDL NVL+ KI DFGLAR D S +MAPE + L++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 470 KSDVFSFGILVLEIVS 485
SDV+SFGIL+ EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYGY 456
L YLH +++RDLK N++LD D + KI+DFGL + +G+T K GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497
+APE D + D + G+++ E++ G+ YN D+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 23/168 (13%)
Query: 328 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLDYFIFDQTKRELLDW 384
+L+NE++ +L H N++K+ E++L E +M + D+ ++ E DW
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 385 SKR------FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
R I+ + Y+H ++IHRD+K N+ L+ D + DFG A F
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 439 GGDEIEGSTNKVIGTYGYMAPE-YATDGLFSVKSDVFSFGILVLEIVS 485
E E +GT +PE A DG + +D++S G+++L+++S
Sbjct: 318 -EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L YLH +++RD+K N++LD D + KI+DFGL + G + GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
APE D + D + G+++ E++ G+ YN D++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 46/222 (20%)
Query: 294 LGEGGFGRVYKGTLVD---GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGC 350
LG G G V+ VD + +AVK++ Q + E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 351 CIQGEEKLLIYE--FMPNKSLDYFIFDQTK-------RELLDWSKRFHIICGTA------ 395
+YE L + T+ +E ++ + G
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 396 -------RGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLARTFGGD-EIEGS 446
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGLAR +G
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKS-DVFSFGILVLEIVSGK 487
++ + T Y +P K+ D+++ G + E+++GK
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
L YLH +I++RDLK N++LD D + KI+DFGL + G + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEY 161
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
+APE D + D + G+++ E++ G+ YN D++
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 68/234 (29%), Positives = 102/234 (43%), Gaps = 53/234 (22%)
Query: 293 KLGEGGFGRVY----KGTLVDGQEIAVKRLSKISEQGLNELKN---EVILFSKLQHRNLV 345
LG+G GRV+ KGT G+ A+K L K N++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 346 KLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARGLLYL 401
L Q E L L+ ++ P L + Q + L + RF+ ++ L YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA------------------RTFGGDEI 443
H L I++RDLK N+LL + +SDF L+ R + I
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 444 -------EGS--TNKVIGTYGYMAPEYAT-DG-LFSVKSDVFSFGILVLEIVSG 486
E S +N +GT Y+APE + DG +V D ++ GIL+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKI-----SEQGLNELKNEVILFSKL 339
+++ + +G G FG V Q++ A+K LSK S+ + +++ F+
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-- 100
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+ V L C Q ++ L ++ E+MP L + + E W+K + TA +
Sbjct: 101 -NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAEVV 152
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
L L + +IHRD+K N+LLD + K++DFG + + +GT Y++
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYIS 211
Query: 459 PEY----ATDGLFSVKSDVFSFGILVLEIVSG 486
PE DG + + D +S G+ + E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQE-IAVKRLSKISEQGLNELKN-EVILFSKLQHRNL 344
++ + N +G G FG VY+ +D E +A+K++ + + KN E+++ L H N+
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINI 121
Query: 345 VKLLGC----CIQGEEKLL----IYEFMP---NKSLDYFIFDQTKRELLDWSKRFHIICG 393
+ L C + EK + + EF+P +K + ++ + L + +C
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC- 180
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEGSTNKVIG 452
R L Y+H I HRDLK N+L+D + + K+ DFG A+ + S I
Sbjct: 181 --RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YIC 232
Query: 453 TYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSG 486
+ Y APE AT+ ++ D++S G ++ E++ G
Sbjct: 233 SRFYRAPELMLGATN--YTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 54/242 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNE-----LKNEVILFSKLQ 340
+ + + K+G G FG V+ QE + IS +GL E L EV + +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 341 HRNLVKLLGCCI-QGEEKLLI-YEFMPNKSLDYFIFDQTKRELLDWSKRF-----HIICG 393
H+N+V+ + + + +KL I EF L R + K F H I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDL--------SRNIQKCYKMFGKIEEHAIVD 122
Query: 394 TARGLL----YLHQ----DSRLRIIHRDLKTSNVLLD-------------HDMN----PK 428
R LL Y H + R++HRDLK N+ L +++N K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 429 ISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE---YATDGLFSVKSDVFSFGILVLEIVS 485
I DFGL++ G IE + +GT Y +PE + T + KSD+++ G ++ E+ S
Sbjct: 183 IGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKS-YDDKSDMWALGCIIYELCS 238
Query: 486 GK 487
GK
Sbjct: 239 GK 240
|
Length = 1021 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/209 (23%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRL------SKISEQGLNELKNEVILFSK 338
+ F + +GEG +G V K + +EI A+K+ ++ E L ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
L+ N+V+L + + L++E++ L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
+ H++ I+HRD+K N+L+ H+ K+ DFG AR + + + + T Y +
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGK 487
PE + D++S G ++ E+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-07
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 9/84 (10%)
Query: 169 PGGEGFLKLPKMKLPENY-WSNQSMSLRECEAECTK-NCSCRAYANSQVVGGGNGCLMW- 225
+ F++LP KLP SL EC ++C NCSCR++ + G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYN---NGTKGCLLWS 57
Query: 226 FGDLIDIKECSEKYVWGQDFFIRV 249
L D + G D + ++
Sbjct: 58 ESSLGDAR---LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 286 DNFSINNKLGEGGFGRVY----KGTLVDGQEIAVKRLSK---ISEQGLNELKNEVILFSK 338
+F + + +G G FG V K T G A+K + K ++++ ++ + E + S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI---FDQTKRELLDWSKRFHIICGTA 395
+ +L + L+ E+ P L + DQ ++ +F++ A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYL----A 109
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+L +H ++ +HRD+K NVL+D + K++DFG A +++ S V GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPD 168
Query: 456 YMAPEYAT------DGLFSVKSDVFSFGILVLEIVSGK 487
Y+APE T G + V+ D +S G++ E++ G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGCC 351
K+G G +G VYK DG++ L +I G++ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 352 IQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY-----LHQD 404
+ ++ L++++ + F + + K + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 405 SRLRIIHRDLKTSNVLLDHDMNP-----KISDFGLARTFGGD-EIEGSTNKVIGTYGYMA 458
++HRDLK +N+L+ + P KI+D G AR F + + V+ T+ Y A
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 459 PEYATDGLFSVKS-DVFSFGILVLEIVSGK 487
PE K+ D+++ G + E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 294 LGEGGFGRVYKGTLVD---------GQEIAVKRLSKISEQGLNELK----NEVILFSKLQ 340
LG G ++Y G L E +K + K+ + ++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H+++V L G C++ E +++ EF+ LD F+ ++ ++L +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 401 LHQDSRLRIIHRDLKTSNVLL-----DHDMNP--KISDFGLARTFGGDEIEGSTNKVIGT 453
L +D L +H ++ T N+LL D + P K+SD G+ T S + +
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVER 171
Query: 454 YGYMAPEYATDG-LFSVKSDVFSFGILVLEI 483
++APE D S+ +D +SFG + EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLVKLLGCC 351
K+G G +G VYK DG++ L +I G++ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 352 IQGEEK--LLIYEFMPNKSLDYFIFDQTKRE-----LLDWSKRFHIICGTARGLLYLHQD 404
+ ++ L++++ + F + + L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 405 SRLRIIHRDLKTSNVLL----DHDMNPKISDFGLARTFGGD-EIEGSTNKVIGTYGYMAP 459
++HRDLK +N+L+ KI+D G AR F + + V+ T+ Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 460 EYATDGLFSVKS-DVFSFGILVLEIVSGK 487
E K+ D+++ G + E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 288 FSINNKLGEGGFGRVYKGTLVD---GQEIAVKRLSKISEQGLNELK--NEVILFSKLQHR 342
+ I +G+G +G V + +D G+++A+K+++ + E + + E+ L L+H
Sbjct: 2 YKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHP 59
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLD-YFIFDQTKRELL-------DWSKRFH--IIC 392
++V E K ++ + D Y +F+ + +L D + H +
Sbjct: 60 DIV---------EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY 110
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST----N 448
R L Y+H + + HRDLK N+L + D KI DFGLAR D T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWT 164
Query: 449 KVIGTYGYMAPEYATDGLFSVKS----DVFSFGILVLEIVSGK 487
+ T Y APE G F K D++S G + E+++GK
Sbjct: 165 DYVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 17/214 (7%)
Query: 288 FSINNKLGEGGFGRVYKGTL---VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
++I + L G G V+ T +++ VK ++ G E+ + + HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAI 148
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ L+ K + MP D F + L + I L YLH
Sbjct: 149 INLIHAY---RWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGR 204
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
IIHRD+KT N+ LD N + DFG A GT +PE
Sbjct: 205 G---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
+ K+D++S G+++ E+ +N L+ K
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSV--KNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 277 ELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNEL--KNEV 333
++ + ++F + +G G FG V +++ A+K LSK E+ +++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF------EMIKRSDS 87
Query: 334 ILFSK----LQHRN--LVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSK 386
F + + H N + L Q ++ L ++ E+MP L + + E W+
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWA- 144
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
RF+ TA +L L + IHRD+K N+LLD + K++DFG + +
Sbjct: 145 RFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200
Query: 447 TNKVIGTYGYMAPEY----ATDGLFSVKSDVFSFGILVLEIVSG 486
V GT Y++PE DG + + D +S G+ + E++ G
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 32/156 (20%)
Query: 294 LGEGGFGRVYKGTLV----DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVK 346
+G G FG V LV G A+K+L K + ++ + ++ E + ++ + +VK
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 347 LLGCCIQGEEKL-LIYEFMPNKSL-------DYFIFDQTKRELLDWSKRFHIICGTARGL 398
L Q E L LI E++P + D F ++T RF+I A +
Sbjct: 66 LY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---------RFYI----AETI 111
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 22/163 (13%)
Query: 332 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHII 391
E + + H ++++L G + LI +P D + + KR + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI--------AI 181
Query: 392 C-------GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
C R + YLH++ RIIHRD+K N+ ++H + + DFG A F D
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA 237
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT APE + D++S GI++ E+ +
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 30/167 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSK---ISEQGLNELKNEVILFSK 338
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------DYFIFDQTKRELLDWSKRFHII 391
+V L + LI EF+P L D F D T RF++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---------RFYM- 107
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
A +L + +L IHRD+K N+L+D + K+SDFGL+ F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418
++ E+MP L + + E W+ RF+ TA +L L + IHRD+K N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE--KWA-RFY----TAEVVLALDAIHSMGFIHRDVKPDN 172
Query: 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY----ATDGLFSVKSDVF 474
+LLD + K++DFG + + + +GT Y++PE DG + + D +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 475 SFGILVLEIVSG 486
S G+ + E++ G
Sbjct: 232 SVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 24/81 (29%), Positives = 46/81 (56%)
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF 467
+++HRDLK++N+ L K+ DFG ++ + + GT Y+APE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 468 SVKSDVFSFGILVLEIVSGKR 488
S K+D++S G+++ E+++ R
Sbjct: 249 SKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-05
Identities = 18/45 (40%), Positives = 24/45 (53%), Gaps = 2/45 (4%)
Query: 563 SVLAQPKQPGCLVDRKSTGPDSSSSKP--ESSSTNASTFTEVEGR 605
+ + QPKQPG V R DSSSS ES + N T + ++ R
Sbjct: 4 TEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
RF+I A +L +H +L +HRD+K NVLLD + + +++DFG D S
Sbjct: 105 RFYI----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 447 TNKVIGTYGYMAPEY---ATDGL--FSVKSDVFSFGILVLEIVSGK 487
+ V GT Y++PE DG+ + + D +S G+ + E++ G+
Sbjct: 161 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 42/202 (20%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 301 RVYKGTLVDGQEIAVKRLSK-------ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353
+YKG + +E+ ++ K + + NE+KN ++ N++K+ G I
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKN----LRRIDSNNILKIYGFIID 89
Query: 354 GEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLR 408
+ L LI E+ L + K + L + + + +GL L++ ++
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK-- 144
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFS 468
+++L + + L+ + KI GL + + K + Y + + D +FS
Sbjct: 145 -PYKNLTSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFS 197
Query: 469 ---VKSDVFSFGILVLEIVSGK 487
+K D++S G+++ EI +GK
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 278 LATIANATDNFSINNKLG--EGGFGRVY----KGTLVDGQEIAVKRLSKISEQGLNELKN 331
L+ + N I KL +G FG+V K T Q++ V++ I + N ++
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPT----QKLFVQK--IIKAKNFNAIEP 59
Query: 332 EV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE-LLDWSKRFH 389
V L + N +KL + +LI +++ + L FD K+E L ++
Sbjct: 60 MVHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKK 113
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEGSTN 448
II L LH + IIH D+K NVL D + + D+GL + I G+ +
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPS 164
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT Y +PE + V D ++ G+L E+++GK
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQE-----IAVKRLSKISEQGLNE-LKNEVILFSK 338
DN LG G FG+V + T G+E +AVK L + E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEF 363
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 36/168 (21%)
Query: 286 DNFSINNKLGEGGFGRVYKG-TLVDGQEIAVKRLSK---ISEQGLNELKNE--------- 332
+ F I + G FG+VY G + + AVK + K I++ +++++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 333 ---VILFSKLQHRNLVKL-LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF 388
V L+ LQ N V L + I G+ K L++ + YF D
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY------GYF----------DEEMAV 107
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436
I A L YLH+ IIHRDLK N+L+ ++ + K++DFGL++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 47/177 (26%), Positives = 72/177 (40%), Gaps = 32/177 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKR--LSKISEQGLNEL-KNEVIL------F 336
D+F + KLGEG FG VYK +LV+ Q + L K +E G E+ NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191
Query: 337 SKLQHRNLVKL---------LGCCIQGEEKLLIYEFMPNKSLDY----FIFDQTKRELLD 383
+ + L + L +GE L + M +K Y ++ + +
Sbjct: 192 ADFVYGFLEPVSSKKEDEYWLVWRYEGESTL--ADLMQSKEFPYNVEPYLLGKVQDLPKG 249
Query: 384 WSKRFHIICGTARGLLY----LHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLA 435
+ II R +L+ LH I+HRD+K N++ KI D G A
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
+VK+ LI EF+P D K L + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETVLAI 114
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
+VK+ LI EF+P D K L + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETVLAI 114
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT 394
L S++ H +L + G C++G E +++ EF+ + LD + + R + W + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVL-----LDHDMNP--KISDFGLARTFGGDEIEGST 447
A L YL + ++H ++ N+L L +P K+SD G+ +F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREERV 181
Query: 448 NKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEI 483
++ ++APE G S +D +SFG +LEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
RF++ A +L + +L +HRD+K NVLLD + + +++DFG D S
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 447 TNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGK 487
N +GT Y++PE G + + D +S G+ + E++ G+
Sbjct: 161 -NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 47/221 (21%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++F I +G G FG E+AV +L + ++ N+ + + +
Sbjct: 1 EDFEILKVIGRGAFG-----------EVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 49
Query: 346 KLLGCCIQGEEK---LLIYEFMPNKSL----DYFI-------FDQTKRELLDWSKRFHII 391
+ + G+ + L Y F +L DY++ + + L + RF++
Sbjct: 50 EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL- 108
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
A ++ + +L +HRD+K N+L+D + + +++DFG D S+ V
Sbjct: 109 ---AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV- 164
Query: 452 GTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGK 487
GT Y++PE G + + D +S G+ + E++ G+
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 391 ICGTARGLL----YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
+ AR LL Y+H + IIHRD+KT NVL++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLE 482
+ GT APE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR----TFGGDEIEGSTNK 449
T L YLH I+HRDLK N+L+ + K++DFGL++ + + EG K
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 450 ---------VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
V GT Y+APE + D ++ GI++ E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 350 CCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
+ + +++P + I + E+L RF+I A L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYI----AELTLAIESVHKMG 121
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
IHRD+K N+L+D D + K++DFGL F
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 11/82 (13%)
Query: 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 414
E +++ E++ + L + + E L+ S+ + G LH IIH DL
Sbjct: 72 ENFIIVMEYIEGEPLKD-LINSNGMEELELSREIGRLVGK------LH---SAGIIHGDL 121
Query: 415 KTSNVLLDHDMNPKISDFGLAR 436
TSN++L + DFGLA
Sbjct: 122 TTSNMILSGG-KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 32/160 (20%)
Query: 294 LGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQT----------KRELLDWS-KRFHIICGTARGL 398
Y F +L YF+ D + + + RF+I A
Sbjct: 68 -----------YSFQDKDNL-YFVMDYIPGGDMMSLLIRLGIFEEDLARFYI----AELT 111
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
+ ++ IHRD+K N+L+D D + K++DFGL F
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 15/146 (10%)
Query: 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV--KLLGC 350
L G RVY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410
L+ E++ ++LD ++ + A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLC 111
Query: 411 HRDLKTSNVLLDHDMNPKISDFGLAR 436
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.21 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.4 | |
| PLN02236 | 344 | choline kinase | 97.08 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.6 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.25 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.24 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.15 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.97 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.96 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.66 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.56 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=433.68 Aligned_cols=288 Identities=43% Similarity=0.744 Sum_probs=255.7
Q ss_pred CCCcccHHHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeE
Q 007397 272 ELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCC 351 (605)
Q Consensus 272 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 351 (605)
....|++.++..+|++|.-.+.||+|+||.||+|...+++.||||++.....+...+|.+|+.++.+++|+|+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999999999999998764433155699999999999999999999999
Q ss_pred EeCC-eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 352 IQGE-EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 352 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
.+.+ +.+||||||++|+|+++++..... .++|..+++|+.++|+||+|||+....+||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999776554 78999999999999999999999887789999999999999999999999
Q ss_pred ecCCCccCCCCccccccccc-ccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKV-IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|.||++|+++.+...+.....+..+++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999996643211 111112 79999999999999999999999999999999999999988776666666888888999
Q ss_pred hcCCCccccccccc-CCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 510 NKGMPWQLIDACYQ-ESCNP-DEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 510 ~~~~~~~l~d~~~~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.++...+++|+.+. ..... .+..++..++.+|++.+|.+||+|.+|+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 55554 6889999999999999999999999999999554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=386.27 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=208.2
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchh-------hHHHHHHHHHHHHcCCCCceeeeeeeEEeCC
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQ-------GLNELKNEVILFSKLQHRNLVKLLGCCIQGE 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 355 (605)
..+.|.+.+.||+|+||.|-+|.. .+|+.||||++++.... ....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567899999999999999999987 55999999999763211 2233579999999999999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeec
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDF 432 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DF 432 (605)
..|+||||+.||.|.+.+..+ +.+.+.....++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999988544 34677778889999999999999999 9999999999999766 78999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCC-chhHHHHHHHh
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL---FSVKSDVFSFGILVLEIVSGKRNRGLYNSDN-KFNVIRHAWNL 508 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvvl~elltG~~p~~~~~~~~-~~~~i~~~~~~ 508 (605)
|+|+..+.. ....+.||||.|.|||++.+.. +..|+|+||+|||||.+|+|.+||.....+. ....|...
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--- 397 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--- 397 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC---
Confidence 999987533 2356789999999999998765 3458899999999999999999998765544 22222211
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... +......+..++.++||.+||..||++|||+.|++++-
T Consensus 398 ----~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 398 ----RYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ----ccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 110 01123345567788999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=392.83 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=215.7
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.+|...+.||+|||+.+|.+++ ..|..||+|++.+ ......+.+.+|++|.++|+|||||+++++|.+.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 6799999999976 34556778899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|+|+.++|..++. +++.+.+.+++.++.||+.||.|||+++ |+|||||..|+||+++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999884 5567999999999999999999999998 999999999999999999999999999988644
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ....+.+|||.|+|||++....++..+||||+|||||.||.|++||+...-.+....|....-
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-------------- 235 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-------------- 235 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--------------
Confidence 2 235568999999999999999999999999999999999999999986554444444432110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+........+||..+|+.+|.+|||+++|+..
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112334457789999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.79 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=211.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-eeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 362 (605)
.+.+.++.||+|..|+|||++|+ .++.+|+|.+.- ......+++.+|++++++.+||+||++++.|.... ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34566789999999999999994 588899999953 45667789999999999999999999999999988 5999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||++|+|+.++... +.+++...-+|+.++++||.|||+ ++ ||||||||+||||+..|.|||||||.++...+.
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998544 458999999999999999999996 65 999999999999999999999999999887543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CCCchhHHHHHHHhhhcCCCccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN--SDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
...+.+||..|||||.+.+..|+.++||||||++++|+++|+.|+.... ......++..+. .+.+..+
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----~~ppP~l-- 302 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----DEPPPRL-- 302 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh----cCCCCCC--
Confidence 4566889999999999999999999999999999999999999998752 222333333221 2222222
Q ss_pred ccccCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 520 ACYQESCNP-DEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+. .+..++..++..||++||.+||++.+++++-
T Consensus 303 -------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 303 -------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred -------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 22 3566799999999999999999999998853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.64 Aligned_cols=207 Identities=29% Similarity=0.492 Sum_probs=186.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..+|.+.++||+|+||+||+|++. ++..||||.+.+. .....+.+..|+.+|+.++|+|||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999984 4899999999765 5667778899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC------CceEEeecCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD------MNPKISDFGLA 435 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~------~~vkl~DFGla 435 (605)
|||.+|+|.++|+... .+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999996543 5899999999999999999999999 9999999999999765 45899999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 500 (605)
+..... ....+.+|+|-|||||+++...|+.|+|+||+|+|||+|++|+.||...+..+...
T Consensus 163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 998643 33556899999999999999999999999999999999999999998766555444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=382.41 Aligned_cols=255 Identities=32% Similarity=0.516 Sum_probs=210.2
Q ss_pred ccccceecccCeEEEEEEEEcCCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-eeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 364 (605)
..+.+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|++.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999998655559999997532 222679999999999999999999999999988 789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCCCcc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGGDEI 443 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~~~~ 443 (605)
++|+|..++... ....+++..+++++.+|++||.|||+.+. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999765 45679999999999999999999999873 99999999999999997 99999999998764332
Q ss_pred cccccccccccCccchhccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT--DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||..... ...+......+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~-------- 263 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL-------- 263 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC--------
Confidence 2223367999999999999 56999999999999999999999999976543 111222221221
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+...+..+...+..|+.+||+.||+.||++.+++.+|+..
T Consensus 264 -Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 -RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1222333566788999999999999999999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.69 Aligned_cols=242 Identities=27% Similarity=0.362 Sum_probs=205.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|+++++||+|+||+||.++..+ ++.+|+|++++. .....+..++|..+|.+++||.||+++..|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4689999999999999999999865 889999999863 334567889999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
+||+.||.|..+|.+ ...+++..++-++..|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999954 345899999999999999999999999 99999999999999999999999999996533
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. ...+.+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||...+.......|.... .
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------~------ 242 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------L------ 242 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------C------
Confidence 2 223455899999999999999999999999999999999999999998766544433333211 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
...+.-...+..+++...|+.+|++|-
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 001111234577899999999999995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=349.99 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=211.4
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeee-eEEeCCe-eEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 360 (605)
..|+++++||.|.||+||++.. .+|..+|.|.+.- .+.+....+..|+.+|++|+|||||++++ .+.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3588999999999999999986 7799999999873 45667778899999999999999999998 5555555 8899
Q ss_pred EEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 361 YEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDS-RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
||++..|+|..++..- ..+..+++..+++++.|++.||.++|+.= |..|+||||||.||+|+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998553 34567999999999999999999999831 235999999999999999999999999999998
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..... .....+|||.||+||.+.+.+|+.|+||||+||++|||..-.+||...+ ...+-. .+..+....+.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~----KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCK----KIEQGDYPPLP 249 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHH----HHHcCCCCCCc
Confidence 66543 3456889999999999999999999999999999999999999998652 122111 22222222121
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+ ......+..||..|+..||+.||+...+++.+..
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 3456778899999999999999996555555433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.36 Aligned_cols=256 Identities=31% Similarity=0.494 Sum_probs=217.8
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
+.++++++||+|.||.|++|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345567899999999999999988889999999753 3445678899999999999999999999999899999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
.|+|.++|.. ..+..+.....+.++.||++|++||++++ +|||||.+.||||+++..+||+|||+|+....+.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 34556889999999999999999999998 9999999999999999999999999999766555433
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.. ...-...|.|||.+....++.|||||||||+|+||+| |+.|+......+.. +.++.-.+-
T Consensus 361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRl 423 (468)
T KOG0197|consen 361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRL 423 (468)
T ss_pred cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcC
Confidence 22 2234668999999999999999999999999999999 77777654433222 223333455
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
+.+..++..+.+||..||+.+|++|||+..+...|+...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 677778888999999999999999999999999998763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.78 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=211.6
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+.|+.+.++|+|+||+||++++++ |+.||||++... +....+-..+|+.+|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568889999999999999999966 999999999653 33445567899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|++..-|+.+-... .-++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.....
T Consensus 82 ~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99988777654322 23788899999999999999999998 999999999999999999999999999988642
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------HhhhcCC
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NLWNKGM 513 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~~~~~~ 513 (605)
....+.++.|..|+|||.+.+ ..|...+||||+||++.||++|.+.|.....-+....|.... ..+..+.
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 233456788999999999887 789999999999999999999999998776655544444332 1222211
Q ss_pred Cc-cc--cc---ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PW-QL--ID---ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~-~l--~d---~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+ -+ .+ ....+..-+....-+++++..||+.||++|++-++++..
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 11 11 111111222334468899999999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.49 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=214.2
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 358 (605)
...+|.+++.||+|+|++|++|+..+ ++.||||++.+ ..+...+.+..|-.+|.+| .||.|++|+..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999999855 89999999976 2444556677899999999 7999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|+||+++|.|..+|.+. +.+++..++.++.+|+.||+|||+.| ||||||||+|||||.++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999544 56899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCccc-----------ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 439 GGDEIE-----------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 439 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
...... ......+||..|.+||++.....+..+|+|+||||||+|+.|.+||...++-..++.|....-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 543221 111447899999999999999999999999999999999999999987665444444433222
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. +++...+.+.+|+.+.|..||.+|+|..+|-++.
T Consensus 305 ~-----------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 305 E-----------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred c-----------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 2223335677899999999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=328.68 Aligned_cols=282 Identities=26% Similarity=0.322 Sum_probs=221.3
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|...++||+|.||.||+|++ ..|+.||||+++.. .+.......+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5788899999999999999998 55999999999742 33345567899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
||+. +|+..+.+. ...+....+..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 677777554 346889999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc---cc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ---LI 518 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~---l~ 518 (605)
.... ..+-|..|+|||.+.+. .|+..+||||.|||+.||+.|.+-|...+.-+....|-.+.....+..+.+ +.
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 3322 23679999999998775 599999999999999999999988877665444444444332222222211 11
Q ss_pred cc--------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCCCCCCCccccc
Q 007397 519 DA--------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVD 576 (605)
Q Consensus 519 d~--------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~~~ 576 (605)
|- ......-+.....+++|+..+|..+|.+|++++|++++--..+ .|.|..|.-+..
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~~lp~ 298 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPSKLPI 298 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChhhCcC
Confidence 11 0011122344556789999999999999999999999865543 566666655533
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=355.70 Aligned_cols=282 Identities=22% Similarity=0.286 Sum_probs=216.2
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 358 (605)
..+.|+.+++||+|.||.||+|++ .+|+.||+|++.... +.......+|+.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346788899999999999999998 559999999997543 45566778999999999999999999999887 6899
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
||+|||++. |.-++.. ..-.+++.++..++.||+.||.|+|+.+ |+|||||.+|||||.+|++||+|||||+.+
T Consensus 195 lVFeYMdhD-L~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDHD-LSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccch-hhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999875 3333322 2234889999999999999999999999 999999999999999999999999999988
Q ss_pred CCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc--
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW-- 515 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~-- 515 (605)
........ +..+-|..|+|||++++. .|+.++|+||.||||.||++|++.+...+..+....|...-....+..+.
T Consensus 269 ~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 66554433 345679999999999875 69999999999999999999999998877766666665442221111111
Q ss_pred cccccc-cc--CC-------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCCCCCCCcc
Q 007397 516 QLIDAC-YQ--ES-------CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGC 573 (605)
Q Consensus 516 ~l~d~~-~~--~~-------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~ 573 (605)
.+.... +. .+ .-.......++|+..+|..||.+|.|+.+++..=-. +..|.|-.|..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF-~t~p~~~~p~~ 414 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF-TTEPLPCDPSS 414 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc-ccCCCCCCccc
Confidence 111100 00 01 111233456788999999999999999999875433 34444444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=357.83 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=211.6
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhh-HHHHHHHHHHHHcCC-CCceeeeeeeEEeCC-eeE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQG-LNELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKL 358 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 358 (605)
...++|.++++||.|.||.||+|+.. .+..||||++++.-... .-.-.+|+..|++|+ |||||++.+++.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678999999999999999999874 48899999997533222 222357999999999 999999999999988 999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|||||+. +|.+++.+. ...+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999955 677777554 668999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc-
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ- 516 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~- 516 (605)
.... ..+.++.|..|+|||+++ .+.|+.++|||++|||++|+.+-++.|.+.+..+....|-.......+....+
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 5443 345688999999999876 56799999999999999999999999987665444333322221111111110
Q ss_pred -----cccccc-------cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 517 -----LIDACY-------QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 517 -----l~d~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+.-.+ -...-+....++++|+.+|++.||++|||+.+.+++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000000 0111123567789999999999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.72 Aligned_cols=236 Identities=26% Similarity=0.323 Sum_probs=203.5
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++++.||.|+||+|.+++.+. |..+|+|++.+. .....+...+|..+|+.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578999999999999999999854 889999999864 3345566788999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||++||.|..++++. +.+++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999554 34899999999999999999999998 99999999999999999999999999998643
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.+.+.+|||.|+|||+++..+|+.++|.|||||++|||+.|.+||...++...++.|... ..
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-------~v------- 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-------KV------- 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------cc-------
Confidence 366799999999999999999999999999999999999999999987775444444321 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDR 549 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~R 549 (605)
.++.-....+.+|+...|+.|-..|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222333457788888899998888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.54 Aligned_cols=270 Identities=22% Similarity=0.301 Sum_probs=220.1
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
..++|+++..||+|+||.||+|+.++ |..+|+|++++.. ....+.++.|-.+|....+++||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56899999999999999999999865 8999999998753 3456678899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||++||++..+|. +.+.|++..++.++.+++.|+..||++| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999884 4457999999999999999999999999 9999999999999999999999999985431
Q ss_pred C----------------------Ccccc-----c------------------ccccccccCccchhcccCCCCCcccchH
Q 007397 440 G----------------------DEIEG-----S------------------TNKVIGTYGYMAPEYATDGLFSVKSDVF 474 (605)
Q Consensus 440 ~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~~~k~Dvw 474 (605)
. .+... . ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00000 0 0134699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC---
Q 007397 475 SFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS--- 551 (605)
Q Consensus 475 SlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt--- 551 (605)
|||||+||||.|.+||...++.+....|......+.... ......+..+||.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999999888777776665444332221 22223567889999998 9999974
Q ss_pred HHHHHHHh-------cCCCCCCCCCCCcc
Q 007397 552 MPSVILML-------GSDSVLAQPKQPGC 573 (605)
Q Consensus 552 ~~evl~~L-------~~~~~~~~p~~p~~ 573 (605)
++||-++- +.+...++|-.|..
T Consensus 439 ~~EIK~HPfF~~v~W~~l~~~~apfvP~v 467 (550)
T KOG0605|consen 439 AEEIKKHPFFKGVDWDHLREMPAPFVPQV 467 (550)
T ss_pred HHHHhcCCccccCCcchhhcCCCCCCCCC
Confidence 77776654 22244455555554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.90 Aligned_cols=258 Identities=28% Similarity=0.381 Sum_probs=206.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC--eeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 361 (605)
..++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|.....+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3467788999999999999999855 8999999987654444778999999999999999999999855554 588999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~ 440 (605)
||+++|+|.+++.+... .+++..+..++.||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999966543 5899999999999999999999999 999999999999999 79999999999987753
Q ss_pred -CcccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 -DEIEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
...........||+.|||||++.++. ...++|||||||++.||+||++||... ......+ ..........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~---~~ig~~~~~P--- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEAL---LLIGREDSLP--- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHH---HHHhccCCCC---
Confidence 11122234578999999999999633 335999999999999999999999764 1111111 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+........+++.+|++.+|+.|||+.++++..--
T Consensus 243 ------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2233344567889999999999999999999997633
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.85 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=214.0
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.+.|++..+||.|.-++||+|+. +.+..||||++.-. .....+.+++|+..++.++||||++++..|+.+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46899999999999999999987 66899999999742 33347899999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
||.+|++.+++......+ +++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+...-...
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997655443 899999999999999999999999 9999999999999999999999999866543221
Q ss_pred -ccc-cccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 443 -IEG-STNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 443 -~~~-~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
... ......||+.|||||+++. ..|+.|+||||||++..||++|..||..+.+.... ...+.+ .+..+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn-~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQN-DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcC-CCCCcc
Confidence 111 1156789999999999654 46999999999999999999999999887764322 122222 222222
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
-..+..+........+.+++..||++||..|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1122223333445578899999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.93 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=214.8
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
....|....+||+|+.|.||.|+. ..++.||||++........+.+.+|+.+|+..+|+|||.+++.|..++..++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 446788889999999999999987 5589999999987666677788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
||++|+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999998833 34889999999999999999999999 9999999999999999999999999999886554
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. .....+|||.|||||++....|+.|+||||||++++||+-|++||-..++- +..+....++. ..+
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~-P~l----- 489 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT-PKL----- 489 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCC-CCc-----
Confidence 3 344578999999999999999999999999999999999999999753332 22222222222 222
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+++.+||+.|+++||++.|||++
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233445678899999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.17 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=204.5
Q ss_pred hcCccccceecccCeEEEEEEEE------cCCcEEEEEEccccc-hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC-C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKIS-EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG-E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 355 (605)
.++|++.++||+|+||.||+|.+ ..++.||+|++.... ......+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 225689999997532 34456788999999999 899999999988764 4
Q ss_pred eeEEEEEeeCCCchhhHHhhcCc---------------------------------------------------------
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTK--------------------------------------------------------- 378 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 378 (605)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864321
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCc
Q 007397 379 --RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456 (605)
Q Consensus 379 --~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 456 (605)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778888999999999999999998 999999999999999999999999999865433222222334567889
Q ss_pred cchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHH
Q 007397 457 MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI 535 (605)
Q Consensus 457 ~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 535 (605)
+|||++.+..++.++|||||||++|||++ |..||........ .. .....+.... .+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTRMR---------APENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCCCC---------CCCCCCHHHH
Confidence 99999999999999999999999999997 9999875443211 11 1111111111 1112334688
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 536 HISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 536 ~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+|+.+||+.+|++|||+.+|+++|+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.61 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=207.4
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc----ch-hhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCC
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI----SE-QGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGE 355 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 355 (605)
...++|.+.+.||+|+||+|++|.+ ..+..||+|++.+. .. ...+.+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999987 45899999977653 22 34556778999999999 999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGL 434 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGl 434 (605)
..++||||+.+|.|.+++.+ .+.+.+..+..++.||+.|++|+|++| |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999965 345788999999999999999999999 9999999999999999 9999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-FS-VKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+.... ... ...+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---~~k----i~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---YRK----IRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---HHH----HhcC
Confidence 99863 1223455689999999999999977 85 789999999999999999999987332222 221 1111
Q ss_pred CCcccccccccCCCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDACYQESCNPDE-VIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .++... ...+..|+.+||+.+|..|+++.+|+..
T Consensus 239 ~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 239 EF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred Cc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 10 011111 5568899999999999999999999943
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=369.88 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=219.5
Q ss_pred CccccceecccCeEEEEEEEEc------CCcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+-+..++||+|+||.||+|+.. +.+.||||.++...+. ...+|++|++++..++|||||+++|+|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4455689999999999999853 3578999999875544 78899999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceE
Q 007397 360 IYEFMPNKSLDYFIFDQTK-----------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPK 428 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vk 428 (605)
|+|||..|+|..||..... ...++..+.+.|+.|||.|+.||-++. +|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999965321 223889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHH
Q 007397 429 ISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 429 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~ 507 (605)
|+|||+++.+...++-.......-..+|||||.|+.+.|+++||||||||||||+++ |+-|+.....++..+.++
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~---- 719 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR---- 719 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH----
Confidence 999999998765554443333445789999999999999999999999999999999 888888766554433333
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.+.. -+++..++.+++.||+.||+.+|.+||+++||-..|+.-.
T Consensus 720 ---~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 720 ---AGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ---cCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2222 2566777888999999999999999999999999997753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.97 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=205.0
Q ss_pred cCccccceecccCeEEEEEEEEcC-----------------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKL 347 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 347 (605)
++|++.++||+|+||.||++.+.+ +..||+|.+... .......+.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999997532 346999998753 34455678999999999999999999
Q ss_pred eeeEEeCCeeEEEEEeeCCCchhhHHhhcC----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 007397 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQT----------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIH 411 (605)
Q Consensus 348 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 411 (605)
++++......++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885432 1134678889999999999999999998 999
Q ss_pred ecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh--CCCC
Q 007397 412 RDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRN 489 (605)
Q Consensus 412 rDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt--G~~p 489 (605)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987644332222334456889999999998899999999999999999997 4556
Q ss_pred CCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 490 RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 490 ~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+....... .+......+..... .. ....++.....+.+|+.+||+.+|++|||+.+|++.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65433222 22221111111110 00 001122234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=342.58 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=218.1
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+ ..+...+.+.+|++|+++++|||||.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578899999999999999999754 78999999976 355667889999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+.+ +|..++.+ .+.++++.+..++.+++.||.|||+++ |+|||+||.|||++..+.+|++|||+|+....+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 99998854 345899999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
...+.+.|||-|||||++.+++|+..+|+||+|||+|||.+|++||.... ..+++..+ ..+ +.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I---~~d--------~v- 217 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSI---LKD--------PV- 217 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHH---hcC--------CC-
Confidence 23456789999999999999999999999999999999999999996422 12222211 111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh---cCCCCCCCCCCCccccc
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML---GSDSVLAQPKQPGCLVD 576 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L---~~~~~~~~p~~p~~~~~ 576 (605)
..+......+.+++...|++||..|.+..+++.+- ..+.....|.+|++...
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp 272 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP 272 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence 11234556788999999999999999999998754 22244445555555443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.38 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=210.1
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..-|++++.||.|+-|.|-+|++ ..|+.+|||++.+. .......+.+|+.+|+-+.|||++++++++.+.++.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688999999999999999998 55999999999764 333455678999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
.||+++|.|++++.. ++.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..
T Consensus 91 lEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999999854 456899999999999999999999998 99999999999999999999999999976432
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.....+.||+|.|.|||++++.+| +.++||||.|||||.||+|+.||+..+ ...++.+ ...|..
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlK----V~~G~f----- 229 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLK----VQRGVF----- 229 (786)
T ss_pred ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHH----HHcCcc-----
Confidence 233566899999999999999998 588999999999999999999998433 2222222 112211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+.+.....++.+|+.+||..||+.|.|+.||+++.
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12233445688999999999999999999999964
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.96 Aligned_cols=248 Identities=24% Similarity=0.442 Sum_probs=212.3
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..+|++.+.||+|.||.|-+|+. ..|+.||||.+++ .+.+..-.+++|++||..|+||||+.++.+|...+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999986 6799999999986 3567777899999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||..+|.|.+++.. ++.+++.+++++++||..|+.|+|.++ ++|||||.+|||||.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999954 445899999999999999999999998 99999999999999999999999999988765
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
..+ ..+.+|+|-|.+||++.+.+| .+.+|-|||||+||.|+.|..||+..+.......|. .+.
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------~Ga------ 269 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------RGA------ 269 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------ccc------
Confidence 443 456899999999999999998 588999999999999999999998766432221111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+.+ +.......-||+|||..+|++|-|+.+|..+-
T Consensus 270 --YrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 --YRE---PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --ccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 11222456789999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.40 Aligned_cols=283 Identities=22% Similarity=0.248 Sum_probs=214.0
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch--hhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE--QGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 358 (605)
..+.|+.+++|++|.||.||+|+++ ++..||+|+++...+ .-.-...+|+.+|.+++|||||.+-.+... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467899999999999999999984 488999999975322 222345789999999999999999888764 35689
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|||||++ +|..++.... +.+...++.-++.|+++|++|||.+. |+||||||+|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999976 4666664333 46888999999999999999999988 999999999999999999999999999998
Q ss_pred CCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
+... ...+..+-|..|+|||++.+. .|++++|+||+|||+.||+++++.|.....-+....|-.......+..+..+
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 7652 224456779999999999876 4999999999999999999999999877665554444443322222211111
Q ss_pred ccc--------------cccCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCCCCCCCcccc
Q 007397 518 IDA--------------CYQESCNPD-EVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLV 575 (605)
Q Consensus 518 ~d~--------------~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~~ 575 (605)
.+. .+...+... ....-.+|+...|..||.+|.|+++.++.=- ....|.|..|..+.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~-F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY-FRETPLPIDPSMFP 377 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc-cccCCCCCChhhcC
Confidence 110 011111111 2245567888899999999999999876521 25567777777653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.58 Aligned_cols=244 Identities=26% Similarity=0.387 Sum_probs=208.2
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCee
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 357 (605)
...++|.++++||+|.||+|+++..+. ++.+|||++++. .....+..+.|..|+.... ||.++.++.+|...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999854 789999999873 4567788889999988875 99999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+.||++..+ .+.+.+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999994333 34457999999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
-... ...+.+.+|||.|||||++.+..|+.++|.|||||+|||||.|..||...+.++.+..|..
T Consensus 518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------- 582 (694)
T KOG0694|consen 518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------- 582 (694)
T ss_pred cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 5432 3357789999999999999999999999999999999999999999998776555443331
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 552 (605)
.|. .++.-...+.+.++.++|..+|++|.-+
T Consensus 583 d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 2333445567889999999999999876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.49 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=210.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..|+..+.||+|.||.||+|.+. .++.||+|++.- ......+.+++|+.+|.+++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777899999999999999984 488999999974 4455678899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+.+|++.+.+. ....+++..+.-|+++++.||.|||+++ .+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3334577777789999999999999998 99999999999999999999999999988755443
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
. ..+.+|||.|||||++.+..|+.|+||||||++++||++|.+|+....+.....+| -....
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~P 228 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAP 228 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCC
Confidence 3 35688999999999999999999999999999999999999999877664332222 11111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..........+.+++..||+++|++||++.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222445568899999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.80 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=205.3
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc--------------hhhHHHHHHHHHHHHcCCCCceeeeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS--------------EQGLNELKNEVILFSKLQHRNLVKLLG 349 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 349 (605)
.++|++.+.||+|.||.|-+|+. .+++.||||++.+.. -...+...+|+.+|+++.|+|||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 47899999999999999999997 569999999997521 112457889999999999999999999
Q ss_pred eEEe--CCeeEEEEEeeCCCchhhHHhhcCccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 350 CCIQ--GEEKLLIYEFMPNKSLDYFIFDQTKREL-LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 350 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
+..+ .+..|||+|||..|.+...= ..+. +...++++++..++.||.|||.++ ||||||||+|+||+++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 9875 46789999999998875432 2233 899999999999999999999999 999999999999999999
Q ss_pred eEEeecCCCccCCC---CcccccccccccccCccchhcccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCch
Q 007397 427 PKISDFGLARTFGG---DEIEGSTNKVIGTYGYMAPEYATDGL----FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF 499 (605)
Q Consensus 427 vkl~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~ 499 (605)
|||+|||.+..+.. ..........+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||......+.+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999987622 12223344578999999999987632 357899999999999999999999754432222
Q ss_pred hHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 500 NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 500 ~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. .+++..+..+..+++..++.+||.++|++||+.|.+..+|..++
T Consensus 329 ~---------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 D---------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H---------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 12223333344456677889999999999999999999999887
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=345.70 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=213.3
Q ss_pred HHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 279 ATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
.......+.+.+...||+|.||+||+|++.. .||||++.. ...+..+.|++|+..+++-+|.||+-+.|++.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3344445667788999999999999999853 699999874 355678899999999999999999999999998887
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.+|..+|+|.+|..+++... ..++....+.|+.||++|+.|||.++ |||||||..||||.+++.|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 89999999999999996544 45889999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCcccccccccccccCccchhcccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDG---LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
....-.-........|...|||||+++.. +|+..+||||||+|+|||++|..||.....+.....+.+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr--------- 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR--------- 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc---------
Confidence 65433222223345578899999999753 689999999999999999999999985544443322221
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
-....|.. ....++..++.+|+..||.+++++||.+.+|+.+|+.+
T Consensus 608 G~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 608 GYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 10011111 12234566788999999999999999999999988775
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.91 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=203.0
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.|++.+.||+|+||+||++.+ .+++.||+|.+.+.. ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999987 568999999986432 2334467889999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988875432 235789999999999999999999998 9999999999999999999999999998753221
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .....
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~--------- 221 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR---VKEDQ--------- 221 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH---hhccc---------
Confidence 123356899999999999999999999999999999999999999865443222222111 11100
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
...+......+.+|+.+||+.+|++||+ +.++++.
T Consensus 222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112223446788999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=342.75 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=206.3
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||.||+|++.+ ++.||+|++.+.. ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999854 8999999997532 234567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999998543 35788999999999999999999998 99999999999999999999999999986533
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+........ .+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------RPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------CCC
Confidence 23346799999999999999999999999999999999999999976543322222211100000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. ..........+.+++.+||+.+|++||++.+|+++.
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0 000012345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=346.54 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=204.2
Q ss_pred hcCccccceecccCeEEEEEEEE------cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.++||+|+||.||+|+. ..+..||||+++.. .....+.+.+|+.+++.+ +||||+++++++..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999974 23568999999643 233456788999999999 89999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc----------------------------------------------------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK---------------------------------------------------------- 378 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 378 (605)
.++||||+++|+|..++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854221
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 379 --------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 379 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788889999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......++..|+|||++.+..++.++|||||||++|||++ |..||........ .. .....+...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~----~~~~~~~~~-------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FY----KMIKEGYRM-------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HH----HHHHhCccC--------
Confidence 22222345678999999999999999999999999999998 8888865432211 11 111111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+.....++.+|+.+||+.+|++||++.+|+++|+.
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=346.58 Aligned_cols=259 Identities=31% Similarity=0.455 Sum_probs=204.5
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++++ +|+||+++++.+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999998752 2457999999753 334456788999999999 89999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc----------------------------------------------------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK---------------------------------------------------------- 378 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 378 (605)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 379 ---------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 379 ---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
...+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124778889999999999999999998 99999999999999999999999999986543322112222
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNP 528 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~ 528 (605)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||.......... .....+.. ...+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~------~~~~~~~~---------~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY------KMVKRGYQ---------MSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH------HHHHcccC---------ccCCC
Confidence 345678999999999999999999999999999997 999987543322111 11111110 00111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 529 DEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 529 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.....+.+++.+||+.+|++||++.+|+++|+.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=339.37 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=202.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++.+. .....+.+.+|+.++++++||||+++++.+..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999985 4899999998653 223456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999988543 35788899999999999999999998 99999999999999999999999999987533
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... ...+..
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~----i~~~~~------ 232 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEK----ILAGRL------ 232 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHH----HhcCCc------
Confidence 2 22357999999999999999999999999999999999999999643321 11111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..+......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112345779999999999999997 6888765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.39 Aligned_cols=244 Identities=19% Similarity=0.301 Sum_probs=198.2
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccch---hhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeEEEEEee
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE---QGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 364 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 364 (605)
..||+|++|.||+|.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 789999999976432 225778899999999999999999999877 34678999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999998543 3578899999999999999999984 6 8899999999999999999999999998653321
Q ss_pred cccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+. .... ...+..
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~i---~~~~~~------- 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDLI---INKNNS------- 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---HhcCCC-------
Confidence 23468899999999976 6799999999999999999999999975432211 1111 011110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 241 --~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 --LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111222345688999999999999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.46 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=202.5
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999985 5899999998642 2234566889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999988543 35788999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .+..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-------AGKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCc-------
Confidence 223568999999999999999999999999999999999999997543221111111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILML 559 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 559 (605)
..+......+.+|+.+||+.||.+||+ +++++++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 111122345789999999999999995 88888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.80 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=203.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.+.||+|+||+||++++. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999985 4789999998643 23345678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|++++.+..+... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999887765422 235888999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------hhh-cCC
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN--------LWN-KGM 513 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~--------~~~-~~~ 513 (605)
. .......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+..... .+. ...
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122345689999999999998899999999999999999999999976443222111111100 000 000
Q ss_pred CcccccccccC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQE------SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......+.... .........+.+|+.+||+.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0111134568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.48 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=206.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||++++. ++..+|+|.+... .....+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999985 4888999998753 34456679999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999998543 34789999999999999999999853 3999999999999999999999999998765332
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC--------
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP-------- 514 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~-------- 514 (605)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+............
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 223456899999999999999999999999999999999999999654332111110000000000000
Q ss_pred -------------------cccccccc----cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 -------------------WQLIDACY----QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 -------------------~~l~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+.+... ..........++.+|+.+||+.+|++|||+.+|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 0001112345788999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.84 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=208.8
Q ss_pred cCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++|++.+.||+|+||.||+|.+.. .+.+|+|.+... .......+.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 257999998643 3345567899999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 359 LIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
++|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 007397 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~ 504 (605)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 999999999986543332223334557889999999998899999999999999999998 999987544322111
Q ss_pred HHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 505 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+..+... ..+.....++.+|+.+||+.+|++||++.+|+++|+.
T Consensus 238 ---~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1223345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=337.43 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=217.6
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe-eEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 360 (605)
.++|..++++|+|+||.+++.++ .+++.+|+|.+.- ......+...+|+.++++++|||||.+.+.+.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 36799999999999999999987 4588999999863 344445578899999999999999999999999888 8999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|+|++||++.+.+..+. +..++++.+..++.||+.|+.|||++. |+|||||+.|||++.++.|||.|||+|+....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997654 567999999999999999999999887 99999999999999999999999999999865
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
+. .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+...
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~--------------- 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG--------------- 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc---------------
Confidence 54 2345688999999999999999999999999999999999999999876654433322211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...+.+.....++..++..||+.+|+.||++.+|+.+.
T Consensus 222 -~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 222 -LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 12344556677889999999999999999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.87 Aligned_cols=242 Identities=20% Similarity=0.255 Sum_probs=196.9
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.||+|+||.||++++. +++.||+|++.+. .......+.+|+.++++++||||+++++.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 5899999998753 2334456788999999999999999999999999999999999999
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccc
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 447 (605)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 998888543 35889999999999999999999998 9999999999999999999999999987542211 123
Q ss_pred cccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCC
Q 007397 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN 527 (605)
Q Consensus 448 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~ 527 (605)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... .... ..... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~----~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI----LMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHH----HcCCC----------CCC
Confidence 346799999999999999999999999999999999999999965332111 1111 01110 111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 528 PDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 528 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22344678899999999999999 79999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.49 Aligned_cols=240 Identities=28% Similarity=0.454 Sum_probs=201.1
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchh
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 370 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~ 370 (605)
++-||+|+.|.||+|++ .++.||||+++... ..+++-|++|+|+|||.+.|+|...-.++||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 36799999999999998 57899999986422 24788899999999999999999999999999999999999
Q ss_pred hHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccccccc
Q 007397 371 YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450 (605)
Q Consensus 371 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 450 (605)
..|.. +..+.......+..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++..... ...-..
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99944 345777888899999999999999998 999999999999999999999999999876433 223346
Q ss_pred ccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHH
Q 007397 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDE 530 (605)
Q Consensus 451 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 530 (605)
+||..|||||++.+.+.++|+|||||||||||||||..|+...+..... |.. + .-.+.-..+..+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------wGV---G------sNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------WGV---G------SNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------Eec---c------CCcccccCcccC
Confidence 8999999999999999999999999999999999999999765433221 111 1 112223445556
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 531 VIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 531 ~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+..+.-|+..||+..|.+||++.+++.+|.-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 66788889999999999999999999999654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.27 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=208.9
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcc--ccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..+.|++.+.||+|.|+.|++..+ ..|+.+|+|++. +.+..+.+++.+|+.|-+.|+||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 457899999999999999999876 569999999875 34555888999999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla~~ 437 (605)
+|+|.|+.|..-|-. +..+++..+-+.+.||++||.|+|.++ |||||+||+|+||-+. .-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998765533 256788889999999999999999999 9999999999999543 4599999999998
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... ......|||+|||||++...+|+..+|||+.|||||-||.|.+||...+....++.|....--
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd--------- 230 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD--------- 230 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC---------
Confidence 86322 234567999999999999999999999999999999999999999875554444433321110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.....+...++..+|+.+||..||.+|.|+.|.+.+
T Consensus 231 ----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 ----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1112223334567799999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.43 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=201.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||+||+|++. +++.||+|++.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999884 58899999986432 23345678999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 787777443 235788999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH-----hhhcCC----
Q 007397 444 EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN-----LWNKGM---- 513 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~-----~~~~~~---- 513 (605)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+..... .++.-.
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11233568999999999875 5689999999999999999999999976544332222221111 000000
Q ss_pred CcccccccccCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQES----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......+..... .......++.+|+.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.24 Aligned_cols=256 Identities=27% Similarity=0.335 Sum_probs=216.5
Q ss_pred cCccccceecccCeEEEEEEEEcCC-cEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeee-eEEe------CCe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDG-QEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLG-CCIQ------GEE 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~~ 356 (605)
.+++|.+.|.+|||+.||+|.+..+ .++|+|++-..++...+.+++|+.+|++|. |+|||.+++ .... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4577889999999999999999776 999999998778999999999999999997 999999999 3332 135
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
++|+||||.+|.|-+++....... |.+.++++|+.++++|+++||... .+|||||||-|||||+.+++.||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 679999999999999986654443 999999999999999999999985 789999999999999999999999999987
Q ss_pred cCCCCcccccc-------cccccccCccchhcc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 437 TFGGDEIEGST-------NKVIGTYGYMAPEYA---TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 437 ~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
........... -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------- 261 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------- 261 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-------------
Confidence 64322211000 012258999999986 5778999999999999999999999999742
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+++..+..+-.+....++.+||..||+.+|++||++-+|+..+-..
T Consensus 262 ------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 262 ------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 23467777777777788999999999999999999999999999987554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=324.04 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=206.6
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-----CCee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-----GEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 357 (605)
..|...+.||+|+||.|..+.+ .+|+.||||++.. ......+...+|+.+|+.++|+||+.+++++.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4566679999999999999998 4589999999973 345556778899999999999999999999875 3567
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
|+|+|+| +.+|...+.. +..++...+..++.||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+|+.
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 6677777743 334889999999999999999999999 99999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
..........+.++.|..|+|||++.. ..|+.+.||||+|||+.||++|++.|.+.+..+...+|........+.....
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 864433334467888999999998764 6799999999999999999999999988766544444432211110000000
Q ss_pred cc--------ccccc------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 517 LI--------DACYQ------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 517 l~--------d~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+- ..... ...-+......++|+.+||..||.+|+|++|.++..
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 00 00000 000112234577899999999999999999999865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=304.28 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=211.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|-||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 478999999999999999999974 4778999999763 334556789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
+||.+.|.+...|.... ...+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999996433 335788888999999999999999988 9999999999999999999999999987642
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.....+.+||..|+|||...+..++.++|+|++|++.||++.|.+||.....++.+..|....-.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------------ 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------------ 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc------------
Confidence 23345689999999999999999999999999999999999999999876655444444432111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+......+.++|.+|+..+|.+|.+..||+..
T Consensus 241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 112233467899999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.90 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=207.2
Q ss_pred cCccccceecccCeEEEEEEEEcC------CcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++|.+.+.||+|+||.||+|.+.+ ++.||+|.+...... ....+.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998743 478999999764333 5678999999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 359 LIYEFMPNKSLDYFIFDQT-----------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 2345788899999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....... .+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence 9999999976533322222233446789999999999999999999999999999998 999986543322 11111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+.... .+......+.+++.+||+.+|++||++.||++.|+
T Consensus 238 ---~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11123356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=349.88 Aligned_cols=252 Identities=17% Similarity=0.211 Sum_probs=205.5
Q ss_pred CccccceecccCeEEEEEEEEcC--CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD--GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.|.+.+.||+|+||.||+|.... ++.||+|.+..........+++|+.+++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48999999999999999998743 5788999876555556667889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 365 PNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 365 ~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
++++|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888643 23446889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.... .+...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~----~~~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVL----YGKYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCCC--------
Confidence 22234567999999999999999999999999999999999999998643321 1111111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111122346889999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=322.38 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=204.1
Q ss_pred cCccccceecccCeEEEEEEEEc----CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.++++++||||+++++++..+...++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56899999999999999999763 3578999998754 334456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|++++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999986532 35889999999999999999999998 99999999999999999999999998765422
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... .+.. ...+..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~~~----- 226 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----VEDGFR----- 226 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHCCCC-----
Confidence 211 11112345678999999999999999999999999999775 999986543221 1111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+.+......+.+++..||+.+|++||++.+|++.|..
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11122344568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=323.00 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=211.7
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
..+|++.++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45689999999999999999999889999999998766656778999999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996543 345789999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+ .+.... .+. .
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~---------~ 222 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT----AGY---------R 222 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH----hCC---------c
Confidence 123345778999999998899999999999999999998 888886543221 111111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11223334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.41 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=204.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccch--hhHHHHHHHHHHHHcCCCCc-eeeeeeeEEeCC-----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISE--QGLNELKNEVILFSKLQHRN-LVKLLGCCIQGE----- 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 355 (605)
...|..+++||+|+||+||+|+. .+|+.||+|+++-..+ .......+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788999999999999997 5589999999975332 34556789999999999999 999999998877
Q ss_pred -eeEEEEEeeCCCchhhHHhhcCcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 356 -EKLLIYEFMPNKSLDYFIFDQTKR-ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 356 -~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
..++||||++. +|..++...... ..++...++.++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999954 666776544321 34666889999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh--
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN-- 510 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~-- 510 (605)
+|+.+.-+.. .....++|..|+|||++.+. .|+...||||+|||++||+++++.|..... ...+..+...+.
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence 9997753322 24456789999999999887 799999999999999999999999887665 333333332221
Q ss_pred -cCCCcccc---cc--cccCCC-----C---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 -KGMPWQLI---DA--CYQESC-----N---PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 -~~~~~~l~---d~--~~~~~~-----~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+..+..+. +- ...... . +.......+++.+||+.+|.+|.|+..++.+-
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 11111111 11 011000 0 11113677899999999999999999999873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.96 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=214.2
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----eeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 358 (605)
.++|.+.++||+|||+-||+++. .+++.||+|++.-...+..+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 47899999999999999999986 558999999998777788899999999999999999999999876544 489
Q ss_pred EEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 359 LIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++++|...|+|.+.+.... ++..+++.+.++|+.+|++||++||+.. .++.||||||.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999998886543 4558999999999999999999999986 4799999999999999999999999999876
Q ss_pred CCCCcccc-------cccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 438 FGGDEIEG-------STNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 438 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
..-..... ......-|..|+|||.+. +...++++|||||||+||+|+.|..||+.......
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--------- 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--------- 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC---------
Confidence 53111000 011234688999999985 44578999999999999999999999964222110
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.-...+..+.+.-+......+.+.+++.+|||.||.+||++.+++..+..+
T Consensus 250 ----SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ----SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011123333444444445778899999999999999999999999988754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=320.42 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=207.2
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3678999999999999999999888899999998653 234578899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999886542 345788899999999999999999988 999999999999999999999999999876433211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..... ......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~-------- 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGYRM-------- 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCC--------
Confidence 1222345678999999998889999999999999999998 999986533221 11111 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+........+.+++.+||+.+|++||++++++++|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=340.15 Aligned_cols=260 Identities=30% Similarity=0.419 Sum_probs=206.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 356 (605)
.++|++.++||+|+||.||+|++.. +..||||++... .....+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5689999999999999999998632 347999999753 3344567899999999996 9999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc----------------------------------------------------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK---------------------------------------------------------- 378 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 378 (605)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988854210
Q ss_pred -----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC
Q 007397 379 -----------------------------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH 423 (605)
Q Consensus 379 -----------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~ 423 (605)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 007397 424 DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 424 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i 502 (605)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence 99999999999987643322222333457788999999999899999999999999999997 88888654322111 1
Q ss_pred HHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 503 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.....+.. ...+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 351 ----~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 ----NKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ----HHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111111 011223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.22 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=209.3
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999752 245689999987666677789999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 360 IYEFMPNKSLDYFIFDQT----------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~---- 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC---- 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----
Confidence 99999986643322222233446788999999999899999999999999999998 888886543221 1111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+..... +......+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus 235 i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111111111 111234588999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=323.71 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=204.4
Q ss_pred HhcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
..++|++.++||+|+||.||+|.+. .+..+|+|++... ......++.+|+.+++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 2467999998643 23345678899999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK-------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234578888999999999999999988 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----
Confidence 99999876543322222222345788999999998899999999999999999999 68887643321 11111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
........ .+......+.+++.+||+.+|++||++.|++++|+.
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.92 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=198.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999985 58999999987532 2233467789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++ +|.+++... ...++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9964 565555432 235788899999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---Cc---
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM---PW--- 515 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~---~~--- 515 (605)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+......+.... ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 12233568999999999875 4588999999999999999999999975432 1122222111111000 00
Q ss_pred ---cccccccc--CCCC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 ---QLIDACYQ--ESCN-------PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 ---~l~d~~~~--~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
........ .... ......+.+|+.+||+.||++|||+.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 00000000 0000 01124577899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.01 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=198.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.|+++++||+|+||+||+|++. +++.||+|++.+. .......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999874 4889999999653 23445678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999988543 35788899999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cccccccccccCccchhcccCCCCCcccchHHHH
Q 007397 443 I---------------------------------------------EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFG 477 (605)
Q Consensus 443 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG 477 (605)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHH--hcCCCCCCCCCHHHH
Q 007397 478 ILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLL--CVQHHPEDRPSMPSV 555 (605)
Q Consensus 478 vvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt~~ev 555 (605)
|++|||++|..||......+....+. .+ .....+ +........+.+++.+ |+..++..||++.+|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~----~~--~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVI----NW--ENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHH----cc--ccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999997654322111111 00 000000 0111123356677766 556667779999999
Q ss_pred HHHh
Q 007397 556 ILML 559 (605)
Q Consensus 556 l~~L 559 (605)
+.+-
T Consensus 303 l~hp 306 (381)
T cd05626 303 KAHP 306 (381)
T ss_pred hcCc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.35 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=202.6
Q ss_pred hcCccccceecccCeEEEEEEEEcC--CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD--GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|.+.. +..||+|++.+. .......+.+|+.+++.++||||+++++++..+...++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998644 368999998642 23345678899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998543 35889999999999999999999998 9999999999999999999999999998653
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||...+... ..... ..+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i----~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKI----LEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHH----hcCCC-----
Confidence 22 234679999999999999889999999999999999999999997543221 11111 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+......+.+++.+||+.+|++|+ ++++++++.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 01112234577899999999999995 899998863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=331.69 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=193.8
Q ss_pred ecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||.||+|++.+ ++.||+|++.+. .......+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999854 789999998652 334456778899999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9988543 34889999999999999999999998 9999999999999999999999999997643221 12334
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
..||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... .. .... ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~---~~-~~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRK---IL-QEPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHH---HH-cCCC----------CCCCc
Confidence 67999999999999999999999999999999999999999753321 11111 11 1110 11122
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSM---PSVILM 558 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~---~evl~~ 558 (605)
....+.+++.+||+.+|++||++ .+++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 33467899999999999999864 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.56 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=196.0
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.||+|+||.||++++. +|+.||+|++.+. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999974 5899999998753 2334556778999999999999999999999999999999999999
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccc
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 447 (605)
+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 998887543 35889999999999999999999998 9999999999999999999999999987542221 112
Q ss_pred cccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCC
Q 007397 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN 527 (605)
Q Consensus 448 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~ 527 (605)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... .. .. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~~---~~-~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL---ME-EI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHh---cC-CC----------CCC
Confidence 345699999999999999999999999999999999999999965433211 11110 00 00 011
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 528 PDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 528 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
......+.+++.+||+.+|++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12234677899999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.15 Aligned_cols=255 Identities=30% Similarity=0.473 Sum_probs=206.8
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35789999999999999999998778899999986533 34567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345789999999999999999999998 999999999999999999999999999876532211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+..|+|||++.+..++.++||||||++++||++ |+.||...... ..+... .....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~--------- 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQV----DQGYR--------- 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCC---------
Confidence 1111223458999999999899999999999999999999 99888643321 111111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=325.80 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=210.9
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999752 356789999876666666789999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 360 IYEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1235789999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHH
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHA 505 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~ 505 (605)
+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||....... .+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999976543322222334556889999999999999999999999999999999 999986543321 111
Q ss_pred HHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 506 WNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 506 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
....+..... .......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 237 --~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 237 --CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred --HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1122222111 1123456889999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.47 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.+.||+|+||.||++...++..+|+|.+... ......+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999988889999988643 2334678899999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999885432 35889999999999999999999998 9999999999999999999999999988654322211
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...+.. ..+.... .+.. ...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~----~~~~--~~~----- 222 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMIS----RGFR--LYR----- 222 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCC--CCC-----
Confidence 122335668999999998889999999999999999999 88888654321 1122111 1110 000
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
+......+.+++.+||+.+|++||++.+|+++|.
T Consensus 223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.50 Aligned_cols=258 Identities=32% Similarity=0.536 Sum_probs=213.9
Q ss_pred cCccccceecccCeEEEEEEEEcC--Cc----EEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD--GQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++.+..+.||+|+||.||.|...+ +. .||||.+.+. +.+...+|.+|+.+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455667899999999999998744 43 4899999874 6677889999999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 359 LIYEFMPNKSLDYFIFDQT----KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
+++|||.+|+|..+|++.. ....+.....+.++.+||+|+.||++++ +|||||..+|+||+....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997752 2456889999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
|+.+...++-.......-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+... .....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-
Confidence 996654443333333344578999999999999999999999999999999 888887544322211 111222
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+-+.+..+...+.+||..||+.+|++||++..|++.+..+
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1133455667889999999999999999999999988666
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.43 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=196.3
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||++.+. .++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 48999999997532 334467888999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998543 45889999999999999999999998 999999999999999999999999998764321
Q ss_pred cc---------------------------------cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCC
Q 007397 442 EI---------------------------------EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488 (605)
Q Consensus 442 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~ 488 (605)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 007397 489 NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQ--HHPEDRPSMPSVILM 558 (605)
Q Consensus 489 p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~--~dP~~RPt~~evl~~ 558 (605)
||......+....+. . +... ..+ ... ......+.+++.+++. .++..||++.||+++
T Consensus 235 Pf~~~~~~~~~~~i~---~-~~~~--~~~-----p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVM---N-WKET--LIF-----PPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHH---c-CcCc--ccC-----CCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 997544322111111 0 0000 000 000 0112345566665443 344456899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.28 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.||+|+||.||++.+. +++.||+|++.+. .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999974 5899999999753 2344567788999999999999999999999999999999999999
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccc
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 447 (605)
+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 998887443 35889999999999999999999998 9999999999999999999999999987642221 122
Q ss_pred cccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCC
Q 007397 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN 527 (605)
Q Consensus 448 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~ 527 (605)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..... . .... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~---~-~~~~----------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---L-MEDI----------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHh---c-cCCc----------cCC
Confidence 34579999999999999999999999999999999999999996533211 11111 0 0000 111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 528 PDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 528 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22334678899999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.22 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=190.6
Q ss_pred ceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHc-CCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|++.+ ++.||+|++.+. .......+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999854 789999998753 22334455566667665 4899999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 35888999999999999999999998 9999999999999999999999999997643222 22
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+... .+... ..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i----~~~~~----------~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSI----LNDRP----------HF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCCC----------CC
Confidence 334679999999999999999999999999999999999999997544221 11111 11110 11
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMP-SVIL 557 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 557 (605)
+......+.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 122234577899999999999999976 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=336.58 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=200.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||+|++. +++.||||++.+. .......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999985 5899999999753 2334566788999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999988543 35899999999999999999999998 999999999999999999999999998764321
Q ss_pred ccc------------------------------------ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh
Q 007397 442 EIE------------------------------------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485 (605)
Q Consensus 442 ~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt 485 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 00112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 007397 486 GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS---MPSVILM 558 (605)
Q Consensus 486 G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 558 (605)
|..||........ +.... .+. ....+. ........+.+++.+|+. +|.+|++ +.+++++
T Consensus 235 G~~Pf~~~~~~~~---~~~i~-~~~--~~~~~~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET---YRKII-NWK--ETLQFP-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH---HHHHH-cCC--CccCCC-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999975443211 11111 010 000110 011123456788888996 9999998 8888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.47 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=205.1
Q ss_pred cCccccceecccCeEEEEEEEE-----cCCcEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+.|++.++||+|+||+||+|.. ..++.+|+|.+.. ........+.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999985 2467899999975 334455778899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 360 IYEFMPNKSLDYFIFDQT--------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999885322 1235788899999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 007397 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~ 504 (605)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999987643332222333446778999999998889999999999999999998 88888643321 11111
Q ss_pred HHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 505 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
. ...... ..+......+.+++.+||+.+|++||++.+|+++|..
T Consensus 239 ~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111 1111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.45 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=202.3
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||++.+. +++.||+|++.+. .......+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999984 5899999999753 2234567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998654 235889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT------DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ +.. ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~---i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNN---IMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHH---HHcCCCcc
Confidence 221 222346899999999986 45678999999999999999999999965433211 111 11111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. +..+.....+.+|+..||+ +|++||++.++++.
T Consensus 229 ~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 10 1111233457789999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=326.13 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=195.5
Q ss_pred cCccccceecccCeEEEEEEEEc--CCcEEEEEEccccc--hhhHHHHHHHHHHHHcC---CCCceeeeeeeEEe-----
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEIAVKRLSKIS--EQGLNELKNEVILFSKL---QHRNLVKLLGCCIQ----- 353 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 353 (605)
++|++.++||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999873 36889999886422 22234455677776665 69999999998853
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
....++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456789999997 57877775432 234789999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99875432 223345689999999999988999999999999999999999999976544322222221110000000
Q ss_pred Ccc---ccccccc--C-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQ---LIDACYQ--E-----SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~---l~d~~~~--~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... +....+. . ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000000 0 0111233456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.40 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=205.8
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||+|++. +++.||+|++.+. .......+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 5899999999753 2244567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 45889999999999999999999998 999999999999999999999999999876433
Q ss_pred c---------------------------ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 007397 442 E---------------------------IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494 (605)
Q Consensus 442 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 494 (605)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234569999999999999999999999999999999999999997654
Q ss_pred CCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHh
Q 007397 495 SDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-MPSVILML 559 (605)
Q Consensus 495 ~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~L 559 (605)
.......+. . +... +..+........+.+++..||+ +|.+||+ +.++++..
T Consensus 235 ~~~~~~~i~---~-~~~~---------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKII---N-WKES---------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHh---c-cCCc---------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 221111111 0 0000 0001111134567889999997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.41 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=203.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999985 5888999988653 34455678999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999998543 34788999999999999999999742 3999999999999999999999999998765322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh-------------
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW------------- 509 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~------------- 509 (605)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.......
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1233568999999999999899999999999999999999999987543221111000000000
Q ss_pred --------hcCC----CcccccccccCC---C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 --------NKGM----PWQLIDACYQES---C-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 --------~~~~----~~~l~d~~~~~~---~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ...+.+...... . ......++.+|+.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000 000000000000 0 00123467899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.64 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=206.8
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE---- 355 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 355 (605)
...++|.+.++||+|+||+||+|++ .+++.||||++... .......+.+|+.++..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999987 45899999998642 4455677889999999999999999988775432
Q ss_pred ----eeEEEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 356 ----EKLLIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 356 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999886532 3456889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~----~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKT----L 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----h
Confidence 999998765433233334567999999999999999999999999999999999999999653321 111111 1
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.. ...+......+.+++.+||+.+|++||++.+++.+
T Consensus 259 ~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 01122234568899999999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.44 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=204.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEccccc-hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe-CC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKIS-EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ-GE 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 355 (605)
.++|++.+.||+|+||.||+|.+.+ ++.||+|++.... ......+..|+.+++++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4679999999999999999996422 4789999987532 33456678899999999 79999999998865 45
Q ss_pred eeEEEEEeeCCCchhhHHhhcCc---------------------------------------------------------
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTK--------------------------------------------------------- 378 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 378 (605)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998854221
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCcc
Q 007397 379 -RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457 (605)
Q Consensus 379 -~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 457 (605)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 135789999999999999999999998 9999999999999999999999999998764332222233345678899
Q ss_pred chhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHH
Q 007397 458 APEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIH 536 (605)
Q Consensus 458 aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~ 536 (605)
|||++.+..++.++|||||||++|||++ |..||......+. + ......+... ..+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~---~~~~~~~~~~---------~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F---CRRLKEGTRM---------RAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H---HHHHhccCCC---------CCCccCCHHHHH
Confidence 9999999999999999999999999998 9999865332221 1 1111111111 111123356889
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 537 ISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 537 li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
++.+||+.+|++||++.+|+++|...
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.80 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=196.3
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----CeeE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EEKL 358 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 358 (605)
+|++.++||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999974 5899999998642 223445688999999999999999999988643 2479
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+. ++|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 5787777432 35889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-cccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------H
Q 007397 439 GGDEI-EGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------N 507 (605)
Q Consensus 439 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~ 507 (605)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+.......+.... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234579999999999876 678999999999999999999999996543221111111000 0
Q ss_pred hhhcCCCccccccccc-CC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGMPWQLIDACYQ-ES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~-~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+........++.... .. ..+.....+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 00 001123457799999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=334.67 Aligned_cols=261 Identities=19% Similarity=0.229 Sum_probs=196.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+|++.++||+|+||.||++.+. .++.||+|.... ..+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 468999999999999999999984 488999997542 3467899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 5677666432 34789999999999999999999998 9999999999999999999999999997542211
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC----chhHHHHHHHhhh---cCCCc-
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN----KFNVIRHAWNLWN---KGMPW- 515 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~----~~~~i~~~~~~~~---~~~~~- 515 (605)
........||+.|+|||++.+..++.++|||||||++|||++|..|+....... ....+........ .....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112234579999999999999999999999999999999999998865432110 0111111111000 00000
Q ss_pred --ccccccc----------cCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 --QLIDACY----------QESC-----NPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 --~l~d~~~----------~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..++..+ .... .......+.+|+.+||+.||++|||+.|+++.-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000000 0000 012345688999999999999999999999753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.23 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=195.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|+..++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677899999999999999974 5899999998653 334456789999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986432 3466778889999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||................ ....
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~---- 293 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQP---- 293 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccCC----
Confidence 11234579999999998743 234568999999999999999999997433222211111110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..........+.+|+.+||+.+|++||++.||+++
T Consensus 294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122334568899999999999999999999986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.61 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=200.5
Q ss_pred CccccceecccCeEEEEEEEEc----CCcEEEEEEcccc----chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI----SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
+|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999863 4789999998652 223345678899999999 599999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988543 35889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... . ..
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~-~~---- 226 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--L-KC---- 226 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--h-cC----
Confidence 533221 122345799999999999865 47899999999999999999999997554333322222111 1 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
+. ..+......+.+++.+||+.||++|| ++++++++
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 11122234577899999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.15 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=204.8
Q ss_pred cCccccceecccCeEEEEEEEEcC------CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.+|.+.++||+|+||.||+|...+ ++.||+|++.... ....+.+.+|+.++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998643 5789999997543 334567889999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 359 LIYEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
+++||+++++|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999884321 1235788889999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 007397 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~ 504 (605)
.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+......+. +.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IE- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 999999999887643332222333456789999999988889999999999999999998 8878765432211 11
Q ss_pred HHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 505 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
........ ..+......+.+|+..||+.+|++||++.+|++.|+.
T Consensus 238 ---~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ---MIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1122334557899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=317.85 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=205.5
Q ss_pred cCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||+||+|.+.. ...||+|.+... .......+.+|+.++++++|+||+++++.+......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998743 457999998753 344456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986533 36889999999999999999999988 99999999999999999999999999988752
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----
Confidence 222222222345678999999998899999999999999999998 99888543321 111111 111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+.+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.81 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=195.6
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHH---HcCCCCceeeeeeeEEeCCeeEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
|++.+.||+|+||.||+|.+. +++.||||++.+.. ....+.+..|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999874 58999999997532 23345566666655 567899999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887732 35899999999999999999999998 99999999999999999999999999875422
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.... +... .....
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i----~~~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSI----VNDEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC------
Confidence 11 223346799999999999999999999999999999999999999975432211 1111 11111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+......+.+++.+||+.+|.+|| ++.++++..
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 01112234578899999999999999 577777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=321.68 Aligned_cols=250 Identities=35% Similarity=0.572 Sum_probs=195.8
Q ss_pred ccceecccCeEEEEEEEEc-----CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 290 INNKLGEGGFGRVYKGTLV-----DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|+..+++++||||+++++++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4588999999999999986 2678999999653 444578899999999999999999999999988889999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ....+++..+..++.||++||.|||+.+ |+|++|+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999665 2345899999999999999999999998 99999999999999999999999999987633322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
............|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...+... ..+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~----~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL----KQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH----HTTEE--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----ccccc--------
Confidence 222333456789999999999889999999999999999999 6788754422 2222211 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...+......+.+++..||+.+|++||++.+|++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222345688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.36 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=204.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC---------------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD---------------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLL 348 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 348 (605)
.++|++.++||+|+||.||+++... ...||+|.+... .......+.+|+.++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999987632 235899998753 344556789999999999999999999
Q ss_pred eeEEeCCeeEEEEEeeCCCchhhHHhhcCc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCE
Q 007397 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTK---------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419 (605)
Q Consensus 349 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NI 419 (605)
+++......++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999998854321 123678899999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCC
Q 007397 420 LLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDN 497 (605)
Q Consensus 420 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~~~~ 497 (605)
+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++++|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322222233445778999999998899999999999999999998 555665433222
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+......+........ ...+......+.+|+.+||+.+|++||++.+|++.|..
T Consensus 241 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 22211111111110000 01112233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.64 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=202.9
Q ss_pred cCccccceecccCeEEEEEEEEcC-Cc----EEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.+|++.+.||+|+||.||+|.+.. +. .||+|.+... ......++.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 569999999999999999998633 33 4899998753 345567788999999999999999999998764 5779
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999886543 34788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
............++..|+|||++.+..++.++|||||||++|||++ |..||......+ +. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~---~~~~~~~~~--- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS---SILEKGERL--- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HH---HHHhCCCCC---
Confidence 4332222223345678999999999999999999999999999998 999986533211 11 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+..+...+.+++.+||+.+|++||++.+|+..|...
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112234678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.46 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=197.5
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+|+++++||+|+||.||+|++. .++.||+|++.+.. ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999974 48999999986532 2335568899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998543 35788899999999999999999998 9999999999999999999999999985432100
Q ss_pred -----------------------------------------ccccccccccccCccchhcccCCCCCcccchHHHHHHHH
Q 007397 443 -----------------------------------------IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVL 481 (605)
Q Consensus 443 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ 481 (605)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHH
Q 007397 482 EIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP---SMPSVILM 558 (605)
Q Consensus 482 elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~evl~~ 558 (605)
||++|+.||......+....+. .+... +...........+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~----~~~~~---------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVI----NWETT---------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHh----ccCcc---------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999997654322111110 01000 000111112334566777766 4999999 88999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.35 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=203.7
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.+.||+|+||+||+|+..++..+|+|.+... ....+.+.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 468889999999999999998877778999998743 2334678999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 9999998865332 5899999999999999999999998 999999999999999999999999998865433221
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..... ..+...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~--------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQGLRL--------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hcCCCC---------
Confidence 1112335678999999998889999999999999999998 999986544321 11111 111110
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.........+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.94 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=198.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||++... +++.||||++.+. .......+++|+.++++++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999874 5899999998653 2334567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988543 45788999999999999999999998 999999999999999999999999999643211
Q ss_pred ccc---------------------------------------------ccccccccccCccchhcccCCCCCcccchHHH
Q 007397 442 EIE---------------------------------------------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSF 476 (605)
Q Consensus 442 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSl 476 (605)
... ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHH
Q 007397 477 GILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDR---PSMP 553 (605)
Q Consensus 477 Gvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~ 553 (605)
||++|||++|..||......+. ...... +. ....+.+ .......+.+++.+||+ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~---~~~i~~-~~--~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET---YRKIIN-WR--ETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH---HHHHHc-cC--CccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999975443211 111110 00 0001100 11123457789999997 66665 5999
Q ss_pred HHHHHh
Q 007397 554 SVILML 559 (605)
Q Consensus 554 evl~~L 559 (605)
+++.+.
T Consensus 301 ~~l~hp 306 (377)
T cd05629 301 EIKSHP 306 (377)
T ss_pred HHhcCC
Confidence 998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=314.10 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=197.5
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
++||+|+||.||+|++. +++.+|+|.+... .......+.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999984 6899999988643 344567789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988543 235789999999999999999999998 99999999999999999999999999876432211111111
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNP 528 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~ 528 (605)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+........ .. ...... ....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~----~~~~~~---------~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---RE----AIEQGV---------RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HH----HHHcCC---------CCCCcc
Confidence 223467999999999899999999999999999998 8888764332111 11 111111 011122
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 529 DEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 529 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.....+.+++.+||+.+|++||++.+|+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.95 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=208.1
Q ss_pred cCccccceecccCeEEEEEEEEcC--C--cE-EEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD--G--QE-IAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
++-.+.++||+|+||.||+|++.. + .. ||+|..+. .......++.+|++++++++|+|||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556999999999999998743 2 23 89998874 4567788999999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++|||+|.||+|+++|..... .++..+...++.+.|.||+|||+++ +|||||-.+|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999966543 5899999999999999999999998 99999999999999999999999999886
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
-.. +........-...|+|||.+....|+.++|||||||++||+++ |..|+......+....+ ..++.
T Consensus 312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------~~~~~--- 380 (474)
T KOG0194|consen 312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------VKNGY--- 380 (474)
T ss_pred Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH------HhcCc---
Confidence 531 1111112234678999999999999999999999999999999 88888765433222211 11121
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
....+...+..+..++..||+.+|++||+|.++.+.|+....
T Consensus 381 ------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 381 ------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred ------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 112233445567778889999999999999999999987643
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=316.21 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=205.3
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.+|.+.++||+|+||.||+|...+ ++.+|+|++... ......+.+|+.++++++|+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457888999999999999998754 889999998753 334567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885432 345789999999999999999999998 999999999999999999999999999876443221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+++.|+|||++.+..++.++|||||||++|||++ |..|+......+. +........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--------- 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGYR--------- 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC---------
Confidence 1112234668999999999999999999999999999998 8888865332211 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11122234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.90 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=216.4
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccch---hhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCee
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISE---QGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 357 (605)
...+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+++.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345689999999999999999999866 99999999976433 34578999999999998 99999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC----CceEEeecC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD----MNPKISDFG 433 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~----~~vkl~DFG 433 (605)
++|||++.||.|.+.+... .+++..+..++.||+.|+.|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998665 2899999999999999999999998 9999999999999643 479999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+.. +.
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------~~ 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------GD 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------CC
Confidence 9998765 3346678999999999999999999999999999999999999999987665544432221 11
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .+..+........+.+++..++..||..|+|+.+++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 12233344456678899999999999999999999996
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=320.98 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=208.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC-----------------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVK 346 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 346 (605)
..+|++.++||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999998643 246899998754 3345678899999999999999999
Q ss_pred eeeeEEeCCeeEEEEEeeCCCchhhHHhhcC--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007397 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQT--------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418 (605)
Q Consensus 347 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~N 418 (605)
+++++..+...+++|||+++++|..++.... ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 1235889999999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCC
Q 007397 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSD 496 (605)
Q Consensus 419 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~~~ 496 (605)
|+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999886543332223334556789999999998889999999999999999998 6666654322
Q ss_pred CchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 497 ~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+......+........ ...+.....++.+++.+||+.+|++|||+.+|++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2222222222111111111 11122233578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=316.18 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=202.6
Q ss_pred ccccceecccCeEEEEEEEEcC----CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe-----
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 356 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 356 (605)
|.+.+.||+|+||.||+|.+.. +..+|+|+++.. .......+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998743 367999998742 34456788999999999999999999998876554
Q ss_pred -eEEEEEeeCCCchhhHHhhcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 357 -KLLIYEFMPNKSLDYFIFDQT---KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 357 -~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885532 2346889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ..+... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hc
Confidence 99987643322222222335678999999988889999999999999999999 88888543321 111111 11
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11223345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.75 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=206.0
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|.+.++||+|+||.||++... ++..+|+|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999642 356899999887777777889999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 360 IYEFMPNKSLDYFIFDQTK------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865421 135788999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||........ +...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHHH-
Confidence 9999999876543322222223345788999999999999999999999999999998 8888754332211 1111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ---TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111110 011122345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=332.07 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=212.0
Q ss_pred eecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhh
Q 007397 293 KLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDY 371 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~ 371 (605)
+||+|.||+||.|++.+ ...+|||-+.........-+..|+.+.++|.|.|||+++|.+.++.+.-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999866 56789999987777778889999999999999999999999999999999999999999999
Q ss_pred HHhhcCccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCCCccccccc
Q 007397 372 FIFDQTKRELL--DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGDEIEGSTN 448 (605)
Q Consensus 372 ~l~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~ 448 (605)
+++.. -+++ .+...-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||.++...+- ...+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 99653 3344 67778889999999999999998 999999999999964 689999999999887543 34456
Q ss_pred ccccccCccchhcccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 449 KVIGTYGYMAPEYATDG--LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 449 ~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
+..||..|||||++-.+ .|..++|||||||++.||.||++||-....... ..+.-++. ....+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCC
Confidence 67899999999999765 489999999999999999999999965432211 11111111 234566
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HhcCCCCCCCCCCC
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPSVIL--MLGSDSVLAQPKQP 571 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~p~~p 571 (605)
+.+....+.++|++|+..+|.+||+++++++ .|+.....+.|+.+
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 7778888999999999999999999999997 45544344444444
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.02 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=195.6
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.|+++++||+|+||+||+|++. +++.+|+|++.+.. ......+.+|+.++++++|+||+++++.+.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999984 58899999987532 3345678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 35788899999999999999999998 9999999999999999999999999975431100
Q ss_pred ---------------------------------------------ccccccccccccCccchhcccCCCCCcccchHHHH
Q 007397 443 ---------------------------------------------IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFG 477 (605)
Q Consensus 443 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG 477 (605)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHH
Q 007397 478 ILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS---MPS 554 (605)
Q Consensus 478 vvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~e 554 (605)
|++|||++|++||...+..+. .... ...... +..+........+.+++.+++ .+|++|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~---~~~i---~~~~~~-------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET---QMKV---INWQTS-------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH---HHHH---HccCCC-------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999975443211 1111 100000 000111112334566676665 49999997 777
Q ss_pred HHHH
Q 007397 555 VILM 558 (605)
Q Consensus 555 vl~~ 558 (605)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=325.33 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=196.7
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+|++.+.||+|+||.||+|++.. ++.||+|++.+. .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999854 789999998753 223345567788888777 5899999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34788999999999999999999998 999999999999999999999999998754322
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i~----~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM----EHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCC-------
Confidence 1 123346799999999999999999999999999999999999999975443221 11111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSM-----PSVIL 557 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 557 (605)
..+......+.+++.+||+.+|++|++. .++.+
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1112233467889999999999999985 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=317.62 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=203.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999998853 568899988643 334456788999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEe
Q 007397 358 LLIYEFMPNKSLDYFIFDQTK----RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKIS 430 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~ 430 (605)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865421 235889999999999999999999998 99999999999998765 59999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||........ ... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~----~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEF----V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----H
Confidence 9999987643322222222334568999999999999999999999999999997 9988865433211 111 1
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..... ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 0112223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=314.30 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=202.5
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.+|++.+.||+|+||.||+|.+..+..+|+|.+.+. ......+.+|+.++++++|+||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357888999999999999999877788999998643 2234567889999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999886533 25889999999999999999999998 999999999999999999999999999765432211
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. .... ..... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~---------~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESV----SAGYR---------L 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHH----HcCCc---------C
Confidence 1111223457999999999999999999999999999999 7888865433221 1111 11100 0
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+......+.+++.+||+.+|++|||+.+|+++|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111223456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.23 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=195.3
Q ss_pred ceecccCeEEEEEEEEc----CCcEEEEEEcccc----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++||+|+||.||+++.. .++.||+|++.+. .......+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999863 4789999998752 223345678899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999888543 35788888999999999999999998 9999999999999999999999999987543222
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ..+... . .+..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~---~-~~~~--------- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKI---L-KGKL--------- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHH---H-cCCC---------
Confidence 1223457999999999999988999999999999999999999999754321 111111 1 1110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+++.+||+.+|++|| ++.++++.
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11122234678999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=318.31 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=202.9
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+|++.++||+|+||+||++.+. +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999974 58999999986532 2233457789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998875532 245889999999999999999999998 9999999999999999999999999987653222
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. .....|++.|+|||++.+..++.++||||+||++|||++|..||...........+... ....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~~---------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VKED---------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hhhc----------
Confidence 1 12346899999999999989999999999999999999999999764432221111111 1110
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
....+......+.+|+..||+.||++|| ++.+++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112223445678999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=317.81 Aligned_cols=258 Identities=25% Similarity=0.448 Sum_probs=207.2
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.+.||+|+||.||+|.... +..+|+|.+... .......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3678999999999999999998743 368999998653 334456788999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 358 LLIYEFMPNKSLDYFIFDQTK-------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
++||||+++++|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 234788899999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~----~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF----V 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH----H
Confidence 9999987644332222333456789999999998889999999999999999998 888886433221 1111 1
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+..... +......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 11124568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.14 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=204.7
Q ss_pred cCccccceecccCeEEEEEEEEc-----------------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKL 347 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 347 (605)
++|++.++||+|+||.||++... +...+|+|++... .......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998542 2346899998753 34456788999999999999999999
Q ss_pred eeeEEeCCeeEEEEEeeCCCchhhHHhhcCc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCE
Q 007397 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK--------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419 (605)
Q Consensus 348 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NI 419 (605)
++++......++||||+++++|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134778889999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCC
Q 007397 420 LLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDN 497 (605)
Q Consensus 420 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~~~~ 497 (605)
|++.++.++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999999888889999999999999999998 667776443322
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
. +............... .+.+..+...+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 242 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111100000 01112233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=304.32 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=205.6
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-----c---hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-----S---EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ 353 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 353 (605)
.-..|.-.+.||.|..++|.++.+ ..|+++|+|++... + ....+....|+.||+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678889999999999999877 45899999998531 1 12344567899999998 59999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
+...++|+|.|+.|.|.+++... -.+++.+.++|+.|+.+|+.|||..+ ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 99999999999999999999443 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATD------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
+++.+.... .....+|||+|+|||.+.. ..|+..+|+|+.|||||.||.|.+||....... ...
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------MLR 238 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------MLR 238 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------HHH
Confidence 999875433 3556899999999999853 458899999999999999999999997533211 112
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.++... +..+...+......+||.+||+.||..|.|++|++.+
T Consensus 239 ~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 22222221 1223334455667899999999999999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.66 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=206.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-C-----CceeeeeeeEEeCCeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 359 (605)
+|++.+.||+|+||.|.+|.+. .++.||||+++. ...-..+...|+.+|..|+ | -|+|+++++|....+.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7999999999999999999984 489999999965 4556677888999999997 4 479999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC--CceEEeecCCCcc
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD--MNPKISDFGLART 437 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~--~~vkl~DFGla~~ 437 (605)
|+|.+ ..+|.+++..+. ...++...++.++.||+.||..||+.+ |||+||||+||||.+. ..|||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 557888886543 334899999999999999999999998 9999999999999755 3699999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc------
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK------ 511 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~------ 511 (605)
..... ..++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|...+..+....|.......+.
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 64332 2577899999999999999999999999999999999999888876654444333222110000
Q ss_pred CCCcccccc---------------------------------ccc-------CCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 007397 512 GMPWQLIDA---------------------------------CYQ-------ESCNPDEVIRCIHISLLCVQHHPEDRPS 551 (605)
Q Consensus 512 ~~~~~l~d~---------------------------------~~~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt 551 (605)
......++. ... ..........+++++.+||+.||..|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000000000 000 0011134456789999999999999999
Q ss_pred HHHHHHHh
Q 007397 552 MPSVILML 559 (605)
Q Consensus 552 ~~evl~~L 559 (605)
..+.+.+-
T Consensus 496 p~qal~Hp 503 (586)
T KOG0667|consen 496 PAQALNHP 503 (586)
T ss_pred HHHHhcCc
Confidence 99999854
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.52 Aligned_cols=262 Identities=24% Similarity=0.286 Sum_probs=198.7
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----eeEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 360 (605)
.|...+++|.|+||.||+|.... ++.||||++-.... .--.|+.+|+++.|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667999999999999999855 79999999864322 2236899999999999999998886532 23489
Q ss_pred EEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCCCccC
Q 007397 361 YEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTF 438 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGla~~~ 438 (605)
||||+. +|.+.+..- ..+..++...++-+..||.+||.|||+++ |+||||||.|||+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 555555431 22344677777889999999999999998 9999999999999987 99999999999988
Q ss_pred CCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC---
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP--- 514 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~--- 514 (605)
...+.. ..+.-|..|+|||.+.+. .|+.+.||||.|||+.||+.|++.|...+..+....|...........+
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 655433 345678899999998875 6999999999999999999999999886665554444433221111110
Q ss_pred ---------cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 ---------WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ---------~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.++.......-.......+.++|+.++|+.+|.+|.++.+++.+-
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 111111111113334556788999999999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.96 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=196.2
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||++++. +++.||+|++++. .......+..|..+++++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 5889999999753 233456688899999998 699999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 9998887543 35899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--chhHHHHHHHhhhcCCCcccccccccC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN--KFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~--~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .................
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 334679999999999999999999999999999999999999997433221 11111111111111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPS------MPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 558 (605)
..+......+.+++.+||+.+|.+||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011122345788999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.08 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=197.4
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCC-ceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 361 (605)
+|++.+.||+|+||.||+|.+.+ ++.||+|++.+. .....+.+..|+.+++.+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48889999999999999999854 789999998753 234456678899999999765 5888999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34788999999999999999999998 999999999999999999999999998753221
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.... ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~----~~~~------- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM----EHNV------- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCC-------
Confidence 1 12234579999999999999999999999999999999999999997544221 111111 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSM-----PSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 558 (605)
..+......+.+++.+||+.+|.+||+. .++++.
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111223457889999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.67 Aligned_cols=260 Identities=22% Similarity=0.370 Sum_probs=209.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||.||+|+.. +++.||+|.+.. ........+.+|+.+++.++|+||+++++++......++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999974 689999998754 23344556889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+++++|..++.... ....++...+..++.||++||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788999999999999999999998 99999999999999999999999999887643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+...... ....... .......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~----~~~~~~~----- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK----IEQCDYP----- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH----HhcCCCC-----
Confidence 221 122346888999999999888999999999999999999999998543221 1111111 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..........+.+++.+||+.+|++||++.+|++.|++..
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0111233456889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=320.72 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=207.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||.||++...+ ...+|+|.+... .......+.+|+.+++++ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4578899999999999999998743 368999998753 344556788999999999 79999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhc-------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQ-------------TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH 423 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~ 423 (605)
.+++|||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 99999999999999998542 22346889999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 007397 424 DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 424 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i 502 (605)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH---
Confidence 99999999999987654332222223345678999999999899999999999999999998 88888643322111
Q ss_pred HHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 503 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.....+.. ...+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 245 ----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 245 ----KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111 011222345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.25 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=202.5
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
..++|++.++||+|+||.||++++. +++.||+|++.+. .......+.+|+.+++.++|+||+++++++..+...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999985 4889999998642 22344557889999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... .++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988432 3778888899999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccchhcccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDG----LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .... .......
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i---~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI---MDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHH---HcCCCcC
Confidence 3221 112345799999999998653 478999999999999999999999975443211 1111 1110000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILML 559 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 559 (605)
.+ +........+.+++..||+.+|++ ||++.+++.+.
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 267 TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11 111123456788999999999988 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.46 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=194.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--------C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--------E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 355 (605)
.++|++.++||+|+||.||+|.+. .++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 468999999999999999999985 48899999885432 2345799999999999999999877432 2
Q ss_pred eeEEEEEeeCCCchhhHHhh-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecC
Q 007397 356 EKLLIYEFMPNKSLDYFIFD-QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFG 433 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFG 433 (605)
..++||||+++ +|..++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 45689999986 55555533 233456899999999999999999999998 99999999999999765 79999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+....+ ...+...
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI---IQVLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCC
Confidence 998764322 12335689999999998764 6899999999999999999999999764432221111 1111000
Q ss_pred C---------------CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 513 M---------------PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 513 ~---------------~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. ...+....+....+.....++.+|+.+||+.+|.+|||+.|++++-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 0000000011111112335688999999999999999999998754
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.83 Aligned_cols=255 Identities=26% Similarity=0.456 Sum_probs=199.3
Q ss_pred ccccceecccCeEEEEEEEEcCC-c--EEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------Ce
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDG-Q--EIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------EE 356 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 356 (605)
|.+.++||+|+||.||+|...+. + .+|+|.++.. .....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987553 2 6899988643 345567889999999999999999999987532 24
Q ss_pred eEEEEEeeCCCchhhHHhhcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQT---KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
.+++|||+++++|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 2345889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...... .... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcC
Confidence 9987643322212222346778999999999999999999999999999999 78888643221 1111 11122
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.... ........+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 111233457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=320.05 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=204.0
Q ss_pred CccccceecccCeEEEEEEEEcC------CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++.+..+...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998632 3578998886533 3445678899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007397 360 IYEFMPNKSLDYFIFDQT---------------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~N 418 (605)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875421 1235788999999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007397 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDN 497 (605)
Q Consensus 419 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~ 497 (605)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322112223345778999999988889999999999999999998 998886433221
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
. +........ ...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 238 ~-------~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 L-------FNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred H-------HHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 111111111 111122335688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.37 Aligned_cols=259 Identities=17% Similarity=0.224 Sum_probs=202.4
Q ss_pred HHHHHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC
Q 007397 280 TIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE 355 (605)
Q Consensus 280 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 355 (605)
.+....++|++.++||+|+||.||++++.. ++.+|+|++.+. .......+.+|+.+++.++||||+++++++..+.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 334445789999999999999999999854 789999998642 2234456788999999999999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999988432 3788899999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDG----LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||...+.... .... ...
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~~i---~~~ 262 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YSKI---MDH 262 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HHHH---HhC
Confidence 87643221 122346799999999998754 378999999999999999999999975432211 1111 111
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILML 559 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 559 (605)
.....+ +........+.+++..||+.++.+ ||++.+++++-
T Consensus 263 ~~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 263 KNSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CcccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 100000 111122445678888999866544 89999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.12 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=197.2
Q ss_pred ecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||+||++.+. +++.+|+|.+.+.. ....+.+..|+.++++++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999874 58899999987532 23445678899999999999999999999999999999999999999
Q ss_pred hhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccccc
Q 007397 370 DYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448 (605)
Q Consensus 370 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 448 (605)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875432 3346899999999999999999999998 99999999999999999999999999976543221 123
Q ss_pred ccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCH
Q 007397 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNP 528 (605)
Q Consensus 449 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~ 528 (605)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.. ... ... ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~-~~~----------~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--RIL-NDS----------VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH--hhc-ccC----------CCCcc
Confidence 35789999999999999999999999999999999999999975443221111111 000 000 01122
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 529 DEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 529 ~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
.....+.+++..||+.+|++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3345678999999999999999 67778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.95 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=207.7
Q ss_pred hcCccccceecccCeEEEEEEEEc--------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999742 2457999998653 345567789999999999 799999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++++|..++..... ...+++..+..++.||++||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 235788899999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..|+...+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~- 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence 9999999999999987654332222333446778999999998889999999999999999998 77777543322111
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
.....+... ..+......+.+++.+||+.+|++||++.+|++.|.....
T Consensus 250 ------~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 ------KLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111111 1112234568889999999999999999999999977533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=313.40 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=200.5
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||.||+|.+ .+++.+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999987 45889999998653 344456788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997543 3678888899999999999999998 999999999999999999999999999765332
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......||..|+|||++.+..++.++||||||+++|+|++|+.||..........................+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------ 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------
Confidence 123457899999999999999999999999999999999999999754332211111111111111111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......++.+++.+||+.+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011123457899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.22 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCc----EEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQ----EIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|++.+.||+|+||+||+|... +++ .+++|.+.... .....++..|+.+++++.|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56888899999999999999874 344 47888875432 334567888999999999999999999875 456789
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
++||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986432 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
............++..|+|||++.+..++.++||||||+++|||++ |..||........ . ..+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----~---~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----P---DLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----H---HHHHCCCcCCC-
Confidence 3322222334557789999999998899999999999999999998 9988865432111 1 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
+......+.+++.+||..+|++|||+.|+++.|....
T Consensus 233 --------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 --------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112345678999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.05 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=195.3
Q ss_pred ceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.||+|+||.||++.+ .+++.||+|++.+. .......+.+|+.+++.++|+||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 45899999999753 2334556778999999999999999999999999999999999999
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 998887443 358899999999999999999997 67 9999999999999999999999999987542221 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~~~----------~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEI----------RF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cCCC----------CC
Confidence 234569999999999999999999999999999999999999996543221111110 0000 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
+......+.+++.+||+.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112234578899999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=322.11 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=205.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC--------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|.+.++||+|+||.||++.+.. .+.+|+|.+... .......+.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999997532 357999999753 344566788999999999 799999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965422 235889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 9999999999999876643222222222334578999999999889999999999999999998 8888754332111
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. ....+... ..+......+.+++.+||+.+|++||++.+|++.|...
T Consensus 252 -~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 -FK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HH----HHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 11111111 11122345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=316.73 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=208.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC-----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 357 (605)
.++|++.+.||+|+||.||+|.+.+ +..|++|++... .......+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999999865 788999998753 34456778899999999999999999998776 5778
Q ss_pred EEEEEeeCCCchhhHHhhcCcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKR-----ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654322 56889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ... ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA----YLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHc
Confidence 99987643332222223446778999999998889999999999999999999 999986543211 111 1111
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+... .........+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 235 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110 01112234678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.88 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=203.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||+|++.++..||+|++.... ...+.+.+|+.++++++|+||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35699999999999999999998777789999997532 23467889999999999999999998874 45679999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999986532 335789999999999999999999998 999999999999999999999999999766433211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||+..+..++.++||||||+++|+|++ |..||....... .+... .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~----~~~~~--------- 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERGYR--------- 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHH----hcCCC---------
Confidence 1122346678999999988889999999999999999999 787876443211 11111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..........+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11223345568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.08 Aligned_cols=241 Identities=25% Similarity=0.341 Sum_probs=191.4
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|++. +++.||+|.+++.. ......+..|..++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999985 48899999997531 23445567788787754 899999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999888543 35788999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ...... ..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~----~~~~~----------~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI----RVDTP----------HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCCC----------CC
Confidence 33467999999999999999999999999999999999999999754322 111111 11110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMP-SVIL 557 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 557 (605)
+......+.+++.+||+.||++||++. ++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234577899999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.98 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=187.4
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHH-HHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|+||.||+|++. +++.||+|++.+.. ......+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 58899999986532 22233444454 467889999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|...+.. ...+.+..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999887744 235788888999999999999999998 999999999999999999999999998753222 122
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ...... . ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~-~~~----------~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNI---L-HKP----------LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHH---h-cCC----------CCC
Confidence 33467999999999999989999999999999999999999999754321 111111 1 110 011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223345678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=324.33 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=194.9
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|++. +++.+|+|++.+. .......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999985 4789999999753 334456678899888777 799999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9998887543 35889999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc--hhHHHHHHHhhhcCCCcccccccccC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK--FNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2346799999999999999999999999999999999999999964322111 1111111111111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPS------MPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 558 (605)
..+......+.+++.+||+.||++||+ +.+++.+
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 112223345779999999999999998 4676554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=314.16 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=202.8
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++|+||+++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999997 45889999998755445566788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988532 35789999999999999999999998 99999999999999999999999999986532211
Q ss_pred cccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
......|++.|+|||.+. ...++.++|||||||++|||++|..|+...........+. ... +..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~-------~~~---~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS-------KSN---FQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee-------cCC---CCCC
Confidence 122346889999999884 4457889999999999999999999985433221110000 000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... ........+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0112335688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.98 Aligned_cols=269 Identities=27% Similarity=0.370 Sum_probs=202.6
Q ss_pred cCc-cccceecccCeEEEEEEEE-----cCCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--Ce
Q 007397 286 DNF-SINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EE 356 (605)
Q Consensus 286 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 356 (605)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988642 357899999987532 34556788999999999999999999988653 45
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++... .+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999988542 4899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccc-cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 437 TFGGDEIEG-STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 437 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
......... ......++..|+|||.+.+..++.++||||||++++||++|..|+........ ..+.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence 764322111 11223356679999999988899999999999999999999999765332110 0010000000000011
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+++.......+......+.+++..||+.+|++|||+++|+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111122333456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=318.09 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=202.0
Q ss_pred cCccccceecccCeEEEEEEEE-----cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 358 (605)
.+|++.+.||+|+||+||++.. .+++.||+|++........+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 3478999999987666677889999999999999999999998754 34678
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc---------hhHHHHHHHh
Q 007397 439 GGDEIEG-STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK---------FNVIRHAWNL 508 (605)
Q Consensus 439 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~---------~~~i~~~~~~ 508 (605)
....... ......++..|+|||++.+..++.++|||||||+++||++|..++........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 11112234569999999988899999999999999999998776543211000 0000000011
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.... ............+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1010 00111122345688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=325.44 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=195.3
Q ss_pred ceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|+||.||+|++.. ++.||+|++.+. .......+..|..+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999854 789999998753 234455677888888866 799999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|...+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 9998888543 35788999999999999999999998 9999999999999999999999999987643221 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .+.... .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~----~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESIL----HDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCC----------CC
Confidence 234568999999999999999999999999999999999999997544322 111111 1110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHh
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRP-------SMPSVILML 559 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~~L 559 (605)
+......+.+++..||+.+|++|| ++.+++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 111234678899999999999999 888888653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.98 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=203.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357899999999999999999988888999999875332 3457889999999999999999999875 45689999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999986532 235789999999999999999999998 999999999999999999999999999765432211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..+... .....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~--------- 221 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV----ERGYR--------- 221 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCC---------
Confidence 1122335678999999988889999999999999999999 88888643321 111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+.+......+.+|+.+||+.+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.20 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=196.8
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|.+. +++.+|+|++.+. .....+.+.+|+.++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999984 4789999999753 234456688999999888 599999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9998887443 35899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||........................ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 33467999999999999999999999999999999999999999754433222222222222211110 11
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSM------PSVILM 558 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 558 (605)
+......+.+++.+||+.||++||++ .+++++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11223457789999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.91 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=193.9
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||+||+|++. +++.||+|++.+. .......+..|..++..+ +|+||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 4889999998753 233455677888888876 699999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888543 35889999999999999999999998 9999999999999999999999999987642221 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... +... ..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i----~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI----LNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHH----hcCCC----------CC
Confidence 3345799999999999999999999999999999999999999975443211 1111 11111 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSM------PSVILM 558 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 558 (605)
+......+.+++.+||+.||++||++ +++++.
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11123467889999999999999998 666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.72 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=198.3
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----eeE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 358 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 358 (605)
+|++.++||+|+||.||++.+ .+++.||+|++... .......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999997 46899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+.+ +|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 56666533 345889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH------------
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA------------ 505 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~------------ 505 (605)
..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+...
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33221 112334678999999998874 4799999999999999999999999765433222211110
Q ss_pred ----HHhh-hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 506 ----WNLW-NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 506 ----~~~~-~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+ ............ ..........+.+|+.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000000000 00111224567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.46 Aligned_cols=258 Identities=31% Similarity=0.467 Sum_probs=205.6
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|.+.+.||+|+||.||++... .+..+|+|.++.. .....+.+.+|+.+++++ +|+||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999752 2457999998754 234456789999999999 79999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|..++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 234899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... . ....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~----~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--K----LIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--H----HHHcCCcC
Confidence 7643322112223346788999999999999999999999999999998 999886543322111 1 11111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 264 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 ---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.39 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=205.3
Q ss_pred cCccccceecccCeEEEEEEEEcC--------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGE 355 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 355 (605)
.+|++.+.||+|+||.||+|+... ...+|+|.+... ......++.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999997522 236899988743 344567889999999999 7999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~ 422 (605)
..+++|||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235788899999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 007397 423 HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNV 501 (605)
Q Consensus 423 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 501 (605)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---
Confidence 999999999999987643322222222344578999999999999999999999999999998 8888754332111
Q ss_pred HHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 502 i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
. ......... ..+......+.+++.+||+.+|++||++.+|++.|....
T Consensus 246 ~----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 F----KLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred H----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1 111111111 111222346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.66 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=204.7
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 46799999999999999999998889999999987533 3346788999999999999999999886 456789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885543 345789999999999999999999998 999999999999999999999999999776432221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++....++.++||||||+++|||++ |+.||...+... .... .......
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~-------- 222 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----LERGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HHcCCCC--------
Confidence 1122345678999999998889999999999999999999 999986543211 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+........+.+++.+||+.+|++||++++|+++|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.66 Aligned_cols=263 Identities=19% Similarity=0.212 Sum_probs=203.0
Q ss_pred hcCccccceecccCeEEEEEEEEc---CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV---DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..+|++.++||+|+||.||++... .++.||+|.+... ....+|+.++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988642 23468999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 56666662 3346899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc------
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW------ 515 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~------ 515 (605)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333345679999999999999999999999999999999999999997655443333332222211110000
Q ss_pred -cc------ccccccCCCC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 -QL------IDACYQESCN-------PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 -~l------~d~~~~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+ .......... ......+.+++.+||+.+|++||++.+++.+-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00 0000000000 01234577899999999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.62 Aligned_cols=238 Identities=25% Similarity=0.287 Sum_probs=192.3
Q ss_pred ceecccCeEEEEEEEE----cCCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 292 NKLGEGGFGRVYKGTL----VDGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
+.||+|+||.||+++. ..++.+|+|++.+.. ......+.+|+.++++++|+||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999976 247899999997532 2234456789999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 99999888443 35899999999999999999999998 9999999999999999999999999987653321 1
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+... . .... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i---~-~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMI---L-KAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHH---H-cCCC----------C
Confidence 233467999999999999988999999999999999999999999754321 111111 1 1110 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
.+......+.+|+.+||+.+|++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122345778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.02 Aligned_cols=260 Identities=26% Similarity=0.467 Sum_probs=204.4
Q ss_pred HhcCccccceecccCeEEEEEEEEcC------CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
..++|++.++||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999997542 4589999886432 2334567889999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK-------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
.++||||+++++|.+++..... ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788899999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----H
Confidence 99999986543322222223345778999999999899999999999999999998 787875432211 111 1
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+.... .+......+.+++.+||+.+|++|||+.++++.|...
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111111 1112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.35 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=187.9
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHH-HHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||+||+|++. +++.||+|++.+.. ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999985 58999999987532 222334444544 56789999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999888543 35788999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+ ..... . .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i---~-~~~~----------~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNI---L-NKPL----------RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHH---H-cCCC----------CC
Confidence 334579999999999999999999999999999999999999997543211 11111 1 1110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
.+.....+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.91 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=194.1
Q ss_pred ecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||.||+++.. +|+.+|+|.+.... ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 48999999986421 12234556799999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98875433 234788999999999999999999998 9999999999999999999999999987654322 1223
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+. ...... ... . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~-~~~-~--------~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLED-EVK-F--------EHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--HHhhcc-ccc-c--------cccc
Confidence 468999999999998889999999999999999999999987543322111111 111110 000 0 0012
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
....+.+|+..||+.+|++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 234578999999999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=312.81 Aligned_cols=253 Identities=29% Similarity=0.469 Sum_probs=201.7
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHH--HHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLN--ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
|++.+.||+|+||+||+++... ++.+|+|++......... ....|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999865 678999999765433322 3456999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|..++. ....+++..+..++.||++||.+||+.+ |+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999986 3345799999999999999999999998 99999999999999999999999999976411 12
Q ss_pred ccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......++..|+|||++. +..++.++||||||+++++|++|..|+...........+....... +....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~-- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-------LPSSS-- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-------HHHHT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-------ccccc--
Confidence 2344567899999999998 8889999999999999999999999988652222222222111100 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+++..||+.+|++||++.+++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000012678899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.11 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=204.2
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCc----EEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.++||+|+||+||+|++ .+++ .||+|.+... .......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788999999999999999986 3444 4899998653 34456678899999999999999999999875 4578
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988543 235889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||........ .. .+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~---~~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI----PD---LLEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH---HHHCCCcC--
Confidence 43322211222335678999999999899999999999999999998 8888864332111 11 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLA 566 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 566 (605)
.........+.+++..||+.+|++||++.++++.|......+
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111223446788999999999999999999999997764444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.08 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=204.1
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 356 (605)
.++|.+.++||+|+||.||+|++. .++.||+|++... .......+.+|+.++.++. |+||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999863 2468999999753 2333457889999999997 9999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc----------------------------------------------------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK---------------------------------------------------------- 378 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 378 (605)
.++||||+++|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864321
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 379 -------------------------------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 379 -------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124677788899999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence 9999999999999986533221112223456789999999998889999999999999999998 8888764432111
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+ ......+... ..+......+.+|+..||+.+|.+||++.+|++.|+..
T Consensus 351 -~---~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 -F---YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -H---HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1111111110 11122245688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=330.44 Aligned_cols=261 Identities=18% Similarity=0.235 Sum_probs=203.1
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 353 (605)
+..+....++|++.+.||+|+||.||++++. +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344445689999999999999999999985 4789999998642 22344567889999999999999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
+...++||||+++++|..++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999988432 3788888999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDG----LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...+.... ... ..
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~---i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSK---IM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---HHH---HH
Confidence 9987643221 122346799999999998754 378999999999999999999999975432211 111 11
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILML 559 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 559 (605)
.......+ +........+.+++..||+..+.+ ||++.+|+++.
T Consensus 261 ~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111 111223445778999999844443 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.03 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=205.0
Q ss_pred cCccccceecccCeEEEEEEEEc--------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGE 355 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 355 (605)
++|.+.++||+|+||.||+++.. ....+|+|.+... .......+.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999752 2457899998753 344566788999999999 5999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~ 422 (605)
..++||||+++++|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245889999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhH
Q 007397 423 HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNV 501 (605)
Q Consensus 423 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 501 (605)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987643222221222334568999999999899999999999999999999 8888865432221111
Q ss_pred HHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 502 i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+... ..+......+.+++.+||+.+|++||++.+|++.|...
T Consensus 249 -------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 249 -------LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -------HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111 11122234677899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.74 Aligned_cols=265 Identities=27% Similarity=0.425 Sum_probs=218.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+...+.++||+|-||.|.++....+..||||+++.... ...++|..|+++|.+++|||||+++++|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 356678899999999999999987789999999987544 4458999999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
|++|.|.+++..+.... +......+|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++.....++
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998775443 455666789999999999999987 99999999999999999999999999997765555
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS--GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt--G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.....+.+-...|||||.+..+.+++++|||+|||+|||+++ ...||+....++ .++..-..+..+....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV----- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce-----
Confidence 444555566789999999999999999999999999999876 667776544322 2222222222222211
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+.-+...+.+++++||..+-++||++++|...|.+.
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1234555667789999999999999999999999999765
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.50 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=196.0
Q ss_pred eecccCeEEEEEEEE---cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 293 KLGEGGFGRVYKGTL---VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+||+|+||.||+|.+ .+++.+|+|++... .....+++.+|+.+++.+.|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999965 34789999998643 2345678899999999999999999999875 55678999999999
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc-c
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG-S 446 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~-~ 446 (605)
+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||.||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999988543 35889999999999999999999998 9999999999999999999999999998764332211 1
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
.....+++.|+|||.+....++.++||||||+++|||++ |..||......+. ... ...+... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----i~~~~~~---------~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM----IESGERM---------E 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHCCCCC---------C
Confidence 122334678999999988889999999999999999998 9999875433221 111 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+......+.+++.+||+.+|++||++.+|+++|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=308.93 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=194.0
Q ss_pred ceecccCeEEEEEEEEcC---CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLVD---GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 4679999987533 334457888999999999999999999999999999999999999
Q ss_pred chhhHHhhcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 368 SLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 368 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865332 234567788889999999999999998 9999999999999999999999999997654333222
Q ss_pred cccccccccCccchhcccCC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 446 STNKVIGTYGYMAPEYATDG-------LFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
......++..|+|||++.+. .++.++||||||+++|||++ |..||......+. ..... ......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh----hcccCCC
Confidence 23335578899999998642 35789999999999999996 9999865432211 11111 1111112
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.++.+... ....+.+++..|+ .+|++|||+.+|+..|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 2234677889998 58999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.02 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=210.0
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+.|++++.||.|.-|+||++++.+ +..+|+|++.+. .......++.|-+||+.++||.++.|+..+..+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467888999999999999999866 689999999874 3445566788999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC-
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG- 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~- 440 (605)
|||+||+|..+.+++. .+.+++..++-++.+++-||+|||-.| ||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998876654 457899999999999999999999999 99999999999999999999999998754311
Q ss_pred --------------------------------C-cc--------------------cccccccccccCccchhcccCCCC
Q 007397 441 --------------------------------D-EI--------------------EGSTNKVIGTYGYMAPEYATDGLF 467 (605)
Q Consensus 441 --------------------------------~-~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~ 467 (605)
. .. .......+||-+|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 001123569999999999999999
Q ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCC
Q 007397 468 SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPE 547 (605)
Q Consensus 468 ~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~ 547 (605)
+.++|.|+|||+|||||.|..||...+..+-...+.. ..+..+..+.....+.+||.+.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---------------QPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---------------CCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999998776554433321 1111222234456788999999999999
Q ss_pred CCCC----HHHHHHHh
Q 007397 548 DRPS----MPSVILML 559 (605)
Q Consensus 548 ~RPt----~~evl~~L 559 (605)
+|.. +.||-++-
T Consensus 378 kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhccccchHHhhcCc
Confidence 9998 88887754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.51 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=205.2
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.++||+|+||.||+|.+. ++..+|+|.+... .......+.+|+.++++++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 367899999999999999999863 4678999998753 344567789999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcC-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQT-------------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~N 418 (605)
++||||+++++|..++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986432 1124678889999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007397 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDN 497 (605)
Q Consensus 419 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~ 497 (605)
||++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322111222345678999999998899999999999999999998 877875432211
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+. ....+... ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 241 ---~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ---VIY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 11111111 1112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.65 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=191.6
Q ss_pred ceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHc-CCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|++.+ ++.||+|++.+.. ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999854 7899999987531 2334556677777775 4899999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 9999988543 35788999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+ ..... ..... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~~~~~------~----~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----RMDNP------C----Y 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCC------C----C
Confidence 234578999999999999999999999999999999999999997543221 11111 11110 0 1
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMP-SVIL 557 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 557 (605)
+......+.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234577899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.61 Aligned_cols=250 Identities=33% Similarity=0.508 Sum_probs=204.7
Q ss_pred ceecccCeEEEEEEEEcC----CcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD----GQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|.... +..+++|.+...... ....+.+|+.+++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999854 789999999764333 377889999999999999999999999999999999999999
Q ss_pred CchhhHHhhcCc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 367 KSLDYFIFDQTK------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 367 ~~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
++|.+++..... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999866421 356899999999999999999999998 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||........ ... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEY----LRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCCCC----
Confidence 432222334567889999999998899999999999999999999 6888876532211 111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+......+.+++.+||+.+|++||++.+++++|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112222457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.37 Aligned_cols=266 Identities=21% Similarity=0.308 Sum_probs=200.8
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|.+.++||+|+||.||+|++. +++.+|+|.+.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999975 57889999987432 22334677899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++ +|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 676666443 335788999999999999999999998 99999999999999999999999999976533221
Q ss_pred cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc-----
Q 007397 444 EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL----- 517 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l----- 517 (605)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+..............+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 46899999999999999999999999765543333332221110000000000
Q ss_pred -ccccccC-------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 -IDACYQE-------SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 -~d~~~~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+..... ...+.....+.+++.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000 00112234577999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.68 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=193.4
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 361 (605)
+|+..+.||+|+||+||+|.+. +++.||+|++.+. .....+.+..|+.+++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999875 5889999998753 2334456778888988886 577888999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999888543 35889999999999999999999998 999999999999999999999999998764322
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~~------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HNV------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC-------
Confidence 1 12234569999999999999999999999999999999999999997543321 1111111 110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 552 (605)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223467889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.31 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=209.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||.||+|... +++.+|+|.++. ........+.+|+.++++++|+|++++++.+......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999986 689999998863 22334667889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+++++|..++.... ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 3445889999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...... ....+..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~------ 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEKCDY------ 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh----hhhcCCC------
Confidence 221 122346889999999999888999999999999999999999998543311 111111 1111111
Q ss_pred cccCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 521 CYQESCN-PDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 521 ~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+ ......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 226 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 ---PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111 13345688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=306.63 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=205.3
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|... +++.+++|.+.. ........+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999984 589999999864 2345667788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999986542 346889999999999999999999998 99999999999999999999999999887643321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......|++.|+|||++.+..++.++||||||+++++|++|+.||...... ...... ..+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~-------- 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI----IRGVFP-------- 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCCCC--------
Confidence 123346889999999999999999999999999999999999998754421 111111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.15 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=195.4
Q ss_pred ceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||+||+|.+.. ++.||+|++.+. .......+..|..+++.+ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999854 789999999753 233456677888998888 699999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9999888543 35889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ..... ..... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i----~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSI----LEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHH----HcCCC----------CC
Confidence 234568999999999999999999999999999999999999996543211 11111 11110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSM-----PSVILM 558 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 558 (605)
+......+.+++.+||+.+|++||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11223467899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.45 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=201.4
Q ss_pred cCccccceecccCeEEEEEEEEcC-C--cEEEEEEccc-cchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G--QEIAVKRLSK-ISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||.||+|.+.+ + ..+++|.++. ......+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998754 3 3578888874 3344566789999999999 799999999999999999999
Q ss_pred EEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 361 YEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1235888999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YEK-- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH--
Confidence 99999998643211 01111223557999999998889999999999999999997 9999865433211 111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+.. ...+......+.+|+.+||+.+|.+||++.+|++.|...
T Consensus 231 --~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 231 --LPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred --HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 011112334678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.37 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=207.3
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||.||++.. .+++.+|||.+... .......+.+|+.+++.++|+||+++++++..+...+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4788999999999999999997 56899999988642 2334567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988643 23456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~~~~------ 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI----EQCDY------ 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhh----hcCCC------
Confidence 221 122346889999999999888999999999999999999999998643221 11111111 01000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...........+.+++.+||+.+|++||||.+|+++|..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 --PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred --CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 001112234568899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.43 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=202.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|++.+.||+|++|.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999874 58999999886421 2234568889999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|+||+++++|.+++... ..++...+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 35788999999999999999999998 9999999999999999999999999987653
Q ss_pred CCccccc-ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGS-TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ..+.. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~---~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFK---IATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHH---HhccCCC----
Confidence 3211111 12345788999999999988999999999999999999999998643221 11111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++|||+.+++++
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11222334467889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.31 Aligned_cols=255 Identities=19% Similarity=0.228 Sum_probs=197.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||++++. .++.||+|++.+. .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999985 4788999998652 2233455788999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999986532 35788999999999999999999998 999999999999999999999999999776433
Q ss_pred cccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+ .+... ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i---~~~~~~~~ 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKI---MNHEERFQ 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHHH---HcCCCccc
Confidence 221 1223569999999999875 467899999999999999999999996543221 11111 11110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 558 (605)
+ . .........+.+++.+|++..+++ |+++.+++++
T Consensus 229 ~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0 001122356778888988865544 4688888775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.42 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=213.4
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.-|.+.+.||+|.|+.|-+|++ -.|.+||||++.+. +......+.+|+..|+.++|||||+||.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588889999999999999998 46999999999864 44556678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE-cCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL-DHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll-~~~~~vkl~DFGla~~~~~~ 441 (605)
.-++|+|.++|.++..+ +.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ .+-|-|||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999877654 889999999999999999999988 9999999999976 56689999999999877443
Q ss_pred cccccccccccccCccchhcccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFS-VKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
...++.+|+..|-|||++.+..|+ +++||||||||||-|+.|++||...+..+-.. .++|.
T Consensus 173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC 234 (864)
T KOG4717|consen 173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC 234 (864)
T ss_pred ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence 235568999999999999999886 67899999999999999999998766544332 23343
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+ ..+.....+|.+||..||+.||.+|-+.++|+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 32 2345566789999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.34 Aligned_cols=238 Identities=22% Similarity=0.291 Sum_probs=188.4
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHH-HHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||+||+|++. +++.+|+|++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 5899999998653 2233344555554 56789999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888743 335889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+... ..... . .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~---~-~~~~----------~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNI---L-HKPL----------VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHH---H-cCCc----------cC
Confidence 334679999999999999999999999999999999999999997543221 11111 1 1110 01
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
.+.....+.+++.+||+.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1123345778999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=314.97 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=202.7
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999875 4788899988643 344556788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|..++... ..+++..+..++.||++||.|||+ .+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999998543 457899999999999999999997 46 999999999999999999999999998765322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC--------
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP-------- 514 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~-------- 514 (605)
......|++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+............
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 123456899999999998888999999999999999999999998644322111111000000000000
Q ss_pred ---------ccccccccc---CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 ---------WQLIDACYQ---ESC-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ---------~~l~d~~~~---~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.++.+.... ... .......+.+++.+||+.+|++||++.+|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 000 001334588999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=329.03 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=197.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||++... .++.||+|++.+. .......+.+|+.++.+++|+||+++++.+..+...++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999985 4899999998653 2334567888999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999988543 35889999999999999999999998 999999999999999999999999998754221
Q ss_pred cc---------------------------------cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCC
Q 007397 442 EI---------------------------------EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488 (605)
Q Consensus 442 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~ 488 (605)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 007397 489 NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS---MPSVILM 558 (605)
Q Consensus 489 p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 558 (605)
||...........+. . + ..... +. .. ......+.+++.+++. +|.+|++ +.+++++
T Consensus 235 Pf~~~~~~~~~~~i~---~-~--~~~~~-~p----~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVM---N-W--KETLV-FP----PE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHH---c-C--CCcee-cC----CC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 997544322211111 0 0 00000 00 00 1123456677777664 9999985 5666655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.52 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=194.3
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcC---CCCceeeeeeeEEe-----CC
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKL---QHRNLVKLLGCCIQ-----GE 355 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 355 (605)
+|++.+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999985 48899999986422 22233455677766655 79999999998864 34
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++ +|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 7777764432 234889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8764322 1233568999999999999899999999999999999999999986544322222211111000000000
Q ss_pred c---cccccc-------cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 Q---LIDACY-------QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~---l~d~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .....+ .....+.....+.+++.+||+.||++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 001112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.27 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=205.9
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
....+|++.+.||+|+||.||+|.+ .+++.+|+|.+........+.+.+|+.+++.+.|+||+++++.+..+...++||
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3456899999999999999999987 458999999987655555677889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999998843 24788899999999999999999998 999999999999999999999999998765332
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ +. ........ .+
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~---~~~~~~~~-~~---- 236 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LY---LIATNGTP-EL---- 236 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HH---HHhcCCCC-CC----
Confidence 21 12234688999999999988899999999999999999999999965432111 11 11111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122233567889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.65 Aligned_cols=262 Identities=20% Similarity=0.214 Sum_probs=196.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+|.+.+.||+|+||.||++.+.. ++.||||.... ..+.+|+.++++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4689999999999999999999854 78999996432 3456899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+. ++|..++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 5777766432 235899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC----chhHHHHHHHhhh--cCCCcc-
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN----KFNVIRHAWNLWN--KGMPWQ- 516 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~----~~~~i~~~~~~~~--~~~~~~- 516 (605)
........||+.|+|||++.+..++.++|||||||+||||++|..++....... ....+........ ......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222234579999999999999999999999999999999999887653322111 0111111111000 000000
Q ss_pred ----ccccc-----------ccCCCCH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 ----LIDAC-----------YQESCNP---DEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 ----l~d~~-----------~~~~~~~---~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.... ....... .....+.+|+.+||+.||.+|||+.||+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000000 112357789999999999999999999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=308.06 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=191.4
Q ss_pred ceecccCeEEEEEEEEcC---CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLVD---GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
++||+|+||.||+|...+ ...+|+|.+... .......+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 457888887643 3344567889999999999999999999999999999999999999
Q ss_pred chhhHHhhcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 368 SLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 368 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999866432 233567788899999999999999998 9999999999999999999999999987643322222
Q ss_pred cccccccccCccchhcccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 446 STNKVIGTYGYMAPEYATD-------GLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... ..+... ... ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~-~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQV---VRE-QDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHH---hhc-cCccC
Confidence 2233446778999998743 456889999999999999999 77777543221 111111 111 11122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+... ......+.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 223345667888888 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=309.09 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=203.7
Q ss_pred cCccccceecccCeEEEEEEEEcC-C---cEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G---QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|+..+.||+|+||.||+|.+.. + ..+|+|.+... .......+.+|+.++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468888999999999999999753 3 37999998754 344566788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999985432 45889999999999999999999998 99999999999999999999999999876643
Q ss_pred Cccccc-ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEIEGS-TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
...... ......++.|+|||++.+..++.++|||||||++|||++ |..||....... .... .....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~----i~~~~----- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA----INDGF----- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----HhcCC-----
Confidence 221111 111223457999999998889999999999999999997 999986543211 1111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+........+.+++.+||+.+|++||++.+|++.|...
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111122345678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.78 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=205.0
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999874 78999999976443 5678899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999855432 35899999999999999999999998 99999999999999999999999999987632211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
....+..|+|||++....++.++||||||+++++|++ |..||........ .. ....+....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~~~~~------- 219 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----HVEKGYRME------- 219 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHhcCCCCC-------
Confidence 2334668999999988889999999999999999997 9988865432211 11 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+......+.+++.+||+.+|++||++.+|+.+|+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111224568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=304.59 Aligned_cols=248 Identities=29% Similarity=0.434 Sum_probs=199.5
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchh
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 370 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~ 370 (605)
++||+|+||.||++.+.+++.||+|.+..... .....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999875433 35678899999999999999999999999999999999999999999
Q ss_pred hHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccccccc
Q 007397 371 YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450 (605)
Q Consensus 371 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 450 (605)
+++.... ..+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9885432 35788899999999999999999998 999999999999999999999999999865432222221222
Q ss_pred ccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 451 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
.++..|+|||++.+..++.++||||||+++|||++ |..||........... ..... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~~~---------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IESGY---------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------HhcCC---------CCCCCcc
Confidence 34667999999998899999999999999999999 7888755432211111 11110 0011122
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
....+.+++.+||+.+|++||++.+|++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3446889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.59 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=200.9
Q ss_pred cCccccceecccCeEEEEEEEEcC-Cc--EEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQ--EIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||.||+|.+.+ +. .+|+|.+... .......+.+|+.++.++ +|+||+++++++..+...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578899999999999999999743 43 4688877643 344566788999999999 899999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 361 YEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
|||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999865421 235789999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~-- 235 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK-- 235 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHH--
Confidence 99999998643211 11111234668999999988889999999999999999998 999986443221 1111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....... ..+......+.+|+.+||+.+|++||++.+++++|...
T Consensus 236 --~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 --LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111000 01111234578999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.24 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=202.2
Q ss_pred cCccccceecccCeEEEEEEEEcC-C---cEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G---QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..|++.+.||+|+||.||+|.+.. + ..||+|.+... .......+..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998743 3 36999998753 445567899999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 235789999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccccccccccc---cccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 441 DEIEGSTNKVI---GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 441 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
........... .+..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQDYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCCc--
Confidence 22111111111 2457999999999999999999999999999886 999986543221 11111 11100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+.+....+.+++..||+.+|++||++.+|+++|+.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 -------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01112233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.64 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=197.4
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----- 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 355 (605)
..++|++.+.||+|+||.||++.+. .++.||+|++... .......+.+|+.+++.++|+||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 4899999998642 3344567789999999999999999999986543
Q ss_pred -eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 356 -EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 356 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
..++||||++++ |...+. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999765 444442 13678888999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH----------
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH---------- 504 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~---------- 504 (605)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97643221 22345789999999999999999999999999999999999999976542111110000
Q ss_pred -----H-HHhhhcC-CC-----ccccccccc---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 505 -----A-WNLWNKG-MP-----WQLIDACYQ---ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 505 -----~-~~~~~~~-~~-----~~l~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. ....... .. .++...... ..........+.+|+.+||+.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 0000000 00 000000000 001111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=304.04 Aligned_cols=247 Identities=29% Similarity=0.431 Sum_probs=198.5
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchh
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 370 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~ 370 (605)
++||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998889999999987543 334456889999999999999999999999999999999999999999
Q ss_pred hHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccccccc
Q 007397 371 YFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450 (605)
Q Consensus 371 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 450 (605)
.++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 9885432 35789999999999999999999998 999999999999999999999999998764332211 11122
Q ss_pred ccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 451 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
.+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ..... ..+.. ...+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~----~~~~~---------~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQV----EKGYR---------MSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCCC---------CCCCCC
Confidence 34678999999998889999999999999999998 898886433211 11111 11110 011122
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
....+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=307.31 Aligned_cols=255 Identities=31% Similarity=0.478 Sum_probs=206.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||+|.+.+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999998888899999987532 34567899999999999999999999999889999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986543 235789999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
. .....++..|+|||.+.+..++.++||||||+++++|++ |+.||..... ...+..... +..
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~----~~~--------- 222 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVER----GYR--------- 222 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC---------
Confidence 1 112234568999999998889999999999999999998 9998854332 112221111 100
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.72 Aligned_cols=193 Identities=23% Similarity=0.314 Sum_probs=164.4
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
....+|++.+.||+|+||.||+|++.. ++.||+|+..+. ....|+.++++++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345689999999999999999999854 778999986432 2346899999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|++. ++|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9996 4666666442 345899999999999999999999998 999999999999999999999999999753221
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNR 490 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~ 490 (605)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999866554
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=306.36 Aligned_cols=253 Identities=29% Similarity=0.470 Sum_probs=202.3
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|.+..+||+|+||.||+|.+..+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999886532 33467889999999999999999998875 456889999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999886532 335789999999999999999999998 999999999999999999999999999765432211
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ...... ..... .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~---------~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV----ERGYR---------M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC---------C
Confidence 1122346778999999998889999999999999999999 88888653321 111111 11110 0
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.73 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=201.0
Q ss_pred hcCccccceecccCeEEEEEEEE------cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC-C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG-E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 355 (605)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999974 34688999999753 234456788999999999 689999999988654 4
Q ss_pred eeEEEEEeeCCCchhhHHhhcCc---------------------------------------------------------
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTK--------------------------------------------------------- 378 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 378 (605)
..++||||+++++|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998854210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccc
Q 007397 379 -------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451 (605)
Q Consensus 379 -------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 451 (605)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999998 9999999999999999999999999998653322111222234
Q ss_pred cccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHH
Q 007397 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDE 530 (605)
Q Consensus 452 gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 530 (605)
+++.|+|||++.+..++.++||||||+++|+|++ |..|+........ ... ....+..... +...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~---------~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRMRA---------PDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCCCC---------CCCC
Confidence 5678999999999899999999999999999997 8888865332211 111 1111111110 0111
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 531 VIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 531 ~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+.+++..||+.+|++||++.+|++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.93 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=201.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.|++.+.||+|+||+||++.+. .++.+|+|.+.+.. ......+.+|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999884 58899999986532 2234567789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998885432 235888999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......|++.|+|||++.+..++.++||||||+++|+|++|..||....................
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------ 221 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------------ 221 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh------------
Confidence 11234689999999999999999999999999999999999999976443222111111111000
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..........+.+|+..||+.+|++||| +.+++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0111122345789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.30 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=188.3
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHH-HHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNE-VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||+||+|++. +++.+|+|++.+.. ......+..| ..+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999985 47889999986532 1222334444 4457889999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+....+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 9999888543 34778888889999999999999998 9999999999999999999999999997543221 12
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||........ ..... .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~----~~~~----------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNIL----NKPL----------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHH----hCCc----------CC
Confidence 3346799999999999999999999999999999999999999975432211 11111 0000 11
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 556 (605)
.+.....+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 122334678899999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.19 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=203.7
Q ss_pred cCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+... .......+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999998742 347999998653 234456789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986533 35789999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccccc-cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEIEG-STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..... ......++..|+|||++.+..++.++||||||+++||+++ |..||......+. .... .+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCCc----
Confidence 32111 1112223568999999998889999999999999999887 9999865443221 1111 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+........+.+++.+||+.+|++||+|.+|++.|..
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 01112234467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.66 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=199.2
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999985 5899999998643 233456788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
++ ++|..++........+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 578777755444456899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---------
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM--------- 513 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~--------- 513 (605)
.......+++.|+|||++.+. .++.++||||||+++++|++|+.||...........+........+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112234578899999988754 578999999999999999999999875432111111100000000000
Q ss_pred ----CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 ----PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ----~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......... ........++.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0011123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.62 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=204.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+.|++.++||+|+||.||+|.+.. ++.+|+|.+..........+.+|+.++++++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999999854 899999999876667778899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++.+.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 99999988875432 35889999999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.......+++.|+|||++. ...++.++|||||||++|||++|..|+....... .+.. . .......+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~---~-~~~~~~~~- 235 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLK---I-AKSEPPTL- 235 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHH---H-hcCCCccC-
Confidence 1123356889999999985 3457889999999999999999999986543211 1111 1 11111010
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 236 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1112233467889999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.68 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=188.6
Q ss_pred cceecccCeEEEEEEEEc---CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEEEEEeeC
Q 007397 291 NNKLGEGGFGRVYKGTLV---DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 365 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 365 (605)
.++||+|+||+||+|++. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999874 46789999986532 23456789999999999999999998864 456789999986
Q ss_pred CCchhhHHhhcC------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE----cCCCceEEeecCCC
Q 007397 366 NKSLDYFIFDQT------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLA 435 (605)
Q Consensus 366 ~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll----~~~~~vkl~DFGla 435 (605)
+ +|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6666653221 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred ccCCCCcc-cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc------hhHHHHHHH
Q 007397 436 RTFGGDEI-EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK------FNVIRHAWN 507 (605)
Q Consensus 436 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~------~~~i~~~~~ 507 (605)
+.+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||.....+.. ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 87643321 122334678999999999877 4589999999999999999999999975443211 011111111
Q ss_pred hhhcCC------------Ccccccccc---cC---------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGM------------PWQLIDACY---QE---------SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~------------~~~l~d~~~---~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ...+..... .. .........+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 100000 000000000 00 0000112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.30 Aligned_cols=256 Identities=20% Similarity=0.236 Sum_probs=196.7
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||++++. +++.||+|++.+. .......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999985 4899999998652 2334556889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 235788999999999999999999998 999999999999999999999999998765432
Q ss_pred cccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+. ... .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---~~~---i~~~~~~~~ 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGK---IMNHKEHFQ 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH---HHH---HHcCCCccc
Confidence 211 1223469999999999863 4578899999999999999999999865332111 111 111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHh
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHH--PEDRPSMPSVILML 559 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~L 559 (605)
+.. ........+.+++.+||... +..||++.+++.+-
T Consensus 229 ~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 100 01112345667777777543 33478999998873
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.22 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=189.6
Q ss_pred ceecccCeEEEEEEEEcC-------------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 292 NKLGEGGFGRVYKGTLVD-------------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
+.||+|+||.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555667888999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc-------eEEee
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN-------PKISD 431 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~-------vkl~D 431 (605)
+||||+++++|+.++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887543 235889999999999999999999998 999999999999987664 89999
Q ss_pred cCCCccCCCCcccccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIV-SGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~ell-tG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
||++..... .....++..|+|||++. +..++.++|||||||++|||+ .|..|+......+. .. ..
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~---~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER---FY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH---HH
Confidence 999876432 12345788999999887 466899999999999999998 57777654321111 11 01
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.... .. .......+.+|+.+||+.+|++||++.+|++.|+
T Consensus 223 -~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 01 0111346789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=310.33 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=202.4
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.|++.++||+|+||.||+|.+.. +..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 47888999999999999999854 77889999876666677788999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 99998887542 235899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred cccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 446 STNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
......+++.|+|||++. +..++.++|||||||++|||++|++||....... .+..... .....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~----~~~~~~--- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAK----SEPPTL--- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhh----cCCCCC---
Confidence 123356899999999984 3457889999999999999999999986543211 1111100 010011
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+......+.+++.+||+.+|++||++.++++..
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 01112335678999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=308.87 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=202.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|.+. +++.||+|.++.........+.+|+.+++.++|+||+++++.+......++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999874 5889999998765555566788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... +.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999988443 35889999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.......|++.|+|||++. ...++.++|||||||++|+|++|..|+............. ........
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~~~~~~~~--- 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------KSNFQPPK--- 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------ccCCCCCc---
Confidence 1223456899999999874 4568899999999999999999999986543221111100 00000000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... .......+.+++.+||+.+|++||++.+|+++
T Consensus 231 -~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 -LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 01123457899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=342.72 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=202.2
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||.||+|.+. .++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999985 4899999998753 2334567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 362 EFMPNKSLDYFIFDQTK--------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998854211 223566778899999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCccc----------------ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007397 434 LARTFGGDEIE----------------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497 (605)
Q Consensus 434 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 497 (605)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 01123569999999999999999999999999999999999999986532211
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcCC
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-SMPSVILMLGSD 562 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~~ 562 (605)
. ... .. +.++... .........+.+++.+||+.+|++|| +++++++.|+..
T Consensus 239 i----~~~-~~--------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I----SYR-DV--------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h----hhh-hh--------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 000 00 0000000 00112234577899999999999995 667777766543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=305.73 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=200.2
Q ss_pred ceecccCeEEEEEEEEcC--C--cEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD--G--QEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3689999987554 667789999999999999999999999988 888999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc-c
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE-G 445 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~-~ 445 (605)
++|..++..... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999866543 46899999999999999999999998 999999999999999999999999999876432211 1
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||++.+..++.++||||||++++||++ |..|+......+. ...... .... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~~--~------- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGER--L------- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCCc--C-------
Confidence 1123457789999999999899999999999999999999 9999864432221 111110 1100 0
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.42 Aligned_cols=255 Identities=17% Similarity=0.221 Sum_probs=196.7
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||.||++++.. ++.+|+|++.+. .......+.+|+.++..++|+||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999999854 788999998642 2233445788999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999986532 35788999999999999999999998 999999999999999999999999998765332
Q ss_pred cccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+... ..... ........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---~~~~i---~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKI---MNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---HHHHH---hCCCcccc
Confidence 21 1223357999999999986 3468899999999999999999999997543211 11111 11110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 558 (605)
+. .........+.+|+.+|+..++.+ ||++.+++++
T Consensus 229 ~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 001122345777888888654444 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.05 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=204.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||.||++.+.++..+|+|.+... ......+.+|+.++++++|+||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4689999999999999999999878888999988653 3345678899999999999999999999887 7789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999986543 345788899999999999999999988 999999999999999999999999999765432211
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++....++.++|||||||++|+|++ |..||....... ... ....+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~~-------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR----ALERGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhCCCCC--------
Confidence 1222345678999999998889999999999999999999 888886433211 111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+........+.+++.+||+.+|++||++.+|+++|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=309.31 Aligned_cols=239 Identities=23% Similarity=0.340 Sum_probs=188.9
Q ss_pred eecccCeEEEEEEEEcC-------------------------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeee
Q 007397 293 KLGEGGFGRVYKGTLVD-------------------------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKL 347 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 347 (605)
+||+|+||.||+|.... ...||+|++..........+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876555556678889999999999999999
Q ss_pred eeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC--
Q 007397 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-- 425 (605)
Q Consensus 348 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-- 425 (605)
++++......++||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888543 335788999999999999999999998 99999999999997654
Q ss_pred -----ceEEeecCCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCCc
Q 007397 426 -----NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIV-SGKRNRGLYNSDNK 498 (605)
Q Consensus 426 -----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~ell-tG~~p~~~~~~~~~ 498 (605)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988654221 12357788999998875 56899999999999999985 68888865433221
Q ss_pred hhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 499 FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 499 ~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
...+. ... . +... ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~~~~-------~~~--~-----~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYE-------KKH--R-----LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH-------hcc--C-----CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 000 0 0011 1235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.03 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=205.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|...+ ++.+++|.+..... ...+.+|+.++++++|+||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999999865 88999999875432 67899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999988543 346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++.+..++.++||||||+++++|++|+.|+........... ....... .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~-------~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPPP-------T 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCCC-------C
Confidence 12334578999999999998999999999999999999999999875433211100 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 01122234568899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.54 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=200.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||+|++. +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999875 58899999986432 2334567789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|++ ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 4787777543 235788999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc--
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID-- 519 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d-- 519 (605)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+..............+++
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11223457899999998875 4578999999999999999999999976543222221111110000000000000
Q ss_pred -------ccccC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 520 -------ACYQE----SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 520 -------~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+.... .........+.+|+.+||+.||.+|||+.||+++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000 01112234577899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.88 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=203.8
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.+.||+|+||.||++.+. .++.+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999985 6899999988643 344567888999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|..++........+++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988654334468999999999999999999997 46 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccchhcccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDG------LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ..+..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~-- 227 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI----VDGDP-- 227 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH----hhcCC--
Confidence 2234578899999998543 3588999999999999999999998654332222111111 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.+++..
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11223345668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.31 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=203.2
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+|++.++||+|+||.||++.+. +++.+|+|.+.. ......+.+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999984 589999998854 23445677889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|..++... ....++...+..++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887543 2345788999999999999999999998 99999999999999999999999999876643221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.. ..+.. ...+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~-------- 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILK----VCQGSYKP-------- 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHH----HhcCCCCC--------
Confidence 122356889999999999888999999999999999999999998653321 11111 11111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112223457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.99 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=206.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|.+. +++.+++|.+........+.+.+|+.++++++|+||+++++.+..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999984 4788999999765555678899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++... ...++...+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988553 235889999999999999999999998 9999999999999999999999999987654321
Q ss_pred cccccccccccCccchhcccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG---LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.|+...........+ ...... ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~~~~~~----~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------SKSNFP----PP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccCC----Cc
Confidence 112235688899999999776 7899999999999999999999998754422111110 001000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+ .........+.+++.+||+.+|.+||++.+|+.+
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 1123345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.33 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=198.0
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------ 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 354 (605)
..++|++.+.||+|+||.||++.+. .++.+|+|++... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999874 4889999998753 334456778899999999999999999988643
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++||||++++ |...+.. .+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3468999999764 4444422 3788889999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH---------
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA--------- 505 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~--------- 505 (605)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98653321 223457899999999999999999999999999999999999999754422111111000
Q ss_pred ------HHhhhcCC--Ccccc------cccc--cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 506 ------WNLWNKGM--PWQLI------DACY--QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 506 ------~~~~~~~~--~~~l~------d~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...+.... ...+. +... ...........+.+|+.+||+.||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000000 00000 0000 0011112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.85 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=194.7
Q ss_pred eecccCeEEEEEEEEc---CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCc
Q 007397 293 KLGEGGFGRVYKGTLV---DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 368 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~ 368 (605)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 35579999987543 344567899999999999999999999875 457899999999999
Q ss_pred hhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc-cc
Q 007397 369 LDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG-ST 447 (605)
Q Consensus 369 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~-~~ 447 (605)
|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988543 345899999999999999999999998 9999999999999999999999999997654322111 11
Q ss_pred cccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 448 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
....+++.|+|||++....++.++||||||+++|||++ |..||........ . .....+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---M----SFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHHCCCC---------CCC
Confidence 11233578999999988889999999999999999996 9999865432211 1 11111111 112
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22334578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.59 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.|+..+.||+|+||+||+|.+. +++.+|+|.+.... ......+.+|+.++++++|+|++++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999884 58899999986532 2234557789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998885432 235899999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+. ........
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~~~~-------- 222 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLETEE-------- 222 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhcccc--------
Confidence 1223568999999999998899999999999999999999999997543221111111 11111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
.........+.+|+..||+.+|++||+ +.+++..
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111222345678999999999999999 6676664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.96 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=202.6
Q ss_pred cCccccceecccCeEEEEEEEE-----cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--Cee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 357 (605)
..|++.++||+|+||.||+++. ..+..||+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 34788999998754 344556789999999999999999999998775 567
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999985432 35789999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC--------CchhHHHHHHHh
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD--------NKFNVIRHAWNL 508 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~--------~~~~~i~~~~~~ 508 (605)
....... .......++..|+|||++.+..++.++||||||+++|||+++..|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6432211 1122345677899999999888999999999999999999987654321110 000001111111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+... +........+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111111 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.71 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=192.1
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCC------CceeeeeeeEEeC-C
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQH------RNLVKLLGCCIQG-E 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~ 355 (605)
..++|++.++||+|+||+||+|.+. .++.||||+++.. ......+..|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999984 4788999998643 2233455667777776654 4588888888764 5
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCC---------
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDM--------- 425 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~--------- 425 (605)
+.++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ + ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 678899987 66777776443 3588999999999999999999984 7 99999999999998765
Q ss_pred -------ceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007397 426 -------NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498 (605)
Q Consensus 426 -------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~ 498 (605)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998764321 23346799999999999999999999999999999999999999976554322
Q ss_pred hhHHHHHHHhhh----c--------------CCCccccccc----ccCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 499 FNVIRHAWNLWN----K--------------GMPWQLIDAC----YQES---CNPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 499 ~~~i~~~~~~~~----~--------------~~~~~l~d~~----~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
...+......++ . +......++. .... ........+.+|+.+||+.||++|||+.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 222221110000 0 0000000000 0000 0001234577999999999999999999
Q ss_pred HHHHHh
Q 007397 554 SVILML 559 (605)
Q Consensus 554 evl~~L 559 (605)
|++++-
T Consensus 434 e~L~Hp 439 (467)
T PTZ00284 434 QMTTHP 439 (467)
T ss_pred HHhcCc
Confidence 999854
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=304.87 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=202.3
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.+|++.+.||+|+||.||++.+.+++.+|+|.+... ......+.+|+.++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999999877889999998643 2234578899999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999885432 35788999999999999999999998 9999999999999999999999999987654332111
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....++..|+|||++.+..++.++||||||+++|||++ |..||....... .+.. ...+. ....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~--~~~~~---- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET----INAGF--RLYKP---- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH----HhCCC--CCCCC----
Confidence 112234678999999998889999999999999999998 898886433211 1111 11110 11111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
......+.+|+.+||+.+|++||++.+|+++|.
T Consensus 224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.23 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=199.2
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEE-eCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 364 (605)
++|++.+.||+|+||.||++.. .++.+|+|.+... ...+.+.+|+.++++++|+|++++++++. .+...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 4788999998643 23467889999999999999999999765 456789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999886533 335789999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||....... .... ...+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCCCC--------
Confidence 22334668999999998889999999999999999998 888876432211 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=322.77 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=197.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 355 (605)
.++|++.+.||+|+||.||++.+. .++.||||++... .......+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999974 4889999999752 234456778899999999999999999987543 3
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++ +|...+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999976 45555522 3778889999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH----------
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA---------- 505 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~---------- 505 (605)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8653321 223456899999999999999999999999999999999999999765432211111100
Q ss_pred -----HHhhhcCCC--c-----ccccccc---cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 506 -----WNLWNKGMP--W-----QLIDACY---QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 506 -----~~~~~~~~~--~-----~l~d~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
......... . .+..... ...........+.+|+.+||+.||.+|||+.+++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000000 0 0000000 0011111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.73 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=201.7
Q ss_pred CccccceecccCeEEEEEEEEcCCcEEEEEEccccc------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999886321 22345688999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 34788999999999999999999998 99999999999999999999999999876532
Q ss_pred Cc----ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 441 DE----IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 441 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
.. .........|+..|+|||++.+..++.++||||||+++++|++|..||...........+.. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~-- 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-----HRGLM-- 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-----ccCCC--
Confidence 11 11112335689999999999998899999999999999999999999965432111110000 00000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 228 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 -------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122234567899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.17 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=204.5
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.+.||.|+||.||+|.+. +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999975 58899999986532 44556788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988543 6889999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||...+.... +.. ........+.+
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~----~~~~~~~~~~~---- 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFL----IPKNNPPSLEG---- 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHH----hhhcCCCCCcc----
Confidence 122335688899999999988899999999999999999999999965442211 111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .....+.+++.+||+.+|++||++.+++++
T Consensus 221 -~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 -N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 034467889999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.62 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=204.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+|++.++||.|+||.||+|.+ .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999987 56899999998765555567888999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998843 24789999999999999999999998 99999999999999999999999999886543321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ... ..... ..+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~---~~~~~-~~~------ 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLI---ATNGT-PEL------ 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH---HhcCC-ccc------
Confidence 122346889999999999888999999999999999999999998654432111 111 10110 000
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111223457789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.84 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=205.7
Q ss_pred cCccccceecccCeEEEEEEEEc-----CCcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-----DGQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 357 (605)
+.|++.+.||+|+||.||+|... .++.+|+|.+...... ....+.+|+.+++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999863 3688999999764432 56789999999999999999999999877 5678
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999986543 24889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch--------hHHHHHHHh
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF--------NVIRHAWNL 508 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~~i~~~~~~ 508 (605)
....... .......++..|+|||.+.+..++.++||||||++++||++|..|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532111 1111234556799999999889999999999999999999999887543322110 001111111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..... ....+......+.+|+.+||+.+|++||+|.+|+++|+..
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 1111222335688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=309.10 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=199.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC------C
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG------E 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 355 (605)
+.+.|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4677999999999999999999875 4889999998653 23456788999999998 699999999998753 4
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999988653 2345889999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
....... .......|++.|+|||++. +..++.++|||||||++|||++|..||.......... ....
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc
Confidence 7653221 1223456899999999986 3458889999999999999999999986433211111 1111
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+. .......+.+|+.+||+.+|.+|||+.+|++.
T Consensus 231 -~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111111 11223457899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.77 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=201.0
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+.+.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.++++++|+||+++++++..+...++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3455556679999999999999974 478899999887666677789999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~~ 441 (605)
|+++++|..++.........+...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999865432212277888889999999999999998 999999999999986 679999999998765332
Q ss_pred cccccccccccccCccchhcccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. ......|++.|+|||++.+.. ++.++||||||+++|+|++|..|+.......... ...... .
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~--~------- 228 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF--K------- 228 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh--c-------
Confidence 21 122345789999999986643 7899999999999999999999986533211100 000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+......+.+++.+||+.+|++|||+.+|+..
T Consensus 229 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 --IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111222334567899999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.52 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=207.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.+.||.|+||+||+|... ++..+|+|++... .......+.+|+.+++.++|+|++++++.+..+...++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999974 5789999998643 233667889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++........+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999966544456899999999999999999999998 99999999999999999999999999877644322
Q ss_pred c--ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 E--GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. .......|+..|+|||++... .++.++|||||||++++|++|+.||...+.......+ ... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~------~~~-~~~~---- 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT------LQN-DPPS---- 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH------hcC-CCCC----
Confidence 2 122345689999999998877 7899999999999999999999998754432211111 111 1101
Q ss_pred cccCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESC-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.... .......+.+++.+||+.+|++||++.+|++.
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 -LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11000 12334567899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.45 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=206.6
Q ss_pred HHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.....+|++.++||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 34457899999999999999999997 46899999999765555567788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999998843 34788899999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+....... ....+.. .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~~~-~---- 234 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP-E---- 234 (297)
T ss_pred Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCCCC-C----
Confidence 221 12335688999999999998899999999999999999999999965433211100 0000000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.+|++.
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 ---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.46 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=204.9
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||++.+. +++.+|+|.+........+.+.+|+.++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999974 5899999999766666777889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999885532 35899999999999999999999998 99999999999999999999999999876532211
Q ss_pred cccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
......+++.|+|||++. ...++.++||||||+++|+|++|+.||....... .+.. ........+
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~~- 228 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLK----ILKSEPPTL- 228 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHH----HhcCCCCCc-
Confidence 123356899999999975 3457889999999999999999999986543211 1111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++..||+.+|.+||++.+|++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0112233467889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.36 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=195.3
Q ss_pred ceecccCeEEEEEEEEcC-Cc--EEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD-GQ--EIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|+.+++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999854 43 5688888743 345566788999999999 799999999999999999999999999
Q ss_pred CchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 367 KSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 367 ~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
++...... ........+..|+|||++....++.++||||||++++||++ |..||...+... .... ...+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK----LPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH----HhCC
Confidence 98643211 11111223567999999988889999999999999999997 999986433211 1111 1111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
... .........+.+++.+||+.+|.+||++.+++..|...
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 110 11112234678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.54 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=216.4
Q ss_pred CccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
...|.++||.|.||.|++|+++- ...||||.++.. .+....+|..|+.||.+++||||++|.|+........+|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34667899999999999999843 457999999853 4566778999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|||++|+||.||+.+.. .+.+.+..-++++|+.|++||-+.+ +|||||...||||+.+...||+|||+++...++
T Consensus 710 EyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999987654 4888888999999999999999998 999999999999999999999999999976443
Q ss_pred ccccccccccc--ccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIG--TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
. ....+...| ...|.|||.+....++.++||||||+||||.++ |.+|+......+....|
T Consensus 785 ~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI---------------- 847 (996)
T KOG0196|consen 785 P-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI---------------- 847 (996)
T ss_pred C-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------------
Confidence 3 222222222 468999999999999999999999999999887 99999876544333322
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+.-++-+.+++++..|.+||+.|||+|-.+||.+.+|+.+|...
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 23345567788899999999999999999999999999999765
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.56 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=200.6
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccch---------hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE---------QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
+|.+...||+|+||.||+|.+. +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999874 588999998864221 233568899999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998543 35788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 437 TFGGDEIE----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 437 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~-~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKI---G-EN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHH---h-cc
Confidence 76432111 1112345889999999999888999999999999999999999998753221 111111 0 11
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ....+......+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 A---------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred C---------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 111122334567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.96 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=202.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999985 58999999886432 2334567899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999887643 234899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh--------hhcCC
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL--------WNKGM 513 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~--------~~~~~ 513 (605)
. ......++..|+|||++.+ ..++.++||||||+++++|++|+.||......+....+...... +....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 55789999999999999999999999765433222222111100 00000
Q ss_pred C-cccccccccCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 P-WQLIDACYQESC-----NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~-~~l~d~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .....+...... .......+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000000 01224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.16 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=203.9
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++|++...||+|+||.||+|+.. +.+.+++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999864 2467999988754433 5678999999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCcc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 359 LIYEFMPNKSLDYFIFDQTKR------ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654422 25899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
|++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .+.. ...
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQA 233 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHc
Confidence 998754322211 1223356778999999988888999999999999999999 777875433211 1111 111
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.... . .........+.+++.+||+.+|++||++.+++++|+
T Consensus 234 ~~~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 0 011123346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.40 Aligned_cols=258 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------ 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 354 (605)
..++|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999874 57899999987532 23345677899999999999999999987643
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++++|++ +++|..++. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468899987 778877763 235889999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+... .+..........
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~- 235 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTP- 235 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCC-
Confidence 9865432 234568999999999877 568999999999999999999999986543211 111111110000
Q ss_pred Cccccccc--------cc--CCCC--------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDAC--------YQ--ESCN--------PDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~--------~~--~~~~--------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........ .. ...+ ......+.+|+.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 0000 0112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.73 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=205.2
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||.++. .+++.+++|.+... .......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999987 45889999987642 345567788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999886543 345789999999999999999999988 99999999999999999999999999987643331
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......|++.|+|||++.+..++.++||||||+++++|++|..||......+ .... . ..+....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~---~-~~~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVK---I-VQGNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---H-HcCCCCC-------
Confidence 2234568999999999998889999999999999999999999986533211 1111 1 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
........+.+++.+||+.+|++||++.++++.+
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.77 Aligned_cols=251 Identities=33% Similarity=0.518 Sum_probs=198.8
Q ss_pred ceecccCeEEEEEEEEcC-------CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVD-------GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+.||+|+||.||+|+..+ ++.+|+|.+.+.. ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998743 2578999886532 34566788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-----ceEEeecCC
Q 007397 364 MPNKSLDYFIFDQT----KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-----NPKISDFGL 434 (605)
Q Consensus 364 ~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-----~vkl~DFGl 434 (605)
+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999988 99999999999999887 899999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ...... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcCC
Confidence 986643322222223345788999999999999999999999999999998 99988643321 111111 1111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.. ..+......+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1112234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.79 Aligned_cols=248 Identities=31% Similarity=0.463 Sum_probs=196.2
Q ss_pred ceecccCeEEEEEEEEcC----CcEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD----GQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|+||.||+|.... +..+|+|.+..... ...+.+.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 26899999875433 35567889999999999999999999875 5568999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc-
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG- 445 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~- 445 (605)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999986543 5789999999999999999999998 9999999999999999999999999998764332111
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...... ....... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCcC---------
Confidence 1111224568999999998899999999999999999998 99998654321 1111111 11110
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122334678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.53 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||+||++.+. +++.+|+|++... .....+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57889999999999999999974 5889999987643 344567889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|..++... +.+++..+..++.+++.||.|||+ ++ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999887542 358899999999999999999997 46 999999999999999999999999998654221
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc-----hhHHHHHHHhhhcCCCccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK-----FNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~-----~~~i~~~~~~~~~~~~~~l 517 (605)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ............. ....+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRL 233 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCC
Confidence 12345689999999999888999999999999999999999999986543211 1111111111111 10000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
........+.+++.+||+.+|++||++.||++++-.
T Consensus 234 --------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 234 --------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred --------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 011134568899999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=318.77 Aligned_cols=241 Identities=23% Similarity=0.269 Sum_probs=186.6
Q ss_pred ecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcC---CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
||+|+||+||+|++. +++.||+|++.+.. ......+..|..++..+ .||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999985 48999999986521 22233445566666655 699999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988854 335889999999999999999999998 9999999999999999999999999987643221 12
Q ss_pred ccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 447 TNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+. .. ....+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~----~i~~~~~-~~~~------ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR----NIAFGKV-RFPK------ 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH----HHHcCCC-CCCC------
Confidence 3346799999999998764 489999999999999999999999865432211 11 1111111 0100
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRP----SMPSVILM 558 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RP----t~~evl~~ 558 (605)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 01234567899999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=302.50 Aligned_cols=238 Identities=25% Similarity=0.419 Sum_probs=189.7
Q ss_pred ceecccCeEEEEEEEEcCCc-----------EEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 292 NKLGEGGFGRVYKGTLVDGQ-----------EIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5788877654333 6788899999999999999999999988 778999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-------ceEEeecC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-------NPKISDFG 433 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-------~vkl~DFG 433 (605)
|||+++++|+.++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5889999999999999999999988 99999999999999887 79999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCC--CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDG--LFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
++..... .....++..|+|||++.+. .++.++||||||+++++|++ |..|+.......... ...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~----~~~--- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----FYQ--- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH----HHh---
Confidence 9986533 1223467789999999876 78999999999999999999 566665543221111 000
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
.... . +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~--~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR--L---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC--C---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 0001157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=306.95 Aligned_cols=240 Identities=24% Similarity=0.411 Sum_probs=190.4
Q ss_pred ceecccCeEEEEEEEEcC--------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998633 235888888765556667889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc--------eEEeecCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN--------PKISDFGLA 435 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~--------vkl~DFGla 435 (605)
+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986543 25788999999999999999999998 999999999999987765 699999998
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGK-RNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
..... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .|+....... ... .... .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~-~ 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYED-R 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHc-c
Confidence 76432 123457889999999986 45799999999999999999985 5544322111 111 0000 0
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
. ..+......+.+++..||+.+|++|||+.+|++.|+
T Consensus 222 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=338.68 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=198.6
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 358 (605)
..++|+++++||+|+||+||++++.. ++.+|+|.+.. ........+..|+.++++++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 34689999999999999999999854 77889998864 234456678899999999999999999998865 35689
Q ss_pred EEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEecCCCCCEEEcCC---------
Q 007397 359 LIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSR----LRIIHRDLKTSNVLLDHD--------- 424 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~iiHrDlkp~NIll~~~--------- 424 (605)
|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+..
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999886532 23468999999999999999999998531 249999999999999642
Q ss_pred --------CceEEeecCCCccCCCCcccccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 007397 425 --------MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494 (605)
Q Consensus 425 --------~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 494 (605)
..+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|..||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998764322 1234579999999999864 458999999999999999999999996433
Q ss_pred CCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 495 SDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 495 ~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
. ....+. .+....... .......+.+||..||+.+|.+||++.+++.
T Consensus 248 ~--~~qli~----~lk~~p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N--FSQLIS----ELKRGPDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c--HHHHHH----HHhcCCCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2 111111 111111000 0112346889999999999999999999985
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.40 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=195.9
Q ss_pred ccceeccc--CeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 290 INNKLGEG--GFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 290 ~~~~LG~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
++++||+| +|++||++.. .+|+.||+|++... .......+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 7899999987 56899999998653 3345567888999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865432 34789999999999999999999998 999999999999999999999999865443211100
Q ss_pred -----ccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 445 -----GSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 445 -----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .... .+....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCcccc
Confidence 01122346788999999976 46899999999999999999999999753321110 0000 0000000
Q ss_pred ccc------------------------------------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDA------------------------------------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~------------------------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
++. .............+.+++.+||+.||++|||+.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 00001122234568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.47 Aligned_cols=261 Identities=25% Similarity=0.315 Sum_probs=200.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccch-----hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE-----QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
+|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999974 589999999975322 2345577899999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+ +++|..++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885433 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC------
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM------ 513 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 513 (605)
... ......+++.|+|||++.+ ..++.++|||||||+++||++|.++|......+ .+...........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence 321 1222356788999998865 457899999999999999999987776443321 1111111110000
Q ss_pred ---CcccccccccCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 ---PWQLIDACYQES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ---~~~l~d~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
............ ........+.+++.+||+.+|++|||+.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000001 112234678899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.38 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=203.2
Q ss_pred cCccccceecccCeEEEEEEEEcC-C----cEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G----QEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.+|++.+.||+|+||.||+|...+ + ..+|+|.+.... ......+.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568889999999999999998743 3 268999887543 3456778899999999999999999999887 78899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986532 34889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
............++..|+|||.+....++.++||||||++++||++ |..||......+... ....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-------LLEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHhCCCCC---
Confidence 3322111122234578999999988889999999999999999998 999986543322111 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++..||..+|++||++.++++.|...
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.38 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=201.8
Q ss_pred HHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEE-----
Q 007397 280 TIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCI----- 352 (605)
Q Consensus 280 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----- 352 (605)
.+....++|++.+.||+|+||.||++.+. .++.+|+|++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456789999999999999999999884 48899999886532 2345678899999999 6999999999884
Q ss_pred eCCeeEEEEEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 353 QGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 353 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
.+...++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999887543 23446788999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ +.
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~--- 239 (286)
T cd06638 168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LF--- 239 (286)
T ss_pred CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hh---
Confidence 999876543221 1233468999999999853 4578999999999999999999999865432111 11
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. ........+.+ +......+.+|+.+||+.+|++||++.||++.+
T Consensus 240 ~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 K-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00111111111 111234588999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=301.42 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=190.7
Q ss_pred ceecccCeEEEEEEEEcCC---cEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 292 NKLGEGGFGRVYKGTLVDG---QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
++||+|+||.||+|...++ ..+++|.+... .....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976443 34667766543 2345678899999999999999999999999999999999999999
Q ss_pred chhhHHhhcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 368 SLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 368 ~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
+|..++..... ....+...+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865422 334667778899999999999999988 99999999999999999999999999864322221122
Q ss_pred ccccccccCccchhcccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 447 TNKVIGTYGYMAPEYATD-------GLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+... +. +....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~---~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHV---IK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---Hh-hcccccC
Confidence 234567899999998753 245789999999999999997 4566643322 1122211 11 1112233
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
++.+... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322222 2345777888999 57999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.57 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=212.2
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+-|.++.+||+|+||.||+|.++. |+.+|+|.+.- +....++..|+.++++...+++|+++|.+......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 347788999999999999999854 99999999864 446788999999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
..|++.++++.. ++.+.+.++..++...++||+|||... -||||||..||||+.+|.+||+|||.|-.+....
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 999999999653 457999999999999999999999876 8999999999999999999999999998764332
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
...+++.|||.|||||++..-.|+.++||||||++..||..|++|+....+......| +...+ ...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PP-------PTF 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPP-------PTF 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCC-------CCC
Confidence 2345688999999999999999999999999999999999999999865543321111 01111 111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+-+++..||-+.|++|-|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2345667788899999999999999999998875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.35 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=202.0
Q ss_pred CccccceecccCeEEEEEEEEcC--CcEEEEEEccc----------cchhhHHHHHHHHHHHHc-CCCCceeeeeeeEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD--GQEIAVKRLSK----------ISEQGLNELKNEVILFSK-LQHRNLVKLLGCCIQ 353 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 353 (605)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.. ........+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999855 68899998753 223345567788888875 799999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
+...++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 234468899999999999999999996 55 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~----~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKI----VE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHH----hh
Confidence 99998754332 233456899999999999888999999999999999999999998643221 111111 11
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+..... ........+.+++.+||+.+|++||++.||..+|+.
T Consensus 228 ~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111 011123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.70 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=203.7
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEcc--ccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 360 (605)
....|+++++||+||.+.||++...+.+.+|+|++. ..+.+....+.+|+.+|.+|+ |.+||+|+++-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 346799999999999999999998888999999875 356778889999999999996 99999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||- ..+|..+|..... ....| .++.+..|++.|+.++|++| |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9975 4577777754332 22334 67789999999999999999 99999999999984 57899999999999877
Q ss_pred CcccccccccccccCccchhcccCCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGL-----------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
+.........+||+.||+||.+.... .++++||||||||||+|+.|+.||..+. +.+.+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl---- 582 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKL---- 582 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHH----
Confidence 76666667788999999999885322 5689999999999999999999997432 222221
Q ss_pred hcCCCcccccccccCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGMPWQLIDACYQESCNPD-EVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+.|+...-+++.. ...+++++|..||+.||++||+..+||+.
T Consensus 583 -----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 -----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 123333221111111 11128999999999999999999999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.02 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=201.4
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 362 (605)
+|++.+.||+|++|.||++.+. +++.+|+|++... .....+.+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999974 4789999998642 33456678899999999999999999988764 446789999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ....+++..+..++.|++.||.+||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988653 2345899999999999999999999998 9999999999999999999999999997664322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...+.. ..... ...+...
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~----~~~~~~~------- 220 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYR----IIEGKLP------- 220 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHhcCCC-------
Confidence 1223456889999999999999999999999999999999999998643321 11111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.77 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=202.7
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccch---hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISE---QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||+|...+ ++.+|+|.+.+... .....+.+|+.+++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999999855 89999999875322 35567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+.+++|.+++... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988543 2346889999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 007397 442 EIE---------------------------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494 (605)
Q Consensus 442 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~ 494 (605)
... .......||..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999999889999999999999999999999986544
Q ss_pred CCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 007397 495 SDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS----MPSVILM 558 (605)
Q Consensus 495 ~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~~ 558 (605)
..... . ...... ............+.+++.+||+.+|++||+ +.+++..
T Consensus 237 ~~~~~---~---~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETF---S---NILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHH---H---HHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 32111 1 111010 000111113467889999999999999999 6666663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.19 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777889999999999999874 4788999998743 344556789999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++.. ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988743 35788999999999999999999988 99999999999999999999999999977643221
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......|+..|+|||++.+..++.++||||||++++||++|..|+.......... .......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~~--------- 218 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNSP--------- 218 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCCC---------
Confidence 1223457889999999999889999999999999999999999986433221111 0111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..........+.+++.+||+.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122234568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.40 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=200.8
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.++||+|+||.||+|.+. .++.+|+|++.+.. ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999985 48999999986532 2245668899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..+.... ..+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876432 24789999999999999999999998 9999999999999999999999999988754332
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC-----Ccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM-----PWQ 516 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~-----~~~ 516 (605)
.......++..|+|||++.+ ..++.++||||||++++||++|++||......+....+......+.... ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 12233567899999999875 4578899999999999999999988864432111111111000000000 000
Q ss_pred ccc----cccc-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LID----ACYQ-----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d----~~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.+ +... ....+.....+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0000 00112234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.59 Aligned_cols=268 Identities=21% Similarity=0.298 Sum_probs=199.0
Q ss_pred CccccceecccCeEEEEEEEEc---CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV---DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 358 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 358 (605)
+|++.++||+|+||.||+|... .++.||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999984 47899999997632 34456778899999999999999999999988 8899
Q ss_pred EEEEeeCCCchhhHHhhcC-c-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC----CCceEEeec
Q 007397 359 LIYEFMPNKSLDYFIFDQT-K-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH----DMNPKISDF 432 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~----~~~vkl~DF 432 (605)
+||||+++ +|..++.... . ...++...+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 4545543322 2 236889999999999999999999998 999999999999999 899999999
Q ss_pred CCCccCCCCcc-cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch------hHHHH
Q 007397 433 GLARTFGGDEI-EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF------NVIRH 504 (605)
Q Consensus 433 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~------~~i~~ 504 (605)
|++........ ........+++.|+|||++.+. .++.++||||||+++++|++|.+||......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122345688999999988764 5789999999999999999999999765543310 01111
Q ss_pred HHHhhhcC------------CCcccccccccCCCC---------H--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 505 AWNLWNKG------------MPWQLIDACYQESCN---------P--DEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 505 ~~~~~~~~------------~~~~l~d~~~~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+... ......+.......+ . .....+.+++.+||+.+|++|||+.+|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111000 000000000000000 0 233468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.78 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=202.3
Q ss_pred cCccccceecccCeEEEEEEEEcC----CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|.+.++||+|+||.||+|.+.+ ...+|+|...... ....+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568889999999999999998744 2478999887543 4566789999999999999999999998865 567899
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999985432 34799999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
..... .....+++.|+|||.+....++.++||||||++++||++ |..||......+. ... ...+....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~~~~--- 228 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IENGERLP--- 228 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCCcCC---
Confidence 32211 122334568999999988889999999999999999996 9999865443221 111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+......+.+++.+|+..+|++|||+.++++.|+..
T Consensus 229 ------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 ------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122334688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=319.43 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=202.8
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..|.-++.||.|+||.||-|++ .+...||||+++. .+......+..|+..|+++.|||+|.+-+||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3467778999999999999998 4578899999974 34455677899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|||-| +-.+++.- .++++.+.++..|+.+.+.||+|||+++ .||||||..||||++.|.|||+|||.|....
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99955 44555532 3456888999999999999999999998 9999999999999999999999999997653
Q ss_pred cccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..+..+|||.|||||++. .+.|+-|+||||||++..||.-.++|....+.... +.++. .+..
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIA---QNes----- 242 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA---QNES----- 242 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHH---hcCC-----
Confidence 245678999999999986 46799999999999999999999999765443322 22211 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.+ ...+....+.+++..||++-|.+|||..+++..
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 156778889999999999999999999988764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=303.52 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=199.6
Q ss_pred ccccceecccCeEEEEEEEEc----CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 288 FSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
|.+.+.||+|+||.||+|.+. .++.+|+|++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999863 3688999998643 3445677889999999999999999999886542
Q ss_pred eeEEEEEeeCCCchhhHHhhcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQT---KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
..++++||+.+++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999988875322 2234788899999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
|+++...............+++.|++||.+.+..++.++||||||+++|+|++ |.+||...... ..... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH----HHc
Confidence 99987643322222223345678999999999899999999999999999999 88887643321 11111 111
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 01122345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.74 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=187.6
Q ss_pred ceecccCeEEEEEEEEcC---CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD---GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 366 (605)
.+||+|+||+||+|+..+ ++.+|+|.+.... ....+.+|+.++++++|+||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999999753 5789999986532 23457789999999999999999998854 4567899999876
Q ss_pred CchhhHHhhc------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE----cCCCceEEeecCCCc
Q 007397 367 KSLDYFIFDQ------TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLAR 436 (605)
Q Consensus 367 ~~L~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll----~~~~~vkl~DFGla~ 436 (605)
+|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554321 12235788999999999999999999998 9999999999999 566789999999998
Q ss_pred cCCCCccc-ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch------hHHHHHHHh
Q 007397 437 TFGGDEIE-GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF------NVIRHAWNL 508 (605)
Q Consensus 437 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~------~~i~~~~~~ 508 (605)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.....+... ..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 76433211 12234568999999999876 45899999999999999999999999754332110 011111110
Q ss_pred hhcCC------------Ccccccc----cc--------cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WNKGM------------PWQLIDA----CY--------QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~~~~------------~~~l~d~----~~--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.... ...+... .. ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0000000 00 000111123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.09 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=200.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc----------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS----------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE 355 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 355 (605)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+..|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999874 58999999875311 112346788999999999999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++++|..++... ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998554 45888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+...............|+..|+|||.+.... ++.++||||||+++++|++|..|+...... ..+ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAM---FKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHH---HHhhcccc
Confidence 7654322222233456889999999987654 899999999999999999999998532211 111 11111111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+ . ..........+.+++..||+.+|++||++.+|+++
T Consensus 230 ~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI-P----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC-C----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 1 11122334578889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.33 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=204.5
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..|+..++||+|+||.||+|.+. .++.+|+|.+... .......+.+|+.+++++.|+||+++++++..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999975 4889999998643 345567889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998843 34788889999999999999999988 99999999999999999999999999977643321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......++..|+|||++.+..++.++|||||||++|||++|..|+...........+ .... .
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~---------~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNN---------P 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcCC---------C
Confidence 122345788999999999888999999999999999999999998754332111100 0111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233455678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.46 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=204.2
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999985 4889999998642 33345778999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|++++.+..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999888766533 234789999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC--------C
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG--------M 513 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~--------~ 513 (605)
. .......++..|+|||++.+. .++.++||||||+++|+|++|.+||......+....+.......... .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678999999999888 88999999999999999999999987543322111111111000000 0
Q ss_pred ------Ccccccc-cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 ------PWQLIDA-CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ------~~~l~d~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+. ......+......+.+++.+||+.+|++||++++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 00001111225678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.33 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=201.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCc----EEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQ----EIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... .....++.+|+.++++++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56788899999999999999874 343 57889886532 33345788999999999999999999998654 4679
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988543 235788999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
............++..|+|||++.+..++.++||||||+++|||++ |..||........ . .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~----~---~~~~~~~~~--- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI----P---DLLEKGERL--- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----H---HHHHCCCCC---
Confidence 4332222333446778999999998899999999999999999997 8888864332111 1 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..+......+.+++..||..+|++||++.+|++.|....
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=298.98 Aligned_cols=251 Identities=34% Similarity=0.558 Sum_probs=201.4
Q ss_pred ccccceecccCeEEEEEEEEcC-----CcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+++.+.||+|+||.||++.+.+ +..+|+|.+...... ....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577899999999999999854 388999999764433 5678999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++...... .+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998553321 2799999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
...... ...+++.|+|||.+.+..++.++||||||+++++|++ |.+|+...... ...... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~----- 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYL----KKGYRL----- 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCCCC-----
Confidence 222111 2336789999999988889999999999999999998 77777653221 111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.........+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.30 Aligned_cols=254 Identities=25% Similarity=0.423 Sum_probs=203.8
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccccc------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+|+..+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999987 558999999986422 2245778999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTF 438 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~ 438 (605)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999988543 35788999999999999999999998 99999999999998776 5999999998776
Q ss_pred CCCccc--ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 439 GGDEIE--GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 439 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... .......|+..|+|||++.+..++.++||||+|+++++|++|..||...........+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---ASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH---hcc-----
Confidence 433211 1122346889999999998888999999999999999999999998654432222211111 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......+......+.+++.+||+.+|++||++.+++..
T Consensus 227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01112333445678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.74 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=201.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+.|.....||+|+||.||++.+. ++..||+|.+........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555578999999999999874 58899999987655566777899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 99999988733 24788999999999999999999998 99999999999999999999999999876533221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+..... .....+.+
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~----~~~~~~~~----- 240 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRD----NLPPRVKD----- 240 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----cCCCcccc-----
Confidence 123356899999999999888999999999999999999999998643321 11111111 11111100
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......+.+++.+||+.+|.+|||+.++++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11223457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.06 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=202.6
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999974 58999999987533 34456788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+ +++|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886543 45899999999999999999999998 99999999999999999999999999987644321
Q ss_pred cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC--------
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP-------- 514 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~-------- 514 (605)
.......|+..|+|||++.+. .++.++||||+|++++||++|.++|....... .+............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence 122335689999999998654 46899999999999999999987775433221 11111111100000
Q ss_pred ----cccccccc----cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 ----WQLIDACY----QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ----~~l~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+..... .....++....+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.00 Aligned_cols=263 Identities=28% Similarity=0.394 Sum_probs=204.2
Q ss_pred ccHHHHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe
Q 007397 276 FELATIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ 353 (605)
Q Consensus 276 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 353 (605)
+.+..+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334455566789999999999999999999984 58899999986532 2345677899999999 79999999999875
Q ss_pred C-----CeeEEEEEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 354 G-----EEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 354 ~-----~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
. ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999988543 23346889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-----LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i 502 (605)
||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....... .+
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~ 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TL 242 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HH
Confidence 9999999886543221 12234688999999997643 36899999999999999999999986543211 11
Q ss_pred HHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 503 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. . ...+....+.+ .......+.+++.+||+.+|++||++.+++++
T Consensus 243 ~---~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 F---K-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H---H-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 1 11111111111 11233468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=300.46 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=195.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 357 (605)
.+|++.+.||+|+||.||+|.+. .++.+|+|++... .......+.+|+.++++++|+||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999885 4899999988642 22345668899999999999999999998875 3567
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++++||+++++|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988543 34788899999999999999999988 99999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEI-EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~---~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFK---IATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHH---HhcCCC---
Confidence 532111 11122345889999999999888999999999999999999999998643221 11111 111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+......+..++ .||..+|++||++.||+++
T Consensus 227 ------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 ------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111222233445555 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=299.96 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=191.8
Q ss_pred ceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEE-eCCeeEEEEEeeC
Q 007397 292 NKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFMP 365 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 365 (605)
+.||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.+++.++|+||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 457999998643 3445678889999999999999999999776 4556789999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc-
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE- 444 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~- 444 (605)
+++|..++.... ..+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999986432 23577788889999999999999988 999999999999999999999999999765332211
Q ss_pred -ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 445 -GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG-KRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 445 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.......+++.|+|||.+.+..++.++||||||+++|||++| .+|+.... ........ . .+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~---~-~~~~~~------ 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL---L-QGRRLL------ 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---h-cCCCCC------
Confidence 111233467789999999888999999999999999999995 45554322 11111111 1 111100
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111234688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.58 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=201.6
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
+|+..+.||+|+||.||+|... +++.|++|.+.... ......+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999986 68999999886432 33567789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
+||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34788999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. ......|++.|+|||.+.... ++.++|+||||+++|+|++|..||....... .+. ........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~---~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVF---KIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHH---HHHhcccC-----
Confidence 32 223456889999999987766 8999999999999999999999987544211 111 11000111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01122234567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=298.68 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=202.8
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.++||+|+||.||++... +++.+|+|.+... ......++.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999874 5899999998642 344556889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998885432 234788999999999999999999998 99999999999999999999999999976643221
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......|++.|+|||++.+..++.++|||||||++++|++|+.|+...... .... ... .+...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~~~-~~~~~-------- 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVL---KII-RGSYP-------- 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHH---HHh-cCCCC--------
Confidence 122345888999999999888999999999999999999999998643221 1111 111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.17 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--Cee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 357 (605)
.+|++.+.||+|+||.||+|.+.+ ++.||+|.+... .....+.+.+|+.+++++.|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999854 899999987531 223456788999999999999999999988763 467
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 34788889999999999999999998 99999999999999999999999999886
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~---~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIF---KIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHH---HHhcCC----
Confidence 5332111 1123345889999999999888999999999999999999999998643211 1111 111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+......+.+++.+|+. +|++||++++|++.
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0112233445567788899985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=298.59 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=198.3
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.+.||+|+||.||++.. .++.+|+|.+.... ....+.+|+.++++++|+|++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999875 67889999986532 345788999999999999999999998654 5799999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986543 335789999999999999999999998 999999999999999999999999998764321
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .. ....+...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~--------- 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KE----CVEKGYRM--------- 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HH----HHhCCCCC---------
Confidence 112234568999999998899999999999999999998 8988865432211 11 11111110
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112233567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=301.40 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=202.2
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCC-----
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGE----- 355 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 355 (605)
..+++|++.+.||+|+||.||+|.+. +++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999985 578999999865433 456789999999999 6999999999997644
Q ss_pred -eeEEEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 356 -EKLLIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 356 -~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886532 2456889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|..||....... .+.. .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~ 230 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFK---I 230 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHH---h
Confidence 987653321 11233568999999998753 347889999999999999999999996433211 1111 1
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......+ .........+.+++.+||+.+|++|||+.+|+++
T Consensus 231 -~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 -PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111 1122245578899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=306.24 Aligned_cols=256 Identities=18% Similarity=0.203 Sum_probs=201.1
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||.||++.+.. ++.||+|.+.+.. ......+.+|+.+++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999999854 7899999987532 234567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 35788999999999999999999998 999999999999999999999999998742110
Q ss_pred c-------------ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 442 E-------------IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 442 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
. .........++..|+|||.+.+..++.++||||||+++|||++|..||...... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~-- 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVI-- 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--
Confidence 0 000112245788999999999888999999999999999999999998643321 1111110
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.... ..+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 --~~~~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 --SDDI---EWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --hccc---CCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1110 0000 001233457899999999999999997777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.33 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=197.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367999999999999999999985 58999999986432 2223456789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+.+ +|..++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 7888775433 35789999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc-----
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ----- 516 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~----- 516 (605)
. ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||..... ....+...+..........
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhh
Confidence 1 1122346889999999875 4589999999999999999999999865431 1111111111111000000
Q ss_pred -----------cc-cccccCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 -----------LI-DACYQESC-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 -----------l~-d~~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. ...+.... .......+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00000000 00112567789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=295.03 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=208.4
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.+.||+|++|.||+|.+.. ++.+|+|++..... .....+.+|+..+++++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999865 89999999876433 4567899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|.+++... ..++...+..++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998554 458999999999999999999999 88 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..|+................ .....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~------- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPP------- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCC-------
Confidence 21 124568899999999999899999999999999999999999987654322222222111 11111
Q ss_pred cCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPD-EVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+.. ....+.+++..||+.+|++||++.+++++
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122 34578899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.17 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.|....+||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445568999999999999874 589999999875545556778899999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 9999987733 34789999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
......|++.|+|||++.+..++.++|||||||+++||++|+.||...... ..+... ........ .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~~~~-------~ 238 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRL----RDSPPPKL-------K 238 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hccCCCCc-------c
Confidence 123356899999999999888999999999999999999999998643321 111111 11110000 0
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........+.+++..||+.+|++||++.+|++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011123457789999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.97 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=196.2
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.++||+|+||.||+|++. +|+.+|+|++... .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999985 5899999998642 222345677899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++ +|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 666665432 235899999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC------Ccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM------PWQ 516 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~------~~~ 516 (605)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|+...... ...+........... ...
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 112234578899999998764 4789999999999999999999886433221 111111111100000 000
Q ss_pred cccc----ccc-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDA----CYQ-----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~----~~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.+. ... .+..+.....+.+++.+||+.+|.+|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 000 01112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.49 Aligned_cols=268 Identities=21% Similarity=0.277 Sum_probs=216.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|..++.||+|.||.|.+++.+ .++.+|+|++++. .......-..|-.+|+..+||.+..+-..|...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468899999999999999999874 4899999999873 344555667899999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||..||.|..++.+ ...+++...+-+-..|+.||.|||+.+ ||+||||.+|+|||.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 999999999988844 456888888889999999999999988 9999999999999999999999999998632
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.....+.+.+|||+|+|||++....|..++|.|.+|||+|||+.|+.||...+.+..+.+|....-
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------- 385 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------- 385 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-------------
Confidence 223446678999999999999999999999999999999999999999987766655555442211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh--cCC-------CCCCCCCCCcccccC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML--GSD-------SVLAQPKQPGCLVDR 577 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L--~~~-------~~~~~p~~p~~~~~~ 577 (605)
.++.....+...|+...|.+||.+|. .+.||.++- .+. +.+++|=.|+..+..
T Consensus 386 ----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSet 452 (516)
T KOG0690|consen 386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSET 452 (516)
T ss_pred ----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccccc
Confidence 11222233456677788899999996 455665532 221 455667666665543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.81 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=202.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|+|++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999874 5889999998643 334567889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~~~ 442 (605)
+++++|.+++.... ...+++..+..++.|+++||.|||+++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986532 345789999999999999999999998 99999999999998654 58999999998764332
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......|+..|+|||.+.+..++.++||||||+++++|++|+.||...+... ...... ......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~----~~~~~~------ 220 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM----SGTFAP------ 220 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH----hcCCCC------
Confidence 1223568899999999998889999999999999999999999986543221 111110 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........+.+++.+||+.+|++|||+.+|++.
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.57 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=203.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.+.||+|+||.||++.+. +++.+|+|++.... ......+.+|+.++++++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999985 58999999987643 34566788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|.+++.... ..++...+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986543 468889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.....++..|+|||.+.+..++.++||||||+++++|++|..|+........ .......... ......
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~------ 223 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPPPR------ 223 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-cCCCCC------
Confidence 1125688999999999999999999999999999999999999875432111 1111111111 111111
Q ss_pred cCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPD-EVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ....+.+++..||..+|++|||+.+++.+
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 ---LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 34568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.18 Aligned_cols=245 Identities=26% Similarity=0.311 Sum_probs=201.7
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||.||++.+. +++.+|+|.+.+. .....+.+.+|+.++++++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999985 5899999998653 2234567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ..++...+..++.||++||.|||+.+ |+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999988554 45889999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.....|++.|+|||.+.+...+.++||||||+++|+|++|..||...... ...... ..+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKI----LEGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hcCCc-------
Confidence 23456899999999998888899999999999999999999998654421 111111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+++.+||+.+|.+|| ++.+++..
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11112245678999999999999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.13 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=205.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++|||++++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478999999999999999999874 5889999998755555567788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 24788899999999999999999998 99999999999999999999999999876543321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ..+.. .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~~~--------~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGTP--------E 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCCCC--------C
Confidence 1233468899999999988889999999999999999999999997543322111000 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..........+.+++..||+.+|++||++.+++.+-
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 011122334677899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=302.29 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=199.8
Q ss_pred HHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe-----
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ----- 353 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 353 (605)
.....+.|++.+.||+|+||.||+|.+. +++.+|+|.+... ......+..|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3345678999999999999999999984 5889999988653 33446788899999998 69999999999863
Q ss_pred -CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 354 -GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 354 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
....+++|||+++++|..++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence 457899999999999999886533 335788888999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
|++....... .......|++.|+|||++. ...++.++|||||||++|||++|..||.......... ..
T Consensus 166 g~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~-- 238 (282)
T cd06636 166 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LI-- 238 (282)
T ss_pred cchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hH--
Confidence 9987653221 1223356899999999876 3468889999999999999999999986543211111 00
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ......+ ........+.+++..||+.+|.+||++.+|++.
T Consensus 239 -~-~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 -P-RNPPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -h-hCCCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0000000 011233468899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=297.80 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=203.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 361 (605)
++|++.++||.|++|.||++.+. .++.+|+|.+... .......+.+|++++++++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999984 4889999998753 334567789999999999999999999988654 4689999
Q ss_pred EeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+++++|.+++... .....++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23445788999999999999999999998 99999999999999999999999999876532
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--CCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNS--DNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... .......+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhc
Confidence 21 1234578899999999999999999999999999999999999976533 1111111111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+.. .........+.+++.+||+.+|++|||+.||++.-
T Consensus 230 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 230 DEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred cCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 110 10112345688999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.83 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=202.9
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 361 (605)
+|++.+.||+|+||.||++.+ .+++.+|+|.+.. ......+.+.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 488899999999999999987 4578999998864 234456678899999999999999999998764 45678999
Q ss_pred EeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 362 EFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLH-----QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 362 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
||+++++|..++... .....+++..++.++.||++||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22456899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
........ ......+++.|+|||++.+..++.++||||||+++++|++|..|+..... ..... ....+..
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~- 227 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKF- 227 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCC-
Confidence 87654322 12235689999999999988899999999999999999999999875441 11111 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.+|+++
T Consensus 228 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222344578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.18 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=200.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 360 (605)
++|++.+.||+|+||.||+|.+. +++.+|+|.++... ......+.+|+.++++++|+||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999985 48899999986432 22334567899999999999999999999877 889999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+.+ +|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8887775432 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------Hhhhc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NLWNK 511 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~~~~ 511 (605)
.. .......+++.|+|||++.+. .++.++||||||+++++|++|.+||...........+.... ..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112334578899999998764 46899999999999999999999997654332222221110 00000
Q ss_pred ------CCCcccccccccCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 512 ------GMPWQLIDACYQESCNPD-EVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 512 ------~~~~~l~d~~~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..........+....... ....+.+++..||+.+|++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000111111111 34567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.01 Aligned_cols=264 Identities=24% Similarity=0.312 Sum_probs=196.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCe-----
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 356 (605)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999984 58999999876432 223456788999999995 6999999999987665
Q ss_pred eEEEEEeeCCCchhhHHhhcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFG 433 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFG 433 (605)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 67777654322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ .......+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence 9886533211 1122356889999998865 4579999999999999999999999875432211 11111111000
Q ss_pred C--Cc----ccccc----c----ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 M--PW----QLIDA----C----YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~--~~----~l~d~----~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .. .+.+. . ......+.....+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00 00000 0 0000112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.59 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=197.2
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++++|.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999874 58999999986532 233346778999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+. +++...+.... ..+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 56655554322 34678888899999999999999998 999999999999999999999999998764322
Q ss_pred cccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC-------
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM------- 513 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~------- 513 (605)
.. ......+++.|+|||++.+. .++.++|||||||++++|++|..||..... ....+...+..+....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence 11 12234578999999998764 578999999999999999999999975432 1222222222111000
Q ss_pred --Ccccccccc----cCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 --PWQLIDACY----QES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 --~~~l~d~~~----~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......... ... ........+.+++.+|++.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000 000 000113467789999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.47 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=207.1
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
...+.|++.+.||+|+||.||+|.+. +++.+++|++..... ....+.+|+.+++.++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45678999999999999999999985 589999999976443 5677889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999986543 36899999999999999999999988 999999999999999999999999998765432
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|..|+........ .... .......+.
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~~~~--- 237 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLI----TTKGIPPLK--- 237 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhcCCCCCc---
Confidence 21 12234578899999999988899999999999999999999999864432211 1110 011111110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
........+.+++.+||+.+|.+||++.+|+.+.
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 1111345688999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=348.08 Aligned_cols=263 Identities=25% Similarity=0.435 Sum_probs=209.0
Q ss_pred HHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
......|...+.||+|+||.||+|++ .+++.||||++...... ...|+.++++++|||||++++++......++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 34445678889999999999999997 56899999998653322 23468899999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++. .++|..+.+++.||++||+|||.....+|+||||||+||+++.++.+++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999984 27899999999999999999996544459999999999999999988876 666543321
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....................+|+
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCc
Confidence 12236789999999999999999999999999999999999998543222 22233333333333333344555
Q ss_pred cccC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 521 CYQE--SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 521 ~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.. .....+..++.+++.+||+.+|++||+|.+|+++|+..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 5433 34556777889999999999999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=290.59 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=207.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 361 (605)
+|.+.+.||+|++|.||+|.+. +++.+++|++.... ....+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999986 58999999987543 35677899999999999999999999999988 8899999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 6899999999999999999999988 999999999999999999999999999877554
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
..........++..|+|||.+.+..++.++||||||+++++|++|..||..... .....+.......
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGE-------- 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCC--------
Confidence 322123345688999999999988899999999999999999999999876551 1111111111011
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+......+.+++.+||+.+|++||++.+++..
T Consensus 222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111222335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.10 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=201.5
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+|++.++||+|++|.||+|++. +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999985 58899999987543 223456778999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++ +|..++........+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 77777765554456899999999999999999999998 99999999999999999999999999976532211
Q ss_pred ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------HhhhcCC--
Q 007397 445 GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NLWNKGM-- 513 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~~~~~~-- 513 (605)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+.... ..+....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12234578899999988664 57899999999999999999999987654332222111110 0000000
Q ss_pred ---CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 ---PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ---~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+... ....+.....+.+++.+||+.+|.+||++.+|++.
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 01112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.25 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=211.3
Q ss_pred HhcCccccceecccCeEEEEEEEEcCC-cEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDG-QEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..+.|+|+..||.|+||.||+|..++. -..|.|++...+....+.+.-|+.||....||+||+|++.|......+++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 456788999999999999999988664 4457788877778888999999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
||.||.++.++..-. ..+.+..+..++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+......
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 999999999986544 36899999999999999999999998 999999999999999999999999997654221
Q ss_pred ccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
........|||.|||||+.+ ..+|+.++||||||++|.||..+.+|-...++...... +....+..+
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-------iaKSePPTL 255 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-------IAKSEPPTL 255 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-------HhhcCCCcc
Confidence 12234578999999999875 57899999999999999999999999765544322111 122333344
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+. +......+.+++.+||..+|..||++.+++++-
T Consensus 256 lq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 LQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred cC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 33 345566788999999999999999999998753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.03 Aligned_cols=263 Identities=25% Similarity=0.315 Sum_probs=198.6
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------ 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 354 (605)
..++|++.+.||+|+||.||+|.+. +++.||+|++.+. .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999984 5899999998642 334456677899999999999999999988643
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++||||+.+ +|...+.. .++...+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999965 66666532 1788889999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH----------
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH---------- 504 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~---------- 504 (605)
++...... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98754322 12334678999999999999999999999999999999999999875442111111100
Q ss_pred -----HHHhhhcCCC-------cccccccc----cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 505 -----AWNLWNKGMP-------WQLIDACY----QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 505 -----~~~~~~~~~~-------~~l~d~~~----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......... ..+..... ...........+.+++.+||+.||++|||+.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00000000 011122345567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=294.17 Aligned_cols=252 Identities=28% Similarity=0.459 Sum_probs=201.7
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccch--hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE--QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999874 689999999875433 3677899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999988543 34788999999999999999999998 99999999999999999999999999887644322
Q ss_pred ccc--ccccccccCccchhcccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 444 EGS--TNKVIGTYGYMAPEYATDGL---FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 444 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
... .....+++.|+|||++.+.. ++.++||||||+++++|++|..||...... . .+..... ......+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~-~~~~~~~---~~~~~~~- 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F-QIMFHVG---AGHKPPI- 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H-HHHHHHh---cCCCCCC-
Confidence 111 12356789999999998766 899999999999999999999999654311 1 1111100 0111011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+........+.+++.+||+.+|++||++.+++.
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 ------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011112445778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=306.73 Aligned_cols=253 Identities=24% Similarity=0.436 Sum_probs=210.7
Q ss_pred cCccccceecccCeEEEEEEEEcC---C--cEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD---G--QEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+..+..+.||+|.||.||+|...+ | -.||||..+. ......+.|..|+.+++++.|||||+++|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999998532 3 3689998876 344557889999999999999999999999975 56799
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|||.++.|.|..++..+ +..++......++.||..||+|||+.. .|||||...|||+.+...|||+|||+++...
T Consensus 468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999654 345888899999999999999999987 9999999999999999999999999999987
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.+.+-... ...-..-|||||.+.-..++.++|||-|||.+||++. |..||......+... .+
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~i 605 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HI 605 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------Ee
Confidence 65443322 3345678999999999999999999999999999987 999997655433322 22
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+..-+.++++.++..|.-|+.+||..+|.+||.+.++...|+.
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 2223446788888999999999999999999999999887744
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=297.23 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=199.9
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 361 (605)
.|++.+.||+|+||.||+|.+ .+++.+|+|.+... .......+.+|+.++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 478889999999999999997 56899999998653 3445667889999999996 999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999887432 5889999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .........+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~--- 222 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSKPPRL--- 222 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCCCCCC---
Confidence 31 1233468899999999875 457899999999999999999999996543211110 0001111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... .....+.+++.+||+.+|++||++.+++.+
T Consensus 223 --~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 --EDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 133567889999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.68 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=201.3
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.+.|+||+++++++......++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355568999999999999987 4688999999865555556678899999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998854 34788999999999999999999998 99999999999999999999999998876543221
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
......|++.|+|||.+.+..++.++||||||+++++|++|..||...+.. ..+.... ......+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~----~~~~~~~~------- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIR----DNLPPKLK------- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHH----hcCCCCCc-------
Confidence 122346899999999999888999999999999999999999998653321 1111111 11111110
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 011123468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=289.84 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=205.7
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.|++.+.||+|++|.||++.+. +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999985 689999999977555567889999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|.+++.... ..+++..+..++.|+++||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885542 45899999999999999999999988 99999999999999999999999999887654321
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
.....++..|+|||++.+..++.++||||||+++++|++|..|+........ +.... ......+..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIA----TNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHH----hcCCCCcCc------
Confidence 2345688999999999988899999999999999999999999865432111 11111 011111111
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......+.+++.+||+.+|++|||+.+|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.77 Aligned_cols=272 Identities=18% Similarity=0.266 Sum_probs=189.5
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC--CcEEEEEE--------------cc---ccchhhHHHHHHHHHHHHcCCCCc
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD--GQEIAVKR--------------LS---KISEQGLNELKNEVILFSKLQHRN 343 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~n 343 (605)
...++|+++++||+|+||+||++.... +...++|. +. .........+.+|+.++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 22222221 11 122334556889999999999999
Q ss_pred eeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK--RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 344 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
|+++++++...+..++|+|++.+ +|..++..... ........+..++.||+.||.|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999865 45555433211 122345667789999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV 501 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 501 (605)
+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++...........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643321 122345799999999999999999999999999999999998755433222222222
Q ss_pred HHHHHHhhh---cCCC------ccccccc-cc--CCCC------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 502 IRHAWNLWN---KGMP------WQLIDAC-YQ--ESCN------PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 502 i~~~~~~~~---~~~~------~~l~d~~-~~--~~~~------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+......+. +..+ ...++.. +. .... ......+.+++.+||+.||++|||+.|++++-
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 211111110 0000 0000000 00 0000 00123466789999999999999999999853
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.05 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=201.2
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
-|++.++||+|+||.||+|.+ .+++.+|+|.+... .......+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477889999999999999987 45889999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|..++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988843 35789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......++..|+|||.+.+..++.++|||||||++++|++|..|+........ .. ........
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~--------- 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LF----LIPKNNPP--------- 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HH----HHhcCCCC---------
Confidence 12234678899999999888889999999999999999999999864332111 11 01111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122234567889999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.12 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=196.7
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Cee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 357 (605)
.++|++.++||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999987 45899999998643 233456678899999999999999999987654 357
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++|+||+.+ +|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 6665552 235889999999999999999999998 99999999999999999999999999887
Q ss_pred CCCCccc-ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC-
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP- 514 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~- 514 (605)
....... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+... .+............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 5432211 12233568999999998754 568999999999999999999999996533211 11111111110000
Q ss_pred --ccccccc-------c--cCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 --WQLIDAC-------Y--QES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 --~~l~d~~-------~--~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+.+.. . ... ..+.....+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 000 011224568899999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=300.59 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=213.0
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
..+.|..-++||+||||.|+-+...+ |+.+|.|++.+ ...++.....+|..+|.+++.+.||.+-..|...+..+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34678889999999999999998754 99999999865 234566678899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|+..|.||+|..+|.+... ..+++..++-++.+|+.||++||... ||+|||||+|||||+.|+++|+|+|+|..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999977655 46899999999999999999999988 9999999999999999999999999999886
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
..... ...+||.+|||||++.+..|+...|.|||||+||||+.|+.||...........+.+.... +
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------~ 405 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------D 405 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----------c
Confidence 55432 2348999999999999999999999999999999999999999877665555444322110 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
...++....+++..|....|+.||++|. .+.+|-++
T Consensus 406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1234445556677888888999999996 45566553
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=294.97 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=203.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+|++.+.||+|+||.||+|.+. .++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999985 48999999997532 2456788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+.+++|..++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988543 46889999999999999999999998 9999999999999999999999999988764332
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......|+..|+|||++.+..++.++|+||||+++|+|++|..|+.............. ... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~----------~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET----------A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc----------c
Confidence 12335688899999999988899999999999999999999999876554311111111 100 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSM--PSVI 556 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 556 (605)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111222234678899999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.22 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=197.0
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999884 5899999998643 223345788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 57877775432 345889999999999999999999998 99999999999999999999999999876543211
Q ss_pred cccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---------
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM--------- 513 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~--------- 513 (605)
......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .+...........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhH
Confidence 122335688999999887644 6889999999999999999999986543211 1111111000000
Q ss_pred -------CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 -------PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 -------~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........+. ...+.....+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 0011123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.18 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=199.6
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEEEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 362 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 362 (605)
|++.++||+|+||.||+|...+ ++.+|+|++.... ......+.+|+.++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6788999999999999999854 8899999997642 33455688999999999999999999999988 88999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++ +|..++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 7777774432 46899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc----
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL---- 517 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l---- 517 (605)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+..............+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1 11223456889999998765 45789999999999999999999998765532222222111100000000000
Q ss_pred ----------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ----------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ----------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+.......+...+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.02 Aligned_cols=251 Identities=28% Similarity=0.399 Sum_probs=209.8
Q ss_pred CccccceecccCeEEEEEEEEcC--C--cEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD--G--QEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
...+.++||+|.||.|++|.+.. | ..||||.++..... ....|.+|+.+|.+|+|+|+|+|||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34556899999999999998743 4 36899999865433 78899999999999999999999999887 7788999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|.++.|+|.+.|++ ..+..+-......++.|||.|+.||.+++ +|||||...||||-....|||+|||+.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999988 56677888999999999999999999998 999999999999999999999999999998654
Q ss_pred ccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 442 EIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 442 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
+.. .......-...|.|||.+....++.++|||+|||++|||++ |+.||-....-... +.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhcc
Confidence 322 22223334678999999999999999999999999999999 77787654432221 2333
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..-.-..+..+.+++++++..||..+|++|||+..|++.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 333445667788899999999999999999999999743
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=299.96 Aligned_cols=248 Identities=28% Similarity=0.413 Sum_probs=196.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.+.|++.++||+|+||+||+|.+. +++.||+|.+... .......+.+|+.+++.++|+||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356899999999999999999984 5899999988642 234456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+.+ ++.+++... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999975 555555322 235899999999999999999999998 99999999999999999999999999875432
Q ss_pred CcccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.....+++.|+|||++. ...++.++||||||+++|||++|..|+....... .+.. .. ......+
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~~---~~-~~~~~~~ 234 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH---IA-QNDSPTL 234 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHHH---Hh-cCCCCCC
Confidence 12346788999999874 4568899999999999999999999986432211 1111 10 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
........+.+++.+||+.+|++||++.+|+.+.
T Consensus 235 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 --------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1122345688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.99 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=193.7
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHH-HHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+..|+.+ ++.++|+||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999985 58999999987532 2233445556554 666789999999999999999999999
Q ss_pred eeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 363 FMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 363 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|++ ++|..++... .....+++..+..++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5777776542 2345689999999999999999999987 6 99999999999999999999999999986533
Q ss_pred CcccccccccccccCccchhcccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATD----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
.. ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||..... ....+.. ... +....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~---~~~-~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQ---VVE-EPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHH---HHh-cCCCC
Confidence 21 1222457889999998864 4568999999999999999999999864221 1111111 111 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.. ......+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1123468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.93 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=197.1
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
|++.++||+|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++|+|++++++++..+...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999874 69999999986432 233456888999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
+ ++|..++..... ..+++..+..++.||++||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 588888754332 35899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC------Cccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM------PWQL 517 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~------~~~l 517 (605)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||........... ......... ...+
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR---IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhhhhhc
Confidence 112223568899999988664 578999999999999999999999865432211111 111000000 0000
Q ss_pred cc---c------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ID---A------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d---~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+ . .............+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0 00001112233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.17 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=197.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 359 (605)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999984 48999999986422 22233566899999999999999999998765 56799
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+.+ +|..++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677766443 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC----
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP---- 514 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~---- 514 (605)
... .......+++.|+|||++.+ ..++.++||||||+++|||++|.+||...+.......+......-.....
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 322 11222345788999999865 55799999999999999999999999754432222222111000000000
Q ss_pred -------ccccccccc--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 -------WQLIDACYQ--ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 -------~~l~d~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+...... ..........+.+++.+||+.||++|||+.+++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000000 000011244567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.05 Aligned_cols=269 Identities=20% Similarity=0.281 Sum_probs=196.2
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----- 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 355 (605)
..++|++.++||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999985 5899999988642 2223345678999999999999999999987654
Q ss_pred ---eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 356 ---EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 356 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
..++||||+.+ +|...+... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 666666332 235899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCccc--ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 433 GLARTFGGDEIE--GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 433 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|..||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999876432211 112234578899999988664 47899999999999999999999987554332222222211111
Q ss_pred hcCCCc-----cccccc-ccCC---------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGMPW-----QLIDAC-YQES---------CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~~~-----~l~d~~-~~~~---------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ...+.. +... ........+.+++.+||+.+|++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 000000 0000 000112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.13 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=188.4
Q ss_pred eecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHH---HcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 293 KLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.||+|+||.||++.+. +++.+|+|.+.+.. ......+.+|..++ ....|+||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999984 48899999886421 12222334444333 34479999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 35899999999999999999999998 9999999999999999999999999987653321
Q ss_pred cccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||......... .+..... . ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---~----------~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---T----------VNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---c----------CCc
Confidence 22346899999999986 456899999999999999999999999765432221 1111100 0 011
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+.....++.+++..||+.+|++|| ++++++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 12223345688999999999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.59 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=198.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Ce
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 356 (605)
.++|.+.+.||+|+||+||+|++. +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999974 5899999998652 233445677899999999999999999988654 34
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 577777643 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh-----
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN----- 510 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~----- 510 (605)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764321 11233467889999998865 4689999999999999999999999865432211111111100000
Q ss_pred ---cCCCcccc-------cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 511 ---KGMPWQLI-------DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 511 ---~~~~~~l~-------d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......+ +... ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0000 00112234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.56 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=207.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
....|.+.++||+|.|+.|.+|++. .+..||||.+.+. .......+.+|+++|+.++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3568999999999999999999984 4999999999874 333445588999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||..+|.+++++.++.+ ..+..+..++.|++.|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999966544 455888899999999999999998 99999999999999999999999999988753
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.......+|++.|.|||++.+..| .+.+|+||+|++||-|+.|..||+..+-.+..... +-
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~ 269 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LR 269 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------ee
Confidence 334556899999999999999877 58899999999999999999999865543322111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..++ .+.-...+|.++++++|-.+|.+|++++++.+.
T Consensus 270 gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 111122357789999999999999999999874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.58 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=198.3
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..|...+.||+|+||.||+|.+. ++..+|+|++... .......+.+|+.++++++|+|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999974 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 666655432 335889999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.....|++.|+|||++. ...++.++|||||||++|||++|..||........ +... ...... .
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~---~~~~~~-~-- 243 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI---AQNESP-T-- 243 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH---HhccCC-C--
Confidence 22346889999999974 45688999999999999999999999865332111 1111 001110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
.........+.+++.+||+.+|.+||++.+|++.+-....
T Consensus 244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0111233457899999999999999999999997655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.82 Aligned_cols=244 Identities=27% Similarity=0.369 Sum_probs=194.4
Q ss_pred ecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||+||++... +++.+|+|.+.+.. ......+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999874 58999999986422 23344567899999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 998865433 35889999999999999999999998 9999999999999999999999999987653311 1223
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
..++..|+|||++.+..++.++||||||+++++|++|+.||...........+..... . . ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-~---------~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL---E-M---------AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc---c-c---------cccCCcc
Confidence 4578899999999888899999999999999999999999976544222222211100 0 0 0111222
Q ss_pred HHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 007397 530 EVIRCIHISLLCVQHHPEDRP-----SMPSVIL 557 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 557 (605)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 345678999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.12 Aligned_cols=258 Identities=16% Similarity=0.198 Sum_probs=183.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCC----cEEEEEEccccchhhH-----------HHHHHHHHHHHcCCCCceeeeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDG----QEIAVKRLSKISEQGL-----------NELKNEVILFSKLQHRNLVKLLG 349 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 349 (605)
.++|++.++||+|+||+||+|...++ ..+|+|+......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999997553 4556665432111110 11223344566778999999998
Q ss_pred eEEeCC----eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 350 CCIQGE----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 350 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
++.... ..++++|++.. ++...+... ...++..+..++.||++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776543 34677776643 444444221 23467888999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcc-----cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 007397 426 NPKISDFGLARTFGGDEI-----EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 500 (605)
.+||+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||+++||++|..||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987642211 111223469999999999999999999999999999999999999998664322211
Q ss_pred H-HH-HHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 501 V-IR-HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 501 ~-i~-~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
. .. ........+. +.. ......+.+++..|++.+|++||++.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGK--------IKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhh--------hcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 11 0111111111 110 111356788999999999999999999998864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.57 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=200.6
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccccch--hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE--QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 667899999999999999984 588999999865322 34567888999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++ +|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 7777765432 46889999999999999999999998 9999999999999999999999999987765432
Q ss_pred ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---Cccccc-
Q 007397 445 GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM---PWQLID- 519 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~---~~~l~d- 519 (605)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+. +......+.... ...+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 112234578899999998876 789999999999999999999999865443222 111111111100 000000
Q ss_pred ----------c--cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ----------A--CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ----------~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .............+.+++..||+.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00011122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.47 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=195.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|+..++||+|+||.||++.+. +++.+|+|.+... .......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999984 4899999998753 2345567889999999996 9999999999999999999999
Q ss_pred eeCCCchhhHHhh--cCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFD--QTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|+.. ++..+... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9865 44433211 11234688999999999999999999975 6 9999999999999999999999999997654
Q ss_pred CCcccccccccccccCccchhcccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDG---LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
.... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.... ........... ....
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~- 229 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPP- 229 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCC-
Confidence 3221 2234588999999998776 68999999999999999999999986543 11111111111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+...........+.+|+.+||+.+|++|||+.+|++.
T Consensus 230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111222345568899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=295.13 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=193.0
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeC--CeeEEEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 362 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 362 (605)
|++.++||+|+||.||+|... +++.+|+|++.+.. ........+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999874 58999999987532 222233457888888885 99999999999987 88999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 666666442 246899999999999999999999998 999999999999999 999999999998764322
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------HhhhcCC
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NLWNKGM 513 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~~~~~~ 513 (605)
. .....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+....+.... .......
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 123457899999997654 557899999999999999999999996644322111111100 0000000
Q ss_pred Cccccccccc----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......+... ..........+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 00112335678999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.53 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=201.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999985 4889999998643 223456788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~~~ 442 (605)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886532 235789999999999999999999998 99999999999999886 46999999988764322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......|++.|+|||++.+..++.++||||||+++++|++|..|+...+.. ..+. ... .....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~~------- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVL---KIC-QGYFA------- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHh-cccCC-------
Confidence 1 122345889999999998888999999999999999999999998643321 1111 111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+.....+.+++.+||+.+|++|||+.+|++.
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112233468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.28 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=204.9
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.++||+|+||.||++.+. +++.+|+|.+... .......+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999874 5789999998753 334456778899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885532 2356889999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+... +.. ....+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~---~~~~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRY---KVQRGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---HHhcCCC--------
Confidence 1223457899999999999999999999999999999999999986543211 111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.07 Aligned_cols=267 Identities=24% Similarity=0.360 Sum_probs=198.7
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC--Cee
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 357 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 357 (605)
..++|++.+.||+|+||.||+|.+. +++.+|+|++.+. .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999985 5889999988542 233445677899999999 999999999988653 467
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++ +|..++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999974 887777432 5788899999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc---ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-------
Q 007397 438 FGGDEIE---GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW------- 506 (605)
Q Consensus 438 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~------- 506 (605)
....... .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433211 22334568999999998765 457899999999999999999999986543322111111100
Q ss_pred -HhhhcCCCccccccccc------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 507 -NLWNKGMPWQLIDACYQ------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 507 -~~~~~~~~~~l~d~~~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+.......+++.... ....+.....+.+++.+||+.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000001110000 00111134568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.08 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=195.2
Q ss_pred ceeccc--CeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEG--GFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
..||+| +||+||++.+. .++.||+|++... .....+.+.+|+.+++.++|+||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 567777 99999999984 6999999998642 334557889999999999999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc--
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE-- 444 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~-- 444 (605)
++|..++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999998865432 34788999999999999999999998 999999999999999999999999865432211100
Q ss_pred ---ccccccccccCccchhcccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH------------
Q 007397 445 ---GSTNKVIGTYGYMAPEYATDG--LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN------------ 507 (605)
Q Consensus 445 ---~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~------------ 507 (605)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 001112346679999999763 478999999999999999999999875432111 0000000
Q ss_pred --------------------hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 508 --------------------LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 508 --------------------~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.........+.+..+.......+...+.+|+.+||+.+|++|||+.++++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000000011111122223344567789999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.77 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=211.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+..+..+||-|.||.||.|.++. .-.||||.++. +.-..++|..|+.+|+.++|||+|+|+++|..+...|||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3445667899999999999999865 67899999964 556788999999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
|.+|+|.++|+.-.+ ..++....+.++.||..|+.||..++ +|||||...|.|+.++..|||+|||+++....+.+
T Consensus 345 M~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999976544 45677788899999999999999988 99999999999999999999999999999876644
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.... ...-.+-|.|||-+.-..++.|+|||+|||+|||+.| |-.|+...+-.+.+. +++.-+
T Consensus 421 TAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~----------------LLEkgy 483 (1157)
T KOG4278|consen 421 TAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG----------------LLEKGY 483 (1157)
T ss_pred eccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH----------------HHhccc
Confidence 3222 1223568999999999999999999999999999999 777776544222222 222233
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
+...+..+...+++||+.||+..|.+||++.|+-+.++
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 33445556677999999999999999999999888764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=304.68 Aligned_cols=268 Identities=20% Similarity=0.312 Sum_probs=199.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 357 (605)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999975 58999999987532 2345667789999999999999999998753 3567
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578777743 334899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCccc--ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh------
Q 007397 438 FGGDEIE--GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL------ 508 (605)
Q Consensus 438 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~------ 508 (605)
....... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11123578999999999865 45899999999999999999999999654432211111110000
Q ss_pred --hhcCCCccccccc-ccCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 509 --WNKGMPWQLIDAC-YQES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 509 --~~~~~~~~l~d~~-~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..........+.. .... ..+.....+.+++..||+.+|++||++.+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000000000000 0000 0122356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.51 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=196.9
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----- 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 355 (605)
..++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999985 48899999986432 233456778999999999999999999987654
Q ss_pred -----eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 356 -----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 356 -----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 555555332 335899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||...........+.......
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987643321 11122346788999998865 457899999999999999999999987543222211121111000
Q ss_pred hcCCCcccc--------cc------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGMPWQLI--------DA------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~~~~l~--------d~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......+. +. ..... .......+.+++..||+.+|.+||++.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred Chhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 00 00000 00123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.37 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=195.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.++||+|++|+||+|.+. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999985 58999999986432 2344678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~~ 441 (605)
|+++ +|..++.... ...+++..+..++.||+.||+|||+++ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 6666664322 223578888899999999999999998 999999999999985 467999999999765322
Q ss_pred cccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc-----
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW----- 515 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~----- 515 (605)
. .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+ .+.............
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccc
Confidence 1 11223457889999998876 457899999999999999999999987543221 111111111100000
Q ss_pred -ccccc-----ccc----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 -QLIDA-----CYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 -~l~d~-----~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.+- ... ....+.....+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000 00112233457899999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.12 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=196.1
Q ss_pred ecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||.|+||.||++++.. ++.+|+|.+.+.. ....+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999854 8999999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
.+++... ..++...+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998543 34788999999999999999999998 9999999999999999999999999998764432 1233
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....+. ....... ..... ....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---~~~~~---------~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDI---LKGNG---------KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHH---hccCC---------CCCCCcc
Confidence 468899999999988889999999999999999999999997654311 1111111 00000 1111222
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 007397 530 EVIRCIHISLLCVQHHPEDRPS-----MPSVIL 557 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 557 (605)
....+.+++..||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457889999999999999999 677766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.49 Aligned_cols=245 Identities=22% Similarity=0.239 Sum_probs=190.4
Q ss_pred ceecccCeEEEEEEEEc-CCcEEEEEEccccch---hhHHHHHHHHHHH-HcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE---QGLNELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.||+|+||.||+|.+. +++.||+|.+.+... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999884 589999999875322 2223344555444 455899999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|..++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999988543 35788999999999999999999998 99999999999999999999999999876432
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.... ... ....... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDN----ILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHH----HHhcccC------CCCcc
Confidence 2234588899999999888899999999999999999999999965433211 111 1111100 00011
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.......+.+++.+||+.+|++||++.++.+.|..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11234568899999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=286.34 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=206.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|.+.+.||.|+||.||++.+. +++.+|+|++.... ......+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888899999999999999985 58999999987532 35667788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+++++|..++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886542 2356899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.......|++.|+|||.+.+..++.++||||+|+++++|++|..|+...... ..... ........
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~------ 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALK----ILKGQYPP------ 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHH----HhcCCCCC------
Confidence 1223356889999999999888999999999999999999999998654321 11111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+......+.+++.+||..+|++||++.+|++.
T Consensus 223 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.38 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=207.5
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+.+-++.-..+||.|.||.||.|...+ |...|+|-+.- ........+.+|+.++..++|||+|+++|+=..++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344577778999999999999998755 88889997753 335566778899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
.||||.+|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||.||||+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999843 334667777788999999999999999 9999999999999999999999999999886
Q ss_pred CCc--ccccccccccccCccchhcccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDE--IEGSTNKVIGTYGYMAPEYATDG---LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
... ........+||+-|||||++.+. ....++||||||||+.||+||++||...+.+ ..|-+. ...+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~---V~~gh- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYH---VAAGH- 1458 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhH---HhccC-
Confidence 542 23344568899999999999764 3568899999999999999999999765532 111111 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+.+.....+-.+++.+||+.||+.|-++.++++.=
T Consensus 1459 --------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 --------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1233444555667899999999999999999888764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=285.52 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=203.1
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccch--hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE--QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|++.+.||+|++|.||++.+. +++.+++|.+..... .....+.+|+.++++++|+|++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 578999999976433 4667899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 46899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
. .....++..|+|||.+.+..++.++||||||+++++|++|..|+...... . ..+.......
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~~---------- 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---A---ALFRIVQDDH---------- 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---H---HHHHHhccCC----------
Confidence 1 23356889999999998888899999999999999999999998643311 1 1111111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 01112224567899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=301.84 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=203.4
Q ss_pred Cccc--cceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSI--NNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~--~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
-|++ .+.||+|.||+||-|++ +.|+.||||++.+ .......++++|+.||+++.||.||.+-..|...+..++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 3444 47899999999999998 5699999999976 35566689999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla~~~ 438 (605)
|-+.|.-|+-++.... +.+++....-++.||+.||.|||.++ |+|+||||+||||.+. -++||||||.|+.+
T Consensus 643 EKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred hhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 9998888887775443 34888888889999999999999998 9999999999999654 57999999999998
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
+...+. ..++|||.|+|||++++..|+..-|+||+|||+|.-|+|..||.... +....|+.+.-..+.
T Consensus 718 gEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp------- 785 (888)
T KOG4236|consen 718 GEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPP------- 785 (888)
T ss_pred chhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCC-------
Confidence 766543 34789999999999999999999999999999999999999986432 222333322222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.-..+.....++||...||..-.+|.+...-++.
T Consensus 786 ------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 ------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1122334457789999999999999988776553
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.33 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=193.8
Q ss_pred cccceecccCeEEEEEEEEc-CCcEEEEEEcc--c--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe--eEEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLV-DGQEIAVKRLS--K--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY 361 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 361 (605)
+...+||+|+|-+||+|.+. .|..||=-.++ + .++...+.|..|+.+|+.|+|+|||++++.+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999984 36666533222 1 245566889999999999999999999999987655 77899
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGla~~~~~ 440 (605)
|.|..|+|..++.+..+ ++......|++||++||.|||++. .+|||||||-+||||+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999966543 678899999999999999999986 789999999999999866 8999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. ...++|||.|||||..- ..|++.+||||||+.++||+|+..|+..-.. . ..+......|....-+.
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~----AQIYKKV~SGiKP~sl~- 266 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--P----AQIYKKVTSGIKPAALS- 266 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--H----HHHHHHHHcCCCHHHhh-
Confidence 32 33478999999999887 7899999999999999999999999864332 1 11222222222211111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.-...++.++|.+||.. .++|||+.|+|..
T Consensus 267 -------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -------KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11123577899999998 9999999999983
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.27 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=197.6
Q ss_pred ecccCeEEEEEEEEcC-CcEEEEEEccccch---hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKISE---QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||.||++.+.+ ++.+|+|.+..... .....+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 89999999865332 4566788999999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc------
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI------ 443 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~------ 443 (605)
..++.... .+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99885533 5899999999999999999999998 99999999999999999999999999876532211
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
........++..|+|||.+.+...+.++||||||+++++|++|..||........ ... ...+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQN----ILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCCcC--------
Confidence 1122345678899999999888899999999999999999999999865442211 111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000124567899999999999999999777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=285.87 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=192.4
Q ss_pred HHHHHHhcCcccccee--cccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 279 ATIANATDNFSINNKL--GEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.......++|++.+.+ |+|+||.||++... +++.+|+|.+........ |+.....+ +|+||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444556778887777 99999999999874 578899999864321111 22222222 699999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFG 433 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFG 433 (605)
+..++||||+++++|..++.... .+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999985432 6899999999999999999999998 99999999999999998 99999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||....... .. ........ . .
T Consensus 156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~-~~~~~~~~-~-~ 225 (267)
T PHA03390 156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD-LESLLKRQ-Q-K 225 (267)
T ss_pred cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh-HHHHHHhh-c-c
Confidence 98765322 22457899999999999899999999999999999999999997433222 11 11111111 0 0
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-MPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 558 (605)
.. .........+.+++..||+.+|.+||+ ++++++.
T Consensus 226 ~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 KL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00 111234456889999999999999996 6888753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.43 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=197.9
Q ss_pred ccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCc
Q 007397 290 INNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 368 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~ 368 (605)
...+||+|+||.||++.. .+++.+|+|++..........+.+|+.++++++|+|++++++.+..++..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346899999999999988 4689999999865555566778999999999999999999999999999999999999999
Q ss_pred hhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccccc
Q 007397 369 LDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448 (605)
Q Consensus 369 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 448 (605)
|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~ 174 (292)
T cd06657 104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 174 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence 9987733 24788999999999999999999998 99999999999999999999999999876543221 123
Q ss_pred ccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCH
Q 007397 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNP 528 (605)
Q Consensus 449 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~ 528 (605)
...|++.|+|||++.+..++.++||||||+++|+|++|..||........ +..... .....+ . ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~----~~~~~~-----~--~~~ 240 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD----NLPPKL-----K--NLH 240 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----hCCccc-----C--Ccc
Confidence 35688999999999888889999999999999999999999865332211 111111 110000 0 011
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 529 DEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 529 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+.+++.+||+.+|.+||++.+|+++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 123457789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.49 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=198.2
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--Cee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 357 (605)
.+|++.+.||+|+||.||+|++. +++.+|+|.+... .......+++|+.++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999974 4899999987431 234556788999999999999999999998764 457
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++++||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988543 34788889999999999999999998 99999999999999999999999999986
Q ss_pred CCCCcc-cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEI-EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... ........++..|+|||++.+..++.++|||||||++++|++|+.||...... ..+.. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~~~--- 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFK---IATQPT--- 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHH---HHcCCC---
Confidence 532211 11122356899999999999888999999999999999999999998643221 11111 111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+......+.+++..||+ +|..||++.+++.+
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111233344568899999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=299.07 Aligned_cols=268 Identities=21% Similarity=0.291 Sum_probs=195.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
.++|++.++||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999975 58999999886432 222345678999999999999999999876543
Q ss_pred --eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 356 --EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 356 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
..++|+||+.+ +|...+... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999976 455544332 335899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCccc---------ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 007397 434 LARTFGGDEIE---------GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503 (605)
Q Consensus 434 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~ 503 (605)
+++........ .......+++.|+|||++.+. .++.++||||||+++|||++|++||...+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 111234578899999988654 58899999999999999999999987544332222221
Q ss_pred HHHHhhhcCC------CcccccccccCCC-------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 504 HAWNLWNKGM------PWQLIDACYQESC-------NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 504 ~~~~~~~~~~------~~~l~d~~~~~~~-------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.......... .....+....... .......+.+++.+||+.+|++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111000000 0000000000000 01122567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.06 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=192.7
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------ 354 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 354 (605)
.-..+|+.++.||+||||.||+++. -||+.||||++.-. +......+.+|+..|.+|+|||||+++..+++.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456789999999999999999997 67999999999743 455566788999999999999999997532210
Q ss_pred --------------------------------------------------------------------------------
Q 007397 355 -------------------------------------------------------------------------------- 354 (605)
Q Consensus 355 -------------------------------------------------------------------------------- 354 (605)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHH
Q 007397 355 ---------------------------------EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401 (605)
Q Consensus 355 ---------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 401 (605)
...|+-||||+..++.+++.++.... .....++++.+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01367789999999888885543221 4678899999999999999
Q ss_pred HhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC------C----------CcccccccccccccCccchhcccCC
Q 007397 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG------G----------DEIEGSTNKVIGTYGYMAPEYATDG 465 (605)
Q Consensus 402 H~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~ 465 (605)
|+.| ||||||||.||+|++++.|||+|||+|.... . .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 0111133557899999999999765
Q ss_pred C---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhc
Q 007397 466 L---FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCV 542 (605)
Q Consensus 466 ~---~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl 542 (605)
. |+.|+|+||||+||+||+. ||.. ..+....+. .++.+.+..- ..+.......-..+|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 4 9999999999999999986 4432 222222222 2223322211 1112222333467999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 007397 543 QHHPEDRPSMPSVILM 558 (605)
Q Consensus 543 ~~dP~~RPt~~evl~~ 558 (605)
+.||.+|||+.|+|..
T Consensus 856 ~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLNS 871 (1351)
T ss_pred cCCCccCCCHHHHhhc
Confidence 9999999999999763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=292.98 Aligned_cols=265 Identities=20% Similarity=0.220 Sum_probs=196.7
Q ss_pred ccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
+.+.+.+|.|+++.|+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++......+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455566666666666654 6899999998753 45566789999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc--
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI-- 443 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~-- 443 (605)
+++|..++..... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999865432 34788899999999999999999998 99999999999999999999999998875532111
Q ss_pred ---cccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh----c---
Q 007397 444 ---EGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN----K--- 511 (605)
Q Consensus 444 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~----~--- 511 (605)
........++..|+|||++.. ..++.++|||||||+++||++|+.||....... ..+........ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 111223457789999999876 458899999999999999999999997543211 11111100000 0
Q ss_pred ----CCCcc----cccc----cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 512 ----GMPWQ----LIDA----CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 512 ----~~~~~----l~d~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..... ..+. .............+.+++.+||+.+|++|||+.+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000 0000 011122233445788999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=280.32 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=201.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-----CcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 356 (605)
-..|++..+||+|.||.||+|...+ .+.+|+|+++... +......-+|+.+++.++|+|++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999995432 3479999997532 2233456789999999999999999999988 788
Q ss_pred eEEEEEeeCCCchhhHHhh--cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC----CceEEe
Q 007397 357 KLLIYEFMPNKSLDYFIFD--QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD----MNPKIS 430 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~----~~vkl~ 430 (605)
.++++||.++..+ .+|.- ..+...++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987654 44422 233467899999999999999999999976 9999999999999877 899999
Q ss_pred ecCCCccCCCCc-ccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc----h--hHH
Q 007397 431 DFGLARTFGGDE-IEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK----F--NVI 502 (605)
Q Consensus 431 DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~----~--~~i 502 (605)
|||+++.+...- .-.....++-|..|+|||.+.+. .|+.+.|||++|||+.|||+-++.|.....+.. + ..+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986542 22244567789999999999886 589999999999999999999998876443221 1 112
Q ss_pred HHHHHhhhcCC---Ccc----------ccccc--ccCCCCHH--------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 503 RHAWNLWNKGM---PWQ----------LIDAC--YQESCNPD--------EVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 503 ~~~~~~~~~~~---~~~----------l~d~~--~~~~~~~~--------~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.++...+.... +.. +.+.. ....++.. -.....+|+.++|+.||.+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 22222221110 000 00000 00010000 111256889999999999999999998876
Q ss_pred cC
Q 007397 560 GS 561 (605)
Q Consensus 560 ~~ 561 (605)
-.
T Consensus 339 yF 340 (438)
T KOG0666|consen 339 YF 340 (438)
T ss_pred cc
Confidence 44
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=302.43 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=202.5
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-----eeE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 358 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 358 (605)
+|++.++||+|+||.||+|+... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58899999999999999999854 8999999987643 445567889999999999999999999988775 789
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++ +|..++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 777777432 36899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC----
Q 007397 439 GGDEI-EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG---- 512 (605)
Q Consensus 439 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~---- 512 (605)
..... ........+++.|+|||++.+. .++.++||||||+++++|++|..||......+....+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 0112335678999999999887 78999999999999999999999997655432222221111000000
Q ss_pred ----CCcccccc------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 ----MPWQLIDA------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ----~~~~l~d~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+.. .-.....+.....+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 00000111234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=290.10 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=201.1
Q ss_pred CccccceecccCeEEEEEEEEc----CCcEEEEEEccccc----hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKIS----EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
+|++.+.||+|+||.||+++.. +++.+|||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999752 47889999986432 23345678899999999 599999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|..++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999888543 35788999999999999999999988 99999999999999999999999999877
Q ss_pred CCCCcccccccccccccCccchhcccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
+...... ......|+..|+|||.+.+.. .+.++||||||+++++|++|..||...........+.. ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~--- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILKSK--- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--HHHccC---
Confidence 5433211 122346889999999987654 78899999999999999999999864332221111111 111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++|||+.++.+.|...
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011122334678899999999999999999998887663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.12 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=203.9
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 360 (605)
++|.+.+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999985 5899999998652 2344567889999999998 99999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||++++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc------------------ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 007397 441 DEIE------------------GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 441 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i 502 (605)
.... .......++..|+|||++.+..++.++||||||+++++|++|..||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHH
Confidence 3221 1223345789999999998888999999999999999999999998755421 111
Q ss_pred HHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 007397 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM----PSVILM 558 (605)
Q Consensus 503 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~~ 558 (605)
.... .. ....+......+.+++.+||+.+|++||++ .++++.
T Consensus 232 ~~~~---~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKIL---KL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH---hc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111 00 001122224568899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=288.81 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=195.1
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEcccc--chhhHHHHHHHHHHHHcC---CCCceeeeeeeEEeCCe-----
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI--SEQGLNELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 356 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 356 (605)
|++.+.||+|+||.||+|++.. ++.+|+|++... .......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999864 899999999642 222234566777777655 69999999999988776
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.+++|||+++ +|..++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 6777775432 235899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc-
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW- 515 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~- 515 (605)
....... .....++..|+|||++.+..++.++||||||+++|+|++|.+||......+....+ ..........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI---FDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH---HHHcCCCChHh
Confidence 7643321 22345788999999999999999999999999999999999988754432221111 1111000000
Q ss_pred ---------cccccccc---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 ---------QLIDACYQ---ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ---------~l~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........ ....+.....+.+++.+||+.+|++||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 11112334667899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.13 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred hcCccc-cceecccCeEEEEEEEEc-CCcEEEEEEccccchhh--------------HHHHHHHHHHHHcCCCCceeeee
Q 007397 285 TDNFSI-NNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQG--------------LNELKNEVILFSKLQHRNLVKLL 348 (605)
Q Consensus 285 ~~~y~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 348 (605)
.++|.. .+.||+|+||+||+|.+. +++.||+|++....... ...+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 577999999999999975 58999999986432111 12477899999999999999999
Q ss_pred eeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceE
Q 007397 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPK 428 (605)
Q Consensus 349 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vk 428 (605)
+++..+...++||||+. ++|..++.. ...+++.....++.||+.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 578777743 335889999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCcc------------cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 007397 429 ISDFGLARTFGGDEI------------EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNS 495 (605)
Q Consensus 429 l~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 495 (605)
|+|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999977642110 1111223468899999998764 468999999999999999999999976543
Q ss_pred CCchhHHHHHHHhhhcCCCc---ccc------------cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 496 DNKFNVIRHAWNLWNKGMPW---QLI------------DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 496 ~~~~~~i~~~~~~~~~~~~~---~l~------------d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+. +............. ... ..... .........+.+++.+||+.+|++||++.+|+.+.
T Consensus 240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 IDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 222 11111111111000 000 00000 00112245678999999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.98 Aligned_cols=277 Identities=19% Similarity=0.211 Sum_probs=219.3
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 353 (605)
+..+.-..++|.+++.||+|+||.|.+++++. ++.||+|++++ ........|..|-.+|..-+.+-|+.++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34445556899999999999999999999855 88999999987 344566778999999999999999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
..+.|+|||||+||+|-.++.+.. .+++..++-++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999985443 6899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
.+-....+.. ......+|||.|++||++.. +.|+..+|.||+||++||||.|..||....-.+-+..|.....
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~- 298 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE- 298 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-
Confidence 9887764432 23345789999999999852 5689999999999999999999999976544333333322211
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHh--c-----CCCCCCCCCCCcccc
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS---MPSVILML--G-----SDSVLAQPKQPGCLV 575 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~L--~-----~~~~~~~p~~p~~~~ 575 (605)
.+..+...+......+||...+. +|+.|.. +.++-.+. . +++...+|-.|..-+
T Consensus 299 ------------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 299 ------------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred ------------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 11111122344566778877664 7888888 88888765 2 224555666665543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=288.90 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=197.5
Q ss_pred CccccceecccCeEEEEEEEEc----CCcEEEEEEccccc----hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKIS----EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
+|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999873 68899999986532 22346678899999999 599999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999988543 35788889999999999999999998 99999999999999999999999999987
Q ss_pred CCCCcccccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..|+...........+.. ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH--HhhccC---
Confidence 6433211 1223568899999999875 3478899999999999999999999864332222111111 111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
...+......+.+++.+||+.+|++|| ++.+++.+
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011222345678999999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=287.46 Aligned_cols=243 Identities=25% Similarity=0.302 Sum_probs=188.3
Q ss_pred eecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHH---HHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 293 KLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.||+|+||.||+|.+. .++.||+|.+.+.. ......+..|. .+++...|+||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 48899999986532 11122233343 34455689999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988853 346899999999999999999999998 9999999999999999999999999987653321
Q ss_pred cccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||............. . .... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---~~~~----------~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---TLTM----------AV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---hhcc----------CC
Confidence 2234689999999998754 68999999999999999999999997653322211111 0 0000 01
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+......+.+++.+||+.+|.+|| ++.+++++-
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 11122245688999999999999999 999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=277.08 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=199.2
Q ss_pred ceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 292 NKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
+.||+|+|+.|--+.. ..|++||||++.+........+.+|++++.+.+ |+||++|+++|.+++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6899999999998875 679999999999987778888999999999996 99999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecCCCccCCCC-----
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFGLARTFGGD----- 441 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFGla~~~~~~----- 441 (605)
..+|.++ ..+++.++.+++..|+.||.+||.+| |.||||||+|||-.+... |||+||.+..-....
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9998543 45899999999999999999999999 999999999999976654 899999987654211
Q ss_pred cccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-------CCchhHH-HHHHHh
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNS-------DNKFNVI-RHAWNL 508 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~-------~~~~~~i-~~~~~~ 508 (605)
.......+.+|+.+|||||+.. ...|+.++|.||||||||-||+|.+||...-. .+.-..- ......
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1122234578999999999863 34589999999999999999999999976322 1111111 111122
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+.++.. ++. +.-......+..+++...|..++.+|.++..++..
T Consensus 318 IQEGkY-eFP-----dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 318 IQEGKY-EFP-----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HhccCC-cCC-----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 222221 111 11122334456678888888999999999988873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.23 Aligned_cols=204 Identities=27% Similarity=0.442 Sum_probs=176.8
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------CeeE
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------EEKL 358 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 358 (605)
.+...+.||+||||.||+|++ ..|+.||||.+++.. ....+..-+|+++|++++|+|||+++++=... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455668999999999999996 559999999998643 33455667899999999999999999875543 4568
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc--CCC--ceEEeecCC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD--HDM--NPKISDFGL 434 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~--~~~--~vkl~DFGl 434 (605)
+|||||.+|+|...+.+..+..-+++.+.+.++..++.||.|||+++ |+||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888778999999999999999999999998 99999999999983 334 479999999
Q ss_pred CccCCCCcccccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD 496 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 496 (605)
|+....+. ......||..|++||++. .+.|+..+|.|||||++|+++||..||-.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99987654 456688999999999998 588999999999999999999999999876543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=290.99 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=193.3
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc-hhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.++||+|+||.||+|.+.+ ++.||||.+.+.. ......+..|+.++.+.. |+||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678899999999999999999865 8999999987532 233455666777666665 9999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|+.+ ++..++.... ..+++..+..++.||++||.|||+ .+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 ~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 6666554322 368899999999999999999997 46 999999999999999999999999998765432
Q ss_pred cccccccccccccCccchhcccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGL----FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.. .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ...+.. ..... ...+
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---~~~~~-~~~~ 239 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---ILQEE-PPSL 239 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---HhcCC-CCCC
Confidence 21 12235788999999987553 789999999999999999999998643221 111111 11111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. .......++.+++.+||+.+|++||++.+++++.
T Consensus 240 ~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 P-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0112334688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=288.67 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=196.3
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEccccch-hhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISE-QGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
|++.+.||+|+||+||+|...+ ++.+|+|++..... .......+|+..++++. |+|++++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6778999999999999999854 78999999865322 22234457899999999 999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
+++|..++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 778887775443 246899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH-----hhhcC-----C
Q 007397 445 GSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN-----LWNKG-----M 513 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~-----~~~~~-----~ 513 (605)
......++..|+|||++. ...++.++||||||+++++|++|++||...........+..... .+.+. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122356788999999875 45579999999999999999999999865543222111111000 00000 0
Q ss_pred Cccccccccc---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQ---ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+..... ..........+.+++.+||+.+|++||++.||+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.58 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=194.9
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC---------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--------- 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 354 (605)
..+|.+.+.||+|+||.||+|.+. .++.||+|++........+.+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999984 4899999998765556677888999999999999999999776543
Q ss_pred -----CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceE
Q 007397 355 -----EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPK 428 (605)
Q Consensus 355 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vk 428 (605)
...++||||++ ++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 477776632 34789999999999999999999998 999999999999974 56789
Q ss_pred EeecCCCccCCCCccc-ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 429 ISDFGLARTFGGDEIE-GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 429 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765322111 11123457889999998754 568899999999999999999999996544322111111000
Q ss_pred H--------hhhcCCCcccccccccCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 507 N--------LWNKGMPWQLIDACYQES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 507 ~--------~~~~~~~~~l~d~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .................. ..+.....+.+++.+||+.+|++|||+.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000000000000000 011223567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.21 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=192.7
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
|...++||+|+||+||+|++. .++.+|+|++... .......+.+|+.+++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999874 5889999998642 223445688899999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+.+ ++.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 965 565555332 235889999999999999999999998 99999999999999999999999999865321
Q ss_pred cccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.....|+..|+|||++. ...++.++|||||||++|+|++|.+|+...+..... .. ..... ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~---~~~~~-~~~~--- 240 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YH---IAQND-SPTL--- 240 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HH---HHhcC-CCCC---
Confidence 22356889999999984 456889999999999999999999998654321111 11 11111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111123457889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.45 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=194.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.+. .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999974 5899999998642 2333456789999999999999999999987543
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++|+||+.. +|..++ ...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999864 555543 224788999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh----
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN---- 510 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~---- 510 (605)
+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+... .+........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 764321 223467889999999876 468999999999999999999999997543211 1111111100
Q ss_pred -------cCCCcccccc--cc-cCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcCC
Q 007397 511 -------KGMPWQLIDA--CY-QES---CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM--LGSD 562 (605)
Q Consensus 511 -------~~~~~~l~d~--~~-~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~~ 562 (605)
.......... .. ... ..+.....+.+++.+||+.+|++||++.+|+.. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000 00 000 001123457899999999999999999999975 4443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=291.99 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=196.7
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+.|...+.||+|+||.||+|++. +++.+|+|.+.. ........+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777899999999999999984 478899998863 23344567888999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9997 4666665432 234788999999999999999999998 99999999999999999999999999876432
Q ss_pred cccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.....+++.|+|||++. ...++.++|||||||++|+|++|..|+...........+. .+....
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~~-- 233 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNESPA-- 233 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-------hcCCCC--
Confidence 22346788999999975 3567889999999999999999999986543221111110 111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.........+.+++.+||+.+|++||++.+|+...-..
T Consensus 234 ------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 01122345678999999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.43 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=197.8
Q ss_pred HHHHHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-
Q 007397 279 ATIANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG- 354 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 354 (605)
..+....++|.+.+.||+|+||.||+|.+ .+++.||+|++.+. .....+.+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34555678999999999999999999987 46899999998753 223345678899999999999999999988643
Q ss_pred -----CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 355 -----EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 355 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
...+++++++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3357777776 7788777632 24889999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998764321 233567899999999876 56889999999999999999999998654322111111110000
Q ss_pred --------hhcCCCccc---ccccccC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 509 --------WNKGMPWQL---IDACYQE---SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 509 --------~~~~~~~~l---~d~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+........ +...... .........+.+++.+||+.+|.+||++.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000000 0000000 00001234578999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.65 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=197.1
Q ss_pred HHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC---
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE--- 355 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 355 (605)
....++|++.+.||+|+||.||++.. .+++.||||++.+. .......+.+|+.++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34568899999999999999999987 45899999998642 2334556889999999999999999999987543
Q ss_pred ---eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 356 ---EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 356 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
..++||||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6788877732 35889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH------
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA------ 505 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~------ 505 (605)
|++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999865322 223457889999999876 45889999999999999999999998754321111111000
Q ss_pred --HHhhhcCCCcccccc--ccc----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 506 --WNLWNKGMPWQLIDA--CYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 506 --~~~~~~~~~~~l~d~--~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+........... ... ..........+.+++.+|++.+|++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 000 00111223457899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.57 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=197.7
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CCeeE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 358 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 358 (605)
..+++|++.+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35688999999999999999999875 6899999988642 23345677889999999999999999999876 56788
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+++||+ +++|..++.. ..++...+..++.||++||.|||+.+ |+||||+|+||+++.++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 4578777632 34778888899999999999999998 999999999999999999999999998754
Q ss_pred CCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--------HHhh
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA--------WNLW 509 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~--------~~~~ 509 (605)
... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+... ....
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 221 223457889999998866 56899999999999999999999998654432111111110 0000
Q ss_pred hcCCCccccccc-ccCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 510 NKGMPWQLIDAC-YQESCN-----PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 510 ~~~~~~~l~d~~-~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.......++... .....+ +.....+.+++.+||+.+|++||++.+++..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000000000 000111 11235788999999999999999999998773
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.17 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=192.1
Q ss_pred CccccceecccCeEEEEEEEEc-C--CcEEEEEEcccc--chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC----Ce
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-D--GQEIAVKRLSKI--SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 356 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 356 (605)
+|++.+.||+|+||.||++... . ++.+|+|++... .......+.+|+.+++++ +|+||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999974 3 778999998642 222355678899999999 599999999875432 45
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++++||+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 578777743 345889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc--ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH------
Q 007397 437 TFGGDEIE--GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN------ 507 (605)
Q Consensus 437 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~------ 507 (605)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76432211 11234578999999998765 5689999999999999999999999875442111111110000
Q ss_pred --hhhcCCCccccc---cc---ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 --LWNKGMPWQLID---AC---YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 --~~~~~~~~~l~d---~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.......... .. ......+.....+.+++.+||+.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 00 0000011123568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=287.60 Aligned_cols=263 Identities=27% Similarity=0.357 Sum_probs=199.7
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
|++.+.||+|+||.||+|+..+ ++.+|+|.+.... ......+..|+.++++++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5677899999999999999854 8999999987642 334567788999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++ +|..++.... ..+++..+..++.|+++||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 84 8988885532 35889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH-----hhhcCCCcccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN-----LWNKGMPWQLI 518 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~-----~~~~~~~~~l~ 518 (605)
......++..|+|||.+.+. .++.++||||||++++||++|.+||...........+..... .+.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223457789999998776 789999999999999999999999865443222111111000 00000000000
Q ss_pred ccccc-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQ-------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+..+. ....+.....+.+++..||+.+|++||++.+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 00111124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.22 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=197.8
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe----
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 356 (605)
..++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999985 4889999998642 23344667789999999999999999998876654
Q ss_pred --eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 357 --KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 357 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887743 35899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .+......... .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~-~ 235 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGT-P 235 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCC-C
Confidence 9875432 233467889999999865 467899999999999999999999996543321 11111111100 0
Q ss_pred Cccc------------cccccc---C---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQL------------IDACYQ---E---SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l------------~d~~~~---~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+ +..... . .........+.+++.+||+.+|++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 000000 0 0001124578899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=274.27 Aligned_cols=253 Identities=22% Similarity=0.253 Sum_probs=198.9
Q ss_pred HhcCcccc-ceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe----CCe
Q 007397 284 ATDNFSIN-NKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ----GEE 356 (605)
Q Consensus 284 ~~~~y~~~-~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 356 (605)
.+++|++. ++||-|-.|.|..+.++. ++++|+|++... ...++|+++.-.. .|+|||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35677764 679999999999998854 889999998642 3456788876666 59999999998864 456
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFG 433 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFG 433 (605)
..+|||.|+||.|...+.++. ...+.+.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 779999999999999996653 346899999999999999999999988 999999999999964 4579999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+|+.-.. .....+.+-||.|.|||++....|+..+|+||+||++|-||.|.+||......... .++
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgM 275 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGM 275 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhH
Confidence 9987543 23345577899999999999999999999999999999999999999764432111 111
Q ss_pred Ccccccccc--cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 514 PWQLIDACY--QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 514 ~~~l~d~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
-..+....+ ..+......+...++|+.+|..+|.+|.|+.+++..-
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 111111111 1222334456677899999999999999999998864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.00 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=195.7
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
+|.+.++||+|+||.||++.+.. +..+++|.++.. .......+..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998744 455666655431 222344567899999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456899999999999999999999998 999999999999975 569999999987754
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.... ......|++.|+|||.+.+..++.++|+||||+++++|++|..||..... ...... . ..+...
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~---~-~~~~~~---- 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLR---I-VEGPTP---- 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH---H-HcCCCC----
Confidence 3221 12234578899999999888899999999999999999999999853221 111111 1 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 -----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1123344578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=314.16 Aligned_cols=146 Identities=26% Similarity=0.415 Sum_probs=131.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|.+.++||+|+||+||+|.+. .++.||||++.+. .......+..|+.+++.++|+||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999985 5899999998653 234456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
|||+.+++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999988543 35788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=283.98 Aligned_cols=240 Identities=26% Similarity=0.346 Sum_probs=196.3
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 360 (605)
.+|..+.+||+|+||.|.+|..+. ...+|||++++. .....+--..|-.+|.... -|.+++++.+|..-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 578889999999999999998754 678999999862 3444555566777777664 67899999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+.||+|-.+|.+- +.+.+..+.-++..|+-||-+||++| ||+||||.+|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999998888543 34677888889999999999999999 99999999999999999999999999986422
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
+ ...+.+.+|||.|+|||++.-.+|+.++|.||+||+||||+.|.+||+..+.++.+..|...
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------------- 565 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------------- 565 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------------
Confidence 2 23456789999999999999999999999999999999999999999987765554433311
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
+-.++.....+...++...|.++|.+|.
T Consensus 566 --nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 --NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1123444455666777778888999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=283.81 Aligned_cols=266 Identities=28% Similarity=0.402 Sum_probs=202.9
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC--CCCceeeeeeeEEeCC----eeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL--QHRNLVKLLGCCIQGE----EKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 359 (605)
+..++.+.||+|.||.||||.+ +++.||||++. .+....+++|-.|.+.. +|+||+++++.-..++ .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445668999999999999998 45999999995 45667788888887754 7999999998766555 7899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS------RLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
|+||.+.|+|.++|..+ .++|....+|+..+++||+|||+.- +..|+|||||..||||.+++...|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999544 6899999999999999999999763 4579999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCC-CC-----cccchHHHHHHHHHHHhCCCCCCCCCCCCchhHH-----
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-FS-----VKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI----- 502 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i----- 502 (605)
+|..+........+...+||..|||||++.+.. +. .+.||||+|.|||||++...-+......+.....
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999987666666666688999999999997643 22 3589999999999999976555321111111101
Q ss_pred -----HHHHH-hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 503 -----RHAWN-LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 503 -----~~~~~-~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
...+. ...+..-..+.+.... .....-+.+.+..||..||+.|.|+.=|-+.+....
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11111 1111111122222211 133456788999999999999999999988887764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.04 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=215.0
Q ss_pred ccccceecccCeEEEEEEEE-cCC----cEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTL-VDG----QEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.+..++||+|+||+||+|.+ ++| -+||+|++.. ...+...++..|+.+|.++.|||++||++++.... .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34468999999999999987 443 4789998865 44556788999999999999999999999998766 77899
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
+||+.|.|.++++. .++.+.....+.|..||++||.|||++. ++||||-.+||||.+...+||.|||+++....+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999966 3456888999999999999999999987 999999999999999999999999999998777
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
..+.......-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++...+++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------------- 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------------- 916 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------------
Confidence 66655555555678999999999999999999999999999998 99999877766555444422
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
-+-+.++.+..++.-++.+||-.|++.||+++++......
T Consensus 917 -eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 -ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1235677788899999999999999999999999876643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.16 Aligned_cols=267 Identities=22% Similarity=0.279 Sum_probs=222.9
Q ss_pred cCccccceecccCeEEEEEEEEcCCc-EEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQ-EIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.+++++..||-||||.|=++...... .+|+|++++ ......+.+..|-.+|.....+.||+++..|.+.+..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45677789999999999998875433 489998876 35556677889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|-|-||.|-..+++. +.++...+.-++..+++|+.|||+++ ||+|||||+|.+|+.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999554 45788888889999999999999999 999999999999999999999999999998654
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .+.+.+|||+|.|||++.+...+.++|.||||+++||||+|.+||...++...+++|......+.
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~----------- 639 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE----------- 639 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-----------
Confidence 3 46778999999999999999999999999999999999999999999999888888876554432
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh-------cCC--CCCCCCCCCccccc
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILML-------GSD--SVLAQPKQPGCLVD 576 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L-------~~~--~~~~~p~~p~~~~~ 576 (605)
.+........+|+.+....+|.+|.- +.+|-++- +++ ..+++|..|.....
T Consensus 640 ----~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p 704 (732)
T KOG0614|consen 640 ----FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP 704 (732)
T ss_pred ----cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence 22233445678888888899999975 66776654 222 45667777666544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=282.99 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=199.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcc--cc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLS--KI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GE 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~--~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 355 (605)
.++|-++..||+|||+.||+|.+. ..+.||||+-. +. .....+...+|..|.+.|.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 468889999999999999999874 47788888753 21 12234456789999999999999999999864 56
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeec
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDF 432 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DF 432 (605)
..+-|+||++|.+|+.+|..+ ..+++.+++.|+.||+.||.||.+.. .+|||-||||.||||-. .|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 678999999999999999543 46899999999999999999999985 78999999999999954 478999999
Q ss_pred CCCccCCCCccc-----ccccccccccCccchhcccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 007397 433 GLARTFGGDEIE-----GSTNKVIGTYGYMAPEYATD----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503 (605)
Q Consensus 433 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~ 503 (605)
|+++...++... ..+....||..|++||.+.- ..++.|+||||+|||+|+.+.|++||+....... |
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---I- 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---I- 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---H-
Confidence 999998655433 12345679999999998753 3478999999999999999999999986544221 1
Q ss_pred HHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 504 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+.++.+... ..+..+..+-...+...+|++||++.-++|....++..
T Consensus 694 -----LqeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 -----LQENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -----Hhhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111 11122222333445678999999999999998888754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.42 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=199.3
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|.-.++||+|.||+||+|+..+ +..||+|+++- .++.......+|+-+++.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999855 78899999864 3344456778999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+.. .|..+.. .-.+.++.+.++.++.|+++||.++|+++ +.||||||.|+||+.+|.+||+|||+++.++-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 3433331 22345888999999999999999999998 99999999999999999999999999998865432
Q ss_pred cccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc---cc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ---LI 518 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~---l~ 518 (605)
. ....+-|..|++|.++.+.. |++..|+||.|||+.|+.. |.+.|...+.++....|-+......+..+.. +.
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 2 22245689999999998764 8999999999999999997 6666665554444444444333333333222 22
Q ss_pred cccccCCCC---------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 519 DACYQESCN---------PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 519 d~~~~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
|-.....++ +.....=.++....|.-+|..|.++++.++.-
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 221111111 11112234677788888999999999987653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=280.84 Aligned_cols=263 Identities=18% Similarity=0.232 Sum_probs=203.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCC--Cc----eeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQH--RN----LVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~~ 357 (605)
..+|.+..++|+|.||.|-.+.+.. +..||||+++.. ....+..+-|+.+|+++.+ |+ +|++.++|....+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5789999999999999999998744 789999998643 4455667789999999942 22 88888999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC--------------
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-------------- 423 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-------------- 423 (605)
++|+|.+ |.++.+++..+ +...++...++.++.||++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 56788888543 3456889999999999999999999988 999999999999931
Q ss_pred ------CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007397 424 ------DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497 (605)
Q Consensus 424 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 497 (605)
+..|||+|||.|...... ...++.|..|+|||++++.+++..+||||+||||+||.+|...|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 335899999999875333 245778999999999999999999999999999999999999987766433
Q ss_pred chhHHHHHHHhhhcCCCcc-------------------------cccc----cccCCCCHHHHHHHHHHHHHhcCCCCCC
Q 007397 498 KFNVIRHAWNLWNKGMPWQ-------------------------LIDA----CYQESCNPDEVIRCIHISLLCVQHHPED 548 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~-------------------------l~d~----~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 548 (605)
.....+.+....+..++.. ..+. .........+..+|.+|+.+||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2222222211111111000 0000 0011234456778999999999999999
Q ss_pred CCCHHHHHHH
Q 007397 549 RPSMPSVILM 558 (605)
Q Consensus 549 RPt~~evl~~ 558 (605)
|+|+.|+++.
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.27 Aligned_cols=241 Identities=22% Similarity=0.273 Sum_probs=195.4
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+.+.|++...+|.|+|+.|-.+.+ ..++..++|++.+. ..+..+|+.++... +|+||+++++.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467899999999999999999887 45899999999764 22334566555544 6999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE-cCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL-DHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll-~~~~~vkl~DFGla~~~~~ 440 (605)
|.+.++-+.+.+..... .. .++..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988777754322 22 778889999999999999999 9999999999999 5889999999999988654
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. ..+.+-|..|.|||++....|+.++|+||||++||+||+|+.||...+.+ .+ +...+..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~--------- 528 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQM--------- 528 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcC---------
Confidence 3 33345688999999999999999999999999999999999999876654 11 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+..+........+|+.+||+.+|.+||+|.++...
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11223334567789999999999999999999764
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=243.57 Aligned_cols=109 Identities=42% Similarity=0.941 Sum_probs=105.9
Q ss_pred EeecCCCCceeecccccc-cccceEEEEEcCceeEEEEeecCCCeeeEEEEccCCcEEEEEEecCCcceEEeeecCCCCC
Q 007397 41 ARSGPWNGQTFEGIPWMK-DSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWHKLYSWPFDHC 119 (605)
Q Consensus 41 ~rsg~w~g~~f~~~p~~~-~~~~~~~~~~n~~e~~~~~~~~~~s~~~r~~l~~~G~~~~~~w~~~~~~w~~~~~~~~~~C 119 (605)
||||||||..|+|+|+|. .+++.+.|+.|.+|+||+|.+.+.++++|++|+.+|++++++|++.+++|.+.|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999997 7889999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccCCCCCCcccccCcccccC
Q 007397 120 DNYAECGANSNCRVSETPSCECLTGFISKS 149 (605)
Q Consensus 120 ~~~~~CG~~~~C~~~~~~~C~C~~gf~~~~ 149 (605)
|+|+.||+||+|+.+..|.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.45 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=193.9
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEcccc-chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.+.+..||.|..|.|++++... |+.+|||.+.+. +....+.+...+.++.+-+ +|.||+.+|+|+.+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 3455789999999999999855 899999999864 4445566777777776665 999999999999999999999988
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
.. -++.++... .+.+++..+-++...+++||.||.+++ .|+|||+||+|||+|+.|++||||||++-......
T Consensus 174 s~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 ST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 43 233334322 335888888899999999999998765 59999999999999999999999999987654332
Q ss_pred ccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
..++..|-+.|||||.+. ...|+..+||||||+.|+||+||..||...+.+ +..+....+ ..+. .++.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln----~ePP-~L~~- 317 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN----EEPP-LLPG- 317 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh----cCCC-CCCc-
Confidence 234567899999999885 356899999999999999999999999875542 333333222 1221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ......+++++..||++|+.+||...++++.
T Consensus 318 ---~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 ---H--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---c--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1145568899999999999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.20 Aligned_cols=236 Identities=26% Similarity=0.322 Sum_probs=192.2
Q ss_pred ecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 294 LGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
||+|+||.||++.+. +++.+|+|.+.+.. ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999985 48999999987532 23556788999999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 449 (605)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988543 25789999999999999999999988 9999999999999999999999999987754322 12334
Q ss_pred cccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 450 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
..++..|+|||.+.+...+.++|+||||+++|+|++|..||...+. ........ ... ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~----~~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL----KDP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh----cCC----------CCCCCC
Confidence 5688899999999888889999999999999999999999865432 11111111 010 011122
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
....+.+++.+||..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.78 Aligned_cols=254 Identities=27% Similarity=0.352 Sum_probs=196.9
Q ss_pred cccceecccCeEEEEEEEE-cCCcEEEEEEccccc-hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 289 SINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS-EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
+-+..||.|+||+|+|-.+ +.|+..|||+++... .....++..|.+...+- +.||||+++|.+..+...++.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457899999999999987 559999999998643 35667788888866555 69999999999999999999999995
Q ss_pred CCchhhHHhh--cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 366 NKSLDYFIFD--QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 366 ~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
- +|+.+... ..+...+++...-+|....++||.||... ++|||||+||+||||+..|.+||||||++-.....
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 4 55554322 22345688888889999999999999875 46999999999999999999999999998765322
Q ss_pred cccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
...+.-.|...|||||.+.. ..|+.++||||||++|+|+.||+.|+...+. .+.+..+ ...+.+..+...
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~-Vv~gdpp~l~~~- 293 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQ-VVIGDPPILLFD- 293 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHH-HHcCCCCeecCc-
Confidence 12334568889999998853 4599999999999999999999999876543 2222222 233444333222
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+....+.+++..||.+|-.+||...++.++
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2223455678899999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=270.67 Aligned_cols=219 Identities=19% Similarity=0.128 Sum_probs=176.0
Q ss_pred cCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhh
Q 007397 297 GGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD 375 (605)
Q Consensus 297 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 375 (605)
|.||.||++.+. +++.+|+|++.+.. .+..|...+....||||+++++++......++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999984 58999999997642 233455566667799999999999999999999999999999998854
Q ss_pred cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccC
Q 007397 376 QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455 (605)
Q Consensus 376 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 455 (605)
. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 3 24889999999999999999999998 999999999999999999999999988665332 122345778
Q ss_pred ccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHH
Q 007397 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI 535 (605)
Q Consensus 456 y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 535 (605)
|+|||.+.+..++.++||||+|+++|||++|..|+........ .. .....+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH---------TTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc---------cccCCcccCCHHHH
Confidence 9999999888899999999999999999999987653221100 00 00011122334678
Q ss_pred HHHHHhcCCCCCCCCCH
Q 007397 536 HISLLCVQHHPEDRPSM 552 (605)
Q Consensus 536 ~li~~Cl~~dP~~RPt~ 552 (605)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 89999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=262.53 Aligned_cols=284 Identities=21% Similarity=0.324 Sum_probs=217.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
-.+|.++.+||+|+|+.|.+++++. .+.+|+|++++ .....++-++.|-.+..+. +||.+|.++.+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3679999999999999999999855 78899999986 3455566677788877766 69999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|.||+++|+|-.++.++ ..++++.++-+...|.-||.|||+.| ||+||||.+|+|||..|.+||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999998777544 34889999999999999999999999 9999999999999999999999999998743
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch-hHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF-NVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~l~ 518 (605)
.+ ...+.+.+|||.|+|||++.+..|...+|.|+|||+++||+.|+.||+....++.. +...+..+.+-+
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------- 473 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------- 473 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------
Confidence 32 34466789999999999999999999999999999999999999999875433222 222222222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHH----------HHhcCCCCCCCCCCCcccccCCCCCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPS------MPSVI----------LMLGSDSVLAQPKQPGCLVDRKSTGP 582 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl----------~~L~~~~~~~~p~~p~~~~~~~~~~~ 582 (605)
..++ .+.....+...++..-|.+||.+|.. +.++- .+|++.+ ..+|-+|+....+.++--
T Consensus 474 -kqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~-v~ppf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 474 -KQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQ-VLPPFQPQITDDYGLDNF 549 (593)
T ss_pred -hccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcc-cCCCCCCccccccCcccc
Confidence 1111 11122234456777788899999852 23332 3445443 456777777766665544
Q ss_pred CCCCC
Q 007397 583 DSSSS 587 (605)
Q Consensus 583 ~~~~~ 587 (605)
+++.+
T Consensus 550 d~qft 554 (593)
T KOG0695|consen 550 DTQFT 554 (593)
T ss_pred ccccc
Confidence 44433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=290.96 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=214.1
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe--
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ-- 353 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 353 (605)
+..+...++.|++.+.||+|.+|.||+++. ++++..|+|++... ....+++..|..+|+.+ .|||++.+++++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445678899999999999999999997 55889999988653 34456778899999988 59999999999864
Q ss_pred ---CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 354 ---GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 354 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
++.++||||||.+|+..+++.... ...+.|..+..|+..++.||.+||.+. ++|||||-.|||++.++.|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 678999999999999999996655 667899999999999999999999987 9999999999999999999999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA 505 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~ 505 (605)
|||++...... ....++..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+....+.....
T Consensus 166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----- 238 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 238 (953)
T ss_pred eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence 99999876432 334556789999999999863 347889999999999999999999987655432211
Q ss_pred HHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 506 WNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 506 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+.+.+..+ ..+....+.+.++|..||.+|.+.||++.+++++
T Consensus 239 --~IpRNPPPkL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 --LIPRNPPPKL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --cCCCCCCccc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1112222222 3356778889999999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=298.80 Aligned_cols=262 Identities=29% Similarity=0.419 Sum_probs=208.7
Q ss_pred HHHhcCccccceecccCeEEEEEEEEcC--------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCC-CCceeeeeeeE
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQ-HRNLVKLLGCC 351 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 351 (605)
+...++..+.+.||+|+||.|++|.... ...||||.++.. .....+.+..|+.+++.+. |+||+.+++++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3334555677799999999999997421 457999999753 3456778999999999995 99999999999
Q ss_pred EeCCeeEEEEEeeCCCchhhHHhhcC------cc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007397 352 IQGEEKLLIYEFMPNKSLDYFIFDQT------KR-------ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418 (605)
Q Consensus 352 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~N 418 (605)
..+...++|+||+..|+|..+++... .. ..+.....+.++.||+.|++||++.. +|||||-.+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999997654 00 24888999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCccCCCCcccccccccc--cccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 007397 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI--GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNS 495 (605)
Q Consensus 419 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~ 495 (605)
||+..+..+||+|||+|+............ .. -...|||||.+....|+.|+|||||||+||||++ |..|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999765443322111 11 2345999999999999999999999999999999 8888765221
Q ss_pred CCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 496 ~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. .+ ...++.+.- ...+..+..++.++|..||+.+|++||++.++++.++..
T Consensus 528 ~~--~l----~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TE--EL----LEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HH--HH----HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 11 222333332 233444566788999999999999999999999999873
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=279.74 Aligned_cols=211 Identities=22% Similarity=0.359 Sum_probs=179.9
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.-|..++.||-|+||.|-+++..| ...||+|.+++.+ ......++.|-.||.....+-||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457888999999999999998766 6778999998743 344556889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC--
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG-- 439 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~-- 439 (605)
+|++||++-.+|. +.+.+.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988874 3457889999999999999999999998 9999999999999999999999999986431
Q ss_pred -------C-C----c-c-------------------------cccccccccccCccchhcccCCCCCcccchHHHHHHHH
Q 007397 440 -------G-D----E-I-------------------------EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVL 481 (605)
Q Consensus 440 -------~-~----~-~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ 481 (605)
. + + . .......+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0 0 0 00112356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHH
Q 007397 482 EIVSGKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 482 elltG~~p~~~~~~~~~~~~i 502 (605)
||+.|++||-...+.+....+
T Consensus 863 em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred HHhhCCCCccCCCCCcceeee
Confidence 999999999887776654433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=262.57 Aligned_cols=268 Identities=21% Similarity=0.346 Sum_probs=198.3
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--------C
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--------G 354 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 354 (605)
..|+-..+||+|.||.||+|+..+ ++.||+|++-- ....-.....+|+.+|+.+.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456777899999999999999855 78889987642 222334456789999999999999999988753 3
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...|+||.++++ +|.-++.+.. ..++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 457899999976 4555553322 34788999999999999999999887 99999999999999999999999999
Q ss_pred CccCCCCc--ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH----
Q 007397 435 ARTFGGDE--IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN---- 507 (605)
Q Consensus 435 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~---- 507 (605)
++.+.... .....+..+-|..|++||.+.+ ..|+++.|||..|||+.||.++.+.+..........+|...-.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98775322 1222334556999999998886 4699999999999999999999999887776655555554322
Q ss_pred -hhhcCCCccccccc-----ccCCC--CHHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 508 -LWNKGMPWQLIDAC-----YQESC--NPDE------VIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 508 -~~~~~~~~~l~d~~-----~~~~~--~~~~------~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.|++-.-..+.... ..+.. -.+. ....++|+..++..||.+|+++++++..-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 22221111111111 00000 0111 12567889999999999999999987654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=291.92 Aligned_cols=260 Identities=18% Similarity=0.205 Sum_probs=168.3
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-----CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeee------EE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGC------CI 352 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 352 (605)
..++|++.++||+|+||.||+|++.+ +..||+|++...... +...+| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999844 689999998643221 111111 1222222222222221 23
Q ss_pred eCCeeEEEEEeeCCCchhhHHhhcCcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 007397 353 QGEEKLLIYEFMPNKSLDYFIFDQTKR-----------------ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 415 (605)
Q Consensus 353 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlk 415 (605)
.+...++||||+++++|.+++...... .......+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999888543210 01123345679999999999999998 9999999
Q ss_pred CCCEEEcC-CCceEEeecCCCccCCCCcccccccccccccCccchhcccCC----------------------CCCcccc
Q 007397 416 TSNVLLDH-DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG----------------------LFSVKSD 472 (605)
Q Consensus 416 p~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D 472 (605)
|+|||++. ++.+||+|||+|+...... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5899999999998653221 1223446789999999965322 2445679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC----cccccccccC------CCCHHHHHHHHHHHHHhc
Q 007397 473 VFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP----WQLIDACYQE------SCNPDEVIRCIHISLLCV 542 (605)
Q Consensus 473 vwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~----~~l~d~~~~~------~~~~~~~~~l~~li~~Cl 542 (605)
|||||||||||+++..+... ....+..... ..+.. ...+.+.... +..........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLK--RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHH--hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997655321 1111110000 00000 0000100000 000001223458999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 007397 543 QHHPEDRPSMPSVILM 558 (605)
Q Consensus 543 ~~dP~~RPt~~evl~~ 558 (605)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=260.48 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=192.7
Q ss_pred CeEEEEEEEEcC-CcEEEEEEccccchhh-HHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhh
Q 007397 298 GFGRVYKGTLVD-GQEIAVKRLSKISEQG-LNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD 375 (605)
Q Consensus 298 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 375 (605)
+||.||+|.... ++.+|+|++....... .+.+.+|+..+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999997654433 68899999999999999999999999999999999999999999998854
Q ss_pred cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccC
Q 007397 376 QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455 (605)
Q Consensus 376 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 455 (605)
... +++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 788999999999999999999998 9999999999999999999999999998764432 2334567889
Q ss_pred ccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHH
Q 007397 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI 535 (605)
Q Consensus 456 y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 535 (605)
|+|||.+.+..++.++||||||+++++|++|..|+..... ..... ........... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~----~~~~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELF----KKIGKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHH----HHHhccCCCCc-------cccccCCHHHH
Confidence 9999999988899999999999999999999999865311 11111 11111111000 00000335688
Q ss_pred HHHHHhcCCCCCCCCCHHHHHH
Q 007397 536 HISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 536 ~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.11 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=180.3
Q ss_pred HhcCccccceecccCeEEEEEEEE-----------------cCCcEEEEEEccccchhhHHHH--------------HHH
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-----------------VDGQEIAVKRLSKISEQGLNEL--------------KNE 332 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 332 (605)
..++|++.++||+|+||+||+|.+ .+++.||||++........+++ ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 2356899999865333222222 346
Q ss_pred HHHHHcCCCCce-----eeeeeeEEe--------CCeeEEEEEeeCCCchhhHHhhcCc---------------------
Q 007397 333 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDYFIFDQTK--------------------- 378 (605)
Q Consensus 333 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------- 378 (605)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 667777653 3567999999999999998854211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccc
Q 007397 379 RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458 (605)
Q Consensus 379 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 458 (605)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788899999999999999998 99999999999999999999999999976533211 11122335889999
Q ss_pred hhcccCCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCCCCCCC-ch---hHHHHHHHhhhc
Q 007397 459 PEYATDGL--------------------F--SVKSDVFSFGILVLEIVSGKR-NRGLYNSDN-KF---NVIRHAWNLWNK 511 (605)
Q Consensus 459 PE~~~~~~--------------------~--~~k~DvwSlGvvl~elltG~~-p~~~~~~~~-~~---~~i~~~~~~~~~ 511 (605)
||.+.... | ..+.||||+|||+++|++|.. |+....... .. ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875322 1 235799999999999999875 554211100 00 011111222111
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHH
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHP---EDRPSMPSVILM 558 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~~ 558 (605)
... + .+..........+|+.++|..+| .+|+|+.|++++
T Consensus 459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 0 01111223457788999998766 689999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=261.45 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=200.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHc--CCCCceeeeeeeEEeC----CeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK--LQHRNLVKLLGCCIQG----EEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 358 (605)
.++..+.+.||+|.||.||+|++ .|..||||++.... .....+|.+|++. |+|+||+.+++.-..+ ...+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45678899999999999999998 68999999997543 3455667777764 5899999998876544 3578
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
||.+|-+.|+|.++|.. ..++....++++..+|.||+|||- +|+..|.|||||..||||.+++...|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999954 458899999999999999999995 467789999999999999999999999999
Q ss_pred CCccCCCC--cccccccccccccCccchhcccCCC----C-C-cccchHHHHHHHHHHHhC----------CCCCCCCCC
Q 007397 434 LARTFGGD--EIEGSTNKVIGTYGYMAPEYATDGL----F-S-VKSDVFSFGILVLEIVSG----------KRNRGLYNS 495 (605)
Q Consensus 434 la~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~k~DvwSlGvvl~elltG----------~~p~~~~~~ 495 (605)
+|...... ......+..+||-.|||||++.... + + ..+||||||+|+||++-. ..||....+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877543 3444556788999999999986532 2 2 348999999999998752 245544333
Q ss_pred CCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 496 ~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.+... .......=...... ..-+.-.+.+....+.+||..||..+|.-|-|+-.+-+.|....
T Consensus 442 ~DPs~--eeMrkVVCv~~~RP---~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 SDPSF--EEMRKVVCVQKLRP---NIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCH--HHHhcceeecccCC---CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 22211 10000000000000 01112344567788999999999999999999999988886653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=259.46 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=215.4
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEEcC------CcEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeee
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGC 350 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 350 (605)
...+.....+++....+-+|.||.||.|.+.+ .+.|.+|.++. .+.-....+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34455556788899999999999999996533 45677887764 345567788899999999999999999999
Q ss_pred EEeC-CeeEEEEEeeCCCchhhHHh-----hcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC
Q 007397 351 CIQG-EEKLLIYEFMPNKSLDYFIF-----DQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD 424 (605)
Q Consensus 351 ~~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~ 424 (605)
+++. +..+++|.++.-|+|..++. +......+...+...++.|++.|+.|||+++ |||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8764 56788899999999999997 4444556777788889999999999999999 9999999999999999
Q ss_pred CceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHH
Q 007397 425 MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIR 503 (605)
Q Consensus 425 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~ 503 (605)
.++||+|=.+++..-..++.......-....||+||.+.+..|+.++|||||||+||||.| |+.|+...++.+....+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999987755444433333344678999999999999999999999999999998 999987766544433332
Q ss_pred HHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 504 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
. + .+-..+.+++.+|..+|.-||+..|++||++++++.-|..
T Consensus 513 d-------G---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 513 D-------G---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred c-------c---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2 1 1223455667789999999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=254.15 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=192.1
Q ss_pred ccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----CeeEEEE
Q 007397 290 INNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EEKLLIY 361 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 361 (605)
-.+.||-|+||.||.+++ .+|+.||+|++... +-...+.+-+|+.+|..++|.|++..+++..-. ++.|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 347899999999999998 56999999998642 223445677899999999999999998876543 3456677
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|.|. .+|..+| .....++...+.-++.||++||+|||+.+ |.||||||.|+|++++..+||+|||+|+....+
T Consensus 137 ELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 7663 3455555 23445777888889999999999999998 999999999999999999999999999987655
Q ss_pred cccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------hhhcC
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN--------LWNKG 512 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~--------~~~~~ 512 (605)
+....+. .+-|..|+|||++++. .|+.++||||+|||+.|||..+..|...++.+...+|..... .--++
T Consensus 210 ~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 4444333 4568999999999985 589999999999999999999888877665544444432210 00011
Q ss_pred CCcccccc--------c-ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 513 MPWQLIDA--------C-YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 513 ~~~~l~d~--------~-~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...-++.. . +.-........+.+.+...++..+|+.|.+..+.+..+..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 00000000 0 0111111222344567778899999999999999887743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=236.18 Aligned_cols=202 Identities=29% Similarity=0.383 Sum_probs=166.4
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc-cchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK-ISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 362 (605)
+...-+..||+|++|.|-+-++ .+|+..|+|++.. .+.+....+..|+.+..+- .+|.+|+++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444567899999999999888 5699999999974 3556667788888877655 69999999999999999999999
Q ss_pred eeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
.|.. +|+.+..+- .+...+++...-+|+..+++||.|||++ +.+||||+||+||||+.+|+||+||||++-.+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9954 666665332 3456788999999999999999999995 57999999999999999999999999998776432
Q ss_pred cccccccccccccCccchhccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 007397 442 EIEGSTNKVIGTYGYMAPEYAT----DGLFSVKSDVFSFGILVLEIVSGKRNRGLY 493 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~k~DvwSlGvvl~elltG~~p~~~~ 493 (605)
.. .+--.|...|||||.+. ...|+.|+||||||+++.||.+++.|+...
T Consensus 203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 21 22245778999999875 347999999999999999999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=275.98 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=186.6
Q ss_pred cccceecccCeEE-EEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 289 SINNKLGEGGFGR-VYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 289 ~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
.-.+.+|.|+.|+ ||+|.. +|+.||||++-. .-....++|+..|+.- +|||||++++.=.++...|+..|.| .
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 3346789999985 688887 788999999853 3345678999999988 5999999999888899999999998 4
Q ss_pred CchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---C--CceEEeecCCCccCCC
Q 007397 367 KSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---D--MNPKISDFGLARTFGG 440 (605)
Q Consensus 367 ~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~--~~vkl~DFGla~~~~~ 440 (605)
.+|++++... ...........+.++.|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5888888553 11111111345678999999999999987 999999999999976 3 4789999999999865
Q ss_pred Cccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG-KRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
+... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||+..-..+ .+.+....-...
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH- 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee-
Confidence 4332 224567799999999999998888999999999999999995 99997533211 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
-....++ ...+||.+|+..+|..||++.+|+.+
T Consensus 735 -----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1112222 67799999999999999999999854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=251.84 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=192.6
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-----C---CceeeeeeeEE----
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-----H---RNLVKLLGCCI---- 352 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~---- 352 (605)
.+|.+.++||-|.|++||++.+ ...+.||+|+.+. .....+....|+.+|+++. | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999998 4477889998854 3445566788999999883 2 36999999986
Q ss_pred eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC--------
Q 007397 353 QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-------- 424 (605)
Q Consensus 353 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-------- 424 (605)
.+.++++|+|++. .+|..+|..... .-++...+++|+.||+.||.|||... +|||-||||+|||+...
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 4678999999994 455555544322 34789999999999999999999975 79999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 007397 425 -------------------------------------------------------------------------------- 424 (605)
Q Consensus 425 -------------------------------------------------------------------------------- 424 (605)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 007397 425 ------------------------------------------------------------------------------MN 426 (605)
Q Consensus 425 ------------------------------------------------------------------------------~~ 426 (605)
..
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc---hhHHH
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK---FNVIR 503 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~---~~~i~ 503 (605)
+||+|||-|+.+... .+.-+.|..|+|||++.+..|++.+||||++|++|||+||...|+....... ...|.
T Consensus 393 vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 355555555443211 2234578899999999999999999999999999999999999987554321 11122
Q ss_pred HHHHhh--------hcCC-Ccccccc-----------------ccc--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 007397 504 HAWNLW--------NKGM-PWQLIDA-----------------CYQ--ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555 (605)
Q Consensus 504 ~~~~~~--------~~~~-~~~l~d~-----------------~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 555 (605)
.+...+ ..+. ...+++. .+. =..+.++..++.+++.=||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 111111 1111 0011111 111 14566788889999999999999999999999
Q ss_pred HHHh
Q 007397 556 ILML 559 (605)
Q Consensus 556 l~~L 559 (605)
++.-
T Consensus 548 l~hP 551 (590)
T KOG1290|consen 548 LKHP 551 (590)
T ss_pred hcCc
Confidence 8753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=260.19 Aligned_cols=268 Identities=19% Similarity=0.187 Sum_probs=207.2
Q ss_pred HHHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCC------CCceeeeeeeEEeC
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQ------HRNLVKLLGCCIQG 354 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 354 (605)
+....+|.+....|+|-|++|..|.+.. |+.||||++.. ++-..+.=+.|+++|++|+ .-|.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3455789999999999999999999844 88999999975 3334455568999999996 34899999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFG 433 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFG 433 (605)
.+++||+|-+ .-+|...|..-...--|....+..++.|+.-||..|...+ |+|.||||+|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999977 4578888877666666788889999999999999999887 9999999999999877 468999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
.|.....++.. .+.-+..|.|||++.+.+|+...|+||+||.||||.||+..|..........+.......+++.+
T Consensus 583 SA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99877655432 24456789999999999999999999999999999999999987665544333222111111100
Q ss_pred C------ccccccc--------------------------------c-----cCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 514 P------WQLIDAC--------------------------------Y-----QESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 514 ~------~~l~d~~--------------------------------~-----~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
+ .+-+|.. + ...-.+..+..+.+|+..||..||+.|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0 0001100 0 0112234566788899999999999999
Q ss_pred CHHHHHHH
Q 007397 551 SMPSVILM 558 (605)
Q Consensus 551 t~~evl~~ 558 (605)
|..+.|++
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=233.05 Aligned_cols=211 Identities=35% Similarity=0.568 Sum_probs=183.6
Q ss_pred ecccCeEEEEEEEEcC-CcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhh
Q 007397 294 LGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDY 371 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~ 371 (605)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.+.|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999855 899999999764332 45678999999999999999999999999999999999999999999
Q ss_pred HHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCCCccccccccc
Q 007397 372 FIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGDEIEGSTNKV 450 (605)
Q Consensus 372 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~ 450 (605)
++.... ..++...+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35789999999999999999999998 999999999999999 89999999999987643321 12234
Q ss_pred ccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHH
Q 007397 451 IGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPD 529 (605)
Q Consensus 451 ~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~ 529 (605)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 530 EVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 530 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=233.87 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=192.8
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeC--CeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 360 (605)
.++|++.+++|+|-++.||.|.. .++.+++||+++. -..+.+++|+.+|+.|. ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999986 5688999999975 34567889999999997 99999999998765 456799
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~ 439 (605)
+||+.+.+...+. ..+....+...+.++++||.|+|+.| |+|||+||.|++||... .++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988776554 23566777889999999999999999 99999999999999764 69999999998875
Q ss_pred CCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc---
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW--- 515 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~--- 515 (605)
... .-+..+.+..|--||.+-.- .|+..-|+|||||+|..|+..+.||...... ..++. .+...+......
T Consensus 185 p~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLV-kIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 185 PGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLV-KIAKVLGTDELYAYL 259 (338)
T ss_pred CCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHH-HHHHHhChHHHHHHH
Confidence 432 12234456788999988764 5899999999999999999999998653322 22222 111111100000
Q ss_pred ----cccccccc----------------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 ----QLIDACYQ----------------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 ----~l~d~~~~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
--+|+.+. .+.......+.++++.+.|..|-.+|||+.|.+.+-
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00122111 111111225677888999999999999999987653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=243.73 Aligned_cols=262 Identities=25% Similarity=0.282 Sum_probs=195.6
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------e
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------E 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 356 (605)
.+|.-++.+|.|+- .|-.+.+ ..++.||+|++.. ......+...+|..++..++|+||++++.++.-.+ .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999988 5655654 5589999999864 23344566778999999999999999999997543 5
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.|+|||+|.. +|...+. -.++......|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 6899999954 5655553 23677888999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH-----------
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA----------- 505 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~----------- 505 (605)
.-... -..+.++.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+.-+....+...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 74332 2345678899999999999999999999999999999999999988754432222221111
Q ss_pred -----HHhhhcCCC-------cc-ccccccc--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 506 -----WNLWNKGMP-------WQ-LIDACYQ--ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 506 -----~~~~~~~~~-------~~-l~d~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..... ... .+ +.|.... .+.++.....+.+++.+||-.+|++|.++.++|++---
T Consensus 244 L~~~~r~yv~-~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 244 LQPTVRNYVE-NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred hhHHHHHHhh-cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 11111 000 00 1111111 11223344456789999999999999999999998743
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=261.26 Aligned_cols=197 Identities=26% Similarity=0.380 Sum_probs=169.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc--------hhhHHHHHHHHHHHHcCC---CCceeeeeeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQ---HRNLVKLLGCCI 352 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 352 (605)
...|..++.||+|+||.|++|.++. ...|+||.+.+.. +.....+-.|++||..++ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999999855 6789999887631 122334567999999997 999999999999
Q ss_pred eCCeeEEEEEee-CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 353 QGEEKLLIYEFM-PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 353 ~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
+++.+||+||-- ++.+|+++|.. ...+++.++..|+.|++.|+++||+.+ |||||||-+|+.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999965 56678888833 345899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRG 491 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~ 491 (605)
||.|....... ....+||.+|.|||++.+..| ...-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998765433 445789999999999999887 566899999999999999888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=230.10 Aligned_cols=199 Identities=32% Similarity=0.462 Sum_probs=173.2
Q ss_pred ccccceecccCeEEEEEEEEcC-CcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
|.+.+.||+|++|.||++.+.+ ++.+|+|.+...... ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999865 899999999865444 67789999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+++|..++...... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 99999988553321 788999999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccccccccCccchhcc-cCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 007397 446 STNKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 492 (605)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=257.19 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=205.5
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+..++|+.+..+|.|.+|.|||+++. .+...|+|+++-.......-+++|+.+++..+|+|||.+++.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 44578999999999999999999984 48999999998777778888999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+.+|+|.+..+- -..+++.++..+.+..++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999987632 346888899999999999999999998 899999999999999999999999998776432
Q ss_pred cccccccccccccCccchhcc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYA---TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
- .......||+.|||||+. +.+.|..++|||++|+...|+---.+|.....+.....+. .-..-.+..+-
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-----TkS~~qpp~lk 238 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-----TKSGFQPPTLK 238 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-----hccCCCCCccc
Confidence 1 223346799999999987 4678999999999999999998777664332221111000 00011111222
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
| ......-+.+++..|+-.+|++||+++.+++
T Consensus 239 D-------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C-------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2 2334566889999999999999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=236.91 Aligned_cols=268 Identities=23% Similarity=0.378 Sum_probs=198.6
Q ss_pred HHHHhcCccccceecccCeEEEEEEEEc----CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCC
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGE 355 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 355 (605)
+....+.|..+++||+|.|++||++++. ..+.||+|.+... .....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567999999999999999999873 3678999998753 33456889999999995 999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGL 434 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGl 434 (605)
...+|+||+++....++++. ++...+..++..+++||.++|.+| ||||||||.|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888743 668888999999999999999999 9999999999999865 6789999999
Q ss_pred CccCCCCc-------------c-----------------------------cccccccccccCccchhcccCC-CCCccc
Q 007397 435 ARTFGGDE-------------I-----------------------------EGSTNKVIGTYGYMAPEYATDG-LFSVKS 471 (605)
Q Consensus 435 a~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~ 471 (605)
|....... . ........||++|+|||++..- .-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 0 0001124599999999998764 468999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCc-hhHH---------HHHHH------hhhcCCCccccc-----------cccc-
Q 007397 472 DVFSFGILVLEIVSGKRNRGLYNSDNK-FNVI---------RHAWN------LWNKGMPWQLID-----------ACYQ- 523 (605)
Q Consensus 472 DvwSlGvvl~elltG~~p~~~~~~~~~-~~~i---------~~~~~------~~~~~~~~~l~d-----------~~~~- 523 (605)
||||.|||+.-++++..||.....+-. ...+ +.... .|.......+.+ ....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999865433211 1111 11000 111111111111 0000
Q ss_pred -------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 524 -------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 524 -------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.....-....+++|+.+|+..+|.+|.|+++.|++-
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 001111223688999999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=217.12 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=185.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeee-EEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 361 (605)
.+.|.|.+.||+|.||.+-+++++. .+.+|+|.+.+. .-...+|.+|...--.| .|.||+..++. |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999854 788999988652 33456777887766566 48999988765 55667778999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc--CCCceEEeecCCCccCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD--HDMNPKISDFGLARTFG 439 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~--~~~~vkl~DFGla~~~~ 439 (605)
||++.|+|...+.. .-+.+.-..+++.|++.||.|+|+++ +||||||.+||||- +..+|||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887743 23677788899999999999999998 99999999999993 33589999999988754
Q ss_pred CCcccccccccccccCccchhcccCC---C--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDG---L--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
... ...--+..|.|||+.... . ..+.+|||.||+|+|.+++|+.|+.....++. -...|..|..+..
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN 246 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence 221 112245689999976432 2 36789999999999999999999974333322 2233444444443
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+.+. -.. ....+.++..+-|..+|++|-...++.++.
T Consensus 247 ~~~P~~--F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKK--FNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchh--hcc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 322111 111 234566778888999999995555555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=268.13 Aligned_cols=197 Identities=17% Similarity=0.194 Sum_probs=138.0
Q ss_pred cCCC-CceeeeeeeE-------EeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007397 338 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409 (605)
Q Consensus 338 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 409 (605)
.++| .||+++++.+ ......++++|++ +++|.+++... ...+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4555 5777788876 2334567788887 55899998543 345899999999999999999999998 9
Q ss_pred EEecCCCCCEEEcCCC-------------------ceEEeecCCCccCCCCc--------------ccccccccccccCc
Q 007397 410 IHRDLKTSNVLLDHDM-------------------NPKISDFGLARTFGGDE--------------IEGSTNKVIGTYGY 456 (605)
Q Consensus 410 iHrDlkp~NIll~~~~-------------------~vkl~DFGla~~~~~~~--------------~~~~~~~~~gt~~y 456 (605)
+||||||+||||+..+ .+||+|||+++...... ........+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45566666655321100 00001124588999
Q ss_pred cchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHH
Q 007397 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIH 536 (605)
Q Consensus 457 ~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~ 536 (605)
+|||++.+..++.++|||||||+||||++|.+|+.... ..+...... .+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~--------~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR--------VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh--------hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887754211 111111000 00100 0112234567
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 007397 537 ISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 537 li~~Cl~~dP~~RPt~~evl~~ 558 (605)
++.+||+.+|.+||+|.+|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=202.36 Aligned_cols=166 Identities=18% Similarity=0.159 Sum_probs=124.2
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
|+|.+++... ...+++..++.++.||++||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6788888543 345899999999999999999999875 999999999999999 9998765332
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+............. ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~-------~~~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPR-------DRSN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCcc-------cccc
Confidence 1258999999999999999999999999999999999999986433211 1111111111110000 0001
Q ss_pred CHHHH--HHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 527 NPDEV--IRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 527 ~~~~~--~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..... ..+.+++.+||+.+|++||++.++++++..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122 258899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=219.09 Aligned_cols=175 Identities=21% Similarity=0.212 Sum_probs=134.5
Q ss_pred HHhcCccccceecccCeEEEEEEEEc--CCcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceee-eeeeEEeC
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV--DGQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVK-LLGCCIQG 354 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 354 (605)
...++|.+.+.||+|+||+||+|++. +++.+|||++... .......+.+|+.+|++++|+|+++ +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 34578999999999999999999874 4777899987532 2234566899999999999999985 443 2
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCEEEcCCCceEEeecC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDl-kp~NIll~~~~~vkl~DFG 433 (605)
...++||||+++++|.... .. . ...++.|+++||.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996321 10 1 1467889999999999998 999999 9999999999999999999
Q ss_pred CCccCCCCccccc------ccccccccCccchhcccCCC------CCcccchH
Q 007397 434 LARTFGGDEIEGS------TNKVIGTYGYMAPEYATDGL------FSVKSDVF 474 (605)
Q Consensus 434 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~k~Dvw 474 (605)
+|+.+........ .....+++.|+|||++.... .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9997754321111 13567889999999985322 33446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=215.18 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=194.4
Q ss_pred CccccceecccCeEEEEEEEEcCC--cEEEEEEccccchhhHHHHHHHHHHHHcCCC----CceeeeeeeE-EeCCeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVDG--QEIAVKRLSKISEQGLNELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 359 (605)
+|.+.++||+|+||.||++.+... ..+|+|............++.|+.++..++. +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998663 4788888765433333378889999998873 6899999988 47788899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-----CceEEeecCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-----MNPKISDFGL 434 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-----~~vkl~DFGl 434 (605)
||+.+ |.+|.++..... ...++..++..|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 788888765544 567899999999999999999999999 9999999999999765 4699999999
Q ss_pred Cc--cCCCCcc----cc-c-ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 435 AR--TFGGDEI----EG-S-TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 435 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
++ .+..... .. . .....||..|.++....+...+.+.|+||++.++.||+.|..|+...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 3322111 11 1 223559999999999999999999999999999999999999986555433332222221
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..... .. .....+.+ +..+...+-..+..++|....+...|...
T Consensus 254 ~~~~~-------~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 RKLLT-------DR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhhcc-------cc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11100 00 11223333 33444444448999999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-22 Score=202.09 Aligned_cols=261 Identities=28% Similarity=0.368 Sum_probs=198.4
Q ss_pred ccccceecccCeEEEEEEEEcCCcEEEEEEccccchh---hHHHHHHHHHHHHcCCCC-ceeeeeeeEEeCCeeEEEEEe
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ---GLNELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 363 (605)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677899999999999999986 88999998753322 477889999999999988 799999999777778999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~~~ 442 (605)
+.++++..++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321135888999999999999999999998 99999999999999998 79999999998664433
Q ss_pred ccc----cccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCC-CchhHHHHHHHhhhcCCC
Q 007397 443 IEG----STNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD-NKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 443 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~-~~~~~i~~~~~~~~~~~~ 514 (605)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ............ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----PT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----CC
Confidence 221 2456789999999999987 57899999999999999999999996554432 011111111111 10
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .................+.+++..++..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000002223467788999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=226.62 Aligned_cols=255 Identities=22% Similarity=0.238 Sum_probs=188.6
Q ss_pred cccceecccCeEEEEEEEEcC-CcEEEEEEcc----c-cchhh-HHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLVD-GQEIAVKRLS----K-ISEQG-LNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.....+|.|++|.|+...... ....+.|... . ..... ...+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999888776533 3434444332 1 11111 122667888888999999998888887777666669
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++ +|..++... ..+...++..++.|++.|+.|||+.| |.||||||+|+++..+|.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998888443 35777888899999999999999999 999999999999999999999999999877543
Q ss_pred ccc--ccccccccccCccchhcccCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIE--GSTNKVIGTYGYMAPEYATDGLFSV-KSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
... ......+|+..|+|||++.+..|.+ ..||||.|+|+..|++|+.||......+..... ........+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccccccc
Confidence 322 4456678999999999999999865 589999999999999999999765554332200 0000000010
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. -..........+...++.++|+.+|..|-|+++|++.
T Consensus 548 ~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 E--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0112233445567789999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=188.52 Aligned_cols=212 Identities=19% Similarity=0.294 Sum_probs=175.3
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
-.|.+.++||+|.||.++.|+. .+++.||||.-...+ ..-++..|....+.|. .++|..++.+..++.+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3699999999999999999985 679999999865422 3356777888888885 78999999999999999999998
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-----CceEEeecCCCccC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-----MNPKISDFGLARTF 438 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-----~~vkl~DFGla~~~ 438 (605)
+ |-+|+++..-- ...++..++..|+.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 77887765322 234889999999999999999999998 9999999999999644 35899999999998
Q ss_pred CCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH
Q 007397 439 GGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA 505 (605)
Q Consensus 439 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~ 505 (605)
.+.... ......-||..||+---.++..-+..-|+-|||-|++..|-|..||.........+..+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 654332 1223456999999999999999999999999999999999999999987776655544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=183.19 Aligned_cols=256 Identities=18% Similarity=0.208 Sum_probs=192.4
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC-CceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 362 (605)
..+|.++++||+|+||.+|.|.. .+|..||||.-+. .....++..|..+...|++ ..|.++..+..++.+..+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999987 6699999998754 3344577889999999985 568888888889999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla~~~~ 439 (605)
.+ |.+|+++..--.+ .++..+++-++-|++.-++|+|.++ .|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 7788877643332 3778899999999999999999998 9999999999999543 569999999999875
Q ss_pred CCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+.... .......||..|.+--...+..-+..-|+-|+|.+|..+.-|..||....+....+..+.+.+.-....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 43221 2234567999999988888888889999999999999999999999987776665555544433222111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
.. +-..++. ++.-.+.-|-...-++-|...-+.+
T Consensus 246 e~-----LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 246 EV-----LCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred HH-----HhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 11 1122222 2333444555566666666554444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=191.24 Aligned_cols=171 Identities=13% Similarity=0.149 Sum_probs=134.5
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccc---hhhHH------HHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS---EQGLN------ELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
..++|.+.+.||.|+||.||++.. ++..+|+|.+.... ..... .+.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357999999999999999999765 67789999997432 22222 267899999999999999999886643
Q ss_pred --------CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 355 --------EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 355 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
...++||||++|.+|.++.. ++. ....+++.+|..||+.| ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 34789999999999977631 222 24668999999999999 99999999999999988
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHH
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIV 484 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ell 484 (605)
++|+|||.......+.. ...+++...|..++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998876532211 111455666778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=182.11 Aligned_cols=139 Identities=19% Similarity=0.172 Sum_probs=108.8
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchh--h------------------------HHHHHHHHHHHHcCCCCce
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ--G------------------------LNELKNEVILFSKLQHRNL 344 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 344 (605)
...||+|+||.||+|.+.+|+.||||+++..... . ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4789999999999999888999999998653110 0 1123459999999988776
Q ss_pred eeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCCEEEcC
Q 007397 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDLKTSNVLLDH 423 (605)
Q Consensus 345 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiHrDlkp~NIll~~ 423 (605)
.....+.. ...++||||++++++...+.. ...++...+..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 234899999999877654322 23578899999999999999999 6888 99999999999998
Q ss_pred CCceEEeecCCCccC
Q 007397 424 DMNPKISDFGLARTF 438 (605)
Q Consensus 424 ~~~vkl~DFGla~~~ 438 (605)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=214.99 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=180.8
Q ss_pred CccccceecccCeEEEEEEEEcCCcEEEEEEccccc-hhhHHHHHHHHHH--HHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS-EQGLNELKNEVIL--FSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+|...+.||++.|=+|.+|++.+|. |+||++-+.. ......+++++.- ...++|||.+++.-........|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8999886543 3344444443333 5556899999988877777778888888
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC--C
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG--D 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~--~ 441 (605)
+.+ +|.+.+ ..+..+...+.+.|+.||+.||..+|..| |+|||||.+||||+.-+-+.|+||..-+...- +
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 455555 34566788888899999999999999998 99999999999999999999999988765421 1
Q ss_pred c---ccccccccccccCccchhcccCC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 442 E---IEGSTNKVIGTYGYMAPEYATDG----------L-FSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 442 ~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
. +.....+...-..|+|||.+... . .+++.||||+|||++||++ |.++|.. -+++.+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 1 11111222234579999987431 2 6789999999999999998 6777742 11221110
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
. ......++++. . +...+.++++.|++.||+.|.++++.|+--.+.
T Consensus 250 ~--~~~~~e~~Le~-----I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 G--NADDPEQLLEK-----I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred c--CccCHHHHHHh-----C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0 00011111110 0 112577999999999999999999999986654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=181.85 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=191.5
Q ss_pred ccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
..+..+|.+...|..|+|++. |..+++|++.- ........|..|.-.|+-+.||||+.+++.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 445578999999999999984 55666777642 334445678888889999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE-ecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIH-RDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH-rDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
.|+|...+..+.. -..+..++.+++..|++|++|||+.. +++- --|....++||++.+.+|+= +-++. .
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kf------s 340 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKF------S 340 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-cccee------e
Confidence 9999999966543 35677889999999999999999987 3443 35888999999998877652 11111 1
Q ss_pred ccccccccccCccchhcccCCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLF---SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~---~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
-......-.|.||+||.++..+- -.++|+|||.+++|||.|...||....+.+--..+. -+.
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------leg 405 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------LEG 405 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------hcc
Confidence 11222334789999999987653 467999999999999999999998777654432221 122
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
++...++.....+.+|+.-|+..||.+||.+..|+-+|+.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 3344566666778899999999999999999999988864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=175.33 Aligned_cols=141 Identities=20% Similarity=0.209 Sum_probs=111.3
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchh--------------------------hHHHHHHHHHHHHcCCCCce
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ--------------------------GLNELKNEVILFSKLQHRNL 344 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 344 (605)
...||+|+||.||+|.+.+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999888999999998753210 01224678999999999887
Q ss_pred eeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcC
Q 007397 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDH 423 (605)
Q Consensus 345 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~ 423 (605)
.....+... ..++||||++++++...... ...++......++.|++.++.+||+ .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 34899999998865443222 2346778889999999999999999 88 99999999999999
Q ss_pred CCceEEeecCCCccCCC
Q 007397 424 DMNPKISDFGLARTFGG 440 (605)
Q Consensus 424 ~~~vkl~DFGla~~~~~ 440 (605)
++.++|+|||++....+
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=203.47 Aligned_cols=233 Identities=26% Similarity=0.302 Sum_probs=181.0
Q ss_pred eecccCeEEEEEEEE----cCCcEEEEEEccccchh--hHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 293 KLGEGGFGRVYKGTL----VDGQEIAVKRLSKISEQ--GLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
.+|+|.||.|++++. ..++.+|+|.+.+.... .......|..++...+ ||.+|+++..+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 34788999998763221 1124567888888887 9999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|.|...+. ....+.+.........++-|+.++|+.+ |+|||+|++||+++.+|.+|+.|||+.+..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999887763 3344666666777888999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
.+||..|||||++. ....++|.||||++++||++|..||.. +....|.. ....
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~-----------------~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK-----------------AELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-----------------hccC
Confidence 28999999999998 568899999999999999999999976 11111110 0112
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHhc
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSM--PSVILMLG 560 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl~~L~ 560 (605)
.+......+.+++..++..+|..|--. ..+.++++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 344445556677888888999999755 35555543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=169.68 Aligned_cols=188 Identities=19% Similarity=0.154 Sum_probs=141.8
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEccccchh----hHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEe
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ----GLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+.+|++|+ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998766 6788888877643321 1125789999999995 5789998885 456999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDl-kp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
+.|.+|...+.. ....++.|++++|.++|++| |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654311 11347789999999999999 999999 7999999999999999999998654332
Q ss_pred c-----c-c-----cccccccccCccchhcccCC-CCC-cccchHHHHHHHHHHHhCCCCCCCCC
Q 007397 443 I-----E-G-----STNKVIGTYGYMAPEYATDG-LFS-VKSDVFSFGILVLEIVSGKRNRGLYN 494 (605)
Q Consensus 443 ~-----~-~-----~~~~~~gt~~y~aPE~~~~~-~~~-~k~DvwSlGvvl~elltG~~p~~~~~ 494 (605)
. . . .......++.|++|+...-. ..+ ...+.++.|.-+|.++|+..+.....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1 0 0 01123368899999865432 233 56789999999999999988765544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-20 Score=206.31 Aligned_cols=198 Identities=21% Similarity=0.265 Sum_probs=158.6
Q ss_pred HHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 359 (605)
...+.|.|.+.||+|+||+||+|...+|+.||+|+-+.......-- -.+++.+|+ -+.|+++..++...+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3446899999999999999999999889999999976543321110 011222222 3456667777778888999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-------CCceEEeec
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-------DMNPKISDF 432 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-------~~~vkl~DF 432 (605)
|+||.+.|+|.+++. ..+.+++..++.++.|+++-+.+||..+ |||+||||+|.||.. ...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999995 5567899999999999999999999998 999999999999942 345899999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCC
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN 489 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p 489 (605)
|.+....--..........+|-.+-.+|...+.+.+..+|.|.|..+++-||.|+..
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 998765432222334556788999999999999999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=177.82 Aligned_cols=233 Identities=22% Similarity=0.312 Sum_probs=151.4
Q ss_pred CccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcCCC----------CceeeeeeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH----------RNLVKLLGCCI 352 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 352 (605)
.+...+.||.|+++.||.+++.+ ++++|+|++.. ......+++++|...+..+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34566899999999999999966 89999998753 334467778888776666433 12222222221
Q ss_pred ---------eCC--------eeEEEEEeeCCCchhhHHh---hcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 007397 353 ---------QGE--------EKLLIYEFMPNKSLDYFIF---DQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIH 411 (605)
Q Consensus 353 ---------~~~--------~~~lv~e~~~~~~L~~~l~---~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 411 (605)
... ..+++|+-+ .++|..++. .... ...+....+..+..|+++.+++||++| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 225677766 556666542 2222 122445556678899999999999999 999
Q ss_pred ecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccC--------CCCCcccchHHHHHHHHHH
Q 007397 412 RDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD--------GLFSVKSDVFSFGILVLEI 483 (605)
Q Consensus 412 rDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvvl~el 483 (605)
+||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999887765432211 234578999997643 2478899999999999999
Q ss_pred HhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 007397 484 VSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDR 549 (605)
Q Consensus 484 ltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 549 (605)
.+|..||+.......... .-..|. +.++.+..||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986543222110 123455 677788899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=165.76 Aligned_cols=135 Identities=19% Similarity=0.262 Sum_probs=105.9
Q ss_pred ccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC-----CCCceeeeeeeEEeCC---eeE-EE
Q 007397 290 INNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-LI 360 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv 360 (605)
-.+.||+|+||.||. +++....+||++........+.+.+|+.+++++ .||||+++++++..+. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 544344479988765444567899999999999 5799999999998864 333 78
Q ss_pred EEe--eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEecCCCCCEEEcCC----CceEEeecC
Q 007397 361 YEF--MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL-LYLHQDSRLRIIHRDLKTSNVLLDHD----MNPKISDFG 433 (605)
Q Consensus 361 ~e~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~iiHrDlkp~NIll~~~----~~vkl~DFG 433 (605)
+|| +++++|.+++.+. .+++. ..++.|++.++ .|||+++ |+||||||+|||++.. .+++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999442 24444 35678888877 9999999 9999999999999743 479999954
Q ss_pred CC
Q 007397 434 LA 435 (605)
Q Consensus 434 la 435 (605)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=178.84 Aligned_cols=215 Identities=26% Similarity=0.382 Sum_probs=160.9
Q ss_pred HHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEecC
Q 007397 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI-IHRDL 414 (605)
Q Consensus 336 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-iHrDl 414 (605)
|+.+.|.|+.++++.+.++...+.|.+|+..|+|.+.+.... ..+++.-...+++.|++||.|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 467899999999999999999999999999999999997633 34788888899999999999999876 4 99999
Q ss_pred CCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCC-------CCcccchHHHHHHHHHHHhCC
Q 007397 415 KTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-------FSVKSDVFSFGILVLEIVSGK 487 (605)
Q Consensus 415 kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~DvwSlGvvl~elltG~ 487 (605)
+..|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987653210001111112345789999987631 467799999999999999999
Q ss_pred CCCCCCCCCCch-hHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 488 RNRGLYNSDNKF-NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 488 ~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.||......... ..+.+... .+. ..+-+.+.... +....+..++..||..+|++||++..|-..+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK---GGS--NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh---cCC--CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999875544443 22222111 111 11111111110 2233688999999999999999999999888665
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=164.25 Aligned_cols=147 Identities=18% Similarity=0.168 Sum_probs=112.5
Q ss_pred HHhcCccccceecccCeEEEEEEE--EcCCcEEEEEEccccchh------------------------hHHHHHHHHHHH
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGT--LVDGQEIAVKRLSKISEQ------------------------GLNELKNEVILF 336 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l 336 (605)
.....|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334458899999999999999998 467999999998642110 112356899999
Q ss_pred HcCCCCc--eeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 007397 337 SKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 414 (605)
Q Consensus 337 ~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDl 414 (605)
+++.+.. +.+++.. ...++||||+++.+|...... ...+.......++.||+.+|.+||+++ .|+||||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 9997532 3344432 235899999999888665422 223455667889999999999999876 4999999
Q ss_pred CCCCEEEcCCCceEEeecCCCccCC
Q 007397 415 KTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 415 kp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.6e-18 Score=168.00 Aligned_cols=197 Identities=20% Similarity=0.223 Sum_probs=136.3
Q ss_pred CCCceeeeeeeEEeC---------------------------CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHH
Q 007397 340 QHRNLVKLLGCCIQG---------------------------EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC 392 (605)
Q Consensus 340 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ 392 (605)
.|||||+++++|.+. ...|+||..++. +|..++..+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999999887542 346788876643 666666332 356677788999
Q ss_pred HHHHHHHHHHhCCCCCeEEecCCCCCEEE--cCCC--ceEEeecCCCccCCCCc----ccccccccccccCccchhcccC
Q 007397 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLL--DHDM--NPKISDFGLARTFGGDE----IEGSTNKVIGTYGYMAPEYATD 464 (605)
Q Consensus 393 qi~~aL~~LH~~~~~~iiHrDlkp~NIll--~~~~--~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 464 (605)
|+++|+.|||.+| |.|||+|.+|||| |+++ .+.|+|||++-.-.... +........|.-..||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 3333 57899999875433211 1112223457778999999864
Q ss_pred CC------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHH
Q 007397 465 GL------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHIS 538 (605)
Q Consensus 465 ~~------~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li 538 (605)
.+ .-.|+|.|+.|.+.||++....||...........- ..+.... ..+......+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~------Yqe~qLP---------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT------YQESQLP---------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh------hhhhhCC---------CCcccCChHHHHHH
Confidence 32 236899999999999999999998763321111000 1111111 12223334577899
Q ss_pred HHhcCCCCCCCCCHHHHHHHh
Q 007397 539 LLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 539 ~~Cl~~dP~~RPt~~evl~~L 559 (605)
...|+.||.+||+..=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=190.55 Aligned_cols=212 Identities=22% Similarity=0.269 Sum_probs=149.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+|+.++.|..|++|.||..+++. .+.+|+ ++.+..-- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee------------------
Confidence 4689999999999999999999865 678888 44332110 011 22222333333
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC--
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD-- 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~-- 441 (605)
|+-...+ ..-+.++.. ++.+++|||+.+ |+|||+||+|.+|..-|.+|+.|||+.+.....
T Consensus 136 ---gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2222222 111223322 268999999998 999999999999999999999999998764211
Q ss_pred ------cc-----cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 442 ------EI-----EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 442 ------~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
.. +.....++|||.|+|||++....|...+|.|++|+|+||.+-|+.||....+++.+..+......|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 00 1112356899999999999999999999999999999999999999998877766665555444444
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
++.. ....++.+++...|+.+|.+|--..
T Consensus 279 E~de--------------a~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 EEDE--------------ALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccCc--------------CCCHHHHHHHHHHHHhChHhhcccc
Confidence 4421 1223466778888889999995433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-17 Score=159.41 Aligned_cols=134 Identities=21% Similarity=0.277 Sum_probs=112.9
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccch--------hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE--------QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 678899997653211 1124577899999999999988877777777888999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887432 11 77889999999999999998 99999999999999 78999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=156.34 Aligned_cols=144 Identities=18% Similarity=0.172 Sum_probs=111.7
Q ss_pred HHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccch----------------------hhHHHHHHHHHHHHc
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE----------------------QGLNELKNEVILFSK 338 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~ 338 (605)
+......|.+.+.||+|+||.||++...+|+.+|||++..... .....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333445888899999999999999988899999998653210 011235678889999
Q ss_pred CCCCc--eeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007397 339 LQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKT 416 (605)
Q Consensus 339 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp 416 (605)
+.|++ +++.++ ....++||||+++++|..... ......++.++++++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 88774 444443 245589999999999876542 0234568899999999999988 99999999
Q ss_pred CCEEEcCCCceEEeecCCCccCCC
Q 007397 417 SNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 417 ~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-18 Score=177.40 Aligned_cols=175 Identities=24% Similarity=0.341 Sum_probs=131.4
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++.|+++...+|.++|.........++.....++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999877777778889999999999999999 66 999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCchhHHHHHHHhhh
Q 007397 436 RTFGGDE----IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG-KRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 436 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
....... .....+...||..||+||.+.+..|+.|+||||||+||+||+.- ...++ . ..+..-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r-~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------R-IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------H-HHhhhhhh
Confidence 7765433 22334557799999999999999999999999999999999971 11111 0 01111122
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 555 (605)
.+.+. +...... ..-..++++++...|.+||++.++
T Consensus 474 ~g~ip----~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIP----PEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCC----hHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 22221 1111111 123468889999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=154.51 Aligned_cols=130 Identities=23% Similarity=0.347 Sum_probs=106.6
Q ss_pred eecccCeEEEEEEEEcCCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.||+|+||.||+|.. +++.+++|+..... ......+.+|+.++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999864321 112356778999999999887666555666677789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++++|...+..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887733210 68999999999999998 99999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=176.14 Aligned_cols=138 Identities=21% Similarity=0.298 Sum_probs=111.7
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEcccc-------chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI-------SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
...|...++||+|+||+||+|.......++.+++.+. .....+.+.+|+.++++++|++++....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3455678999999999999998755443332222221 112235688999999999999999887777777788
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 34678999999999999998 9999999999999 678999999999976
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.8e-16 Score=145.58 Aligned_cols=137 Identities=20% Similarity=0.225 Sum_probs=97.5
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchh--hHHH----------------------HHHHHHHHHcCCCCc--e
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ--GLNE----------------------LKNEVILFSKLQHRN--L 344 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 344 (605)
.+.||+|+||+||+|.+.+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999888999999988642211 1111 134555555554332 3
Q ss_pred eeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcC
Q 007397 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDH 423 (605)
Q Consensus 345 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~ 423 (605)
.+.+++ ...++||||++++.+......... . ...+..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344332 245899999999544321111100 0 15567899999999999999 87 99999999999999
Q ss_pred CCceEEeecCCCccCC
Q 007397 424 DMNPKISDFGLARTFG 439 (605)
Q Consensus 424 ~~~vkl~DFGla~~~~ 439 (605)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-16 Score=122.23 Aligned_cols=64 Identities=58% Similarity=1.224 Sum_probs=55.5
Q ss_pred CCCCCCeeEecCCCCCCc--cccccccChHHHHHHHhhcCCcccccceeecCCCcceeEeeeccccc
Q 007397 168 CPGGEGFLKLPKMKLPEN--YWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMWFGDLIDI 232 (605)
Q Consensus 168 c~~~~~f~~~~~~~~p~~--~~~~~~~~~~~C~~~C~~~C~C~a~~~~~~~g~~~gc~~w~g~l~~~ 232 (605)
|+.+|+|++|++|++|++ +.++.++++++|++.|++||+|+||+|.++. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999994 4444779999999999999999999998655 668999999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-15 Score=135.58 Aligned_cols=135 Identities=24% Similarity=0.202 Sum_probs=113.8
Q ss_pred ccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC--CceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 290 INNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++......+..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999865433 5678899999999976 58889988888778899999999988
Q ss_pred chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 368 SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 368 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
.+..+ +......++.+++++|.+||......++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999986444599999999999999999999999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.1e-17 Score=179.75 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=193.6
Q ss_pred hcCccccceecccCeEEEEEEEEcC--CcEEEEEEccccc--hhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD--GQEIAVKRLSKIS--EQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 359 (605)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-+.+. |.|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3567888889999999998887633 4556777765432 333445566888888887 9999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCcc
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH-QDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLART 437 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~ 437 (605)
+.+|..++++...+.... ....+...+-..+.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988774211 113445566678999999999999 877 99999999999999999 999999999998
Q ss_pred CCC-Cccccccccccc-ccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 438 FGG-DEIEGSTNKVIG-TYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 438 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+..........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------------- 240 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------------- 240 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------------
Confidence 877 566666667788 9999999999885 45678999999999999999999987655433211
Q ss_pred ccccccc--ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 515 WQLIDAC--YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 515 ~~l~d~~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
....+.. ..............++..+++..+|..|.+.+++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0111110 001111122234567788889899999999888755
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=142.43 Aligned_cols=135 Identities=16% Similarity=0.182 Sum_probs=103.8
Q ss_pred ceec-ccCeEEEEEEEEcCCcEEEEEEccccc-------------hhhHHHHHHHHHHHHcCCCCce--eeeeeeEEeCC
Q 007397 292 NKLG-EGGFGRVYKGTLVDGQEIAVKRLSKIS-------------EQGLNELKNEVILFSKLQHRNL--VKLLGCCIQGE 355 (605)
Q Consensus 292 ~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 355 (605)
..|| .||.|+||.+.. .+..+|||++.... ......+.+|+.++.++.|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 888899998877 47789999875311 1223457889999999998875 66776644332
Q ss_pred e----eEEEEEeeCC-CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 356 E----KLLIYEFMPN-KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 356 ~----~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
. .++|||++++ .+|..++... .++.. .+.+|+.+|.+||+.| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6888877432 23433 3678999999999999 9999999999999999999999
Q ss_pred ecCCCccC
Q 007397 431 DFGLARTF 438 (605)
Q Consensus 431 DFGla~~~ 438 (605)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.7e-13 Score=142.60 Aligned_cols=140 Identities=25% Similarity=0.305 Sum_probs=98.9
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhhH------------------------------H----------HHHH
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGL------------------------------N----------ELKN 331 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 331 (605)
+.||.|++|.||+|++.+|+.||||+.+....... + .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864211100 0 1334
Q ss_pred HHHHHHcC----CCCceeeeeeeEE-eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 007397 332 EVILFSKL----QHRNLVKLLGCCI-QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR-GLLYLHQDS 405 (605)
Q Consensus 332 E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~ 405 (605)
|+..+.++ +|.+-+.+-.++. ..+..+|||||++|++|.+........ . ....++.++++ .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 55545444 2333333333332 245579999999999998876432111 1 23346666665 478899988
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 406 ~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
++|+|+||.||+++.++.++|+|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=109.21 Aligned_cols=71 Identities=20% Similarity=0.372 Sum_probs=59.5
Q ss_pred CCCCCCeeEecCCCCCCccccccccChHHHHHHHhh---cCCcccccceeecCCCcceeEeeecc-ccccccccceeccc
Q 007397 168 CPGGEGFLKLPKMKLPENYWSNQSMSLRECEAECTK---NCSCRAYANSQVVGGGNGCLMWFGDL-IDIKECSEKYVWGQ 243 (605)
Q Consensus 168 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~C~~~C~~---~C~C~a~~~~~~~g~~~gc~~w~g~l-~~~~~~~~~~~~~~ 243 (605)
|...++|+++.+|++|+... .+++||+++|++ ||+|.||++.+ .+.||.+|++++ ++++..... ++
T Consensus 5 ~~~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~---~~~gC~~W~~~l~~d~~~~~~~---g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAK---ARKQCLWFPFNSMSGVRKEFSH---GF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccC---CCCCeEEecCcchhhHHhccCC---Cc
Confidence 34457899999999998433 689999999999 99999999974 245899999999 999877554 78
Q ss_pred eeeEe
Q 007397 244 DFFIR 248 (605)
Q Consensus 244 ~~~~~ 248 (605)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 89987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.1e-13 Score=128.54 Aligned_cols=202 Identities=22% Similarity=0.245 Sum_probs=140.6
Q ss_pred HHHcCCCCceeeeeeeEEeCC-----eeEEEEEeeCCCchhhHHhhcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007397 335 LFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLR 408 (605)
Q Consensus 335 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 408 (605)
-|.++.|.|||+++.++.+.+ ...++.|||..|++..+|.+..+ ...+....-.+++.||+.||.|||+.. .+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 445567999999999886543 46789999999999999976533 345666777789999999999999985 77
Q ss_pred eEEecCCCCCEEEcCCCceEEeecCCCccCC---CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh
Q 007397 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFG---GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485 (605)
Q Consensus 409 iiHrDlkp~NIll~~~~~vkl~DFGla~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt 485 (605)
|+|+++..+.|++..++-+|+.--.- ..+. .......+....+-++|.|||.=.....+.++|||+||+...||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888753211 1110 0111111223446789999998877778899999999999999998
Q ss_pred CCCCCCCCCCC-CchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 486 GKRNRGLYNSD-NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 486 G~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+..-....... .....+... +..+-+. .-..++..|++-.|..||+|.+++.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~--------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV--------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhh--------eeeccCc------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 77543222111 111111111 1111111 11256778999999999999988754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.7e-12 Score=118.79 Aligned_cols=131 Identities=24% Similarity=0.148 Sum_probs=97.7
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEEeeCCCch
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
.+.|+.|.++.||+++.. ++.+++|....... ....+..|+.+++.+.+.+++ +++.. .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 367899999999999864 78899999765322 223467899999988765544 44443 23446899999999887
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
.... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 011245678999999999986 22359999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.8e-12 Score=138.88 Aligned_cols=145 Identities=20% Similarity=0.225 Sum_probs=94.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchh----------------------------------hHHH-
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLNE- 328 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 328 (605)
...|+. +.||+|++|.||+|++++ |+.||||++++.... ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999987 999999998753111 0111
Q ss_pred -----HHHHHHHHHcC----CCCceeeeeeeEEe-CCeeEEEEEeeCCCchhhHHhhcCcc---CCCCHHHHHHHHHHHH
Q 007397 329 -----LKNEVILFSKL----QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDYFIFDQTKR---ELLDWSKRFHIICGTA 395 (605)
Q Consensus 329 -----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~---~~l~~~~~~~i~~qi~ 395 (605)
+.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..-.... ..+....+..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~---- 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF---- 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH----
Confidence 22333333333 23333443333322 45678999999999997753111111 112222222233
Q ss_pred HHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeecCCCccCCC
Q 007397 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDFGLARTFGG 440 (605)
Q Consensus 396 ~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DFGla~~~~~ 440 (605)
..++..| ++|+|+||.||+++.++ .++++|||++.....
T Consensus 274 ---~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 ---TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344566 99999999999999988 999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=133.47 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=177.4
Q ss_pred cCccccceecc--cCeEEEEEEEE---cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCee
Q 007397 286 DNFSINNKLGE--GGFGRVYKGTL---VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 357 (605)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........-.+|+...+++. |+|.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677789999 99999999986 3478899998432 22233333345677777775 99999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeec
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR----GLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDF 432 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DF 432 (605)
++-+|++. .+|..+... ....++....+.++.+... ||.++|+.. |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 555555422 2334667777788888888 999999998 9999999999999999 88999999
Q ss_pred CCCccCCCCcccccc---cccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 433 GLARTFGGDEIEGST---NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 433 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|+...++...+.... ....|...|++||... ..++.+.|+|++|.+..+..++.......... .|..+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccccc
Confidence 999988765533222 2335788899999775 45688999999999999998887665432100 11111
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+.+. +-+ ++-..-..++..++..+++.+|..|++.+.+..
T Consensus 339 r~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 111 111111223444788899999999998877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.5e-10 Score=122.06 Aligned_cols=229 Identities=15% Similarity=0.158 Sum_probs=151.6
Q ss_pred EcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHH
Q 007397 307 LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSK 386 (605)
Q Consensus 307 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 386 (605)
..++.+|.|+..+..+.......++-++.|+.++||||+++++.+......|||+|-+ ..|...+.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 3568888888887655555566788899999999999999999999999999999987 334444422 22455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCC
Q 007397 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL 466 (605)
Q Consensus 387 ~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 466 (605)
....+.||+.||.+||..+ +++|++|..+.|+|+..|..||++|.++.....-.. ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6668899999999999765 699999999999999999999999988765432211 111112223466666543322
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCC--CCCCCch-hHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcC
Q 007397 467 FSVKSDVFSFGILVLEIVSGKRNRGL--YNSDNKF-NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQ 543 (605)
Q Consensus 467 ~~~k~DvwSlGvvl~elltG~~p~~~--~~~~~~~-~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~ 543 (605)
-..|.|.||++++|++.|..+... ...+... ..+....+..... ...... .++++..|+.
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~--------------~~~r~n-~~~~~~~~~~ 244 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGAT--------------ELKRPN-KLRFILECRL 244 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccc--------------cccccc-hhhHHHHHHh
Confidence 356999999999999999322211 1111111 0111000000000 000011 4456677777
Q ss_pred CCCCCCCCHHHHHHHhcCCCC
Q 007397 544 HHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 544 ~dP~~RPt~~evl~~L~~~~~ 564 (605)
..+-.|-.+-+++..|+....
T Consensus 245 ~~gff~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 245 LGGFFRNDFVDTLLFLEELRL 265 (690)
T ss_pred ccccccchHHHHHHHHHhccc
Confidence 777777778888888777644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-10 Score=109.35 Aligned_cols=139 Identities=14% Similarity=0.113 Sum_probs=100.0
Q ss_pred cceecccCeEEEEEEEEcC-------CcEEEEEEcccc-------------c---------hhhHHHHH----HHHHHHH
Q 007397 291 NNKLGEGGFGRVYKGTLVD-------GQEIAVKRLSKI-------------S---------EQGLNELK----NEVILFS 337 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~ 337 (605)
...||.|--+.||.|...+ +..+|||+.+.. . ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 479999986420 0 01122333 7999999
Q ss_pred cCCC--CceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecC
Q 007397 338 KLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDL 414 (605)
Q Consensus 338 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiHrDl 414 (605)
++.. -++.+++++ ...+|||||+.+..+..... +...++......+..+++.+|..| |..+ |+|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9863 456666654 56789999998754422111 111244456677889999999999 8888 999999
Q ss_pred CCCCEEEcCCCceEEeecCCCccCCC
Q 007397 415 KTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 415 kp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
++.|||++ ++.+.|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 47899999999877643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-11 Score=99.16 Aligned_cols=79 Identities=43% Similarity=0.939 Sum_probs=61.8
Q ss_pred CCCCCC---CCeeEecCCCCCCccccccccChHHHHHHHhhcCCcccccceeecCCCcceeEeeeccccccccccceecc
Q 007397 166 SDCPGG---EGFLKLPKMKLPENYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMWFGDLIDIKECSEKYVWG 242 (605)
Q Consensus 166 ~~c~~~---~~f~~~~~~~~p~~~~~~~~~~~~~C~~~C~~~C~C~a~~~~~~~g~~~gc~~w~g~l~~~~~~~~~~~~~ 242 (605)
++|... +.|++++++++|+........++++|++.|++||+|.||++.+ ++.+|.+|.+.+.+....... +
T Consensus 3 ~~C~~~~~~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~---~ 76 (84)
T cd01098 3 LNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSG---G 76 (84)
T ss_pred cccCCCCCCCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCC---C
Confidence 356544 6899999999998533336789999999999999999999873 356899999999887654332 4
Q ss_pred ceeeEeec
Q 007397 243 QDFFIRVP 250 (605)
Q Consensus 243 ~~~~~~l~ 250 (605)
..+||+++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 67888874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=109.94 Aligned_cols=142 Identities=20% Similarity=0.231 Sum_probs=108.5
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccch-hhHHHHHHHHHHHHcCCCC--ceeeeeeeEEeCC---eeEEEEEeeC
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE-QGLNELKNEVILFSKLQHR--NLVKLLGCCIQGE---EKLLIYEFMP 365 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~ 365 (605)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+.+++.+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999999865322 2456788999999999763 4566776665532 5689999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS---------------------------------------- 405 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 405 (605)
+.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23566677777888888888887531
Q ss_pred -------------CCCeEEecCCCCCEEEcC--CCceEEeecCCCcc
Q 007397 406 -------------RLRIIHRDLKTSNVLLDH--DMNPKISDFGLART 437 (605)
Q Consensus 406 -------------~~~iiHrDlkp~NIll~~--~~~vkl~DFGla~~ 437 (605)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.7e-10 Score=101.88 Aligned_cols=131 Identities=20% Similarity=0.297 Sum_probs=100.3
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEE-cccc--c-----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKR-LSKI--S-----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~-~~~~--~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..+++|+-+.+|.+...+ ..+++|. +.|. . .-......+|+.++.++.-..|.-..-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999986643 3455553 3321 1 11233456899999998766665555566778888999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++|..|.+.+... ...++..+-..+.-||..| |+|+||.++||++...+ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888443 2457788888999999999 99999999999998776 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.8e-10 Score=100.78 Aligned_cols=143 Identities=27% Similarity=0.344 Sum_probs=106.5
Q ss_pred ccceecccCeEEEEEEEEcCCcEEEEE-Ecccc-------chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 290 INNKLGEGGFGRVYKGTLVDGQEIAVK-RLSKI-------SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~~~~~vavK-~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
....|-||+-+.|+++.. .|+..+|| ++.+. ..-.....++|+.+|.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999987 56666666 34331 1223445678999999987555555555667777788999
Q ss_pred EeeCC-CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecCCCcc
Q 007397 362 EFMPN-KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFGLART 437 (605)
Q Consensus 362 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFGla~~ 437 (605)
||+++ .++.+++.........+ .....++..|.+.+.-||..+ |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 57777776554433222 233678889999999999998 999999999999977654 58999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.4e-11 Score=124.89 Aligned_cols=248 Identities=21% Similarity=0.187 Sum_probs=175.1
Q ss_pred HhcCccccceecccCeEEEEEEEE--cCCcEEEEEEccccchhhHHHH--HHHHHHHHcCC-CCceeeeeeeEEeCCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL--VDGQEIAVKRLSKISEQGLNEL--KNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 358 (605)
...+|..+..||.|.|+.|+.... .++..|++|.+.+.......++ ..|+.+...+. |.+++++...+..-...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788899999999999998764 3478899998865333222222 34666666664 899999888888888888
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCCCcc
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLART 437 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGla~~ 437 (605)
+--||+.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||++..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 889999999887665 23345777888999999999999999988 9999999999999886 7889999999864
Q ss_pred CCCCcccccccccccccCcc--chhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 438 FGGDEIEGSTNKVIGTYGYM--APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
+.-. .....+.-.+. +|+......+..++|++|||.-+.+.+++...-..... |.....+...
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p 481 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTP 481 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeeccccc
Confidence 3211 01111223344 45555567789999999999999999998765432111 0111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+.....+..+...++..++..||.+.++..+...+
T Consensus 482 ----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 482 ----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111124455666677889999999999988776554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.2e-11 Score=135.12 Aligned_cols=251 Identities=17% Similarity=0.225 Sum_probs=172.2
Q ss_pred HHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
...+.+.+.+-+-+|.++.++.+.-.. |...+.|.... ......+....+-.++-...+|-+++...-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 456788888899999999998876422 44444444332 12222233333333333344566666655566678889
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
|+++|+.+++|...++... ..+...+...+..+.+++.|||+.. +.|||++|.|+|+..++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988875433 3455556667777889999999976 999999999999999999999999844332
Q ss_pred CC-------------------------Cccc----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCC
Q 007397 439 GG-------------------------DEIE----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN 489 (605)
Q Consensus 439 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p 489 (605)
+- .... .......||+.|.|||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112235699999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 490 RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 490 ~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
|....+...+..+......|.. -+.+......+++...+..+|..|-.|.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~--------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPE--------------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCC--------------CccccChhhhhhhhhhhccCchhccCcc
Confidence 9876665444322211111111 1122223455677777788999997776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6e-09 Score=108.19 Aligned_cols=170 Identities=23% Similarity=0.332 Sum_probs=130.7
Q ss_pred CeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeEEEEEeeCC-Cchhh
Q 007397 298 GFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMPN-KSLDY 371 (605)
Q Consensus 298 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-~~L~~ 371 (605)
.-.+.|++.. .||..|++|++.....+.......-+++++++.|.|+|++.+++.. +...++||+|.++ .+|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3468899986 6799999999954444444444566889999999999999998873 4567899999985 56766
Q ss_pred HHhhcC------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 372 FIFDQT------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 372 ~l~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
..+... ....+++...+.++.||..||.++|+.| +.-+-|.|.+||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654422 2234678899999999999999999999 8889999999999999999999988876543
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCC
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN 489 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p 489 (605)
.+.. |-+.+ -.+-|.=.||.+++.|.+|...
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 3220 11111 2356888999999999999755
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=96.44 Aligned_cols=126 Identities=23% Similarity=0.251 Sum_probs=83.2
Q ss_pred EEEEEEEcCCcEEEEEEcccc--------------c------------hhhHHHHHHHHHHHHcCCCC--ceeeeeeeEE
Q 007397 301 RVYKGTLVDGQEIAVKRLSKI--------------S------------EQGLNELKNEVILFSKLQHR--NLVKLLGCCI 352 (605)
Q Consensus 301 ~Vy~~~~~~~~~vavK~~~~~--------------~------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 352 (605)
.||.|...+|..+|||+.+.. . .......++|...|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999986420 0 01123467899999999865 45666544
Q ss_pred eCCeeEEEEEeeC--CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 353 QGEEKLLIYEFMP--NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY-LHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 353 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
....|||||++ +..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 66665443211 1122345577777775555 57887 9999999999999988 9999
Q ss_pred eecCCCccCC
Q 007397 430 SDFGLARTFG 439 (605)
Q Consensus 430 ~DFGla~~~~ 439 (605)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.2e-08 Score=97.94 Aligned_cols=133 Identities=18% Similarity=0.133 Sum_probs=95.5
Q ss_pred EEEEEEEEcCCcEEEEEEccccchh-hHH----------HHHHHHHHHHcCCCCc--eeeeeeeEEe-----CCeeEEEE
Q 007397 300 GRVYKGTLVDGQEIAVKRLSKISEQ-GLN----------ELKNEVILFSKLQHRN--LVKLLGCCIQ-----GEEKLLIY 361 (605)
Q Consensus 300 g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv~ 361 (605)
..|++... +|+.+.||+....... ..+ .+.+|...+.++...+ .++++.+... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666554 6788999977432211 111 3678888888885433 3344455443 23568999
Q ss_pred EeeCCC-chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-------CCceEEeecC
Q 007397 362 EFMPNK-SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-------DMNPKISDFG 433 (605)
Q Consensus 362 e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-------~~~vkl~DFG 433 (605)
|++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++. +..+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8888874322 223456677789999999999999999 999999999999985 4679999999
Q ss_pred CCcc
Q 007397 434 LART 437 (605)
Q Consensus 434 la~~ 437 (605)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.8e-07 Score=93.74 Aligned_cols=260 Identities=13% Similarity=0.098 Sum_probs=154.5
Q ss_pred ccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeee------E-EeCCeeEEEE
Q 007397 290 INNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGC------C-IQGEEKLLIY 361 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lv~ 361 (605)
....||+|+-+.+|-.- .-...+.|+...-......+.. ..|.+. .||-+-.-+.+ . ..+....++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35789999999999642 2233456777653333222222 222222 45533321111 0 1123356888
Q ss_pred EeeCCCch-hhHHhh---cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 362 EFMPNKSL-DYFIFD---QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 362 e~~~~~~L-~~~l~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
..+++..- ..++.. .......+|.-.+++++.|+.+.+.||.+| .+-+|+.++|+|+++++.|.|.|-.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 88876532 223222 223456789999999999999999999999 88999999999999999999998654433
Q ss_pred CCCCcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCC----Cchh-HHHHHH
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSG-KRNRGLYNSD----NKFN-VIRHAW 506 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG-~~p~~~~~~~----~~~~-~i~~~~ 506 (605)
..+. ......+|.++|.+||.-. +..-+...|.|.|||++++||.| ++||...... ...+ .|....
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2211 1223356899999999754 34456789999999999999987 9999764321 1111 121111
Q ss_pred HhhhcCCCcccccccccCCCCH-HHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNP-DEVIRCIHISLLCVQHH--PEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~-~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~L~~~ 562 (605)
-......-.-+.-+ ..+.+. -....+..|...|+... +.-|||++-.+..|...
T Consensus 244 f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 244 FAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00000000000000 001111 11234555666777543 56899999988887443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.2e-08 Score=92.70 Aligned_cols=139 Identities=20% Similarity=0.195 Sum_probs=98.5
Q ss_pred CccccceecccCeEEEEEEEEcCCcEEEEEEccc----------c----------c--hhhHHHHHHHHHHHHcCCCC--
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK----------I----------S--EQGLNELKNEVILFSKLQHR-- 342 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~----------~----------~--~~~~~~~~~E~~~l~~l~h~-- 342 (605)
-..+..+||-|--+.||.|..++|.++|||.=+- . + .-.....++|.++|++|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3556789999999999999999999999995321 0 0 01123456899999999754
Q ss_pred ceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc
Q 007397 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422 (605)
Q Consensus 343 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~ 422 (605)
.+.+.+++ +...+||||+++-.|...- ++......++..|++-+.-+-..| |||+|+++-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 66666653 4567999999997765432 122222334444444444444556 99999999999999
Q ss_pred CCCceEEeecCCCccCCC
Q 007397 423 HDMNPKISDFGLARTFGG 440 (605)
Q Consensus 423 ~~~~vkl~DFGla~~~~~ 440 (605)
++|.+.++||-.+.....
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999988766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-07 Score=88.91 Aligned_cols=124 Identities=25% Similarity=0.244 Sum_probs=90.1
Q ss_pred CCcEEEEEEccc-cc------hhhHHHHHHHHHHHHcCCC--CceeeeeeeEEeC----CeeEEEEEeeCC-CchhhHHh
Q 007397 309 DGQEIAVKRLSK-IS------EQGLNELKNEVILFSKLQH--RNLVKLLGCCIQG----EEKLLIYEFMPN-KSLDYFIF 374 (605)
Q Consensus 309 ~~~~vavK~~~~-~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~-~~L~~~l~ 374 (605)
.++.+.+|.+.. .. ........+|...+..+.. -...+.+.+.... ...+||+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 356666665432 11 1233456778887777753 3345556665543 245899999988 47888885
Q ss_pred hcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEeecCCCccC
Q 007397 375 DQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKISDFGLARTF 438 (605)
Q Consensus 375 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~DFGla~~~ 438 (605)
.... .+......++.++++.+.-||+.| |+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5322 556677889999999999999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.1e-08 Score=106.64 Aligned_cols=155 Identities=18% Similarity=0.267 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC-ccccc------ccccccccCccchhcc
Q 007397 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD-EIEGS------TNKVIGTYGYMAPEYA 462 (605)
Q Consensus 390 i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~-~~~~~------~~~~~gt~~y~aPE~~ 462 (605)
-+.+++.|+.|+|.+. .+||+.|.|++|.++..+..||+.|+.+...... .+... ..-......|.|||++
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445568999999875 6999999999999999999999999987665331 11000 0112245689999999
Q ss_pred cCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHh
Q 007397 463 TDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLC 541 (605)
Q Consensus 463 ~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~C 541 (605)
.+...+.++|+||+||++|.+.. |+..+.............. .+..-....+.+...++.+=+.++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-------------~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-------------LLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-------------ccccccccccccCcHHHHHHHHHH
Confidence 99888999999999999999994 5555544332222111110 000011112233344566666778
Q ss_pred cCCCCCCCCCHHHHHHHh
Q 007397 542 VQHHPEDRPSMPSVILML 559 (605)
Q Consensus 542 l~~dP~~RPt~~evl~~L 559 (605)
+..++.-||++.++.+..
T Consensus 249 l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred hcCCcccCcchhhhhccc
Confidence 889999999888876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.1e-07 Score=95.68 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=91.8
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhh------------------------------HHH----------HHH
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG------------------------------LNE----------LKN 331 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~~----------~~~ 331 (605)
+.|+.++-|.||+|++++|+.||||+.++.-... .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999976421110 111 223
Q ss_pred HHHHHHcC----CCCceeeeeeeE-EeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 007397 332 EVILFSKL----QHRNLVKLLGCC-IQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG-LLYLHQDS 405 (605)
Q Consensus 332 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~~~ 405 (605)
|+.-+.++ +...-+++=.++ .-.....|+|||++|-.+.+...-... .++.. .++..++++ +..+-.+|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence 44444433 122222222222 235677899999999999888533222 23322 233333332 33333355
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 406 ~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.3e-06 Score=81.22 Aligned_cols=138 Identities=16% Similarity=0.152 Sum_probs=102.2
Q ss_pred ecccCeEEEEEEEEcCCcEEEEEEcccc------chhhHHHHHHHHHHHHcCCCCc--eeeeeeeEE-e----CCeeEEE
Q 007397 294 LGEGGFGRVYKGTLVDGQEIAVKRLSKI------SEQGLNELKNEVILFSKLQHRN--LVKLLGCCI-Q----GEEKLLI 360 (605)
Q Consensus 294 LG~G~fg~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lv 360 (605)
-|+||-+.|+.... +|+.+-+|+-... -+.+...|.+|...|+++...+ +.++. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46688899998765 4557899987521 1346778999999999986333 44444 332 1 1235799
Q ss_pred EEeeCC-CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc--eEEeecCCCcc
Q 007397 361 YEFMPN-KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN--PKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~--vkl~DFGla~~ 437 (605)
+|-+++ .+|.+++.+.. ....+......++.++++++.-||+.| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 68888874432 224567777889999999999999999 999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.4e-06 Score=79.00 Aligned_cols=138 Identities=14% Similarity=0.129 Sum_probs=91.3
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHH---------HHHHHHHHHcCC---CCceeeeeeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNE---------LKNEVILFSKLQ---HRNLVKLLGCC 351 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~ 351 (605)
...+|.+.+.+-......|.+-.. +|+.+++|..+......... ..+++..+.++. -..++.++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346788888888888888877654 78999999886432221111 223333333332 22333322222
Q ss_pred E-----eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 352 I-----QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 352 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
. .....+++|||++|..|.++.. ++. .+...|++++.-||++| ++|+|..|.|++++.++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2244568999999988865431 221 24456778899999999 99999999999998655
Q ss_pred eEEeecCCCcc
Q 007397 427 PKISDFGLART 437 (605)
Q Consensus 427 vkl~DFGla~~ 437 (605)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=7e-06 Score=80.25 Aligned_cols=140 Identities=16% Similarity=0.151 Sum_probs=85.3
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeeeeEEeCCeeEEEEEeeCCCc-
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 368 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~~~- 368 (605)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+..-. +.+.+.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35567888876522 3455788999999886443 4567777767777789999999963
Q ss_pred hhhHH--------------hh-----cCc-cCCCCHHHHH-HHHHH----------HHH-HHHHHHhC-CCCCeEEecCC
Q 007397 369 LDYFI--------------FD-----QTK-RELLDWSKRF-HIICG----------TAR-GLLYLHQD-SRLRIIHRDLK 415 (605)
Q Consensus 369 L~~~l--------------~~-----~~~-~~~l~~~~~~-~i~~q----------i~~-aL~~LH~~-~~~~iiHrDlk 415 (605)
+...+ .. +.- .......... .+..+ +.+ ...+|.+. .+..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 000 0001111100 01000 111 11222211 12357899999
Q ss_pred CCCEEEcCCCceEEeecCCCcc
Q 007397 416 TSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 416 p~NIll~~~~~vkl~DFGla~~ 437 (605)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.4e-06 Score=78.52 Aligned_cols=154 Identities=19% Similarity=0.199 Sum_probs=99.9
Q ss_pred ccHHHHHHHhcCccccc---eecccCeEEEEEEEEcCCcEEEEEEccccchh-------------------hHH-----H
Q 007397 276 FELATIANATDNFSINN---KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ-------------------GLN-----E 328 (605)
Q Consensus 276 ~~~~~~~~~~~~y~~~~---~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~ 328 (605)
..+..+.....+..+.. .|..|--+.||+|...++..+|+|++...... ... -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44555555555655544 45667778999999888999999998532111 001 1
Q ss_pred HHHHHHHHHcCC--CCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 007397 329 LKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DS 405 (605)
Q Consensus 329 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ 405 (605)
..+|..-|+++. +-.+.+.+.+ ....|||||+....+-.-. -+.-.+....+..+..++++.+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 235666666663 3334444443 2457999999665221100 011112233566777788888887776 55
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 406 ~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
+||+||+.-|||+. ++.+.|+|||.|....+
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 89999999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-07 Score=101.55 Aligned_cols=194 Identities=17% Similarity=0.154 Sum_probs=140.4
Q ss_pred HHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc-eeeeeeeEEeCCeeEE
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLL 359 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 359 (605)
+...+.-+...+.+++|+.+.++|.+....+....+.+... ....-++++|.+++||| .++.++-+..++...+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445566667889999999999988655555556665432 44556889999999999 7777777888888899
Q ss_pred EEEeeCCC-chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 360 IYEFMPNK-SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 360 v~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+++++..+ +....+ ......+...+...+.+.-++++++||+.. =+|+| ||+..+ +..|..||+.+..+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999877 211111 000111222233345555667899999864 48888 777655 77899999998877
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 492 (605)
.+.. ......+|+.++|||+.....+..+.|+|++|+-..+|.-|.+|...
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 5443 24456789999999999999999999999999988888888887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=78.90 Aligned_cols=144 Identities=22% Similarity=0.201 Sum_probs=85.0
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCC--ceeeeeeeEEe---CCeeEEEEEeeC
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHR--NLVKLLGCCIQ---GEEKLLIYEFMP 365 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 365 (605)
++.|+.|..+.||+....+ ..+++|..... .....+.+|+.+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999876 69999997653 4567778888888888533 34566654432 334689999999
Q ss_pred CCchhh----------------HHhh--cC--ccCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 007397 366 NKSLDY----------------FIFD--QT--KRELLDWSKR---------FHI------------ICGTAR-GLLYLHQ 403 (605)
Q Consensus 366 ~~~L~~----------------~l~~--~~--~~~~l~~~~~---------~~i------------~~qi~~-aL~~LH~ 403 (605)
+..+.. .+.. .. .......... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 1110 00 0011111100 000 111222 2333332
Q ss_pred ----CCCCCeEEecCCCCCEEEc-CCCceEEeecCCCcc
Q 007397 404 ----DSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLART 437 (605)
Q Consensus 404 ----~~~~~iiHrDlkp~NIll~-~~~~vkl~DFGla~~ 437 (605)
.....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334599999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.5e-06 Score=68.13 Aligned_cols=59 Identities=39% Similarity=0.854 Sum_probs=47.3
Q ss_pred CCeeEecCCCCCCcc-ccccccChHHHHHHHhh-cCCcccccceeecCCCcceeEee-ecccccc
Q 007397 172 EGFLKLPKMKLPENY-WSNQSMSLRECEAECTK-NCSCRAYANSQVVGGGNGCLMWF-GDLIDIK 233 (605)
Q Consensus 172 ~~f~~~~~~~~p~~~-~~~~~~~~~~C~~~C~~-~C~C~a~~~~~~~g~~~gc~~w~-g~l~~~~ 233 (605)
..|++++++++++.. ......++++|++.|+. +|+|.||.+.. ++.+|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence 569999999999632 22456799999999999 99999999974 466899999 6666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.9e-06 Score=60.87 Aligned_cols=44 Identities=50% Similarity=0.645 Sum_probs=39.9
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCCCCC--CCCCCCCcccccccCC
Q 007397 562 DSVLAQPKQPGCLVDRKSTGPDSSSSKP--ESSSTNASTFTEVEGR 605 (605)
Q Consensus 562 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 605 (605)
...+|+|++|+|+..+.....+++++.. +.++.|.+|+|.|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4678999999999999988888887766 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.1e-05 Score=76.75 Aligned_cols=141 Identities=15% Similarity=0.115 Sum_probs=85.4
Q ss_pred eecccCe-EEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEeeCCCchh
Q 007397 293 KLGEGGF-GRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 370 (605)
Q Consensus 293 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~~~L~ 370 (605)
.|..|.. ..||+.... +..+++|+..... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555666 788998764 4788888876432 345678888888884 334556777766666789999999998876
Q ss_pred hHHh-------------------hcCc-cCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 007397 371 YFIF-------------------DQTK-RELLDW--SKRFHIIC--------------------GTARGLLYLHQ----D 404 (605)
Q Consensus 371 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qi~~aL~~LH~----~ 404 (605)
.... .... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 000000 00000000 01111122211 1
Q ss_pred CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 405 ~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
....++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124589999999999999988889999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.8e-05 Score=74.88 Aligned_cols=105 Identities=22% Similarity=0.199 Sum_probs=82.1
Q ss_pred HHHHHHHHcCCC-CceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007397 330 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408 (605)
Q Consensus 330 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 408 (605)
.+|..+++.+++ +++++++|.| ..++|.||...+++......-......+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999986 6999999999 34789999987755321100011123689999999999999999999855445
Q ss_pred eEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 409 iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+.-.|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.2e-05 Score=82.66 Aligned_cols=141 Identities=14% Similarity=0.190 Sum_probs=88.9
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhh---------------------------HH----H------HHHHHH
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG---------------------------LN----E------LKNEVI 334 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~----~------~~~E~~ 334 (605)
+.||.-+.|.||+|++++|+.||||+-++.-... .+ . |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999865411100 01 1 223333
Q ss_pred HHH----cCCCCc---eeeeeeeEE-eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 007397 335 LFS----KLQHRN---LVKLLGCCI-QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL-LYLHQDS 405 (605)
Q Consensus 335 ~l~----~l~h~n---iv~l~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ 405 (605)
-.. .+.|-+ -|++=.++. ......|+||||+|..+.+.-.-... -++... ++..+.++. ..|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence 222 223444 112222222 24567999999999988776422221 234333 344444432 2333445
Q ss_pred CCCeEEecCCCCCEEEcC----CCceEEeecCCCccCCC
Q 007397 406 RLRIIHRDLKTSNVLLDH----DMNPKISDFGLARTFGG 440 (605)
Q Consensus 406 ~~~iiHrDlkp~NIll~~----~~~vkl~DFGla~~~~~ 440 (605)
++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 56899999999887643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.4e-05 Score=70.68 Aligned_cols=128 Identities=16% Similarity=0.248 Sum_probs=92.0
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccc----------------hhhHHHHHHHHHHHHcCC------CCceeeee
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS----------------EQGLNELKNEVILFSKLQ------HRNLVKLL 348 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 348 (605)
...||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36799999999996 6777888889887544 223566667777666665 88899999
Q ss_pred eeEEeCCeeEEEEEeeCC------CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc
Q 007397 349 GCCIQGEEKLLIYEFMPN------KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422 (605)
Q Consensus 349 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~ 422 (605)
|+...+....+|+|.+.. .+|.+++.+ +.++. ..... +-+-..||-+++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 356777632 23444 33333 334456666666 99999999999995
Q ss_pred CCC----ceEEee
Q 007397 423 HDM----NPKISD 431 (605)
Q Consensus 423 ~~~----~vkl~D 431 (605)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.1e-05 Score=69.89 Aligned_cols=130 Identities=20% Similarity=0.250 Sum_probs=91.2
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCc
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 368 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~ 368 (605)
.+.+.|++|++|.||++.+. |..+|+|+-.. +.....+..|+++|..++-.++.+=+-.+ +..++.|||+.|..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 45688999999999999884 55888887654 44567788999999999876665433222 22345599999988
Q ss_pred hhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC-CCCEEEcCCCceEEeecCCCcc
Q 007397 369 LDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK-TSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 369 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlk-p~NIll~~~~~vkl~DFGla~~ 437 (605)
|...-... + .+-+..++++---|...| |-|..|. |..++|-.++.+.|+||.-|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 86654211 1 223445566655566666 9999985 5666666666999999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=84.16 Aligned_cols=79 Identities=14% Similarity=0.297 Sum_probs=57.6
Q ss_pred cceecccCeEEEEEEEEcCC---cEEEEEEccccc-hhhHHHHHHHHHHHHcCC-CCce--eeeeeeEEeC---CeeEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDG---QEIAVKRLSKIS-EQGLNELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 360 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 360 (605)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57889999999999877553 467888764322 123456889999999995 6664 6777776654 357899
Q ss_pred EEeeCCCch
Q 007397 361 YEFMPNKSL 369 (605)
Q Consensus 361 ~e~~~~~~L 369 (605)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=72.24 Aligned_cols=73 Identities=15% Similarity=0.278 Sum_probs=46.0
Q ss_pred ceecccCeE-EEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCC---ceeeeeeeEEeC---CeeEEEEEee
Q 007397 292 NKLGEGGFG-RVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHR---NLVKLLGCCIQG---EEKLLIYEFM 364 (605)
Q Consensus 292 ~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 364 (605)
+.|+.|+.. .||+. +..+++|.... ......+.+|+.++..+... -+.+++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 58875 34577777544 22345788899999887532 233444333222 2347899999
Q ss_pred CCCchh
Q 007397 365 PNKSLD 370 (605)
Q Consensus 365 ~~~~L~ 370 (605)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00017 Score=70.91 Aligned_cols=74 Identities=22% Similarity=0.312 Sum_probs=49.4
Q ss_pred cceecccCeEEEEEEEEcC--CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce-eeeeeeEEeCCeeEEEEEeeCCC
Q 007397 291 NNKLGEGGFGRVYKGTLVD--GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
++.|..|-...+|+....+ ++.+++|+...... ......+|+.+++.+....+ ++++.... ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3578888889999988764 67899998764322 22233578888888854333 34443322 24899999997
Q ss_pred ch
Q 007397 368 SL 369 (605)
Q Consensus 368 ~L 369 (605)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 76
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00014 Score=72.71 Aligned_cols=139 Identities=17% Similarity=0.142 Sum_probs=79.3
Q ss_pred eecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEEeeCCCchhh
Q 007397 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLDY 371 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~~~L~~ 371 (605)
.+..|-...+|+.. .+++.+++|..........-...+|..+++.+....++ +++... . .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 45677788999887 45778889876543222212357788888888644333 333332 2 368999999877642
Q ss_pred H--------------H---hhcC-ccCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCCeEEecCCCCC
Q 007397 372 F--------------I---FDQT-KRELLDWSKR-FHIICGT---------ARGLLYLHQD-----SRLRIIHRDLKTSN 418 (605)
Q Consensus 372 ~--------------l---~~~~-~~~~l~~~~~-~~i~~qi---------~~aL~~LH~~-----~~~~iiHrDlkp~N 418 (605)
. + +... ....++.... .....++ ...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 0110 0111121111 1111111 1112222211 12358999999999
Q ss_pred EEEcCCCceEEeecCCCcc
Q 007397 419 VLLDHDMNPKISDFGLART 437 (605)
Q Consensus 419 Ill~~~~~vkl~DFGla~~ 437 (605)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=70.15 Aligned_cols=76 Identities=12% Similarity=0.071 Sum_probs=55.7
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC---CceeeeeeeEEe---CCeeEEEEEee
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH---RNLVKLLGCCIQ---GEEKLLIYEFM 364 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~ 364 (605)
.+.||+|..+.||.....++ .+++|..+. ......+.+|+..|+.|.. -.+.++++++.. .+..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46899999999999876555 466676432 1133578899999998853 357778877654 35689999999
Q ss_pred CCCch
Q 007397 365 PNKSL 369 (605)
Q Consensus 365 ~~~~L 369 (605)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0007 Score=71.37 Aligned_cols=75 Identities=15% Similarity=0.230 Sum_probs=54.1
Q ss_pred ceecccCeEEEEEEEEcCC-cEEEEEEcccc----c---hhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEE
Q 007397 292 NKLGEGGFGRVYKGTLVDG-QEIAVKRLSKI----S---EQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 360 (605)
+.||.|.+..||++...+| +.++||.-... . ....+....|...|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999999777 58999985421 1 224566777888888763 2346666655 44667899
Q ss_pred EEeeCCCc
Q 007397 361 YEFMPNKS 368 (605)
Q Consensus 361 ~e~~~~~~ 368 (605)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00036 Score=80.02 Aligned_cols=199 Identities=19% Similarity=0.188 Sum_probs=136.5
Q ss_pred HHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE----EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHH
Q 007397 326 LNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401 (605)
Q Consensus 326 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 401 (605)
......|...+.++.|+|++.++.+..+..... +..|++...++...+. .-..++....+.+..++.+||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence 334456888889999999999999887765444 3347777777777663 334578888888999999999999
Q ss_pred HhCCCCCeEEecCCCC---CEEEcCCCceEEe--ecCCCccCCCCcccccccccccccCccchhcccCCCCC--cccchH
Q 007397 402 HQDSRLRIIHRDLKTS---NVLLDHDMNPKIS--DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFS--VKSDVF 474 (605)
Q Consensus 402 H~~~~~~iiHrDlkp~---NIll~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~k~Dvw 474 (605)
|+.. ..|.-+..+ +--.+..+.+.++ ||+..+.......... ..-+..+.|||......+. ...|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence 9985 555555444 4445566777777 9998887654433221 2234567788877665544 447999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 475 SFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 475 SlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
.+|..+..+..|..+-..... +..+++.. ... .+......|+..++++|+++.+
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~-----~~~---~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV------------------PVSLLDVL-----STS---ELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc------------------hhhhhccc-----cch---hhhhhhhhhcchhhhhccchhh
Confidence 999999999998766432111 01111110 111 3456677899999999999999
Q ss_pred HHHHh
Q 007397 555 VILML 559 (605)
Q Consensus 555 vl~~L 559 (605)
++.+.
T Consensus 431 ll~~~ 435 (1351)
T KOG1035|consen 431 LLTHP 435 (1351)
T ss_pred hhhch
Confidence 99865
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00084 Score=63.46 Aligned_cols=125 Identities=27% Similarity=0.405 Sum_probs=88.5
Q ss_pred cCccccceecccCe-EEEEEEEEcCCcEEEEEEccc---c---------ch---------hhHHHHHHHHHHHHcCC---
Q 007397 286 DNFSINNKLGEGGF-GRVYKGTLVDGQEIAVKRLSK---I---------SE---------QGLNELKNEVILFSKLQ--- 340 (605)
Q Consensus 286 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~~~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 340 (605)
..++.++.||.|.- |.||+++. +|+.+|+|.+.. . .. ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 99999987 678999999321 0 00 11224667777777664
Q ss_pred CCce--eeeeeeEEeCC------------------eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHH
Q 007397 341 HRNL--VKLLGCCIQGE------------------EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400 (605)
Q Consensus 341 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~ 400 (605)
+.++ |+.+|+..-.. ...+|.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4456 89998874331 1246777765543 1122345677888899
Q ss_pred HHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 401 LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
+|..| |+-+|+++.|.. .=||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999975 3489999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0017 Score=66.99 Aligned_cols=143 Identities=20% Similarity=0.196 Sum_probs=76.9
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeee------eEEeCCeeEEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLG------CCIQGEEKLLIYE 362 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e 362 (605)
.+.|+.|....+|+....+| .+++|++.... .+.+..|+.+++.|.... +.+++. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999876555 68889875222 233444555555553211 333332 1123456789999
Q ss_pred eeCCCchhh-----H------H---hhcCcc------C--CCCH-HHHHH------------HHHH-HHHHHHHHHhC--
Q 007397 363 FMPNKSLDY-----F------I---FDQTKR------E--LLDW-SKRFH------------IICG-TARGLLYLHQD-- 404 (605)
Q Consensus 363 ~~~~~~L~~-----~------l---~~~~~~------~--~l~~-~~~~~------------i~~q-i~~aL~~LH~~-- 404 (605)
|++|..+.. . + +..... . .+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999975421 1 1 000000 0 0111 11111 1111 11122233211
Q ss_pred --CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 405 --SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 405 --~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
-...++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123599999999999999776668999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00081 Score=68.87 Aligned_cols=141 Identities=26% Similarity=0.343 Sum_probs=83.6
Q ss_pred ceecccCeEEEEEEEEcC-------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVD-------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 363 (605)
+.|..|--..||+....+ ++.+++|+..... .......+|+.+++.+....+. +++..+. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 566777778999988655 5789999876533 2334567788888887543333 4444442 2368999
Q ss_pred eCCCchhhHH-----------------hhcCccC------CCC--HHHHHH--------------------------HHH
Q 007397 364 MPNKSLDYFI-----------------FDQTKRE------LLD--WSKRFH--------------------------IIC 392 (605)
Q Consensus 364 ~~~~~L~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 392 (605)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764310 0000000 011 111100 111
Q ss_pred HHHHHHHHHHh------CCCCCeEEecCCCCCEEEcCC----CceEEeecCCCcc
Q 007397 393 GTARGLLYLHQ------DSRLRIIHRDLKTSNVLLDHD----MNPKISDFGLART 437 (605)
Q Consensus 393 qi~~aL~~LH~------~~~~~iiHrDlkp~NIll~~~----~~vkl~DFGla~~ 437 (605)
.+.+.+..|.. .....++|+|+.|.|||++.+ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234569999999999999985 8899999988754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=66.32 Aligned_cols=143 Identities=20% Similarity=0.159 Sum_probs=85.4
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeeee------EEeCCeeEEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 362 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 362 (605)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.. +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 467888888899998654 45788898764 23455667888877775332 4444331 123445689999
Q ss_pred eeCCCchhh----HH----------hhcCc--------cCCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 007397 363 FMPNKSLDY----FI----------FDQTK--------RELLDWSKRF----------HIICGTARGLLYLHQD----SR 406 (605)
Q Consensus 363 ~~~~~~L~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~qi~~aL~~LH~~----~~ 406 (605)
+++|..+.. .. +.... .....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 10 00000 0111111110 0111233344554431 12
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 407 ~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.004 Score=64.99 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=82.6
Q ss_pred ceecccCeEEEEEEEEcC-----CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEEeeC
Q 007397 292 NKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 365 (605)
..|-.|--..+|+....+ ++.+++|+.........+ -.+|..+++.+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 566668888999987532 368899988664433333 36788888888644443 455554322 5899998
Q ss_pred CCchhhH-------H----------hhcC--ccC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 007397 366 NKSLDYF-------I----------FDQT--KRE-LLDWSKRFHIICGT-----------------ARGLLYL----HQ- 403 (605)
Q Consensus 366 ~~~L~~~-------l----------~~~~--~~~-~l~~~~~~~i~~qi-----------------~~aL~~L----H~- 403 (605)
+.++... + +... ... ...+.....++.++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 0 0000 000 11122222222111 1112222 21
Q ss_pred CCCCCeEEecCCCCCEEEcC-CCceEEeecCCCcc
Q 007397 404 DSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLART 437 (605)
Q Consensus 404 ~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~ 437 (605)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 46899999988754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.013 Score=60.07 Aligned_cols=144 Identities=24% Similarity=0.223 Sum_probs=81.4
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeeeeE------EeCCeeEEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLGCC------IQGEEKLLIYE 362 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~e 362 (605)
.+.++.|.-..+|+....++ .+++|+..... ..+.+..|+.++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999875444 68888875421 2334556677776664222 33443311 12355689999
Q ss_pred eeCCCchhh-----------H---HhhcCcc------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 007397 363 FMPNKSLDY-----------F---IFDQTKR------E---LLDWSKRF------------HIICGTARGLLYLHQ---- 403 (605)
Q Consensus 363 ~~~~~~L~~-----------~---l~~~~~~------~---~l~~~~~~------------~i~~qi~~aL~~LH~---- 403 (605)
|++|..+.. . ++..... . .-.|.... .....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865421 0 1110000 0 01111100 011123334555532
Q ss_pred CCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 404 ~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
.-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1124599999999999999988778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00071 Score=67.64 Aligned_cols=139 Identities=16% Similarity=0.185 Sum_probs=96.0
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEcc--cc-------ch---------hh--H--HHHHHHHHHHHcCC-CC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KI-------SE---------QG--L--NELKNEVILFSKLQ-HR 342 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~-------~~---------~~--~--~~~~~E~~~l~~l~-h~ 342 (605)
--+.+.++||-|--+.||.+-+.+|++.++|.-+ .. .. .+ + -...+|...|+.|. |.
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3477889999999999999999999999999522 00 00 00 1 12346777888775 32
Q ss_pred c-eeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 343 N-LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 343 n-iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
. +.+.++ ....++|||++.+-.|...- ...+...+. ..+..-+.-|..+| +||+|..-=||++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEE
Confidence 2 344443 34568899999888775432 123333333 33444456677788 9999999999999
Q ss_pred cCCCceEEeecCCCccCCC
Q 007397 422 DHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~ 440 (605)
++++.++++||-.......
T Consensus 236 ~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred ecCCCEEEeechHhhccCC
Confidence 9999999999987765543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0058 Score=61.62 Aligned_cols=31 Identities=26% Similarity=0.511 Sum_probs=26.0
Q ss_pred CCeEEecCCCCCEEEcCCCc-eEEeecCCCcc
Q 007397 407 LRIIHRDLKTSNVLLDHDMN-PKISDFGLART 437 (605)
Q Consensus 407 ~~iiHrDlkp~NIll~~~~~-vkl~DFGla~~ 437 (605)
..++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00047 Score=80.82 Aligned_cols=163 Identities=12% Similarity=-0.036 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEEEEEeeCCCchhhHHhhcCcc-CCCCHHHHHHHHHHHHHHHHHHH
Q 007397 326 LNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDWSKRFHIICGTARGLLYLH 402 (605)
Q Consensus 326 ~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH 402 (605)
.+....|...++...|+++.....-... ....+.+++|+.+|.+...|.+...+ ..++...+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3444556666677789988876654433 34568899999999999988665433 33333333333333355555555
Q ss_pred hCC--CCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHH
Q 007397 403 QDS--RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILV 480 (605)
Q Consensus 403 ~~~--~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl 480 (605)
+.. ....+|+++|+-|.+|..+.++|+.++|+.+..... ........+++.|++|++.....++.++|+|..|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 442 345789999999999999999999999999843222 1223345678899999999999999999999999999
Q ss_pred HHHHhCCCCC
Q 007397 481 LEIVSGKRNR 490 (605)
Q Consensus 481 ~elltG~~p~ 490 (605)
|++-.|..+|
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9998888765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.015 Score=58.91 Aligned_cols=73 Identities=21% Similarity=0.276 Sum_probs=48.4
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
.+.|+.|....+|+.. .+++.+.||.-. ......|..|+.-|+.|. --.+.+++.+....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678989999999977 578899999875 334456778888888773 455778888888778889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.026 Score=57.58 Aligned_cols=148 Identities=17% Similarity=0.282 Sum_probs=83.6
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCC--ceeeeeeeEEeCC--eeEEEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR--NLVKLLGCCIQGE--EKLLIYE 362 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~--~~~lv~e 362 (605)
.+.+.+..|..-.+|..... ++++++. ... ..........+|..+++.+.-- -+.+.+++|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34455544444445554443 7788888 321 2233455667788888887542 3444566666665 6699999
Q ss_pred eeCCCchhh----------HHh--------h---c--------------CccCCCCHHHHHHH--------HHHHHHHHH
Q 007397 363 FMPNKSLDY----------FIF--------D---Q--------------TKRELLDWSKRFHI--------ICGTARGLL 399 (605)
Q Consensus 363 ~~~~~~L~~----------~l~--------~---~--------------~~~~~l~~~~~~~i--------~~qi~~aL~ 399 (605)
|++|..+.. +.. . - ..++...+...... +-....-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 998843211 111 0 0 00001111111100 001112234
Q ss_pred HHHhC-----CCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 400 YLHQD-----SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 400 ~LH~~-----~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|+.+ ++..++|+|+++.||+++..+-+-|+||+++..-
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 44433 2346999999999999999988999999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.043 Score=56.20 Aligned_cols=144 Identities=23% Similarity=0.249 Sum_probs=95.5
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEcccc-------------------------chhhH-HHHHHHHHHHHcCCCC
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI-------------------------SEQGL-NELKNEVILFSKLQHR 342 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~-------------------------~~~~~-~~~~~E~~~l~~l~h~ 342 (605)
.+..-|.-|--+.||.|.-.+|..+|||+++-. +.... .-...|+.-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345668889999999999999999999987420 00001 1134577777777644
Q ss_pred ceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc
Q 007397 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422 (605)
Q Consensus 343 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~ 422 (605)
.|.-.--+.. ....|||+|+....... ..-+.-.++...+...-.|++.-+.-|-+.+ ++||.||.--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 4322111111 23479999986432211 1112334666778888888888888887765 59999999999988
Q ss_pred CCCceEEeecCCCccCCC
Q 007397 423 HDMNPKISDFGLARTFGG 440 (605)
Q Consensus 423 ~~~~vkl~DFGla~~~~~ 440 (605)
.+|.+.|+|-+.+.....
T Consensus 299 hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred ECCEEEEEEccccccCCC
Confidence 567899999988776543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.041 Score=57.00 Aligned_cols=72 Identities=14% Similarity=0.194 Sum_probs=47.9
Q ss_pred eecccCeEEEEEEEEcCC-cEEEEEEccc-------cchhhHHHHHHHHHHHHcCC--CCc-eeeeeeeEEeCCeeEEEE
Q 007397 293 KLGEGGFGRVYKGTLVDG-QEIAVKRLSK-------ISEQGLNELKNEVILFSKLQ--HRN-LVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~ 361 (605)
.||.|....||++...+| +.++||.-.. .-+...+...-|...|+... -|. +.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 589999999999998654 6899997542 11333455566777776653 343 33443 33556667999
Q ss_pred EeeCC
Q 007397 362 EFMPN 366 (605)
Q Consensus 362 e~~~~ 366 (605)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.0043 Score=48.78 Aligned_cols=51 Identities=16% Similarity=0.351 Sum_probs=35.8
Q ss_pred eEecCCCCCC-ccccccccChHHHHHHHhhcCCcccccceeecCCCcceeEeeec
Q 007397 175 LKLPKMKLPE-NYWSNQSMSLRECEAECTKNCSCRAYANSQVVGGGNGCLMWFGD 228 (605)
Q Consensus 175 ~~~~~~~~p~-~~~~~~~~~~~~C~~~C~~~C~C~a~~~~~~~g~~~gc~~w~g~ 228 (605)
..++++.++. +.......+.++|+..|+.+|+|.||.+. .+...|+++.+.
T Consensus 7 ~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~---~~~~~C~lk~~~ 58 (73)
T cd01100 7 RQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYN---TKSKKCFLKSSE 58 (73)
T ss_pred cccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEE---CCCCeEEcccCC
Confidence 3345666655 22222356889999999999999999986 334579987664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.056 Score=55.53 Aligned_cols=32 Identities=25% Similarity=0.300 Sum_probs=28.4
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 406 ~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
+..++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.039 Score=56.87 Aligned_cols=141 Identities=23% Similarity=0.271 Sum_probs=81.8
Q ss_pred eecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc------eeeeeee----EEeCCeeEEEEE
Q 007397 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN------LVKLLGC----CIQGEEKLLIYE 362 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~----~~~~~~~~lv~e 362 (605)
.|.+ .-..||+....+|+. ++|+.... ....++..|+..++.|.-.. +..+-|- ...+...+.+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556788888777766 88888664 45566777788877773211 1111111 111236778999
Q ss_pred eeCCCchhh-H----H----------hhc---------CccCCCCHHH----H---------HHHHHHHHHHHHHHHhC-
Q 007397 363 FMPNKSLDY-F----I----------FDQ---------TKRELLDWSK----R---------FHIICGTARGLLYLHQD- 404 (605)
Q Consensus 363 ~~~~~~L~~-~----l----------~~~---------~~~~~l~~~~----~---------~~i~~qi~~aL~~LH~~- 404 (605)
|++|..+.. . + ... .......|.. . .....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 1 0 000 0011222320 0 01223333344444332
Q ss_pred ------CCCCeEEecCCCCCEEEcCCCc-eEEeecCCCcc
Q 007397 405 ------SRLRIIHRDLKTSNVLLDHDMN-PKISDFGLART 437 (605)
Q Consensus 405 ------~~~~iiHrDlkp~NIll~~~~~-vkl~DFGla~~ 437 (605)
++..+||+|+.|.||+++.+.. +.++||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1122999999999999999985 89999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.12 Score=54.72 Aligned_cols=73 Identities=12% Similarity=0.121 Sum_probs=49.6
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccc----cch---hhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSK----ISE---QGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 360 (605)
.+.||.|....||+.... ++.++||.-.. ... ........|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998874 56799997652 111 13344445566666553 246777777665 557889
Q ss_pred EEeeCC
Q 007397 361 YEFMPN 366 (605)
Q Consensus 361 ~e~~~~ 366 (605)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.04 Score=57.20 Aligned_cols=141 Identities=16% Similarity=0.211 Sum_probs=79.5
Q ss_pred ceecccCeEEEEEEEEcC----CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD----GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 366 (605)
+.|..|--..+|+....+ +..|++|+....... .-.-.+|..+++.+...++. ++++++.. .+|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhcC
Confidence 556667777889886543 247889987654332 22336788888888655553 45555422 258999988
Q ss_pred CchhhH-------H-------hh-cCc-----cCCCCHHHHHHHHHH----------------------HHHHHHH---H
Q 007397 367 KSLDYF-------I-------FD-QTK-----RELLDWSKRFHIICG----------------------TARGLLY---L 401 (605)
Q Consensus 367 ~~L~~~-------l-------~~-~~~-----~~~l~~~~~~~i~~q----------------------i~~aL~~---L 401 (605)
.++..- + .. +.. ....-+....++..+ +.+-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 00 000 001112222222211 1111222 1
Q ss_pred H-hC-CCCCeEEecCCCCCEEEcC-CCceEEeecCCCcc
Q 007397 402 H-QD-SRLRIIHRDLKTSNVLLDH-DMNPKISDFGLART 437 (605)
Q Consensus 402 H-~~-~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~ 437 (605)
. .. .....+|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 1234799999999999975 57899999988754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.028 Score=53.52 Aligned_cols=138 Identities=15% Similarity=0.175 Sum_probs=82.7
Q ss_pred EEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHH
Q 007397 312 EIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI 390 (605)
Q Consensus 312 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i 390 (605)
+..+|++....-. ....+.++..++.++. .|+++..- ..-...++.|+|.....- . ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h----hHH
Confidence 4456666543333 3445678888888875 36666532 334456888988432210 0 111
Q ss_pred HHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcc
Q 007397 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVK 470 (605)
Q Consensus 391 ~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k 470 (605)
+..=+++|.-.|+.. ...+|+|-.|+||+-|+.|.+||.|=+..-. .+..|.--|+ ...+.+
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~lT~~ 208 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESLTQE 208 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---cccChH
Confidence 211146778889553 4699999999999999999999999664321 0112222111 234667
Q ss_pred cchHHHHHHHHHHHhCC
Q 007397 471 SDVFSFGILVLEIVSGK 487 (605)
Q Consensus 471 ~DvwSlGvvl~elltG~ 487 (605)
+.+=+|=.-++++....
T Consensus 209 aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 77777776677766643
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.012 Score=56.90 Aligned_cols=31 Identities=35% Similarity=0.534 Sum_probs=21.7
Q ss_pred CCeEEecCCCCCEEE-cCCCceEEeecCCCcc
Q 007397 407 LRIIHRDLKTSNVLL-DHDMNPKISDFGLART 437 (605)
Q Consensus 407 ~~iiHrDlkp~NIll-~~~~~vkl~DFGla~~ 437 (605)
..+.|.|+.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348999999999999 8899999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.26 Score=50.50 Aligned_cols=30 Identities=23% Similarity=0.333 Sum_probs=25.7
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 407 ~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 35899999999999988 6789999987643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.3 Score=47.09 Aligned_cols=178 Identities=18% Similarity=0.269 Sum_probs=98.6
Q ss_pred eecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 293 KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 293 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
++.-|---.-|...+ ...++.||.=. ......|..|+.-|..|. .-.+.+++.+..+..+.|+|+||++.+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344444344444332 45678888643 234456777777666664 45677888888899999999999999877
Q ss_pred hhH-----------HhhcCcc---------------CC----CCH-----HHHHHHHHHHH--------------HHHHH
Q 007397 370 DYF-----------IFDQTKR---------------EL----LDW-----SKRFHIICGTA--------------RGLLY 400 (605)
Q Consensus 370 ~~~-----------l~~~~~~---------------~~----l~~-----~~~~~i~~qi~--------------~aL~~ 400 (605)
+.. |+..... .. -+| ++++-+..|++ ..+.-
T Consensus 99 d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~e 178 (286)
T COG3001 99 DAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQE 178 (286)
T ss_pred CchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHH
Confidence 621 1110000 00 111 12222233332 23333
Q ss_pred HHhCC--CCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccC--------CCCCcc
Q 007397 401 LHQDS--RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD--------GLFSVK 470 (605)
Q Consensus 401 LH~~~--~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k 470 (605)
+-... ....+|+||-..|..+..+| +.+.| -|...++.+.........|. .+||...+ ..|..+
T Consensus 179 lL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~eR 252 (286)
T COG3001 179 LLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYLER 252 (286)
T ss_pred HHhcCCCCcceeecccccccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchHHH
Confidence 32221 24599999999999999999 77766 34444444333333333333 45665433 224455
Q ss_pred cchHHHHHHH
Q 007397 471 SDVFSFGILV 480 (605)
Q Consensus 471 ~DvwSlGvvl 480 (605)
-+||.|=-+|
T Consensus 253 k~iYqLY~ll 262 (286)
T COG3001 253 KPIYQLYHLL 262 (286)
T ss_pred hHHHHHHHHH
Confidence 5666554333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 605 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-140
Identities = 97/314 (30%), Positives = 153/314 (48%), Gaps = 20/314 (6%)
Query: 263 ENQD-QIEDLELPLFELATIANATDNFS------INNKLGEGGFGRVYKGTLVDGQEIAV 315
EN+ ++ D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 316 KRLSKI----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDY 371
K+L+ + +E+ + E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 372 FIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431
+ L W R I G A G+ +LH++ IHRD+K++N+LLD KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRG 491
FGLAR T++++GT YMAPE G + KSD++SFG+++LEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-- 233
Query: 492 LYNSDNKFNVIRHAWNLW-NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP 550
+ ++ + + ID + V ++ C+ RP
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 551 SMPSVILMLGSDSV 564
+ V +L +
Sbjct: 293 DIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-136
Identities = 118/306 (38%), Positives = 175/306 (57%), Gaps = 10/306 (3%)
Query: 269 EDLELPL-----FELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE 323
ED E+ L F L + A+DNFS N LG GGFG+VYKG L DG +AVKRL +
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 324 QGLN-ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK-REL 381
QG + + EV + S HRNL++L G C+ E+LL+Y +M N S+ + ++ + +
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 382 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441
LDW KR I G+ARGL YLH +IIHRD+K +N+LLD + + DFGLA+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKF 499
+ +T V GT G++APEY + G S K+DVF +G+++LE+++G+R +D+
Sbjct: 188 DTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 500 NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
++ L + L+D Q + +EV + I ++LLC Q P +RP M V+ ML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 560 GSDSVL 565
D +
Sbjct: 307 EGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-121
Identities = 101/286 (35%), Positives = 154/286 (53%), Gaps = 6/286 (2%)
Query: 276 FELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVIL 335
L + AT+NF +G G FG+VYKG L DG ++A+KR + S QG+ E + E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGT 394
S +H +LV L+G C + E +LIY++M N +L ++ + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF-GGDEIEGSTNKVIGT 453
ARGL YLH + IIHRD+K+ N+LLD + PKI+DFG+++ D+ ST V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513
GY+ PEY G + KSDV+SFG+++ E++ + N+ A N G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
Q++D + P+ + + ++ C+ EDRPSM V+ L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 5e-93
Identities = 70/325 (21%), Positives = 127/325 (39%), Gaps = 37/325 (11%)
Query: 260 VDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS 319
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 1 MGHHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP 56
Query: 320 KISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDYFIFD 375
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 57 IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113
Query: 376 QTKRELLDWSKRFHIICGTARGLLYLHQD-------SRLRIIHRDLKTSNVLLDHDMNPK 428
K ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL +++
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 429 ISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-----FSVKSDVFSFGILVLEI 483
I+DFGLA F + G T+ +GT YMAPE + ++ D+++ G+++ E+
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 484 VSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA-CYQ-------ESCNPDEVIRCI 535
S + + + + ++ + + +
Sbjct: 232 ASRCTAADGPVDEYMLPF---EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 536 -HISLLCVQHHPEDRPSMPSVILML 559
C H E R S V +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-79
Identities = 72/324 (22%), Positives = 123/324 (37%), Gaps = 44/324 (13%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG-LNELKNEVILFSKLQHR 342
DN + +G G +G VYKG+L D + +AVK S + Q +NE + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK--NIYRVPLMEHD 67
Query: 343 NLVKLLGCCIQGE-----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
N+ + + + E LL+ E+ PN SL ++ T DW + RG
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRG 123
Query: 398 LLYLHQD------SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG------DEIEG 445
L YLH + + I HRDL + NVL+ +D ISDFGL+ G E +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 446 STNKVIGTYGYMAPEYATDGL-------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
+ +GT YMAPE + + D+++ G++ EI + S +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 499 FNVIRHAWNLWNKGMPWQLIDA-CYQ-------ESCNPDEVIRCIHISLL--CVQHHPED 548
+ + + N + + E+ + + + C E
Sbjct: 244 YQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 549 RPSMPSVILMLGS-DSVLAQPKQP 571
R + + + + K
Sbjct: 303 RLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 79/299 (26%), Positives = 137/299 (45%), Gaps = 31/299 (10%)
Query: 263 ENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRL--SK 320
+ +D+++P +L +I K+G G FG V++ G ++AVK L
Sbjct: 24 QGAMDGDDMDIPWCDL----------NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD 72
Query: 321 ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE 380
+ +NE EV + +L+H N+V +G Q ++ E++ SL + RE
Sbjct: 73 FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440
LD +R + A+G+ YLH I+HR+LK+ N+L+D K+ DFGL+R
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500
+ S+ GT +MAPE D + KSDV+SFG+++ E+ + ++ + + N
Sbjct: 192 TFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PWGNLNPAQ 246
Query: 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
V + K ++ +V I C + P RPS +++ +L
Sbjct: 247 V---VAAVGFKCKRLEIPRNL------NPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 7e-64
Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 53/304 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ +G G FG V K +++A+K++ SE E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
KL G C+ L+ E+ SL + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 406 RLRIIHRDLKTSNVLLDHDMN-PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+IHRDLK N+LL KI DFG A +I+ G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 465 GLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
+S K DVFS+GI++ E+++ ++ + G ++++ A +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEI------------------GGPAFRIMWAVHN 219
Query: 524 -------ESCNPD--EVIRCIHISLLCVQHHPEDRPSMPSVILML--------GSDSVLA 566
++ ++ C P RPSM ++ ++ G+D L
Sbjct: 220 GTRPPLIKNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 567 QPKQ 570
P Q
Sbjct: 274 YPCQ 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-62
Identities = 74/322 (22%), Positives = 122/322 (37%), Gaps = 34/322 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ LG+G FG+ K T G+ + +K L + E+ EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+K +G + + I E++ +L I + WS+R A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE------------IEGSTNKVIG 452
+ IIHRDL + N L+ + N ++DFGLAR ++ V+G
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512
+MAPE + K DVFSFGI++ EI+ Y + + ++
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-DFGLNVRGFLDRY 243
Query: 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPG 572
P +C P I++ C PE RPS + L +++
Sbjct: 244 CP---------PNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWL--ETLRMHLAGHL 288
Query: 573 CLVDRKSTGPDSSSSKPESSST 594
L + +
Sbjct: 289 PLGPQLEQLDRGFWETYRRGES 310
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-62
Identities = 72/289 (24%), Positives = 133/289 (46%), Gaps = 38/289 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQG-------LNELKNEVILFS 337
+ ++G+GGFG V+KG LV D +A+K L +G E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
L H N+VKL G ++ EF+P L + + K + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALG 134
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLD-----HDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
+ Y+ I+HRDL++ N+ L + K++DFGL++ + S + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 453 TYGYMAPE--YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510
+ +MAPE A + ++ K+D +SF +++ I++G+ + + + I+ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244
Query: 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+G+ + + C P + I LC P+ RP ++ L
Sbjct: 245 EGLRPTIPEDC------PPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-62
Identities = 81/304 (26%), Positives = 142/304 (46%), Gaps = 36/304 (11%)
Query: 262 QENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRL--S 319
++D +D E+P ++ ++ ++G G FG VYKG ++AVK L +
Sbjct: 10 HGSRDAADDWEIPDGQI----------TVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVT 57
Query: 320 KISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR 379
+ Q L KNEV + K +H N++ +G + ++ ++ SL + +
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASE 114
Query: 380 ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439
+ K I TARG+ YLH IIHRDLK++N+ L D KI DFGLA
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 440 GDEIEGSTNKVIGTYGYMAPE---YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLY-NS 495
++ G+ +MAPE +S +SDV++FGI++ E+++G+ Y N
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL---PYSNI 228
Query: 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
+N+ +I + + L + +C P + R + C++ ++RPS P +
Sbjct: 229 NNRDQII---EMVGRGSLSPDLSKV--RSNC-PKRMKRLM---AECLKKKRDERPSFPRI 279
Query: 556 ILML 559
+ +
Sbjct: 280 LAEI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-61
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 36/282 (12%)
Query: 290 INNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ----GLNELKNEVILFSKLQHRNLV 345
+ +G GGFG+VY+ G E+AVK ++ + ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
L G C++ L+ EF L+ + + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 406 RLRIIHRDLKTSNVLLDHDMNP--------KISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+ IIHRDLK+SN+L+ + KI+DFGLAR + + G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
APE +FS SDV+S+G+L+ E+++G+ + + V A+ + + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFRGIDGLAV---AYGVAMNKLALPI 235
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
C P+ + + C P RPS +++ L
Sbjct: 236 PSTC------PEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-60
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 48/289 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRL--SKISEQGLNELKNEVILFSKLQHRN 343
+ KL E G ++KG G +I VK L S + + E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 344 LVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++ +LG C I +MP SL + + T + D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE- 460
H L I L + +V++D DM +IS + +F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 461 --YATDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNKGM---- 513
+ +D++SF +L+ E+V+ + L N + V +G+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA-------LEGLRPTI 232
Query: 514 PWQLIDACYQESCNPDEVIRCIHISLL---CVQHHPEDRPSMPSVILML 559
P +P H+S L C+ P RP ++ +L
Sbjct: 233 P---------PGISP-------HVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 73/317 (23%), Positives = 129/317 (40%), Gaps = 47/317 (14%)
Query: 257 RRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVK 316
R + +++ ++P +L I +G+G FG+VY G E+A++
Sbjct: 14 FPRKASQTSIFLQEWDIPFEQL----------EIGELIGKGRFGQVYHGRW--HGEVAIR 61
Query: 317 RL--SKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIF 374
+ + +E L K EV+ + + +H N+V +G C+ +I ++L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV- 120
Query: 375 DQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
+ + +LD +K I +G+ YLH I+H+DLK+ NV D + I+DFGL
Sbjct: 121 -RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGL 175
Query: 435 ARTFGGDEIEGSTNK---VIGTYGYMAPE---------YATDGLFSVKSDVFSFGILVLE 482
G + +K G ++APE FS SDVF+ G + E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 483 IVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCV 542
+ + + + + +I GM L Q E+ + L C
Sbjct: 236 LHAREW---PFKTQPAEAIIWQM----GTGMKPNLS----QIGM-GKEISDIL---LFCW 280
Query: 543 QHHPEDRPSMPSVILML 559
E+RP+ ++ ML
Sbjct: 281 AFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-55
Identities = 74/317 (23%), Positives = 129/317 (40%), Gaps = 47/317 (14%)
Query: 273 LPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG-LNELKN 331
LPL TIA + ++G+G +G V+ G G+++AVK E E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRET-- 80
Query: 332 EVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDYFIFDQTKRELLDWSKR 387
E+ ++H N++ + I+G LI ++ N SL ++ K LD
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSM 136
Query: 388 FHIICGTARGLLYLHQDSRLR-----IIHRDLKTSNVLLDHDMNPKISDFGLARTF--GG 440
+ + GL +LH + I HRDLK+ N+L+ + I+D GLA F
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 441 DEIEGSTNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494
+E++ N +GT YM PE + +D++SFG+++ E+ + G+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 495 SDNKFNVIRHAWNLWNKGMP--WQLIDA-CYQ-------ESCNPDEVIRCIHISLL--CV 542
+ ++ P + + C + + DE +R + L+ C
Sbjct: 257 E------YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECW 309
Query: 543 QHHPEDRPSMPSVILML 559
H+P R + V L
Sbjct: 310 AHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 47/310 (15%)
Query: 280 TIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG-LNELKNEVILFSK 338
T+A + ++ +G+G +G V++G+ G+ +AVK S E+ E E+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRET--ELYNTVM 58
Query: 339 LQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT 394
L+H N++ + + LI + SL ++ + LD I+
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSI 114
Query: 395 ARGLLYLHQDSRLR-----IIHRDLKTSNVLLDHDMNPKISDFGLAR--TFGGDEIEGST 447
A GL +LH + I HRDLK+ N+L+ + I+D GLA + ++++
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 448 NKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV 501
N +GT YMAPE + D+++FG+++ E+ + G+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED------ 228
Query: 502 IRHAWNLWNKGMP--WQLIDA-CYQ-------ESCNPDEVIRCIHISLL--CVQHHPEDR 549
+ + P + C D + + L+ C +P R
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSAR 287
Query: 550 PSMPSVILML 559
+ + L
Sbjct: 288 LTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 71/318 (22%), Positives = 123/318 (38%), Gaps = 49/318 (15%)
Query: 273 LPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQG-LNELKN 331
LPL TIA + +G+G FG V++G G+E+AVK S E+ E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA-- 85
Query: 332 EVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDYFIFDQTKRELLDWSKR 387
E+ L+H N++ + + L+ ++ + SL FD R +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGM 141
Query: 388 FHIICGTARGLLYLHQD-----SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF--GG 440
+ TA GL +LH + + I HRDLK+ N+L+ + I+D GLA
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 441 DEIEGSTNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN 494
D I+ + N +GT YMAPE ++D+++ G++ EI G++
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 495 SDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN-------PDEVIRCIHISLL------C 541
+ + P ++ + C P+ C + ++ C
Sbjct: 262 D------YQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 542 VQHHPEDRPSMPSVILML 559
+ R + + L
Sbjct: 314 WYANGAARLTALRIKKTL 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 36/292 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRL-SKISEQGLNELKNEVILFSKLQHRN 343
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
+V+L+G C Q + ++ E + F+ +T+ L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
IHRDL N L+ KISDFG++R S + APE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 464 DGLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
G +S +SDV+SFGIL+ E S + L N ++
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREF-------------VEKG 331
Query: 522 YQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPK 569
+ E C PD V R + C + P RPS ++ L S+ + +
Sbjct: 332 GRLPCPELC-PDAVFR---LMEQCWAYEPGQRPSFSTIYQEL--QSIRKRHR 377
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 58/303 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE------IAVKRLSKISEQGLNELKNEVILFSKL 339
+ + +LGEG FG+V+ + +AVK L + SE + + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF------------IFDQTKRELLDWSKR 387
QH+++V+ G C +G L+++E+M + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+ A G++YL + L +HRDL T N L+ + KI DFG++R +I +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTD 212
Query: 448 NKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFN 500
+G +M PE F+ +SDV+SFG+++ EI + GK+ L N++
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---- 268
Query: 501 VIRHAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
I I + +C P EV I C Q P+ R S+ V
Sbjct: 269 AIDC-------------ITQGRELERPRAC-PPEVYA---IMRGCWQREPQQRHSIKDVH 311
Query: 557 LML 559
L
Sbjct: 312 ARL 314
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 74/316 (23%), Positives = 127/316 (40%), Gaps = 83/316 (26%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKISEQGLNELKNEVILFSKL 339
+ + +LGEG FG+V+ + +AVK L + + + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF-------------IFDQTKRELLDWSK 386
QH ++VK G C G+ ++++E+M + L+ F + + L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
HI A G++YL + +HRDL T N L+ ++ KI DFG++R ++ +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYST 186
Query: 447 TNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500
+G + +M PE F+ +SDV+SFG+++ EI + GK
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------- 233
Query: 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI-----------------HISLLCVQ 543
PW + EVI CI + L C Q
Sbjct: 234 ------------QPWF--------QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQ 273
Query: 544 HHPEDRPSMPSVILML 559
P+ R ++ + +L
Sbjct: 274 REPQQRLNIKEIYKIL 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 34/280 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ ++G G FG V+ G ++ ++A+K + + + E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+IHRDL N L+ + K+SDFG+ R D+ ST + +PE +
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-PVKWASPEVFSFS 180
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
+S KSDV+SFG+L+ E+ S + NS+ V+ I ++
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVED-------------ISTGFR 223
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
V + I C + PEDRP+ ++ L
Sbjct: 224 LYKPRLA-STHVYQ---IMNHCWRERPEDRPAFSRLLRQL 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 76/329 (23%), Positives = 124/329 (37%), Gaps = 78/329 (23%)
Query: 260 VDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDG----QEIAV 315
++ E ++ + + L N +G G FG VY GTL+D AV
Sbjct: 7 LNPELVQAVQHVVIGPSSL--------IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 316 KRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMPNKSLDYFI 373
K L++I +++ E I+ H N++ LLG C++ E L + +M + L FI
Sbjct: 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 374 FDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433
+ + A+G+ YL + + +HRDL N +LD K++DFG
Sbjct: 119 --RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 434 LARTFGGDEIEGSTNKVIGTYG------YMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
LAR D + V G +MA E F+ KSDV+SFG+L+ E+++
Sbjct: 174 LAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-- 227
Query: 488 RNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI------------ 535
RG P+ N ++ +
Sbjct: 228 --RG--------------------APPYP--------DVNTFDITVYLLQGRRLLQPEYC 257
Query: 536 -----HISLLCVQHHPEDRPSMPSVILML 559
+ L C E RPS ++ +
Sbjct: 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 71/310 (22%), Positives = 126/310 (40%), Gaps = 76/310 (24%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE------IAVKRLSKI-SEQGLNELKNEVILFSK 338
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF-------IFDQTKRELLDWSKRFHII 391
++V+LLG QG+ L+I E M L + + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
A G+ YL + + +HRDL N ++ D KI DFG+ R +I +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRK 196
Query: 452 GTYGY-----MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506
G G M+PE DG+F+ SDV+SFG+++ EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----LA--------------- 237
Query: 507 NLWNKGMPWQLIDACYQESCNPDEVIRCI-----------------HISLLCVQHHPEDR 549
P+Q + ++V+R + + +C Q++P+ R
Sbjct: 238 -----EQPYQ--------GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 284
Query: 550 PSMPSVILML 559
PS +I +
Sbjct: 285 PSFLEIISSI 294
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 51/301 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-----DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
+ +LG+G FG V G+ +AVK+L +E+ L + + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 341 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
H N+VK G C + LI E++P SL ++ Q +E +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY-- 456
YL R IHRDL T N+L++++ KI DFGL + D+ +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----------FKV 173
Query: 457 ----------MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506
APE T+ FSV SDV+SFG+++ E+ + ++ +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 507 NLWNKGMP-WQLIDACYQ-------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558
M + LI+ + C PDE+ I C ++ RPS + L
Sbjct: 234 ----GQMIVFHLIELLKNNGRLPRPDGC-PDEI---YMIMTECWNNNVNQRPSFRDLALR 285
Query: 559 L 559
+
Sbjct: 286 V 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 51/301 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-----DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
+ +LG+G FG V G+ +AVK+L +E+ L + + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 341 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
H N+VK G C + LI E++P SL ++ Q +E +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY-- 456
YL R IHRDL T N+L++++ KI DFGL + D+ Y
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-----------YKV 204
Query: 457 ----------MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506
APE T+ FSV SDV+SFG+++ E+ + ++ +
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 507 NLWNKGMP-WQLIDACYQ-------ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558
M + LI+ + C PDE+ I C ++ RPS + L
Sbjct: 265 ----GQMIVFHLIELLKNNGRLPRPDGC-PDEI---YMIMTECWNNNVNQRPSFRDLALR 316
Query: 559 L 559
+
Sbjct: 317 V 317
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ ++ +LG G FG V G ++AVK + K +E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
K G C + ++ E++ N L ++ ++ + L+ S+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ IHRDL N L+D D+ K+SDFG+ R D+ S + APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-PVKWSAPEVFHYF 180
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
+S KSDV++FGIL+ E+ S + NS+ V+ + ++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLK-------------VSQGHR 223
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
D + + I C PE RP+ ++ +
Sbjct: 224 LYRPHLA-SDTIYQ---IMYSCWHELPEKRPTFQQLLSSI 259
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 55/303 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-----DGQEIAVKRL-SKISEQGLNELKNEVILFSKL 339
LGEG FG+V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 340 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
H N+VK G C + LI EF+P+ SL ++ + ++ ++ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY- 456
+ YL + +HRDL NVL++ + KI DFGL + D+ Y
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-----------YT 184
Query: 457 -----------MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504
APE F + SDV+SFG+ + E+++ + + +
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLK 238
Query: 505 AWNLWNKGMPWQ----LIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
+ M + + +C PDEV + + C + P +R S ++I
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNC-PDEVYQ---LMRKCWEFQPSNRTSFQNLI 294
Query: 557 LML 559
Sbjct: 295 EGF 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 34/280 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + +LG G FG V G ++A+K + K +E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L G C + +I E+M N L ++ + R + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ +HRDL N L++ K+SDFGL+R DE S + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYS 196
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
FS KSD+++FG+L+ EI S + NS+ H I +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEH-------------IAQGLR 239
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
++V I C ++RP+ ++ +
Sbjct: 240 LYRPHLA-SEKVYT---IMYSCWHEKADERPTFKILLSNI 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-44
Identities = 80/305 (26%), Positives = 125/305 (40%), Gaps = 60/305 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKI-SEQGLNELKNEVILFSK 338
+LGE FG+VYKG L Q +A+K L E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF-------------IFDQTKRELLDWS 385
LQH N+V LLG + + +I+ + + L F D+T + L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 386 KRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445
H++ A G+ YL S ++H+DL T NVL+ +N KISD GL R E+
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYA 180
Query: 446 STNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNK 498
+ + +MAPE G FS+ SD++S+G+++ E+ S G + G N D
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-- 238
Query: 499 FNVIRHAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPS 554
V+ I + C P V + + C P RP
Sbjct: 239 --VVEM-------------IRNRQVLPCPDDC-PAWVYA---LMIECWNEFPSRRPRFKD 279
Query: 555 VILML 559
+ L
Sbjct: 280 IHSRL 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-44
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 44/314 (14%)
Query: 258 RRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQE----I 313
R +D +++D+ +P E + +G+G FG VY G +D +
Sbjct: 1 RDLDSALLAEVKDVLIP-HERVVT-------HSDRVIGKGHFGVVYHGEYIDQAQNRIQC 52
Query: 314 AVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDY 371
A+K LS+I Q + E +L L H N++ L+G + E ++ +M + L
Sbjct: 53 AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ 112
Query: 372 FIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431
FI ++ + ARG+ YL + + +HRDL N +LD K++D
Sbjct: 113 FI--RSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVAD 167
Query: 432 FGLARTFGGDEIEGSTNKVIGTY--GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRN 489
FGLAR E + A E F+ KSDV+SFG+L+ E+++
Sbjct: 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
Query: 490 --RGLYNSDNKFNVIRHAWNLWNKG--MPWQLIDACYQESCNPDEVIRCIHISLLCVQHH 545
R + D + +G +P E C PD + + + C +
Sbjct: 228 PYRHIDPFD----LTHFL----AQGRRLP-------QPEYC-PDSLYQ---VMQQCWEAD 268
Query: 546 PEDRPSMPSVILML 559
P RP+ ++ +
Sbjct: 269 PAVRPTFRVLVGEV 282
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 80/330 (24%), Positives = 133/330 (40%), Gaps = 64/330 (19%)
Query: 255 GYRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQE-- 312
G R +E Q+++ED+ + + + LGEG FG V +G L
Sbjct: 13 GLVPRGSEELQNKLEDVVIDR----------NLLILGKILGEGEFGSVMEGNLKQEDGTS 62
Query: 313 --IAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLIYEF 363
+AVK + S++ + E +E H N+++LLG CI+ + ++I F
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 364 MPNKSLDYFI---FDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVL 420
M L ++ +T + + + A G+ YL S +HRDL N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCM 179
Query: 421 LDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFS 475
L DM ++DFGL++ +I G ++A E D +++ KSDV++
Sbjct: 180 LRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234
Query: 476 FGILVLEIVSGKRNRGL--YNSDNKFNVIRHAWNLWNKG----MPWQLIDACYQESCNPD 529
FG+ + EI + RG+ Y + + G P E C D
Sbjct: 235 FGVTMWEIAT----RGMTPYPGVQNHEMYDYL----LHGHRLKQP---------EDC-LD 276
Query: 530 EVIRCIHISLLCVQHHPEDRPSMPSVILML 559
E+ I C + P DRP+ + L L
Sbjct: 277 ELYE---IMYSCWRTDPLDRPTFSVLRLQL 303
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 74/300 (24%), Positives = 116/300 (38%), Gaps = 51/300 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL---VDGQEI--AVKRL-SKISEQGLNELKNEVILFSKL 339
LGEG FG+V DG AVK L + Q + K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 340 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQ--TKRELLDWSKRFHIICGTA 395
H +++K GCC L+ E++P SL ++ +LL ++
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA------QQIC 144
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
G+ YLH IHRDL NVLLD+D KI DFGLA+
Sbjct: 145 EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----------- 190
Query: 456 Y------------MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
Y APE + F SDV+SFG+ + E+++ + + +
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
Query: 504 HAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + +L++ + + C P EV H+ C + RP+ ++I +L
Sbjct: 251 AQGQMTVLRLT-ELLERGERLPRPDKC-PAEV---YHLMKNCWETEASFRPTFENLIPIL 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 54/302 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-----DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
+ ++LG+G FG V G +AVK+L + + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 341 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+VK G + L+ E++P+ L F+ Q R LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY-- 456
YL R +HRDL N+L++ + + KI+DFGLA+ D+ Y
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-----------YVV 186
Query: 457 ----------MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHA 505
APE +D +FS +SDV+SFG+++ E+ + ++ + +F
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEF---LRM 240
Query: 506 WNLWNKGMPWQ----LIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
L++ + +C P EV + LC P+DRPS ++
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPAC-PAEV---HELMKLCWAPSPQDRPSFSALGP 296
Query: 558 ML 559
L
Sbjct: 297 QL 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 79/325 (24%), Positives = 133/325 (40%), Gaps = 75/325 (23%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILF 336
D ++ LGEG FG+V V +AVK L +E+ L++L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DY------------FIFDQTKRELL 382
+ +H+N++ LLG C Q +I E+ +L +Y + ++ E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
+ ARG+ YL + + IHRDL NVL+ + KI+DFGLAR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 206
Query: 443 IEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNR 490
I T G +MAPE D +++ +SDV+SFG+L+ EI + G
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 491 GLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHP 546
L+ +L+ ++ +C +E+ + C P
Sbjct: 267 ELF----------------------KLLKEGHRMDKPANC-TNELYM---MMRDCWHAVP 300
Query: 547 EDRPSMPSVILMLGSDSVLAQPKQP 571
RP+ ++ L D +L
Sbjct: 301 SQRPTFKQLVEDL--DRILTLTTNE 323
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 73/337 (21%), Positives = 122/337 (36%), Gaps = 87/337 (25%)
Query: 260 VDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDG----QEIAV 315
+ E ++++ED+ +P F++ LG+G FG V + L ++AV
Sbjct: 7 ISDELKEKLEDVLIPE----------QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAV 56
Query: 316 KRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK------LLIYEFMPNK 367
K L I+ + E E + H ++ KL+G ++ K ++I FM +
Sbjct: 57 KMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116
Query: 368 SLDYFIFD---QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD 424
L F+ L + A G+ YL S IHRDL N +L D
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAED 173
Query: 425 MNPKISDFGLARTFGGDEIEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGIL 479
M ++DFGL+R +I G ++A E D L++V SDV++FG+
Sbjct: 174 MTVCVADFGLSR-----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 480 VLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI---- 535
+ EI++ RG P+ E+ +
Sbjct: 229 MWEIMT----RG--------------------QTPYA--------GIENAEIYNYLIGGN 256
Query: 536 -------------HISLLCVQHHPEDRPSMPSVILML 559
+ C P+ RPS + + L
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 82/272 (30%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + +LG G FG V+ G ++AVK L K + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L Q E +I E+M N SL F+ L +K + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
IHRDL+ +N+L+ ++ KI+DFGLAR +E + APE G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYG 185
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
F++KSDV+SFGIL+ EIV+ R G+ N + VI++ ++ Y+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQN-------------LERGYR 228
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
++C P+E+ + + LC + PEDRP+
Sbjct: 229 MVRPDNC-PEELYQ---LMRLCWKERPEDRPT 256
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 77/313 (24%), Positives = 130/313 (41%), Gaps = 73/313 (23%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRL-SKISEQGLNELKNEVILF 336
D ++ LGEG FG+V V +AVK L +E+ L++L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DY------------FIFDQTKRELL 382
+ +H+N++ LLG C Q +I E+ +L +Y + ++ E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
+ ARG+ YL + + IHRDL NVL+ + KI+DFGLAR +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 252
Query: 443 IEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNR 490
I T G +MAPE D +++ +SDV+SFG+L+ EI + G
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 491 GLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHP 546
L+ +L+ ++ +C +E+ + C P
Sbjct: 313 ELF----------------------KLLKEGHRMDKPANC-TNELYM---MMRDCWHAVP 346
Query: 547 EDRPSMPSVILML 559
RP+ ++ L
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-43
Identities = 81/272 (29%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG G FG V+ T ++AVK + K + E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
KL + E +I EFM SL F+ + K A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ IHRDL+ +N+L+ + KI+DFGLAR +E + APE G
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 360
Query: 466 LFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
F++KSDV+SFGIL++EIV+ G+ G+ N + VIR ++ Y+
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRA-------------LERGYR 403
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
E+C P+E+ I + C ++ PE+RP+
Sbjct: 404 MPRPENC-PEELYN---IMMRCWKNRPEERPT 431
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 81/346 (23%), Positives = 138/346 (39%), Gaps = 77/346 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE---IAVKRL-SKISEQGLNELKNEVILFSKL-Q 340
++ + +GEG FG+V K + A+KR+ S+ + E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT------ 394
H N++ LLG C L E+ P+ +L F+ E + T
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 395 -------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
ARG+ YL S+ + IHRDL N+L+ + KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 448 N-----KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-------GKRNRGLYNS 495
+ +MA E +++ SDV+S+G+L+ EIVS G LY
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-- 251
Query: 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+ + Y+ +C DEV + C + P +RPS
Sbjct: 252 --------------------EKLPQGYRLEKPLNC-DDEVYD---LMRQCWREKPYERPS 287
Query: 552 MPSVILMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNAS 597
+++ L + +L + K V+ + + + + S+ A+
Sbjct: 288 FAQILVSL--NRMLEERK---TYVN-TTLYEKFTYAGIDCSAEEAA 327
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 79/299 (26%), Positives = 125/299 (41%), Gaps = 54/299 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKI-SEQGLNELKNEVILFSK 338
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI----FDQTKRELLDWSKRFHIICGT 394
H+N+V+ +G +Q + ++ E M L F+ ++ L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLARTFGGDEIEGSTNKVI 451
A G YL IHRD+ N LL KI DFG+AR +I ++
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRK 201
Query: 452 GTYGY-----MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRH 504
G M PE +G+F+ K+D +SFG+L+ EI S G N + V+
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF 257
Query: 505 AWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + + ++C P V I C QH PEDRP+ ++ +
Sbjct: 258 -------------VTSGGRMDPPKNC-PGPV---YRIMTQCWQHQPEDRPNFAIILERI 299
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 75/334 (22%), Positives = 126/334 (37%), Gaps = 92/334 (27%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKI-SEQGLNELKNEVILFSK 338
N + LGEG FG+V K T +AVK L + S L +L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL---------------------DYFIFDQT 377
+ H +++KL G C Q LLI E+ SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 378 KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437
L ++G+ YL + ++++HRDL N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 438 FGGDEIEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492
++ + V + G +MA E D +++ +SDV+SFG+L+ EIV+ G
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LG- 249
Query: 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI----------------- 535
G P+ P+ + +
Sbjct: 250 -------------------GNPYP--------GIPPERLFNLLKTGHRMERPDNCSEEMY 282
Query: 536 HISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPK 569
+ L C + P+ RP + L + ++ + +
Sbjct: 283 RLMLQCWKQEPDKRPVFADISKDL--EKMMVKRR 314
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 44/278 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG-QEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ ++ +KLG G +G VY+G +AVK L K + E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN-----KVIGTYGYMAP 459
+ IHRDL N L+ + K++DFGL+R GD K + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
E FS+KSDV++FG+L+ EI + + G+ S V
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYEL------------- 224
Query: 518 IDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
++ Y+ E C P++V + C Q +P DRPS
Sbjct: 225 LEKDYRMERPEGC-PEKVYE---LMRACWQWNPSDRPS 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ ++ +KLG G +G VY+G +AVK L K + E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+ IHR+L N L+ + K++DFGL+R GD + APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKG--MPWQLIDA 520
FS+KSDV++FG+L+ EI + + G+ S V K M
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL----EKDYRME------ 439
Query: 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
E C P++V + C Q +P DRPS +
Sbjct: 440 -RPEGC-PEKVYE---LMRACWQWNPSDRPSFAEIHQAF 473
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 62/296 (20%)
Query: 289 SINNKLGEGGFGRVYKGTLVDG----QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRN 343
N +G G FG VY GTL+D AVK L++I +++ E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 344 LVKLLGCCIQGEEKLL-IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
++ LLG C++ E L + +M + L FI + + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY--GYMAPE 460
+ + +HRDL N +LD K++DFGLAR E + NK +MA E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
F+ KSDV+SFG+L+ E+++ RG P+
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT----RG--------------------APPYP---- 298
Query: 521 CYQESCNPDEVIRCI-----------------HISLLCVQHHPEDRPSMPSVILML 559
N ++ + + L C E RPS ++ +
Sbjct: 299 ----DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 57/287 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRLSK-ISEQGLNELKNEVILFSKL 339
F LG G FG VYKG + E +A+K L + S + E+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ----TKRELLDWSKRFHIICGTA 395
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+G+ YL R++HRDL NVL+ + KI+DFGLA+ G +E E G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 456 -----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRHAWNL 508
+MA E +++ +SDV+S+G+ V E+++ G + G+ S+ +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS------ 229
Query: 509 WNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+++ + C +V I C + RP
Sbjct: 230 -------SILEKGERLPQPPIC-TIDV---YMIMRKCWMIDADSRPK 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 75/324 (23%), Positives = 119/324 (36%), Gaps = 90/324 (27%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKI-SEQGLNELKNEVILFSK 338
+N +GEG FGRV++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF---------------------IFDQT 377
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 378 KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437
L +++ I A G+ YL S + +HRDL T N L+ +M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 438 FGGDEIEGSTNKVIGTYGY-----MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492
I + M PE ++ +SDV+++G+++ EI S G
Sbjct: 223 ----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----YG- 273
Query: 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI----------------- 535
P+ +EVI +
Sbjct: 274 -------------------LQPYY--------GMAHEEVIYYVRDGNILACPENCPLELY 306
Query: 536 HISLLCVQHHPEDRPSMPSVILML 559
++ LC P DRPS S+ +L
Sbjct: 307 NLMRLCWSKLPADRPSFCSIHRIL 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 79/299 (26%), Positives = 124/299 (41%), Gaps = 54/299 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG------QEIAVKRLSKI-SEQGLNELKNEVILFSK 338
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI----FDQTKRELLDWSKRFHIICGT 394
H+N+V+ +G +Q + ++ E M L F+ ++ L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLARTFGGDEIEGSTNKVI 451
A G YL IHRD+ N LL KI DFG+AR +I +
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRK 242
Query: 452 GTYGY-----MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRH 504
G M PE +G+F+ K+D +SFG+L+ EI S G N + V+
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF 298
Query: 505 AWNLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + + ++C P V I C QH PEDRP+ ++ +
Sbjct: 299 -------------VTSGGRMDPPKNC-PGPV---YRIMTQCWQHQPEDRPNFAIILERI 340
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 67/288 (23%), Positives = 122/288 (42%), Gaps = 49/288 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+F +G GGFG+V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 345 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRF 388
V GC + L I EF +L+ +I ++ + E LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448
+ +G+ Y+H ++I+RDLK SN+ L KI DFGL + D G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508
+ GT YM+PE + + + D+++ G+++ E++ + + F +R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRD---- 233
Query: 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
+I + + +++ + PEDRP+ ++
Sbjct: 234 -------GIISDIFDKKEK--TLLQ------KLLSKKPEDRPNTSEIL 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 48/291 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRL-SKISEQGLNELKNEVILFSKLQ 340
I +G G G V G L +++ A+K L + +E+ + +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H N+++L G +G +++ E+M N SLD F+ +T + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG----- 455
L S L +HRDL NVL+D ++ K+SDFGL+R +E + T G
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAYTTTGGKIPI 218
Query: 456 -YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKG 512
+ APE FS SDV+SFG+++ E+++ G+R + N D VI
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----VISS-------- 266
Query: 513 MPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
++ Y+ C P + + + L C RP ++ +L
Sbjct: 267 -----VEEGYRLPAPMGC-PHALHQ---LMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 72/278 (25%), Positives = 109/278 (39%), Gaps = 50/278 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ +G+G FG V G G ++AVK + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 346 KLLGCCIQGEEKLLI-YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+LLG ++ + L I E+M SL ++ + R +L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN-----KVIGTYGYMAP 459
+HRDL NVL+ D K+SDFGL + + K + AP
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK------WTAP 183
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
E + FS KSDV+SFGIL+ EI S R + D V+
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR------------- 226
Query: 518 IDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
++ Y+ + C P V + C RPS
Sbjct: 227 VEKGYKMDAPDGC-PPAVYE---VMKNCWHLDAAMRPS 260
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 40/281 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ +G+G FG V G G ++AVK + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 346 KLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+LLG ++ + L ++ E+M SL ++ + R +L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+HRDL NVL+ D K+SDFGL + + + + APE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALRE 360
Query: 465 GLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
FS KSDV+SFGIL+ EI S G+ + D V+ ++ Y
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR-------------VEKGY 403
Query: 523 Q----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + C P V + C RP+ + L
Sbjct: 404 KMDAPDGC-PPAVYD---VMKNCWHLDAATRPTFLQLREQL 440
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-42
Identities = 86/335 (25%), Positives = 148/335 (44%), Gaps = 53/335 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRLSK-ISEQGLNELKNEVILFSKLQ 340
N SI+ +G G FG V G L +EI A+K L +E+ + E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H N+++L G + + +++ E+M N SLD F+ + + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG----- 455
L S + +HRDL N+L++ ++ K+SDFGL R +E T G
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPI 214
Query: 456 -YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKG 512
+ +PE F+ SDV+S+GI++ E++S G+R + N D VI+
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKA-------- 262
Query: 513 MPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQP 568
+D Y+ C P + + + L C Q +RP ++ +L D ++
Sbjct: 263 -----VDEGYRLPPPMDC-PAALYQ---LMLDCWQKDRNNRPKFEQIVSIL--DKLI--- 308
Query: 569 KQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVE 603
+ PG L S S+ + S+ + +TF
Sbjct: 309 RNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTG 343
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 50/235 (21%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE------IAVKRL-SKISEQGLNELKNEVILFSK 338
+ S LG G FG+V + T + +AVK L L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF---------------------IFDQ 376
L H N+V LLG C G L+I E+ L F
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 377 TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436
+LL +S + + A+G+ +L + IHRDL N+LL H KI DFGLAR
Sbjct: 143 DLEDLLSFS--YQV----AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 437 -TFGGDEIEGSTN-----KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
N K +MAPE + +++ +SDV+S+GI + E+ S
Sbjct: 194 DIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 73/226 (32%), Positives = 106/226 (46%), Gaps = 36/226 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE------IAVKRL-SKISEQGLNELKNEVILFSK 338
+N LG G FG+V + T + +AVK L S L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT--- 394
L QH N+V LLG C G L+I E+ L F+ + K +L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 395 ----------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
A+G+ +L + IHRD+ NVLL + KI DFGLAR +I
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIM 215
Query: 445 GSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+N ++ +MAPE D +++V+SDV+S+GIL+ EI S
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG+G FG V+ GT +A+K L K E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L + E ++ E+M SL F+ + + L + + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
R+ +HRDL+ +N+L+ ++ K++DFGLAR +E + APE A G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
F++KSDV+SFGIL+ E+ + R G+ N + V+ ++ Y+
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ-------------VERGYR 399
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
C P+ + + C + PE+RP+ + L
Sbjct: 400 MPCPPEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 435
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 58/298 (19%), Positives = 115/298 (38%), Gaps = 59/298 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKISEQGLNELKNEVILFS 337
++ N LG+G F +++KG + E+ +K L K + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
KL H++LV G C+ G+E +L+ EF+ SLD ++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--------KISDFGLARTFGGDEIEGSTNK 449
+ +L +IH ++ N+LL + + K+SD G++ T +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 450 VIGTYGY-----MAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNV 501
+ PE + ++ +D +SFG + EI SG L +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----K 227
Query: 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
++ + +Q + ++ C+ + P+ RPS ++I L
Sbjct: 228 LQF-------------YEDRHQLPAPKAAELA--NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILF 336
D + LGEG FG+V + ++AVK L +E+ L++L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DY------------FIFDQTKRELL 382
+ +H+N++ LLG C Q +I E+ +L +Y + E L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
ARG+ YL + + IHRDL NVL+ D KI+DFGLAR +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 240
Query: 443 IEGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
I T G +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 7e-41
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG+G FG V+ GT +A+K L K E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L + E ++ E+M SL F+ + + L + + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
R+ +HRDL+ +N+L+ ++ K++DFGLAR +E + APE A G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 466 LFSVKSDVFSFGILVLEIVSGKRN--RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523
F++KSDV+SFGIL+ E+ + R G+ N + V+ ++ Y+
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQ-------------VERGYR 482
Query: 524 ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
C P+ + + C + PE+RP+ + L
Sbjct: 483 MPCPPEC-PESLHD---LMCQCWRKEPEERPTFEYLQAFL 518
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRL-SKISEQGLNELKNEVILFSK 338
D + LG G FG+V + + +AVK L + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 339 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT-- 394
+ H N+V LLG C + L +I EF +L ++ + + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 395 -----------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443
A+G+ +L + + IHRDL N+LL KI DFGLAR +I
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DI 198
Query: 444 EGSTNKVIGTYG-----YMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
+ V +MAPE D +++++SDV+SFG+L+ EI S
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHR 342
+ + K+GEG FG+ DG++ +K +S++S + E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+V+ + ++ ++ L I Q K L + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
+I+HRD+K+ N+ L D ++ DFG+AR IGT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKR 488
+ ++ KSD+++ G ++ E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 77/339 (22%), Positives = 139/339 (41%), Gaps = 60/339 (17%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRL-SKISEQGLNELKNEVILFSKL 339
F LG G FG VYKG + E +A+K L S + E+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ----TKRELLDWSKRFHIICGTA 395
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+G+ YL R++HRDL NVL+ + KI+DFGLA+ G +E E G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 456 -----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKR-NRGLYNSDNKFNVIRHAWNL 508
+MA E +++ +SDV+S+G+ V E+++ G + G+ S+ +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----IS------ 229
Query: 509 WNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564
+++ + C +V I + C + RP +I+ +
Sbjct: 230 -------SILEKGERLPQPPIC-TIDV---YMIMVKCWMIDADSRPKFRELIIEF--SKM 276
Query: 565 LAQPKQPGCL-VDRKSTGPDSSSSKPESSSTNASTFTEV 602
P++ + D + P + S + + +V
Sbjct: 277 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDV 315
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 71/339 (20%), Positives = 129/339 (38%), Gaps = 62/339 (18%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRL-SKISEQGLNELKNEVILFSKL 339
LG G FG V+KG + E + +K + K Q + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ----TKRELLDWSKRFHIICGTA 395
H ++V+LLG C L+ +++P SL + + LL+W A
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIA 125
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+G+ YL ++HR+L NVLL +++DFG+A D+ + ++
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----A 177
Query: 456 -----YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNL 508
+MA E G ++ +SDV+S+G+ V E+++ G GL ++ V
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VP------ 227
Query: 509 WNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564
L++ + + C +V + + C RP+ + +
Sbjct: 228 -------DLLEKGERLAQPQIC-TIDV---YMVMVKCWMIDENIRPTFKELANEF---TR 273
Query: 565 LAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVE 603
+A+ P + K + PE EVE
Sbjct: 274 MAR--DPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVE 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 72/292 (24%), Positives = 129/292 (44%), Gaps = 49/292 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRLSK-ISEQGLNELKNEVILFSKL 339
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
H N+++L G + + ++I E+M N +LD F+ + K + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG---- 455
YL + + +HRDL N+L++ ++ K+SDFGL+R D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 456 --YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNK 511
+ APE + F+ SDV+SFGI++ E+++ G+R L N + V++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKA------- 262
Query: 512 GMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
I+ ++ C P + + + + C Q RP ++ +L
Sbjct: 263 ------INDGFRLPTPMDC-PSAIYQ---LMMQCWQQERARRPKFADIVSIL 304
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 67/236 (28%), Positives = 99/236 (41%), Gaps = 47/236 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE------IAVKRL-SKISEQGLNELKNEVILFSK 338
+N LG G FG+V T + +AVK L K L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT--- 394
L H N+V LLG C LI+E+ L ++ ++KRE + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEE 162
Query: 395 -------------------ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435
A+G+ +L +HRDL NVL+ H KI DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 436 R-TFGGDEIEGSTN-----KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
R N K +MAPE +G++++KSDV+S+GIL+ EI S
Sbjct: 220 RDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRLSK-ISEQGLNELKNEVILFSKLQ 340
+ + +GEG FG V++G + + + A+K S+ + E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H ++VKL+G + +I E L F+ Q ++ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L R +HRD+ NVL+ + K+ DFGL+R ++ + +MAPE
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 187
Query: 461 YATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518
F+ SDV+ FG+ + EI+ G + +G+ N+D VI I
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG-------------RI 230
Query: 519 DACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQ 570
+ + +C P + + C + P RP + L ++L + K
Sbjct: 231 ENGERLPMPPNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL--STILEEEKA 280
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 49/290 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRLSKI-SEQGLNELKNEVILFSKLQ 340
++ +N LGEG FG VY+G G++I AVK K + + +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H ++VKL+G + E +I E P L +++ + + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN-----KVIGTYG 455
L + +HRD+ N+L+ K+ DFGL+R ++ ++ K
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGM 513
+M+PE F+ SDV+ F + + EI+S GK+ L N D VI
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG---------- 225
Query: 514 PWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+++ + + C P + + C + P DRP ++ L
Sbjct: 226 ---VLEKGDRLPKPDLC-PPVLYT---LMTRCWDYDPSDRPRFTELVCSL 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 58/291 (19%), Positives = 103/291 (35%), Gaps = 43/291 (14%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ KLGEGGF V L DG A+KR+ +Q E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 346 KLLGCCIQ----GEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
+L+ C++ E L+ F +L + + K L + ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-------GT 453
+H HRDLK +N+LL + P + D G + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 454 YGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGKR--NRGLYNSDNKFNVIRHA 505
Y APE + ++DV+S G ++ ++ G+ + D+ +
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260
Query: 506 WNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
+ ++ + P RP +P ++
Sbjct: 261 ----QNQLSIPQSPRHSSALWQ---LLNS------MMTVDPHQRPHIPLLL 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 27/222 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQGLNELKNEVILFSKLQHRN 343
+F LG GGFG V++ VD A+KR+ E ++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 344 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHII 391
+V+ + K+ +Y + ++L ++ + E + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR----------TFGGD 441
A + +LH ++HRDLK SN+ D K+ DFGL
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEI 483
+GT YM+PE +S K D+FS G+++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 68/292 (23%), Positives = 112/292 (38%), Gaps = 44/292 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
+F LG+G FG+V K +D + A+K++ +E+ L+ + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW--SKRFHIICGTAR---- 396
+V+ ++ + + KS + + L D S+ +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 397 ----GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF------------GG 440
L Y+H IIHRDLK N+ +D N KI DFGLA+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 441 DEIEGSTNKVIGTYGYMAPE-YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF 499
+ IGT Y+A E G ++ K D++S GI+ E++ N
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG--MERVNIL 238
Query: 500 NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+R + P D + +IR L + H P RP
Sbjct: 239 KKLRSV----SIEFPPDFDDNKMKVEKK---IIR------LLIDHDPNKRPG 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 62/270 (22%), Positives = 112/270 (41%), Gaps = 31/270 (11%)
Query: 290 INNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRNLVK 346
+ ++G G F VYKG E+A + K+++ K E + LQH N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 347 LLGCCI---QGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
+G++ +++ E M + +L ++ + +++ +GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 403 QDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
+ IIHRDLK N+ + + KI D GLA VIGT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM 201
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+ + DV++FG+ +LE+ + + N + R G+ D
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFD-- 252
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+ P+ I C++ + ++R S
Sbjct: 253 --KVAIPE----VKEIIEGCIRQNKDERYS 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 60/284 (21%)
Query: 290 INNKLGEGGFGRVYKGTLVDGQE---IAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLV 345
+ +LG G FG V +G ++ +A+K L + + E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L+G C Q E +L+ E L F+ KRE + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY--------- 456
+HRDL NVLL + KISDFGL++ G D+ Y
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSAGKWP 176
Query: 457 ---MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNK 511
APE FS +SDV+S+G+ + E +S G++ + + + V+
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF------- 225
Query: 512 GMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
I+ + C P E+ + C + EDRP
Sbjct: 226 ------IEQGKRMECPPEC-PPELYA---LMSDCWIYKWEDRPD 259
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHR 342
+++ + +G G +GR K DG+ + K ++E L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 343 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTKR-------ELLDWSKRFHIICG 393
N+V+ I L + E+ L I TK +L +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---MTQLT- 121
Query: 394 TARGLLYLHQ--DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
L H+ D ++HRDLK +NV LD N K+ DFGLAR D T +
Sbjct: 122 --LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
GT YM+PE ++ KSD++S G L+ E+ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI 352
LG+G +G VY G L + IA+K + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 353 QGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIH 411
+ I+ E +P SL + + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 412 RDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE---YATDGLF 467
RD+K NVL++ + KISDFG ++ G I T GT YMAPE G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-Y 202
Query: 468 SVKSDVFSFGILVLEIVSGKR 488
+D++S G ++E+ +GK
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 27/228 (11%)
Query: 272 ELPLFELATIANATDNFSINNKLGEGGFGRVYKGTL--VDGQEI--AVKRL---SKISEQ 324
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 325 GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR----E 380
+++ EV L HRNL++L G + ++ E P SL +
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440
L ++ A G+ YL R IHRDL N+LL KI DFGL R
Sbjct: 123 LSRYA------VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 441 DEIEGSTNKVIGT---YGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485
++ + + + APE FS SD + FG+ + E+ +
Sbjct: 174 NDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 62/282 (21%)
Query: 293 KLGEGGFGRVYKGTL-VDGQEI--AVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKL 347
+LG G FG V KG + AVK L +EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 348 LGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRL 407
+G C + E +L+ E L+ ++ + + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY----------- 456
+HRDL NVLL KISDFGL++ DE Y
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----------YKAQTHGKWPVK 185
Query: 457 -MAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGM 513
APE FS KSDV+SFG+L+ E S G++ RG+ S+ V
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VT----------- 230
Query: 514 PWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPS 551
+++ + C P E+ + LC + E+RP
Sbjct: 231 --AMLEKGERMGCPAGC-PREMYD---LMNLCWTYDVENRPG 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEI--AVKRL-SKISEQGLNELKNEVILFSKLQ 340
+ + +GEG FG V++G + + + A+K + S+ + E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H ++VKL+G + +I E L F+ Q ++ LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L R +HRD+ NVL+ + K+ DFGL+R ++ + +MAPE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 461 YATDGLFSVKSDVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518
F+ SDV+ FG+ + EI+ G + +G+ N+D VI I
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VI-------------GRI 605
Query: 519 DACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPK 569
+ + +C P + + C + P RP + L ++L + K
Sbjct: 606 ENGERLPMPPNC-PPTLYS---LMTKCWAYDPSRRPRFTELKAQL--STILEEEK 654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRL---SKISEQGLNELKNEVILFSKLQH 341
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 342 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKR-------ELLDWSKRFHIICG 393
N++K I+ + +L I E L I K+ + + F +C
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLC- 146
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
L ++H R++HRD+K +NV + K+ D GL R F + ++GT
Sbjct: 147 --SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
YM+PE + ++ KSD++S G L+ E+ + +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 61/271 (22%), Positives = 102/271 (37%), Gaps = 34/271 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKL-QH 341
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 342 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
V+L + L + E SL + L ++ + + T L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH ++H D+K +N+ L K+ DFGL G G+ G YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPE 226
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
+ +DVFS G+ +LE+ L + + +R +P +
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNME---LPHGGEGWQQLR------QGYLPPEFTAG 276
Query: 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
E + V+ + ++ P+ R +
Sbjct: 277 LSSELRS---VLV------MMLEPDPKLRAT 298
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRNL 344
+SI ++G GG +V++ Q A+K L + Q L+ +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 345 --VKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++L ++ + ++ E N L+ ++ K++ +D +R + +
Sbjct: 89 KIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE- 460
HQ I+H DLK +N L+ D K+ DFG+A D + +GT YM PE
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 461 ----------YATDGLFSVKSDVFSFGILVLEIVSGK 487
+ S KSDV+S G ++ + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 73/344 (21%), Positives = 141/344 (40%), Gaps = 36/344 (10%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNL 344
+SI ++G GG +V++ Q A+K ++ Q L+ +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 345 --VKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++L ++ + ++ E N L+ ++ K++ +D +R + +
Sbjct: 70 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE- 460
HQ I+H DLK +N L+ D K+ DFG+A D + +GT YM PE
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 461 ----------YATDGLFSVKSDVFSFGILVLEIVSGKRN-RGLYNSDNKFNVI---RHAW 506
+ S KSDV+S G ++ + GK + + N +K + I H
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 507 NLWNKGMPW--QLIDACYQESCNPDEVIRCIHI---SLLCVQHHPEDRPSMPSVILMLGS 561
+ ++ C + +P + I + + +Q HP ++ + + M
Sbjct: 241 EFPDIPEKDLQDVLKCCLKR--DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 298
Query: 562 DSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNASTFTEVEGR 605
L P ++ T + S +S+++ TF + G+
Sbjct: 299 LGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 342
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 62/283 (21%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKR--LSKISEQGLNELKNEVILFSKLQHRNL 344
+SI ++G GG +V++ Q A+K L + Q L+ +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 345 --VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
++L ++ + + N L+ ++ K++ +D +R + +H
Sbjct: 117 KIIRLYDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-- 460
Q I+H DLK +N L+ D K+ DFG+A D + +G YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 461 ---------YATDGLFSVKSDVFSFGILVLEIVSGKRN-RGLYNSDNKFNVIRHAWNLWN 510
+ S KSDV+S G ++ + GK + + N +K + I +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------D 282
Query: 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP 553
+ + + D + C++ P+ R S+P
Sbjct: 283 PNHEIE-----FPDIPEKD----LQDVLKCCLKRDPKQRISIP 316
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 75/326 (23%), Positives = 129/326 (39%), Gaps = 51/326 (15%)
Query: 239 YVWGQDFFIRVPTSDLGYRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGG 298
+ D +P + + + + L L L + +LG G
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA---------DIELGCGN 348
Query: 299 FGRVYKGTL-VDGQEI--AVKRL-SKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354
FG V +G + ++I A+K L + E+ E + +L + +V+L+G C Q
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 407
Query: 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 414
E +L+ E L F+ KRE + S ++ + G+ YL +HR+L
Sbjct: 408 EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNL 462
Query: 415 KTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT---YGYMAPEYATDGLFSVKS 471
NVLL + KISDFGL++ G D+ + + APE FS +S
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSRS 520
Query: 472 DVFSFGILVLEIVS-GKRN-RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ----ES 525
DV+S+G+ + E +S G++ + + + V+ I+ +
Sbjct: 521 DVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF-------------IEQGKRMECPPE 563
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPS 551
C P E+ + C + EDRP
Sbjct: 564 C-PPELYA---LMSDCWIYKWEDRPD 585
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 55/223 (24%), Positives = 114/223 (51%), Gaps = 16/223 (7%)
Query: 269 EDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLN 327
E++ L + ++ + ++ K+G+G G VY + GQE+A+++++ +
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 328 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR 387
+ NE+++ + ++ N+V L + G+E ++ E++ SL + + E
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------ 116
Query: 388 FHI--IC-GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
I +C + L +LH + ++IHRD+K+ N+LL D + K++DFG +
Sbjct: 117 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQ 170
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+ ++GT +MAPE T + K D++S GI+ +E++ G+
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 42/251 (16%)
Query: 256 YRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIA 314
R + E+ + + E + ++G G FG V++ G + A
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87
Query: 315 VK--RLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY-EFMPNKSL-- 369
VK RL + E++ + L +V L G +G + I+ E + SL
Sbjct: 88 VKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGSLGQ 139
Query: 370 ---DYFIFDQTK-----RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421
+ + + L GL YLH RI+H D+K NVLL
Sbjct: 140 LIKQMGCLPEDRALYYLGQAL-------------EGLEYLHTR---RILHGDVKADNVLL 183
Query: 422 DHDMNP-KISDFGLARTFGGDEIEGSTNK---VIGTYGYMAPEYATDGLFSVKSDVFSFG 477
D + + DFG A D + S + GT +MAPE K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 478 ILVLEIVSGKR 488
++L +++G
Sbjct: 244 CMMLHMLNGCH 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 60/293 (20%), Positives = 105/293 (35%), Gaps = 55/293 (18%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKR--LSKISEQGLNELKNEVILFSKL-Q 340
T F K+G G FG V+K +DG A+KR EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 341 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDYFIFDQTKR-ELLDWSKRFHIICGTARGL 398
H ++V+ + + +LI E+ SL I + + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNP-------------------KISDFGLARTFG 439
Y+H ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 440 GDEIEGSTNKVIGTYGYMAPE-YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
S G ++A E + K+D+F+ + V+ + L + ++
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---LPRNGDQ 236
Query: 499 FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
++ IR +G I + E+++ + + PE RPS
Sbjct: 237 WHEIR-------QGRL-PRIPQVLSQEFT--ELLK------VMIHPDPERRPS 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 22/243 (9%)
Query: 252 SDLGYRRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDG 310
DLG Q E + L + + K+GEG G V G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 311 QEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 370
+++AVK + +Q L NEV++ QH N+V++ + GEE ++ EF+ +L
Sbjct: 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 371 YFIFDQTKRELLDWSKRFHI--IC-GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427
+ E I +C + L YLH +IHRD+K+ ++LL D
Sbjct: 131 DIVSQVRLNEE-------QIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 428 KISDFGLARTFGGDEIEGSTNK---VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIV 484
K+SDFG +I K ++GT +MAPE + L++ + D++S GI+V+E+V
Sbjct: 181 KLSDFGFCA-----QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
Query: 485 SGK 487
G+
Sbjct: 236 DGE 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 56/334 (16%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNL 344
+ L EGGF VY+ + G+E A+KRL E+ + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 345 VKLLGCCIQGEEK-------LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK-------- 449
+ ++H+ + IIHRDLK N+LL + K+ DFG A T + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 450 --VIGTYGYMAPEYATDGLFSV--------KSDVFSFGILVLEIVSGKRNRGLYNSDNKF 499
T Y PE + + K D+++ G ++ + + + K
Sbjct: 208 ITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---FEDGAKL 259
Query: 500 NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI--- 556
++ Y + + + +Q +PE+R S+ V+
Sbjct: 260 RIVN----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
Query: 557 -LMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKP 589
+ + +V + L G + S P
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 24/222 (10%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQ 340
+ + +++ LG+G V++G G A+K + IS + ++ E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 341 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 454 YGYMAPE--------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+ P+ + D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQH 341
+ LG+GGF + ++ + D + A K + K + + E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGT 394
+++V G + + + ++ E +SL + KR K + +
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQI 124
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GT 453
G YLH R R+IHRDLK N+ L+ D+ KI DFGLA D G KV+ GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGT 178
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+APE + S + DV+S G ++ ++ GK
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRL-SKISEQGLNELKNEV-ILFSKLQHR 342
D+ +LG G +G V K V GQ +AVKR+ + ++ Q L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGTAR 396
V G + + + E M + SLD F ++++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST--NKVIGTY 454
L +LH S+L +IHRD+K SNVL++ K+ DFG++ + + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLVDDVAKDIDAGCK 173
Query: 455 GYMAPE----YATDGLFSVKSDVFSFGILVLEIVSGK 487
YMAPE +SVKSD++S GI ++E+ +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQH 341
+ LG+GGF + ++ + D + A K + K + + E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGT 394
+++V G + + + ++ E +SL + KR K + +
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQI 150
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GT 453
G YLH+ R+IHRDLK N+ L+ D+ KI DFGLA D G KV+ GT
Sbjct: 151 VLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGT 204
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+APE + S + DV+S G ++ ++ GK
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 68/335 (20%), Positives = 114/335 (34%), Gaps = 90/335 (26%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQGLNELKNEVILFSKLQHRN 343
+F +G GGFG V++ VD A+KR+ E ++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 344 LVKLLGCCIQG----------------------------------EEKLL-------IYE 362
+V+ ++ + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 363 FMPNKSLDYFIFDQT----KRELLDWSKR------------FHIICGTARGLLYLHQDSR 406
+ S +++ Q K L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN----------KVIGTYGY 456
++HRDLK SN+ D K+ DFGL DE E + +GT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
M+PE +S K D+FS G+++ E++ + +I ++ N P
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-----TQMERVRIIT---DVRNLKFPLL 294
Query: 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551
QE +++ + P +RP
Sbjct: 295 FTQKYPQEH----MMVQ------DMLSPSPTERPE 319
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 57/208 (27%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQGLNELKNEVILFSKL 339
A+ + F+ K+G+G FG V+KG + +A+K + + +E + +++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
+ K G ++ + +I E++ S D + LD ++ I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
YLH + + IHRD+K +NVLL K++DFG+A + + N +GT +MAP
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 188
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGK 487
E + K+D++S GI +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 24/222 (10%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQ 340
+ + +++ LG+G V++G G A+K + IS + ++ E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 341 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 454 YGYMAPE--------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+ P+ + D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 258 RRVDQENQD--QIEDLELPLFELATIANAT-DNFSINNKLGEGGFGRVYKGTLV-DGQEI 313
+++++ D Q + LE L + + D+F ++LG G G V+K + G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 314 AVKRLS-KISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF 372
A K + +I N++ E+ + + +V G E + E M SLD
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-- 119
Query: 373 IFDQTKRELLDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426
++L + R + +GL YL + +I+HRD+K SN+L++
Sbjct: 120 -------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGE 170
Query: 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
K+ DFG++ G I+ N +GT YM+PE +SV+SD++S G+ ++E+ G
Sbjct: 171 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 487 K 487
+
Sbjct: 227 R 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 275 LFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV 333
L E + + F + KLGEG +G VYK GQ +A+K++ E L E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 334 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG 393
+ + ++VK G + + ++ E+ S+ I + + + L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
T +GL YLH R IHRD+K N+LL+ + + K++DFG+A + N VIGT
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGT 188
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+MAPE + ++ +D++S GI +E+ GK
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRL-SKISEQGLNELKNEV-ILFSKLQHR 342
++ ++G G +G V K GQ +AVKR+ S + E+ +L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGTAR 396
+V+ G + + + E M + S D F K I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG----LARTFGGDEIEGSTNKVIG 452
L +L L+IIHRD+K SN+LLD N K+ DFG L + + + G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-------AKTRDAG 187
Query: 453 TYGYMAPE----YATDGLFSVKSDVFSFGILVLEIVSGK 487
YMAPE A+ + V+SDV+S GI + E+ +G+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 62/208 (29%), Positives = 113/208 (54%), Gaps = 15/208 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQH 341
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
++++L + + L+ E N ++ ++ ++ K + R H + G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEAR-HFMHQIITGMLY 127
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYGYMAP 459
LH I+HRDL SN+LL +MN KI+DFGLA ++ + + GT Y++P
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL---KMPHEKHYTLCGTPNYISP 181
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGK 487
E AT ++SDV+S G + ++ G+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 277 ELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVIL 335
+ + + + I +LG+G FG+VYK G A K + SE+ L + E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--IC- 392
+ H +VKLLG + ++ EF P ++D I + R L I +C
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL----TEPQIQVVCR 124
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
L +LH RIIHRDLK NVL+ + + +++DFG++ + + IG
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIG 179
Query: 453 TYGYMAPE-----YATDGLFSVKSDVFSFGILVLEIVSGK 487
T +MAPE D + K+D++S GI ++E+ +
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 275 LFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS---KISEQGLNELK 330
+ EL + FS ++G G FG VY + + + +A+K++S K S + ++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 331 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI 390
EV KL+H N ++ GC ++ L+ E+ + D + + K+ L + I
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPL----QEVEI 156
Query: 391 --IC-GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
+ G +GL YLH +IHRD+K N+LL K+ DFG A
Sbjct: 157 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APA 207
Query: 448 NKVIGTYGYMAPE---YATDGLFSVKSDVFSFGILVLEIVSGK 487
N +GT +MAPE +G + K DV+S GI +E+ K
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQH 341
++F I LG+G FG VY +A+K L K + + G+ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGT 394
N+++L G ++ LI E+ P ++ + + ++ +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKL-----SKFDEQRTATYITEL 118
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GT 453
A L Y H R+IHRD+K N+LL KI+DFG + S + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGT 170
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+ PE + K D++S G+L E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLV 345
+F + LG G G + + D +++AVKR+ + + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 346 KLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ C + + + E +Y + K + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 405 SRLRIIHRDLKTSNVLL-----DHDMNPKISDFGLARTFGGDEIEGSTNK-VIGTYGYMA 458
L I+HRDLK N+L+ + ISDFGL + S V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 459 PEY---ATDGLFSVKSDVFSFGILVLEIVSG 486
PE + D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 70/226 (30%), Positives = 109/226 (48%), Gaps = 22/226 (9%)
Query: 276 FELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVI 334
+L+ + + F + +G G +G+VYKG + GQ A+K + ++ E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 335 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSL-DYFIFDQTKRELLDWSK 386
+ K HRN+ G I+ +++L L+ EF S+ D + TK L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEW 130
Query: 387 RFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446
+I RGL +LHQ ++IHRD+K NVLL + K+ DFG++ D G
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGR 185
Query: 447 TNKVIGTYGYMAPE-----YATDGLFSVKSDVFSFGILVLEIVSGK 487
N IGT +MAPE D + KSD++S GI +E+ G
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 2e-30
Identities = 35/222 (15%), Positives = 68/222 (30%), Gaps = 22/222 (9%)
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKISEQGLNELKNEVILFSK 338
+ +++ LGEG F +VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI--FDQTKRELLDWSKRFHIICGTAR 396
+K + +L+ E +L I + T +++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLL-----------DHDMNPKISDFGLARTFGGDEIEG 445
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T G+ E ++ ++ + D F V ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRL-SKISEQGLNELKNEV-ILFSKLQHR 342
++ ++G G G+V+K G IAVK++ +++ + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
+V+ G I + + E M + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFG----LARTFGGDEIEGSTNKVIGTYGYMA 458
+ +IHRD+K SN+LLD K+ DFG L + ++ G YMA
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-------AKDRSAGCAAYMA 192
Query: 459 PE-----YATDGLFSVKSDVFSFGILVLEIVSGK 487
PE T + +++DV+S GI ++E+ +G+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-30
Identities = 68/289 (23%), Positives = 109/289 (37%), Gaps = 28/289 (9%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHR 342
+ + +LG GGFG V + G+++A+K+ + E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 343 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA 395
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
L YLH+ RIIHRDLK N++L + KI D G A+ E+ + +G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVG 185
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNK 511
T Y+APE ++V D +SFG L E ++G R + +R N +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE-HI 244
Query: 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCV-------QHHPEDRPSMP 553
+ L A S P ++ H R + P
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 290 INNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-----LKNEVILFSKLQHRN 343
I +KLG GG VY + ++A+K + E + EV S+L H+N
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 344 LVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
+V ++ EE Y E++ +L +I L + G+ +
Sbjct: 73 IVSMID---VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H +RI+HRD+K N+L+D + KI DFG+A+ + TN V+GT Y +PE
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPE 182
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKR 488
A +D++S GI++ E++ G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 41/210 (19%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 290 INNKLGEGGFGRVYKG--TLVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLVK 346
+ + GG G +Y V+G+ + +K L + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 347 LLGCCIQGEE-----KLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+ E + Y E++ +SL ++K + L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
YLH + +++ DLK N++L + K+ D G S + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQA 245
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
PE G +V +D+++ G + +
Sbjct: 246 PEIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 16/217 (7%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLS-KISEQGLNELKNEVILFSKLQ 340
D++ + +G G V +++A+KR++ + + ++EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFH-----IIC-GT 394
H N+V + +E L+ + + S+ I + S I
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA---RTFGGDEIEGSTNKVI 451
GL YLH++ IHRD+K N+LL D + +I+DFG++ T G +
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 452 GTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGK 487
GT +MAPE + K+D++SFGI +E+ +G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 42/223 (18%), Positives = 85/223 (38%), Gaps = 18/223 (8%)
Query: 278 LATIANATDNFSINNKLGEG--GFGRVYKGT-LVDGQEIAVKR--LSKISEQGLNELKNE 332
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 333 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DYFIFDQTKRELLDWSKRFHII 391
+ + H N+V I E ++ FM S D + + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYIL 134
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE-----IEGS 446
G + L Y+H +HR +K S++L+ D +S + +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 447 TNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGK 487
+ +++PE L + KSD++S GI E+ +G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 45/233 (19%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--DGQEIAVKRLSK----------------ISEQGLN 327
+++ I L +G F ++ L D + A+K+ K IS +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 328 E-LKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWS 385
+ KNE+ + + +++ + G I +++ +IYE+M N S+ + +++
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI-LKFDEYFFVLDKNYT 145
Query: 386 KRF------HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439
II Y+H + I HRD+K SN+L+D + K+SDFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 440 GDEIEGSTNKVIGTYGYMAPE-----YATDGLFSVKSDVFSFGILVLEIVSGK 487
+I+GS GTY +M PE + +G K D++S GI + +
Sbjct: 204 DKKIKGS----RGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQH 341
D+F I LG+G FG VY +A+K L K + ++G+ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF------HIICGT 394
N++++ +++ L+ EF P L + + ++ RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEEL 123
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
A L Y H ++IHRD+K N+L+ + KI+DFG + + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTL 176
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+ PE K D++ G+L E + G
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 41/355 (11%), Positives = 80/355 (22%), Gaps = 58/355 (16%)
Query: 243 QDFFIRVPTSDLGYRRRVDQENQDQIEDLELPLFELAT-------IANATDNFSINNKLG 295
+D R R +E +E + ++ ++ + L
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71
Query: 296 EGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCC 351
G V+ V+ ++ A+K + S L L ++L + +
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 352 ----------IQGEEK----------------LLIYEFMP---NKSLDYFIFDQTKRELL 382
+Q + LL+ F R
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
+ R L ++H N+ + D + D G
Sbjct: 192 GILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG--- 245
Query: 443 IEGSTNKVIGTYGYMAPEYATDG--LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500
Y E+ F+ + + G+ + + GL K +
Sbjct: 246 --TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
R +L G +C +I L R
Sbjct: 304 WKRP--SLRVPGTDSLAFGSCTPLPDFVKTLIGR----FL--NFDRRRRLLPLEA 350
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 50/356 (14%), Positives = 96/356 (26%), Gaps = 82/356 (23%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH-------- 341
LG+ + T G+ V + ++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 342 --------RNLVKLLGCCIQGEEK--------LLIYEFMPNKSLDYFIF------DQTKR 379
+LVK + L + P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 380 ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439
+ L R + R L LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 440 GDEIEGSTNKVIGTYGYMAPEY----------ATDGLFSVKSDVFSFGILVLEIVSGKRN 489
+G++ G+ PE L + D ++ G+ + I
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL- 315
Query: 490 RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDR 549
D + +C P V + L ++ EDR
Sbjct: 316 --PNTDDAALGGSE------------WIFRSCKNI---PQPVRALLE-GFL--RYPKEDR 355
Query: 550 PSMPSVI-------LMLGSDSVLAQPKQPGCLVDRKSTGPDSSSSKPESSSTNAST 598
+ L + L + G R+ P S +S+P+ + +
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDG-EPTREGGAPPSGTSQPDEAGAAEAV 410
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEV-ILFSKLQHRNL 344
+ LG G G V G+ +AVKR+ + E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 345 VKLLGCCIQGEEKL-LIYEFMPNKSLDYFI----FDQTKRELLDWSKRFHIICGTARGLL 399
++ C + L + E N +L + +L ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDH-------------DMNPKISDFGLARTFGGDE--IE 444
+LH L+IIHRDLK N+L+ ++ ISDFGL + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSV-------KSDVFSFGILVLEIVSGKRNRGLYNSDN 497
+ N GT G+ APE + D+FS G + I+S ++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 498 KFNVIRHAWNL-WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
+ N+IR ++L K + + + ++I + H P RP+ V
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSL------IAEATDLISQ------MIDHDPLKRPTAMKV 293
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 73/221 (33%), Positives = 118/221 (53%), Gaps = 32/221 (14%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE--LKNEVILFSKL 339
+++ F KLG G + VYKG G +A+K + SE+G ++ E+ L +L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPN---KSLDYFIFDQTKREL-LDWSKRF-HIICG 393
+H N+V+L I E KL L++EFM N K +D T R L L+ K F +
Sbjct: 61 KHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL- 118
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
+GL + H++ +I+HRDLK N+L++ K+ DFGLAR F G + +++V+ T
Sbjct: 119 --QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 454 YGYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y AP+ Y+T S+ D++S G ++ E+++GK
Sbjct: 172 LWYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR---- 396
VKL Q +EKL + N L ++ F C R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----LKYIRKI-----GSFDETC--TRFYTA 137
Query: 397 ----GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
L YLH IIHRDLK N+LL+ DM+ +I+DFG A+ + + N +G
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T Y++PE T+ SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 35/217 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ------GLNELKNEVILFSKL 339
+ + K+GEG +G VYK G+ +A+KR+ +E + E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF-HIICGTARG 397
H N+V L+ I E L L++EFM K L + + K + + + RG
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLL---RG 131
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+ + HQ RI+HRDLK N+L++ D K++DFGLAR F G + T++V+ T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 458 APE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
AP+ Y+T SV D++S G + E+++GK
Sbjct: 187 APDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 21/208 (10%)
Query: 290 INNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-----LKNEVILFSKLQHRN 343
+ +G GG G VY+ V + +A+K +S + ++ E +LQ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMS--ETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 344 LVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
+V + GE +Y + L + ++ L + I+ L
Sbjct: 96 VVPIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H HRD+K N+L+ D + DFG+A +++ +GT YMAPE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPE 205
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKR 488
++ + ++D+++ ++ E ++G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 30/239 (12%), Positives = 68/239 (28%), Gaps = 54/239 (22%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQ--------- 340
LG+ + T G+ V + ++K EV+ L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 341 ----------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYF--IFD-QTKR 379
+ ++++ +Y M + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 380 ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439
+ L R + R L LH ++H L+ +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 255
Query: 440 GDEIEGSTNKVIGTYGYMAPEY-----------ATDGLFSVKSDVFSFGILVLEIVSGK 487
+G+ + G+ PE L + D ++ G+++ I
Sbjct: 256 ----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQ------GLNELKNEVILFSK 338
+ K+GEG +G V+K + +A+KR+ + L E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF-HIICGTAR 396
L+H+N+V+L + ++KL L++EF + L + + K F + +
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLL---K 112
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
GL + H ++HRDLK N+L++ + K+++FGLAR F G + + +V+ T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 457 MAPE-------YATDGLFSVKSDVFSFGILVLEIVSGKR 488
P+ Y+T S+ D++S G + E+ + R
Sbjct: 168 RPPDVLFGAKLYST----SI--DMWSAGCIFAELANAGR 200
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 290 INNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-----LKNEVILFSKLQHRN 343
+ LG GG V+ L D +++AVK L ++ + + E + L H
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 344 LVKLLGCCIQGEEKL-------LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
+V + GE + ++ E++ +L + + + +I +
Sbjct: 74 IVAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 127
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG-STNKVIGTYG 455
L + H + IIHRD+K +N+++ K+ DFG+AR T VIGT
Sbjct: 128 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
Y++PE A +SDV+S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE--LKNEVILFSKLQHR 342
+ + +KLGEG + VYKG + +A+K + E+G ++ EV L L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 343 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+V L I E+ L L++E++ +K L ++ +++ + RGL Y
Sbjct: 61 NIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE- 460
H+ +++HRDLK N+L++ K++DFGLAR + N+V+ T Y P+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDI 171
Query: 461 ------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+T + D++ G + E+ +G+
Sbjct: 172 LLGSTDYST----QI--DMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ------GLNELKNEVILFSKL 339
+ + K+GEG +G VYK G+ A+K++ E + E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF-HIICGTARG 397
+H N+VKL I +++L L++E + + L + +K F + G
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLL---NG 112
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+ Y H R++HRDLK N+L++ + KI+DFGLAR F G + T++++ T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 458 APE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
AP+ Y+T ++ D++S G + E+V+G
Sbjct: 168 APDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
D F LG GGFG V+ + ++ A K+L+K +G E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF----------HI 390
R +V L + + L L+ M + Y I++ + F I
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-----PGFQEPRAIFYTAQI 298
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ G L +LHQ II+RDLK NVLLD D N +ISD GLA + T
Sbjct: 299 VSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGY 349
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT G+MAPE + D F+ G+ + E+++ +
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN--------EVILF 336
+ + LGEG F VYK Q +A+K KI +E K+ E+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALREIKLL 66
Query: 337 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF-HIICGT 394
+L H N++ LL + + L+++FM L+ I D + K + +
Sbjct: 67 QELSHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTL-- 122
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
+GL YLHQ I+HRDLK +N+LLD + K++DFGLA++F G T++V+ T
Sbjct: 123 -QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TR 176
Query: 455 GYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y APE Y V D+++ G ++ E++
Sbjct: 177 WYRAPELLFGARMYGV----GV--DMWAVGCILAELLLRV 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN-----EVILFSKL 339
+ + K+GEG +G V+K GQ +A+K K E + + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+H NLV LL + + +L L++E+ + ++ + + + K T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAV 115
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
+ H+ IHRD+K N+L+ K+ DFG AR + ++V T Y +
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRS 170
Query: 459 PE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
PE Y V DV++ G + E++SG
Sbjct: 171 PELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-26
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
++ + KLG G +G V V E A+K + K +S ++L EV + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLY 400
N++KL L+ E L FD+ R + II G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 401 LHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
LH+ I+HRDLK N+LL + D KI DFGL+ F + + +GT Y+
Sbjct: 152 LHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYI 205
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
APE + K DV+S G+++ +++G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQ 340
+D + LG+G FG V + GQE AVK +SK + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGL 398
H N++KL + + L+ E L FD+ R+ II G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 399 LYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
Y+H+ +I+HRDLK N+LL D N +I DFGL+ F + IGT
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAY 193
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
Y+APE G + K DV+S G+++ ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HIICGTARG 397
R +V L + ++ L L+ M L + I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L LH R RI++RDLK N+LLD + +ISD GLA + + +GT GYM
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYM 352
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGK 487
APE + ++ D ++ G L+ E+++G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 71/218 (32%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
+ ++I LG+G FG V K + QE AVK ++K + + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRF------HII 391
N++KL I E + S Y + + T EL D KRF II
Sbjct: 81 PNIMKLFE----------ILE---DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTN 448
G+ Y+H+ I+HRDLK N+LL + D + KI DFGL+ F +
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
IGT Y+APE G + K DV+S G+++ ++SG
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKL-- 339
++FS++ +G GGFG VY D ++ A+K L K +QG NE I+ S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 340 -QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGT 394
+V + +KL I + M L Y + + RF+ II G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG- 304
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
L ++H +++RDLK +N+LLD + +ISD GLA F + + +GT+
Sbjct: 305 ---LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTH 354
Query: 455 GYMAPEYATDGL---FSVKSDVFSFGILVLEIVSGK 487
GYMAPE G+ S D FS G ++ +++ G
Sbjct: 355 GYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 52/228 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQ------GLNELKNEVILFSK 338
D + KLGEG +G VYK V + +A+KR+ E+ + E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HIICGT 394
LQHRN+++L I +L LI+E+ + ++ +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 395 A---RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-----KISDFGLARTFGGDEIEGS 446
G+ + H R +HRDLK N+LL KI DFGLAR F G I
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 447 TNKVIGTYGYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
T+++I T Y PE Y+T SV D++S + E++
Sbjct: 195 THEII-TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN-----EVILFSKL 339
+ + +GEG +G V K G+ +A+K K E +++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+H NLV LL + +++ L++EF+ + LD + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGI 137
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
+ H IIHRD+K N+L+ K+ DFG ART E ++V T Y A
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRA 192
Query: 459 PE-------YATDGLFSVKSDVFSFGILVLEIVSGK 487
PE Y +V DV++ G LV E+ G+
Sbjct: 193 PELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNE--LKNEVILFSKLQHRNLVKLL 348
LGEG +G+V + AVK L K + E +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 349 GCCIQGEEKLLIY---EFMPNKSLDYFIFDQTKRELLDWSKRF--HIICGTARGLLYLHQ 403
+ EEK +Y E+ + KR + + + +I G YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
I+H+D+K N+LL KIS G+A + + G+ + PE A
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 464 -----DGLFSVKSDVFSFGILVLEIVSGK 487
G K D++S G+ + I +G
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
F LG G F V+ + G+ A+K + K + L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRF------HIICG 393
+V L IYE + + Y + + EL D + +I
Sbjct: 68 IVTLED----------IYE---STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ 114
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ YLH+ I+HRDLK N+L + + I+DFGL++ G +
Sbjct: 115 VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTA 167
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGI 478
GT GY+APE +S D +S G+
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 55/234 (23%), Positives = 88/234 (37%), Gaps = 37/234 (15%)
Query: 263 ENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKI 321
I P + D++ I+ +LG G FG V++ T G A K +
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 322 SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL 381
E ++ E+ S L+H LV L E ++IYEFM + EL
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM------------SGGEL 241
Query: 382 LDW--SKRFHI-----------ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP- 427
+ + + +C GL ++H+ +H DLK N++ +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPENIMFTTKRSNE 295
Query: 428 -KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILV 480
K+ DFGL + S GT + APE A +D++S G+L
Sbjct: 296 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK-------------ISEQGLNELK 330
+++ KLG G +G V E A+K + K E+ E+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 331 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ-TKRELLDWSKRF 388
NE+ L L H N++KL + ++ L+ EF L F+Q R D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA 149
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEG 445
+I+ G+ YLH+ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-- 204
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
+GT Y+APE ++ K DV+S G+++ ++ G
Sbjct: 205 -LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
+ ++I LG+G FG V K + QE AVK ++K + + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD-QTKRELLDW---SKRF------HII 391
N++KL +E + + S Y + + T EL D KRF II
Sbjct: 81 PNIMKL-------------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTN 448
G+ Y+H+ I+HRDLK N+LL + D + KI DFGL+ F +
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGI 478
IGT Y+APE G + K DV+S G+
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRL--SKISEQGLNELKNEVILFSKLQHRN 343
N+ + +G+G F +V ++ G+E+A+K + ++++ L +L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 344 LVKLLGCCIQGEEKL-LIYEFMPNKSL-DYFIFDQTKRELLDWSKRF--HIICGTARGLL 399
+VKL I+ E+ L LI E+ + DY + +E ++ I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKE--KEARSKFRQIVSAVQ---- 128
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF-GGDEIEGSTNKVIGTYGYMA 458
Y H + RI+HRDLK N+LLD DMN KI+DFG + F G +++ G Y A
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAA 181
Query: 459 PE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
PE Y DG + DV+S G+++ +VSG
Sbjct: 182 PELFQGKKY--DGP---EVDVWSLGVILYTLVSGS 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
++ +G G FG V++ LV+ E+A+K++ + EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 345 VKLLGCCIQGEEKL------LIYEFMP---NKSLDYFIFDQTKREL-LDWSKRF-HIICG 393
V L +K L+ E++P ++ + + + K+ + + K + + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH--YAKLKQTMPMLLIKLYMYQLL- 151
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEGSTNKVIG 452
R L Y+H + I HRD+K N+LLD K+ DFG A+ E + + +
Sbjct: 152 --RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204
Query: 453 TYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSGK 487
Y Y APE AT+ ++ D++S G ++ E++ G+
Sbjct: 205 RY-YRAPELIFGATN--YTTNIDIWSTGCVMAELMQGQ 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/250 (24%), Positives = 101/250 (40%), Gaps = 72/250 (28%)
Query: 279 ATIANATDNFSINN-----KLGEGGFGRVYKGT-LVDGQEIAVKRLSK------------ 320
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 321 --------------ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM-- 364
+ ++ E+ + KL H N+VKL E +
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-------------VEVLDD 107
Query: 365 PNKSLDYFIFDQTKR-ELLDWSKR-----------FH-IICGTARGLLYLHQDSRLRIIH 411
PN+ Y +F+ + +++ F +I G + YLH +IIH
Sbjct: 108 PNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIH 160
Query: 412 RDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE--YATDGLFS- 468
RD+K SN+L+ D + KI+DFG++ F G + + +GT +MAPE T +FS
Sbjct: 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSG 218
Query: 469 VKSDVFSFGI 478
DV++ G+
Sbjct: 219 KALDVWAMGV 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
+ D + I +LG G FG V++ G+ K ++ +KNE+ + ++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR-----FHIICGTA 395
H L+ L E +LI EF+ L FD+ E S+ C
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACE-- 160
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGSTNKVIGT 453
GL ++H+ I+H D+K N++ + KI DFGLA DEI T
Sbjct: 161 -GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTAT 213
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGIL 479
+ APE +D+++ G+L
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 48/230 (20%), Positives = 88/230 (38%), Gaps = 58/230 (25%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--------ISEQGLNELKNEVILFS 337
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR--ELLDW----------- 384
+++H N++K+ + N+ + ++ +L +
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 385 -SKRFH-IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
S F ++ YL IIHRD+K N+++ D K+ DFG A +
Sbjct: 132 ASYIFRQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 443 IEGSTNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSG 486
+ GT Y APE Y G + +++S G+ + +V
Sbjct: 185 L---FYTFCGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFE 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLVKLLGCC 351
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 352 IQGEEKL-LIYEFMPNKSL-DYFIFDQTKRELLDWSKRF--HIICGTARGLLYLHQDSRL 407
+ L E+ L D D E ++RF ++ G YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMAGVV----YLH---GI 124
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE------Y 461
I HRD+K N+LLD N KISDFGLA F + E NK+ GT Y+APE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSG 486
DV+S GI++ +++G
Sbjct: 185 --HAE---PVDVWSCGIVLTAMLAG 204
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 38/213 (17%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDW--SKRFH---------- 389
RN++ L EE ++I+EF+ + ++ + + F
Sbjct: 61 RNILHLHESFESMEELVMIFEFI------------SGLDIFERINTSAFELNEREIVSYV 108
Query: 390 -IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGS 446
+C L +LH I H D++ N++ + KI +FG AR +
Sbjct: 109 HQVCE---ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ Y APE + S +D++S G L
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ 340
+ +++ N +G G +G V A K++ K + ++ K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRF------HI 390
H N+++L YE + + Y + + T EL + + F I
Sbjct: 65 HPNIIRL-------------YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 111
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGST 447
+ + Y H+ L + HRDLK N L D K+ DFGLA F ++
Sbjct: 112 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---M 165
Query: 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGI 478
+GT Y++P+ +GL+ + D +S G+
Sbjct: 166 RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 29/189 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
+DN+ + +LG+G F V + G E A K ++ +S + +L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 342 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDYFIFDQ-TKRELL---DWSKRFHIICGT 394
N+V+L +E+ Y + + L F+ RE D S I
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE- 116
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
+ Y H I+HR+LK N+LL K++DFGLA E +
Sbjct: 117 --SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA 168
Query: 452 GTYGYMAPE 460
GT GY++PE
Sbjct: 169 GTPGYLSPE 177
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 33/221 (14%)
Query: 257 RRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAV 315
+ + + Q E L + A + + +G G V + G E AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 316 KRLSK--------ISEQGLNELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 363
K + E+ + E IL H +++ L+ E ++ +
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMFLVFDL 181
Query: 364 MPNKSLDYFIFDQ-TKRELL---DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419
M L FD T++ L + + + +LH I+HRDLK N+
Sbjct: 182 MRKGEL----FDYLTEKVALSEKETRSIMRSLLE---AVSFLHA---NNIVHRDLKPENI 231
Query: 420 LLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LLD +M ++SDFG + E ++ GT GY+APE
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKI-SEQGLNELKNEVILFSKL 339
D F KLG G FG V+ G E +K ++K S+ + +++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 340 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSL-DYFIFDQTKRELL---DWSKRFHIIC 392
H N++K+ E+ +Y E L + + Q + + L ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNK 449
L Y H ++H+DLK N+L KI DFGLA F DE +
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STN 185
Query: 450 VIGTYGYMAPEYATDGLFSVKSDVFSFGI 478
GT YMAPE + K D++S G+
Sbjct: 186 AAGTALYMAPE-VFKRDVTFKCDIWSAGV 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 64/236 (27%)
Query: 286 DNFSINNKLGEGGFGRVYKG--TLVDGQEIAVKRLSKISEQG------------LNELKN 331
+ ++GEG +G+V+K G+ +A+KR+ + + L L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 332 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSK 386
+H N+V+L E KL L++E + DQ LD
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVP 113
Query: 387 RFHIICGTA--------RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
+ T RGL +LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 439 GGDEIEGS-TNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
+ + T+ V+ T Y APE YAT V D++S G + E+ K
Sbjct: 171 S---FQMALTSVVV-TLWYRAPEVLLQSSYAT----PV--DLWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/197 (32%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLVKLLGCC 351
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 352 IQGEEKL-LIYEFMPNKSL-DYFIFDQTKRELLDWSKRF--HIICGTARGLLYLHQDSRL 407
+ L E+ L D D E ++RF ++ G YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRFFHQLMAGVV----YLH---GI 124
Query: 408 RIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE------Y 461
I HRD+K N+LLD N KISDFGLA F + E NK+ GT Y+APE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 462 ATDGLFSVKSDVFSFGI 478
DV+S GI
Sbjct: 185 --HAE---PVDVWSCGI 196
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELKNEVI 334
+ D++ + +LG G F V K G+E A K + K E++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHI 390
+ +++H N++ L + +LI E + L FD ++E L + ++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQ 116
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFGGDEIEGS 446
I G+ YLH RI H DLK N++L P K+ DFG+A
Sbjct: 117 ILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ GT ++APE +++D++S G++
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--------ISEQGLNELKNEVIL 335
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHII 391
KL H ++K+ E+ ++ E M L FD+ + L F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTN 448
+ YLH IIHRDLK NVLL + D KI+DFG ++ G +
Sbjct: 124 LL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MR 174
Query: 449 KVIGTYGYMAPE 460
+ GT Y+APE
Sbjct: 175 TLCGTPTYLAPE 186
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 59/221 (26%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQHRNLVKLLG 349
LGEG FG+V T Q++A+K +S+ + + ++ ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDW------------SKRFH-IICGTAR 396
Y+ + + + + EL D+ + F IIC
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE----GSTNKVIG 452
Y H R +I+HRDLK N+LLD ++N KI+DFGL+ GS N
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---- 172
Query: 453 TYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y APE Y G + DV+S GI++ ++ G+
Sbjct: 173 ---YAAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 66/240 (27%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG---------------LN 327
AT + ++G G +G VYK G +A+K + + G L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 328 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELL 382
L+ +H N+V+L+ E K+ L++E + DQ R L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYL 109
Query: 383 DWSKRFHIICGTA--------RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
D + + T RGL +LH + I+HRDLK N+L+ K++DFGL
Sbjct: 110 DKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 435 ARTFGGDEIEGS-TNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
AR + + + T V+ T Y APE YAT V D++S G + E+ K
Sbjct: 167 ARIYS---YQMALTPVVV-TLWYRAPEVLLQSTYAT----PV--DMWSVGCIFAEMFRRK 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 52/191 (27%), Positives = 77/191 (40%), Gaps = 28/191 (14%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE---------LKNEV- 333
+N+ LG G V + +E AVK + + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 334 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFH 389
IL H N+++L L+++ M L FD T++ L + K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 390 IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK 449
+ + LH+ L I+HRDLK N+LLD DMN K++DFG + E +
Sbjct: 132 ALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 182
Query: 450 VIGTYGYMAPE 460
V GT Y+APE
Sbjct: 183 VCGTPSYLAPE 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/252 (19%), Positives = 84/252 (33%), Gaps = 52/252 (20%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK-----RLSKISEQGLNELKNEVILFSK 338
+ + +G+G +G V A+K ++ +I+ + + +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRF---------- 388
L H N+ +L + L+ E L + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 389 ---------------------------HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421
+I+ L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 422 --DHDMNPKISDFGLARTFGGDEIEGST--NKVIGTYGYMAPE--YATDGLFSVKSDVFS 475
+ K+ DFGL++ F GT ++APE T+ + K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 476 FGILVLEIVSGK 487
G+L+ ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 27/211 (12%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK-----RLSKISEQGLNELKNEVILFSK 338
D + + +G+G F V + GQ+ AVK + + +LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRF------HII 391
L+H ++V+LL +++EFM L + KR D + H +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRA--DAGFVYSEAVASHYM 136
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTN 448
L Y H IIHRD+K VLL ++ K+ FG+A G +
Sbjct: 137 RQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG- 192
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+GT +MAPE + DV+ G++
Sbjct: 193 -RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 49/203 (24%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQ------GLNELKNEVILFSK 338
+ K+G+G FG V+K GQ++A+K++ +E+ L E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 339 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN--KSL-----DYFIFDQTK---RE 380
L+H N+V L+ C L+++F + L F + K +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440
LL GL Y+H++ +I+HRD+K +NVL+ D K++DFGLAR F
Sbjct: 133 LL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 441 DEIEGS---TNKVIGTYGYMAPE 460
+ TN+V+ T Y PE
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPE 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 60/222 (27%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNE-LKNEVILFSKLQHRNLVKLLG 349
LG G FG+V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDW------------SKRFH-IICGTA 395
Y+ + + + + + EL D+ + F I+
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE----GSTNKVI 451
Y H R ++HRDLK NVLLD MN KI+DFGL+ E GS N
Sbjct: 126 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--- 175
Query: 452 GTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y APE Y G + D++S G+++ ++ G
Sbjct: 176 ----YAAPEVISGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
D+F I +G+G FG+V D +++ A+K ++K + + + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
LV L Q EE + ++ + + L Y + Q + + + I C L Y
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFI-CELVMALDY 130
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L RIIHRD+K N+LLD + I+DF +A + + GT YMAPE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPE 184
Query: 461 --YATDGL---FSVKSDVFSFGILVLEIVSGKR 488
+ G F+V D +S G+ E++ G+R
Sbjct: 185 MFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 30/191 (15%)
Query: 290 INNKLGEGGFGRVYKG---TLVDGQEIAVKRLSKISEQGLN-ELKNEVILFSKLQHRNLV 345
K+G G +G VYK D ++ A+K +I G++ E+ L +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALK---QIEGTGISMSACREIALLRELKHPNVI 81
Query: 346 KLLGCCIQ-GEEKL-LIYEFMPN---KSLDYFIFDQTKRELLDWS----KRF-HIICGTA 395
L + + K+ L++++ + + + + ++ + K + I
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL--- 138
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFG--GDEIEGSTNK 449
G+ YLH + ++HRDLK +N+L+ + KI+D G AR F +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 450 VIGTYGYMAPE 460
V+ T+ Y APE
Sbjct: 196 VV-TFWYRAPE 205
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELKNEVI 334
D + I +LG G F V K G E A K + K E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHI 390
+ ++ H N++ L + +LI E + L FD ++E L + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFGGDEIEGS 446
I G+ YLH +I H DLK N++L P K+ DFGLA
Sbjct: 124 ILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ GT ++APE +++D++S G++
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 25/187 (13%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH 341
+DN+ + +LG+G F V + G E A K ++ +S + +L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHIICGTAR 396
N+V+L IQ E L+++ + L F+ RE D S I
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE--- 139
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
+ Y H I+HR+LK N+LL K++DFGLA E + GT
Sbjct: 140 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
Query: 454 YGYMAPE 460
GY++PE
Sbjct: 194 PGYLSPE 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 30/192 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--------ISEQGLNELKNEVIL 335
D + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHII 391
KL H ++K+ E+ ++ E M L FD+ + L F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTN 448
+ YLH+ IIHRDLK NVLL + D KI+DFG ++ G +
Sbjct: 249 LL---AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MR 299
Query: 449 KVIGTYGYMAPE 460
+ GT Y+APE
Sbjct: 300 TLCGTPTYLAPE 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 282 ANATDNFSINNK--LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSK 338
++++ LG G FG+V+K G ++A K + + E+KNE+ + ++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR-----FHIICG 393
L H NL++L + +L+ E++ L FD+ E + ++ IC
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICE 198
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGSTNKVI 451
G+ ++HQ + I+H DLK N+L + KI DFGLAR + E
Sbjct: 199 ---GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNF 249
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGIL 479
GT ++APE S +D++S G++
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
+++ +G G FG VY+ L D G+ +A+K++ + EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 344 LVKLLGCCIQGEEKL------LIYEFMP---NKSLDYFIFDQTKRELLDWSKRFHI--IC 392
+V+L EK L+ +++P + ++ + K+ L + ++ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLF 166
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEIEGSTNKVI 451
R L Y+H I HRD+K N+LLD D K+ DFG A+ E + + +
Sbjct: 167 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC 218
Query: 452 GTYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSGK 487
Y Y APE ATD ++ DV+S G ++ E++ G+
Sbjct: 219 SRY-YRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQ 254
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 282 ANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLN------ELKNEVI 334
D + I +LG G F V K G E A K + K + E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHI 390
+ ++ H N++ L + +LI E + L FD ++E L + +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFGGDEIEGS 446
I G+ YLH +I H DLK N++L P K+ DFGLA
Sbjct: 124 ILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ GT ++APE +++D++S G++
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 36/191 (18%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
TD + + +G G + + E AVK + K E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDW---SKRF------HIICG 393
++ L +Y+ + Y + + K ELLD K F ++
Sbjct: 78 IITLKD----------VYD---DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLL-DHDMNP---KISDFGLARTFGGDEIEGSTNK 449
+ + YLH ++HRDLK SN+L D NP +I DFG A+ + G
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMT 179
Query: 450 VIGTYGYMAPE 460
T ++APE
Sbjct: 180 PCYTANFVAPE 190
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELKNEVIL 335
N D + +LG G F V K G + A K + K +++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHII 391
++QH N++ L + +LI E + L FD ++E L + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQI 123
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFGGDEIEGST 447
G+ YLH L+I H DLK N++L P KI DFGLA
Sbjct: 124 LN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ GT ++APE +++D++S G++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 35/208 (16%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
+D F + ++LG G VY+ + A+K L K ++ ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRF------HIICG 393
++KL I+E + + + T EL D + +
Sbjct: 110 IIKLKE----------IFE---TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKV 450
+ YLH+ I+HRDLK N+L D KI+DFGL++ + V
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTV 210
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGI 478
GT GY APE + + D++S GI
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 34/198 (17%)
Query: 279 ATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVIL 335
T T+ + + +LG+G F V + ++ GQE A ++ +S + +L+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELLDW---SKRF--- 388
L+H N+V+L + Y IFD T EL + + +
Sbjct: 64 CRLLKHPNIVRLHD----------SIS---EEGHHYLIFDLVTGGELFEDIVAREYYSEA 110
Query: 389 ---HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDE 442
H I +L+ HQ + ++HR+LK N+LL K++DFGLA G+
Sbjct: 111 DASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166
Query: 443 IEGSTNKVIGTYGYMAPE 460
+ + GT GY++PE
Sbjct: 167 -QQAWFGFAGTPGYLSPE 183
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 50/228 (21%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELKNEVILFSK 338
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 339 LQHR--NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFD--QTKRELLDW---------- 384
+ +++L ++ I + + ++L D+
Sbjct: 103 VSSGFSGVIRL-------------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 149
Query: 385 -SKRF--HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGG 440
++ F ++ + + H ++HRD+K N+L+D + K+ DFG
Sbjct: 150 LARSFFWQVLEA----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
Query: 441 DEIEGSTNKVIGTYGYMAPEYATDGLFS-VKSDVFSFGILVLEIVSGK 487
GT Y PE+ + + V+S GIL+ ++V G
Sbjct: 203 TVYTDFD----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKR-----LSKISEQGLNELKNEVILF 336
D F + G+G FG V G G +A+K+ + E L ++
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQ----DL 73
Query: 337 SKLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLDYFIFDQTKRELLDWSK 386
+ L H N+V+L GE ++ E++P ++ + + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILI 131
Query: 387 RFHI--ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTFGGDEI 443
+ + + R + LH S + + HRD+K NVL++ K+ DFG A+ E
Sbjct: 132 KVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 444 EGSTNKVIGTYGYMAPEY---ATDGLFSVKSDVFSFGILVLEIVSGK 487
+ + Y Y APE ++ D++S G + E++ G+
Sbjct: 188 --NVAYICSRY-YRAPELIFGNQH--YTTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 285 TDNFSINNK-LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-H 341
D + + LGEG RV L+ QE AVK + K + + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-TKRELL---DWSKRFHIICGTARG 397
RN+++L+ + + L++E M S+ KR + S +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVAS---A 123
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTF--GGDEIEGSTNK--- 449
L +LH I HRDLK N+L + KI DF L GD ST +
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 450 VIGTYGYMAPE 460
G+ YMAPE
Sbjct: 181 PCGSAEYMAPE 191
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 44/229 (19%), Positives = 87/229 (37%), Gaps = 52/229 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK------ISEQGLNELKNEV----I 334
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR--ELLDW-------- 384
+ + H +++L ++ + + ++ +L D+
Sbjct: 91 VGAGGGHPGVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 385 ---SKRF--HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP-KISDFGLARTF 438
S+ F ++ + + H ++HRD+K N+L+D K+ DFG
Sbjct: 138 EGPSRCFFGQVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFS-VKSDVFSFGILVLEIVSG 486
+ GT Y PE+ + + + + V+S GIL+ ++V G
Sbjct: 191 HDEPYTDFD----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 24/247 (9%)
Query: 249 VPTSDLGYRRRVDQENQDQIEDLELPLFELATIANAT-DNFSINNKLGEGGFGRVYKGTL 307
+ G + +E + ++ L +E + A D F LG G FGRV
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 308 VDGQEI-AVKRLSKISEQGLNEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYE 362
+ A+K L K L ++ NE + + LVKL + L ++ E
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVME 121
Query: 363 FMPNKSLDYFIFDQTKRELLDWSKRF---HIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419
++ + F + + RF I+ YLH L +I+RDLK N+
Sbjct: 122 YVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 420 LLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
L+D +++DFG A+ ++G T + GT +APE ++ D ++ G+L
Sbjct: 173 LIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 480 VLEIVSG 486
+ E+ +G
Sbjct: 228 IYEMAAG 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 60/222 (27%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLG 349
LG G FG+V G + G ++AVK L++ S + +++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKR-ELLDW------------SKRFH-IICGTA 395
Y+ + S + + + EL D+ + F I+ G
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE----GSTNKVI 451
Y H R ++HRDLK NVLLD MN KI+DFGL+ E GS N
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--- 180
Query: 452 GTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSGK 487
Y APE Y G + D++S G+++ ++ G
Sbjct: 181 ----YAAPEVISGRLY--AGP---EVDIWSSGVILYALLCGT 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 262 QENQDQIEDLELPLFELATIANATDNFSINNK-LGEGGFGRVYKGT-LVDGQEIAVKRLS 319
+ DL ++ N + + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 320 K--ISEQGLNELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ 376
K + E+ +E+ + + ++ L E +LI E+ + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL 119
Query: 377 -TKRELLDWSKR-----FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNP 427
S+ I G+ YLHQ I+H DLK N+LL +
Sbjct: 120 CLPELAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173
Query: 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
KI DFG++R G +++GT Y+APE + +D+++ GI+
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 41/214 (19%)
Query: 285 TDNFSINNK-LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV-ILFSKLQH 341
TD++ ++ + LG G G+V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGG 81
Query: 342 RNLVKLLGCCIQGEEKLLIYE-FMPNKSLDYFIFDQ-TKRELLD-----WSKRF------ 388
++V +L +YE K I + EL + F
Sbjct: 82 PHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEG 445
I+ + +LH I HRD+K N+L + D K++DFG A+ +
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QN 184
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGIL 479
+ T Y+APE + D++S G++
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNEL---KNEVILFSKLQH 341
+F I LG G FGRV+ A+K L K L ++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH----------I 390
++++ G Q +++ +I +++ L F ++ +RF +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----FSLLRKS-----QRFPNPVAKFYAAEV 115
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
L YLH II+RDLK N+LLD + + KI+DFG A+ + T +
Sbjct: 116 CLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163
Query: 451 IGTYGYMAPE------YATDGLFSVKSDVFSFGILVLEIVSG 486
GT Y+APE Y S+ D +SFGIL+ E+++G
Sbjct: 164 CGTPDYIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAG 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 49/201 (24%), Positives = 76/201 (37%), Gaps = 34/201 (16%)
Query: 293 KLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGC 350
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLD--WSKRF-------HIICGTARGLLYL 401
L+ E + EL + K+ +I+ + ++
Sbjct: 75 FHDQLHTFLVMELL------------NGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 402 HQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
H + ++HRDLK N+L + ++ KI DFG AR D T T Y A
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAA 177
Query: 459 PEYATDGLFSVKSDVFSFGIL 479
PE + D++S G++
Sbjct: 178 PELLNQNGYDESCDLWSLGVI 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 54/209 (25%)
Query: 294 LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRNLVKLLGCC 351
+G G FG + + +AVK + + ++E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 352 IQGEEKLLIYEFMPNKSLDYFI---------FD---QTKRELLDWSKRF--HIICGTARG 397
E + + I ++ R D ++ F ++ G +
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS-- 130
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHD--MNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
Y H ++I HRDLK N LLD KI DFG +++ ST +GT
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 182
Query: 456 YMAPE------YATDGLFSVKSDVFSFGI 478
Y+APE Y DG +DV+S G+
Sbjct: 183 YIAPEVLLRQEY--DGK---IADVWSCGV 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 286 DNFSINNKLGEGGFGRVY---KGTLVDGQEI-AVKRLSK--ISEQGLNELKNEVILFSKL 339
F + LG+G FG+V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 340 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH--------- 389
H +VKL Q E KL LI +F+ L F + +E F
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKE-----VMFTEEDVKFYLA 133
Query: 390 -IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448
+ L +LH L II+RDLK N+LLD + + K++DFGL++ E
Sbjct: 134 ELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAY 184
Query: 449 KVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT YMAPE + +D +SFG+L+ E+++G
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
+ F LG+G FG+V A+K L K +++ + E + +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
L L Q ++L + E+ L + + +R + RF+ L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDY 263
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH S +++RDLK N++LD D + KI+DFGL + D + GT Y+APE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 319
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGK 487
D + D + G+++ E++ G+
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ- 340
D++ + KLG G + V++ + + +++ VK L + ++ ++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRG 89
Query: 341 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTAR 396
N++ L + L++E + N + L D+ RF++ I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---K 141
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
L Y H S I+HRD+K NV++DH+ ++ D+GLA + +V Y
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY- 195
Query: 456 YMAPE-------YATDGLFSVKSDVFSFGILVLEIVSGKR 488
+ PE Y S+ D++S G ++ ++ K
Sbjct: 196 FKGPELLVDYQMYDY----SL--DMWSLGCMLASMIFRKE 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 40/195 (20%), Positives = 74/195 (37%), Gaps = 40/195 (20%)
Query: 285 TDNFSINNK-LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEV-ILFSKLQH 341
D++ + ++ LG G G+V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQC 114
Query: 342 RNLVKLLGCCIQGEEKLLIYE-FMPNKSLDYFIFDQ-TKRELLD-----WSKRF------ 388
++V+++ +YE + + + EL + F
Sbjct: 115 PHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFGGDEIEG 445
I+ + YLH + I HRD+K N+L + K++DFG A+
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 218
Query: 446 STNKVIGTYGYMAPE 460
S T Y+APE
Sbjct: 219 SLTTPCYTPYYVAPE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 14/207 (6%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F LG+G FG+V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
L L Q ++L + E+ L + + +R + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEY 120
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH +++RD+K N++LD D + KI+DFGL + D + GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 175
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGK 487
D + D + G+++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNEL---KNEVILFSKLQH 341
++F I +G G FG V L + ++ A+K L+K E + E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARG 397
+ + L Q + L L+ ++ L + R + + RF+ ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA---- 187
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
+ +HQ L +HRD+K N+L+D + + +++DFG D ++ +GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYI 243
Query: 458 APE-----YATDGLFSVKSDVFSFGILVLEIVSG 486
+PE G + + D +S G+ + E++ G
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNE-VILFSKLQ 340
+F + +G G + +V L I A+K + K ++ ++ ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTAR 396
H LV L C Q E +L + E++ L + + Q +R+L + RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--- 122
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
L YLH+ II+RDLK NVLLD + + K++D+G+ + +T+ GT Y
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNY 176
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+APE + D ++ G+L+ E+++G+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 286 DNFSINNKLGEGGFGRVY----KGTLVDGQEIAVKRLSKISEQGLNEL---KNEVILFSK 338
D+F I +G G F V K T GQ A+K ++K E+ + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 339 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGT 394
R + +L Q E L L+ E+ L + +R + + RF+ I+
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA- 174
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
+ +H+ L +HRD+K N+LLD + +++DFG D + +GT
Sbjct: 175 ---IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTP 227
Query: 455 GYMAPE-------YATDGLFSVKSDVFSFGILVLEIVSG 486
Y++PE G + + D ++ G+ E+ G
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 43/136 (31%), Positives = 62/136 (45%), Gaps = 9/136 (6%)
Query: 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRI 409
EEK L D + T L+ +S + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSV 469
IHRDL N+LL KI DFGLAR D +MAPE D ++++
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 470 KSDVFSFGILVLEIVS 485
+SDV+SFG+L+ EI S
Sbjct: 275 QSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 35/162 (21%), Positives = 60/162 (37%), Gaps = 19/162 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRL-SKISEQGLNELKNEVILFSK 338
D + LG G FG+V + + +AVK L + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 339 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
+ H N+V LLG C + G ++I EF +L ++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK--ISEQGLNELKNEV--------I 334
+F +G+G FG+V + AVK L K I + K E +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK------KKEEKHIMSERNV 91
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HI 390
L ++H LV L Q +KL + +++ L Y + Q +R L+ RF I
Sbjct: 92 LLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEI 148
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
L YLH L I++RDLK N+LLD + ++DFGL + E +T+
Sbjct: 149 ASA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTF 199
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT Y+APE + D + G ++ E++ G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK--ISEQGLNELKNEV--------I 334
++F ++ LG+G FG+V+ + A+K L K + ++V +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------DDDVECTMVEKRV 70
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG 393
L +H L + C Q +E L + E++ L Y I Q+ + F+
Sbjct: 71 LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAE- 126
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
GL +LH I++RDLK N+LLD D + KI+DFG+ + + TN GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGT 181
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSG 486
Y+APE ++ D +SFG+L+ E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 286 DNFSINNKLGEGGFGRVY---KGTLVDGQEI-AVKRLSKIS-EQGLNEL---KNEVILFS 337
+ F + LG+GG+G+V+ K T + +I A+K L K + + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 338 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRF---HIICG 393
+++H +V L+ Q KL LI E++ L + + + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMA 133
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
L +LHQ II+RDLK N++L+H + K++DFGL + D T+ GT
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGT 184
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
YMAPE + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 23/192 (11%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
D + I + +G G +G V + ++ + +A+K++ ++ E L E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 338 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC 392
+L H ++VK+L I + + ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G+ Y+H S I+HRDLK +N L++ D + K+ DFGLART E S +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 453 TYGYMAPEYATD 464
M
Sbjct: 221 REDDMNLVTFPH 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK--ISEQGLNELKNEV--------I 334
DNF LG+G FG+V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG 393
L H L +L CC Q ++L + EF+ L + I Q R + RF+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAE- 132
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
L++LH II+RDLK NVLLDH+ + K++DFG+ + + +T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGT 187
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
Y+APE + L+ D ++ G+L+ E++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNE-VILFSKLQ 340
+F + +G G + +V L I A++ + K ++ ++ ++ E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTAR 396
H LV L C Q E +L + E++ L + + Q +R+L + RF+ I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA--- 165
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
L YLH+ II+RDLK NVLLD + + K++D+G+ + +T+ GT Y
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNY 219
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+APE + D ++ G+L+ E+++G+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 65/253 (25%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
++ +S+ LG G FG V + ++ G+ A+K++ + EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 342 RNLVKLLGCCIQGEEKL--------------------------------------LIYEF 363
N++KL+ ++ +I E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 364 MP---NKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLLYLHQDSRLRIIHRDLKTSN 418
+P +K L FI ++ R + +I + R + ++H L I HRD+K N
Sbjct: 120 VPDTLHKVLKSFI--RSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQN 171
Query: 419 VLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY---ATDGLFSVKSDVF 474
+L++ D K+ DFG A+ E S + + Y APE AT+ ++ D++
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLW 226
Query: 475 SFGILVLEIVSGK 487
S G + E++ GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK--ISEQGLNELKNEV--------I 334
+F+ LG+G FG+V E+ AVK L K + + ++V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRV 73
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---I 390
L + L +L C Q ++L + E++ L Y I Q + F+ I
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEI 130
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKV 450
G L +L II+RDLK NV+LD + + KI+DFG+ + D +T
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTF 181
Query: 451 IGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
GT Y+APE + D ++FG+L+ E+++G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSKISEQGLNEL---KNEVILFSKLQH 341
+++ + +G G FG V +++ A+K LSK ++ E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 342 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH---IICGTARG 397
+V+L Q + L ++ E+MP L W+ RF+ ++
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWA-RFYTAEVVLA---- 180
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
L +H + IHRD+K N+LLD + K++DFG + + + +GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYI 236
Query: 458 APE----YATDGLFSVKSDVFSFGILVLEIVSG 486
+PE DG + + D +S G+ + E++ G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 50/229 (21%)
Query: 286 DNFSINNKLGEGGFGRVY---KGTLVDGQEI-AVKRLSKIS--------EQGLNELKNEV 333
+NF + LG G +G+V+ K + D ++ A+K L K + E E +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE-RQ-- 110
Query: 334 ILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFH--- 389
+L Q LV L Q E KL LI +++ L F + +RF
Sbjct: 111 VLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQR-----ERFTEHE 160
Query: 390 -------IICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
I+ L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DE
Sbjct: 161 VQIYVGEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 443 IEGSTNKVIGTYGYMAPEYATDGL----FSVKSDVFSFGILVLEIVSGK 487
E GT YMAP+ G +V D +S G+L+ E+++G
Sbjct: 214 TER-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ +G G G V V + +A+K+LS+ + EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD-----YFIFD-------QTKRELLDWS 385
+ H+N++ LL F P K+L+ Y + + Q + LD
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 386 KRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445
+ +++ G+ +LH IIHRDLK SN+++ D KI DFGLART
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM 219
Query: 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T V+ T Y APE + D++S G ++ E+V K
Sbjct: 220 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 43/223 (19%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ +G G G V + + +A+K+LS+ + EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD-----YFIFD--QT------KRELLDW 384
+ H+N++ LL F P KSL+ Y + + + EL
Sbjct: 80 CVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
+ ++ G+ +LH IIHRDLK SN+++ D KI DFGLART
Sbjct: 128 RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSF 181
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T V+ T Y APE + D++S G ++ E++ G
Sbjct: 182 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEI-AVKRLSK---ISEQGLNELKNE-VILFSKLQ 340
+F+ LG+G FG+V E+ AVK L K I + + E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 341 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
L +L C Q ++L + E++ L Y I Q + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IAIGLF 456
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
+L II+RDLK NV+LD + + KI+DFG+ + D +T GT Y+AP
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAP 511
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGK 487
E + D ++FG+L+ E+++G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 51/224 (22%), Positives = 84/224 (37%), Gaps = 34/224 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK------ 338
+++ + G +G V G +G +A+KR+ G K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 339 -----LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRF 388
H N++ L + E + L+ E M L I DQ + + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQHIQY 138
Query: 389 HIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTN 448
+ GL LH+ ++HRDL N+LL + + I DF LAR D T+
Sbjct: 139 -FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTH 192
Query: 449 KVIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
V Y APE + K D++S G ++ E+ + K
Sbjct: 193 YVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ +G G +G V G+++A+K+LS+ + EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD-----YFIFD--QT------KRELLDW 384
+QH N++ LL F P SL Y + QT + +
Sbjct: 79 HMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE 126
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
++ ++ +GL Y+H ++HRDLK N+ ++ D KI DFGLAR +
Sbjct: 127 KIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179
Query: 445 GSTNKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGK 487
T V+ T Y APE + ++ D++S G ++ E+++GK
Sbjct: 180 -MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG-----LNELKNEVILFSK 338
++ + +GEG +G V ++ +A+K++S Q L E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 339 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG 393
+H N++ + E++ ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS--TNKVI 451
RGL Y+H S ++HRDLK SN+LL+ + KI DFGLAR D T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 452 GTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
T Y APE + + K D++S G ++ E++S +
Sbjct: 194 -TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 34/225 (15%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN---EVILFSKLQ 340
+ LG GG G V+ + +A+K KI +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD-YFIFD--QT-------KRELLDWSKRFHI 390
H N+VK+ +L + Y + + +T + LL+ R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-F 125
Query: 391 ICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGS--T 447
+ RGL Y+H + ++HRDLK +N+ ++ D+ KI DFGLAR +
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 448 NKVIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
++ T Y +P L S + D+++ G + E+++GK
Sbjct: 183 EGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 23/193 (11%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
DN+ I + +G G +G VY + +A+K+++++ E L E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 338 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC 392
+L+ +++L I K ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G ++H IIHRDLK +N LL+ D + K+ DFGLART ++ N +
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 453 TYGYMAPEYATDG 465
Sbjct: 194 NEEPGPHNKNLKK 206
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 42/183 (22%)
Query: 274 PLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNE 332
++ A D + LG G G+V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 333 V-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFI----------FDQ-TKRE 380
V + + Q ++V+++ +YE + I F + R
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 381 LLDWSKR-----FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDF 432
+++R I + YLH + I HRD+K N+L + K++DF
Sbjct: 111 DQAFTEREASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 433 GLA 435
G A
Sbjct: 165 GFA 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ + + +G G +G V G +AVK+LS+ + EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 338 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHII 391
++H N++ LL + + L+ M L+ + Q +L D +F +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQ---KLTDDHVQF-LI 138
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR + T V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVA 191
Query: 452 GTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGK 487
T Y APE ++ D++S G ++ E+++G+
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ +G G +G V G ++A+K+L + + EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD-----YFIFD--QT------KRELLDW 384
++H N++ LL F P+++LD Y + T K E L
Sbjct: 80 HMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 127
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444
+ ++ +GL Y+H IIHRDLK N+ ++ D KI DFGLAR +
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 181
Query: 445 GSTNKVIGTYGYMAPEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
T V+ T Y APE + + D++S G ++ E+++GK
Sbjct: 182 -MTGYVV-TRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG-----LNELKNEVILFSK 338
+ +F + + LGEG +G V T G+ +A+K++ + L E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 339 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICG 393
+H N++ + E +I E M L I Q L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQY-FIYQ 120
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
T R + LH + +IHRDLK SN+L++ + + K+ DFGLAR DE ++ G
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQ 175
Query: 454 YGYM----------APEYATDGLFSVKS-----DVFSFGILVLEIVSGK 487
M APE + + DV+S G ++ E+ +
Sbjct: 176 QSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 3e-14
Identities = 37/219 (16%), Positives = 63/219 (28%), Gaps = 57/219 (26%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLN--------ELKNEVIL 335
T+ K+GEG FG V++ D +A+K ++ +N E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 336 FSKLQ---------HRNLVKLLGCCI-------------------QGEEKLLIYEFMPNK 367
+L + L +G F ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 368 SLDYFIF-------DQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVL 420
F +Q + +L + I+ L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 421 LDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
L K+ ++ I + G
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 20/191 (10%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG------LNELKNEVILFS 337
+ + KLG+G +G V+K G+ +AVK++ + E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 338 KLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA 395
H N+V LL + L++++M L I L K++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQY-VVYQLI 119
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL+R+F + +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 456 YMAPEYATDGL 466
+ L
Sbjct: 177 TENFDDDQPIL 187
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 49/238 (20%), Positives = 87/238 (36%), Gaps = 68/238 (28%)
Query: 290 INNKLGEGGFGRVYKGT-LVDGQEIAVKRL---SKISEQGLNELK-------NEVILFSK 338
+ KLG G F V+ +V+ +A+K + +E +E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRE------------LLDWSK 386
+ +++KLL D+F LL K
Sbjct: 83 MGANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 387 RFH-------IICGTAR----GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP------KI 429
++ + ++ GL Y+H R IIH D+K NVL++ +P KI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+D G A + + I T Y +PE + +D++S L+ E+++G
Sbjct: 180 ADLGNA-CWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 21/200 (10%), Positives = 53/200 (26%), Gaps = 41/200 (20%)
Query: 293 KLGEGGFGRVYKGT-LVDGQEIAVKRL---SKISEQGLNELKNEVILFSKLQHRNLVKLL 348
G + ++ +++A+ + + + L E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 349 GCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLR 408
L++ E++ SL + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFS 468
+ S V + D G V+ M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA-------N 180
Query: 469 VKSDVFSFGILVLEIVSGKR 488
+ D+ G + ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RN 343
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLL-- 399
+ + C +G+ +++ E + SL+ +F+ R +F + + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSR-------KFSLKTVLLLADQMISR 117
Query: 400 --YLHQDSRLRIIHRDLKTSNVLLDHDMNPK---ISDFGLARTF----GGDEIEGSTNK- 449
Y+H + IHRD+K N L+ I DFGLA+ + I NK
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 450 VIGTYGYM 457
+ GT Y
Sbjct: 175 LTGTARYA 182
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 52/225 (23%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRL---SKISEQGLNELKNEVILFSKLQHR- 342
+ + +G+G FG+V K Q +A+K + + Q E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 343 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDYFIFDQTK---RELLDW 384
N++ +L C+ E LL +YE + F + +L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ- 211
Query: 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDE 442
L LH + RIIH DLK N+LL K+ DFG + +
Sbjct: 212 ------------CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR 255
Query: 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
+ I + Y APE + + D++S G ++ E+++G
Sbjct: 256 V----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK---RLSKISEQGLNELKNEVILFSKLQ 340
D + I++ +G+G FG+V K V+ + +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 341 HR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDYFIFDQTK---REL 381
+V L C+ E +L +Y+ + N + + T+ +++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 382 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFG 439
LL+L L IIH DLK N+LL + KI DFG +
Sbjct: 167 CT-------------ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQL 211
Query: 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
G I + I + Y +PE + + D++S G +++E+ +G+
Sbjct: 212 GQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 43/188 (22%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ F + K+G G FG +Y GT + +E+A+K + ++ +L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 345 V-KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLL-- 399
+ + ++G+ +L+ + + SL+ +F+ R + + + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSR-------KLSLKTVLMLADQMINR 115
Query: 400 --YLHQDSRLRIIHRDLKTSNVLLDHDMNPK---ISDFGLARTF----GGDEIEGSTNK- 449
++H S +HRD+K N L+ I DFGLA+ + I NK
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 450 VIGTYGYM 457
+ GT Y
Sbjct: 173 LTGTARYA 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RNL 344
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLL--- 399
++ G+ ++ E + SL+ +FD R F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDR-------TFSLKTVLMIAIQLISRM 118
Query: 400 -YLHQDSRLRIIHRDLKTSNVLLDHDMNPK-----ISDFGLARTF----GGDEIEGSTNK 449
Y+H + +I+RD+K N L+ N I DF LA+ + I +K
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 450 -VIGTYGYM 457
+ GT YM
Sbjct: 176 SLTGTARYM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 40/190 (21%), Positives = 85/190 (44%), Gaps = 32/190 (16%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RN 343
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHI--ICGTARGLL-- 399
+ + +G +L+ + + SL+ + D R +F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGR-------KFSVKTVAMAAKQMLAR 118
Query: 400 --YLHQDSRLRIIHRDLKTSNVLLDHDMNPK-----ISDFGLARTF----GGDEIEGSTN 448
+H+ S +++RD+K N L+ + + DFG+ + + I
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 449 K-VIGTYGYM 457
K + GT YM
Sbjct: 176 KNLSGTARYM 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 28/170 (16%), Positives = 67/170 (39%), Gaps = 22/170 (12%)
Query: 287 NFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 346 ----KLLGCCIQGEEKLLIYEFMPNKSLDY--FIFD---QTKRELLDWSKRFHI--ICGT 394
+ G K Y + + +++ + F +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 395 ARGLL----YLHQDSRLRIIHRDLKTSNVLLDHDMNPKI--SDFGLARTF 438
+L Y+H++ +H D+K +N+LL + ++ +D+GL+ +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 55/249 (22%), Positives = 90/249 (36%), Gaps = 82/249 (32%)
Query: 288 FSINNKLGEGGFGRVYKG--TLVDGQEIAVK---RLSKISEQGLNELKNEVILFSKLQHR 342
+ I + LGEG FG+V + G+ +AVK + + E +E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 343 ------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDYFIFDQTK---RELLD 383
V++L CI E LL Y+F+ F D + ++
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC- 128
Query: 384 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP---------------- 427
+ + +LH ++ H DLK N+L
Sbjct: 129 ------------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 428 ---KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE------YATDGLFSVKSDVFSFGI 478
K+ DFG A T+ + ST ++ T Y APE + S DV+S G
Sbjct: 174 PDIKVVDFGSA-TYDDEHH--ST--LVSTRHYRAPEVILALGW------SQPCDVWSIGC 222
Query: 479 LVLEIVSGK 487
+++E G
Sbjct: 223 ILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 50/246 (20%), Positives = 88/246 (35%), Gaps = 70/246 (28%)
Query: 285 TDNFSINNKLGEGGFGRVYKG--TLVDGQEIAVK---RLSKISEQGLNELKNEVILFSKL 339
+ + I LGEG FG+V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 340 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDYFIFDQTK---RE 380
+ + V + CI E LL +EF+ + + + +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 381 LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP------------- 427
L L +LH ++ H DLK N+L +
Sbjct: 132 LC-------------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 428 ------KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVL 481
+++DFG A TF + +T ++ T Y PE + ++ DV+S G ++
Sbjct: 176 VKNTSIRVADFGSA-TFDHEHH--TT--IVATRHYRPPEVILELGWAQPCDVWSIGCILF 230
Query: 482 EIVSGK 487
E G
Sbjct: 231 EYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 63/247 (25%), Positives = 96/247 (38%), Gaps = 74/247 (29%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVK---RLSKISEQGLNELKNEVILFSKLQHR- 342
F + K+G+G FGRV + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 343 ----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDYFIFDQTK---RELLDWS 385
N+VK G C+ E L +YE + + + F + K E+L
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL--- 147
Query: 386 KRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP------------------ 427
+ L YL ++ + H DLK N+LLD
Sbjct: 148 ----------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 428 -------KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILV 480
K+ DFG A TF D +I T Y APE + + V SD++SFG ++
Sbjct: 195 RTKSTGIKLIDFGCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 481 LEIVSGK 487
E+ +G
Sbjct: 250 AELYTGS 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 32/196 (16%), Positives = 67/196 (34%), Gaps = 28/196 (14%)
Query: 287 NFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KISEQGLNELKNEVILFSKLQHRNL 344
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 345 V----KLLGCCIQGEEKLLIYEFMPNKSLDYFI-----FDQTKRELLDW-SKRFHI--IC 392
+ + G K Y F +++ + +KRF +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 393 GTARGLL----YLHQDSRLRIIHRDLKTSNVLLDHDMNPKI--SDFGLARTF----GGDE 442
+ +L Y+H+ +H D+K SN+LL++ ++ D+GLA +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 443 IEGSTNKV-IGTYGYM 457
+ GT +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 32/202 (15%), Positives = 72/202 (35%), Gaps = 40/202 (19%)
Query: 287 NFSINNKLGEGGFGRVYKGT---------LVDGQEIAVKRLSKISEQGLNELK------- 330
+ + + G +Y+ Q+ ++K L + NE
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 331 -NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDYFIFDQTKRELL 382
+V + KL L+ +G + ++ Y F+ +SL D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI--SDFGLARTF-- 438
+ C L +LH++ +H ++ N+ +D + ++ + +G A +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 439 GGDEI---EGSTNKVIGTYGYM 457
G + EGS + G ++
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFI 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 8e-08
Identities = 63/418 (15%), Positives = 122/418 (29%), Gaps = 102/418 (24%)
Query: 228 DLIDIKECSEKYVWGQ---DFFIRVPTSDLGYRRRVD-----QENQDQ--IEDLELPLFE 277
D D+++ K + + D I + G R QE Q +E++ ++
Sbjct: 34 DCKDVQD-MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 278 --LATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIA---VKRLSKISE--QGLNELK 330
++ I S+ ++ R+Y D Q A V RL + Q L EL+
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELR 148
Query: 331 -------------------NEVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYE 362
+V L K+Q + K+ L C E L L+Y+
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD 422
PN + K + R LL ++ +++ +
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 423 HDMNPKI----SDFGLARTFGGDEIEGSTNKVI----GTYGYMAPEYATDGLFSVKSDVF 474
+++ KI + D + +T I + E L D
Sbjct: 262 FNLSCKILLTTRFKQVT-----DFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCR 314
Query: 475 SFGI---------LVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL---IDACY 522
+ L I+ + R + W+ W +L I++
Sbjct: 315 PQDLPREVLTTNPRRLSII-AESIRD--------GLAT--WDNWKHVNCDKLTTIIESSL 363
Query: 523 QESCNPDEVIRCIH-ISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCLVDRKS 579
P E + +S+ P ++ ++ D + + + + S
Sbjct: 364 -NVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 52/270 (19%), Positives = 92/270 (34%), Gaps = 80/270 (29%)
Query: 285 TDNFSINNKLGEGGFGRVYKG-TLVDGQEIAVK---RLSKISEQGLNELKNEVILFSKLQ 340
+ + KLG G F V+ + + +A+K +E L+E++ +L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR---LL-KSVR 91
Query: 341 --------HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDYFIFDQTKREL-LDWSKR 387
+V+LL I G +++E + L +I + L L K+
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL-------------------------- 421
II +GL YLH ++ RIIH D+K N+LL
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 422 -----------------------DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
+ KI+D G A + I T Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGKR 488
E ++ +D++S + E+ +G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.55 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.54 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 95.32 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.23 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 90.86 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 89.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 87.27 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 80.31 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=447.52 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=208.9
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||++++++.++...+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999864 478999999988777788899999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 360 IYEFMPNKSLDYFIFDQT------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
|||||++|+|.+++.... ....+++..++.|+.||++||.|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996543 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ..+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHH-
Confidence 9999999997755444444455789999999999999999999999999999999999 89999754432 222211
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..+... +.+......+.+|+.+||+.||++||||.||+++|+...
T Consensus 274 ---~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 ---TQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ---HHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 111111 122233456889999999999999999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=442.85 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=216.3
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||++++++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999864 378899999988777788899999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcC----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 360 IYEFMPNKSLDYFIFDQT----------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
|||||++|+|.++|.... ....+++..++.++.||++||.|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996542 2356999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+.. ..+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 99999987654443333445679999999999999999999999999999999999 89999764432 222211
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+... +.+......+.+|+.+||+.||++||||.+|++.|+..
T Consensus 244 -~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 -TQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112111 12223345688999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=438.52 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=213.8
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
..+++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||++++++.++...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677899999999999999862 4688999999753 3445678999999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 359 LIYEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
+|||||++|+|.++|.... ....+++..+++|+.||++||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996532 1346899999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHH
Q 007397 426 NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRH 504 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~ 504 (605)
++||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |..||...+.. ..+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHH
Confidence 999999999987654443344455789999999999999999999999999999999998 89999764432 22221
Q ss_pred HHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 505 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+... +.+..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus 260 ----i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ----IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122211 22333455688999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=431.07 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=203.1
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
+++++.++||+|+||+||+|++. ..||||+++. ......+.|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 57888999999999999999864 3699999864 345667889999999999999999999998764 568999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
|++|+|.+++.... ..+++..+..|+.||++||.|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999996543 45899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cccccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+.. ..+... ...+.....+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~---~~~~~~~p~~-- 259 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFM---VGRGYASPDL-- 259 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHH---HHTTCCCCCS--
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHH---HhcCCCCCCc--
Confidence 334456789999999999964 45899999999999999999999999754321 111111 1111111000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+..+...+.+|+.+||+.+|++||||.+|+++|+.+
T Consensus 260 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 ---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223445688999999999999999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=437.21 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=204.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999984 5999999999653 44566789999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++|+|.++|... +...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999653 3345789999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.......+||+.|||||++.+..|+.++||||||||||||++|++||...+.. ..+.... . +...
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~---~-~~~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKII---S-GSFP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH---H-TCCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHH---c-CCCC-------
Confidence 12234568999999999999999999999999999999999999999754322 2222211 1 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|||+.|+++.
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122234568899999999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=430.97 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=210.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||+|++. +++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999984 5899999999753 2345678999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999643 45899999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.........+||+.|||||++.+..|+.++|||||||+||||++|++||...+.. ..+..... ... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~----~~~-~----- 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKIIK----LEY-D----- 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH----TCC-C-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc----CCC-C-----
Confidence 4444456678999999999999999999999999999999999999999754322 22222211 111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 556 (605)
.+.....++.+|+.+||+.||++|||+.|++
T Consensus 253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112234578999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=435.13 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=210.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999985 5999999999765555566788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++|+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999998854 34899999999999999999999999 9999999999999999999999999998775432
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+||+.|||||++.+..|+.++||||||||||||++|++||...+. ...+..... .....+
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~----~~~~~~------ 290 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRD----NLPPRL------ 290 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH----SSCCCC------
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHc----CCCCCC------
Confidence 223457899999999999999999999999999999999999999975432 222222211 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+|+.+||+.||++|||+.|++++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112233568899999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=429.66 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=206.5
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+.|++.++||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.++...||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888999999999999999984 489999999975321 246999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCCCcc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGGDEI 443 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~~~~ 443 (605)
++|+|.+++... +.+++..+..++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999643 35899999999999999999999998 99999999999999998 699999999998754322
Q ss_pred cc---cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 444 EG---STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 444 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|++||...+.......+.. .....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~~~----- 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPPPI----- 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCCGG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCCCc-----
Confidence 21 22346799999999999999999999999999999999999999987665554433321 11100
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...++.....+.+|+.+||+.||++|||+.||++.|..
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01222334568899999999999999999999988744
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=436.18 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=210.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++..++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999985 5999999999765555667789999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
|++|+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999998853 24899999999999999999999999 9999999999999999999999999998775432
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+||+.|||||++.+..|+.++|||||||++|||++|++||...+. ...+.... ......+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~----~~~~~~~------ 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----DNLPPRL------ 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSCCCCC------
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH----cCCCCCC------
Confidence 223457899999999999999999999999999999999999999975432 22222221 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+|+.+||+.||++|||+.|++++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111223468899999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=412.05 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=191.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||+||+|++. +|+.||||++.+. .......+.+|+.++++++|||||++++++.+.+..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999984 5999999999753 234456789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 67888888543 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. .....+||+.|+|||++.+..| +.++|||||||++|||++|+.||...+. ........ .+.. .
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~----~~~~-~--- 230 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNIS----NGVY-T--- 230 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HTCC-C---
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----cCCC-C---
Confidence 32 2345789999999999998876 5799999999999999999999975332 12222211 1111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+......+.+|+.+||+.||++|||+.|++++
T Consensus 231 ------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 ------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111123467899999999999999999999884
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=429.75 Aligned_cols=268 Identities=26% Similarity=0.409 Sum_probs=217.5
Q ss_pred cHHHHHHHhcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCC-Cceeeee
Q 007397 277 ELATIANATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQH-RNLVKLL 348 (605)
Q Consensus 277 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~ 348 (605)
+..+.+...++|++.++||+|+||+||+|++.. ++.||||++... .....+.+.+|+.+|+++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344444556889999999999999999998643 368999999764 34456789999999999975 8999999
Q ss_pred eeEEeC-CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 007397 349 GCCIQG-EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 414 (605)
Q Consensus 349 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDl 414 (605)
++|.+. ...++|||||++|+|.++|..... ...+++..++.++.||++||.|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 568999999999999999975432 346899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 007397 415 KTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLY 493 (605)
Q Consensus 415 kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 493 (605)
||+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998755444344556789999999999999999999999999999999998 99999765
Q ss_pred CCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 494 NSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 494 ~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+. ... .+..+... ..+.....++.+|+.+||+.||++||||.+|+++|+..
T Consensus 292 ~~~~~--~~~----~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE--FCR----RLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH--HHH----HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH--HHH----HHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 43221 111 11122111 11222345688999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=414.30 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=199.0
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeEEE
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 360 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 360 (605)
|++.++||+|+||+||+|.+. .++.||+|++.+ ......+.+.+|+.++++++|||||++++++.. +...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999985 489999999864 244556789999999999999999999999865 3557999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~ 439 (605)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ .+|+||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999653 45899999999999999999999875 35999999999999984 7999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|++||..... ..... .....+.....
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~----~~i~~~~~~~~-- 250 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPAS-- 250 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCGG--
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHH----HHHHcCCCCCC--
Confidence 32 2345789999999999875 699999999999999999999999964322 11111 11112211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+ .++.+|+.+||+.||++|||+.|++++
T Consensus 251 --~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 --FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222 357889999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=411.51 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=200.4
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----eeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 361 (605)
++|.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+.+++|||||++++++.++. ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688889999999999999988 689999999975332 2223345677778899999999999998754 579999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
||+++|+|.+++... .+++..+.+++.|+++||+|||++. ..+|+||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999543 4899999999999999999999871 2249999999999999999999999999998
Q ss_pred cCCCCcc--cccccccccccCccchhcccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch--------h
Q 007397 437 TFGGDEI--EGSTNKVIGTYGYMAPEYATDG------LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF--------N 500 (605)
Q Consensus 437 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~ 500 (605)
....... .......+||+.|||||++.+. .++.++||||||||||||+||.+|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7643321 1223346799999999999764 4788999999999999999998877543321110 0
Q ss_pred HHHHHHHhhhcCCCccccccccc-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQ-ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.............. ++.+. ...+.+....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111111111 11111 112335667788999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=417.59 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=197.8
Q ss_pred cCccccceecccCeEEEEEEEEc----CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|+++++||+|+||+||+|++. .++.||||++.+. .......+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999873 3689999999753 22234467889999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......+||+.|||||++.+..|+.++|||||||+||||++|++||...+..+ .+..... ...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~----~~~----- 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILK----AKL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CCC-----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHc----CCC-----
Confidence 322 22345789999999999999999999999999999999999999997544322 2222111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM-----PSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 558 (605)
..+.....++.+|+.+||+.||++|||+ +|++++
T Consensus 244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1111223467899999999999999984 677753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=404.36 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=192.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC--------
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 355 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 355 (605)
++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45999999999999999999984 5899999999753 3445577899999999999999999999987644
Q ss_pred ----eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 356 ----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 356 ----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
..|+||||+++|+|.+++.........++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976655555677888999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCcccc----------cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 007397 432 FGLARTFGGDEIEG----------STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV 501 (605)
Q Consensus 432 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 501 (605)
||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.. ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 99998875432211 1234579999999999999999999999999999999996 5532 1111
Q ss_pred HHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 502 i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ........... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 11111111111 11223456789999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=408.13 Aligned_cols=267 Identities=20% Similarity=0.300 Sum_probs=203.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe------CC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ------GE 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 355 (605)
.++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999984 5999999999753 33455678899999999999999999998764 35
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..|+|||||+ |+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 578888843 346999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc--ccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 436 RTFGGDE--IEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 436 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+.+.... ........+||+.|+|||++.+. .|+.++||||+|||+|||++|++||...+..+....+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 12234457899999999998875 56999999999999999999999997654433322222211100000
Q ss_pred CCcccccc-------cc--cCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDA-------CY--QESCN-----PDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~-------~~--~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........ .+ ....+ +.....+.+|+.+||+.||++|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00 00000 1123467899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=395.68 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=171.7
Q ss_pred HHhcCccccceecccCeEEEEEEEEc----CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
...++|++.++||+|+||+||+|+++ .++.||+|++.+.. ....+.+|+.+|+.+ +|||||++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999863 36789999986533 345678999999998 699999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCCCc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLAR 436 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGla~ 436 (605)
++||||+++++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 3889999999999999999999999 9999999999999877 799999999998
Q ss_pred cCCCCccc--------------------------ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCC
Q 007397 437 TFGGDEIE--------------------------GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRN 489 (605)
Q Consensus 437 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p 489 (605)
........ ......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432111 112345799999999999875 589999999999999999999999
Q ss_pred CCCC
Q 007397 490 RGLY 493 (605)
Q Consensus 490 ~~~~ 493 (605)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=385.58 Aligned_cols=278 Identities=35% Similarity=0.598 Sum_probs=242.8
Q ss_pred HHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
...+++|++.+.||+|+||+||+|++.+++.||||++........+.+.+|+.++++++||||+++++++......++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 34678999999999999999999998889999999998766677888999999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999865432 235899999999999999999999998 99999999999999999999999999987543
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+....++++
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 33222334456899999999999999999999999999999999999999887766666666555555556666677777
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+...........+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777778889999999999999999999999999999999765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=409.82 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=204.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHH---HHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLN---ELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|+++++||+|+||+||+|++. +|+.||||++.+.. ..... ..+.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999985 48999999997521 12222 334456777888999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
||||||++||+|..+|... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999653 45899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.................. ..
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----~~-- 411 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AV-- 411 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----CC--
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----CC--
Confidence 65432 345789999999999974 57999999999999999999999999765554433333222111 10
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|++ +.||+++
T Consensus 412 --------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111223346889999999999999998 6888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=414.62 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=210.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|++. +|+.||+|++........+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999984 5899999999876666778899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC--CceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD--MNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~--~~vkl~DFGla~~~~~~ 441 (605)
|++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988543 345899999999999999999999998 9999999999999854 89999999999987543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .....+||+.|||||++.+..|+.++|||||||+||||++|.+||...+..+. +.... .... .+.+ .
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~----~~~~-~~~~-~ 378 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVK----SCDW-NMDD-S 378 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH----TTCC-CCCS-G
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHH----hCCC-CCCc-c
Confidence 2 23456899999999999999999999999999999999999999976443222 22111 1110 0001 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. ......+.+|+.+||+.||++|||+.|++++
T Consensus 379 ~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 AF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1123457899999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=378.32 Aligned_cols=288 Identities=40% Similarity=0.675 Sum_probs=242.5
Q ss_pred CCcccHHHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccch-hhHHHHHHHHHHHHcCCCCceeeeeeeE
Q 007397 273 LPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE-QGLNELKNEVILFSKLQHRNLVKLLGCC 351 (605)
Q Consensus 273 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 351 (605)
+..++..++....++|++.+.||+|+||.||+|++.+++.||||++..... .....+.+|+.++++++|+||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 445677888889999999999999999999999988899999999975332 2233688999999999999999999999
Q ss_pred EeCCeeEEEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEEecCCCCCEEEcCCCce
Q 007397 352 IQGEEKLLIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQD---SRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 352 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~~~~iiHrDlkp~NIll~~~~~v 427 (605)
......++||||+++++|.+++.... ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCE
Confidence 99999999999999999999997653 344589999999999999999999999 7 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CCCchhHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN--SDNKFNVIRHA 505 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~--~~~~~~~i~~~ 505 (605)
||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...........
T Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999987643322 22334569999999999998899999999999999999999999996321 12223333444
Q ss_pred HHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 506 WNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 506 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
...........+.+..+...........+.+++.+||+.+|++|||+.+|+++|++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 44555566667777777788889999999999999999999999999999999988643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.71 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=213.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999985 5899999999877777888999999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 335899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchh--HHHHHHHhh
Q 007397 444 EG------------STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN--VIRHAWNLW 509 (605)
Q Consensus 444 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~--~i~~~~~~~ 509 (605)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 11 1124579999999999999999999999999999999999999987654322211 111100
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 241 -------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 241 -------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111122234578899999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=356.55 Aligned_cols=285 Identities=33% Similarity=0.528 Sum_probs=232.9
Q ss_pred cCCCcccHHHHHHHhcCcccc------ceecccCeEEEEEEEEcCCcEEEEEEcccc----chhhHHHHHHHHHHHHcCC
Q 007397 271 LELPLFELATIANATDNFSIN------NKLGEGGFGRVYKGTLVDGQEIAVKRLSKI----SEQGLNELKNEVILFSKLQ 340 (605)
Q Consensus 271 ~~~~~~~~~~~~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 340 (605)
.....+.+.++..++++|... ++||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345567888888888888776 8999999999999987 6889999998642 2345678999999999999
Q ss_pred CCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEE
Q 007397 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVL 420 (605)
Q Consensus 341 h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIl 420 (605)
||||+++++++......++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999976555567999999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 007397 421 LDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500 (605)
Q Consensus 421 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 500 (605)
++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|.+||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999987654333333344679999999998865 58899999999999999999999998766554443
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+...... ........++..+ ..........+.+++..||+.+|.+|||+.+|+++|+..
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIED-EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHT-TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhh-hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 33322111 1111222233322 345667788899999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.59 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=210.4
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|++.++||+|+||+||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 457899999999999999999997 5589999999976555567788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998543 4889999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+... ...... .+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~---~~~~~~-~~----- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI---ATNGTP-EL----- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHHCSC-CC-----
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCCCC-CC-----
Confidence 2 2334679999999999999999999999999999999999999996543211 11111 111111 00
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+......+.+++.+||+.||++|||+.++++.-
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 11222345678999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=371.51 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=214.0
Q ss_pred hcCccccceecccCeEEEEEEEEc--------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|++.+.||+|+||.||+|++. ++..||||++... .......+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999863 3467999999754 445567899999999999 899999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235789999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~- 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999999999987654433333444567899999999999999999999999999999999 99998765432221
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. ...+.. ...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 316 --~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 316 --KL----LKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --HH----HHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HH----HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111111 112223345688999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=366.77 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=204.8
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++ .++.||||++... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999987 6889999998753 34556788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++........+++..++.++.||++||.|||+++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976544445899999999999999999999875 349999999999999999999999999997643322
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+..... ....
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~---~~~~-------- 257 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF---KCKR-------- 257 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH---SCCC--------
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---cCCC--------
Confidence 12334679999999999999999999999999999999999999997543221 1111100 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 258 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 -LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111222334688999999999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.07 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=207.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.+.||+|+||.||+|++ .+|+.||||++.+. .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999998 56999999998653 4455677889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998654 34899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFS-VKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.... ..... .+..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~----~~~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RERVL----RGKY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCC------
Confidence 2 23456799999999999988775 899999999999999999999975442211 11111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+......+.+|+.+||+.||.+|||+.++++.-
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 01112234678999999999999999999998863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=361.60 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=205.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999985 68999999986432 2334678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998843 334899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ... +...... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~----~~~~~~~--~--- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD----WKEKKTY--L--- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHH----HHTTCTT--S---
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHH----Hhccccc--C---
Confidence 3333445689999999999988775 78999999999999999999999765433221 111 1111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.........+.+|+.+||+.||++|||+.|+++..
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 00112234577899999999999999999998864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.45 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=208.8
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----eeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 361 (605)
++|++.++||+|+||+||+|++. ++.||||++.... ........|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 67999999999999999999875 7999999996543 33445567999999999999999999998754 369999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD----------SRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
||+++++|.+++... .+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999542 489999999999999999999998 7 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHH---
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR--- 503 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~--- 503 (605)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987655443333445679999999999986 356778999999999999999999997654432221111
Q ss_pred ------HHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 504 ------HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 504 ------~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..............+.... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111111111111 1234556789999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.61 Aligned_cols=274 Identities=20% Similarity=0.266 Sum_probs=219.7
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC--eeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 360 (605)
.++|++.++||+|+||+||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999854 8999999997533 344677889999999999999999999998765 77999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE----cCCCceEEeecCCCc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLAR 436 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll----~~~~~vkl~DFGla~ 436 (605)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655556999999999999999999999998 9999999999999 788889999999998
Q ss_pred cCCCCcccccccccccccCccchhccc--------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc-hhHHHHHHH
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYAT--------DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK-FNVIRHAWN 507 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~-~~~i~~~~~ 507 (605)
...... ......||+.|+|||++. +..++.++|||||||++|||++|..||........ ...+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 765432 223456999999999986 57789999999999999999999999976543222 222222222
Q ss_pred hhhcCCCccccc-----------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 508 LWNKGMPWQLID-----------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 508 ~~~~~~~~~l~d-----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
..+...+..+.. ..............+.+++.+||+.||++|||+.|+++..+++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 222111111100 011124556777889999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.83 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=209.2
Q ss_pred hcCccccceecccCeEEEEEEEEc----CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++..+...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367999999999999999999984 3456999999753 45556789999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 235899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 440 GDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 440 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... .+... ..+.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~~---- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSV----EEGY---- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHH----HTTC----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCC----
Confidence 43211 12223456788999999999999999999999999999999 999986543221 11111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
....+......+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus 272 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 272 -----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122233456889999999999999999999999998763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.66 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=207.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||+||+|++. +++.||+|++.+. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999985 5899999999753 234566788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+... ...... . ...
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~---~-~~~------ 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL---M-EEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H-CCC------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHH---c-CCC------
Confidence 22 22345689999999999999999999999999999999999999997543211 111111 1 110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+|+.+||+.+|++|| ++.+|+++
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01112234678999999999999999 89999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.01 Aligned_cols=266 Identities=27% Similarity=0.324 Sum_probs=206.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++.+++.||+|++... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4789999999999999999999988999999998743 23345678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9986 666666443 345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc----
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL---- 517 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l---- 517 (605)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...............
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 12334578999999999876 56899999999999999999999999876665544433322211111110000
Q ss_pred ---------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ---------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ---------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+........+....++.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000011123467899999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=369.16 Aligned_cols=271 Identities=28% Similarity=0.418 Sum_probs=217.7
Q ss_pred hcCccccceecccCeEEEEEEEEc--------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|.+.++||+|+||+||+|++. .++.||||++... .......+.+|+.+++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 478999999999999999999863 2367999999753 445567889999999999 899999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 245899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987755443334445567899999999999999999999999999999999 99998654321 1
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCCCCCCCccc
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQPGCL 574 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~ 574 (605)
.. .....+... ..+......+.+|+.+||+.+|++|||+.+|++.|+...........+..
T Consensus 302 ~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 302 LF----KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp HH----HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred HH----HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11 111111111 11122334688999999999999999999999999887443434444443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.45 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=207.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||.||+|++. .++.||+|++.. ......+.+.+|+.++++++||||+++++++..+...++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999984 589999999853 3345567889999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-~~--- 232 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVP-NV--- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCC-CH---
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCC-Cc---
Confidence 321 22334679999999999999999999999999999999999999996543211 11111111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcCCCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-SMPSVILMLGSDSV 564 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~~~~ 564 (605)
...........+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0111222345688999999999999998 99999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=355.11 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=207.3
Q ss_pred ccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 288 FSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
|...++||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 777889999999999999986 6999999999766666778899999999999999999999999999999999999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 999998843 35899999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCC
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESC 526 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~ 526 (605)
.....||+.|+|||++.+..++.++||||||+++|||++|..||..... ...+.... ......+. .
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~----~~~~~~~~-------~ 263 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLR----DSPPPKLK-------N 263 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSSCCCCT-------T
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCCCCCcC-------c
Confidence 2346799999999999999999999999999999999999999975432 11121111 11111110 1
Q ss_pred CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 527 NPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 527 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.......+.+++.+||+.+|++|||+.+|++..
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 112234578999999999999999999999853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=368.25 Aligned_cols=269 Identities=27% Similarity=0.428 Sum_probs=215.3
Q ss_pred ccHHHHHHHhcCccccceecccCeEEEEEEEE------cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeee
Q 007397 276 FELATIANATDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKL 347 (605)
Q Consensus 276 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 347 (605)
+.........++|++.++||+|+||.||+|++ .+++.||||++... .....+.+.+|+.+++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44455556678999999999999999999984 23689999999763 344567799999999999 79999999
Q ss_pred eeeEEeCCe-eEEEEEeeCCCchhhHHhhcCc------------------------------------------------
Q 007397 348 LGCCIQGEE-KLLIYEFMPNKSLDYFIFDQTK------------------------------------------------ 378 (605)
Q Consensus 348 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 378 (605)
++++..... .++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 8999999999999999965432
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 379 ---------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 379 ---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 223889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
........||+.|+|||++.+..++.++||||||+++|||++ |..||......... ... ...+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~~~~------- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEGTRM------- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHTCCC-------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcCCCC-------
Confidence 333445678999999999999999999999999999999998 99999764433211 111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++..||+.+|++|||+.+|+++|+..
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11112234688999999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=369.85 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=210.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467899999999999999999985 6899999998753 33445678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999986532 34889999999999999999999998 9999999999999999999999999998754433
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||....... ... ....+..
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~------- 333 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TRE----FVEKGGR------- 333 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHH----HHHTTCC-------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCC-------
Confidence 2222223346788999999998899999999999999999998 999987543211 111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 334 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222345688999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=358.53 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=206.9
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch------hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE------QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
..+.|++.+.||+|+||+||+|++. +|+.||+|++.+... ...+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999985 589999999975322 135789999999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeec
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDF 432 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DF 432 (605)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999844 346899999999999999999999998 99999999999998877 7999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+ .+... ...
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i----~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANI----TAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH----HTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----Hhc
Confidence 9998765432 2334679999999999999999999999999999999999999997643221 11111 111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. . .+...... ....+.+|+.+||+.||++|||+.+++++
T Consensus 234 ~~-~-~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SY-D-FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC-C-CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC-C-CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 0 01111111 23457899999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.31 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=211.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|++.++..||+|++.... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999999888899999997532 34467899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999986543 34899999999999999999999998 999999999999999999999999999876544322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ .... ..+...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~-------- 224 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKV----SQGHRL-------- 224 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHH----HTTCCC--------
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHH----HcCCCC--------
Confidence 2233456788999999999899999999999999999999 9999865443211 1111 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..+......+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011112346889999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.63 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=210.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36799999999999999999999889999999997532 23467899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999998543 345899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...... ..+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~----~~~~~--------- 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI----STGFR--------- 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HTTCC---------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----hcCcc---------
Confidence 22233457888999999999999999999999999999999 99998754322 111111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 011112234688999999999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=353.93 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=213.7
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468999999999999999999862 3578999999753 445667889999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTK---------------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKT 416 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp 416 (605)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 234789999999999999999999998 99999999
Q ss_pred CCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 007397 417 SNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNS 495 (605)
Q Consensus 417 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~ 495 (605)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333444567889999999999999999999999999999999 9999976544
Q ss_pred CCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 496 ~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
......+ ..+... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 259 ~~~~~~~-------~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERLFNLL-------KTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGHHHHH-------HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHh-------hcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3221111 111111 11222345688999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.51 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=195.7
Q ss_pred hcCccccceecccCeEEEEEEEEcCC----cEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee-
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDG----QEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK- 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 357 (605)
.++|++.+.||+|+||.||+|++... ..||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46899999999999999999987543 27999999753 345567899999999999999999999999887665
Q ss_pred -----EEEEEeeCCCchhhHHhhcCc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 358 -----LLIYEFMPNKSLDYFIFDQTK---RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 358 -----~lv~e~~~~~~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
++||||+++++|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999865432 225899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...........+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----- 253 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----- 253 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-----
Confidence 99999987654433333334557889999999999999999999999999999999 899987654332211111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.. ...+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 254 --~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 254 --GGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 111222335688999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.77 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=207.3
Q ss_pred hcCccccceecccCeEEEEEEEE-----cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 357 (605)
.++|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 3588999999987777778889999999999999999999999865 3568
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---------CchhHHHHHHH
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD---------NKFNVIRHAWN 507 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~---------~~~~~i~~~~~ 507 (605)
....... .......+++.|+|||++.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433211 1223345778899999999999999999999999999999999987642210 00001111111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...... ....+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 244 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 1122233445788999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.75 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=202.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.++||+|+||+||+|++. +++.||||++.+. .......+.+|+.+++.+ +||||+++++++......++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999985 4899999999753 334566788999999988 69999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998654 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ..... .+..
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~----~~~~----- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAIL----NDEV----- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCC-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCCC-----
Confidence 222 224456899999999999999999999999999999999999999976443222 11111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM------PSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 558 (605)
..+......+.+|+.+||+.+|++||++ .+|+++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111223457889999999999999998 777764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.91 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=214.3
Q ss_pred HHHhcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
....++|++.+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|+.++++++||||+++++++..+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3346789999999999999999999853 488999999754 445567899999999999999999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK---------------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRD 413 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrD 413 (605)
...++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999966421 256899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 007397 414 LKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGL 492 (605)
Q Consensus 414 lkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~ 492 (605)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987644332233344568999999999999899999999999999999999 9999865
Q ss_pred CCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 493 ~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.... .... ....+.... .+......+.+|+.+||+.+|++||++.+|+++|+...
T Consensus 280 ~~~~---~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 280 MAHE---EVIY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp SCHH---HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CChH---HHHH----HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 4321 1111 111222111 12223356889999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=358.14 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=202.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC-Cc----EEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.++||+|+||+||+|++.. ++ +||+|.+... .......+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3679999999999999999999743 44 4688888543 3456678999999999999999999999998754 78
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|+||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999986543 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.............+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+. .+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC----
Confidence 55443333444567889999999999999999999999999999999 999997654432211111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1112223345688999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.42 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=199.0
Q ss_pred hcCccccceecccCeEEEEEEEEc----CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999875 4678999999753 44556789999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 335899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 440 GDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 440 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..+... ..+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i----~~~----- 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAV----DEG----- 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHH----HTT-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC-----
Confidence 43211 11222345788999999999999999999999999999998 99998654321 111111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.....+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11122233445788999999999999999999999999765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=366.34 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=209.6
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.++||+|+||+||+|++. +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999842 3678999999653 455566788999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEe
Q 007397 358 LLIYEFMPNKSLDYFIFDQT----KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKIS 430 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~ 430 (605)
++||||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996643 2245899999999999999999999998 99999999999999555 59999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ..+.. .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~----i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF----V 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H
Confidence 9999976532222223344568999999999999999999999999999999998 99998654321 11111 1
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+... ..+......+.+|+.+||+.+|++||++.+|++.|+..
T Consensus 300 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 11122234688999999999999999999999999665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=355.48 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=207.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.+.||+|+||+||+|.+. +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999985 4889999998653 34456788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC--CCceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH--DMNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~--~~~vkl~DFGla~~~~~~ 441 (605)
+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999988442 235899999999999999999999998 999999999999987 789999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..... .... .+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~----~~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMN----AEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH----TCCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHc----CCCC--CChh
Confidence 2 233467999999999999988999999999999999999999999754322 11111111 1100 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... .....+.+++.+||+.||++|||+.|+++.-
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 001 1234678999999999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=368.22 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=206.4
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
...++|++.++||+|+||+||+|.+ .+++.+|+|++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999988 45899999998653 34456678999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc---CCCceEEeecCCCc
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLAR 436 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~---~~~~vkl~DFGla~ 436 (605)
||||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999988653 45899999999999999999999998 99999999999998 45789999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+... ...... .+.. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i~----~~~~-~ 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQIK----AGAY-D 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH----HTCC-C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH----hCCC-C
Confidence 7654322 2234679999999999999999999999999999999999999996543221 111111 1111 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ...........+.+|+.+||+.||++|||+.++++.
T Consensus 232 ~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 001111223468899999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.50 Aligned_cols=260 Identities=17% Similarity=0.176 Sum_probs=210.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+|+.+++++ +|+||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999997 568999999986432 234578999999999 89999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc-----eEEeecCCCcc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN-----PKISDFGLART 437 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~-----vkl~DFGla~~ 437 (605)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998654 346899999999999999999999998 999999999999999887 99999999987
Q ss_pred CCCCcccc-----cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 438 FGGDEIEG-----STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 438 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64332211 1245679999999999999999999999999999999999999998776555444443322211110
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. ..+. .. .. .+.+++..||+.+|.+||++.+|++.|+..
T Consensus 240 ~~-----~~~~-~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PI-----EVLC-EN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CH-----HHHT-TT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CH-----HHHh-cc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0000 01 12 688999999999999999999999998543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=354.69 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=206.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch------hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE------QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++.+... ...+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999985 589999999865322 2467899999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeecC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDFG 433 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DFG 433 (605)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 345899999999999999999999998 99999999999999887 89999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ .+..... ..
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~----~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA----VN 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH----TC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHh----cC
Confidence 998764322 2334679999999999999999999999999999999999999996543211 1111111 00
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. .. ....... ....+.+|+.+||+.||++|||+.+++++-
T Consensus 234 ~-~~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 234 Y-EF-EDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp C-CC-CHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred C-Cc-Ccccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 0 00 0001111 234578899999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=347.86 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=203.3
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|++.++||+|+||+||+|++. +++.||+|++... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999985 5899999998643 33445778899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|++++.+..+. . ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875554443 2 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc---cc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ---LI 518 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~---l~ 518 (605)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.... .....+.............. ..
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 1233457899999999998765 8999999999999999999888864322 22222332222221111000 00
Q ss_pred ---c---------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 ---D---------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 ---d---------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+ ........+.....+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000011122344567899999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=360.69 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=202.9
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.++||+|+||+||+|++.. ++.||+|++.+. .....+.+.+|..++.++ +||||+++++++......++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999854 789999999753 233345678899999887 89999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999988653 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch--hHHHHHHHhhhcCCCccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF--NVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~~l 517 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 221 2344578999999999999999999999999999999999999999754322111 001111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM------PSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 558 (605)
..+......+.+|+.+||+.||++||++ .+|+++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1122234468899999999999999995 566664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=367.26 Aligned_cols=264 Identities=16% Similarity=0.202 Sum_probs=210.0
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEe
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 353 (605)
+..+....++|++.++||+|+||+||+|++.+ ++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 33444556899999999999999999999865 7899999997522 1223348899999999999999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
....++||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999653 345899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+......
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 9987644322 1233467999999999997 567899999999999999999999999764433222222111110
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILML 559 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 559 (605)
. ... .........+.+|+.+||+.+|++ ||++.||+++-
T Consensus 300 ~---~~p---------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 F---QFP---------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp C---CCC---------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred c---cCC---------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0 000 000112345788999999988888 99999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=359.30 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=206.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999985 5899999999643 345567789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~DFGla~~ 437 (605)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988854 346899999999999999999999998 99999999999998654 599999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ...... ..+... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i----~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI----KAGAYD-Y 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHTCCC-C
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HhCCCC-C
Confidence 65332 223467999999999999999999999999999999999999999754321 111111 111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .........+.+|+.+||+.||++||++.+++++
T Consensus 250 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011223467899999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.21 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=209.8
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||.||+|++. .++.||+|++... .....+.+.+|+.+++++ +||||+++++++.....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 478999999999999999999962 3568999999753 334457789999999999 89999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCcc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKR--------------------ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKT 416 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp 416 (605)
.++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999654321 34789999999999999999999998 99999999
Q ss_pred CCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 007397 417 SNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNS 495 (605)
Q Consensus 417 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~ 495 (605)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987644332233344567899999999999999999999999999999998 9999976543
Q ss_pred CCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 496 DNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 496 ~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..... .....+.. ...+......+.+|+.+||+.+|.+|||+.+|+++|+..
T Consensus 281 ~~~~~------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 281 DANFY------KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp SHHHH------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH------HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 22111 11111111 111222345688999999999999999999999999775
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=349.81 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=199.1
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.+.||+|+||+||+|++ .++.||+|++.. ....+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5789999999999999999987 478999999964 334577899999999999999999999886 45799999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc-eEEeecCCCccCCCCccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN-PKISDFGLARTFGGDEIE 444 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~-vkl~DFGla~~~~~~~~~ 444 (605)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976655556889999999999999999999932223999999999999998886 799999999765322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+... .+....+
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~------- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-NGTRPPL------- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH-TTCCCCC-------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh-cCCCCCc-------
Confidence 223468999999999999999999999999999999999999997543321 11111111 1111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 112234578999999999999999999999999775
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=352.22 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=212.8
Q ss_pred hcCccccceecccCeEEEEEEEE------cCCcEEEEEEccccc-hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKIS-EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++..+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 236899999997543 34567889999999999 89999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK---------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999866432 225899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999987755433333344567889999999999999999999999999999999 99998765432221
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
... ...... ...+......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 258 --~~~---~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 --YKM---IKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp --HHH---HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---hccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111 111110 111122335688999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.23 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=201.6
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHc--CCCCceeeeeeeEEeC----CeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK--LQHRNLVKLLGCCIQG----EEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 358 (605)
.++|++.++||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 7899999998653 33445556666665 7999999999987653 4578
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
+||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999933 35899999999999999999999 777 9999999999999999999999
Q ss_pred ecCCCccCCCCccc--ccccccccccCccchhcccCC------CCCcccchHHHHHHHHHHHhC----------CCCCCC
Q 007397 431 DFGLARTFGGDEIE--GSTNKVIGTYGYMAPEYATDG------LFSVKSDVFSFGILVLEIVSG----------KRNRGL 492 (605)
Q Consensus 431 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvvl~elltG----------~~p~~~ 492 (605)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765432211 112335799999999999876 456799999999999999999 777765
Q ss_pred CCCCCch-hHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 493 YNSDNKF-NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 493 ~~~~~~~-~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
....... ..+.... ........+.. ..........+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVV--CVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHHHHHH--TTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHH--hccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 4433322 2121111 11111111111 11223466789999999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.08 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=202.7
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999985 6999999999743 3445678999999999999999999999986643
Q ss_pred ---------------------------------------------------eeEEEEEeeCCCchhhHHhhcCccCCCCH
Q 007397 356 ---------------------------------------------------EKLLIYEFMPNKSLDYFIFDQTKRELLDW 384 (605)
Q Consensus 356 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 384 (605)
..++||||+++++|.+++..........+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27899999999999999987666666778
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc----------cccccccccc
Q 007397 385 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE----------GSTNKVIGTY 454 (605)
Q Consensus 385 ~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~ 454 (605)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999998 999999999999999999999999999877543211 1223457999
Q ss_pred CccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHH
Q 007397 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRC 534 (605)
Q Consensus 455 ~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l 534 (605)
.|+|||++.+..++.++||||||+++|||++|..|+. .... ............ ........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCH---------HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCc---------ccccCChhH
Confidence 9999999999999999999999999999999876532 1111 111111111110 112233567
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 535 IHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 535 ~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+++.+||+.+|++|||+.++++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=346.86 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=207.1
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46899999999999999999999888899999997532 23467899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999998653 235899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .... ..+..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~--------- 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHI----AQGLR--------- 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHH----HTTCC---------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---HHHH----hcccC---------
Confidence 12233456888999999998899999999999999999998 9999875443211 1111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++|||+.+|++.|...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011111234688999999999999999999999999653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=344.46 Aligned_cols=253 Identities=29% Similarity=0.484 Sum_probs=197.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccc----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||.||+|.+. ++.+|||++.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999974 8899999987532 23457789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC--------CCceEEeec
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH--------DMNPKISDF 432 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~--------~~~vkl~DF 432 (605)
|||+++++|.+++. ...+++..+..++.||++||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 335899999999999999999999987555889999999999986 678999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... . .........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---A---VAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---H---HHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHhhhcCC
Confidence 9998654322 22356899999999999999999999999999999999999999754321 1 111111111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.. ...+......+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LA---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 11222234568899999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.08 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=206.9
Q ss_pred cCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||.||++++.. ++.||+|++.+. .......+.+|+.++++++||||+++++++......++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 679999999999999999999854 889999998653 2344577889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+.+++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999854 345899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+...... .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----~----- 236 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----V----- 236 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----C-----
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----c-----
Confidence 2 2345679999999999974 45899999999999999999999999865554433333222111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-MPSVIL 557 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 557 (605)
...+......+.+|+.+||+.+|++||+ +.+|++
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112223456889999999999999998 777765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.02 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=201.2
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||+||+|++.+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999789999999986432 23346788999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++ +|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 888777543 245889999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC---ccc--
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP---WQL-- 517 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~---~~l-- 517 (605)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+............ ...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 112335689999999999764 58999999999999999999999997644322 22222221111100 000
Q ss_pred ---ccccc-------cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ---IDACY-------QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ---~d~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.++.+ ...........+.+|+.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 001111234567899999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.20 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=204.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-Cc----EEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQ----EIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.++||+|+||+||+|.+.. ++ +||+|.+... .......+.+|+.++++++|+||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3679999999999999999999743 44 3788877542 2333456778999999999999999999886 56789
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998653 335888999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.............||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. .+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~-- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGERL-- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTCBC--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCCCC--
Confidence 55444334455678889999999999999999999999999999999 999997654432222111 11110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011112234678999999999999999999999997763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=371.98 Aligned_cols=257 Identities=30% Similarity=0.445 Sum_probs=211.2
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..++|++.++||+|+||.||+|.+.+++.||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 457899999999999999999999889999999997533 45678999999999999999999999986 6678999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 235788999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......+|+.|+|||++....++.++|||||||+||||++ |+.||...... ..+.... .+.
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~----~~~--------- 402 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RGY--------- 402 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH----HTC---------
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC---------
Confidence 1 1223446789999999998999999999999999999999 99999754322 1221111 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
....+......+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11112233456889999999999999999999999998873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.45 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=208.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|.+. +++.+|+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999985 5899999999876666667899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC--CCceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH--DMNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~--~~~vkl~DFGla~~~~~~ 441 (605)
+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 235899999999999999999999998 999999999999974 477999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..... ... .
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~----~~~-~----- 268 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR----CDW-E----- 268 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH----CCC-C-----
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCC-C-----
Confidence 22 2335799999999999999999999999999999999999999975432 111211111 110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
............+.+|+.+||+.||++|||+.++++.
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011112233468899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=351.42 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=205.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||+||+|++. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999985 5899999999753 223466788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998653 35899999999999999999999998 99999999999999999999999999987533
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ...... ... ..
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i---~~~-~~------ 220 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKI---LNA-EL------ 220 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---HHC-CC------
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC-CC------
Confidence 233467999999999999999999999999999999999999999754321 111111 111 10
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+++.+||+.+|++|| ++.+|+++
T Consensus 221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11122234678999999999999999 89999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.56 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=205.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++......+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999984 58999999986421 124678899999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecCC
Q 007397 359 LIYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFGL 434 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFGl 434 (605)
+||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775542 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....... ..+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i----~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGI----IKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHH----HHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHH----HcCCC
Confidence 987654322 2334579999999999999999999999999999999999999997532 1111111 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ..+..... ....+.+|+.+||+.||++|||+.+++++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000011 23467899999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=343.78 Aligned_cols=261 Identities=15% Similarity=0.183 Sum_probs=212.8
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+.+++++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999997 568999999986432 334578899999999 79999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc-----eEEeecCCCcc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN-----PKISDFGLART 437 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~-----vkl~DFGla~~ 437 (605)
|+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996542 35899999999999999999999998 999999999999987776 99999999987
Q ss_pred CCCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 438 FGGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 438 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 12345679999999999999999999999999999999999999998766555444443332221111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+ .. .....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 241 ~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 11111 11 1234688999999999999999999999999765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=365.89 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=209.2
Q ss_pred HHHHHHhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 279 ATIANATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
..+....++|++.++||+|+||+||+|++.. ++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3444556899999999999999999999854 8899999996521 22234578999999999999999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++||||+++|+|..++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999988542 4889999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL----FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 987654322 1233568999999999998765 88999999999999999999999975443222222211110000
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPED--RPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 559 (605)
.+........+.+|+.+||+.+|.+ ||++.||+++.
T Consensus 294 -------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 294 -------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp -------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred -------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0001112346789999999999998 99999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=349.23 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=196.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch--------------------------hhHHHHHHHHHHHH
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE--------------------------QGLNELKNEVILFS 337 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 337 (605)
.++|++.+.||+|+||.||+|++. +++.||||++.+... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999984 588999999864321 12356889999999
Q ss_pred cCCCCceeeeeeeEEe--CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 007397 338 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 415 (605)
Q Consensus 338 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlk 415 (605)
+++||||+++++++.. ....++||||+++++|.+++ ....+++..+..++.||++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56889999999999998764 2346899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCC---CCcccchHHHHHHHHHHHhCCCCCCC
Q 007397 416 TSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL---FSVKSDVFSFGILVLEIVSGKRNRGL 492 (605)
Q Consensus 416 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvvl~elltG~~p~~~ 492 (605)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654321 123457999999999998755 47889999999999999999999965
Q ss_pred CCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 493 ~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ...... ..... .. +........+.+|+.+||+.||++|||+.+|++.
T Consensus 243 ~~~~---~~~~~~----~~~~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIM---CLHSKI----KSQAL-EF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHH---HHHHHH----HHCCC-CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHH---HHHHHH----hcccC-CC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 3321 111111 11110 00 1111223468899999999999999999999763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.89 Aligned_cols=247 Identities=21% Similarity=0.223 Sum_probs=207.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++......++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999985 5899999999653 223466788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998653 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ....... .+..
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~----~~~~------ 255 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIV----SGKV------ 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCC------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHH----cCCC------
Confidence 2 33467999999999999999999999999999999999999999754322 1111111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 559 (605)
..+......+.+|+.+||+.||++||+ +.+|+++-
T Consensus 256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 111122346889999999999999998 89988753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=351.26 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=204.5
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||.||+|++. +++.||+|++.+. .....+.+.+|+.+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999985 4889999999753 344566788999999988 899999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988653 35899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch--hHHHHHHHhhhcCCCcccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF--NVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~~l~ 518 (605)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 2234568999999999999999999999999999999999999999753221110 001111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM------PSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 558 (605)
..+......+.+|+.+||+.||++||++ .+++++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1112233468899999999999999996 566654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.50 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=204.9
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
...++|++.+.||+|+||.||+|++. +++.||+|++.+.. ......+..|..+++.+ +||||+++++++...+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999985 48999999997532 33456778899999877 899999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 35899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+... ...... ....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~----~~~~--- 235 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR----MDNP--- 235 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCC---
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----hCCC---
Confidence 43221 12345689999999999999999999999999999999999999997544321 111111 1110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP-SVIL 557 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 557 (605)
..+......+.+|+.+||+.+|++||++. +|++
T Consensus 236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 01112234678999999999999999998 7764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=353.92 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=204.1
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 568999999986521 22345788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 67887777543 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ..
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~~ 222 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------NS 222 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------CS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------Hc
Confidence 32 2334679999999999988776 78999999999999999999999764433221110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.. ...+......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 223 ~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 CV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 00 011222335678999999999999999999998854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.46 Aligned_cols=262 Identities=18% Similarity=0.216 Sum_probs=208.3
Q ss_pred HHHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 279 ATIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
.......++|++.++||+|+||+||++++. +++.||+|++.+.. ......+.+|+.++.+++|+||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445689999999999999999999985 58999999997532 22344578999999999999999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++||||+++++|..++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999996532 35899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCcccccccccccccCccchhccc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYAT-------DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 987654322 1223467999999999997 45689999999999999999999999976543322222221111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHh
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDR---PSMPSVILML 559 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~L 559 (605)
.. .. +.. .......+.+|+.+||+ +|++| |++.||+++-
T Consensus 288 ~~---~~-----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 288 HL---SL-----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HC---CC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred Cc---CC-----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 00 00 000 11223468899999999 99998 6999998854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.69 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=195.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||++++. +++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999985 58999999996532 3346688999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc--eEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN--PKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~--vkl~DFGla~~~~~~ 441 (605)
+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999988553 34899999999999999999999998 999999999999987765 999999999754222
Q ss_pred cccccccccccccCccchhcccCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVK-SDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+... ......
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~~~------- 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR--ILSVKY------- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH--HHTTCC-------
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH--HhcCCC-------
Confidence 12334579999999999988887665 89999999999999999999865544333222211 111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+........+.+|+.+||+.+|++|||+.+++++
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001111123467899999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.08 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=211.7
Q ss_pred hcCccccceecccCeEEEEEEEEc--------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999873 4678999999753 345567889999999999 899999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965432 234889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987755433333444567889999999998899999999999999999999 999986543211
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.... ...+... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 268 ~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 LFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----HhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 1111111 11122334688999999999999999999999999776
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.31 Aligned_cols=270 Identities=17% Similarity=0.225 Sum_probs=207.0
Q ss_pred hcCccccceeccc--CeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEG--GFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.++||+| +||+||+|++. +++.||||++... .....+.+.+|+.++++++|||||++++++..+...++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999985 5999999999753 34556778899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986542 235899999999999999999999998 9999999999999999999999999886542
Q ss_pred CCc-----ccccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH-HHhhhc
Q 007397 440 GDE-----IEGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA-WNLWNK 511 (605)
Q Consensus 440 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~-~~~~~~ 511 (605)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1111233478999999999987 67999999999999999999999999765543322111100 000000
Q ss_pred C------C-------------Cccccc---------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 512 G------M-------------PWQLID---------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 512 ~------~-------------~~~l~d---------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. . ....+. ..............+.+|+.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0 000000 000001122334568899999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.82 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=207.1
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC-eeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467899999999999999999874 7899999997543 4577899999999999999999999987765 78999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999996542 335789999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. .+..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYK-------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCC--------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC--------
Confidence 122357889999999999999999999999999999998 999997665443322211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 405 -~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 -MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112223345688999999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=355.02 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=198.8
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCC--CceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||.||++.+.+++.||||++.. ......+.+.+|+.++++++| +||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 467999999999999999999998899999999864 345566789999999999986 9999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999998653 45889999999999999999999998 99999999999997 67899999999988754
Q ss_pred CcccccccccccccCccchhcccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATD-----------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
...........||+.|+|||++.+ ..++.++|||||||++|||++|..||..... .+.......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 443333445679999999999865 6789999999999999999999999964321 111111111
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... .....+......+.+|+.+||+.||++|||+.+|+++.
T Consensus 235 ~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111 11111222234678999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=371.62 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=213.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||.||+|.+.. ++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4678999999999999999999865 8899999997543 3467899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999996533 345889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......+++.|+|||++.+..++.++|||||||+||||++ |..||...+.... .... ..+.
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~--------- 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKDY--------- 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH----HTTC---------
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCC---------
Confidence 2 2233456789999999999999999999999999999999 9999876543222 1111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+......+.+|+.+||+.+|++|||+.+|+++|+..
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1112223345688999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=368.37 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=205.6
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..++|++.++||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346789999999999999999999888899999997533 345678999999999999999999999876 678999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999543 2235899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ..+... ..+.
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~--------- 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGY--------- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTC---------
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC---------
Confidence 1 1223457889999999999999999999999999999999 99998654321 111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
....+......+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11122334456889999999999999999999999998873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=354.57 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=201.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC-Cc----EEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQ----EIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.++||+|+||+||+|.+.. ++ +||+|.+.. ........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3689999999999999999999743 44 457777754 23456778999999999999999999999998754 78
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+|+||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999986543 35899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.............+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+. .+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~---- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 54443333444567889999999999999999999999999999999 999997654433221111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
....+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112223446889999999999999999999999998763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=353.52 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=196.8
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 356 (605)
.++|++.++||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999998 56899999999753 33455678999999999999999999999876543
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999998643 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 437 TFGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 437 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~---~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---V---AYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---H---HHHHhcCCCCC
Confidence 76433221 22334569999999999999999999999999999999999999996543211 1 11111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HhcC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL-MLGS 561 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~-~L~~ 561 (605)
. ..... .....+.+|+.+||+.||++||++.+++. .|..
T Consensus 239 ~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp H---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0 00011 12345789999999999999997666554 4443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.01 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=212.7
Q ss_pred cCccccceecccCeEEEEEEEE-----cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEE--eCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI--QGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 358 (605)
++|++.++||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++|+||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 358899999998777777788999999999999999999999887 456688
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999986533 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC--------CchhHHHHHHHhh
Q 007397 439 GGDEI-EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD--------NKFNVIRHAWNLW 509 (605)
Q Consensus 439 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~--------~~~~~i~~~~~~~ 509 (605)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43322 12233456888999999999999999999999999999999999998642211 0000111111111
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
..+. ....+......+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus 258 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 12223334556889999999999999999999999998763
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.54 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=191.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999984 58999999986533 3344678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQT---KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 2245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc-
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL- 517 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l- 517 (605)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...............
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 321 12234578999999999976 46899999999999999999999999765433222222211110000000000
Q ss_pred ----------------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ----------------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ----------------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+...+...........+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000111123468899999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.11 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=205.4
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|++.. ++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999865 789999999753 234566788999999988 79999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999998653 34899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ ...
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~----~~~----- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIME----HNV----- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH----CCC-----
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHHHh----CCC-----
Confidence 222 2234567999999999999999999999999999999999999999754322 11221111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..+......+.+|+.+||+.+|++||+ +.+|+++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111223356889999999999999995 5777764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.97 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=212.5
Q ss_pred HhcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
..++|++.+.||+|+||.||+|.+. .++.||+|++... .......+.+|+.++++++|+||+++++++.....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 3578999999999999999999864 3688999999753 33455678899999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTK-------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 9999999999999999865321 245789999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .... .
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR----F 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH----H
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH----H
Confidence 99999987644333333344567899999999999999999999999999999999 88888654321 1111 1
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
...+... ..+......+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 253 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 253 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111111 111223356889999999999999999999999998763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.48 Aligned_cols=266 Identities=17% Similarity=0.225 Sum_probs=204.9
Q ss_pred hcCccccceecccCeEEEEEEEEcC------CcEEEEEEccccchhhHH-----------HHHHHHHHHHcCCCCceeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKISEQGLN-----------ELKNEVILFSKLQHRNLVKL 347 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l 347 (605)
.++|++.++||+|+||.||+|.+.. ++.||||++......... .+..|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998855 478999998754322211 23456667788899999999
Q ss_pred eeeEEeC----CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-
Q 007397 348 LGCCIQG----EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD- 422 (605)
Q Consensus 348 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~- 422 (605)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998775 4579999999 99999998653 345899999999999999999999998 99999999999999
Q ss_pred -CCCceEEeecCCCccCCCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007397 423 -HDMNPKISDFGLARTFGGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD 496 (605)
Q Consensus 423 -~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 496 (605)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876433211 1113345999999999999999999999999999999999999999854332
Q ss_pred CchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 497 ~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
... ........ ......+++..+... .....+.+++..||+.+|++||++.+|+++|+..
T Consensus 268 ~~~--~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 PKY--VRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHH--HHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH--HHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 221 11111111 112223333333211 1234678899999999999999999999999665
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.50 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=196.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998743 457999998753 4455677899999999999999999999974 567899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998643 235899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. +... ..+...
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~~~--- 236 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGERL--- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTCCC---
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCCCC---
Confidence 33221 1233457889999999998999999999999999999997 9999876543322 1111 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222345688999999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.88 Aligned_cols=268 Identities=26% Similarity=0.414 Sum_probs=214.3
Q ss_pred cHHHHHHHhcCccccceecccCeEEEEEEEE------cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeee
Q 007397 277 ELATIANATDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLL 348 (605)
Q Consensus 277 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~ 348 (605)
.........++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444568999999999999999999985 23689999999753 344566789999999999 699999999
Q ss_pred eeEEeCC-eeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 007397 349 GCCIQGE-EKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 414 (605)
Q Consensus 349 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDl 414 (605)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987754 48999999999999999965432 223789999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 007397 415 KTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLY 493 (605)
Q Consensus 415 kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~ 493 (605)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433333445668999999999999999999999999999999998 99998764
Q ss_pred CCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 494 NSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 494 ~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..... ..... ..+... ..+......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 255 ~~~~~--~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDEE--FCRRL----KEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSHH--HHHHH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH--HHHHh----ccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 43221 11111 111111 11112234688999999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.77 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=204.9
Q ss_pred hcCccccceecccCeEEEEEEEEcC-C-------cEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-G-------QEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||+||+|.+.. + +.||+|++........+.+.+|+.++++++||||+++++++..+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3679999999999999999998744 3 5799999987777778889999999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc--------eE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN--------PK 428 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~--------vk 428 (605)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999996543 34889999999999999999999998 999999999999998887 99
Q ss_pred EeecCCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 429 ISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 429 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..... ...... .
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~-~-- 230 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQ-F-- 230 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHH-H--
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHH-H--
Confidence 9999998765322 23458899999999987 6789999999999999999996555432221 111111 1
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
..... .+ +......+.+|+.+||+.+|++|||+.+|++.|+..-.
T Consensus 231 -~~~~~--~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 -YEDRH--QL---------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHTTC--CC---------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -hhccC--CC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11100 00 01112347789999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.87 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=196.2
Q ss_pred hcCccccceecccCeEEEEEEEE----cCCcEEEEEEccccc----hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL----VDGQEIAVKRLSKIS----EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||.||++++ .+++.||+|++.+.. ......+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999997 368999999997532 2345567889999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998543 35889999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.. ..+..... ...
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~----~~~-- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILK----CKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH----TCC--
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh----CCC--
Confidence 643221 1233467999999999999999999999999999999999999999754321 11221111 110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+......+.+++.+||+.+|++|| ++.+++++-
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 11122235688999999999999999 778888753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=358.03 Aligned_cols=272 Identities=24% Similarity=0.252 Sum_probs=208.3
Q ss_pred ccHHHHHHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-----CCceeeeee
Q 007397 276 FELATIANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-----HRNLVKLLG 349 (605)
Q Consensus 276 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 349 (605)
+.+.......++|++.++||+|+||+||+|++ .+++.||||++.. .......+..|+.++++++ |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33444445568999999999999999999998 4589999999964 3445567788999999996 999999999
Q ss_pred eEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC------
Q 007397 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH------ 423 (605)
Q Consensus 350 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~------ 423 (605)
++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 9999998865432 34889999999999999999999998 999999999999975
Q ss_pred -------------------CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHH
Q 007397 424 -------------------DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIV 484 (605)
Q Consensus 424 -------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ell 484 (605)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999864332 23467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHHHHHhhh--------cCCCcccccc-c----ccCC-CCH---------------HHHHHHH
Q 007397 485 SGKRNRGLYNSDNKFNVIRHAWNLWN--------KGMPWQLIDA-C----YQES-CNP---------------DEVIRCI 535 (605)
Q Consensus 485 tG~~p~~~~~~~~~~~~i~~~~~~~~--------~~~~~~l~d~-~----~~~~-~~~---------------~~~~~l~ 535 (605)
+|+.||......+....+........ ........+. . .... ... .....+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999976543222222211100000 0000000000 0 0000 000 0114677
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHH
Q 007397 536 HISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 536 ~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+|+.+||+.||++|||+.||++.
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=340.29 Aligned_cols=254 Identities=27% Similarity=0.501 Sum_probs=203.0
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchh-------hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQ-------GLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||+||+|++ .+++.||+|++...... ..+.+.+|+.++++++|+||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999998 46899999998643221 1267889999999999999999999986554
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc-----eEEee
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN-----PKISD 431 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~-----vkl~D 431 (605)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888553 346899999999999999999999875 34999999999999988776 99999
Q ss_pred cCCCccCCCCcccccccccccccCccchhccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT--DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|..||......... ..... .
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~---~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMI---R 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHH---H
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHH---h
Confidence 999985432 233467999999999984 456789999999999999999999999765433221 11111 1
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..... ...+......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 244 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 11222334568899999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=353.41 Aligned_cols=261 Identities=30% Similarity=0.432 Sum_probs=210.9
Q ss_pred HhcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCC
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGE 355 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 355 (605)
..++|++.+.||+|+||.||+|.+.. .+.||+|.+... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999743 248999999754 344567789999999999 8999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcCc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTK-----------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD 424 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~ 424 (605)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 345789999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHH
Q 007397 425 MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIR 503 (605)
Q Consensus 425 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~ 503 (605)
+.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-- 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-- 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH--
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH--
Confidence 9999999999987643332223334567889999999999999999999999999999998 9999875443222111
Q ss_pred HHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 504 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....... ...+......+.+++..||+.+|.+|||+.+|+++|+..
T Consensus 279 ----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 ----LVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111 011112234688999999999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.05 Aligned_cols=267 Identities=24% Similarity=0.322 Sum_probs=200.5
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc-----hhhHHHHHHHHHHHHcC---CCCceeeeeeeEEeC
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS-----EQGLNELKNEVILFSKL---QHRNLVKLLGCCIQG 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 354 (605)
..++|++.++||+|+||+||+|++ .+++.||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999997 558999999986422 11234566777777666 499999999999875
Q ss_pred C-----eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 355 E-----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 355 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
. ..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5789999997 589888855432 34899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...........+.......
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998764332 2344678999999999999999999999999999999999999997654332222222111111
Q ss_pred hcCCCcc---cccccccC-------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGMPWQ---LIDACYQE-------SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~~~~---l~d~~~~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....... +....+.. ...+.....+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111000 00000000 0011233567899999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.41 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCC--CCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.++||+|+||+||+|.+.+++.||||++.. ......+.+.+|+.++++++ |+||+++++++......++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 56999999999999999999998899999999864 34556778999999999996 599999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999998653 35788899999999999999999998 99999999999995 589999999999877544
Q ss_pred cccccccccccccCccchhcccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-----------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
..........||+.|+|||++.+ ..++.++|||||||++|||++|..||..... . .........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~---~~~~~~~~~ 282 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKLHAIID 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--H---HHHHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--H---HHHHHHHhC
Confidence 33333445679999999999875 3689999999999999999999999964321 1 111111111
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... ....+......+.+|+.+||+.||++|||+.+|++..
T Consensus 283 ~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 283 PNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp TTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 111 1111111134678999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=342.81 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=196.0
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++. ..+|+|++.. ......+.+.+|+.++++++|+||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999863 4699999864 3455667899999999999999999999965 5567899999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999988543 345899999999999999999999998 9999999999999999999999999998664433
Q ss_pred ccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.........||+.|+|||++. +..++.++||||||+++|+|++|..||....... ....... .+.......
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~----~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVG----RGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHH----HTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhc----ccccCcchh
Confidence 233334567999999999986 5678899999999999999999999997543221 1111111 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.........+.+|+..||+.+|++|||+.+|+++|+...
T Consensus 249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111223456889999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=339.17 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=209.8
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999999889999999997543 23467899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998653 245889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... ...+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~~~~~--------- 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTGFR--------- 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----HhcCCc---------
Confidence 12233457889999999998899999999999999999999 89998653321 11111 111110
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112234688999999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.15 Aligned_cols=267 Identities=16% Similarity=0.216 Sum_probs=201.6
Q ss_pred hcCccccceecccCeEEEEEEEEc----CCcEEEEEEccccchh-----------hHHHHHHHHHHHHcCCCCceeeeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKISEQ-----------GLNELKNEVILFSKLQHRNLVKLLG 349 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 349 (605)
.++|++.+.||+|+||.||+|.+. .+..+|+|++...... ....+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999985 5788999998754321 1123567889999999999999999
Q ss_pred eEEe----CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC
Q 007397 350 CCIQ----GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 350 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~ 425 (605)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 78889999999 999999985433 6899999999999999999999998 99999999999999887
Q ss_pred --ceEEeecCCCccCCCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007397 426 --NPKISDFGLARTFGGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498 (605)
Q Consensus 426 --~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~ 498 (605)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432111 112345799999999999999999999999999999999999999964332211
Q ss_pred hhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCC
Q 007397 499 FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSV 564 (605)
Q Consensus 499 ~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 564 (605)
.+..............+. .... .......+.+++..||+.+|++||++.+|++.|+....
T Consensus 269 --~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLLDELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHHHTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhcccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111111111111 0000 01223468899999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.95 Aligned_cols=247 Identities=25% Similarity=0.299 Sum_probs=198.0
Q ss_pred cceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 291 NNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 57899999999999998 45899999999876666778899999999999999999999999999999999999999999
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE--cCCCceEEeecCCCccCCCCcccccc
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL--DHDMNPKISDFGLARTFGGDEIEGST 447 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll--~~~~~vkl~DFGla~~~~~~~~~~~~ 447 (605)
.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 98886532 34889999999999999999999998 9999999999999 5678899999999987654322 2
Q ss_pred cccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCC
Q 007397 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCN 527 (605)
Q Consensus 448 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~ 527 (605)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ..+..... ... .+... ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~---~~~--~~~~~-~~---- 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILA---CRW--DLEDE-EF---- 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH---TCC--CSCSG-GG----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---ccC--CCChh-hh----
Confidence 3356999999999999999999999999999999999999999754422 12221111 110 01010 01
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 528 PDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 528 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
......+.+|+.+||+.+|++|||+.++++.
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123468899999999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.84 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=194.4
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCC--ee
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK 357 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 357 (605)
..++|++.++||+|+||+||+|.+ .+++.||||++.+ ........+.+|+.+++++. |+||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999998 4589999999864 24455667889999999997 999999999997544 68
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 578888754 35889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCc-------------------ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007397 438 FGGDE-------------------IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497 (605)
Q Consensus 438 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 497 (605)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53210 1112334679999999999986 678999999999999999999999997654322
Q ss_pred chhHHHHHHHhhhcCCCcc-----------ccc--------------ccc--------cCCCCHHHHHHHHHHHHHhcCC
Q 007397 498 KFNVIRHAWNLWNKGMPWQ-----------LID--------------ACY--------QESCNPDEVIRCIHISLLCVQH 544 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~-----------l~d--------------~~~--------~~~~~~~~~~~l~~li~~Cl~~ 544 (605)
....+. .......... .+. ..+ ...........+.+|+.+||+.
T Consensus 239 ~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 QLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 222221 1111000000 000 000 0000001234678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007397 545 HPEDRPSMPSVILM 558 (605)
Q Consensus 545 dP~~RPt~~evl~~ 558 (605)
||++|||+.|++++
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=345.81 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=201.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.++||+|+||+||+|++.. ++.||+|++... .....+.+.+|+.++++++|+||+++++++......++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999854 899999998653 3344567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887433 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH--------hhhcC
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN--------LWNKG 512 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~--------~~~~~ 512 (605)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+..... .+...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 21 2234578999999999976 6689999999999999999999999976544322222221100 00000
Q ss_pred CCc---ccccccccC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPW---QLIDACYQE---SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~---~l~d~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... .+.++.... ...+.....+.+|+.+||+.||++|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000000000 0001233457899999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.00 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=206.9
Q ss_pred cCccccceecccCeEEEEEEEE-----cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--Cee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 357 (605)
+.|++.++||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 45899999999753 334567889999999999999999999999876 668
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999985543 34899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------CCCchhHHHHHHHh
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYN--------SDNKFNVIRHAWNL 508 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~--------~~~~~~~i~~~~~~ 508 (605)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7543221 22334568889999999999999999999999999999999998864211 00111111111111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+. ....+......+.+|+.+||+.+|++|||+.+|+++|+.
T Consensus 256 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11111 112223344578899999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=344.81 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=207.2
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 359 (605)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36799999999999999999998 5689999999977667778889999999999999999999999873 347789
Q ss_pred EEEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 360 IYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988653 23456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCccc-------ccccccccccCccchhcccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 439 GGDEIE-------GSTNKVIGTYGYMAPEYATDGL---FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 439 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........... . .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~-~--- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-L-A--- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-H-H---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-H-H---
Confidence 321111 0112345799999999987654 68999999999999999999999854221111100 0 0
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.... ............+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 260 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000 011111223456889999999999999999999999998874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.16 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=202.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||+||+|.+.. ++.||+|++.+. .......+.+|+.++++++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4689999999999999999999854 779999998642 223456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999988554 34899999999999999999999998 99999999999999999999999999865433
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. . ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~------- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---R----VE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---H----TC-------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---h----CC-------
Confidence 21 234578999999999999999999999999999999999999997543221111111 1 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...+......+.+|+.+||+.+|++|||+.+|++..
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 011122234678999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=346.93 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=193.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||+||+|++. +++.||||++... ..........|+..+.++ +|+||+++++++.++...++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 6999999998642 233344455555555555 899999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+ +++|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 668888775543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... .+..+..+.. .+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~----~~ 271 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC----CH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC----Cc
Confidence 32 2334569999999999876 78999999999999999999977654311 1111111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.. .....+.+++.+||+.+|++|||+.+|+++
T Consensus 272 ~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111 123568899999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.14 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=196.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||.||+|++. +++.||||++.+. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999984 5899999999753 334456678899999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|||+++++|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999988543 358999999999999999999998 88 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... .. ..
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~---~~-~~----- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL---ME-EI----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HC-CC-----
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHH---hC-CC-----
Confidence 322 223446799999999999999999999999999999999999999975432211 11111 11 10
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILML 559 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 559 (605)
..+......+.+|+.+||+.||++|| ++.+++++-
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 01112234688999999999999999 999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=362.63 Aligned_cols=260 Identities=24% Similarity=0.283 Sum_probs=197.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 355 (605)
.++|++.++||+|+||+||+|.+. +++.||||++.+. .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999984 4899999999753 445567788999999999999999999999654 3
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999876 444442 13889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC---
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG--- 512 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~--- 512 (605)
+...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+. ......
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~---~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI---EQLGTPCPE 285 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCSCCHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCCHH
Confidence 8764321 2344679999999999999999999999999999999999999997654322222111 111000
Q ss_pred ---------------CC--c-----ccccccccCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 513 ---------------MP--W-----QLIDACYQES---CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 513 ---------------~~--~-----~l~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.. . ......+... ........+.+|+.+||+.||++|||+.|++++-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 00 0 0000000000 0111256788999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.95 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=202.3
Q ss_pred HHHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-----chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-----SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
+....++|++.+.||+|+||+||+|.+ .+++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345667899999999999999999998 45889999998643 345567899999999999999999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcC-------------------------------------ccCCCCHHHHHHHHHHHHHH
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQT-------------------------------------KRELLDWSKRFHIICGTARG 397 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~a 397 (605)
...++||||+++++|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01123567788999999999
Q ss_pred HHHHHhCCCCCeEEecCCCCCEEEcCCC--ceEEeecCCCccCCCCc--ccccccccccccCccchhcccC--CCCCccc
Q 007397 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDM--NPKISDFGLARTFGGDE--IEGSTNKVIGTYGYMAPEYATD--GLFSVKS 471 (605)
Q Consensus 398 L~~LH~~~~~~iiHrDlkp~NIll~~~~--~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~ 471 (605)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+.... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 89999999998653211 1112344679999999999975 6789999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 007397 472 DVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS 551 (605)
Q Consensus 472 DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 551 (605)
||||||+++|||++|+.||......+ .+. ......... ..+ ........+.+|+.+||+.+|++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~---~~~---~~~~~~~~~--~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD---TIS---QVLNKKLCF--ENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCCCT--TSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH---HHH---HHHhccccc--CCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999997544321 111 111111110 000 01112346889999999999999999
Q ss_pred HHHHHHH
Q 007397 552 MPSVILM 558 (605)
Q Consensus 552 ~~evl~~ 558 (605)
+.++++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=348.16 Aligned_cols=255 Identities=21% Similarity=0.244 Sum_probs=183.3
Q ss_pred Ccccc---ceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSIN---NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~---~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 361 (605)
+|++. ++||+|+||+||+|.+. +++.||||++.+. ....+.+|+.+++.+. ||||+++++++.++...++||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45543 78999999999999985 5899999999653 4466788999999997 999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~DFGla~~~ 438 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999998653 45899999999999999999999998 99999999999998766 8999999999865
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....................+... ..
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~ 236 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FE 236 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CC
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CC
Confidence 43321 2334578999999999999999999999999999999999999997654432211122222222222211 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .........+.+|+.+||+.||++|||+.+|++.
T Consensus 237 ~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 237 G-----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp S-----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred c-----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 0001224568899999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.59 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=199.1
Q ss_pred HhcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe-
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE- 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 356 (605)
..++|.+.+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998743 458999998743 44556789999999999999999999999987553
Q ss_pred ----eEEEEEeeCCCchhhHHhhc---CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 357 ----KLLIYEFMPNKSLDYFIFDQ---TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 357 ----~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
.++||||+++++|..++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 49999999999999998543 23456899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHh
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~-- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DYLL-- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHH--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHH--
Confidence 99999987654433233334567889999999999999999999999999999999 88888754432221 1111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+... ..+......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 264 --~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 264 --HGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --TTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 11122334688999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=337.78 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=206.2
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999985 4899999998642 445567788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFGla~~ 437 (605)
|||+++++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888543 35899999999999999999999998 999999999999987665 99999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ...... .+... .
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~----~~~~~-~ 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAYD-Y 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC-C
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHH----hcccc-C
Confidence 643321 234578999999999999999999999999999999999999996543221 111111 11100 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ..........+.+++.+||+.+|++|||+.+++++
T Consensus 227 ~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 P-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp C-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00111223457899999999999999999999884
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.31 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=206.0
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|++.++||+|+||.||+|.+.. +..+|+|++.+......+.+.+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45689999999999999999999855 78999999987656667889999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~~ 439 (605)
|+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999888553 34899999999999999999999998 9999999999999 788999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+ ..... ..+... ...
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~-~~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKI----REGTFT-FPE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCCC-CCH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HhCCCC-CCc
Confidence 332 22345699999999998764 8999999999999999999999997543221 11111 111110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ... .....+.+++.+||+.+|++|||+.++++.
T Consensus 229 ~-~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 K-DWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp H-HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred h-hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 123468899999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.72 Aligned_cols=272 Identities=21% Similarity=0.270 Sum_probs=216.7
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC--eeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 360 (605)
.++|++.++||+|+||+||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999854 8999999997533 344677889999999999999999999998765 67999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE----cCCCceEEeecCCCc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKISDFGLAR 436 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll----~~~~~vkl~DFGla~ 436 (605)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 778889999999998
Q ss_pred cCCCCcccccccccccccCccchhcccC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-chhHHHHHHH
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATD--------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN-KFNVIRHAWN 507 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~-~~~~i~~~~~ 507 (605)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764432 2234679999999999865 567889999999999999999999997654422 2233332222
Q ss_pred hhhcCCCccccc-----------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 508 LWNKGMPWQLID-----------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 508 ~~~~~~~~~l~d-----------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+...+..+.. ..............+.+++.+||+.||++||++.++++.|...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 211111111100 0111234567778889999999999999999999999888654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=350.75 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=190.7
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|++.+.||+|+||.||+|++.. ++.||||++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 35789999999999999999999864 7899999997532 34668899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFGla~~~~ 439 (605)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998854 345899999999999999999999998 999999999999975 8899999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... .... ...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~----~~~~-~~~- 271 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRIL----NCEY-YFI- 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHH----TTCC-CCC-
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHH----hCCC-ccC-
Confidence 322 2234679999999999999999999999999999999999999986543221 1111111 1111 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+........+.+|+.+||+.||++|||+.++++.
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112234568899999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=340.53 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=213.0
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|++.++||+|+||+||+|.+.. ++.||+|++... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35689999999999999999999865 889999999753 3456788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996543 345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------~~~-------- 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDY-------- 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTC--------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------ccC--------
Confidence 2 22334557889999999999999999999999999999999 999987654332221111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+......+.+|+.+||+.+|++|||+.+|+++|+..
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111222345688999999999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.72 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=210.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++. +|+.||+|++.+. .......+.+|+.++++++||||+++++++......++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999985 5899999999653 233456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|..++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886543 334899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.........
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--------- 406 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--------- 406 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC---------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc---------
Confidence 32 123457999999999999999999999999999999999999999876544333333222111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|| ++.||+++
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11122335688999999999999999 78888875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.65 Aligned_cols=255 Identities=30% Similarity=0.463 Sum_probs=207.8
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46799999999999999999999888899999997532 34578899999999999999999999876 45689999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999985432 225899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ..+... ..+..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~~~~--------- 228 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL----ERGYR--------- 228 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCC---------
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH----hcccC---------
Confidence 2233457889999999998889999999999999999999 89998653321 111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011122335688999999999999999999999999765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.29 Aligned_cols=263 Identities=22% Similarity=0.263 Sum_probs=201.2
Q ss_pred hcCcccc-ceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSIN-NKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.+.|++. +.||+|+||+||+|.+ .+++.||||++..........+.+|+.++.++ +||||+++++++...+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 7899999999999997 46899999999776666677899999999985 7999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFGla~~~ 438 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998653 35899999999999999999999998 999999999999998776 999999999865
Q ss_pred CCCcc-----cccccccccccCccchhcccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhH-------
Q 007397 439 GGDEI-----EGSTNKVIGTYGYMAPEYATD-----GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV------- 501 (605)
Q Consensus 439 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~------- 501 (605)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223569999999999875 5589999999999999999999999976543321000
Q ss_pred -HHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 502 -IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 502 -i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..........+.. .+... ... .....+.+|+.+||+.||++|||+.++++.-
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHhccCc-ccCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0011111111111 00000 000 1234688999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=361.38 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=206.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|.+.+.||+|+||.||+|++. +|+.||||++.+.. ......+.+|+.+++.++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999985 69999999997532 23456789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999853 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...... ..+..
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i----~~~~~----- 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKI----CDGIF----- 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHH----HTTCC-----
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHH----hcCCc-----
Confidence 32 2334679999999999988766 78999999999999999999999754322 112111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|||+.+|+++
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0111123457899999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.64 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=207.8
Q ss_pred cCccccc-eecccCeEEEEEEEEc---CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINN-KLGEGGFGRVYKGTLV---DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|.+.+ .||+|+||.||+|.+. .++.||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677766 9999999999999863 5788999999763 445677899999999999999999999999 56678999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999998543 345899999999999999999999998 99999999999999999999999999987653
Q ss_pred Cccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+ .... ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----i~~~~~---- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKR---- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTTCC----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HhcCCc----
Confidence 3221 22233457899999999998889999999999999999998 999987544321 1111 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112223345788999999999999999999999999765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.51 Aligned_cols=257 Identities=25% Similarity=0.296 Sum_probs=190.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEE--------eC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCI--------QG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~ 354 (605)
..+|++.++||+|+||.||+|++. +++.||||++..........+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999984 58999999997766777788999999999996 999999999984 33
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCC
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGl 434 (605)
...++||||+. |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999996 688888866545557999999999999999999999874 3499999999999999999999999999
Q ss_pred CccCCCCccc----------ccccccccccCccchhcc---cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhH
Q 007397 435 ARTFGGDEIE----------GSTNKVIGTYGYMAPEYA---TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV 501 (605)
Q Consensus 435 a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 501 (605)
++........ .......||+.|+|||++ .+..++.++||||||+++|+|++|..||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 9876432211 111235689999999998 566789999999999999999999999864332110
Q ss_pred HHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 502 i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+...............+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 262 ----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 ----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000011111123467899999999999999999999999776
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.76 Aligned_cols=262 Identities=18% Similarity=0.247 Sum_probs=205.2
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeE-EeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 361 (605)
..++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+|+.++++++|++++..+..+ ..+...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999998 568999999865422 223578899999999988877666655 6678889999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~ 438 (605)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999986432 35899999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 439 GGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 439 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 443221 122346799999999999999999999999999999999999999987665544444433322211111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. ...... ...+.+++..||+.+|++|||+.+|++.|+..
T Consensus 239 ~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IE-----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 001111 34688999999999999999999999999765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.78 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=207.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3468999999999999999999985 5899999998643 3345678899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998843 335899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .... +...... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~~~~--~-- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD----WKEKKTY--L-- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHH----HHTTCTT--S--
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH----hhhcccc--c--
Confidence 32233445679999999999987765 7899999999999999999999976543321 1111 1111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011223467889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=336.01 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.3
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC--CeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 360 (605)
.++|++.++||+|+||.||+|++. ++.+|||++... .....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367999999999999999999984 889999998753 345567899999999999999999999999877 778999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.... ...+++..+..++.||++||.|||+++ ..|+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996532 235899999999999999999999864 3499999999999999999999999988765322
Q ss_pred CcccccccccccccCccchhcccCCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSV---KSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
....||+.|+|||++.+..++. ++||||||+++|||++|..||....... .. ..........
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~~~~~~~~~~-- 230 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IG---MKVALEGLRP-- 230 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HH---HHHHHSCCCC--
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HH---HHHHhcCCCC--
Confidence 2356899999999998765544 7999999999999999999997543211 11 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++..||+.+|++|||+.+|++.|+..
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 -------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 12222345688999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.28 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=206.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch------hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE------QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999985 589999999865322 2367899999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeecC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDFG 433 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DFG 433 (605)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999854 345889999999999999999999998 99999999999999888 79999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+... ....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i----~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANI----TSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH----HTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----Hhcc
Confidence 998765432 223456999999999999999999999999999999999999999654321 111111 1111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. . .+....... ...+.+++.+||+.||++|||+.+++++
T Consensus 235 ~-~-~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y-D-FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-C-CCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-c-cChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 011111112 2457899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.17 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=206.2
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|.+.+.||+|+||.||++.+.+ ++.+|+|++.+. .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999999854 789999998653 345567789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ ..... .....
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~----~~~~~------ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRI----KKNEY------ 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH----HHTCC------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH----hcCCC------
Confidence 221 2334579999999999999999999999999999999999999997543211 11111 11110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++||++.+|++.
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111123457889999999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=346.87 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchh-hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQ-GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|++.++||+|+||+||+|++. +++.||+|++...... ....+.+|+.++++++|+||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999985 6899999998653222 122345799999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 787777543 345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc-
Q 007397 444 EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC- 521 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~- 521 (605)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12234568999999999876 568999999999999999999999997654333222222211111111111111000
Q ss_pred --------cc----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 522 --------YQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 522 --------~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.. ....+.....+.+|+.+||+.||++|||+.||++.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 00 000112234678999999999999999999999843
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.15 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=209.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++. +|+.||+|++.+.. ......+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999985 59999999997532 23456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|||+++++|..++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 446899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .. ....
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~--i~-~~~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VL-EQAV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH--HH-HCCC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH--Hh-hccc-----
Confidence 4321 233458999999999999999999999999999999999999999875443332222211 11 1110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM-----PSVIL 557 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 557 (605)
..+......+.+|+.+||+.+|++||++ .+|++
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1122234567889999999999999975 66665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=339.60 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=201.3
Q ss_pred HHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHc--CCCCceeeeeeeEEeC---
Q 007397 280 TIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK--LQHRNLVKLLGCCIQG--- 354 (605)
Q Consensus 280 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--- 354 (605)
......++|++.++||+|+||.||+|++. ++.||||++.... ......|.+++.. ++|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445578999999999999999999875 8999999986432 2334445555554 4899999999999887
Q ss_pred -CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEEecCCCCCEEEcCCC
Q 007397 355 -EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD--------SRLRIIHRDLKTSNVLLDHDM 425 (605)
Q Consensus 355 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~~iiHrDlkp~NIll~~~~ 425 (605)
...++||||+++++|.+++... .+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 7889999999999999999543 489999999999999999999998 7 99999999999999999
Q ss_pred ceEEeecCCCccCCCCcccc--cccccccccCccchhcccCCCCCcc------cchHHHHHHHHHHHhC----------C
Q 007397 426 NPKISDFGLARTFGGDEIEG--STNKVIGTYGYMAPEYATDGLFSVK------SDVFSFGILVLEIVSG----------K 487 (605)
Q Consensus 426 ~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------~DvwSlGvvl~elltG----------~ 487 (605)
.+||+|||+++......... ......||+.|+|||++.+..+..+ +|||||||++|||++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999998764332211 1234579999999999988766655 9999999999999999 5
Q ss_pred CCCCCCCCCCch-hHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 488 RNRGLYNSDNKF-NVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 488 ~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.||......... ...... ........... ...........+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREI---VCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHH---HTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHH---HhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 555543332221 111111 11111000000 0011235677899999999999999999999999999765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.84 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=192.2
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccc---hhhHHHHHHHHHH-HHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKIS---EQGLNELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||.||+|++.. ++.||+|++.+.. ......+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3679999999999999999999854 8899999997532 2334556677776 577899999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998553 35889999999999999999999998 9999999999999999999999999998642
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ...... . ..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~---~-~~----- 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN---K-PL----- 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HHHHHH---S-CC-----
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHh---c-cc-----
Confidence 221 224456899999999999999999999999999999999999999975433211 111111 1 10
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
..+......+.+|+.+||+.||++||++.+
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 011122346789999999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=348.27 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=202.5
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..++|++.+.||+|+||.||++.+. +++.||+|++.+... ...+|+.++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999985 589999999975432 234678888887 7999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC----CceEEeecCCCcc
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD----MNPKISDFGLART 437 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~----~~vkl~DFGla~~ 437 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988543 45899999999999999999999998 9999999999998543 3599999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... .+...
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~-- 241 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS-- 241 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC--
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc--
Confidence 64332 12334678999999999998889999999999999999999999997654333333322221 11110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+...........+.+|+.+||+.||++||++.++++.
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111112234568899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.30 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=185.6
Q ss_pred HhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
..++|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.++++++||||+++++++......++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999998 468999999996432 2335678999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|..++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998643 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ . . .+
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~-~------~~ 228 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------V-L------AD 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------C-S------SC
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------h-h------cc
Confidence 3221 123456899999999999989999999999999999999999999765433221100 0 0 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 Y----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 1112223467899999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=351.69 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=206.9
Q ss_pred cCc-cccceecccCeEEEEEEEE-----cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCe
Q 007397 286 DNF-SINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEE 356 (605)
Q Consensus 286 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 356 (605)
++| ++.++||+|+||+||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8999999999999998864 25889999999764 34556779999999999999999999999987 467
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999998543 3899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC--------CchhHHHHHHH
Q 007397 437 TFGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSD--------NKFNVIRHAWN 507 (605)
Q Consensus 437 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~--------~~~~~i~~~~~ 507 (605)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77543221 2233456888999999999999999999999999999999999998643210 00000111111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.... ......+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 263 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 263 LLER---------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc---------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 111222333446788999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.46 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=203.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEE-eCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCI-QGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 358 (605)
..+|++.++||+|+||+||+|.+.+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3578999999999999999998743 236899998753 4455678899999999999999999999864 456789
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999543 345789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 439 GGDEIE--GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 439 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+|+...........+. .+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-------TTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------cCCCC
Confidence 543221 12234567889999999999999999999999999999999 555555443332221111 11110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 252 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 ---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111234688999999999999999999999999765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=332.98 Aligned_cols=261 Identities=18% Similarity=0.250 Sum_probs=207.4
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeE-EeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 362 (605)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+|+.+++.++|++++..+..+ ..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999998 568999999986432 234688999999999988876665554 66778899999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~~ 439 (605)
|+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999985432 35899999999999999999999998 9999999999999 588999999999998765
Q ss_pred CCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43221 1124467999999999999999999999999999999999999999876554443333332221111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+.+... ....+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 240 -----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 -----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 001111 224588999999999999999999999999765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=335.56 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=203.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||+||+|.+.+ +..||+|++... .....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998643 346999999764 34556789999999999999999999999764 45789
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999998653 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+. . +...
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~----~~~~--- 233 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K----GDRL--- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H----TCCC---
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c----CCCC---
Confidence 43221 1233457889999999998899999999999999999998 999997544332221111 1 1110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11112234688999999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.25 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=199.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|.+.++||+|+||+||++.+. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999984 58999999987533 3456789999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccC
Q 007397 363 FMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTF 438 (605)
Q Consensus 363 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~ 438 (605)
|+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988554 23456899999999999999999999998 9999999999999 45678999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ .... .. ..... ..
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~~~-~~-~~~~~-~~- 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQKA-TY-KEPNY-AV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-HH-CCCCC-CC-
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---Hhhh-cc-CCccc-cc-
Confidence 4332 233456899999999886 5689999999999999999999999975432111 1111 11 01000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ... ....+.+|+.+||+.||++|||+.||++.
T Consensus 247 ~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 E---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011 13457789999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=348.40 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=200.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.+.|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999997 56899999998643 334456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+. |+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 5676666433 245899999999999999999999998 99999999999999999999999999987532
Q ss_pred CcccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ...+. ........ .+
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~---~~~~~~~~-~~ 273 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY---HIAQNESP-AL 273 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HHHHSCCC-CC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHH---HHHhcCCC-CC
Confidence 22357999999999985 56789999999999999999999999865432 11111 11111111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. .......+.+++.+||+.+|++|||+.+|++..
T Consensus 274 ~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 112234578899999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.64 Aligned_cols=261 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred HHHHHHhcCcccc-ceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCC-CCceeeeeeeEEe
Q 007397 279 ATIANATDNFSIN-NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQ 353 (605)
Q Consensus 279 ~~~~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 353 (605)
.......++|.+. ++||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++++. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3445566788887 89999999999999985 5899999998753 2334678899999999995 6999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEe
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKIS 430 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~ 430 (605)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999988543 2346899999999999999999999998 999999999999988 7899999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ....... .
T Consensus 177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~-~ 249 (327)
T 3lm5_A 177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQV-N 249 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT-C
T ss_pred eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHhc-c
Confidence 999998764322 12345799999999999999999999999999999999999999965443211 1111111 0
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.. ............+.+++.+||+.+|++|||+.++++.-
T Consensus 250 ~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 250 VD---------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp CC---------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred cc---------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 00 01111122344688999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.13 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=200.1
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
..++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999985 5889999999753 23345778999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .+. .........
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~---~~~~~~~~~---- 253 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMG---AHINQAIPR---- 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHH---HHHHSCCCC----
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHH---HHhccCCCC----
Confidence 33211 223456899999999999999999999999999999999999999753321 111 111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcCCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRP-SMPSVILMLGSDS 563 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~~~ 563 (605)
. ..........+.+++.+||+.+|++|| ++.++++.|+...
T Consensus 254 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0 011122234578899999999999999 9999999998763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=369.80 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=210.4
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
..++|++.++||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++|+||+++++++.+ ...++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346789999999999999999999888899999997533 345678999999999999999999999866 678999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999995432 235889999999999999999999998 99999999999999999999999999987653321
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+... ..+..
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~-------- 482 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGYR-------- 482 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH----HTTCC--------
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC--------
Confidence 1 1223456789999999999999999999999999999999 89998654321 112111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
...+......+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus 483 -~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1122233456889999999999999999999999998873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.32 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=202.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|++.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.++++++||||+++++++......+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999998743 246999999753 3445667899999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998653 245899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 439 GGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 439 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ..... ...+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~----~~~~~~-- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKA----INDGFR-- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCC--
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHCCCc--
Confidence 433211 11223346789999999999999999999999999999999 99998654321 11111 111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222345688999999999999999999999999765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=348.65 Aligned_cols=254 Identities=19% Similarity=0.221 Sum_probs=193.7
Q ss_pred hcCcccc-ceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHH-cCCCCceeeeeeeEEe----CCee
Q 007397 285 TDNFSIN-NKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFS-KLQHRNLVKLLGCCIQ----GEEK 357 (605)
Q Consensus 285 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 357 (605)
.++|.+. +.||+|+||+||++.+. +++.||||++... ..+.+|+.++. ..+|+||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 78999999999999985 5899999999642 35667888774 5589999999999875 5678
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGL 434 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFGl 434 (605)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 345899999999999999999999998 999999999999998 78899999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..... .+..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQY 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcc
Confidence 98754322 23356789999999999999999999999999999999999999976554332211111111 1110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+ ...........+.+|+.+||+.||++|||+.+|++..
T Consensus 285 -~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 -EF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -CC-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -cC-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 0001112334688999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.37 Aligned_cols=267 Identities=23% Similarity=0.266 Sum_probs=194.6
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
...++|++.++||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999974 58999999997532 2335567899999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-----CCCceEEeecCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-----HDMNPKISDFGL 434 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-----~~~~vkl~DFGl 434 (605)
||||+++ +|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 888888543 34899999999999999999999998 99999999999994 445699999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+....+...........
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764322 123345689999999999874 489999999999999999999999976443222111111111000000
Q ss_pred Cccc-------------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQL-------------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l-------------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ....+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00000000001123567899999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.73 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=203.6
Q ss_pred CccccceecccCeEEEEEEEEcC-C---cEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee-EEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLVD-G---QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 360 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 360 (605)
.|.+.++||+|+||+||+|.+.+ + ..+|+|++... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999998643 2 37999998753 345567889999999999999999999999876665 999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+.+++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999998553 345789999999999999999999998 99999999999999999999999999987644
Q ss_pred Ccc--cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEI--EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ......... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~---- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRR---- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCC----
Confidence 321 1223345688999999999999999999999999999999996655433221 111111111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122234688999999999999999999999999775
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.88 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=195.7
Q ss_pred cCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe-CCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 359 (605)
..|++.+.||+|+||+||+|++.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.. +...++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998743 246899998753 34566789999999999999999999998754 567899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999543 335789999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 440 GDEIE--GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 440 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||......+....+. .+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~~~- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRRL- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTCCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCCCC-
Confidence 33221 11233457889999999999999999999999999999999 677776554433222111 11110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 316 --------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01112234688999999999999999999999999775
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.26 Aligned_cols=269 Identities=20% Similarity=0.278 Sum_probs=202.4
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-------- 353 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 353 (605)
.++|++.++||+|+||+||+|++ .+++.||+|++... .......+.+|+.++++++|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 56899999998643 22334567899999999999999999999987
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
....++||||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 555555332 234899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCc--ccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 434 LARTFGGDE--IEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 434 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764321 1122344678999999999876 5589999999999999999999999986543333222222211111
Q ss_pred cCCCcccccccc--------cCCCCH-H------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 KGMPWQLIDACY--------QESCNP-D------EVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~~~--------~~~~~~-~------~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
............ ...... . ....+.+|+.+||+.||++|||+.|+++.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 111111100000 000000 1 123478999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=347.15 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=202.9
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEe
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 353 (605)
...++|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999997 458999999987532 1234457789999999999999999999999
Q ss_pred CCeeEEEEEeeCCC-chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 354 GEEKLLIYEFMPNK-SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 354 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
....++||||+..+ +|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 999888543 35899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
|+++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 9998765432 2234679999999999988876 88999999999999999999999642210
Q ss_pred CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 512 ~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...... .+......+.+|+.+||+.+|++|||+.+|++..
T Consensus 237 ------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 ------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 0111234588999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=337.36 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=199.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc---cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.. ........+.+|+.++++++|+||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999997 5689999999874 2345667889999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
|||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999886532 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ....... ........+
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~~~~~~~~-- 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK----IEQCDYPPL-- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHH----HHTTCSCCC--
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHH----hhcccCCCC--
Confidence 3221 123456899999999999999999999999999999999999998653321 1111111 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
........+.+++.+||+.||++|||+.+|+++|+..
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0112234688999999999999999999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.60 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=193.4
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEe
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQ 353 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 353 (605)
...++|.+.++||+|+||+||+|.+. +++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999984 48999999986521 122235789999999999999999999975
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---ceEEe
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---NPKIS 430 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~vkl~ 430 (605)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5568999999999999988843 345899999999999999999999998 99999999999997654 59999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~i-- 357 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQI-- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HHH--
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HHH--
Confidence 999998765332 2334679999999999864 568899999999999999999999997654332211 111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+... .. +.... .....+.+|+.+||+.+|++|||+.+++++
T Consensus 358 --~~~~~~-~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 --TSGKYN-FI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HTTCCC-CC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --hcCCCC-CC-chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111110 00 00001 123468899999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.00 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=206.5
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|.+.+.||+|+||.||++.+.+ ++.+|+|++.+. .....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4679999999999999999999854 889999998653 344567788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. .. .......
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~------ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YL----RIKKNEY------ 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH----HHHTTCC------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHhhccC------
Confidence 221 23345789999999999998999999999999999999999999975432111 11 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+......+.+++.+||+.+|++|||+.++++..
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 01112234578899999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.69 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=206.2
Q ss_pred cCccccceecccCeEEEEEEEE----cCCcEEEEEEccccc----hhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL----VDGQEIAVKRLSKIS----EQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
++|++.++||+|+||.||++++ .+++.||||++.+.. ....+.+.+|+.+++++ +|+||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999998 368999999987532 23445677899999999 69999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999998653 35899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+...... . .
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~-~- 282 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S-E- 282 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--C-C-
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--c-C-
Confidence 7643322 22334679999999999986 34789999999999999999999999865544433333221111 1 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhc
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILMLG 560 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~ 560 (605)
...+......+.+|+.+||+.||++|| ++.++++.+-
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111222334678999999999999999 9999998763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.04 Aligned_cols=266 Identities=25% Similarity=0.367 Sum_probs=201.3
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3689999999999999999999854 899999998543 3344566889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998876432 34899999999999999999999998 999999999999999999999999999875432
Q ss_pred cccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------Hhhhc-
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NLWNK- 511 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~~~~- 511 (605)
. .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.... ..+..
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2 122345689999999999875 78999999999999999999999997654322211111100 00000
Q ss_pred -----CCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 512 -----GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 512 -----~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.....+..........+.....+.+|+.+||+.||++|||+.||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000111234568899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.60 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=197.5
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.. ......+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36899999999999999999998 4589999999964 23445677889999999999999999999997653
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+ +++|..++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899998854 35889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+. ...... .
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~~-~ 246 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM---KVTGTP-P 246 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCC-C
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCC-C
Confidence 875432 334678999999999987 679999999999999999999999997654322221111 111000 0
Q ss_pred cccc-------------------cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLI-------------------DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~-------------------d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+++ ...+ ..........+.+|+.+||+.||++|||+.+++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0000 0000 011122245688999999999999999999999963
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.89 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=196.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHH--HHHHHHcCCCCceeeeeeeEEe-----CCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKN--EVILFSKLQHRNLVKLLGCCIQ-----GEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~-----~~~~ 357 (605)
.++|++.++||+|+||.||+|+. +++.||||++.... ...+.. |+..+..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999976 68999999996532 233333 4444556899999999986542 2356
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEEecCCCCCEEEcCCCceE
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD---------SRLRIIHRDLKTSNVLLDHDMNPK 428 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~iiHrDlkp~NIll~~~~~vk 428 (605)
++||||+++++|.+++... ..++..+..++.||++||.|||+. + |+||||||+||||+.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999999543 348889999999999999999998 7 99999999999999999999
Q ss_pred EeecCCCccCCCCcc------cccccccccccCccchhcccC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 007397 429 ISDFGLARTFGGDEI------EGSTNKVIGTYGYMAPEYATD-------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNS 495 (605)
Q Consensus 429 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 495 (605)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 112234569999999999987 4567899999999999999999877654433
Q ss_pred CCchhH-HH----------HHHHhhh-cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 496 DNKFNV-IR----------HAWNLWN-KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 496 ~~~~~~-i~----------~~~~~~~-~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...... +. ....... ......+.+ ...........+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 222111 10 0000010 110001100 0112334666799999999999999999999999999775
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=331.87 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=204.8
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe---------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--------- 353 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 353 (605)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999985 69999999997543 346789999999999999999998864
Q ss_pred -------CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 354 -------GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 354 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 445789999999999999996542 346899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence 9999999998765432 123456899999999999999999999999999999999999876311 1111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLA 566 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 566 (605)
........ ... ....+.+++.+||+.+|++|||+.+++++|......+
T Consensus 229 ~~~~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 TDLRDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHhhcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111111 111 2235778999999999999999999999998764433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=345.07 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=205.0
Q ss_pred hcCccccceecccCeEEEEEEEE------cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 34779999999753 445567789999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEe
Q 007397 358 LLIYEFMPNKSLDYFIFDQTK----RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKIS 430 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~ 430 (605)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245889999999999999999999998 9999999999999844 469999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhh
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLW 509 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~ 509 (605)
|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF----V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH----H
Confidence 9999876533332223344568999999999999999999999999999999998 99998654321 11111 1
Q ss_pred hcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 510 ~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+... ..+......+.+++.+||+.+|++||++.+|++.|...
T Consensus 259 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111 11122334688999999999999999999999999765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.20 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=204.0
Q ss_pred hcCccccc-eecccCeEEEEEEEE---cCCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 285 TDNFSINN-KLGEGGFGRVYKGTL---VDGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 285 ~~~y~~~~-~LG~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
.++|.+.+ .||+|+||+||+|.+ ..++.||||++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788888 999999999999965 236889999997532 33467899999999999999999999999 667789
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 34889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 439 GGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 439 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ... ....+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC--
Confidence 443221 11223446789999999998889999999999999999999 999987543211 111 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111223345688999999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=356.01 Aligned_cols=195 Identities=25% Similarity=0.416 Sum_probs=154.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Ce
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 356 (605)
.++|++.++||+|+||+||+|++. +++.||||++.+. .....+.+.+|+.+|++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 378999999999999999999985 5899999998652 344567789999999999999999999998543 56
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 678887743 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc-------------------------ccccccccccCccchhcc-cCCCCCcccchHHHHHHHHHHHhC
Q 007397 437 TFGGDEIE-------------------------GSTNKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSG 486 (605)
Q Consensus 437 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvvl~elltG 486 (605)
........ ......+||+.|+|||++ .+..++.++||||||||||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422110 123446789999999986 466799999999999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.69 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=204.1
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|.+.+.||+|+||.||++++. +++.||+|++..........+.+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999985 689999999986555556678899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~~ 439 (605)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988543 35899999999999999999999998 9999999999999 788999999999997653
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...... ..+.. ..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i----~~~~~-~~-- 226 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKI----KEGYY-EF-- 226 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----HHCCC-CC--
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HcCCC-CC--
Confidence 32 223456899999999999999999999999999999999999998654321 111111 11111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...........+.+++.+||+.||++|||+.++++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112234568899999999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=333.70 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=199.9
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc----hhhHHHHHHHHHHHHcCCCCceeeeeeeEE--eCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS----EQGLNELKNEVILFSKLQHRNLVKLLGCCI--QGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 356 (605)
..++|++.+.||+|+||.||++.+. +++.+|+|++.... ......+.+|+.++++++|+||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999984 58899999997532 245678899999999999999999999984 4567
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999987 55555443 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
...............||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... .... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE----NIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH----HHhcCCC
Confidence 765433333334566999999999997644 478999999999999999999999753321 1111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+......+.+++.+||+.||++|||+.++++..
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11112234678899999999999999999999853
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.20 Aligned_cols=251 Identities=15% Similarity=0.137 Sum_probs=202.1
Q ss_pred hcCccccceecccCeEEEEEEE------EcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGT------LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGE 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 355 (605)
.++|.+.++||+|+||+||+|. ...++.||||++.... ..++..|+.+++.++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4789999999999999999994 3558999999997643 345667777777776 999999999999999
Q ss_pred eeEEEEEeeCCCchhhHHhhcC--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC----------
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQT--KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---------- 423 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---------- 423 (605)
..++||||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999996532 3456999999999999999999999998 999999999999998
Q ss_pred -CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHH
Q 007397 424 -DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502 (605)
Q Consensus 424 -~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i 502 (605)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 899999999999765322222334456799999999999999999999999999999999999999854332110
Q ss_pred HHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhcCC
Q 007397 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDR-PSMPSVILMLGSD 562 (605)
Q Consensus 503 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~L~~~ 562 (605)
.+...+.... ....+.+++..||+.+|.+| |++.++.+.|+..
T Consensus 294 --------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 --------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0111111111 13456678899999999999 6788888877653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.38 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=200.6
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999985 6999999998753 334566788999999999 89999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC--------------
Q 007397 360 IYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-------------- 424 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-------------- 424 (605)
||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999865432 256899999999999999999999998 9999999999999844
Q ss_pred -----CceEEeecCCCccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007397 425 -----MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498 (605)
Q Consensus 425 -----~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~ 498 (605)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998764322 24589999999999876 56789999999999999999988764211
Q ss_pred hhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 499 FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 499 ~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .....+.... .+......+.+++.+||+.||++|||+.++++.
T Consensus 236 --~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 --QW----HEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HH----HHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --HH----HHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 1111222111 111223468899999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.96 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=201.6
Q ss_pred CccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 287 NFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
+|.....||+|+||.||+|.+ .+++.||+|.+........+.+.+|+.++++++||||+++++++......++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455556999999999999998 4588999999987666667889999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-CCceEEeecCCCccCCCCccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-DMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-~~~vkl~DFGla~~~~~~~~~ 444 (605)
+++|.+++........+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999976555556778999999999999999999998 999999999999988 89999999999987643221
Q ss_pred ccccccccccCccchhcccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...... ... ..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~--~~--------- 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKV-GMF--KV--------- 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHHH-HHH--CC---------
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHhh-ccc--cc---------
Confidence 223457899999999997654 8899999999999999999999986432211 111110 000 00
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+......+.+++.+||+.+|++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011122234568899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.62 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=205.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999985 5899999998754 44556788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999998553 3488999999999999999999995 7 99999999999999999999999999875421
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH---------------
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------------- 506 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------------- 506 (605)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 12334579999999999999999999999999999999999999997544221111100000
Q ss_pred --------HhhhcCCCccccccccc----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 507 --------NLWNKGMPWQLIDACYQ----ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 507 --------~~~~~~~~~~l~d~~~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..........+++.... ..........+.+|+.+||+.||++|||+.+++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000000010000 001111234688999999999999999999998853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.75 Aligned_cols=266 Identities=25% Similarity=0.306 Sum_probs=199.2
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccch-----hhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE-----QGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
...++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+.++++++|+||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999985 489999999974321 112467899999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++ +|..++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 777777443 335788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+.............
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence 764332 123345789999999999764 5899999999999999999999998754432 2222222221111100
Q ss_pred c------cccccc---cCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 Q------LIDACY---QESCN-----PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 ~------l~d~~~---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. +.+... ....+ ......+.+|+.+||+.||++|||+.|++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 000000 00011 12235688999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.01 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=204.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++|+||+++++++......++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999985 4789999998653 223356789999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988654 34899999999999999999999998 99999999999999999999999999876533
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... .... .. ....
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~---~~-~~~~------ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THRR---IV-NVDL------ 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HH-TTCC------
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHHH---Hh-cccc------
Confidence 21 234578999999999999999999999999999999999999997543211 1111 11 1110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1112223467899999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=338.00 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=209.4
Q ss_pred hcCccccceecccCeEEEEEEEE-----cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC--ee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-----VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 357 (605)
.++|++.++||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++|+||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999983 358899999998776777788999999999999999999999987644 78
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---------CCchhHHHHHHH
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNS---------DNKFNVIRHAWN 507 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~---------~~~~~~i~~~~~ 507 (605)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+..... ............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 112334577889999999988899999999999999999999988753210 000000111111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+. ....+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1112223345688999999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=354.85 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=208.6
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC-CceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||.||+|++ .+++.||||++.... ....+.+|+.+++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999997 558999999876432 22357889999999987 556666667778889999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~~~ 439 (605)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999985432 35899999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
..... .......||+.|+|||++.+..++.++||||||||||||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43221 1123567999999999999999999999999999999999999999876665554444433222211111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+ ...+ ...+.+|+..||+.+|++||++.+|+++|+..
T Consensus 238 ~~l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EAL-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 1112 34688999999999999999999999988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=368.44 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=201.9
Q ss_pred Cccccc-eecccCeEEEEEEEEc---CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 287 NFSINN-KLGEGGFGRVYKGTLV---DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 287 ~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++.+.+ +||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.++++++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999874 4567999999764 33467889999999999999999999999876 5689999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999999998543 345899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 442 EIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 442 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+ .... ...+..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~~~~----- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKR----- 557 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHH----HHTTCC-----
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCC-----
Confidence 211 11222346789999999999999999999999999999998 999997654322 1111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+|+..||+.+|++||++.+|++.|+..
T Consensus 558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122233445788999999999999999999999999765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.46 Aligned_cols=243 Identities=15% Similarity=0.156 Sum_probs=190.5
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccc---cchhhHHHHHHHH---HHHHcCCCCceeeee-------ee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSK---ISEQGLNELKNEV---ILFSKLQHRNLVKLL-------GC 350 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 350 (605)
.++|++.+.||+|+||+||+|++ .+++.||||++.. ......+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999997 4599999999873 3445567889999 555566899999998 55
Q ss_pred EEeCC-----------------eeEEEEEeeCCCchhhHHhhcCc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007397 351 CIQGE-----------------EKLLIYEFMPNKSLDYFIFDQTK----RELLDWSKRFHIICGTARGLLYLHQDSRLRI 409 (605)
Q Consensus 351 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 409 (605)
+.... ..++||||+ +|+|.+++..... ...+++..++.++.||++||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54443 278999999 6799999865422 112335888899999999999999998 9
Q ss_pred EEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCC-----------CCCcccchHHHHH
Q 007397 410 IHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-----------LFSVKSDVFSFGI 478 (605)
Q Consensus 410 iHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGv 478 (605)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 479 LVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 479 vl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
++|||++|+.||...........+ ... .... ...+.+|+.+||+.||++|||+.++++.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI---------------FRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG---------------GSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhhh---------------hhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999654432221111 000 0112 3468899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=335.53 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.+.|++.++||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999874 5899999998643 23456789999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998843 35899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+... ....... +
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~-----~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFLI----PKNNPPT-----L 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----HHSCCCC-----C
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHHh----hcCCCCC-----C
Confidence 2 223457899999999999999999999999999999999999998654321 111111 1111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.......+.+|+..||+.+|++|||+.+|++..
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112234588999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=351.08 Aligned_cols=200 Identities=25% Similarity=0.412 Sum_probs=167.4
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Ce
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 356 (605)
.++|++.+.||+|+||.||+|++. +++.||||++.+. .......+.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999985 4889999999753 344567789999999999999999999999776 57
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 588888843 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCccc--------------------ccccccccccCccchhcc-cCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 007397 437 TFGGDEIE--------------------GSTNKVIGTYGYMAPEYA-TDGLFSVKSDVFSFGILVLEIVSGKRNRG 491 (605)
Q Consensus 437 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvvl~elltG~~p~~ 491 (605)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76433211 123557899999999986 55679999999999999999998655543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.94 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=203.3
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcE--EEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQE--IAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.+.||+|+||.||+|++. ++.. +|+|++... .......+.+|+.+++++ +||||+++++++......++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999974 4554 499988652 334556788999999999 899999999999999999999
Q ss_pred EEeeCCCchhhHHhhcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 361 YEFMPNKSLDYFIFDQT-------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
|||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... . .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~----~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----Y 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----H
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---H----H
Confidence 9999999875321 112233457889999999998889999999999999999998 999986543211 1 1
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.....+.. ...+......+.+|+.+||+.+|++|||+.++++.|+..
T Consensus 252 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 111222345688999999999999999999999999765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.37 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=208.0
Q ss_pred HHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHc--CCCCceeeeeeeEEeCC-
Q 007397 279 ATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSK--LQHRNLVKLLGCCIQGE- 355 (605)
Q Consensus 279 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 355 (605)
.......++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|+.+++. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33445567899999999999999999998 5899999999653 34567788888887 78999999999998876
Q ss_pred ---eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCEEEcCC
Q 007397 356 ---EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKTSNVLLDHD 424 (605)
Q Consensus 356 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiHrDlkp~NIll~~~ 424 (605)
..++||||+++++|.+++... .+++..++.++.||+.||.||| +.+ |+||||||+|||++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 789999999999999999542 4889999999999999999999 777 9999999999999999
Q ss_pred CceEEeecCCCccCCCCccc--ccccccccccCccchhcccCC------CCCcccchHHHHHHHHHHHhC----------
Q 007397 425 MNPKISDFGLARTFGGDEIE--GSTNKVIGTYGYMAPEYATDG------LFSVKSDVFSFGILVLEIVSG---------- 486 (605)
Q Consensus 425 ~~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvvl~elltG---------- 486 (605)
+.+||+|||++......... .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876433211 123445799999999999875 344789999999999999999
Q ss_pred CCCCCCCCCCCc-hhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 487 KRNRGLYNSDNK-FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 487 ~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..||........ ...+. ..........-+.. ..........+.+|+.+||+.+|++|||+.+|+++|+..
T Consensus 264 ~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMR---KVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSSCCHHHHH---HHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHH---HHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 667655433221 11111 11111111110110 012345667899999999999999999999999999765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=370.74 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=206.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 358 (605)
..++|+++++||+|+||.||+|++. +++.||||++.+. .....+.+..|..++..+ +|+||+++++++...+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999985 4889999999753 234456788899999988 6999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999654 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|..||...+..+ .+..+. ....
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~----~~~~---- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM----EHNV---- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----SSCC----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHH----hCCC----
Confidence 3222 22445789999999999999999999999999999999999999997644322 222111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM-----PSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 558 (605)
..+......+.+|+.+||+.||++||++ .+|+++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1122234568899999999999999998 777753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.28 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=202.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999985 58999999986432 12467899999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeecC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDFG 433 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DFG 433 (605)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998543 35899999999999999999999998 99999999999998877 89999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+.. .....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTN----ISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH----HHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHH----hHhcc
Confidence 998764322 1234568999999999999999999999999999999999999997543211 1111 11111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. . ........ ....+.+++.+||+.+|++||++.++++.
T Consensus 228 ~-~-~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y-D-FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C-C-CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c-C-Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 0 00111111 23457889999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.60 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=189.2
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999874 58999999986532 344567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhc-----CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 362 EFMPNKSLDYFIFDQ-----TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 362 e~~~~~~L~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988542 12446899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcc---cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 437 TFGGDEI---EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 437 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ +..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~----~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQ----N 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHT----S
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhc----c
Confidence 6543211 111234568999999999876 5689999999999999999999999976543221 111111 1
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
....+................+.+++.+||+.||++||++.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111111111112223467899999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.62 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=198.9
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe------eE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 358 (605)
..+|++.++||+|+||+||+|++..+..+|+|++..... ...+|+.+++.++|+||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999998877899998864322 12369999999999999999999865433 78
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCceEEeecCCCcc
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLART 437 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~vkl~DFGla~~ 437 (605)
+||||++++.+............+++..+..++.||++||.|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998766555433334557899999999999999999999998 99999999999999 789999999999987
Q ss_pred CCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH--------Hh
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW--------NL 508 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~--------~~ 508 (605)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+.... ..
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643322 2345789999999998765 58999999999999999999999997654322222221110 00
Q ss_pred hh----cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WN----KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~----~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. ......+....+...........+.+|+.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 000000000000001111233568899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.86 Aligned_cols=262 Identities=15% Similarity=0.206 Sum_probs=205.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC---------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceee---------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD---------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK--------- 346 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 346 (605)
.++|++.+.||+|+||.||+|++.. ++.||+|++... +.+.+|+.++++++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999864 789999998653 46788999999999999988
Q ss_pred ------eeeeEEe-CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCE
Q 007397 347 ------LLGCCIQ-GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419 (605)
Q Consensus 347 ------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NI 419 (605)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5666665 67889999999 999999996542 346899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEeecCCCccCCCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 007397 420 LLDHDM--NPKISDFGLARTFGGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492 (605)
Q Consensus 420 ll~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~ 492 (605)
|++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876432211 112345799999999999999999999999999999999999999976
Q ss_pred CCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 493 ~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..... ..+......+... ...+.+.... .......+.+|+.+||+.+|++||++.+|+++|+..
T Consensus 271 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH--HHHHHHHHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 54221 1222222111111 1112111110 011124688899999999999999999999999765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.89 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=206.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 359 (605)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999985 5899999998642 34556789999999999999999999998864 567899
Q ss_pred EEEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 360 IYEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986543 2345899999999999999999999975 1239999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..... ...+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK----IREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHH----Hhhccccc
Confidence 7643221 122356899999999999999999999999999999999999999765421 11111 11121111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+......+.+++.+||+.+|++||++.+|++.+..
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112233568899999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.80 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=204.1
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC--------CCceeeeeeeEE---
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ--------HRNLVKLLGCCI--- 352 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 352 (605)
.++|++.++||+|+||+||+|++. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999974 5889999999653 445677889999999885 788999999987
Q ss_pred -eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCC-----
Q 007397 353 -QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDM----- 425 (605)
Q Consensus 353 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~----- 425 (605)
.+...++||||+.+ +|...+... ....+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 55678999999955 444444332 224589999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------ceEEeecCCCccCCCCcccccccccccccCccchhc
Q 007397 426 --------------------------------------------NPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461 (605)
Q Consensus 426 --------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 461 (605)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999875422 334578999999999
Q ss_pred ccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHH---HHHHHhhhcC--------C-Ccccccc---------
Q 007397 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI---RHAWNLWNKG--------M-PWQLIDA--------- 520 (605)
Q Consensus 462 ~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i---~~~~~~~~~~--------~-~~~l~d~--------- 520 (605)
+.+..++.++|||||||++|||++|..||............ .......... . .......
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999876554432221 1111111100 0 0000000
Q ss_pred --------c--ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 --------C--YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 --------~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. -....+......+.+|+.+||+.||++|||+.+|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 0113456677889999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.03 Aligned_cols=260 Identities=20% Similarity=0.327 Sum_probs=207.7
Q ss_pred cHHHHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--------hhhHHHHHHHHHHHHcC-CCCceee
Q 007397 277 ELATIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--------EQGLNELKNEVILFSKL-QHRNLVK 346 (605)
Q Consensus 277 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~ 346 (605)
.........++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34445566688999999999999999999985 69999999986432 12245678999999999 7999999
Q ss_pred eeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc
Q 007397 347 LLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN 426 (605)
Q Consensus 347 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~ 426 (605)
+++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 999999999999999999999999998643 35899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchh
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFN 500 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 500 (605)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---IL 312 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HH
Confidence 9999999998765332 2334679999999999863 3588999999999999999999999965332 11
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+.... .+... ...+. ... ....+.+++.+||+.+|++|||+.++++.
T Consensus 313 ~~~~i~----~~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIM----EGQYQ-FSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH----HTCCC-CCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHH----hCCCC-CCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 11110 00000 011 12457899999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=333.29 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=198.1
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-CeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 363 (605)
.++|++.+.||+|+||+||+|++ .++.||+|++... ...+.+.+|+.++++++|+||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 4889999999753 2456789999999999999999999987654 478999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++++|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999986532 224788999999999999999999998 999999999999999999999999999765332
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ... ...+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----~~~~~~-------- 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----VEKGYK-------- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH----HTTTCC--------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HhcCCC--------
Confidence 223457889999999999999999999999999999998 9999876543221 111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111222345688999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=357.89 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=203.5
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
..++|++.++||+|+||+||+|++. +++.||||++.+. .......+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999985 5899999998642 234567889999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc---CCCceEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~---~~~~vkl~DFGla~~ 437 (605)
|||+.+++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888554 35899999999999999999999998 99999999999995 456799999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... ..+.... .+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~----~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE----TGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCCCCC
Confidence 64332 2334579999999999876 5899999999999999999999999754322 1222111 1111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. +........+.+|+.+||+.+|++|||+.++++.
T Consensus 243 ~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0011223467899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=358.44 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=199.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.++||+|+||+||+|++. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999985 58899999987532 334577899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla~~~ 438 (605)
||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888543 34899999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||......+ .+.... .+... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~----~~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVE----KGKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCCC-CC
Confidence 4332 233467999999999886 469999999999999999999999997644322 111111 11110 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+. .......+.+|+.+||+.+|.+|||+.+++++
T Consensus 258 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 01123457899999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.25 Aligned_cols=257 Identities=17% Similarity=0.287 Sum_probs=201.3
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEe--CCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 360 (605)
.++|++.++||+|+||+||+|++ .+++.||||++... ..+.+.+|+.++++++ |+||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999987 55899999999753 3467889999999997 9999999999987 6678999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFG 439 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~ 439 (605)
|||+++++|..++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 2788999999999999999999998 99999999999999777 89999999998764
Q ss_pred CCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh---------
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW--------- 509 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~--------- 509 (605)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+.......
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence 332 2334578999999999987 67899999999999999999999998543321 11111111100
Q ss_pred hcCC--------------CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGM--------------PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~--------------~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ....................+.+|+.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000001111111122234568899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.47 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=196.9
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999985 6899999998653 223456788999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998654 34889999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..... ...+..
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~~~~----- 228 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKK----IRGGVF----- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCC-----
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHH----hhcCcc-----
Confidence 321 233568999999999988765 68999999999999999999998653321 11111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111123457889999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.11 Aligned_cols=271 Identities=20% Similarity=0.269 Sum_probs=200.4
Q ss_pred cHHHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccc-----------hhhHHHHHHHHHHHHcCCCCcee
Q 007397 277 ELATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS-----------EQGLNELKNEVILFSKLQHRNLV 345 (605)
Q Consensus 277 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 345 (605)
.+..+....++|++.+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456677789999999999999999999999889999999986421 22347889999999999999999
Q ss_pred eeeeeEEeC-----CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEE
Q 007397 346 KLLGCCIQG-----EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVL 420 (605)
Q Consensus 346 ~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIl 420 (605)
++++++... ...++||||+. ++|.+.+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 567666643 3346899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch
Q 007397 421 LDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF 499 (605)
Q Consensus 421 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~ 499 (605)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999997643322 2334578999999999887 6789999999999999999999999976443222
Q ss_pred hHHHHHHHhhhcCCCcc-----------cccccc-------cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 500 NVIRHAWNLWNKGMPWQ-----------LIDACY-------QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 500 ~~i~~~~~~~~~~~~~~-----------l~d~~~-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
+.............. .+.... .....+.....+.+|+.+||+.||++|||+.+++++-
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 243 --LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp --HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred --HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 221111111100000 000000 0001112234588999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.77 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=197.2
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-------
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------- 354 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 354 (605)
...++|++.++||+|+||+||+|++ .+++.||||++..... ...+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999998 5689999999865322 224799999999999999999998543
Q ss_pred -------------------------------CeeEEEEEeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHH
Q 007397 355 -------------------------------EEKLLIYEFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLH 402 (605)
Q Consensus 355 -------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH 402 (605)
...++||||+++ +|...+... .....+++..+..++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347899999984 777766542 23456899999999999999999999
Q ss_pred hCCCCCeEEecCCCCCEEEc-CCCceEEeecCCCccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHH
Q 007397 403 QDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILV 480 (605)
Q Consensus 403 ~~~~~~iiHrDlkp~NIll~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl 480 (605)
+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 68899999999998764332 22345789999999998875 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---------------CcccccccccCCCCHHHHHHHHHHHHHhcCCC
Q 007397 481 LEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM---------------PWQLIDACYQESCNPDEVIRCIHISLLCVQHH 545 (605)
Q Consensus 481 ~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~d 545 (605)
|||++|+.||......+....+. ....... ...+.........+......+.+|+.+||+.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~---~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRII---QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999997654322222221 1111000 00000000011112223446889999999999
Q ss_pred CCCCCCHHHHHHH
Q 007397 546 PEDRPSMPSVILM 558 (605)
Q Consensus 546 P~~RPt~~evl~~ 558 (605)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=334.49 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=197.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC--Cc--EEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD--GQ--EIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.++||+|+||+||+|++.. ++ .||+|++... .....+.+.+|+.++++++|+||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3679999999999999999998632 33 6899998753 3345678899999999999999999999998755 8
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++++|.+++.... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999986542 34889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..+.. .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---~~~~~~~- 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK---IDKEGER- 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHTSCCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH---HHccCCC-
Confidence 6543221 12234567889999999998889999999999999999999 99998754321 11111 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 011222345688999999999999999999999999765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.85 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=200.7
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
..++|++.+.||+|+||.||+|++. +++.+|+|++........+.+.+|+.++++++||||+++++++......++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999985 489999999987666677889999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999886532 34899999999999999999999998 999999999999999999999999987542111
Q ss_pred ccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
........||+.|+|||++. +..++.++||||||+++|+|++|..||...... ..+.. ....... ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~~~~-~~ 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLK---IAKSDPP-TL 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHSCCC-CC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH---HhccCCc-cc
Confidence 11123356899999999983 667899999999999999999999998754421 11111 1111111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0112223468899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.26 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=202.2
Q ss_pred HhcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccch-------------hhHHHHHHHHHHHHcCCCCceeeeee
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISE-------------QGLNELKNEVILFSKLQHRNLVKLLG 349 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 349 (605)
..++|.+.++||+|+||+||+|++.. ++.||+|++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999854 78999999865321 34567899999999999999999999
Q ss_pred eEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC---c
Q 007397 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM---N 426 (605)
Q Consensus 350 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~---~ 426 (605)
++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888553 35899999999999999999999998 99999999999998776 6
Q ss_pred eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 427 PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 427 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||...+..+. +....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 9999999998765432 233467999999999987 4689999999999999999999999976443221 11111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+.... +...... ....+.+|+.+||+.+|.+|||+.++++.-
T Consensus 261 ----~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 261 ----KGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp ----HCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----cCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 111100 0000011 234688999999999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.05 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=203.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Cee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 357 (605)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999984 5889999999753 344557788999999999999999999998765 368
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+.+ +|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999985 88887743 34899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCccc-ccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 438 FGGDEIE-GSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 438 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... .......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH---HCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH---hCCCCHH
Confidence 6433221 11244679999999998765 45899999999999999999999999765544333322211 1100000
Q ss_pred ---cccc--------ccc-cCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 ---QLID--------ACY-QESC-----NPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 ---~l~d--------~~~-~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+.+ ... .... .......+.+|+.+||+.||++|||+.++++.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 000 0000 011234678999999999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.01 Aligned_cols=200 Identities=21% Similarity=0.272 Sum_probs=172.9
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcC------CCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKL------QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 357 (605)
..+|++.++||+|+||+||+|.+.. ++.||||++... ......+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4689999999999999999998854 899999999753 34456677888888776 577999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc--eEEeecCCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN--PKISDFGLA 435 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~--vkl~DFGla 435 (605)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 57888775543 234899999999999999999999998 999999999999999987 999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNS 495 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~ 495 (605)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...+.
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 764322 2346789999999999999999999999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=332.68 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=188.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.++||+|+||+||+|++ .+++.||+|++... .......+.++...++.++||||+++++++..+...++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999998 46899999999753 2223344555666688899999999999999999999999
Q ss_pred EeeCCCchhhHHhhc-CccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 362 EFMPNKSLDYFIFDQ-TKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 362 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||+++ +|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99985 777766442 2345689999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYA----TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ....+.. ........
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~---~~~~~~~~ 233 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQ---VVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHH---HHHSCCCC
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHH---HhccCCCC
Confidence 332 12334689999999996 566789999999999999999999999964322 1111211 11111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ........+.+++.+||+.+|++|||+.+|++.
T Consensus 234 -~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 -L--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -c--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 111223468899999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=329.14 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=200.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 357 (605)
.+.|.+.++||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888999999999999999984 4889999998642 45566788999999999999999999999875 4568
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCceEEeecCCCc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLAR 436 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~vkl~DFGla~ 436 (605)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999543 35889999999999999999999874 3499999999999998 78999999999997
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ... ......+....
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~----~~~~~~~~~~~ 249 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI----YRRVTSGVKPA 249 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH----HHHHTTTCCCG
T ss_pred cccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHH----HHHHhccCCcc
Confidence 654322 234568999999998874 5899999999999999999999999653321 111 11111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. ..... ...+.+++..||+.+|++|||+.+|++.
T Consensus 250 ~----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 S----FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G----GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c----cCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11111 2358899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=345.66 Aligned_cols=252 Identities=11% Similarity=0.059 Sum_probs=182.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHHHHHHH---HHHcCCCCceeeee-------eeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNELKNEVI---LFSKLQHRNLVKLL-------GCC 351 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~~ 351 (605)
..|++.++||+|+||+||+|++. +++.||||++.... ....+.+.+|+. +|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45899999999999999999985 68999999997633 344566778854 5555 799988855 344
Q ss_pred EeC-----------------CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 007397 352 IQG-----------------EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKR------FHIICGTARGLLYLHQDSRLR 408 (605)
Q Consensus 352 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~~ 408 (605)
... ...++||||++ ++|.+++..... .+.+..+ ..++.||++||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 33799999999 899999966422 2344455 677899999999999998
Q ss_pred eEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhC
Q 007397 409 IIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSG 486 (605)
Q Consensus 409 iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG 486 (605)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876422 213567799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 487 KRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 487 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+.||.......... +........................+.+|+.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998654322110 0000000000111111111233456889999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=339.55 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=193.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999984 589999999865 23455677889999999999999999999997654
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999985 5666663 23889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc----
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK---- 511 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~---- 511 (605)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... +.........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 8754321 22346789999999999999999999999999999999999999976442211 1111110000
Q ss_pred --------------CCC-------cccccccccCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 512 --------------GMP-------WQLIDACYQES---CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 512 --------------~~~-------~~l~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
... ..+........ ........+.+|+.+||+.||++|||+.++++.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000 00000000000 0122356788999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.34 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=200.8
Q ss_pred HHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
...++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+|+.++++++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999985 4899999998653 24567889999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+. ... ......+.
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~~~~~--- 246 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIF---MIP-TNPPPTFR--- 246 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHH-HSCCCCCS---
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHH---HHh-cCCCcccC---
Confidence 21 223457899999999999999999999999999999999999999754321 1111 111 11111110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111223468899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.03 Aligned_cols=252 Identities=28% Similarity=0.326 Sum_probs=205.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.++||+|+||.||+|++. +++.||||++.+. .......+.+|+.++++++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999985 6899999998643 234567899999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---cCCCceEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL---DHDMNPKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll---~~~~~vkl~DFGla~~ 437 (605)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999888543 35899999999999999999999998 9999999999999 5678999999999987
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.. ..+.... .+....-
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~----~~~~~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVE----KGKYTFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCCCCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----cCCCCCC
Confidence 64332 2334579999999999876 6899999999999999999999999764432 1222111 1111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+........+.+|+.+||+.+|++|||+.+++++-
T Consensus 248 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 248 ------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred ------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000112235688999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.27 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=185.7
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------C
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------E 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 355 (605)
.++|++.+.||+|+||.||+|.+ .+|+.||||++... .......+.+|+.+++.++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999997 45899999999652 344567788999999999999999999998754 5
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++|+|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6888888743 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+. .......
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~p~- 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPG- 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCC-
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCC-
Confidence 875322 334679999999999987 678999999999999999999999997654322222221 1111000
Q ss_pred ccccc------------cccc-CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLID------------ACYQ-ESCN-----PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d------------~~~~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.+.+. .... .... ......+.+|+.+||+.||++|||+.+++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 00000 0000 0000 11234578999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=366.96 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=197.2
Q ss_pred ceecccCeEEEEEEEEc---CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLV---DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++++++|+|||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 3678999999753 3345688999999999999999999999986 4568899999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc-cc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI-EG 445 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~-~~ 445 (605)
++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999543 35899999999999999999999998 99999999999999999999999999987654321 11
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. .. ....+.. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~----~i~~~~~---------~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKGER---------M 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTTCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCCC---------C
Confidence 2233457889999999999999999999999999999998 9999975443211 11 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+......+.+|+..||+.+|++||++.+|++.|+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1222334578899999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=350.36 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=194.2
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------CeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------EEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 358 (605)
.+|++.+.||+|+||.||+|++. +++.||||++.... ....+|+.++++++|+||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999985 58999999986532 2234699999999999999999988542 2357
Q ss_pred EEEEeeCCCchhhHHhh-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecCCCc
Q 007397 359 LIYEFMPNKSLDYFIFD-QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLAR 436 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFGla~ 436 (605)
+||||+++ +|...+.. ......+++..+..++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999987 45444432 233456899999999999999999999998 9999999999999965 568999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc----
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK---- 511 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~---- 511 (605)
....... .....||+.|+|||++.+. .++.++||||||||+|||++|++||......+. +......+..
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 7643321 2345789999999999765 789999999999999999999999976443222 2111111100
Q ss_pred ------CCCcccccccccC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 512 ------GMPWQLIDACYQE-----SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 512 ------~~~~~l~d~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.....+..+.+.. .........+.+|+.+||+.||++||++.|++++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0000000000000 01122235688999999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.68 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=197.4
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQG 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 354 (605)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999985 48899999986432 12234578999999999999999999998765
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEee
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISD 431 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~D 431 (605)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999988843 345899999999999999999999998 999999999999987665 99999
Q ss_pred cCCCccCCCCcccccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
||+++...... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.......... ....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~-- 233 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQIT-- 233 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH--HHHH--
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH--HHHH--
Confidence 99998764332 123456899999999974 5678999999999999999999999997654432211 1111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+... .. +.... .....+.+++.+||+.||++||++.++++.
T Consensus 234 --~~~~~-~~-~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 --SGKYN-FI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --HTCCC-CC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --hCccc-cC-chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11110 00 00111 123467899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=342.84 Aligned_cols=273 Identities=21% Similarity=0.224 Sum_probs=193.5
Q ss_pred HHHHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe--
Q 007397 280 TIANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 356 (605)
Q Consensus 280 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 356 (605)
......++|++.++||+|+||+||+|++. +++.||||++... ........+|+..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999984 5899999998653 2233456678888899999999999999976433
Q ss_pred -----eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEecCCCCCEEEcC-CCceE
Q 007397 357 -----KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH--QDSRLRIIHRDLKTSNVLLDH-DMNPK 428 (605)
Q Consensus 357 -----~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~iiHrDlkp~NIll~~-~~~vk 428 (605)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999997544443333344556889999999999999999999 887 999999999999997 89999
Q ss_pred EeecCCCccCCCCcccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-
Q 007397 429 ISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW- 506 (605)
Q Consensus 429 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~- 506 (605)
|+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999987654322 23456899999999987654 8999999999999999999999997654322222221110
Q ss_pred -------HhhhcC-CCccccc------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 507 -------NLWNKG-MPWQLID------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 507 -------~~~~~~-~~~~l~d------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+... ......+ ..............+.+|+.+||+.||++|||+.||+++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 000000 0000000 0001112222456788999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.34 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=196.2
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEE-----------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCI----------- 352 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 352 (605)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8999999998777777888999999999999999999998873
Q ss_pred ---eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCceE
Q 007397 353 ---QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPK 428 (605)
Q Consensus 353 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~vk 428 (605)
.....++||||++ ++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 589888843 35889999999999999999999998 99999999999997 567999
Q ss_pred EeecCCCccCCCCcc-cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 429 ISDFGLARTFGGDEI-EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 429 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
|+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999987643211 122334567999999998875 6789999999999999999999999976543221 11111
Q ss_pred HhhhcC----------CCccccccccc-CC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 507 NLWNKG----------MPWQLIDACYQ-ES-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 507 ~~~~~~----------~~~~l~d~~~~-~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... .....+..... .. ........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110000 00000000000 00 001224568899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.49 Aligned_cols=263 Identities=19% Similarity=0.272 Sum_probs=205.3
Q ss_pred hcCccccceecccCeEEEEEEEE--cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc------eeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL--VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN------LVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 356 (605)
.++|++.++||+|+||+||+|.+ .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++.....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 35889999999653 445677889999999887654 9999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH------------- 423 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~------------- 423 (605)
.++||||+ +++|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889988885543 235889999999999999999999998 999999999999987
Q ss_pred ------CCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007397 424 ------DMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497 (605)
Q Consensus 424 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 497 (605)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+..+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999864322 234578999999999999999999999999999999999999997654332
Q ss_pred chhHHHHHHHhhhc-----CCCcccc---------------------cc-cccCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 498 KFNVIRHAWNLWNK-----GMPWQLI---------------------DA-CYQESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 498 ~~~~i~~~~~~~~~-----~~~~~l~---------------------d~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
....+.......+. ....... .. .-...........+.+|+.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 22222211110000 0000000 00 000112345567889999999999999999
Q ss_pred CHHHHHHH
Q 007397 551 SMPSVILM 558 (605)
Q Consensus 551 t~~evl~~ 558 (605)
|+.||++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=327.91 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=204.7
Q ss_pred HHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---------hhhHHHHHHHHHHHHcCC-CCceeeeeee
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---------EQGLNELKNEVILFSKLQ-HRNLVKLLGC 350 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 350 (605)
....++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345689999999999999999999985 58999999986432 223456789999999996 9999999999
Q ss_pred EEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEe
Q 007397 351 CIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKIS 430 (605)
Q Consensus 351 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~ 430 (605)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999998653 35899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCcccccccccccccCccchhccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHH
Q 007397 431 DFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT------DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRH 504 (605)
Q Consensus 431 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~ 504 (605)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...... .....
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 240 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRM 240 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHH
Confidence 999998764332 233456899999999985 456889999999999999999999999654321 11111
Q ss_pred HHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 505 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .+... . ..+........+.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~----~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 241 IM----SGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HH----HTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred Hh----cCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11 11110 0 001112234568899999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.46 Aligned_cols=268 Identities=21% Similarity=0.318 Sum_probs=185.3
Q ss_pred cCccc-cceecccCeEEEEEEEEc---CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEE
Q 007397 286 DNFSI-NNKLGEGGFGRVYKGTLV---DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 359 (605)
Q Consensus 286 ~~y~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 359 (605)
+.|++ .++||+|+||+||+|++. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45766 458999999999999975 47899999997532 23467899999999999999999999965 678899
Q ss_pred EEEeeCCCchhhHHhhcC------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE----cCCCceEE
Q 007397 360 IYEFMPNKSLDYFIFDQT------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL----DHDMNPKI 429 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll----~~~~~vkl 429 (605)
||||+.+ +|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666553221 1234899999999999999999999998 9999999999999 67789999
Q ss_pred eecCCCccCCCCcc-cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCC------chhH
Q 007397 430 SDFGLARTFGGDEI-EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN------KFNV 501 (605)
Q Consensus 430 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~------~~~~ 501 (605)
+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|.+||....... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 1223456799999999999874 58999999999999999999999997654321 1122
Q ss_pred HHHHHHhhhcCCCc--ccccc-------------cccCCCC---------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 502 IRHAWNLWNKGMPW--QLIDA-------------CYQESCN---------PDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 502 i~~~~~~~~~~~~~--~l~d~-------------~~~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
+......+...... ..+.. ....... ......+.+|+.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22222221111100 00000 0000000 001345789999999999999999999998
Q ss_pred Hh
Q 007397 558 ML 559 (605)
Q Consensus 558 ~L 559 (605)
+-
T Consensus 334 hp 335 (405)
T 3rgf_A 334 DP 335 (405)
T ss_dssp SG
T ss_pred Ch
Confidence 64
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=336.20 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=205.1
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchh-----------------hHHHHHHHHHHHHcCCCCceeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQ-----------------GLNELKNEVILFSKLQHRNLVKL 347 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 347 (605)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 9999999998643211 12789999999999999999999
Q ss_pred eeeEEeCCeeEEEEEeeCCCchhhH------HhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEE
Q 007397 348 LGCCIQGEEKLLIYEFMPNKSLDYF------IFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVL 420 (605)
Q Consensus 348 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIl 420 (605)
++++...+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224578999999999999999999999 88 999999999999
Q ss_pred EcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007397 421 LDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSV-KSDVFSFGILVLEIVSGKRNRGLYNSDNK 498 (605)
Q Consensus 421 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwSlGvvl~elltG~~p~~~~~~~~~ 498 (605)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876433 23446789999999999887 6766 999999999999999999999765432
Q ss_pred hhHHHHHHHhhhcCCCcccc------ccc---ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 499 FNVIRHAWNLWNKGMPWQLI------DAC---YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 499 ~~~i~~~~~~~~~~~~~~l~------d~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ...+...... ... ............+.+|+.+||+.+|++|||+.++++.
T Consensus 259 ~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 1111110000 000 0000012234568899999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.58 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=197.6
Q ss_pred HhcCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCC--CCceeeeeeeEEeCCeeEE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 359 (605)
..++|++.+.||+|+||.||++.+.+++.||||++.. ......+.+.+|+.++++++ |+||+++++++......++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 3467999999999999999999998899999999864 34556778999999999997 5999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||| +.+++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6788999998653 35889999999999999999999998 999999999999964 899999999998765
Q ss_pred CCcccccccccccccCccchhcccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATD-----------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
............||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHH
Confidence 4433333344679999999999875 4688999999999999999999999964322 11111111
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
...... ...+......+.+++.+||+.+|++||++.+|++..
T Consensus 253 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 253 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Hhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111111 111111234678899999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=337.74 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=197.9
Q ss_pred HHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEe------
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQ------ 353 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------ 353 (605)
....++|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+|+.+++++ +|+||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34568899999999999999999998 468999999986432 3456788999999999 79999999999987
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 467899999999999999986542 346889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
++....... .......||+.|+|||++. +..++.++||||||+++|+|++|..||...... ..+. ..
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~ 246 (326)
T 2x7f_A 175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALF---LI 246 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HH
T ss_pred CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH---Hh
Confidence 998754321 1223457899999999987 567899999999999999999999998653321 1111 11
Q ss_pred hhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 509 ~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... ....+. .......+.+++.+||+.+|++||++.+|++.
T Consensus 247 ~~~-~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PRN-PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHS-CCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcC-ccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 111111 11123467899999999999999999999884
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.36 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=200.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Cee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 357 (605)
.++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999985 5899999999753 344556788999999999999999999988764 678
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+. ++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588888754 35899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCcccc--------cccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh
Q 007397 438 FGGDEIEG--------STNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508 (605)
Q Consensus 438 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~ 508 (605)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHH
Confidence 64322111 1223578999999998765 67899999999999999999999999765432111111 111
Q ss_pred hhcCCCc----cccccc-------c-c-C-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 509 WNKGMPW----QLIDAC-------Y-Q-E-----SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 509 ~~~~~~~----~l~d~~-------~-~-~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
....... .+.... + . . ...+.....+.+|+.+||+.||++|||+.+|++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 1100000 000000 0 0 0 00012335678999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.25 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=194.5
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe---------
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--------- 353 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 353 (605)
..++|++.+.||+|+||.||+|++. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467999999999999999999984 689999999964 34556788999999999999999999998865
Q ss_pred ----CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 354 ----GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 354 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
....++||||+++++|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 356789999999999999996532 34678899999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCcc------------cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007397 430 SDFGLARTFGGDEI------------EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSD 496 (605)
Q Consensus 430 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~ 496 (605)
+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++ |+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 99999987643210 1122345689999999999864 68999999999999999998 332110
Q ss_pred CchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 497 ~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ....... ..+....+......+.+++.+||+.||++|||+.+|++.
T Consensus 233 ~~~~~~----~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ERVNIL----KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH----HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hHHHHH----Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 011111 1111111 011122333344567899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.31 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=197.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK---- 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 357 (605)
.++|.+.+.||+|+||+||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999984 5899999999753 344567888999999999999999999999877655
Q ss_pred --EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 358 --LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 358 --~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
++||||+. ++|..++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57776662 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+. +.......... .
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC-C
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC-c
Confidence 865322 334578999999999987 6789999999999999999999999976443222 11111111000 0
Q ss_pred ccccc------------ccccC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLID------------ACYQE------SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d------------~~~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..... ..... .........+.+|+.+||+.||++|||+.++++.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000 00000 00112245688999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.84 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=200.7
Q ss_pred HhcCccccceecccCeEEEEEEEE--cCCcEEEEEEccccc--hhhHHHHHHHHHHHHcC---CCCceeeeeeeEE----
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTL--VDGQEIAVKRLSKIS--EQGLNELKNEVILFSKL---QHRNLVKLLGCCI---- 352 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 352 (605)
..++|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 358899999986422 12223455677766665 8999999999987
Q ss_pred -eCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 353 -QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 353 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 58988886543 234889999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhc
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~ 511 (605)
||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+.........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 99998764322 2334678999999999999999999999999999999999999997644322 22222211110
Q ss_pred CCCccc------ccc-------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 512 GMPWQL------IDA-------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 512 ~~~~~l------~d~-------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ... .............+.+|+.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000 00001112234567899999999999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.25 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=202.8
Q ss_pred HhcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CC-----ceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HR-----NLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 356 (605)
..++|++.++||+|+||+||+|++. +++.||||++.. ......++..|+.+++.++ |+ +|+++++++.....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999985 588999999974 3345667788898888875 44 49999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc--CCCceEEeecCC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD--HDMNPKISDFGL 434 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~--~~~~vkl~DFGl 434 (605)
.++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++. .+|+||||||+||||+ .++.+||+|||+
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999965 8888886543 234899999999999999999999531 2399999999999995 478899999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh-----h
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL-----W 509 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~-----~ 509 (605)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+...... +
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876432 23467899999999999999999999999999999999999999865433222222211100 0
Q ss_pred hcC-CCccccccc----------------------------c-------------cCCCCHHHHHHHHHHHHHhcCCCCC
Q 007397 510 NKG-MPWQLIDAC----------------------------Y-------------QESCNPDEVIRCIHISLLCVQHHPE 547 (605)
Q Consensus 510 ~~~-~~~~l~d~~----------------------------~-------------~~~~~~~~~~~l~~li~~Cl~~dP~ 547 (605)
... .....++.. + .......+...+.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 000 000000000 0 0011234456789999999999999
Q ss_pred CCCCHHHHHHH
Q 007397 548 DRPSMPSVILM 558 (605)
Q Consensus 548 ~RPt~~evl~~ 558 (605)
+|||+.|+++.
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.13 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=202.4
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-----------CCceeeeeeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-----------HRNLVKLLGCCI 352 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 352 (605)
.++|++.++||+|+||+||+|++ .+++.||||++.. .......+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999998 5589999999974 3345567888999999886 889999999998
Q ss_pred eCC----eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEc-----
Q 007397 353 QGE----EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLD----- 422 (605)
Q Consensus 353 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~----- 422 (605)
... ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 788999999 8999998865432 3488999999999999999999998 8 99999999999995
Q ss_pred -CCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCc---
Q 007397 423 -HDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK--- 498 (605)
Q Consensus 423 -~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~--- 498 (605)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999875432 2345789999999999999999999999999999999999999986543221
Q ss_pred hhHHHHHHHhhhcC------------------CCccccc--------cc--ccCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 499 FNVIRHAWNLWNKG------------------MPWQLID--------AC--YQESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 499 ~~~i~~~~~~~~~~------------------~~~~l~d--------~~--~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
...+.......... .....+. .. -....+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11122211111100 0000000 00 01234567788899999999999999999
Q ss_pred CHHHHHHHh
Q 007397 551 SMPSVILML 559 (605)
Q Consensus 551 t~~evl~~L 559 (605)
|+.+|+++-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999854
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=336.38 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=199.1
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.+.||+|+||.||+|++.. .+|+|++... .....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 5789999999999999999998754 5999998642 23334567789999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999998543 335889999999999999999999998 99999999999998 6899999999987653211
Q ss_pred ---ccccccccccccCccchhcccC---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 443 ---IEGSTNKVIGTYGYMAPEYATD---------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 443 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
.........||+.|+|||++.+ ..++.++||||||+++|||++|..||...... ..... . .
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~---~-~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQ---M-G 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHHH---H-H
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---h-c
Confidence 1122233468999999999874 45789999999999999999999998654321 11111 1 1
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCCC
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDS 563 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 563 (605)
.+....... ......+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 257 ~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 257 TGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp TTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred cCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111111 011235789999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=335.48 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=197.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe-----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 356 (605)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999984 5899999998652 34456778899999999999999999999987654
Q ss_pred -eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 357 -KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 357 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
.++||||+. ++|..++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 57776662 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+ .+............
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 865322 234578999999999887 678999999999999999999999997644322 11111111000000
Q ss_pred ---ccccc-----------ccc---cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 ---WQLID-----------ACY---QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ---~~l~d-----------~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+.+ ... ...........+.+|+.+||+.||++|||+.++++.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000 000 0011223345788999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.04 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=203.7
Q ss_pred HHHhcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 282 ANATDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 282 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
....++|++.++||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++||||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999985 5899999998643 2345678899999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLA 435 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla 435 (605)
+||||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998888543 34899999999999999999999998 9999999999999764 46999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+.. ...+...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKR----VETGKYA 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHcCCCC
Confidence 8764332 1233468999999999876 4899999999999999999999999754321 11111 1111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... .. ......+.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~~~--~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 FDLP--QW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCSG--GG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCch--hh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 00 1123467899999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.97 Aligned_cols=263 Identities=17% Similarity=0.260 Sum_probs=201.0
Q ss_pred hcCccccceecccCeEEEEEEEEcC-C-cEEEEEEccccchhhHHHHHHHHHHHHcCCCCc------eeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-G-QEIAVKRLSKISEQGLNELKNEVILFSKLQHRN------LVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 356 (605)
.++|++.+.||+|+||+||+|.+.. + +.||+|++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999999843 4 68999999653 345667888999999997665 8999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE---------------
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL--------------- 421 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll--------------- 421 (605)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55555555433 2235899999999999999999999998 9999999999999
Q ss_pred ----cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007397 422 ----DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497 (605)
Q Consensus 422 ----~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~ 497 (605)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67789999999999864322 234579999999999999999999999999999999999999997654322
Q ss_pred chhHHHHHHHhhhc-----CCCccc-ccc---------------------cccCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 007397 498 KFNVIRHAWNLWNK-----GMPWQL-IDA---------------------CYQESCNPDEVIRCIHISLLCVQHHPEDRP 550 (605)
Q Consensus 498 ~~~~i~~~~~~~~~-----~~~~~l-~d~---------------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 550 (605)
....+.......+. ...... ... .........+...+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 22222111100000 000000 000 000112334456788999999999999999
Q ss_pred CHHHHHHH
Q 007397 551 SMPSVILM 558 (605)
Q Consensus 551 t~~evl~~ 558 (605)
|+.+|++.
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.64 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=204.1
Q ss_pred HhcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
..++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. +...+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34789999999999999999998743 467999998753 4455678999999999999999999999985 46689
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998643 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ..+.... .+...
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~----~~~~~-- 611 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NGERL-- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----HTCCC--
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cCCCC--
Confidence 443221 2233457889999999999999999999999999999997 99998754322 1121111 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222345688999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.84 Aligned_cols=254 Identities=19% Similarity=0.235 Sum_probs=174.5
Q ss_pred hcCccccc-eecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeE
Q 007397 285 TDNFSINN-KLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 358 (605)
Q Consensus 285 ~~~y~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 358 (605)
.++|.+.+ .||+|+||+||+|.+. +++.||||++... . .........++.+.|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 57899865 6999999999999985 5899999998652 2 122233344667799999999999876 45589
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC---CceEEeecCCC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD---MNPKISDFGLA 435 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~---~~vkl~DFGla 435 (605)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996543 246899999999999999999999998 9999999999999864 55999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. ..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~-- 249 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---GQ-- 249 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc---cc--
Confidence 8654322 23456899999999999889999999999999999999999999765433221111100000 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..............+.+|+.+||+.+|++|||+.++++..
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0001111122345688999999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.41 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=179.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHH-HHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999984 5899999999753 3334445556665 777889999999999999999999999
Q ss_pred EeeCCCchhhHHhhc--CccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 362 EFMPNKSLDYFIFDQ--TKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 362 e~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
||+++ +|..++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 776666431 2245689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYA----TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
.... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ .. .....+..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCC
Confidence 4332 12234689999999998 456789999999999999999999999975432110 00 00001111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. +...........+.+|+.+||+.+|++||++.+|++.
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11 1111112234568899999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.36 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=189.0
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++..+...++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998777778999999998642 345678899999876 8999999999999999999999999
Q ss_pred CCCchhhHHhhcCccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-------------Cce
Q 007397 365 PNKSLDYFIFDQTKRE----LLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-------------MNP 427 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-------------~~v 427 (605)
. ++|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 59999986543211 1123345789999999999999998 9999999999999764 489
Q ss_pred EEeecCCCccCCCCccc--ccccccccccCccchhcccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007397 428 KISDFGLARTFGGDEIE--GSTNKVIGTYGYMAPEYATD-------GLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDN 497 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~ 497 (605)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999887543221 12234679999999999976 568999999999999999999 999986432211
Q ss_pred chhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 498 ~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... ....... +.............+.+|+.+||+.||++|||+.+|+++
T Consensus 248 -----~~i---~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -----SNI---IRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -----HHH---HHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHH---hcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111 1110000 011112244566789999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.34 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=191.6
Q ss_pred HHHHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccch------hhHHHHHHHHHHHHcC----CCCceeeeee
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISE------QGLNELKNEVILFSKL----QHRNLVKLLG 349 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 349 (605)
.....++|++.+.||+|+||.||+|++ .+++.||||++..... .....+.+|+.+++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999987 4589999999965322 1223456789999888 8999999999
Q ss_pred eEEeCCeeEEEEEe-eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCce
Q 007397 350 CCIQGEEKLLIYEF-MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNP 427 (605)
Q Consensus 350 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~v 427 (605)
++...+..++|||+ +.+++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999998653 35899999999999999999999998 99999999999999 88999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .+.
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~--- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL--- 246 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh---
Confidence 999999998765432 234568999999999987666 458999999999999999999986321 110
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.. .. ..+......+.+++.+||+.+|++|||+.+|++..
T Consensus 247 ---~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 247 ---EA-EL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ---HT-CC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ---hh-cc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 00 11122234678999999999999999999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.57 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=199.1
Q ss_pred HHhcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccch------hhHHHHHHHHHHHHcCC--CCceeeeeeeEEe
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISE------QGLNELKNEVILFSKLQ--HRNLVKLLGCCIQ 353 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 353 (605)
...++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+.+++++. |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999987 4589999999865321 12245667999999996 5999999999999
Q ss_pred CCeeEEEEEeeCC-CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCceEEee
Q 007397 354 GEEKLLIYEFMPN-KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISD 431 (605)
Q Consensus 354 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~vkl~D 431 (605)
.+..++|||++.+ ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999976 8999988653 35899999999999999999999998 99999999999999 779999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.... .+. .
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~------~ 257 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII------R 257 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH------H
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh------c
Confidence 99998765332 233568999999999987665 788999999999999999999986421 010 0
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
. .. ..... ....+.+|+.+||+.+|++|||+.+|++..
T Consensus 258 ~-~~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 258 G-QV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp C-CC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c-cc------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 00 01111 234678999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.90 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=180.9
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc--hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS--EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367899999999999999999985 58999999997532 223344555666788899999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
||+ ++.+..+.... ...+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 45555554322 34589999999999999999999995 8 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
.. ......||+.|+|||++. ...++.++||||||+++|+|++|..||..... ....+.... .... .
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~---~~~~-~ 248 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVL---QEEP-P 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHH---HSCC-C
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHh---ccCC-C
Confidence 22 123456899999999984 55688999999999999999999999875322 112222111 1111 1
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+. ........+.+++.+||+.+|.+||++.+|++.
T Consensus 249 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110 011123457899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=334.75 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=186.4
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.+|.+.+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +|||||++++++......++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46889999999999997766667899999999865322 2356799999999 7999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-----CceEEeecCCCccCC
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-----MNPKISDFGLARTFG 439 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-----~~vkl~DFGla~~~~ 439 (605)
. ++|.+++..... .+....+..++.||+.||.|||+++ |+||||||+||||+.+ ..+||+|||+++...
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 7 588888865432 2344456789999999999999998 9999999999999532 358899999998764
Q ss_pred CCcc-cccccccccccCccchhccc---CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEI-EGSTNKVIGTYGYMAPEYAT---DGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||...... .... .. ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~---~~-~~~~ 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANI---LL-GACS 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHH---HT-TCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHH---Hh-ccCC
Confidence 3321 12234467999999999997 4567889999999999999999 89888533211 1110 11 1111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... .........+.+|+.+||+.||++|||+.+|+++
T Consensus 247 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1110 1122345567899999999999999999999954
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=342.73 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe------CCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 356 (605)
.++|++.++||+|+||+||+|.+ .+++.||||++... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999998 45899999998753 45566788999999999999999999998765 677
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCc---eEEeecC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMN---PKISDFG 433 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~---vkl~DFG 433 (605)
.++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999977655556889999999999999999999998 999999999999997765 9999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch-hHH--HHHHHhhh
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF-NVI--RHAWNLWN 510 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~-~~i--~~~~~~~~ 510 (605)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+ ........
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998765432 223467999999999999999999999999999999999999999653210000 000 00000000
Q ss_pred cCCCcc--cccc--cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 007397 511 KGMPWQ--LIDA--CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPS 554 (605)
Q Consensus 511 ~~~~~~--l~d~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 554 (605)
...... .... .............+.+++.+||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 0000 0112344556778999999999999999999966
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.19 Aligned_cols=230 Identities=11% Similarity=0.065 Sum_probs=183.7
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
.++|++.+.||+|+||.||+|++.. ++.||||++... .......+.+|+.++++++|+||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999854 899999999753 244557889999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++... .....+..++.||+.||.|||+++ |+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998431 355678889999999999999998 9999999999999999999998543
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
|++ .++.++|||||||++|||++|+.||.............. .. .+. ....
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---~~-~~~---~~~~ 225 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---DT-AGQ---PIEP 225 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---CT-TSC---BCCH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---Hh-ccC---CCCh
Confidence 333 268899999999999999999999987554321100000 00 000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..........+.+|+.+||+.||++| |+.++++.|+..
T Consensus 226 ---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 ---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp ---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred ---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 00111223458899999999999999 999999999775
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=346.09 Aligned_cols=238 Identities=17% Similarity=0.274 Sum_probs=192.6
Q ss_pred hcCccccceecccCeEEEEEEEEc--CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe-----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV--DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 356 (605)
.++|++.++||+|+||+||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999985 5899999998653 34556678899999999999999999999987665
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999998 9999999999999885 89999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+|+.........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 76432 3457999999999987654 89999999999999999999887642211100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhcC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-MPSVILMLGS 561 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~L~~ 561 (605)
...........+.+|+.+||+.+|++||+ ++++.+.|..
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122356789999999999999995 5556555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.53 Aligned_cols=229 Identities=19% Similarity=0.250 Sum_probs=179.2
Q ss_pred hcCcccc-ceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHH-HcCCCCceeeeeeeEEe----CCee
Q 007397 285 TDNFSIN-NKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEK 357 (605)
Q Consensus 285 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 357 (605)
.++|.+. +.||+|+||.||+|.+ .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4678877 7799999999999998 45899999999642 3566788887 66689999999999987 6778
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGL 434 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFGl 434 (605)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999996643 335899999999999999999999998 999999999999998 78899999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
+.... +..++.++|||||||++|||++|..||.......... ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHH
Confidence 86532 2346789999999999999999999996543321100 000
Q ss_pred cccccccccCCCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 515 WQLIDACYQESCN----PDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 515 ~~l~d~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
..+..... ..+ ......+.+++.+||+.+|++|||+.+++++.
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 212 TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00000000 011 11245688999999999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.35 Aligned_cols=241 Identities=16% Similarity=0.174 Sum_probs=178.8
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCC-Cceeee---------eee-
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQH-RNLVKL---------LGC- 350 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l---------~~~- 350 (605)
..|...+.||+|+||+||+|++ .+|+.||||++... .....+.+++|+.+++.+.| .|...+ ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999997 45999999998732 22346779999999999987 321111 111
Q ss_pred -----------EEe-----CCeeEEEEEeeCCCchhhHHhh----cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 007397 351 -----------CIQ-----GEEKLLIYEFMPNKSLDYFIFD----QTKRELLDWSKRFHIICGTARGLLYLHQDSRLRII 410 (605)
Q Consensus 351 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 410 (605)
+.. ....+++|++ .+++|.+++.. ......+++..++.++.||++||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 1224556665 46888888742 122345778899999999999999999998 99
Q ss_pred EecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcc----------cCCCCCcccchHHHHHHH
Q 007397 411 HRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA----------TDGLFSVKSDVFSFGILV 480 (605)
Q Consensus 411 HrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwSlGvvl 480 (605)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998875322 344567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 481 LEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 481 ~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
|||++|+.||........... ++... ... ...+.+|+.+||+.+|++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEW---------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGG---------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHHH---------------HHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999976443222111 11100 112 256889999999999999999766643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.04 Aligned_cols=244 Identities=16% Similarity=0.133 Sum_probs=183.5
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCC---------CCceeee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQ---------HRNLVKL 347 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 347 (605)
.++|++.++||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 78999999997532 234477889999988886 6666555
Q ss_pred eee-----------------EEe-------------CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHH
Q 007397 348 LGC-----------------CIQ-------------GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397 (605)
Q Consensus 348 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~a 397 (605)
.++ +.. ....++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 333 6789999999999976655522 458999999999999999
Q ss_pred HHHHH-hCCCCCeEEecCCCCCEEEcCCC--------------------ceEEeecCCCccCCCCcccccccccccccCc
Q 007397 398 LLYLH-QDSRLRIIHRDLKTSNVLLDHDM--------------------NPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456 (605)
Q Consensus 398 L~~LH-~~~~~~iiHrDlkp~NIll~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 456 (605)
|.||| +++ |+||||||+||||+.++ .+||+|||+|+.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 898 99999999999999887 899999999987532 235799999
Q ss_pred cchhcccCCCCCcccchHHHHHH-HHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHH
Q 007397 457 MAPEYATDGLFSVKSDVFSFGIL-VLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCI 535 (605)
Q Consensus 457 ~aPE~~~~~~~~~k~DvwSlGvv-l~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~ 535 (605)
+|||++.+.. +.++||||||++ .+++++|..||... ............... ................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhc---cCcccchhhhhhcCHHHH
Confidence 9999998776 899999998777 77888898887320 000001111100000 000001112235667899
Q ss_pred HHHHHhcCCCCCCCCCHHHHH-HH
Q 007397 536 HISLLCVQHHPEDRPSMPSVI-LM 558 (605)
Q Consensus 536 ~li~~Cl~~dP~~RPt~~evl-~~ 558 (605)
+|+.+||+.+ |+.|++ ++
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999998 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=285.04 Aligned_cols=185 Identities=18% Similarity=0.167 Sum_probs=131.4
Q ss_pred ceecccCeEEEEEEEE-cCCcEEEEEEcccc----------chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEE
Q 007397 292 NKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI----------SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 359 (605)
..++.|++|.+..++. --|+.+|+|++.+. .....+++.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567777777776554 34889999998642 233456799999999999 69999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||++|++|.++|... +.++.. +|+.||+.||.|||++| ||||||||+||||+.++++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999999543 345554 48999999999999999 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCC
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR 488 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~ 488 (605)
... ......+||+.|+|||++.+. +..++|+||+|+++++|.++..
T Consensus 391 ~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 391 QDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 432 223457899999999999764 6778999999999988876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=254.33 Aligned_cols=185 Identities=17% Similarity=0.180 Sum_probs=145.6
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEccccc--------hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--------EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
...++||+|+||+||+|. ..++.+++|+..... ....+.+.+|+.++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345789999999999994 457888998764311 11244588999999999999999777677788888999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999844 4579999999999999998 999999999999999 999999999998754
Q ss_pred Ccccc-----cccccccccCccchhcccC--CCCCcccchHHHHHHHHHHHhCCCCC
Q 007397 441 DEIEG-----STNKVIGTYGYMAPEYATD--GLFSVKSDVFSFGILVLEIVSGKRNR 490 (605)
Q Consensus 441 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvvl~elltG~~p~ 490 (605)
..... ......||+.|+|||++.. ..|+..+|+||..+-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1235679999999999987 66888999999999888887776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7e-24 Score=213.72 Aligned_cols=166 Identities=19% Similarity=0.134 Sum_probs=130.8
Q ss_pred HHHHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccch------------------hhHHHHHHHHHHHHcC
Q 007397 278 LATIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISE------------------QGLNELKNEVILFSKL 339 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 339 (605)
+..+......|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667888899999999999999997799999999964221 1355688999999999
Q ss_pred CCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCE
Q 007397 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNV 419 (605)
Q Consensus 340 ~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NI 419 (605)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 777775543 56699999999999987 411 223469999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccC----------CCCCcccchHHH
Q 007397 420 LLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD----------GLFSVKSDVFSF 476 (605)
Q Consensus 420 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~k~DvwSl 476 (605)
|++ ++.+||+|||+|+. +..+.|||++.. ..|...+|+|.+
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999 99999999999864 346789998753 335555666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=179.72 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=107.0
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcE--EEEEEccccch------------------------hhHHHHHHHHHHHHc
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQE--IAVKRLSKISE------------------------QGLNELKNEVILFSK 338 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~ 338 (605)
.-|++.+.||+|+||.||+|.+ .+|+. ||||+++.... .....+.+|+.++++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999998 67888 99998753211 112357889999999
Q ss_pred CCCCce--eeeeeeEEeCCeeEEEEEeeCC-C----chhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 007397 339 LQHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH-QDSRLRII 410 (605)
Q Consensus 339 l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ii 410 (605)
+.|+++ +.++.. ...+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 333332 356899999942 3 66655422 123456789999999999999 888 99
Q ss_pred EecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 411 HRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 411 HrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.1e-18 Score=175.25 Aligned_cols=146 Identities=14% Similarity=0.162 Sum_probs=102.1
Q ss_pred HHHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccc--------------hhhHHHH--------HHHHHHHH
Q 007397 280 TIANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS--------------EQGLNEL--------KNEVILFS 337 (605)
Q Consensus 280 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~E~~~l~ 337 (605)
.+.....-|++.++||+|+||.||+|.+.+|+.||||+++... ....... ..|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3334344599999999999999999999999999999875210 0011111 23555555
Q ss_pred cCCCCceeeeeeeEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 007397 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTS 417 (605)
Q Consensus 338 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~ 417 (605)
++.+.++.-. ..+. ....+|||||+++.+|..+.. ......++.||+.+|.+||+.| ||||||||.
T Consensus 169 rL~~~gv~vp-~p~~-~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVP-EPIA-QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCC-CEEE-EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCC-eeee-ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 5543332111 1111 123479999999998865431 1234568899999999999998 999999999
Q ss_pred CEEEcCCC----------ceEEeecCCCccCC
Q 007397 418 NVLLDHDM----------NPKISDFGLARTFG 439 (605)
Q Consensus 418 NIll~~~~----------~vkl~DFGla~~~~ 439 (605)
||||++++ .+.|+||+.+....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99998876 38999999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-12 Score=128.00 Aligned_cols=146 Identities=15% Similarity=0.055 Sum_probs=114.5
Q ss_pred HHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEE
Q 007397 283 NATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 283 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 361 (605)
...+.|++...++.|+++.||++... ++.+++|+...........+.+|+.+++.+. +..+.+++++.......++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 44567999999999999999999754 6899999986422223346888999999885 677888999998888999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS------------------------------------ 405 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 405 (605)
||++|.+|...+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999977531 11223468889999999999811
Q ss_pred --------------------CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 406 --------------------RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 406 --------------------~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
...++|+|++|.|||++.+..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766678999987743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.7e-11 Score=119.50 Aligned_cols=138 Identities=17% Similarity=0.138 Sum_probs=101.8
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 363 (605)
..+.+....+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++.+...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444466679999998777888999997643 2345778999998886444 55688888777788999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS-------------------------------------- 405 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 405 (605)
++|.+|. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 211 11 1256777888888888643
Q ss_pred -----------------CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 406 -----------------RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 406 -----------------~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
...++|+|++|.|||++.++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998877778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=113.76 Aligned_cols=143 Identities=16% Similarity=0.182 Sum_probs=106.6
Q ss_pred cccceecccCeEEEEEEEEcCCcEEEEEEcc--ccc-hhhHHHHHHHHHHHHcCC--CCceeeeeeeEEeC---CeeEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLVDGQEIAVKRLS--KIS-EQGLNELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLI 360 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 360 (605)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999998864 4688898875 321 122456788999999987 45577888887766 347999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS----------------------------------- 405 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------- 405 (605)
|||++|..+.+.. ...++...+..++.+++++|..||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998874321 123567788889999999999999831
Q ss_pred --------------------CCCeEEecCCCCCEEEcCCCc--eEEeecCCCcc
Q 007397 406 --------------------RLRIIHRDLKTSNVLLDHDMN--PKISDFGLART 437 (605)
Q Consensus 406 --------------------~~~iiHrDlkp~NIll~~~~~--vkl~DFGla~~ 437 (605)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998865
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-09 Score=108.26 Aligned_cols=104 Identities=14% Similarity=0.099 Sum_probs=75.0
Q ss_pred CccccccccCCeeeEEecCCCCCCCCCceEEeecCCC---------ceEEeecCCCCceeecccccccccceEEEEEcCc
Q 007397 1 MKLGWNLKTGFERYLTPWRSADDPTPGDVSFRLDNST---------AKHARSGPWNGQTFEGIPWMKDSVFKLIVEHKED 71 (605)
Q Consensus 1 mklg~n~~tg~~~~L~Swks~~Dps~G~~s~~~~~~~---------~~~~rsg~w~g~~f~~~p~~~~~~~~~~~~~n~~ 71 (605)
||+|+|+++|.+ | +|.+||++|.|+++|+++| .+||++|+|++.... -.++ ..-.+.+.++.+
T Consensus 143 ~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~~~--l~l~-~dGnLvl~d~~~ 214 (276)
T 3m7h_A 143 AIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVR--AVFQ-GDGNLVVYGAGN 214 (276)
T ss_dssp CTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTCCE--EEEC-TTSCEEEECTTS
T ss_pred cccccccccCcc--c---ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCccEE--EEEc-CCCeEEEEeCCC
Confidence 899999999976 6 6789999999999999765 689999999864311 1122 222344444433
Q ss_pred -eeEEEEeecCCCeeeEEEEccCCcEEEEEEecCCcceEEeeecCCC
Q 007397 72 -EVYYKFKPINDTVTTRLQLENNGTYHRFVWDETTSKWHKLYSWPFD 117 (605)
Q Consensus 72 -e~~~~~~~~~~s~~~r~~l~~~G~~~~~~w~~~~~~w~~~~~~~~~ 117 (605)
.+.++++. .....|++|+.||++++|.| ...|..+|.+|+.
T Consensus 215 ~~vWsS~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 215 AVLWHSHTG--GHASAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp CEEEECSCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred cEEEEecCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 55554443 23358999999999999999 4678888887753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.7e-10 Score=111.33 Aligned_cols=187 Identities=19% Similarity=0.187 Sum_probs=121.2
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCc--eeeeeeeEEeCC---eeEEEEEee
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRN--LVKLLGCCIQGE---EKLLIYEFM 364 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 364 (605)
.+.++.|....||+.. ..+++|+... ......+.+|+.+++.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999863 5688888643 244567889999998874 333 334444433332 347899999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS--------------------------------------- 405 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 405 (605)
+|.+|..... ..++...+..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 13566777788888888888888621
Q ss_pred ----------------CCCeEEecCCCCCEEEcC--CCceEEeecCCCccCCCCcccccccc------------cccccC
Q 007397 406 ----------------RLRIIHRDLKTSNVLLDH--DMNPKISDFGLARTFGGDEIEGSTNK------------VIGTYG 455 (605)
Q Consensus 406 ----------------~~~iiHrDlkp~NIll~~--~~~vkl~DFGla~~~~~~~~~~~~~~------------~~gt~~ 455 (605)
...++|+|++|.||+++. ...+.|+||+.+..-.....-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134899999999999998 56689999998865322100000000 000001
Q ss_pred ccc-hhcccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 007397 456 YMA-PEYATDGLFSVKSDVFSFGILVLEIVSGKRNR 490 (605)
Q Consensus 456 y~a-PE~~~~~~~~~k~DvwSlGvvl~elltG~~p~ 490 (605)
... |+..... ....+.|+++.+++.+.+|..++
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 2221111 12258999999999999998664
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=3.1e-08 Score=96.32 Aligned_cols=92 Identities=4% Similarity=-0.041 Sum_probs=69.3
Q ss_pred cccc-ccCC-----eeeEEecCCCCCCCCCceEEeecCCC--------ceEEeecCCCCceeecccccccccceEEEEEc
Q 007397 4 GWNL-KTGF-----ERYLTPWRSADDPTPGDVSFRLDNST--------AKHARSGPWNGQTFEGIPWMKDSVFKLIVEHK 69 (605)
Q Consensus 4 g~n~-~tg~-----~~~L~Swks~~Dps~G~~s~~~~~~~--------~~~~rsg~w~g~~f~~~p~~~~~~~~~~~~~n 69 (605)
|.|. .+|+ +++|+| .+||++|.|+++++++| .+||++|+|++. +++.|+|......+.|..+
T Consensus 124 g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~ 199 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQ 199 (236)
T ss_dssp CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETT
T ss_pred cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCCcEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCC
Confidence 5565 7777 778985 78999999999999887 578999999764 7788888633222334446
Q ss_pred CceeEEEEeecCCCeeeEEEEccCCcEEEEE
Q 007397 70 EDEVYYKFKPINDTVTTRLQLENNGTYHRFV 100 (605)
Q Consensus 70 ~~e~~~~~~~~~~s~~~r~~l~~~G~~~~~~ 100 (605)
.++++++|..... ..+|++|+.+|++++|.
T Consensus 200 ~~~vw~s~~~~~~-~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 200 NIAVWTSGNSRSA-GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp TEEEEECCCCCSS-SCCEEEECSSSCEEEEC
T ss_pred CcEEEEeCCCCCC-CCEEEEEcCCCcEEEeC
Confidence 6678877776544 46899999999999984
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-06 Score=88.05 Aligned_cols=136 Identities=21% Similarity=0.164 Sum_probs=94.0
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCC---ceeeeeeeEE-eCCeeEEEEEeeCC
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPN 366 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 366 (605)
.+.++.|....||+. +..+++|+-. .......+.+|+.+|+.+.+. .+.+++.+.. .....++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467889999999987 5778888853 234456788999999999753 2455666553 34557899999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS----------------------------------------- 405 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------- 405 (605)
.++...... .++......++.++++.|..||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988763211 1234444445555555555555422
Q ss_pred ----------------CCCeEEecCCCCCEEEcC---CCc-eEEeecCCCcc
Q 007397 406 ----------------RLRIIHRDLKTSNVLLDH---DMN-PKISDFGLART 437 (605)
Q Consensus 406 ----------------~~~iiHrDlkp~NIll~~---~~~-vkl~DFGla~~ 437 (605)
...++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 234799999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.8e-06 Score=85.24 Aligned_cols=135 Identities=17% Similarity=0.141 Sum_probs=96.9
Q ss_pred eecccCeE-EEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 293 KLGEGGFG-RVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 293 ~LG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
.+..|..+ .||+.... ++..+++|+-.. .....+..|+.+|+.+. +--+.+++.++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987764 467889998643 23456788999998885 33467788888888999999999999988
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS-------------------------------------------- 405 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------------- 405 (605)
....... ......+..++++.|..||+..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654221 1122345666667777776531
Q ss_pred -----------CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 406 -----------RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 406 -----------~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887788999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.7e-06 Score=89.34 Aligned_cols=80 Identities=6% Similarity=0.007 Sum_probs=55.3
Q ss_pred ccee-cccCeEEEEEEEEc-------CCcEEEEEEccccc---hhhHHHHHHHHHHHHcCCC---CceeeeeeeEEeC--
Q 007397 291 NNKL-GEGGFGRVYKGTLV-------DGQEIAVKRLSKIS---EQGLNELKNEVILFSKLQH---RNLVKLLGCCIQG-- 354 (605)
Q Consensus 291 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 354 (605)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 89999999998764 26788999865422 0012456778888887742 3466777776554
Q ss_pred -CeeEEEEEeeCCCchh
Q 007397 355 -EEKLLIYEFMPNKSLD 370 (605)
Q Consensus 355 -~~~~lv~e~~~~~~L~ 370 (605)
...++|||+++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=6.6e-05 Score=76.47 Aligned_cols=141 Identities=16% Similarity=0.227 Sum_probs=79.7
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC--Cceeeeee------eEEeCCeeEEEEEe
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH--RNLVKLLG------CCIQGEEKLLIYEF 363 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 363 (605)
+.|+.|..+.||+....++ .+++|+.... ...+..|+.+++.|.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887544 5899998652 2333445555554431 12333332 12345678899999
Q ss_pred eCCCchh-----------hH---HhhcCc----c-------CCCCHHHHH------------------------------
Q 007397 364 MPNKSLD-----------YF---IFDQTK----R-------ELLDWSKRF------------------------------ 388 (605)
Q Consensus 364 ~~~~~L~-----------~~---l~~~~~----~-------~~l~~~~~~------------------------------ 388 (605)
++|..+. .. ++.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 00 111100 0 011222110
Q ss_pred -HHHHHHHHHHHHHHh--------C--CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 389 -HIICGTARGLLYLHQ--------D--SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 389 -~i~~qi~~aL~~LH~--------~--~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
.+..++.+++.+|++ . ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 0 234599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.9e-05 Score=82.75 Aligned_cols=75 Identities=9% Similarity=0.171 Sum_probs=49.6
Q ss_pred cceecccCeEEEEEEEEc-CCcEEEEEEccccch-------hhHHHHHHHHHHHHcCCC--Cc-eeeeeeeEEeCCeeEE
Q 007397 291 NNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISE-------QGLNELKNEVILFSKLQH--RN-LVKLLGCCIQGEEKLL 359 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 359 (605)
.+.||.|.++.||++... +++.++||....... ...+.+..|+.+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 468899997643211 123456778888887742 33 3345433 4556789
Q ss_pred EEEeeCCC
Q 007397 360 IYEFMPNK 367 (605)
Q Consensus 360 v~e~~~~~ 367 (605)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=9.3e-05 Score=73.74 Aligned_cols=80 Identities=16% Similarity=0.223 Sum_probs=58.5
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCC---ceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHR---NLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e 362 (605)
....-.+.+|.|..+.||+.+..||+.+++|+...........+..|+..|+.|... -+.+++.. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 345567889999999999999999999999987654444445678899998888532 23444443 23478999
Q ss_pred eeCCCch
Q 007397 363 FMPNKSL 369 (605)
Q Consensus 363 ~~~~~~L 369 (605)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=75.77 Aligned_cols=76 Identities=13% Similarity=0.089 Sum_probs=45.8
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccccccccc--cccCccchhcccCCC---CCcccchHHHHHHHH
Q 007397 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI--GTYGYMAPEYATDGL---FSVKSDVFSFGILVL 481 (605)
Q Consensus 407 ~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~k~DvwSlGvvl~ 481 (605)
..++|+|++|.|||++.++ ++|+||+.+..-.. ... ..... -...|.+|+...... -....++.+....++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998876 99999998865321 100 00000 013456666553111 112244557777777
Q ss_pred HHHhC
Q 007397 482 EIVSG 486 (605)
Q Consensus 482 elltG 486 (605)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00041 Score=69.89 Aligned_cols=138 Identities=16% Similarity=0.123 Sum_probs=92.0
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC---CCceeeeeeeEEeCCeeEEEEEeeCCC
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 367 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~~ 367 (605)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|. ...+.+++.+.......++|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 56799999999999876 5778899987542 3567888998888884 356788888887778899999999988
Q ss_pred chhh--------H---HhhcCc-c--C----------------CCCHHHHH---HHH----------------HHHHHHH
Q 007397 368 SLDY--------F---IFDQTK-R--E----------------LLDWSKRF---HII----------------CGTARGL 398 (605)
Q Consensus 368 ~L~~--------~---l~~~~~-~--~----------------~l~~~~~~---~i~----------------~qi~~aL 398 (605)
.+.. . |..... . + .-+|...+ ++. ..+++.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 111111 0 0 11344322 111 1122222
Q ss_pred -HHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 399 -LYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 399 -~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
..|.. .....++|+|+.+.||+++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23422 1245699999999999999888 8999984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00034 Score=70.63 Aligned_cols=144 Identities=17% Similarity=0.135 Sum_probs=79.3
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc--eeeeeee------EEeCCeeEEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 362 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 362 (605)
.+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.+.... +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677888899999987555 6889988652 12234556777776664212 2333321 123456789999
Q ss_pred eeCCCchhh----H----------HhhcCc----c--CCC---CHHHHHH------------HHHHHHHHHHHHHhC---
Q 007397 363 FMPNKSLDY----F----------IFDQTK----R--ELL---DWSKRFH------------IICGTARGLLYLHQD--- 404 (605)
Q Consensus 363 ~~~~~~L~~----~----------l~~~~~----~--~~l---~~~~~~~------------i~~qi~~aL~~LH~~--- 404 (605)
+++|..+.. . ++.... . ... .|..... +...+.+.+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0 111100 0 001 1221100 001133445555432
Q ss_pred -CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 405 -SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 405 -~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123599999999999999876678999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00044 Score=69.26 Aligned_cols=72 Identities=10% Similarity=0.164 Sum_probs=45.7
Q ss_pred cceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce-eeeeeeEEeCCeeEEEEEee-CCCc
Q 007397 291 NNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKS 368 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~~~ 368 (605)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .+++.. ..+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 688999999999998 56888887643221 1123467777776643233 345443 344567899999 7766
Q ss_pred hh
Q 007397 369 LD 370 (605)
Q Consensus 369 L~ 370 (605)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00041 Score=73.29 Aligned_cols=73 Identities=19% Similarity=0.301 Sum_probs=49.8
Q ss_pred cceecccCeEEEEEEEEcC--------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce-eeeeeeEEeCCeeEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 361 (605)
.+.|+.|....||+....+ ++.+++|+..... ..+.+..|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889999999998753 5789999884311 12445578888888753333 456655432 3899
Q ss_pred EeeCCCch
Q 007397 362 EFMPNKSL 369 (605)
Q Consensus 362 e~~~~~~L 369 (605)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00076 Score=69.83 Aligned_cols=141 Identities=17% Similarity=0.246 Sum_probs=82.1
Q ss_pred ceecccCeEEEEEEEEc--------CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc-eeeeeeeEEeCCeeEEEEE
Q 007397 292 NKLGEGGFGRVYKGTLV--------DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 362 (605)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.|...+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57878888899998864 2578999986432 223456668999888875322 3456655433 39999
Q ss_pred eeCCCchhhH--------------H---hhc--CccCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 007397 363 FMPNKSLDYF--------------I---FDQ--TKRELLD--WSKRFHIICGTAR-------------------GLLY-- 400 (605)
Q Consensus 363 ~~~~~~L~~~--------------l---~~~--~~~~~l~--~~~~~~i~~qi~~-------------------aL~~-- 400 (605)
|++|.+|..- | +.. .-..... +..+.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998765421 0 000 0011112 3344444433321 1222
Q ss_pred --HHhC-CCCCeEEecCCCCCEEEcCC----CceEEeecCCCcc
Q 007397 401 --LHQD-SRLRIIHRDLKTSNVLLDHD----MNPKISDFGLART 437 (605)
Q Consensus 401 --LH~~-~~~~iiHrDlkp~NIll~~~----~~vkl~DFGla~~ 437 (605)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 23459999999999999876 7899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0021 Score=65.15 Aligned_cols=141 Identities=15% Similarity=0.084 Sum_probs=71.5
Q ss_pred ceecccCeEE-EEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC--CceeeeeeeEEeCCeeEEEEEeeCCCc
Q 007397 292 NKLGEGGFGR-VYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKS 368 (605)
Q Consensus 292 ~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~~ 368 (605)
+.|+.|+... +|+....+++.+++|....... ..+..|+.+++.+.. -.+.+++.+.. +.-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4566665554 6677654477788886543221 234456666666532 23455555432 22378999998766
Q ss_pred hhhHHhhcC---------------------c--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 007397 369 LDYFIFDQT---------------------K--RELLDWSKRF-------H-------------IICGTARGLLYLH--- 402 (605)
Q Consensus 369 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~qi~~aL~~LH--- 402 (605)
+...+.... . ...++..... . ....+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 643331100 0 0011111100 0 0001112222221
Q ss_pred hCCCCCeEEecCCCCCEEEcCC----CceEEeecCCCcc
Q 007397 403 QDSRLRIIHRDLKTSNVLLDHD----MNPKISDFGLART 437 (605)
Q Consensus 403 ~~~~~~iiHrDlkp~NIll~~~----~~vkl~DFGla~~ 437 (605)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0037 Score=63.11 Aligned_cols=142 Identities=14% Similarity=0.138 Sum_probs=80.9
Q ss_pred ceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCC--ceeeeeee-----EEeCCeeEEEEEee
Q 007397 292 NKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFM 364 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 364 (605)
..|+ |....||+....+|+.+++|+..... .....+..|..+++.+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4576 88889999877678789999986321 1344566777777776422 23444432 12245567899999
Q ss_pred CCCchhh-----H---------HhhcC------ccCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 007397 365 PNKSLDY-----F---------IFDQT------KRELLDWSKR----------------------FHIICGTARGLLYLH 402 (605)
Q Consensus 365 ~~~~L~~-----~---------l~~~~------~~~~l~~~~~----------------------~~i~~qi~~aL~~LH 402 (605)
+|..+.. . ++... .....++... ...+..++..+..+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 11100 0111222111 011112222222211
Q ss_pred h-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 403 Q-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 403 ~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00096 Score=68.85 Aligned_cols=74 Identities=14% Similarity=0.179 Sum_probs=44.7
Q ss_pred cceecccCeEEEEEEEEcC---------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc-eeeeeeeEEeCCeeEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVD---------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 360 (605)
...|+.|....+|+....+ ++.+++|+....... ......|+.+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3578888889999988654 268888887543221 122357788887775333 34555443 2 3789
Q ss_pred EEeeCCCch
Q 007397 361 YEFMPNKSL 369 (605)
Q Consensus 361 ~e~~~~~~L 369 (605)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0022 Score=68.14 Aligned_cols=74 Identities=15% Similarity=0.099 Sum_probs=48.5
Q ss_pred cceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce-eeeeeeEEeCCeeEEEEEeeCCCc
Q 007397 291 NNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKS 368 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~~~ 368 (605)
.+.|+.|....+|+....+ +..+++|+......... .-.+|+.+++.|...++ .++++.+. . .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678889999999998765 57888988754222111 12578888888875555 45666552 2 35999998865
Q ss_pred h
Q 007397 369 L 369 (605)
Q Consensus 369 L 369 (605)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0062 Score=57.03 Aligned_cols=99 Identities=11% Similarity=0.065 Sum_probs=64.1
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccccc
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS 446 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 446 (605)
-+|.++|.. ...++++.+++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 367787744 3457999999999999999987762211 11 1233457999999999998874 1110
Q ss_pred ccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh
Q 007397 447 TNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS 485 (605)
Q Consensus 447 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt 485 (605)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123566888763 345678899999999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.016 Score=58.87 Aligned_cols=31 Identities=23% Similarity=0.334 Sum_probs=27.6
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 407 LRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 407 ~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888999999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.54 E-value=0.014 Score=61.10 Aligned_cols=74 Identities=18% Similarity=0.202 Sum_probs=48.3
Q ss_pred cceecccCeEEEEEEEEcC--------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc-eeeeeeeEEeCCeeEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 361 (605)
.+.|..|-...+|+....+ ++.+++++....... .-...+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4678888889999998753 578999987543222 122356788877775323 34455432 2 37899
Q ss_pred EeeCCCch
Q 007397 362 EFMPNKSL 369 (605)
Q Consensus 362 e~~~~~~L 369 (605)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99999764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=95.32 E-value=0.012 Score=49.39 Aligned_cols=34 Identities=15% Similarity=0.192 Sum_probs=29.9
Q ss_pred EecCCCCCCCCCceEEeecCCC---------ceEEeecCCCCc
Q 007397 16 TPWRSADDPTPGDVSFRLDNST---------AKHARSGPWNGQ 49 (605)
Q Consensus 16 ~Swks~~Dps~G~~s~~~~~~~---------~~~~rsg~w~g~ 49 (605)
+-|.|.+||++|.|++.|+++| .+||+|++|+|.
T Consensus 70 ~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~g~ 112 (112)
T 1xd5_A 70 AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCccCC
Confidence 4599999999999999999877 579999999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.23 E-value=0.15 Score=52.85 Aligned_cols=30 Identities=23% Similarity=0.362 Sum_probs=25.0
Q ss_pred CeEEecCCCCCEEE------cCCCceEEeecCCCcc
Q 007397 408 RIIHRDLKTSNVLL------DHDMNPKISDFGLART 437 (605)
Q Consensus 408 ~iiHrDlkp~NIll------~~~~~vkl~DFGla~~ 437 (605)
.++|+|+.+.|||+ ++...++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4457799999988754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=90.86 E-value=0.16 Score=42.91 Aligned_cols=30 Identities=17% Similarity=0.196 Sum_probs=24.3
Q ss_pred EecCCCCCCCCCceEEeecCCC------ceEEeecC
Q 007397 16 TPWRSADDPTPGDVSFRLDNST------AKHARSGP 45 (605)
Q Consensus 16 ~Swks~~Dps~G~~s~~~~~~~------~~~~rsg~ 45 (605)
+-|.|.+||++|.|++.|+++| .+||+||+
T Consensus 82 ~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~~~W~Sg~ 117 (119)
T 1b2p_A 82 TVWQSPVAGKAGHYVLVLQPDRNVVIYGDALWATQT 117 (119)
T ss_dssp EEEECSCCCCSSCEEEEECTTSCEEEEESEEEECCC
T ss_pred EEEcCCCCCCCCCEEEEEECCCcEEEECccEeCCCC
Confidence 3499999999999999999888 35677765
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=89.66 E-value=0.21 Score=41.78 Aligned_cols=34 Identities=21% Similarity=0.184 Sum_probs=28.6
Q ss_pred EecCCCCCCCCCceEEeecCCC------ceEEeecCCCCc
Q 007397 16 TPWRSADDPTPGDVSFRLDNST------AKHARSGPWNGQ 49 (605)
Q Consensus 16 ~Swks~~Dps~G~~s~~~~~~~------~~~~rsg~w~g~ 49 (605)
+-|.|.+.|++|.|++.|+++| .+||+|++|...
T Consensus 72 ~vW~S~~~~~~g~~~l~l~~dGnlvl~~~~~W~S~~~~~~ 111 (115)
T 2dpf_A 72 DVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSLGPNGCR 111 (115)
T ss_dssp EEEECCCCCSSSCCEEEECTTSCEEEECSEEECSSTTCBC
T ss_pred EEEEcCCCCCCCCEEEEEeCCCeEEEECCCEEECCCCCCc
Confidence 3499999999999999999988 368999999654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=87.27 E-value=0.4 Score=39.66 Aligned_cols=30 Identities=10% Similarity=0.175 Sum_probs=23.4
Q ss_pred ecCCCCCCCCCceEEeecCCC------ceEEeecCC
Q 007397 17 PWRSADDPTPGDVSFRLDNST------AKHARSGPW 46 (605)
Q Consensus 17 Swks~~Dps~G~~s~~~~~~~------~~~~rsg~w 46 (605)
-|.|.++|++|.|++.|+++| .+||+||++
T Consensus 73 ~W~S~t~~~~g~~~l~l~~dGnlvl~~~~~W~S~~~ 108 (110)
T 3a0c_A 73 IWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGSG 108 (110)
T ss_dssp EEECCCCCSSSCCEEEECTTSCEEEECSEEEECSCC
T ss_pred EEecCCCCCCCCEEEEEeCCccEEEECCCEecCCCc
Confidence 488889999999999998887 256666654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=80.31 E-value=4.3 Score=33.25 Aligned_cols=75 Identities=15% Similarity=0.224 Sum_probs=38.0
Q ss_pred CCCceEEeecCCCceEEeecCCCCceee-ccc---ccccccceEEEEEcCceeEEEEeecCCCeeeEEEEccCCcEEEEE
Q 007397 25 TPGDVSFRLDNSTAKHARSGPWNGQTFE-GIP---WMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYHRFV 100 (605)
Q Consensus 25 s~G~~s~~~~~~~~~~~rsg~w~g~~f~-~~p---~~~~~~~~~~~~~n~~e~~~~~~~~~~s~~~r~~l~~~G~~~~~~ 100 (605)
+.|.|.|.|..+|......+-|...+.. +.+ .+... =++.+.+....+...-.........+++|+.||++++|.
T Consensus 19 ~~g~~~L~~q~dGNLvl~~~~Wssnt~~~~~~~~l~l~~d-GnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 19 KNGDFDLVMQDDCNLVLYNGNWQSNTANNGRDCKLTLTDY-GELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp EETTEEEEECTTSCEEEETTTEECCCTTSCSSCEEEECTT-SCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC
T ss_pred ECCCEEEEEecCCeEEEEeCeEEcCCCCCCCcEEEEEcCC-CeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe
Confidence 4699999999988333223345333221 111 11111 112222222233222112222345789999999999995
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 605 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-72
Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 20/277 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ ++G G FG VYKG + + ++ + Q L KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+G + ++ ++ SL + + + + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT-- 463
IIHRDLK++N+ L D+ KI DFGLA ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 464 -DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
+S +SDV++FGI++ E+++G+ Y++ N + I + +G +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL---PYSNINNRDQI---IFMVGRGYLSPDLSKVR 235
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
P + R + C++ ++RP P ++ +
Sbjct: 236 SNC--PKAMKRLM---AECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 76/274 (27%), Positives = 123/274 (44%), Gaps = 22/274 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + +LG G FG V+ G ++AVK L + + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L Q E +I E+M N SL F+ + + L +K + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
IHRDL+ +N+L+ ++ KI+DFGLAR +E + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
F++KSDV+SFGIL+ EIV+ R + Q ++ Y+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHG---------------RIPYPGMTNPEVIQNLERGYRMV 230
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + LC + PEDRP+ + +L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-64
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 22/274 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ ++G G FG V+ G ++ ++A+K + + + E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L G C++ L++EFM + L ++ Q + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+IHRDL N L+ + K+SDFG+ R D+ S+ + +PE +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
+S KSDV+SFG+L+ E+ S + + + + I ++
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLY 222
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
I C + PEDRP+ ++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-64
Identities = 60/274 (21%), Positives = 104/274 (37%), Gaps = 22/274 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ + +LG G FG V G ++A+K + + +E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L G C + +I E+M N L ++ + R + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ +HRDL N L++ K+SDFGL+R DE S + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
FS KSD+++FG+L+ EI S + + + + I +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLY 221
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ I C ++RP+ ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 23/288 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
++ + KLG+G FG V+ GT +A+K L E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+L + E ++ E+M SL F+ +T + L + + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER-- 131
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDG 465
+ +HRDL+ +N+L+ ++ K++DFGLAR +E + APE A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 466 LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525
F++KSDV+SFGIL+ E+ + R Y V+ ++ Y+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQ-------------VERGYRMP 234
Query: 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPK-QPG 572
C P+ + C + PE+RP+ + L +P+ QPG
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 64/296 (21%), Positives = 116/296 (39%), Gaps = 28/296 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENIL 60
Query: 346 KLLGCCIQGEEKL----LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
+ + L+ ++ + SL ++ R + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 402 HQD-----SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF--GGDEIEGSTNKVIGTY 454
H + + I HRDLK+ N+L+ + I+D GLA D I+ + N +GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 455 GYMAPEYATDGL------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDN----KFNVIRH 504
YMAPE D + ++D+++ G++ EI G++
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 505 AWNLWNKGMPWQLIDACYQESCNPDEVIRCIH-ISLLCVQHHPEDRPSMPSVILML 559
+ K + Q + E +R + I C + R + + L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (529), Expect = 5e-63
Identities = 75/321 (23%), Positives = 129/321 (40%), Gaps = 56/321 (17%)
Query: 267 QIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSK 320
++ LE P +N +GEG FGRV++ +AVK L +
Sbjct: 4 KLLSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 53
Query: 321 -ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR 379
S + + E L ++ + N+VKLLG C G+ L++E+M L+ F+ +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 380 EL---------------------LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSN 418
+ L +++ I A G+ YL + + +HRDL T N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 419 VLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGI 478
L+ +M KI+DFGL+R + + +M PE ++ +SDV+++G+
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 479 LVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHIS 538
++ EI S Y VI + + +C + + ++
Sbjct: 231 VLWEIFSYGLQP--YYGMAHEEVIYY-------------VRDGNILACPENCPLELYNLM 275
Query: 539 LLCVQHHPEDRPSMPSVILML 559
LC P DRPS S+ +L
Sbjct: 276 RLCWSKLPADRPSFCSIHRIL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-62
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 11/276 (3%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK-ISEQGLNELKNEVILFSKLQH 341
D+F ++LG G G V+K + G +A K + I N++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
+V G E + E M SLD + K + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
+ +I+HRD+K SN+L++ K+ DFG++ I+ N +GT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+SV+SD++S G+ ++E+ G+ ++ + P +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
S + + I L E P +PS +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-62
Identities = 74/275 (26%), Positives = 111/275 (40%), Gaps = 28/275 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV 345
+ +G+G FG V G G ++AVK + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 346 KLLGCCIQGEEKL-LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+LLG ++ + L ++ E+M SL ++ + R +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+HRDL NVL+ D K+SDFGL + E + + + APE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
FS KSDV+SFGIL+ EI S R Y +V+ KG D C
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPR----VEKGYKMDAPDGC--- 225
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
P V + C RPS + L
Sbjct: 226 ---PPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-61
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 26/279 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR 342
+++ + +G G +GR K DG+ + K L ++E L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 343 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDYFIFDQTK-RELLDWSKRFHIICGTARGLL 399
N+V+ I L + E+ L I TK R+ LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 400 YLHQ--DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
H+ D ++HRDLK +NV LD N K+ DFGLAR D +GT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYM 181
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
+PE ++ KSD++S G L+ E+ + + + ++ + + +P++
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
DE+ I + RPS+ ++
Sbjct: 239 ----------SDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 2e-61
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ ++ +KLG G +G VY+G +AVK L + + E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V+LLG C + +I EFM +L ++ + ++E + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 405 SRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATD 464
+ IHRDL N L+ + K++DFGL+R GD + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
FS+KSDV++FG+L+ EI + + + + ++L++ Y+
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRM 235
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + C Q +P DRPS +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-61
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 27/282 (9%)
Query: 284 ATDNFSI-NNKLGEGGFGRVYKGTLV---DGQEIAVKRLSKISEQG-LNELKNEVILFSK 338
DN I + +LG G FG V +G ++A+K L + +E+ E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
L + +V+L+G C Q E +L+ E L F+ KRE + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS-TNKVIGTYGYM 457
YL + +HRDL NVLL + KISDFGL++ G D+ + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
APE FS +SDV+S+G+ + E +S + +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYG---------------QKPYKKMKGPEVMAF 224
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
I+ + C P+ + C + EDRP +V +
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-61
Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 36/307 (11%)
Query: 261 DQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVK 316
+ E ++ + + L +F N +G G FG VY GTL+D AVK
Sbjct: 10 NPELVQAVQHVVIGPSSL------IVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 317 RLSKISEQG-LNELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDYFIF 374
L++I++ G +++ E I+ H N++ LLG C++ E L++ +M + L FI
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 375 DQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGL 434
++T + F + + + + +HRDL N +LD K++DFGL
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 435 ARTFGGDEIEGSTNK--VIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492
AR E + NK +MA E F+ KSDV+SFG+L+ E+++
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--P 234
Query: 493 YNSDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
Y N F++ + P PD + + L C E RPS
Sbjct: 235 YPDVNTFDITVYLLQGRRLLQP----------EYCPDPLYEVM---LKCWHPKAEMRPSF 281
Query: 553 PSVILML 559
++ +
Sbjct: 282 SELVSRI 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 7e-61
Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 39/310 (12%)
Query: 276 FELATIANATDNFS---------INNKLGEGGFGRVYKGTLV----DGQEIAVKRLSK-I 321
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 322 SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL 381
+E+ + +E + + H N++ L G + ++I EFM N SLD F+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 382 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441
+ ++ G A G+ YL + +HRDL N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 442 EIEGSTNKVIG---TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNK 498
+ + +G + APE F+ SDV+S+GI++ E++S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----------- 230
Query: 499 FNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558
+ I+ Y+ D + L C Q RP ++
Sbjct: 231 ----ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 559 LGSDSVLAQP 568
L D ++ P
Sbjct: 287 L--DKMIRNP 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 3e-60
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 277 ELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNE 332
EL + FS ++G G FG VY + + + +A+K++S S + ++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 333 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIIC 392
V KL+H N ++ GC ++ L+ E+ + D ++ L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 393 GTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
G +GL YLH +IHRD+K N+LL K+ DFG A N +G
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 453 TYGYMAPEYA---TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW 509
T +MAPE +G + K DV+S GI +E+ K + N + + H
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNE 230
Query: 510 NKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+ + + + C+Q P+DRP+
Sbjct: 231 SPALQSGHW---------SEYFRNFV---DSCLQKIPQDRPTS 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-60
Identities = 75/304 (24%), Positives = 117/304 (38%), Gaps = 45/304 (14%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKISEQG-LNELKNEVILFSK 338
+N LG G FG+V T ++AVK L + ++ L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKR------------------ 379
L H N+V LLG C LI+E+ L ++ + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 380 --ELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437
+L + A+G+ +L +HRDL NVL+ H KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDN 497
D +MAPE +G++++KSDV+S+GIL+ EI S N Y
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIP 271
Query: 498 KFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
++LI ++ I C RPS P++
Sbjct: 272 VDANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 558 MLGS 561
LG
Sbjct: 320 FLGC 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-60
Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 40/297 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKISEQG-LNELKNEVILFSK 338
+ S LG G FG+V + T +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 339 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL---------------L 382
L H N+V LLG C G L+I E+ L F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
D A+G+ +L IHRDL N+LL H KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502
+MAPE + +++ +SDV+S+GI + E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ +++I ++ I C P RP+ ++ ++
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-59
Identities = 72/329 (21%), Positives = 131/329 (39%), Gaps = 31/329 (9%)
Query: 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRLSKI-SEQGLNELKNEVI 334
I T+ F LG G FG VYKG + E +A+K L + S + E+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 335 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT 394
+ + + + ++ +LLG C+ LI + MP L ++ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
A+G+ YL R++HRDL NVL+ + KI+DFGLA+ G +E E
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514
+MA E +++ +SDV+S+G+ V E+++ ++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEI 222
Query: 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPKQ-PGC 573
+++ + P I I + C + RP +I+ + P++
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVI 280
Query: 574 LVDRKSTGPDSSSSKPESSSTNASTFTEV 602
D + P + S + + +V
Sbjct: 281 QGDERMHLPSPTDSNFYRALMDEEDMDDV 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-59
Identities = 70/273 (25%), Positives = 111/273 (40%), Gaps = 23/273 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQHRN 343
+++ + LGEG +G V V + +AVK + E +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYAT 463
+ I HRD+K N+LLD N KISDFGLA F + E NK+ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 464 DGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
F + DV+S GI++ +++G+ + PW+ I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI---- 232
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSV 555
+ +H + +P R ++P +
Sbjct: 233 -----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-59
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 27/276 (9%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQH 341
N D + I +LG+G FG+VYK + A K + SE+ L + E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+VKLL ++ EF ++D + + + L S+ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H +IIHRDLK N+L D + K++DFG++ + IGT +MAPE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEV 181
Query: 462 A-----TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
D + K+DV+S GI ++E+ + ++ N V+ K P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLK----IAKSEPPT 234
Query: 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
L + + C++ + + R +
Sbjct: 235 LA---QPSRWSSN----FKDFLKKCLEKNVDARWTT 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-58
Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 28/275 (10%)
Query: 291 NNKLGEGGFGRVYKGTLVD---GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLV 345
+ +LG G FG V KG + +AVK L +EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNK-VIGTYGYMAPEYATD 464
+HRDL NVLL KISDFGL++ DE + APE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
FS KSDV+SFG+L+ E S + + +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERM 229
Query: 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
C + LC + E+RP +V L L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 76/330 (23%), Positives = 128/330 (38%), Gaps = 50/330 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDG---QEIAVKRLSKI-SEQGLNELKNEVILFSKL-Q 340
++ + +GEG FG+V K + + A+KR+ + S+ + E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKREL-------------LDWSKR 387
H N++ LLG C L E+ P+ +L F+ E L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 388 FHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST 447
H ARG+ YL Q + IHRDL N+L+ + KI+DFGL+R G E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 448 NKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507
+MA E +++ SDV+S+G+L+ EIVS Y +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEK--- 238
Query: 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQ 567
+ Y+ + + C + P +RPS +++ L
Sbjct: 239 ----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR------ 282
Query: 568 PKQPGCLVDRKSTGPDSSSSKPESSSTNAS 597
L +RK+ + K + + S
Sbjct: 283 -----MLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-58
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 27/281 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQE-----IAVKRLSK-ISEQGLNELKNEVILFSKL 339
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 340 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
H N+++L G + + ++I E+M N +LD F+ ++ + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI-GTYGYMA 458
YL + +HRDL N+L++ ++ K+SDFGL+R D T + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 459 PEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518
PE + F+ SDV+SFGI++ E+++ R W L N + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEV-MKAI 226
Query: 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ ++ D + + C Q RP ++ +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-57
Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 31/275 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F I LG+G FG VY +A+K L K ++L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N+++L G LI E+ P ++ + +K D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+ K D++S G+L E + GK + ++ + ++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISR----------VEFT 222
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
+ + + ++H+P RP + V+
Sbjct: 223 FPDFVTEG----ARDLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-57
Identities = 62/290 (21%), Positives = 132/290 (45%), Gaps = 28/290 (9%)
Query: 264 NQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKIS 322
+++ +E L + ++ + ++ K+G+G G VY + GQE+A+++++
Sbjct: 2 DEEILEKLR----SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 323 EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELL 382
+ + NE+++ + ++ N+V L + G+E ++ E++ SL + +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---- 113
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
D + + + L +LH ++IHRD+K+ N+LL D + K++DFG +
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169
Query: 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502
+ + ++GT +MAPE T + K D++S GI+ +E++ G+ Y ++N +
Sbjct: 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL 225
Query: 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+ + G P + E + C+ E R S
Sbjct: 226 ---YLIATNGTP----ELQNPEKLSAI----FRDFLNRCLDMDVEKRGSA 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-57
Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 28/282 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSK---ISEQGLNELKNEVILFSK 338
+ + KLG+G FG V +G +AVK L + +++ EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
L HRNL++L G + K+ + E P SL + LL R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGS-TNKVIGTYGYM 457
YL R IHRDL N+LL KI DFGL R ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517
APE FS SD + FG+ + E+ + + + N ++ + +G
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPR 236
Query: 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ C Q+ ++ + C H PEDRP+ ++ L
Sbjct: 237 PEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-57
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 288 FSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNL 344
+ ++G G F VYKG + E+A L +++ K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 345 VKLLGCCIQGEEK----LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
V+ + +L+ E M + +L ++ + +++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 401 LHQDSRLRIIHRDLKTSNVLL-DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAP 459
LH + IIHRDLK N+ + + KI D GLA VIGT +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182
Query: 460 EYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
E + + DV++FG+ +LE+ + + ++ ++A ++ + +
Sbjct: 183 EMYEEK-YDESVDVYAFGMCMLEMATSEYP---------YSECQNAAQIYRR-----VTS 227
Query: 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
S + + I C++ + ++R S+ ++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 32/288 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTL------VDGQEIAVKRLSKI-SEQGLNELKNEVILFSK 338
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIF-------DQTKRELLDWSKRFHII 391
++V+LLG QG+ L+I E M L ++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 392 CGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVI 451
A G+ YL+ + + +HRDL N ++ D KI DFG+ R + K +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511
+M+PE DG+F+ SDV+SFG+++ EI + + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGLSN 241
Query: 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ + + + +C Q++P+ RPS +I +
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-54
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 39/298 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGT------LVDGQEIAVKRLSKISEQGLNE--LKNEVILFS 337
D + LG G FG+V + + +AVK L + + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 338 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDYFIFDQ-------------TKRELLD 383
H N+V LLG C + L++ EF +L ++ + ++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 384 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443
A+G+ +L + IHRDL N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIR 503
+MAPE D +++++SDV+SFG+L+ EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDE 244
Query: 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561
+G + D E L C P RP+ ++ LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (463), Expect = 8e-53
Identities = 59/270 (21%), Positives = 105/270 (38%), Gaps = 24/270 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
D++ I+ +LG G FG V++ T G A K + E ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 405 SRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
+H DLK N++ + K+ DFGL + S GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
+D++S G+L ++SG + +N +R+ + + M
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKS-CDWNMDDSAFSGIS 253
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
++ + P R ++
Sbjct: 254 ED---------GKDFIRKLLLADPNTRMTI 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 30/287 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
VKL E+ + N L +I D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H IIHRDLK N+LL+ DM+ +I+DFG A+ + + N +GT Y++PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
T+ SD+++ G ++ ++V+G + + N++ + + L +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP---PFRAGNEYLIFQKIIKL----------EYD 228
Query: 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQP 568
+ E P + + R + G + A P
Sbjct: 229 FPEKFFPK----ARDLVEKLLVLDATKRLGCEEM---EGYGPLKAHP 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-52
Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 29/289 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKISEQGLNE-LKNEVILFSKLQ 340
+ + +GEG FG V++G + +A+K + + E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H ++VKL+G + +I E L F+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
L R +HRD+ NVL+ + K+ DFGL+R + D +K +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
F+ SDV+ FG+ + EI+ +N G +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233
Query: 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSDSVLAQPK 569
C P + + C + P RP + L ++L + K
Sbjct: 234 C------PPTLYSLM---TKCWAYDPSRRPRFTELKAQL--STILEEEK 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-52
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 41/297 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV--------DGQEIAVKRLSK-ISEQGLNELKNEVILF 336
D + LGEG FG+V + ++AVK L +E+ L++L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 337 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQ-------------TKRELL 382
+ +H+N++ LLG C Q +I E+ +L ++ + E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 383 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442
ARG+ YL + IHRDL NVL+ D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 443 IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI 502
T +MAPE D +++ +SDV+SFG+L+ EI + + Y +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVP----V 243
Query: 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+ L +G C +E+ + C P RP+ ++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNC------TNELYMMM---RDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (444), Expect = 4e-50
Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 24/270 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ L E +LI EF+ L I + + + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 405 SRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
I+H D+K N++ + KI DFGLA DEI T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
+D+++ G+L ++SG + ++ +++ D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKR----------CDWEF 247
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
E +Q P R ++
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 2e-48
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSK---ISEQGLNELKNEVI---LFSK 338
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+V + ++ I + M L Y + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMA 458
++H +++RDLK +N+LLD + +ISD GLA F + + +GT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 459 PEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW-- 515
PE G+ + +D FS G ++ +++ G + + +K + R + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 516 ----QLIDACYQESCNPDEVIRCIHISLLCVQHHP 546
L++ Q + + + C+ V+ P
Sbjct: 234 PELRSLLEGLLQ--RDVNRRLGCLGRGAQEVKESP 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 55/291 (18%), Positives = 111/291 (38%), Gaps = 21/291 (7%)
Query: 280 TIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQG-LNELKNEVILFS 337
+ + ++ + +GEG +G V V+ +A+K++S Q E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 338 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARG 397
+ +H N++ + + + ++ + ++ K + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 398 LLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST-NKVIGTYGY 456
L Y+H ++HRDLK SN+LL+ + KI DFGLAR D + + T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 457 MAPEYATDGLFSVKS-DVFSFGILVLEIVSGKR--------------NRGLYNSDNKFNV 501
APE + KS D++S G ++ E++S + L + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 502 IRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
N + + P+ + + + + +P R +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 2e-46
Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 28/282 (9%)
Query: 285 TDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQ 340
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 341 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG-GDEIEGSTNKVIGTYG 455
L + H + IIHRD+K +N+++ K+ DFG+AR T VIGT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515
Y++PE A +SDV+S G ++ E+++G+ + D+ +V ++ +P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAY--QHVREDPIPP 234
Query: 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
++ + L + +PE+R + +
Sbjct: 235 SARHEGL-----SADLDAVV---LKALAKNPENRYQTAAEMR 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-46
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEV-ILFSKLQ 340
++F ++ LG+G FG+V+ Q A+K L K + + + E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H L + E + E++ L Y I K D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH I++RDLK N+LLD D + KI+DFG+ + + + +T GT Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
++ D +SFG+L+ E++ G+ + + F+ IR + + + + D
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
Query: 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557
+ PE R + I
Sbjct: 234 LVK-----------------LFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-46
Identities = 52/270 (19%), Positives = 102/270 (37%), Gaps = 25/270 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 405 SRLRIIHRDLKTSNVLLDHDMNP--KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
I H D++ N++ + KI +FG AR + + + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
+ S +D++S G LV ++SG + I +A +++ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230
Query: 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
E + + + + R +
Sbjct: 231 -----SIEAMDFVD---RLLVKERKSRMTA 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 3e-45
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 21/272 (7%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-LKNEVILFSKLQ 340
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 341 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLY 400
H N+V L G LI + + L I ++ +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 401 LHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
LH + + LD D ISDFGL++ + + GT GY+APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 461 YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
+S D +S G++ ++ G + +N + D
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK-AEYEFDSPYWDD 235
Query: 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
D I ++ PE R +
Sbjct: 236 I------SDSAKDFI---RHLMEKDPEKRFTC 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 7e-45
Identities = 61/268 (22%), Positives = 114/268 (42%), Gaps = 20/268 (7%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
+F I LG G FGRV+ +G+ A+K L K + + + +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++++ G ++ +I +++ L + + +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
II+RDLK N+LLD + + KI+DFG A+ + T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP---WQLI 518
+ ++ D +SFGIL+ E+++G N+ + I +A + L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 519 DACYQESCNPDEVIRCIHISLLCVQHHP 546
+ + + + V++HP
Sbjct: 233 SRLITR--DLSQRLGNLQNGTEDVKNHP 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (400), Expect = 9e-45
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 39/284 (13%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---------ISEQGLNELKNEVIL 335
+N+ LG G V + +E AVK + ++ EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 336 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT 394
K+ H N+++L L+++ M L ++ T++ L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTY 454
+ LH +L I+HRDLK N+LLD DMN K++DFG + E +V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 455 GYMAPEYATDGL------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL 508
Y+APE + + + D++S G+++ +++G + + ++R +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMS- 229
Query: 509 WNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
N D D V + + P+ R +
Sbjct: 230 GNYQFGSPEWDDY------SDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 3e-44
Identities = 48/283 (16%), Positives = 93/283 (32%), Gaps = 25/283 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ + C + ++ + SL+ +++ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 405 SRLRIIHRDLKTSNVL---LDHDMNPKISDFGLARTFGGDEIEG-----STNKVIGTYGY 456
IHRD+K N L I DFGLA+ + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
+ S + D+ S G +++ G + K
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
L P E ++ C +D+P + +
Sbjct: 240 LCKGY------PSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 1e-42
Identities = 40/285 (14%), Positives = 98/285 (34%), Gaps = 27/285 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 345 VKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQD 404
+ + Q ++ + SL+ + ++ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 405 SRLRIIHRDLKTSNVLLDHDMNP-----KISDFGLARTFGGDEIEG-----STNKVIGTY 454
+++RD+K N L+ + + DFG+ + + + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 455 GYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514
YM+ S + D+ + G + + + G +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILML 559
+L P+E + +H + P + +
Sbjct: 238 RELCAGF------PEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 23/283 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHR 342
+NF K+GEG +G VYK + G+ +A+K RL +E + E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+VKLL + L++EF+ + D + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-Y 461
R++HRDLK N+L++ + K++DFGLAR FG + + T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRN-RGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520
+S D++S G + E+V+ + G D F + R P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 521 CYQESCNPDEVIRCIH---------ISLL--CVQHHPEDRPSM 552
Y+ S SLL + + P R S
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-42
Identities = 60/292 (20%), Positives = 113/292 (38%), Gaps = 32/292 (10%)
Query: 284 ATDNFSINNKLGEGGFGRVYKGTLV--DGQEIAVKRLSK--ISEQGLNELKNEVILFSKL 339
A + ++GEG +G+V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 340 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD---YFIFDQTKRELLDWSKRFHIICG 393
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGT 453
RGL +LH R++HRDLK N+L+ K++DFGLAR + + V+ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 454 YGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL----- 508
Y APE ++ D++S G + E+ K L+ + + + ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 509 ---WNKGMPWQLIDACYQESCNPDEVIRCIHISLL-----CVQHHPEDRPSM 552
W + + + + ++ + I C+ +P R S
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 4e-42
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 23/282 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVK--RLSKISEQGLNELKNEVILFSKLQHRN 343
+ + K+GEG +G VYK G+ A+K RL K E + E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 344 LVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ 403
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 404 DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE-YA 462
R++HRDLK N+L++ + KI+DFGLAR FG I T Y AP+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLM 173
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521
+S D++S G + E+V+G G+ +D + R +K P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 522 YQESCNPDEVIRCIH---------ISLL--CVQHHPEDRPSM 552
Y + E + I LL ++ P R +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 35/290 (12%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL 344
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 345 VKLLGCCIQGEEK------LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
V+L EK L+ +++P ++ L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYM 457
Y+H I HRD+K N+LLD D K+ DFG A+ E S + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRA 190
Query: 458 APEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV---------------I 502
++ DV+S G ++ E++ G+ ++ D+ + I
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 503 RHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
R + + Q+ + + P I + +++ P R +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 32/282 (11%)
Query: 292 NKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNE-----LKNEVILFSKLQHRNLV 345
+ LGEG F VYK Q +A+K++ + E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 346 KLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS 405
LL L+++FM + +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 406 RLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA-TD 464
I+HRDLK +N+LLD + K++DFGLA++FG + + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 465 GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524
++ V D+++ G ++ E++ D+ + + + Q D C
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 525 SCNPDEVIRCIHISLL--------------CVQHHPEDRPSM 552
+ I + + +P R +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-40
Identities = 61/282 (21%), Positives = 102/282 (36%), Gaps = 43/282 (15%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKN------EVILFSK 338
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 339 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
+ +++LL + + +LI E + T+R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
+ + H ++HRD+K N+L+D + K+ DFG GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174
Query: 456 YMAPEY-ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514
Y PE+ + V+S GIL+ ++V G + D + I + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEE---IIRGQVFFRQRVS 228
Query: 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVI 556
+ +IR C+ P DRP+ +
Sbjct: 229 SECQH-----------LIRW------CLALRPSDRPTFEEIQ 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-40
Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 33/281 (11%)
Query: 283 NATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKIS------EQGLNELKNEVIL 335
N D + +LG G F V K G + A K + K +++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 336 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA 395
++QH N++ L + +LI E + L F+ ++E L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP----KISDFGLARTFGGDEIEGSTNKVI 451
G+ YLH L+I H DLK N++L P KI DFGLA +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIF 177
Query: 452 GTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNK 511
GT ++APE +++D++S G++ ++SG + D K + + N
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSA-VNY 233
Query: 512 GMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+ + P+ R ++
Sbjct: 234 EFEDEYFSNTSAL---------AKDFIRRLLVKDPKKRMTI 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 50/276 (18%), Positives = 103/276 (37%), Gaps = 29/276 (10%)
Query: 286 DNFSINNK-LGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN 343
D++ + ++ LG G G+V + ++ A+K L + E++ + + Q +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVE---LHWRASQCPH 66
Query: 344 LVKLLGCCIQGEEK----LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLL 399
+V+++ L++ E + L I D+ + + I+ +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQ 125
Query: 400 YLHQDSRLRIIHRDLKTSNVLLDHDMNP---KISDFGLARTFGGDEIEGSTNKVIGTYGY 456
YLH + I HRD+K N+L K++DFG A+ S T Y
Sbjct: 126 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYY 179
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
+APE + D++S G+++ ++ G + S++ + G
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
+ S +IR ++ P R ++
Sbjct: 237 PNPEWSEVSEEVKMLIRN------LLKTEPTQRMTI 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 54/296 (18%), Positives = 107/296 (36%), Gaps = 35/296 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR 342
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 343 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGT 394
N+V L+ C L+++F + K L + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 395 ARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGST--NKVIG 452
L L+ R +I+HRD+K +NVL+ D K++DFGLAR F + +
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 453 TYGYMAPE-YATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVI--------R 503
T Y PE + + D++ G ++ E+ + ++ +I
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 504 HAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLL-------CVQHHPEDRPSM 552
W + ++ ++ + + ++ + P R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 5e-39
Identities = 52/268 (19%), Positives = 104/268 (38%), Gaps = 17/268 (6%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK---ISEQGLNELKNEVILFSKLQH 341
++F LG+G FG+V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 342 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
L L + + E+ L + + ++ + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
+++RD+K N++LD D + KI+DFGL + D + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 462 ATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP---WQLI 518
D + D + G+++ E++ G+ + + F +I + + + L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 519 DACYQESCNPDEVIRCIHISLLCVQHHP 546
++ +P + + V H
Sbjct: 237 AGLLKK--DPKQRLGGGPSDAKEVMEHR 262
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 7e-38
Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 30/300 (10%)
Query: 257 RRRVDQENQDQIEDLELPLFELATIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAV 315
+ + + +D ++ E P A + D F LG G FGRV G A+
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 316 KRLSK---ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYF 372
K L K + + + NE + + LVKL ++ E++ +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 373 IFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432
+ + YLH L +I+RDLK N+L+D +++DF
Sbjct: 132 LRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGL 492
G A+ ++G T + GT +APE ++ D ++ G+L+ E+ +G
Sbjct: 186 GFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---P 237
Query: 493 YNSDNKFNVIRHAWNLWNKGMPW------QLIDACYQESCNPDEVIRCIHISLLCVQHHP 546
+ +D + + + L+ Q + + + + +++H
Sbjct: 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ--VDLTKRFGNLKNGVNDIKNHK 295
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-38
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 27/285 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR 342
+ K+GEG +G V+K + +A+KR+ E + E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 343 NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLH 402
N+V+L ++ L++EF YF + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 403 QDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYA 462
++HRDLK N+L++ + K+++FGLAR F G + + +V+ +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 463 TDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522
L+S D++S G + E+ + R L+ ++ + ++ + L Q
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 523 QESCNPDEVIRCIH-------------ISLL--CVQHHPEDRPSM 552
P + LL ++ +P R S
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 27/286 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR 342
+ +G G +G V G ++A+K+L + SE E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 343 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
N++ LL E +F + + + K E L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 402 HQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEY 461
H IIHRDLK N+ ++ D KI DFGLAR + + + T Y APE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 462 ATDGL-FSVKSDVFSFGILVLEIVSGKR--------------NRGLYNSDNKFNVIRHAW 506
+ + ++ D++S G ++ E+++GK + +F +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
N ++ S + +++ + E R +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 31/278 (11%)
Query: 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKIS----EQGLNELKNEVILFS 337
+NF + LG G +G+V+ + G+ A+K L K + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 338 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
++ LV L + LI +++ L + + + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
+L L +L II+RD+K N+LLD + + ++DFGL++ F DE E GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 457 MAPEYATDGL--FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514
MAP+ G D +S G+L+ E+++G + D + N K P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253
Query: 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSM 552
Y + + + + P+ R
Sbjct: 254 ------PYPQEMSAL----AKDLIQRLLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 1e-31
Identities = 48/275 (17%), Positives = 109/275 (39%), Gaps = 23/275 (8%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRN 343
D++ + KLG G + V++ + + +++ VK L + ++ ++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 344 LVKLLGCCIQGEEKL--LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYL 401
++ L + L++E + N + L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 402 HQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPE 460
H + I+HRD+K NV++DH+ ++ D+GLA + + N + + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199
Query: 461 YATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519
D ++ D++S G ++ ++ K ++ + ++ + + + ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPS 554
E I H + + + S
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 55/263 (20%), Positives = 99/263 (37%), Gaps = 24/263 (9%)
Query: 286 DNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHR 342
+ +G G G V V + +A+K+LS+ ++ E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 343 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTAR 396
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 397 GLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGY 456
G+ +LH IIHRDLK SN+++ D KI DFGLART G + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 457 MAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516
APE + D++S G ++ E+V K L+ + + P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 517 LIDACYQESCNPDEVIRCIHISL 539
+ + + ++
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTF 264
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-29
Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 25/291 (8%)
Query: 280 TIANATDNFSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSK--ISEQGLNELKNEVILF 336
TI + + + +G G +G V G +AVK+LS+ S E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 337 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTA 395
++H N++ LL + ++ + + + K + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 396 RGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYG 455
RGL Y+H IIHRDLK SN+ ++ D KI DFGLAR + T V +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 184
Query: 456 YMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA--------WN 507
++ D++S G ++ E+++G+ + ++ +I
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 508 LWNKGMPWQLIDACYQ-ESCNPDEVIRCIH---ISLL--CVQHHPEDRPSM 552
+ I + Q N V + + LL + + R +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 2e-27
Identities = 41/215 (19%), Positives = 80/215 (37%), Gaps = 18/215 (8%)
Query: 288 FSINNKLGEGGFGRVYKGT-LVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVK 346
+ + KLG G F V+ +V+ +A+K + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 347 LLGCCIQGEEKLLIYEFMPNKSLDYF-------------IFDQTKRELLDWSKRFHIICG 393
KLL + + + + + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 394 TARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLARTFGGDEIEGSTNKVIG 452
GL Y+H+ R IIH D+K NVL++ D + +A + I
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 453 TYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK 487
T Y +PE + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.1 bits (246), Expect = 1e-24
Identities = 31/161 (19%), Positives = 54/161 (33%), Gaps = 20/161 (12%)
Query: 289 SINNKLGEGGFGRVYKGTLVDGQEIAVK--RLSKIS--------EQGLNELKNEVILFSK 338
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 339 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGL 398
+ R L KL G + +Y + N L I + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 399 LYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439
+ I+H DL NVL+ + I DF + G
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.97 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.22 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 93.23 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 87.11 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 87.01 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.25 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 84.31 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.72 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.28 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=414.40 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=206.0
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999984 58999999986532 3345678999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++|+|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999998843 345899999999999999999999998 9999999999999999999999999999875444
Q ss_pred ccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
........+||+.|+|||++.+..+ +.++|||||||++|||++|++||......... ..... ......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~----~~~~~~----- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWK----EKKTYL----- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHH----TTCTTS-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHh----cCCCCC-----
Confidence 3444556789999999999988776 67899999999999999999999765432221 11111 111100
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+|+.+||+.||++|||+.||+++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011223467789999999999999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=408.42 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=207.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||+|++. +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.++...++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5899999998652 2344677899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|.+++... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998643 35899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.. ..+... .....
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i----~~~~~------- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRI----SRVEF------- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH----HTTCC-------
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCC-------
Confidence 2 33467999999999999999999999999999999999999999754322 112111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|||+.||+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1112223467899999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=413.01 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=209.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|++ .+|+.||||++........+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35899999999999999999997 45999999999765555677899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++|+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988743 35899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.. ..+.. ....... .+
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~---~~~~~~~-~~------ 236 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYL---IATNGTP-EL------ 236 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHHCSC-CC------
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHH---HHhCCCC-CC------
Confidence 234567999999999999999999999999999999999999999654321 11111 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|||+.|++++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=408.51 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=199.9
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.++||+|+||+||+|++.+++.||||++++. ....+++.+|+.++++++|||||++++++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999988999999999753 3445789999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999988553 345889999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
......||+.|+|||++.+..|+.++|||||||++|||+++..|+.... .....+..... +.. ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~----~~~---------~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIST----GFR---------LY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHH----TCC---------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHh----cCC---------CC
Confidence 2234578999999999999999999999999999999999544443221 12222222211 111 11
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.....++.+|+.+||+.+|++||||++|+++|+.+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122235688999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=409.75 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=203.0
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|+.. ..||||+++. ......+.+++|+.++++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999864 4699999864 345567889999999999999999999998754 56899999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999986433 35899999999999999999999998 9999999999999999999999999998775444
Q ss_pred ccccccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.........||+.|+|||++.+ ..|+.++|||||||+||||++|+.||....... .+... ...+.....+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~---~~~~~~~p~~- 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFM---VGRGYLSPDL- 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHH---HHHTSCCCCG-
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHH---HhcCCCCCcc-
Confidence 3344456789999999999864 358999999999999999999999997543221 11111 1111110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
...+......+.+|+.+||+.+|++||||.+|+++|+..
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 232 ----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp ----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011222345688999999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=410.47 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=209.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
+.|+++++||+|+||+||+|++. +++.||||++.+......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999984 58999999998766677788999999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++|+|..++.+. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++++||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987553 235899999999999999999999998 999999999999999999999999999765322 1
Q ss_pred ccccccccccCccchhccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 445 GSTNKVIGTYGYMAPEYAT-----DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||...+..+.. ..... +....+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i~~----~~~~~~-- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKIAK----SEPPTL-- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHH----SCCCCC--
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---HHHHc----CCCCCC--
Confidence 1233567999999999984 456899999999999999999999999765443322 21111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
..+......+.+|+.+||+.||++|||+.|++++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999774
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=411.23 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=204.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999984 5899999998752 2345577899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 35899999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ....... .... .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~----~~~~-~----- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKII----KLEY-D----- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----TTCC-C-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHHH----cCCC-C-----
Confidence 4444445578999999999999999999999999999999999999999754322 2222111 1111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVIL 557 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 557 (605)
.+......+.+|+.+||+.||++|||++|++.
T Consensus 229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11122346789999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-51 Score=411.91 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=211.8
Q ss_pred hcCccccceecccCeEEEEEEEEcC-CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|++.. ++.||||++++. ....+++.+|+.++++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4678999999999999999999854 889999999753 33467899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+++|+|..++.... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++++||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999986543 346899999999999999999999998 99999999999999999999999999998654432
Q ss_pred cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 444 EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
. ......||+.|+|||++.+..|+.++|||||||++|||++|..|+..... . ..+ ......+..
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~-~~~---~~~i~~~~~--------- 234 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--L-SQV---YELLEKDYR--------- 234 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--H-HHH---HHHHHTTCC---------
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--H-HHH---HHHHhcCCC---------
Confidence 2 23345689999999999999999999999999999999997776543221 1 111 111112211
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.+.....++.+|+.+||+.||++||||.+|++.|+..
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122223345688999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=405.75 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=207.0
Q ss_pred hcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 364 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 364 (605)
.++|++.++||+|+||+||+|++.+++.||||+++.. ....+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578999999999999999999988899999999753 3345789999999999999999999998754 5679999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998875432 235899999999999999999999998 999999999999999999999999999987543322
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......||+.|+|||++.+..++.++|||||||++|||+||..|+..... ....+.. ...+...
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~~~~--------- 229 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERGYRM--------- 229 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCC---------
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCCC---------
Confidence 23345789999999999999999999999999999999997665543221 1122221 1111111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+......+.+|+.+||+.+|++||||++|+++|+.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1122233468899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=405.95 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=197.0
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--CCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 360 (605)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999984 5899999998653 44556778999999999999999999999875 4567999
Q ss_pred EEeeCCCchhhHHhhcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 361 YEFMPNKSLDYFIFDQT-KRELLDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986542 3457999999999999999999999864 23499999999999999999999999999988
Q ss_pred CCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL 517 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 517 (605)
+..... ......||+.|+|||++.+..|+.++|||||||++|||++|++||...+.. ..+... ..+....+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i----~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI----REGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH----HHTCCCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHH----HcCCCCCC
Confidence 654321 234568999999999999999999999999999999999999999754432 122211 11221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+......+.+|+.+||+.||++|||+.||++.
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12223468899999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=398.24 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=212.2
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.++||+|+||+||+|++++++.||||++++.. ...+++++|+.++++++||||+++++++.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888999999997633 345689999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|+|..++.... ..+++..+++++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999875543 35889999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+ .+.... .+...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~----~~~~~--------- 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----QGLRL--------- 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----TTCCC---------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHH----hCCCC---------
Confidence 2334678999999999999999999999999999999998 898987654322 222111 11111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
..+......+.+|+.+||+.+|++|||+++|++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112233568899999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=415.12 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=207.9
Q ss_pred cCccccceecccCeEEEEEEEEcC-C-----cEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G-----QEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 357 (605)
++|++.++||+|+||+||+|++.. + ..||+|++... .......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999998743 2 36999998653 344556788999999998 899999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTK--------------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTS 417 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~ 417 (605)
++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965432 245889999999999999999999998 999999999
Q ss_pred CEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 007397 418 NVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSD 496 (605)
Q Consensus 418 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~ 496 (605)
|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||++ |..||...+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333445678999999999999999999999999999999998 89999765443
Q ss_pred CchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 007397 497 NKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLG 560 (605)
Q Consensus 497 ~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 560 (605)
..... ....+.. .+.+......+.+|+.+||+.+|++||||+||+++|.
T Consensus 274 ~~~~~------~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYK------LIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHH------HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH------HHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22111 1111111 1122233456889999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-50 Score=407.72 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=199.6
Q ss_pred cCccccceecccCeEEEEEEEEcC-C---cEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-G---QEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.++||+|+||+||+|++.. + ..||||++.. ......+.+.+|+.+|++++|||||++++++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568889999999999999999743 3 3689999865 3455667899999999999999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++|+|++++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988543 335899999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccccc---cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 441 DEIEG---STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 441 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
..... ......||+.|+|||++.+..++.++|||||||+||||+| |++||...... ..+... ..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i----~~~~--- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAI----EQDY--- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HTTC---
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC---
Confidence 32221 1223457999999999999999999999999999999998 89998754432 111111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+.+......+.+|+.+||+.+|++||||.+|++.|+..
T Consensus 251 ------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 ------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112233445688999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=412.90 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=205.7
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++. +|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999984 5899999998753 34456788999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999999654 358999999999999999999997 47 99999999999999999999999999986532
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH-HHhh-----------
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA-WNLW----------- 509 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~-~~~~----------- 509 (605)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+........... ....
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2234568999999999999999999999999999999999999999765432211100000 0000
Q ss_pred -------hc----CCCcccccccccC---CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 -------NK----GMPWQLIDACYQE---SC-NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 -------~~----~~~~~l~d~~~~~---~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. ....+..+..... .. ......++.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0000000000000 00 00123468889999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=401.92 Aligned_cols=255 Identities=28% Similarity=0.447 Sum_probs=203.7
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeC
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 365 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 365 (605)
++|++.++||+|+||+||+|++.+++.||||++... ....+.+.+|+.++++++|+|||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 679999999999999999999988889999999653 3445789999999999999999999999854 56799999999
Q ss_pred CCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcccc
Q 007397 366 NKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIEG 445 (605)
Q Consensus 366 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 445 (605)
+|+|..++.... ...+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999998886543 235899999999999999999999998 99999999999999999999999999987643332 2
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccCC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQES 525 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~ 525 (605)
......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ....+.. ...+.. .+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~----i~~~~~---------~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQ----VERGYR---------MP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCC---------CC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCC---------CC
Confidence 23345689999999999999999999999999999999997766654332 1112221 111111 12
Q ss_pred CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 526 CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 526 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.....++.+|+.+||+.+|++||+|++|+++|+..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 2233345688999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=399.19 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=207.0
Q ss_pred cCccccc-eecccCeEEEEEEEEc---CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINN-KLGEGGFGRVYKGTLV---DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|.+.+ +||+|+||+||+|.+. ++..||||+++.. .....+.+.+|+.++++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4567777 5999999999999763 3557999999753 34556789999999999999999999999864 568999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++|+|.+++... +..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987433 346899999999999999999999998 99999999999999999999999999998754
Q ss_pred Ccc-cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 441 DEI-EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 441 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
... ........||+.|+|||++.+..++.++|||||||++|||+| |..||...... ..+.. ...+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRM--- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCC---
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC---
Confidence 332 222334568999999999999999999999999999999998 99999764432 11211 1122211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+.+......+.+|+.+||+.+|++||||.+|++.|+.
T Consensus 232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1223334568899999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-49 Score=408.68 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=210.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|++. +|+.||||++.+......+.+.+|+.+|++++|||||++++++.++...++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999984 5899999999877677778899999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC--CCceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH--DMNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~--~~~vkl~DFGla~~~~~~ 441 (605)
+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 335899999999999999999999998 999999999999964 578999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ..+...... ... . ..
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~---~~~--~-~~- 246 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSC---DWN--M-DD- 246 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT---CCC--S-CC-
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC---CCC--C-Cc-
Confidence 2 233467999999999999999999999999999999999999999754322 222221111 100 0 00
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.........+.+|+.+||+.||++|||+.|++++
T Consensus 247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223467899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-49 Score=408.67 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=212.5
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|++ .+|+.||||++.+........+.+|+.++++++|||||++++++.++...++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999998 45999999999876666677889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc--CCCceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD--HDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~--~~~~vkl~DFGla~~~~~~ 441 (605)
+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998877432 335899999999999999999999998 99999999999998 5689999999999887543
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ......||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+ .+..... ... .
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~----~~~------~ 246 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR----CDW------E 246 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH----CCC------C
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC------C
Confidence 2 2344679999999999999999999999999999999999999997544322 2221111 110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcCC
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM--LGSD 562 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~~ 562 (605)
............+.+|+.+||+.||++|||+.|++++ +++.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1111122234567899999999999999999999985 5544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=397.85 Aligned_cols=247 Identities=29% Similarity=0.421 Sum_probs=198.6
Q ss_pred ceecccCeEEEEEEEEcC---CcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEeeCC
Q 007397 292 NKLGEGGFGRVYKGTLVD---GQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 366 (605)
Q Consensus 292 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 366 (605)
++||+|+||+||+|.+.+ ++.||||+++.. .....+.+.+|+.++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999999643 33445789999999999999999999999854 567899999999
Q ss_pred CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc-c
Q 007397 367 KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE-G 445 (605)
Q Consensus 367 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~-~ 445 (605)
|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998543 35899999999999999999999998 999999999999999999999999999876543222 2
Q ss_pred cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccccC
Q 007397 446 STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQE 524 (605)
Q Consensus 446 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~ 524 (605)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+.. .... ....+...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~--------- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERM--------- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC---------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCCCC---------
Confidence 2334578999999999999999999999999999999998 89999754322 1111 11122111
Q ss_pred CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 525 SCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 525 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+.+......+.+|+.+||+.||++|||+.+|+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1222334568899999999999999999999998864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=393.70 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=197.7
Q ss_pred cccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe----CCeeEEEE
Q 007397 289 SINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 361 (605)
Q Consensus 289 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 361 (605)
++.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+.++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999985 4889999998643 44556779999999999999999999999865 34578999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc-CCCceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD-HDMNPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~-~~~~vkl~DFGla~~~~~ 440 (605)
||+++|+|.+++... ..+++..++.++.||++||.|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999998553 35899999999999999999999875 4599999999999996 578999999999986533
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...... ....+....
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~----~i~~~~~~~---- 232 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYR----RVTSGVKPA---- 232 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHH----HHTTTCCCG----
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHH----HHHcCCCCc----
Confidence 2 2335679999999999875 599999999999999999999999964332 111111 111221111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+....+ .++.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCccCC----HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111222 357889999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=403.71 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=193.5
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc-hhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS-EQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
.+.|++.+.||+|+||+||+|++. +++.||||++.+.. ......+.+|+.++++++|||||++++++.++...++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999985 58999999997532 2334567899999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEc---CCCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLD---HDMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~---~~~~vkl~DFGla~~~~ 439 (605)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999854 346899999999999999999999998 99999999999995 57899999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID 519 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d 519 (605)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ....... ....
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~----~~~~----- 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQIL----KAEY----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----TTCC-----
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHh----ccCC-----
Confidence 332 233467999999999999999999999999999999999999999754322 1111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcCC
Q 007397 520 ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM--LGSD 562 (605)
Q Consensus 520 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~~ 562 (605)
....+........+.+|+.+||+.||++|||+.|++++ +.+.
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01111122234568899999999999999999999985 4443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-50 Score=405.44 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=202.6
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
+.|+++++||+|+||+||+|++. +++.||||++... .....+.+.+|+.++++++|||||++++++.++...++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999984 5889999998653 2345567899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|+.++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999876643 245899999999999999999999998 99999999999999999999999999987532
Q ss_pred cccccccccccccCccchhcccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATD---GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... ...+.. ....... .+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~---i~~~~~~-~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH---IAQNESP-ALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH---HHHSCCC-CCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhCCCC-CCC
Confidence 234679999999999864 4589999999999999999999999965432 111211 1111111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
+......+.+|+.+||+.||++|||+.|++++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11223468899999999999999999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=396.91 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=201.2
Q ss_pred cCccccceecccCeEEEEEEEEcCC-----cEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDG-----QEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
+.|++.++||+|+||+||+|.+... ..||||++... ......++.+|+.++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999987542 47999998653 44455678999999999999999999999999999999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+.++++..++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999998875543 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc-cccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEI-EGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... ........||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...... ....+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~----~i~~~~----- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK----AINDGF----- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH----HHHTTC-----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHH----HHhccC-----
Confidence 4322 1223345689999999999999999999999999999999997666543221 111111 111211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+.+......+.+|+.+||+.+|++||||.+|+++|+..
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1122233445788999999999999999999999999765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-49 Score=401.22 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=211.3
Q ss_pred HhcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCe
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 356 (605)
..++|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 3578999999754 34456779999999999999999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 007397 357 KLLIYEFMPNKSLDYFIFDQT---------------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 415 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlk 415 (605)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999986432 1234889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCC
Q 007397 416 TSNVLLDHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK-RNRGLYN 494 (605)
Q Consensus 416 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~-~p~~~~~ 494 (605)
|+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765444334444567899999999999999999999999999999999986 5665433
Q ss_pred CCCchhHHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 495 SDNKFNVIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 495 ~~~~~~~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.. ..+.. ...+.... .+.....++.+|+.+||+.+|++||||.||+++|+..
T Consensus 248 ~~---e~~~~----v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HE---EVIYY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HH---HHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HH---HHHHH----HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22 22221 12222211 1222334688999999999999999999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=395.17 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=206.8
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc------chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI------SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.++||+|+||+||+|++ .+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999998 45899999998642 122467899999999999999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC----ceEEeecC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM----NPKISDFG 433 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~----~vkl~DFG 433 (605)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998653 35899999999999999999999998 99999999999998776 59999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM 513 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~ 513 (605)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ .+.... ...
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~----~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS----AVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----TTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHH----hcC
Confidence 998764332 2334679999999999999999999999999999999999999997543221 111111 111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 514 PWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 514 ~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
. .. ..... ......+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~-~~-~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y-EF-EDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C-CC-CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-CC-Cchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 00011 1123467899999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=399.56 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=207.9
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|++++.||+|+||+||+|++ .+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999998 56999999999753 2345677899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999988553 35899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+ ...... .+.+
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~----~~~~------- 222 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL----MEEI------- 222 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCC-------
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHh----cCCC-------
Confidence 2 22445789999999999999999999999999999999999999997654322 121111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..+......+.+|+.+||+.||++||+ +.+++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111222345789999999999999995 7888874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=397.39 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=203.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCc----EEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQ----EIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
++|+++++||+|+||+||+|.+. +|+ +||+|++.. ......+++.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999874 343 689998865 3445677899999999999999999999999864 5678
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
++||+.+++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887654 346899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
............||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+....+. .+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~----- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE----- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC-----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-----
Confidence 5444444445678999999999999999999999999999999998 788887655433222221 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+.+......+.+|+.+||+.+|++|||+.+|++.|...
T Consensus 231 ----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1112223345688999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-48 Score=395.05 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=205.6
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|+++++||+|+||+||+|++ .+|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999998 45899999999752 2345678899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999888543 34788899999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ..+..... +..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~----~~~------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILN----AEL------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH----CCC-------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHc----CCC-------
Confidence 33468999999999999999999999999999999999999999754322 22221111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+++.+||+.||.+|| |+++++++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11122234578999999999999996 89999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-47 Score=395.77 Aligned_cols=245 Identities=21% Similarity=0.237 Sum_probs=206.4
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 361 (605)
++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999984 5999999998642 2344667899999999999999999999999999999999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGD 441 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~ 441 (605)
||+.+|+|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999988554 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||...+. ...+..... ...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~----~~~------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVS----GKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CCC-------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhc----CCC-------
Confidence 3346799999999999999999999999999999999999999975432 222222111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+......+.+|+.+||+.||.+|+ |+++|+++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 01112234688999999999999994 89999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=394.71 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=200.2
Q ss_pred HhcCccccceecccCeEEEEEEEEcC------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC-
Q 007397 284 ATDNFSINNKLGEGGFGRVYKGTLVD------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG- 354 (605)
Q Consensus 284 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 354 (605)
..++|++.++||+|+||.||+|++.. ++.||||++... .....+.+.+|..++.++ +|+||+++++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34789999999999999999998632 468999999753 344556777888888777 689999999988764
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 468999999999999999965432 345889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK-RNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~-~p~~~~~~~~~~~ 500 (605)
+.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||........
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998765544444455578999999999999999999999999999999999975 56654433221
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+.. ....+.... .+.....++.+|+.+||+.||++|||+.||+++|+..
T Consensus 246 -~~~---~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 -FCR---RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -HHH---HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH---HHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 111221111 1122234688999999999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=386.34 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=197.7
Q ss_pred hcCccccceecccCeEEEEEEEEcC----CcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD----GQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 359 (605)
.++|++.+.||+|+||+||+|++.. +..||||++... .....+.+.+|+.++++++|||||++++++. ....++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3679999999999999999998743 357899998653 4455677999999999999999999999985 467899
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFG 439 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~ 439 (605)
||||+++|+|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987543 335899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcccc
Q 007397 440 GDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLI 518 (605)
Q Consensus 440 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 518 (605)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+.. .... .+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i~----~~~~~--- 228 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE----NGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHH----TTCCC---
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHHH----cCCCC---
Confidence 3322 22334668999999999999999999999999999999998 88888765543322 2111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 519 DACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 519 d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+.+......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1222334568899999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-48 Score=386.30 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=201.1
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----e
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----E 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 356 (605)
.++|++.+.||+|+||+||+|++ .+++.||||++++. .......+.+|+.++++++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999998 46999999999753 3445667899999999999999999999987654 3
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+++++|..++... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888543 35899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCc-ccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCc
Q 007397 437 TFGGDE-IEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPW 515 (605)
Q Consensus 437 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 515 (605)
...... ........+||+.|+|||++.+..++.++|||||||++|||++|++||...+.. ..+ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~---~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVA---YQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHH---HHHHhcCCCC
Confidence 654322 222344567999999999999999999999999999999999999999754321 111 1122222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcC
Q 007397 516 QLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-SMPSVILMLGS 561 (605)
Q Consensus 516 ~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~ 561 (605)
. . .........+.+++.+||+.||++|| |++++++.|..
T Consensus 234 ~---~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P---S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G---G----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---c----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 0 11112234688999999999999999 89999888753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-47 Score=394.68 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=202.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccc---hhhHHHH---HHHHHHHHcCCCCceeeeeeeEEeCCee
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKIS---EQGLNEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 357 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 357 (605)
.++|++.++||+|+||+||+|++. +|+.||||++.+.. ......+ .+|+.+++.++|||||++++++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999985 58999999986421 1222333 3457788888999999999999999999
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
++||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998654 35789999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 438 FGGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 438 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
+.... .....||+.|+|||++.. ..|+.++|||||||+||||++|+.||............... . . ...
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~-~-~~~- 226 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-T-MAV- 226 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---S-S-CCC-
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c-c-CCC-
Confidence 65432 344679999999999975 56899999999999999999999999876554433222211 0 0 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPS-----MPSVILM 558 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 558 (605)
..+......+.+|+.+||+.||++||| ++|++++
T Consensus 227 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111122346889999999999999999 6888764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=383.47 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=198.5
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-CeeEEEEEee
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 364 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 364 (605)
++|++.++||+|+||.||+|++ .|+.||||++++. ...+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688899999999999999998 5789999999753 3457799999999999999999999998664 5679999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996542 235899999999999999999999998 999999999999999999999999999865332
Q ss_pred ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccccc
Q 007397 445 GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACYQ 523 (605)
Q Consensus 445 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~~ 523 (605)
.....+|+.|+|||++.+..++.++|||||||++|||++ |++|+...+..+. +... ..+. .
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~~~---------~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGY---------K 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTTC---------C
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcCC---------C
Confidence 334568999999999999999999999999999999998 6777765433322 2111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 524 ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 524 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.+.....++.+|+.+||+.||++||||.+|+++|+..
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 122233345688999999999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=385.73 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=197.4
Q ss_pred cCccccceecccCeEEEEEEEEcC--C--cEEEEEEcccc---chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD--G--QEIAVKRLSKI---SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++|++.++||+|+||.||+|++.. + ..||||++.+. .....+.+.+|+.++++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998632 2 37899998753 34456789999999999999999999999965 4678
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
+||||++++++.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876543 35899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccc-cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 439 GGDEIEG-STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 439 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
....... ......|++.|+|||++.+..++.++|||||||++|||++ |..||...+..+ .+. .....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~---~i~~~~~~~- 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH---KIDKEGERL- 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTSCCCC-
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHH---HHHhCCCCC-
Confidence 5443222 2334568889999999999999999999999999999998 899986543322 111 111222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 517 LIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 517 l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
+.+......+.+|+.+||+.||++||||.+|+++|..
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1122233568899999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=390.97 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=211.4
Q ss_pred hcCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 356 (605)
.++|++.++||+|+||.||+|++. .++.||||+++.. .......+.+|+.+++++ +|||||++++++.++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367899999999999999999862 3578999999753 344566789999999999 69999999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcC---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 357 KLLIYEFMPNKSLDYFIFDQT---------------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
.++||||+++|+|..++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986543 2335889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+|+...+..+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998765444444455789999999999999999999999999999999999 555554433322211
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
.+ ...+. ....+......+.+|+.+||+.||++||||.+|+++|+.
T Consensus 259 ~~------i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 259 KM------IKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HH------HHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH------HhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 11111 111122234568899999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-47 Score=380.28 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=205.6
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccc---------hhhHHHHHHHHHHHHcCC-CCceeeeeeeEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKIS---------EQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQ 353 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 353 (605)
.++|++.+.||+|+||+||+|++ .+++.||||++.+.. ....+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 468999999986532 123346889999999997 9999999999999
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
++..++||||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999643 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHH
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATD------GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWN 507 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~ 507 (605)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.... .....
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~~~i~- 228 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIM- 228 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---HHHHH-
Confidence 998875432 2344679999999999863 3578899999999999999999999976543221 11111
Q ss_pred hhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 508 LWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 508 ~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+... ...........++.+|+.+||+.+|++|||+.||+++
T Consensus 229 ---~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 ---SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11110 0111112334568899999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=387.95 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=209.1
Q ss_pred hcCccccceecccCeEEEEEEEEcC--------CcEEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQG 354 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 354 (605)
.++|++.++||+|+||.||+|+... +..||||++++. ......++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3689999999999999999998633 247999999764 345567888999999888 799999999999999
Q ss_pred CeeEEEEEeeCCCchhhHHhhcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEE
Q 007397 355 EEKLLIYEFMPNKSLDYFIFDQTK-------------RELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLL 421 (605)
Q Consensus 355 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll 421 (605)
...++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCchh
Q 007397 422 DHDMNPKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVS-GKRNRGLYNSDNKFN 500 (605)
Q Consensus 422 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 500 (605)
+.++.+||+|||+++...............||+.|+|||.+.+..|+.++||||||||+|||++ |.+||...+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999998765544444556779999999999999999999999999999999998 688876443221
Q ss_pred HHHHHHHhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+..+... ..+.....++.+|+.+||+.+|++|||+.||+++|+.+
T Consensus 246 ----~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 ----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11222222211 11222345688999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=386.46 Aligned_cols=258 Identities=24% Similarity=0.267 Sum_probs=197.2
Q ss_pred ccceecccCeEEEEEEEEc-CCcEEEEEEccccchh-----hHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 290 INNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQ-----GLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 290 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4589999999999999984 5899999999653221 234688999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99988776652 3445888999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccc---
Q 007397 444 EGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLID--- 519 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d--- 519 (605)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......+ .+................+
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 2334679999999999875 468999999999999999999999997654322 2222222111100000000
Q ss_pred ---cc---ccCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 520 ---AC---YQESCN-----PDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 520 ---~~---~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .....+ ......+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000011 1123568899999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=388.93 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=206.2
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
.++|++.++||+|+||+||+|.+. +++.||||++.... .....+.+|+.+|++++|||||++++++.++...|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999985 58899999997643 3345688999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC--CceEEeecCCCccCCCC
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD--MNPKISDFGLARTFGGD 441 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~--~~vkl~DFGla~~~~~~ 441 (605)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998543 235899999999999999999999998 9999999999999854 48999999999876443
Q ss_pred cccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccccccc
Q 007397 442 EIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDAC 521 (605)
Q Consensus 442 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~ 521 (605)
. ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+ .+..... ... . ++..
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~----~~~-~-~~~~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMN----AEY-T-FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH----TCC-C-CCHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CCC-C-CChh
Confidence 2 2334678999999999999999999999999999999999999997654322 1111111 110 0 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 522 YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 522 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ...++.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 23457899999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=386.32 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=211.9
Q ss_pred cCccccceecccCeEEEEEEEEc------CCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV------DGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 358 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 358 (605)
++|++.++||+|+||+||+|.+. +++.||||++++. .......+.+|+.++++++|||||++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67899999999999999999873 2578999999753 4455567899999999999999999999999999999
Q ss_pred EEEEeeCCCchhhHHhhcC-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEee
Q 007397 359 LIYEFMPNKSLDYFIFDQT-------KRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISD 431 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~D 431 (605)
+||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+||||+.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999885432 2235789999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCchhHHHHHHHhhh
Q 007397 432 FGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGK-RNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 432 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
||+|+...............||+.|+|||.+.+..++.++||||||+++|||++|. +|+...+. ...+... .
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i----~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV----M 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH----H
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----H
Confidence 99998765444444445567899999999999999999999999999999999985 56644322 1122211 1
Q ss_pred cCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 511 KGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 511 ~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.+.... .+......+.+|+.+||+.+|++||||.+|+++|+..
T Consensus 250 ~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222111 1222335688999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=388.46 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=203.1
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc---chhhHHHHHHHHHHHH-cCCCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI---SEQGLNELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.++||+|+||+||+|++. +++.||||++.+. .....+.+..|..++. .++|||||++++++.++...++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999985 5899999999753 2334556667777665 68999999999999999999999
Q ss_pred EEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCC
Q 007397 361 YEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGG 440 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~ 440 (605)
|||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999998653 34789999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccc
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDA 520 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~ 520 (605)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ....... .+.+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~----~~~~------ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIR----MDNP------ 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCC------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCCC------
Confidence 32 2234467999999999999999999999999999999999999999754432 2222111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 007397 521 CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP-SVIL 557 (605)
Q Consensus 521 ~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 557 (605)
..+......+.+|+.+||+.||++||++. +|++
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112234588999999999999999996 7764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=386.44 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=199.3
Q ss_pred hcCccccc-eecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHc-CCCCceeeeeeeEEe----CCee
Q 007397 285 TDNFSINN-KLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 357 (605)
Q Consensus 285 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 357 (605)
.++|.+.+ .||+|+||+||+|++ .+++.||||++++. ..+.+|+.++.+ ++|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999998 55899999999642 456789988655 589999999999875 4668
Q ss_pred EEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecCC
Q 007397 358 LLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGL 434 (605)
Q Consensus 358 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFGl 434 (605)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 346899999999999999999999998 999999999999986 46799999999
Q ss_pred CccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 435 ARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 435 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
|+...... ......||+.|+|||++.+..|+.++|||||||+||+|++|+.||...+.......+. ........
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY 234 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCCC
Confidence 98765433 2345679999999999999999999999999999999999999997654333221111 00000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.+..........++.+|+.+||+.||++|||+.|++++
T Consensus 235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111112334678899999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=380.84 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=203.6
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|+++++||+|+||+||+|++ .+++.||||++... .....+.+.+|+.++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999998 55899999999643 23345778999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
|+.++.+...... ....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9987655544322 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCC---Ccccc
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGM---PWQLI 518 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~---~~~l~ 518 (605)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+ .+........... .....
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 2234467999999999887665 5889999999999999999999997544322 2221111111100 00000
Q ss_pred ---cc--cccC--C-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcCC
Q 007397 519 ---DA--CYQE--S-----CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM--LGSD 562 (605)
Q Consensus 519 ---d~--~~~~--~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~~ 562 (605)
+. .... . ........+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 0000 0 001223567889999999999999999999986 5443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=385.58 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=203.7
Q ss_pred cCccccceecccCeEEEEEEEEcC-Cc--EEEEEEcccc-chhhHHHHHHHHHHHHcC-CCCceeeeeeeEEeCCeeEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVD-GQ--EIAVKRLSKI-SEQGLNELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 360 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 360 (605)
++|++.++||+|+||+||+|++.+ +. .||||++... .....+.+.+|+.+|+++ +|||||++++++.++...++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678999999999999999999854 43 5788887543 344566899999999999 799999999999999999999
Q ss_pred EEeeCCCchhhHHhhc-------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCce
Q 007397 361 YEFMPNKSLDYFIFDQ-------------TKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNP 427 (605)
Q Consensus 361 ~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~v 427 (605)
|||+++|+|.+++... .....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23457899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCC-CCCCCCCCCchhHHHHHH
Q 007397 428 KISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKR-NRGLYNSDNKFNVIRHAW 506 (605)
Q Consensus 428 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~-p~~~~~~~~~~~~i~~~~ 506 (605)
||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||...+. .....
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~--- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE--- 237 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH---
Confidence 99999999865322 22234568999999999999999999999999999999999765 5543321 11111
Q ss_pred HhhhcCCCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 507 NLWNKGMPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 507 ~~~~~~~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
....+.. .+.+.....++.+|+.+||+.||++||||++|++.|+..
T Consensus 238 -~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 238 -KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp -HGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 112223345788999999999999999999999998775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=378.71 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred cceecccCeEEEEEEEEcCC----cEEEEEEccc-cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-CeeEEEEEee
Q 007397 291 NNKLGEGGFGRVYKGTLVDG----QEIAVKRLSK-ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 364 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 364 (605)
.++||+|+||+||+|++.++ ..||||++++ ......+.+.+|+.++++++|||||++++++... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 3689999975 3556678899999999999999999999998764 5789999999
Q ss_pred CCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCccc
Q 007397 365 PNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEIE 444 (605)
Q Consensus 365 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~~ 444 (605)
++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988543 335778899999999999999999998 999999999999999999999999999876543322
Q ss_pred c--cccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcccccccc
Q 007397 445 G--STNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQLIDACY 522 (605)
Q Consensus 445 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~d~~~ 522 (605)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||....... ...... ..+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~~------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRRL------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCC-------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCCCC-------
Confidence 1 2234568999999999999999999999999999999999888776433211 111111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 523 QESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 523 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
..+......+.+|+.+||+.||++||+|.||+++|+..
T Consensus 254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122234688999999999999999999999999776
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=375.96 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----eeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 361 (605)
+.|.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+.+++|||||++++++.... ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5688889999999999999986 689999999964322 2222334666667889999999999998654 578999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
||+++|+|..++.+. .+++..++.++.|++.||.|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999643 4889999999999999999999741 2349999999999999999999999999998
Q ss_pred cCCCCc--ccccccccccccCccchhcccCCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCch--------h
Q 007397 437 TFGGDE--IEGSTNKVIGTYGYMAPEYATDGL------FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF--------N 500 (605)
Q Consensus 437 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~ 500 (605)
...... .........||+.|+|||++.+.. ++.++|||||||+||||++|..|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 764322 122334567999999999987643 678999999999999999999887543322110 0
Q ss_pred HHHHHHHhhhcCCCccccccccc-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 501 VIRHAWNLWNKGMPWQLIDACYQ-ESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 501 ~i~~~~~~~~~~~~~~l~d~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
.............. .+.+. ...+.+....+.+|+.+||+.||++||||.||+++|+..
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111111111 11110 111234556788999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-46 Score=377.23 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=203.1
Q ss_pred cCccccceecccCeEEEEEEEEcCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 363 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 363 (605)
++|+++++||+|+||+||+|++.+|+.||||++... .....+.+.+|+.++++++|||||++++++...+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999653 333467889999999999999999999999999999999999
Q ss_pred eCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCcc
Q 007397 364 MPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDEI 443 (605)
Q Consensus 364 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~~ 443 (605)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 99887777763 3356999999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCccc-----
Q 007397 444 EGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQL----- 517 (605)
Q Consensus 444 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l----- 517 (605)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.. ..+...............
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence 23345689999999998764 5699999999999999999999999754322 222222111111000000
Q ss_pred ----------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 518 ----------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 518 ----------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
................+.+|+.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011112233568899999999999999999999853
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=377.57 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=198.3
Q ss_pred hcCccccceecccCeEEEEEEEEc-C-CcEEEEEEcccc--chhhHHHHHHHHHHHHcC---CCCceeeeeeeEEe----
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-D-GQEIAVKRLSKI--SEQGLNELKNEVILFSKL---QHRNLVKLLGCCIQ---- 353 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 353 (605)
.++|+++++||+|+||+||+|++. + ++.||||++... .......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999984 4 567999998642 222233455677766655 89999999999863
Q ss_pred -CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeec
Q 007397 354 -GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDF 432 (605)
Q Consensus 354 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DF 432 (605)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346789999999988765543 23445889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 433 GLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 433 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|++||...+..+. +..........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCC
Confidence 999865432 234457899999999999999999999999999999999999999976543222 22222111110
Q ss_pred CCcc------ccccc-------ccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQ------LIDAC-------YQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~------l~d~~-------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ..... ............+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 0001112233467889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=374.45 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=195.6
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccch------hhHHHHHHHHHHHHcCC--CCceeeeeeeEEeCC
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISE------QGLNELKNEVILFSKLQ--HRNLVKLLGCCIQGE 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 355 (605)
.++|++.++||+|+||+||+|++ .+|+.||||++.+... .....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999998 4589999999864211 12234668999999986 899999999999999
Q ss_pred eeEEEEEeeCC-CchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCC-CceEEeecC
Q 007397 356 EKLLIYEFMPN-KSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHD-MNPKISDFG 433 (605)
Q Consensus 356 ~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~-~~vkl~DFG 433 (605)
..++||||+.+ +++..++... ..+++..++.++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5676776443 35899999999999999999999998 9999999999999855 799999999
Q ss_pred CCccCCCCcccccccccccccCccchhcccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 434 LARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLF-SVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 434 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+. . .
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~------~-~ 219 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII------R-G 219 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH------H-C
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh------h-c
Confidence 99875432 2334679999999999987665 677999999999999999999996421 111 0 1
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.. .+.... ..++.+|+.+||+.||++|||+.|++++
T Consensus 220 ~~------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 10 011122 3468899999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=371.82 Aligned_cols=269 Identities=20% Similarity=0.265 Sum_probs=201.1
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe--------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ-------- 353 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 353 (605)
.++|+++++||+|+||+||+|++ .+|+.||||++... .......+.+|+.+|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999998 46999999998642 34455678899999999999999999998865
Q ss_pred CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecC
Q 007397 354 GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFG 433 (605)
Q Consensus 354 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFG 433 (605)
....++||||+.++.+.... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999988776554 23345888999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCccc--ccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhh
Q 007397 434 LARTFGGDEIE--GSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWN 510 (605)
Q Consensus 434 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~ 510 (605)
+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876543222 222345799999999998765 689999999999999999999999976443332222222211111
Q ss_pred cCCCcccccc--------cccCCCCHH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 007397 511 KGMPWQLIDA--------CYQESCNPD-------EVIRCIHISLLCVQHHPEDRPSMPSVILML 559 (605)
Q Consensus 511 ~~~~~~l~d~--------~~~~~~~~~-------~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 559 (605)
.......... ......... ....+++|+.+||+.||++|||++|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 1110000000 000011111 123567899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=374.67 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=197.9
Q ss_pred CccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC------CeeEE
Q 007397 287 NFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 359 (605)
Q Consensus 287 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 359 (605)
+|+..++||+|+||+||+|++. +|+.||||++.+... ...+|+.+|++++|+||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999985 589999999975332 234799999999999999999998643 34689
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccC
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTF 438 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~ 438 (605)
||||++++.+..+.........+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999988766555443344557899999999999999999999998 99999999999999875 8999999999876
Q ss_pred CCCcccccccccccccCccchhcccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHH--------HHhh
Q 007397 439 GGDEIEGSTNKVIGTYGYMAPEYATD-GLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHA--------WNLW 509 (605)
Q Consensus 439 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~--------~~~~ 509 (605)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|++||......+....+... +...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 54332 334679999999998875 56899999999999999999999999765432222211110 0000
Q ss_pred hcC----CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKG----MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~----~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
... .....................+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000000001111122334568899999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=366.22 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=198.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc-chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC----eeE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI-SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE----EKL 358 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 358 (605)
+++|+++++||+|+||+||+|.+ .+|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999987 56999999999753 3445677899999999999999999999987653 335
Q ss_pred EEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccC
Q 007397 359 LIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTF 438 (605)
Q Consensus 359 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~ 438 (605)
++++|+.+++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999998542 4899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccchhccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCCcc
Q 007397 439 GGDEIE-GSTNKVIGTYGYMAPEYAT-DGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMPWQ 516 (605)
Q Consensus 439 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 516 (605)
...... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||......+..... ...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhh
Confidence 443222 2234567999999999985 456799999999999999999999999754432211111 11110000000
Q ss_pred --------cccc--cc--cCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 517 --------LIDA--CY--QESC-----NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 517 --------l~d~--~~--~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... .. .... .+....++.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00 0000 01112357899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=371.75 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=196.8
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccc--cchhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCC------
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSK--ISEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGE------ 355 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 355 (605)
.++|+++++||+|+||+||+|++. +|+.||||++.+ ......+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 368999999999999999999984 599999999975 34455678899999999999999999999997654
Q ss_pred eeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCC
Q 007397 356 EKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLA 435 (605)
Q Consensus 356 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla 435 (605)
..++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5567666532 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHh-----h
Q 007397 436 RTFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNL-----W 509 (605)
Q Consensus 436 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~-----~ 509 (605)
+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|++||...+.......+...... +
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876432 3446799999999998764 5789999999999999999999999765432221111111000 0
Q ss_pred hcCCC----------cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hcCC
Q 007397 510 NKGMP----------WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM--LGSD 562 (605)
Q Consensus 510 ~~~~~----------~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~~ 562 (605)
..... .......+ ..........+.+|+.+||+.||++|||+.|++++ ++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000 00000000 01111223457789999999999999999999986 5543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=359.91 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=197.5
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCcee-eeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++ .+|+.||||++.... ...++..|+.++++++|+|++ .+..++.++...++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 36799999999999999999998 458999999876532 234578899999999877655 55566678888999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC---CCceEEeecCCCccCC
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH---DMNPKISDFGLARTFG 439 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~---~~~vkl~DFGla~~~~ 439 (605)
|+.+ +|...+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9955 454444332 345899999999999999999999998 999999999999864 4579999999999874
Q ss_pred CCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 440 GDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 440 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 33211 2234567999999999999999999999999999999999999999876655544433322221111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcCC
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGSD 562 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~~ 562 (605)
+.+...+ +.++.+++..||+.+|++||+++++.+.|+..
T Consensus 238 -----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111122 24578899999999999999999998888653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-43 Score=357.04 Aligned_cols=260 Identities=14% Similarity=0.185 Sum_probs=207.6
Q ss_pred hcCccccceecccCeEEEEEEEEc-CCcEEEEEEccccchhhHHHHHHHHHHHHcCCC-CceeeeeeeEEeCCeeEEEEE
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKISEQGLNELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 362 (605)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+++|+.+++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999985 58999999886432 23456788999999975 899999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcC-----CCceEEeecCCCcc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDH-----DMNPKISDFGLART 437 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~-----~~~vkl~DFGla~~ 437 (605)
|+ +++|.+++.... ..++...+..++.|++.||.|||+++ |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 688888875433 35899999999999999999999998 999999999999974 57899999999987
Q ss_pred CCCCccc-----ccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcC
Q 007397 438 FGGDEIE-----GSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKG 512 (605)
Q Consensus 438 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~ 512 (605)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6432211 22345679999999999999999999999999999999999999998766655544443322221111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcC
Q 007397 513 MPWQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILMLGS 561 (605)
Q Consensus 513 ~~~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 561 (605)
...+ +...++ .++.+++..|++.+|++||+++.+.+.|+.
T Consensus 236 ~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 111222 457889999999999999999998887754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=355.50 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=205.9
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeCCeeEEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 362 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 362 (605)
++|+++++||+|+||+||+|++ .+++.||||+++.. .......+.+|+.++++++|+||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999998 45899999998642 34457789999999999999999999999999999999999
Q ss_pred eeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCccCCCCc
Q 007397 363 FMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLARTFGGDE 442 (605)
Q Consensus 363 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~~~~~~ 442 (605)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999887743 345789999999999999999999998 9999999999999999999999999998865432
Q ss_pred ccccccccccccCccchhcccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC---c---
Q 007397 443 IEGSTNKVIGTYGYMAPEYATDGL-FSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP---W--- 515 (605)
Q Consensus 443 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~---~--- 515 (605)
. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.... .....+............ .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 223345788999999987665 6899999999999999999999975322 222222222221111100 0
Q ss_pred cccc---------ccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 516 QLID---------ACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 516 ~l~d---------~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...+ ..............+.+|+.+||+.||++|||++||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000111222334567889999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=360.51 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=206.5
Q ss_pred cCccccceecccCeEEEEEEEEc----CCcEEEEEEcccc----chhhHHHHHHHHHHHHcCCC-CceeeeeeeEEeCCe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV----DGQEIAVKRLSKI----SEQGLNELKNEVILFSKLQH-RNLVKLLGCCIQGEE 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 356 (605)
++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998652 22345668899999999976 899999999999999
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.+++|||+.+++|..++.... .+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999985543 4678889999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCcccccccccccccCccchhcccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhhhcCCC
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDG--LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLWNKGMP 514 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 514 (605)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--- 253 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--- 253 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC---
Confidence 76543322 23446799999999999754 4688999999999999999999999877666655554433221111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 007397 515 WQLIDACYQESCNPDEVIRCIHISLLCVQHHPEDRP-----SMPSVILM 558 (605)
Q Consensus 515 ~~l~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 558 (605)
..+.....++.+|+.+||+.||++|| |++|++++
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11223345788999999999999999 47888863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-43 Score=359.10 Aligned_cols=258 Identities=17% Similarity=0.284 Sum_probs=197.9
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeC--CeeEEEE
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 361 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 361 (605)
++|+++++||+|+||+||+|++ .+++.||||++++.. .+.+.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999998 458999999997533 457889999999995 99999999999753 5689999
Q ss_pred EeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCC-ceEEeecCCCccCCC
Q 007397 362 EFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDM-NPKISDFGLARTFGG 440 (605)
Q Consensus 362 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~-~vkl~DFGla~~~~~ 440 (605)
||+.+++|..+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24899999999999999999999999 99999999999998765 699999999987654
Q ss_pred CcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCch-hHHHHH---------HHhh
Q 007397 441 DEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKF-NVIRHA---------WNLW 509 (605)
Q Consensus 441 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~-~~i~~~---------~~~~ 509 (605)
.. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+... ....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 23446789999999998765 4799999999999999999999998764432111 001100 0000
Q ss_pred hcCCCccc-----------ccccccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 510 NKGMPWQL-----------IDACYQESCNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 510 ~~~~~~~l-----------~d~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
........ ...............++.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00011111112233567899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=362.20 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=192.8
Q ss_pred cCccccceecccCeEEEEEEEEc-CCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEe------CCe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTLV-DGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 356 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 356 (605)
++|+++++||+|+||+||+|.+. +|+.||||++.+. .......+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999985 5999999999743 34455678899999999999999999999964 367
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.++||||+.++.+..+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665442 24789999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHH-----Hhhh-
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAW-----NLWN- 510 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~-----~~~~- 510 (605)
...... ......||+.|+|||++.+..++.++||||+||++++|++|+.||...+.......+.... ..+.
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 764332 2345679999999999999999999999999999999999999997544221111111000 0000
Q ss_pred ---------cCCC-------cccccccccCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 511 ---------KGMP-------WQLIDACYQES---CNPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 511 ---------~~~~-------~~l~d~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
.... ..+........ ........+.+|+.+||+.||++|||++||+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00010011111 122345678899999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=363.04 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred hcCccccceecccCeEEEEEEEE-cCCcEEEEEEcccc--chhhHHHHHHHHHHHHcCCCCceeeeeeeEEeC-----Ce
Q 007397 285 TDNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKI--SEQGLNELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 356 (605)
Q Consensus 285 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 356 (605)
.++|+++++||+|+||+||+|++ .+|+.||||++.+. .....+.+.+|+.+|++++|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999998 46999999999753 344556788999999999999999999998643 34
Q ss_pred eEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEEeecCCCc
Q 007397 357 KLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKISDFGLAR 436 (605)
Q Consensus 357 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~ 436 (605)
.+++++|+.+++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999998843 35899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCcccccccccccccCccchhcccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhHHHHHHHhh-----h
Q 007397 437 TFGGDEIEGSTNKVIGTYGYMAPEYATDG-LFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNVIRHAWNLW-----N 510 (605)
Q Consensus 437 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~i~~~~~~~-----~ 510 (605)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....... .
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6532 23446789999999987765 46899999999999999999999997654322222221111000 0
Q ss_pred cCCCcc---ccccccc-CCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 007397 511 KGMPWQ---LIDACYQ-ESC-----NPDEVIRCIHISLLCVQHHPEDRPSMPSVILM 558 (605)
Q Consensus 511 ~~~~~~---l~d~~~~-~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 558 (605)
...... ....... ... .......+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000 0000000 000 01123457899999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-38 Score=328.20 Aligned_cols=264 Identities=19% Similarity=0.209 Sum_probs=196.2
Q ss_pred cCccccceecccCeEEEEEEEE-cCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-----------CCceeeeeeeEEe
Q 007397 286 DNFSINNKLGEGGFGRVYKGTL-VDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 353 (605)
Q Consensus 286 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 353 (605)
.+|+++++||+|+||+||+|++ .+|+.||||++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999998 46999999999763 234567788999888875 5789999988764
Q ss_pred --CCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCEEEcCCCc----
Q 007397 354 --GEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKTSNVLLDHDMN---- 426 (605)
Q Consensus 354 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiHrDlkp~NIll~~~~~---- 426 (605)
....+++++++.................+++..+..++.||++||.|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35667788877666555544445555678999999999999999999998 66 999999999999987654
Q ss_pred --eEEeecCCCccCCCCcccccccccccccCccchhcccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCchhH---
Q 007397 427 --PKISDFGLARTFGGDEIEGSTNKVIGTYGYMAPEYATDGLFSVKSDVFSFGILVLEIVSGKRNRGLYNSDNKFNV--- 501 (605)
Q Consensus 427 --vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvvl~elltG~~p~~~~~~~~~~~~--- 501 (605)
+||+|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||...........
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999986532 23446799999999999999999999999999999999999999976543222111
Q ss_pred HHHHHHhhhc------------------CCCcccccc----------cccCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 007397 502 IRHAWNLWNK------------------GMPWQLIDA----------CYQESCNPDEVIRCIHISLLCVQHHPEDRPSMP 553 (605)
Q Consensus 502 i~~~~~~~~~------------------~~~~~l~d~----------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 553 (605)
+......+.. ......+.. .............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111100 000000000 011234566778899999999999999999999
Q ss_pred HHHHH
Q 007397 554 SVILM 558 (605)
Q Consensus 554 evl~~ 558 (605)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6e-24 Score=199.34 Aligned_cols=164 Identities=19% Similarity=0.159 Sum_probs=122.2
Q ss_pred ccccceecccCeEEEEEEEEcCCcEEEEEEccccc------------------hhhHHHHHHHHHHHHcCCCCceeeeee
Q 007397 288 FSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKIS------------------EQGLNELKNEVILFSKLQHRNLVKLLG 349 (605)
Q Consensus 288 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 349 (605)
+.+.++||+|+||+||+|++.+|+.||||+++... .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35679999999999999999899999999865210 111233456888999999999998876
Q ss_pred eEEeCCeeEEEEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCEEEcCCCceEE
Q 007397 350 CCIQGEEKLLIYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKTSNVLLDHDMNPKI 429 (605)
Q Consensus 350 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiHrDlkp~NIll~~~~~vkl 429 (605)
+. ..+++|||+++..+.. ++...+..++.||+++|.|||+++ |+||||||+|||+++++ ++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 53 2379999999876543 233445678999999999999998 99999999999999654 899
Q ss_pred eecCCCccCCCCcccccccccccccCccch------hcccCCCCCcccchHHHHHHH
Q 007397 430 SDFGLARTFGGDEIEGSTNKVIGTYGYMAP------EYATDGLFSVKSDVFSFGILV 480 (605)
Q Consensus 430 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~k~DvwSlGvvl 480 (605)
+|||+|.....+... .|+.. |.+ ...|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999775433211 11111 111 35678999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.7e-07 Score=90.00 Aligned_cols=148 Identities=15% Similarity=0.083 Sum_probs=102.3
Q ss_pred HHHHhcCccccceecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCC-CCceeeeeeeEEeCCeeEE
Q 007397 281 IANATDNFSINNKLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 281 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 359 (605)
+......|++.+..+.++.+.||+... +++.+++|+...........+.+|+..++.+. +--+.+++.+...++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344456777766655555678998764 56778899886654444556778888887764 3346677888888888999
Q ss_pred EEEeeCCCchhhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 007397 360 IYEFMPNKSLDYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQDS---------------------------------- 405 (605)
Q Consensus 360 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------- 405 (605)
||+++++.++....... .....++.++++.+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886544211 112234555566666666431
Q ss_pred ----------------------CCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 406 ----------------------RLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 406 ----------------------~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01379999999999999877778999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.3e-05 Score=75.94 Aligned_cols=131 Identities=18% Similarity=0.144 Sum_probs=85.5
Q ss_pred eecccCe-EEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCC--CceeeeeeeEEeCCeeEEEEEeeCCCch
Q 007397 293 KLGEGGF-GRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 293 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~~L 369 (605)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..++...++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 689999887788889998754322 345677777776642 3356778877888889999999998776
Q ss_pred hhHHhhcCccCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 007397 370 DYFIFDQTKRELLDWSKRFHIICGTARGLLYLHQ---------------------------------------------- 403 (605)
Q Consensus 370 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------------- 403 (605)
.... .... .++.++++.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 0100 111222233333332
Q ss_pred -----C----CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 404 -----D----SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 404 -----~----~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
. ....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112379999999999999887788999987743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00021 Score=72.07 Aligned_cols=77 Identities=10% Similarity=0.167 Sum_probs=48.7
Q ss_pred cceecccCeEEEEEEEEcC-CcEEEEEEcccc-------chhhHHHHHHHHHHHHcCC-C--CceeeeeeeEEeCCeeEE
Q 007397 291 NNKLGEGGFGRVYKGTLVD-GQEIAVKRLSKI-------SEQGLNELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLL 359 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 359 (605)
.+.||.|....||+....+ ++.++||.-... -....+....|+..|+.+. + ..+.+++. .+.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 4679999999999998755 678999964321 1112334556777776653 2 33445543 35667789
Q ss_pred EEEeeCCCch
Q 007397 360 IYEFMPNKSL 369 (605)
Q Consensus 360 v~e~~~~~~L 369 (605)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.0013 Score=64.17 Aligned_cols=70 Identities=11% Similarity=0.059 Sum_probs=46.3
Q ss_pred eEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce--eeee-----eeEEeCCeeEEEEEeeCCCch
Q 007397 299 FGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL--VKLL-----GCCIQGEEKLLIYEFMPNKSL 369 (605)
Q Consensus 299 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~~~L 369 (605)
--.||+++..+|+.+++|+.+.. ....+++..|...+..|....+ +..+ ..+......+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 35899999999999999998643 2234667778888877742222 1111 123345667889999887543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.39 E-value=0.0026 Score=63.76 Aligned_cols=73 Identities=19% Similarity=0.308 Sum_probs=49.6
Q ss_pred cceecccCeEEEEEEEEcC--------CcEEEEEEccccchhhHHHHHHHHHHHHcCCCCce-eeeeeeEEeCCeeEEEE
Q 007397 291 NNKLGEGGFGRVYKGTLVD--------GQEIAVKRLSKISEQGLNELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIY 361 (605)
Q Consensus 291 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 361 (605)
++.|+.|---.+|++...+ .+.|++++.... .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3688999999999998754 346777666532 223345678888888853344 466666532 6899
Q ss_pred EeeCCCch
Q 007397 362 EFMPNKSL 369 (605)
Q Consensus 362 e~~~~~~L 369 (605)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.97 E-value=0.029 Score=53.64 Aligned_cols=157 Identities=15% Similarity=0.049 Sum_probs=79.8
Q ss_pred HHHHHHHhcCccccc-----eecccCeEEEEEEEEcCCcEEEEEEccccchhhHHHHHHHHHHHHcCCCCc-----eeee
Q 007397 278 LATIANATDNFSINN-----KLGEGGFGRVYKGTLVDGQEIAVKRLSKISEQGLNELKNEVILFSKLQHRN-----LVKL 347 (605)
Q Consensus 278 ~~~~~~~~~~y~~~~-----~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l 347 (605)
..++.....+|.+.+ .|..|---+.|+.+..+| .+++|+..+.. ..+++..|+.++..|...+ .+..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 344555566776643 345666688899887655 58999986531 2234555666666663222 2111
Q ss_pred e---eeEEeCCeeEEEEEeeCCCchhhH--------------Hhhc------CccCCCCH------------------HH
Q 007397 348 L---GCCIQGEEKLLIYEFMPNKSLDYF--------------IFDQ------TKRELLDW------------------SK 386 (605)
Q Consensus 348 ~---~~~~~~~~~~lv~e~~~~~~L~~~--------------l~~~------~~~~~l~~------------------~~ 386 (605)
. .+.........++.++.+...... +... ........ ..
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1 012234455667777666432110 0000 00000000 01
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCCeEEecCCCCCEEEcCCCceEEeecCCCcc
Q 007397 387 RFHIICGTARGLLYLHQD-SRLRIIHRDLKTSNVLLDHDMNPKISDFGLART 437 (605)
Q Consensus 387 ~~~i~~qi~~aL~~LH~~-~~~~iiHrDlkp~NIll~~~~~vkl~DFGla~~ 437 (605)
....+..+...+...+.. -+..+||+|+.++||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222223332221 133599999999999999988788999998753
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.22 E-value=0.0082 Score=36.10 Aligned_cols=33 Identities=30% Similarity=0.675 Sum_probs=26.1
Q ss_pred CCCCccCCCCCCCcccCCC-CCCcccccCcccccC
Q 007397 116 FDHCDNYAECGANSNCRVS-ETPSCECLTGFISKS 149 (605)
Q Consensus 116 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 149 (605)
.|.|.+-+.|| +|.|+.- ..-.|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 37899999998 6888643 345899999999964
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=93.23 E-value=0.24 Score=39.72 Aligned_cols=84 Identities=10% Similarity=-0.005 Sum_probs=46.4
Q ss_pred eeEEecCCCCCC--------------CCCceEEeecCCC--------ceEEeecCCCCceeec-ccccccccceEEEEEc
Q 007397 13 RYLTPWRSADDP--------------TPGDVSFRLDNST--------AKHARSGPWNGQTFEG-IPWMKDSVFKLIVEHK 69 (605)
Q Consensus 13 ~~L~Swks~~Dp--------------s~G~~s~~~~~~~--------~~~~rsg~w~g~~f~~-~p~~~~~~~~~~~~~n 69 (605)
..|-||-+.++| +.|.|+|.|..+| .++|.++..+. ..+ ...+.. .=.+.+.+.
T Consensus 2 ~~~~s~~~~~~~~~~l~~~q~l~~~~~~~~y~l~mQ~DGNLVLy~~~~~vWssnt~~~--~~~~~l~l~~-dGnLvL~d~ 78 (119)
T d1b2pa_ 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGL--GNGCRAVLQP-DGVLVVITN 78 (119)
T ss_dssp CEEECSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCEEEEETTEEEEECCCTTS--CSSCEEEECT-TSCEEEECT
T ss_pred CEEEeeecCCCCCCEEeCCCeEEEecCCceEEEEECCCCcEEEEECCeEEEEecCCCC--CcceEEEEEe-CCCEEEECC
Confidence 346666666666 5799999999888 44555444211 000 011111 111333334
Q ss_pred CceeEEEEeecCCCeeeEEEEccCCcEEEE
Q 007397 70 EDEVYYKFKPINDTVTTRLQLENNGTYHRF 99 (605)
Q Consensus 70 ~~e~~~~~~~~~~s~~~r~~l~~~G~~~~~ 99 (605)
.................+++|+.||++.+|
T Consensus 79 ~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlY 108 (119)
T d1b2pa_ 79 ENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp TCCEEEECSCCCCSSCEEEEECTTSCEEEE
T ss_pred CCcEEEECCCcCCCCceEEEEcCCCCEEEE
Confidence 444444333333334568999999999998
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=87.11 E-value=1.1 Score=35.11 Aligned_cols=84 Identities=12% Similarity=0.097 Sum_probs=44.2
Q ss_pred CceEEeecCCC--------ceEEeecCCCCceeecc-cccccccceEEEEEcCceeEEEEeecCCCeeeEEEEccCCcEE
Q 007397 27 GDVSFRLDNST--------AKHARSGPWNGQTFEGI-PWMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYH 97 (605)
Q Consensus 27 G~~s~~~~~~~--------~~~~rsg~w~g~~f~~~-p~~~~~~~~~~~~~n~~e~~~~~~~~~~s~~~r~~l~~~G~~~ 97 (605)
|.|.|.|..+| .++|.++.-+.. .+. -.++... .+...+ .....+.......+...+++|..||++.
T Consensus 19 g~~~l~~q~DGNLvly~~~~~vW~s~~~~~~--~~~~l~l~~dG-nLvl~~-~~~~~w~s~t~~~~~~~~l~L~ddGNlv 94 (112)
T d1xd5a_ 19 GGYLFIIQNDCNLVLYDNNRAVWASGTNGKA--SGCVLKMQNDG-NLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVV 94 (112)
T ss_dssp TTEEEEECTTSCEEEEETTEEEEECCCTTSC--SSEEEEECTTS-CEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEE
T ss_pred CCEEEEEcCCCCEEEEcCCcEEEEccCccCC--CCcEEEEeccc-cEEEEe-cCCeEEEEeeccCCCceEEEEcCCCCEE
Confidence 99999999887 445554432210 000 0011110 122222 2333333232333345689999999999
Q ss_pred EEEEecCCcceEEeeecCCCCC
Q 007397 98 RFVWDETTSKWHKLYSWPFDHC 119 (605)
Q Consensus 98 ~~~w~~~~~~w~~~~~~~~~~C 119 (605)
+|. ......|+...+.|
T Consensus 95 ly~-----~~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 95 IYD-----NSNNAIWATHTNVG 111 (112)
T ss_dssp EEC-----TTSCEEEECCCCCC
T ss_pred EEC-----CCCcEEecCCCccC
Confidence 984 12346787776665
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=87.01 E-value=1.2 Score=35.46 Aligned_cols=74 Identities=8% Similarity=0.130 Sum_probs=38.4
Q ss_pred CCCceEEeecCCC--ceEEeecC-CCCceee-cc---cccccccceEEEEEcCceeEEEEeecCCCeeeEEEEccCCcEE
Q 007397 25 TPGDVSFRLDNST--AKHARSGP-WNGQTFE-GI---PWMKDSVFKLIVEHKEDEVYYKFKPINDTVTTRLQLENNGTYH 97 (605)
Q Consensus 25 s~G~~s~~~~~~~--~~~~rsg~-w~g~~f~-~~---p~~~~~~~~~~~~~n~~e~~~~~~~~~~s~~~r~~l~~~G~~~ 97 (605)
+.|.|+|.|+.+| ..|....+ |...... +. ..+.... ++.+.+..+++-+.-......-..+++|+.||+++
T Consensus 33 ~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~G-nLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlv 111 (120)
T d1dlpa2 33 QLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNG-RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLA 111 (120)
T ss_dssp BCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTT-EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEE
T ss_pred EcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCe-eEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEE
Confidence 6799999999888 23322111 3221111 11 1122111 23333444444443322223334589999999999
Q ss_pred EE
Q 007397 98 RF 99 (605)
Q Consensus 98 ~~ 99 (605)
+|
T Consensus 112 lY 113 (120)
T d1dlpa2 112 IY 113 (120)
T ss_dssp EE
T ss_pred Ee
Confidence 98
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.25 E-value=0.17 Score=32.24 Aligned_cols=33 Identities=24% Similarity=0.678 Sum_probs=25.1
Q ss_pred CCCCcc-CCCCCCCcccCCC-CCCcccccCccccc
Q 007397 116 FDHCDN-YAECGANSNCRVS-ETPSCECLTGFISK 148 (605)
Q Consensus 116 ~~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 148 (605)
.|+|.. ..-|..+|.|... .+-.|.|++||+..
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 367775 4689999999754 34699999999753
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.31 E-value=0.33 Score=30.26 Aligned_cols=31 Identities=32% Similarity=0.875 Sum_probs=23.8
Q ss_pred CCCccCCCCCCCcccCCC-CCCcccccCccccc
Q 007397 117 DHCDNYAECGANSNCRVS-ETPSCECLTGFISK 148 (605)
Q Consensus 117 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 148 (605)
|.|. .+-|...|.|... ..-.|.|++||+.+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4566 4779999999754 45699999999764
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.72 E-value=0.61 Score=29.68 Aligned_cols=31 Identities=26% Similarity=0.652 Sum_probs=23.7
Q ss_pred CCCCccCCCCCCCcccCCC-CCCcccccCcccc
Q 007397 116 FDHCDNYAECGANSNCRVS-ETPSCECLTGFIS 147 (605)
Q Consensus 116 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 147 (605)
.|+|... .|+.++.|... .+-.|.|++||+.
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 4789765 45678999765 3569999999976
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.28 E-value=0.36 Score=31.01 Aligned_cols=35 Identities=20% Similarity=0.428 Sum_probs=24.1
Q ss_pred CCCCccCCCCCCCcccCCC-CCCcccccCcccccCC
Q 007397 116 FDHCDNYAECGANSNCRVS-ETPSCECLTGFISKSQ 150 (605)
Q Consensus 116 ~~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~~ 150 (605)
.|+|.....+-.++.|... .+-.|.|++||+...+
T Consensus 3 idEC~~~~~~C~~~~C~Nt~Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 3 IDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFM 38 (44)
T ss_dssp CCTTTTCSSTTTTSCEEEETTEEEECCCSSEEECTT
T ss_pred ccccCCCCCCCCCCEeEcCCCCeEEeCCCCCccCCC
Confidence 3678764433357899654 3469999999987543
|